<SEC-DOCUMENT>0001628280-22-027149.txt : 20221027
<SEC-HEADER>0001628280-22-027149.hdr.sgml : 20221027
<ACCEPTANCE-DATETIME>20221027072015
ACCESSION NUMBER:		0001628280-22-027149
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221027
DATE AS OF CHANGE:		20221027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		221334902

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bax-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2,d:aef9f667721343c48067444506cf55c3--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:bax="http://www.baxter.com/20220930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bax-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml8yLTEtMS0xLTEwNDM3Mg_d6ac42d6-0a2f-4ab5-9008-5344fb84e62f">false</ix:nonNumeric><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml8zLTEtMS0xLTEwNDM3Mg_9b861277-42f5-401b-a293-4689496062ba">2022</ix:nonNumeric><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml80LTEtMS0xLTEwNDM3Mg_d7ee9062-5f3b-4633-85fe-af44e40896ed">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml81LTEtMS0xLTEwNDM3Mg_3cfe00a2-1d59-494f-b7d0-422b4da499f8">0000010456</ix:nonNumeric><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml82LTEtMS0xLTEwNDM3Mg_e9428987-8bc8-483a-b128-00052f5b57ed">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i39edd3b053b44656ba6ef1db52a30967_D20220101-20220930" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE4NA_4b48d30d-ec79-4a92-a7cd-7e8e20511e7a">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i4f552247b7024defa099434103c396e8_D20220101-20220930" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3MQ_ecb681a4-8097-4734-b0f9-9c8160b702fe">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="icbf3c6c583244c2fab2e8204429785e0_I20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfNC0xLTEtMS0xMDQzNzI_a8bce7e7-7631-41a7-be44-fbd7caaf20e5">3</ix:nonNumeric><ix:nonNumeric contextRef="i5e89a0afa4d441e69b487b51d995257f_I20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfOC0xLTEtMS0xMDQzNzI_b0a3db66-2c93-49b6-be60-7c8adfbeb870">1</ix:nonNumeric><ix:nonNumeric contextRef="if80d7ff3511a426c8ccbb5d590033061_I20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMTItMS0xLTEtMTA0Mzcy_c58d8b3f-d0e2-4015-a81f-8d6da27374e0">1</ix:nonNumeric><ix:nonNumeric contextRef="i70cf6c6b94e648fab5b4e530b9597a22_I20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMTYtMS0xLTEtMTA0Mzcy_47a43be4-6183-4ab8-993a-630d1589a4e6">1</ix:nonNumeric><ix:nonNumeric contextRef="i6114d388ab3d4e49b91f718263e65571_I20220930" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMjAtMS0xLTEtMTA0Mzcy_0e6370ee-0b5f-4c4a-b795-965cbbe07276"></ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bax-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39976b84175d43efbe32f5536a21818c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc165b9e144140309b5f09674a899d54_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e4d13c497514386a72aa4814ef8a1c0_I20221020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i100fa316fc12492f84183e5383c3e332_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c7f3edeed8429db78b4f553fc45026_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50bf025855184ac89338332505bcf37e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a454fa8809c487b8e3d6d81416aaf44_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a76885f3de4448b4fffc6a3b402755_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id320e76e08184ad18e0d44a027eb0e44_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc7215575114c6e9c9229e98fc5c182_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i150a460e6b5240cf942785db873b20e0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida2ec04c98ba4de6aac9364b884a768f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaafa26dc685d48499145e063e9e41701_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68bb769194c44702bc4f210eb327fd47_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5b6addca054a8c977547a71a11eb9d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46185672532c493c87739cf7e9615db2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2b2f4c215a4c959a65859e3605344e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e06fdeb2414477d921f3587f0c89a44_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0218eda155249b4a4da75408a661f78_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315357d813df434ea52bc4a2bd057649_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ebdd308c0aa480ab3f408048666bc96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725b88481fef4b7db4a008b05245cf1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb99534e9ac74a81934e5e38cb02f00f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2915afd9c994936a8dd5af0ce476706_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i701c21dcb04e48f6873a3307cf046c39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7717dccf2b6422d90b12fdb9dc4ce69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7267511ecf06427ca86cc16435200efe_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07aa4a40cec3445b9b7c2eae2471f420_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445ba8e9550344a6a0934d07c688931b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if779e104e4c64cb0b90cbb72e25d9c25_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfa5f433f3c41f4ad813f18db07aeb6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1097bf8723ad4d40980c7a8684d82542_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9566c813807f46f9bca41a6a1eab60fd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i923c5d6629ac43938dde7322bca7a94f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7adec63f56fe475aa13f80a829a783e3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i378c9497bb354eda8c5fec775c27e410_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46300513cafe40bc8da05e9ae619e87d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95cbf6e7717b42ed8cd2f03aefaa9a00_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bfaa62f2344760ae28e0bcef715667_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ce590d6794464d8f48b6882ce9967b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifebeb40172e54d468de1bba6e61fded4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27b36ac02ab451db59daf7bc158e8b3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i741c91bea17b416e8523648018b62817_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7deaf997b8b04e419ae489df558eb400_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b9bdd01dd21457c955deb29629dbb05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7bbc2059dee49748a9fb82ccedc2cc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i260874a837714dd18b6d85c063e738f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061c707fc46f4796a51c7a57108a7be4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87069b641164461ea1d9c503986a6adb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1a4f269c63413dab2f7eff8c7b4525_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b50155674434910931b52027a356924_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a04eb3f97aa454290cf5576bef8ba31_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcc9d6f153964e0d89122d5270df88f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-13</xbrli:startDate><xbrli:endDate>2021-12-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i773f5845d4754661b8aab38716b10554_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bax:CelerityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d01f750794044e794ffffe67feb1dcf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bax:CelerityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8a3ba76ddc34ac9b96c72e99f2225b5_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8299eafa68647eaaa8620f38dec5bf4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap-supplement:GeographicBasisCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe91520413b489ba3c114405e761908_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b30b6e6d2764728a8fb09e3396c5922_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64b2b5d983114aa88c2446e0dcc3de3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i481a24f4e9cf4e4caadc1f417ed82ed5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic475be483d5d490b9d25f69465a3e693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a0372e6d36f45fc821dbc1d47cc6ea9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16877dc9c8664898918e2920216cd8db_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de2ca57ce45464ca01c64bb1f88e3b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff51ea445a5436dae75f76b782ecd31_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a571604800242eeb2e7147c026d48b7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee5aa4d680b44ec86fe26cdcf3bf099_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b9dbb2b9e54f9aa29cbe19d1203ee2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890c2ffd49774bcdb114954d3d319644_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:PatientSupportSystemsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3675597e4b41a9a723718dced98975_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:FrontLineCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd9fa99362a4b3da7f2454b0437871b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:SurgicalSolutionsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b25966c2f794fccbcda61130bacdf1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7a5cf2a666444178c784c2a4e45771e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ad5d55916c462eabe316458610941a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a9b9c3e62944d59dd3f29abbe86694_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2130e393d1145f1b34fd256df79921e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895aace70e0d4238a25f2489179fc9a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6865ca49209e4856bbee3881f270f09a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a672818e934149a401c70ac3c8e194_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec8d99be5dd04810814673d9bb23b794_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a7528b6cc67470689971a1b5911d02a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e434fa298bb4e53b1687deba4d7259d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A0868SeniorNotesDueMay2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i95d99d7448924622bdb9f324debce4d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A1322SeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie77337e4ad4e498c948df7b374666865_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A1915DebenturesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A2272SeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94dc1bd163de40399e15f75a2e3785a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A2539NotesDue2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i265508560c8841b293b5f093e5c37039_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A3132SeniorNotesDue2051Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae499f05266f4e6fb214cdc0ec19a38d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:FloatingRateNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33078f73774943f3a2ca47a51219a873_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:FloatingRateNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed75a5ce2af4878b5a7a6a8436619f1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841d5a6c0ef8487fa19e286f23e59976_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772c3c7e174041f7bcc4ae5236f20052_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16f417d337d49449cd42abe3f0b4ff1_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A24SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f8b3d4953342d7bb449d644860faac_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A24SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b888e2815b64c00a744bce83922eec7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i33bf0a8e536c465a9ba65e612d25078b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88bc321114a41c986908d3eab85ded7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0c4ec3de054eb99dbb0c9ef6f2e0a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie39c0ccc2d9f48b29fd18d7536c85b21_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>bax:site</xbrli:measure></xbrli:unit><xbrli:context id="icc5868a9f710403f8ce9e04bed2c6144_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i167491d201974a2aaaea593456c7da9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0404dc815a4d388b3b0b1abd15f103_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f8ffc989484986a6b2a7277800a496_D20220218-20220218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-18</xbrli:startDate><xbrli:endDate>2022-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac075bc7be734ce28e3cd0ade633f46d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bax:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="ida6a352adaf74291ac8418e13556460b_I20120731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2cfefd9411642a986838426ebc5fd65_I20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501f33331ff24934a4e311776d6b568e_I20161130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2c054b1e504ee491a43864f0b9a4f1_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c321d55d39c46389f13acfac44288a1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d2d3147ec91465dbab5eeb7b6a2cd5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31930c2af24645f49542738fff75d982_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552ac44c09dc4a709b2712f92ae94231_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c2074ab131415892f8da221a18971e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6a288994bf043d8a63aa03aaa1625a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1edf5496290547488b6fb150515ee067_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63982438af89413496b321655eab4612_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5823aeb3309544349e7a762d49f924ed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2621eddb6c8b4e35b45d30c5f4117f8c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77599f5408a4c88933df293d51078a0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7853bfd3a3f14931bd7a5fb8616f0070_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec0e1e2b8494b57a02dabe89c9521c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589024ff3b0647f4aed88a63568cfbf3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib62950f4131d42f3b649b1a20703c62d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f53d52d2574f558f655a52b076f148_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37683e51faa4ef3a8d7fa7bd5e019f9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c55956d7c449a997855468c8753478_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e127d53ca94f5cbd11265d1621e42b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18bdd75685a84d6ea4c661c64683c09b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7c3783e84d45838caeead615497da4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc60984e5ff401591292f61763183a1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4e1f314d994197aa920eacb9a953ff_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4477b37e0684b1584a8e138855d9585_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6ca2d911f1c41fdbc37513b3ecf53c8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7d5ccda5424cd6a7bd67a5706e35ce_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i119bfe21f51144d990801b60bfeb8623_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i559c50c17138442d8746383974831721_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81178378904d4536bccf75c0f969a644_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033de94989d94ca29ea116ebb6e361e7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4901a3b8cbbd4579a3d8a09a6999f89c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d95941b3e84f7fbc4fd9c0e2f0ecf5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie18534aa529c45f286ef075afba0cf7b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013b33b74c04418da6c7b638e5d50da1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac7b594f1d824d129657241335c72a8e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0df1ff8a1a54c22872aa4b7544e0a23_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf3c6c583244c2fab2e8204429785e0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e89a0afa4d441e69b487b51d995257f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80d7ff3511a426c8ccbb5d590033061_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cf6c6b94e648fab5b4e530b9597a22_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6114d388ab3d4e49b91f718263e65571_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2c21ee9026460f83c4f80341476ca8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39edd3b053b44656ba6ef1db52a30967_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f2aeeaddd4434b899181df93dd41d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f552247b7024defa099434103c396e8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0750513067f4915aeadf4ccac6ac536_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a7066ec33c5413cb82aa1ff74f91430_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25f331f9c16441697383aa057d1019d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8cc01f04c94d908c036d3fb2209bf1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409ea711e6f845c490f196eb8f645359_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3dbd2a395345e89bf32cdbb4960ffd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d9584798cd648e6b0f68b8de0c67383_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae4355d68e2490daec9fa91cb0e265a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i397c997d2efa40a4914ea6ada16e1c97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9100d979f2541629d90815696db7ff7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e238159a98e4530b36025474376c7c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc83d9ed3ee4a2ba978e5473f9f7841_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f24bfa3aee44280868c18852f2add00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fb2acc48954eb78b81311475eb5154_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fcc59e0f14e4f539af996b7ddacaf81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00f9b1190024fc69e527ab0f26e42ae_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1427edc253df478ab7767e33fbd20045_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id83d13706d9146a79d73c772426d5ff8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f249df241c94811b66eb3658e39ec2d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if188a3e6d22a4b7db65d00970ac38a45_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d172fc6220427c9f12e31cf1f52b80_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7eefbfc31c346bca35521fabb975893_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b0cd3ff62c945c9ad487c37b3fd49a4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ec5023912a4ca5bfbb4e7fca74a490_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie96abd97590140b0860c8ae2063b3fc2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee44477cbc4457bba565114bc45fa23_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac3907c853c6419a870b4ed9a47ea65c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id84f4faab40b4939b60934146442e110_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36134bef524d47339914de17640d4657_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c190988faf34c569ba539990a780979_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7778b658da74dfc820fa45dffe480a5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4c4e29d280497495f987d4c7046864_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i994b7b3bd9824fcb955199e80b3d015d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1684b3656ff54e7b88a81aa5ed514327_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8650d0802a0f4458b2b63e441989ada7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aa64b17a72543409df08e6edf8f9be4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0a55b7d81042cebc2597b4a7828ec0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e39a58bafcf47698fa18eba3fd53f41_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf94a6be0e1f4c53a69e7cae23297b88_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be404ce95e74ed18104ee0224861b9c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e142953703144db8673afd8a319673d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec3f619d2fc04691841709d7853758c3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7b3b26880741cc9326ad463d4a8fb2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9f8959592c42928f31e74aadef1a94_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5dd465f33414595a6a158c4dafd368f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b61cb16ec84ff397f4193ae43dab64_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic197cd11b20542f99e6be323e290d337_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4e28760c8541dfbabc414285380144_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35b235ca2534a9eb3695accabe2e56a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6bea95b582841779004ba9afa0dcbd3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50557c7d0a314ffd949e64496b2989ec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c71d0b092845d79272052bbb18994f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic727ea9150bc4dc391144e09e7d7e042_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1e66a2f3c8844b989c39e0f132489b7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ee9e3ed488431ebb9c796f6637ad99_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c1f1c2c43254a579e54a9790105bb7a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36c1df1cfb0e4a7695077dcdae7a8904_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a234e26b18540b7940a2ea492897975_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a8ba54205549e490a8217b028c1dd2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78097a5d3545484eb624e2a51be21d04_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112482d56c394f9c98ec73cd18cf2fef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc9b003385e4853a584b34e1fa30b4c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e1509f4a144b719b8606c6c5a8753b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if689fbf349b341a9ac5411f4ddb65c4e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad592254e2654405a98370ac967c8207_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb64aca6929b495da3e77fc1aa3d032c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7295ea739c464a789ba0766d968ab158_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc030e4ae0fb4916827ef25e38848ee5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856404b99b8647e39c3633d9d681e346_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73cf322b7dcd4b9db7fcc6ee06d209ea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf0aab70eb4c4d9b9357a0f16a10420e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16e357fe9d2f4d669a14180154d0f6de_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7156ab3665b4bd7a5933b82974deaeb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia78721827a43497b8d32a902112bb683_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5eea894996f475286c69c6085cb047b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if602b15a04ab4cee94de3cc0404d3169_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ca6e4d1f814edb8b3dceb8cc93f246_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c44836865d447f5a235810c1d8e5421_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae27fa4503e943d882c2b6fc4fd1b5e1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced73c5c9a5c41689687660c8f52e324_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdfecd8a92a84c1ea9f18f5a8cf72dca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36501cc5b8c1437bac9367d0d934737d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6db8852c6a2a477c9de7a28fc85b2e0e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445016d775dd4f209e977cbc25ca6e43_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f18b4486f2427c843d513b40f25523_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5414e1e552e04f9f8c6d1c6c4b4a4fe6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d34e28fa284f1ba780f48fa13f0b66_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e6724e55eb34d1790b308a597a419d2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ec2539711d4ce5b8b8fed40d4c1deb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffaa8df2c61540d0bb50ac46d4160159_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b435d25b05043a6aaa5dba29add366d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68152a8599574507a548fc0ac92e4967_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id817c0101ced4d6f99e8860b7bbf49e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6624a35872d9468488b80d9b5c5a3bbf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifacde500ddb74a838f3cc9af62684d7c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e1514aa7fc443080c274bc42357af8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde5b46f7b324236890c317a7886f38b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08864ae1bda84a668fd39b3a4061c26c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c06aa2c44648eaa7913d094f119852_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cda3b1cb17849b68369df08696e2ff8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6887a94e2824849a970f1b2b7ac88a8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2305248e0ec7423c9ec651a058186ca2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae35539042854319b592f855a1b59d31_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i206b2c76cea3434e9b38f340fb7d619a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bd891890ba45da8085b5e18a6d0c2d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b1d5114e8a40e58ad899a25fd25a78_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48883a929c674841b54b15a5dfa052c9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic709cdea2757418ba8d3eba64ac18cd3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd006e5337d34042a30f9b2fadf77562_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe1019e59b241e586669181c4ed2172_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f8f1f99c44f4480975af6d8192015a8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b82b81097954a6dbe91e74a172c38a0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996157eb8f024336abb632e6241bd77b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c72c96c8e434f6ca045344246edcf0d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5d4575471c419c84ba4bf97ce903ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdae4e4c5a5242a1b88940fdea051045_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia250b656d037452f82c80809f1305d0e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59b4ff6ffd414f62bb45cf05a387070d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1240a78f95a245e8a86128ad258992e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4c7a30b47c41748e6634ad3c972b6a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3ae3d6aa2b4d09a6a8a1fd463caf0c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bda2e702c6e44df89b96f76ad8d15ab_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id08ebd120d464decaaf14ac1fb137424_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2d778f29a0499e8266532cb33dc627_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3090e8c3fda94423a0d0912d50961819_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e3034fc19a412ea43aa1cfb0412fc7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9dae84b5f6a4563bdf623ffa56038af_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df3f4f4414c4f44918ed058594a3a6d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaddecfa588c45dbbd695699ea74db2e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a0261aa0654089bb88fbb3d2a3a069_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b80e53eaaf246c0a006f99d6c332ef9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82485fb2469a47ecbb6c7c2217dbedb5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c244391ad84185a8d527720e081a70_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428120bbc00c4484801fe373fa42a492_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e9603e0fe354ab996f5149cb7753360_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2b0d89fe81948dbad94f24b2081b1fd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbc08f9e34a4424a04357d4ff58fd2b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34ea41012e54e3a8847c03a4116d7c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i983f956742e148cd9935461bf9c57d85_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa57853da33460a929d418073a4e5ef_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7764dcb4d84344eab48a05c00972e9ca_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79060a21825446f68e990e404b003293_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e5727a5d734abc8a8eceb71d05ff40_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e28f51eca1f4bd9b296c01f4220bd6a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia374726d39fe4c0c815368587eed129e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i000aac4b4eb74546bf63b572c100248c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic27396433bf44b738da6b78bd6987adc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd580e555ab485aa20157d901745b91_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18ee0893dd9643fdbf0354b01a632557_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadc946e2caf484fa6388e999c80bef3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3361742ed1c42fbbb2de2275dd10be2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7dc69941344244b7589680ec54ee1d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe952d9c345f44f88320bf99c72fbf4b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice50f6d87c71414ca4f9c37b27e16086_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04c354156cd54db0bdb335313ca518aa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15c872355344ae39ce7dd39d2d327e4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if78a45e31e0c4f4d810fb14d428a91ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc06387a4f544444a7bbab606971c606_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918c71be12f94ae78f91f363866ba727_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a632ba481346bdaf99d141baafe749_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17907bd75b564e249364985141865dee_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id66df73b2bcb44c6ab4532b0c9ab728b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea336d5c32bc4861902104cb153044f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697542fa1b0a4a98875df15a602c28ec_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09cba0015a754f508a844041cd9e4b69_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55f3be8e44b4bfa864a27180b621ed9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e1f45adb51d457aa5725c517e737b84_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2588cc62cb4d48b7a46b738e92f4072f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99d230df90c142c884206af10ef9f8fc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7199ae522f2f43f4ae0239522889f703_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2312799038e14136a66c60426b4cb5f9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe4632e8764241ee9398872757d10f8e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4990d1e08a374066a38fe1c66495a71f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfdfaa0e8ef4d4790f5cacb41fbc6d5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c145ad188b4727a0ff9e2d211c6b95_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39c83749cf3d4a26b1b79ffab6bc6042_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115a2bff9c784ab99914fe29be8d2d98_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e6c07c99ae4e90bc9ff4f65a602520_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida458b6715084e3a96aa191749dc91fd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bdf1fc538624d7d9910380d7d77b626_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95260f0037d846208bd14cc3ba8adffb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff550217f2b4a8f8d4ae65fe153a1ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbdf433bfc67461d8114a92c13283325_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0679fb1835b4c7795bcea38cf0b9886_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e2ab4fa4974f7889612beb65ce8d19_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491168a2923441709f7ed1cbfe6c88ad_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59821c1a37b043dd8a8397a39a3d0bd4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f65613766e4c30bdf4b47df7bb28b8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11a5054d010e43e2bb824d4b0a88a448_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3df95dfd2c54aaea21d90d6cd142885_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7ff276cb874486b9ea8a16dad3d507f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee715bdb374f4d0fb135cd9a90024cb7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16bdd528aa2f43d699d93d6730eaadc0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4eaef49d9cb47cfa238b4be07c3c11e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7daf0d45954200a36a140244cfa8c3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e760ae3df749d7a28496170682fcdb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife9092a352dc419ebd9202ad5227d8e1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa41f2bd185d4f35992a88175bd33816_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f72f4b6a78548e09b7e4a30258e2a66_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f4353d73fc0409094a9382a8f5b35ed_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32f7b3dac88f4fdeb34925d2fd733bd2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f085c0375204e3d928fcb8db88faac6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087c22c00b8342649cb73bf0310b7e9e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89294089c022435cbb391734e7e95a77_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c1cd55ef43406fb28e3516e8bed426_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f66dbec955f46ba8e2a9f09b30f4234_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dda49a9d7704da6860a7855a38b3484_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d3dbfedff62414dbc6b3c751ec05d46_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a28025718c7422987d5e9a1bb04a33f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie76d49105fd64d3fbed5c1bb08359728_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0522de9f5b144d58800dd0fd0f71c6a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2166896cc67640a7ae96d097acab1f25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950523c03d0e465a8db7b9c48b7e0e3e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ace5ff2293146d4bf055d7cb9bcf636_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9b0b9cb7944866bf75d223bb4c8fea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a10b05f8c504eaea705b787746ae15b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b44d74805841d2ac389e7934b1a17f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1111c82205474cdda375e71c5738d55b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77e3cf538fe4a19a12e07001222f635_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b9c1c44ba84e60af09ae0057af5a4e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fd80b73ae2b420ca679db0cac3a60ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55e4dbb5ee80417da9485fdfabbcc12b_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A130SeniorNotesDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9812ba731b464628b9581ec75cb13f21_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A04SeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c7cce9faa64129b1ddac611011830c_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A13SeniorNotesDueMay2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4219ab86c67549bfa1e56276605a8990_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic762452cc4494022a233acfc178ebafa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03565d5005c4f898506b8c013da1feb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd4b212abcc54d02b74cb18b61508e58_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b0045fb1e0941df98e20a283f36d227_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec3801c7613438c8124f3cde7757903_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i524f33dedfef49de9b3bc2b5e9c14c87_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeaa8f4aa8c140688f7b460b580b43ed_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf0aac0647045d5aa67667953993c07_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d171c4e6be042278f782461c977f45c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2542bc7a65744214aae79ec882f3c054_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c0e3547cbe442938da56027d6f100e8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaa95bf889d043f38f60a617e70b40d3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57bc193f1088457fb04394f5af366882_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4402f6cfbe44c7a47198d315febe1d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b054901d62649cdb8f927a96ce91ace_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd9a491ccff4bbda2839a7be1c36b74_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef3027bf73d4dc6910053458adbcef3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7c0055bf4040c381b494fe4307540c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3c83643aa4f4d08a36b0e3403f878e7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3597ba90139f4ad88f34ea14d4c322e4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia23c6ae90b5e43f18f128140d9efd7b9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f6cdaf8a75405295f0a68abbdc904e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b78a3fb7ef44f86a0bd6a81e7c2f5eb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b24494d1e54bcb900d94e60f0b8ac7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4159e70eae1c4a779c9b692aaa4cf78c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a752302cfc64472917c0dcdd2903e89_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e74411bec474aaea6b669ed608cdde3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia96f099a1e7d4398a154facff7209588_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie089f3302f66450796c1dff4135d452a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1528a977db6d4b2599de78b0fafe3502_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abbbcb680d54d358fcfea6c93ecb0b7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6de69187ee1449e690027dd9b5781e35_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468b5d6abb97433c8ced58e53154b575_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cc534a76f6479cb41d07feb73fe749_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3173187680714658978b04838fce40b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fe54a153e4a40e4a1a669f98ab1f673_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af24cb81eb1423ab102ead43ce324f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d91b9084444f99a2a267da216d851d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i821cd3c29b904c40826ea7cf9fc530c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e5214316a649e3860c819c556c69d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f5e8ee945c84b1da96f6817955ff214_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b104e3d69714250a4d3b01b50f34773_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibec49a9c245a406cad720eaf5a91dba8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i655add2ac3494884b74da98ed4989459_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c384389756a4c369c17d835b9631cb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db585f6be0041fdbc967569ee16766a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie775ab37506340ba914ddb80c6e46611_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bef60de6abe41cebf0448519a3ac267_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e06ddc9fdd4a0295e9c0705d568e98_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefcd1a7cef434b938b81d5633355bbf5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34110c3d1d548c099e33f7257520862_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5785042f0a0a48b2a89a8d5e5292f378_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c975de3f94448528111a2732f5ff183_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b320ae27de4e16915e55e2cea04c39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5af787ce477145f395b6c47dad80c78d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib401981a72924d8cb4fa3b85e149335f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36894205b57049ef997539ec21871c49_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ff000d306648239fede97f2055f01f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8551f83b15496db276708fb0ec4cc2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5748a1a16bd49a496f9c15a091112fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60e9daec1c784937b3bc084af4e7d546_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60aa20a1204d41029dcdf01856f5131f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f7ae0b172974bf08be1404801ce8bf3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672fe12465f04ed1ac1c17454ce41b89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bax:segment</xbrli:measure></xbrli:unit><xbrli:context id="if8cdf58384f44554b6f0c7ae5b485465_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd833938b8fd43d887495cb1fa7f7edd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4917de1dd954a059d60387d14e89f10_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6123385e384e4137985445ff7eee59cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i327518eb465544d693c28e6cd73f5736_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ca18a38e7b24b8b99d1fe4106969b7b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if51f0dd41ec94f6b858c4933e0bd444b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07947bacb9de439897e75f3c619d0f5b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a9d785c00c479d87a0bf2f015e7811_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2 id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="iaef9f667721343c48067444506cf55c3_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xNjY_c9a395cb-628b-4c57-8b99-b08feac3e318">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6YzcxNzQ1MGI5MDEzNGJiMWE2MmJiZmYyZmQ0OTllNDkvdGFibGVyYW5nZTpjNzE3NDUwYjkwMTM0YmIxYTYyYmJmZjJmZDQ5OWU0OV8wLTAtMS0xLTEwNDM3Mg_931e5ae4-47de-40c3-8780-f36aceb10ef9">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8yODM_5a2ccfc5-a484-48d6-b38c-4e7fd8278360">September&#160;30, 2022</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NjdkZmVkZGQ5NmNmNDVhOGFmM2UwYjU0NjE3MjczYmYvdGFibGVyYW5nZTo2N2RmZWRkZDk2Y2Y0NWE4YWYzZTBiNTQ2MTcyNzNiZl8wLTAtMS0xLTEwNDM3Mg_9f2f8883-2e67-4cbd-88c0-736fcc23bf01">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Commission file number  <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8zNzA_fd0350db-3450-43c9-b7ec-58d1769a0eca">1-4448</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:21.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl80NTU_33a1c50d-587a-4d68-8ede-23d83e363570">BAXTER INTERNATIONAL INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18wLTAtMS0xLTEwNDM3Mg_cea67aae-0dc6-4ca4-ac0f-196948db78ae">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18wLTQtMS0xLTEwNDM3Mg_64c44d35-a8bb-4962-ae15-9b878ac42fa7">36-0781620</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTAtMS0xLTEwNDM3Mg_6b003dba-b37d-4623-9cf2-f82074153bc1">One Baxter Parkway,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTEtMS0xLTEwNDM3Mg_93a9fd2a-c72a-46c9-b9c4-e1750d37a377">Deerfield,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTItMS0xLTEwNDM3Mg_7dedce80-6939-48ce-9127-48fa35d021ab">Illinois</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTQtMS0xLTEwNDM3Mg_02b4f1b6-c60c-4668-8b6b-4e3d65e73900">60015</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NzNhMDhhYWY2ZTQxNDk0NzgyNWQ0MmM4YmE4MmFhNzYvdGFibGVyYW5nZTo3M2EwOGFhZjZlNDE0OTQ3ODI1ZDQyYzhiYTgyYWE3Nl8wLTItMS0xLTEwNDM3Mg_74f73d4b-99f9-49a3-9559-e8dd1f84e3a7">224.</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NzNhMDhhYWY2ZTQxNDk0NzgyNWQ0MmM4YmE4MmFhNzYvdGFibGVyYW5nZTo3M2EwOGFhZjZlNDE0OTQ3ODI1ZDQyYzhiYTgyYWE3Nl8wLTMtMS0xLTEwNDM3Mg_42ee60de-703b-4846-9c96-202efdf88c80">948.2000</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTAtMS0xLTEwNDM3Mg_84004c69-a210-4e0f-a626-69e6f753e8e3"><ix:nonNumeric contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTAtMS0xLTEwNDM3Mg_e7a59efc-7b8f-41b8-be43-24ed58395da8">Common Stock, $1.00 par value</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTItMS0xLTEwNDM3Mg_22a2eb1b-bd71-4cd8-80ac-f0855e016ecc"><ix:nonNumeric contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTItMS0xLTEwNDM3Mg_d8f5514b-a03d-42d1-9338-601a50be8165">BAX (NYSE)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTQtMS0xLTEwNDM3Mg_19d1098b-b012-446b-9fc0-1b2dc073fc95">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8yLTQtMS0xLTEwNDM3Mg_aca0fe32-6f5a-4dc2-ba36-b558471f2dbb">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTAtMS0xLTEwNDM3Mg_ffa0eca4-2647-4ca8-a743-ac6d60760e60">0.4% Global Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTItMS0xLTEwNDM3Mg_4f135dc2-7c41-468c-ae20-bc6876be955d">BAX 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTQtMS0xLTEwNDM3Mg_019d41ac-623d-4581-8a27-f2b776aa6fd5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTAtMS0xLTEwNDM3Mg_c32b0f31-ebda-4a2e-aa65-ffa781d63aa6">1.3% Global Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTItMS0xLTEwNDM3Mg_26abfe3d-a4a2-4e61-9a75-8afa9de49071">BAX 25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTQtMS0xLTEwNDM3Mg_09ba9615-2558-4a4e-9c4d-5d06722567a1">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTAtMS0xLTEwNDM3Mg_9e3b53b7-6aba-4330-8d5a-0ef817765b2d">1.3% Global Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTItMS0xLTEwNDM3Mg_3cc3ce3b-d24f-4651-a712-e95c77f53432">BAX 29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTQtMS0xLTEwNDM3Mg_16ff6852-513e-4508-8980-f6c375ab7ffd">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMDg2_cfa078dc-0095-4339-b291-dfb88b4b1cd7">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMzc4_6d576b59-d853-4757-ab90-163071b6b459">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8wLTAtMS0xLTEwNDM3Mg_017bacff-8d26-4757-9d09-04f37bac59ab">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8xLTQtMS0xLTEwNDM3Mg_d7394be0-a11f-4919-88eb-a283452f9bf3">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8yLTEtMS0xLTEwNDM3Mg_20a0c6cd-80a2-4a7e-acd6-22a34a384e54">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMDk5NTExNjMwMDE3_737c672a-adc9-4280-8536-75f446af231a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock, par value $1.00 per share, outstanding as of October&#160;20, 2022 was <ix:nonFraction unitRef="shares" contextRef="i2e4d13c497514386a72aa4814ef8a1c0_I20221020" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8yMjI2_49699ce5-66b6-4724-9c2a-24af1bd5f0ec">504,120,759</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">BAXTER INTERNATIONAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the quarterly period ended September&#160;30, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_10">PART I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_19">Condensed Consolidated Statements of Income</a> (Loss)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_22">Condensed Consolidated Statements of Comprehensive Income</a> (Loss)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_25">Condensed Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_88">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_112">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_112">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_112">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_115">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_115">50</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_118">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_118">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_118">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_121">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_121">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_121">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_127">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_127">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_130">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_130">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaef9f667721343c48067444506cf55c3_133">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iaef9f667721343c48067444506cf55c3_133">53</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="iaef9f667721343c48067444506cf55c3_13"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="iaef9f667721343c48067444506cf55c3_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except share information)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMi0xLTEtMS0xMDQzNzI_682d574d-2039-4309-a1a7-a17640035fd3">1,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMi0yLTEtMS0xMDQzNzI_eb4671a6-91f8-4746-8667-c4d67fe8a911">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo1ZTMyNWVkMjNmZTE0ZjU0YWI2YWMyNTk1YWRmNzlhMV80Ng_3e29f03c-d711-45cc-9949-39c28b1f543b">120</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo1ZTMyNWVkMjNmZTE0ZjU0YWI2YWMyNTk1YWRmNzlhMV81OQ_7c1be297-0be3-4236-be6b-9bc881103cb0">122</ix:nonFraction> in 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0xLTEtMS0xMDQzNzI_8c7e8a59-0af9-4d9b-a80f-2a7f02cb4bb7">2,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0yLTEtMS0xMDQzNzI_25b6a629-2ad8-43eb-aa44-da4079e4d501">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNC0xLTEtMS0xMDQzNzI_2aa69a2b-7285-42ff-9ee2-cf1629e833d5">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNC0yLTEtMS0xMDQzNzI_812bc7d2-29d6-4c2a-8bdf-ec386d82669d">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNS0xLTEtMS0xMDQzNzI_0dcc13b4-4d00-48d1-aac3-e89b7e1fe666">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNS0yLTEtMS0xMDQzNzI_e9dc549d-0862-4159-9c7d-dc280ffe0155">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNi0xLTEtMS0xMDQzNzI_00b06f2d-b14d-444c-b09d-f4c44c8ad839">7,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNi0yLTEtMS0xMDQzNzI_9fb0955a-8537-4dd5-a742-26b10398e00c">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNy0xLTEtMS0xMDQzNzI_08e66666-b724-4d0f-9b71-7e0500606562">4,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNy0yLTEtMS0xMDQzNzI_3a6cb1de-1c08-42ac-9e58-6f80c6cf921d">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOC0xLTEtMS0xMDQzNzI_9c77401f-c328-4867-9c6c-49df393fa0ed">6,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOC0yLTEtMS0xMDQzNzI_e0775612-f81a-4619-a230-04008148a50c">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOS0xLTEtMS0xMDQzNzI_bd941449-4217-4218-85c3-78c78490b072">6,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOS0yLTEtMS0xMDQzNzI_44b72655-5647-4ec6-930b-48f89ab226b2">7,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTAtMS0xLTEtMTA0Mzcy_5300123a-0175-4cde-aff1-e92c9828609f">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTAtMi0xLTEtMTA0Mzcy_c8ae8644-e12c-4af6-95db-ea01a56367c2">630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTEtMS0xLTEtMTA0Mzcy_5aa1d309-2860-4a06-8334-eb2cd9abe96c">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTEtMi0xLTEtMTA0Mzcy_661fd90c-b924-4ad5-82f4-710d1346aa34">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTItMS0xLTEtMTA0Mzcy_5b954511-1b49-4a68-a791-31805652977c">27,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTItMi0xLTEtMTA0Mzcy_91535e40-cb90-482f-a01e-badbc2454356">33,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTQtMS0xLTEtMTA0Mzcy_a764e534-a654-4a72-be2f-9a1b13e2ad54">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTQtMi0xLTEtMTA0Mzcy_30ea9d45-3fbe-40cc-9515-00f561007c11">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTUtMS0xLTEtMTA0Mzcy_33cb272c-caa2-4c69-86a2-46dd9f818d51">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTUtMi0xLTEtMTA0Mzcy_c42210d2-8cef-4957-8948-86ec92ca79d9">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTYtMS0xLTEtMTA0Mzcy_e4cf233d-5163-4671-82e2-bcc9e2120f0e">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTYtMi0xLTEtMTA0Mzcy_48863e4b-b4f7-4098-a492-1e1525efd665">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTctMS0xLTEtMTA0Mzcy_da050810-0328-4364-9858-72b0d6a583bb">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTctMi0xLTEtMTA0Mzcy_9f8d5d79-7559-4bb2-a9bd-4bfea7fd3dfa">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTgtMS0xLTEtMTA0Mzcy_7e3a7623-d0f2-44ac-899a-aeda9cd87ddb">3,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTgtMi0xLTEtMTA0Mzcy_c1b79af3-f6ce-437c-8179-566aedd86f3b">4,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTktMS0xLTEtMTA0Mzcy_93f53f6b-a530-47ee-a8bf-8401a9da9b5f">16,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTktMi0xLTEtMTA0Mzcy_2445a014-12e4-4ce6-b8c5-0bdc2582a263">17,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjAtMS0xLTEtMTA0Mzcy_8f1ad878-8dbe-40ab-95e1-b10ed648f9b0">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjAtMi0xLTEtMTA0Mzcy_2e234b68-de1d-43b2-9f44-b858305cd075">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjEtMS0xLTEtMTA0Mzcy_fdf720fe-5a91-46c7-a087-091efdba9e7b">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjEtMi0xLTEtMTA0Mzcy_f0a2d552-42d3-4db7-8437-df081d48837f">2,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjItMS0xLTEtMTA0Mzcy_037ba1dc-99b9-4d83-9cb4-535ce994c8bb">22,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjItMi0xLTEtMTA0Mzcy_dd683084-3a4d-4d08-8e4a-c3647086fc0c">24,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjMtMS0xLTEtMTA0Mzcy_2926c4e5-cc36-417b-b402-954e6ae14927"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjMtMi0xLTEtMTA0Mzcy_2340f4b0-dab9-4a0e-a661-341c9a61c996"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfMTg_aa366660-5b82-4256-85ab-574886b34ff0"><ix:nonFraction unitRef="usdPerShare" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfMTg_d6927bc4-363f-4719-a97b-454e79699355">1</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNDM_66ba282a-5a2e-41c4-a4f3-e6e749781796"><ix:nonFraction unitRef="shares" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNDM_d56a0cca-9dc0-4e1c-8c3c-d4d9b7309088">2,000,000,000</ix:nonFraction></ix:nonFraction> shares, issued <ix:nonFraction unitRef="shares" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNjE_1c2a8e48-a023-4fa7-a749-2c850907724e"><ix:nonFraction unitRef="shares" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNjE_d45baf24-8f96-40ba-b304-dd8b786eb391">683,494,944</ix:nonFraction></ix:nonFraction> shares in 2022 and 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMS0xLTEtMTA0Mzcy_7104fb64-0b2b-44f7-af26-52cee97c14c6">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMi0xLTEtMTA0Mzcy_78303c21-03aa-4a64-a436-efb69e7d22bd">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock in treasury, at cost,<ix:nonFraction unitRef="shares" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246MzA5MTczZDc1YmJkNGI2ZTk3NDllYWQ1ZTc1OTkzNmRfMzg_9d35a105-86ac-4b7d-aace-7b47966a43ee">179,451,293</ix:nonFraction> shares in 2022 and <ix:nonFraction unitRef="shares" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246MzA5MTczZDc1YmJkNGI2ZTk3NDllYWQ1ZTc1OTkzNmRfNTg_fff92f7f-eda4-4e4b-8fc8-0a11fd04a279">181,879,516</ix:nonFraction> shares in 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMS0xLTEtMTA0Mzcy_0017b6b5-6858-49a5-98be-e5a35a561c85">11,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMi0xLTEtMTA0Mzcy_53e735a3-e097-4e74-a65f-6809f503bbde">11,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjctMS0xLTEtMTA0Mzcy_7b9ec08f-a6cf-439b-91b6-9a3d7c0933e0">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjctMi0xLTEtMTA0Mzcy_01ce8cf1-5177-49ae-bed6-bed1972a92ec">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjgtMS0xLTEtMTA0Mzcy_4d57b544-93b4-49cf-97ff-240d3369a97b">14,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjgtMi0xLTEtMTA0Mzcy_58cdd8db-3b7d-416c-9f54-e453fab47746">17,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjktMS0xLTEtMTA0Mzcy_0d0d1803-7c9a-4a83-9177-97af263388ff">4,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjktMi0xLTEtMTA0Mzcy_e904cc57-f44b-4845-92ae-7aa9167b4488">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzAtMS0xLTEtMTA0Mzcy_05601d1c-db3b-40b7-a15d-cecd58f4921b">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzAtMi0xLTEtMTA0Mzcy_aabfb315-e71a-482b-918f-d33ce31b127a">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzEtMS0xLTEtMTA0Mzcy_48585cdf-2477-4b1d-a79c-dc7ae55e4c8b">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzEtMi0xLTEtMTA0Mzcy_a2b4b80a-1b01-4f18-b15a-1701760a4348">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzItMS0xLTEtMTA0Mzcy_0c60f470-c9a9-4d82-a186-06c6ad5f8d8f">5,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzItMi0xLTEtMTA0Mzcy_12fa3226-e300-4823-b75c-3589f0d10f29">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzMtMS0xLTEtMTA0Mzcy_15b18a9a-57c9-4413-922a-d9966f4c4d57">27,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzMtMi0xLTEtMTA0Mzcy_0b356f7d-5311-453e-ae49-2ba7c8408b46">33,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Income (Loss) (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi0xLTEtMS0xMDQzNzI_7ff1b7a5-c02c-4ef9-a3a3-1b2cec9352a4">3,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi0yLTEtMS0xMDQzNzI_098c9167-675e-4749-b581-26415a5ea07c">3,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi00LTEtMS0xMDQzNzI_b0a56fc0-1ba9-458b-9bdf-f8f463fc4d44">11,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi01LTEtMS0xMDQzNzI_120e61e5-04d6-41f3-b259-6ea18ffb6e1b">9,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy0xLTEtMS0xMDQzNzI_394ae309-1962-42d0-a365-3d95924b0929">2,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy0yLTEtMS0xMDQzNzI_3e40770f-5838-4100-a48d-477cb5f88ebe">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy00LTEtMS0xMDQzNzI_2f534653-8024-4b6a-af0d-218a00c39151">7,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy01LTEtMS0xMDQzNzI_57761791-dd3b-4b9c-8b36-48b28ffa5d03">5,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC0xLTEtMS0xMDQzNzI_7b4cd31b-e66c-4f1a-8568-020bf080bd1d">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC0yLTEtMS0xMDQzNzI_cff86fd1-9776-4c06-888a-17d00166062b">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC00LTEtMS0xMDQzNzI_c050ae4c-8643-4a9a-bbdf-f4a08b1f6c41">3,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC01LTEtMS0xMDQzNzI_83930e7d-c290-458b-801f-0aade1bced00">3,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS0xLTEtMS0xMDQzNzI_2ae5afa6-217b-4af4-b541-d664a3e2c98b">947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS0yLTEtMS0xMDQzNzI_2241fec6-d2e9-4ace-8902-0cef5ae0a57e">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS00LTEtMS0xMDQzNzI_ee2438f7-db68-45d3-bf9e-98bcc7d6ea43">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS01LTEtMS0xMDQzNzI_34b655d7-bb81-4c50-83d9-1f46681782da">1,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi0xLTEtMS0xMDQzNzI_f2d43689-07d3-4eed-a486-e7bf1cbf49cb">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi0yLTEtMS0xMDQzNzI_fb9e3617-c68e-40dd-bba8-6b1b7b545dd1">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi00LTEtMS0xMDQzNzI_4fd8fa51-6de0-49ba-a1ad-a817f64c4d8c">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi01LTEtMS0xMDQzNzI_268a710b-8cee-46fd-aa9b-1740eb5a62de">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0xLTEtMS0xMTQxNTk_7b47f1a4-49eb-4d2b-98d2-2adb93895eb1">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0yLTEtMS0xMTQxNTk_3e7b83b7-1c31-4026-a86d-678a99c6dc5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy00LTEtMS0xMTQxNjc_860eee1b-4b21-435b-a031-3660d0646d88">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy01LTEtMS0xMTQxNjc_16a416f8-051c-40e8-ae3a-98e23a1ac695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0xLTEtMS0xMDQzNzI_aedadce3-f0de-49e7-b777-1ee96b1a2d5d">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0yLTEtMS0xMDQzNzI_35696741-09fc-49ba-b32c-47ff547c9757">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy00LTEtMS0xMDQzNzI_4c56cbc4-d85b-4b06-98e2-e3f4a1f7390e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy01LTEtMS0xMDQzNzI_eb43c1de-1767-41a2-9dfc-f8ba552095fa">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC0xLTEtMS0xMDQzNzI_ef6c48ea-3a90-41f2-a644-f7a7cb87a2d6">2,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC0yLTEtMS0xMDQzNzI_48a7b177-77af-433d-88ea-ab3fecdf0445">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC00LTEtMS0xMDQzNzI_0cb76609-8a0f-4acf-a09a-66222502296a">2,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC01LTEtMS0xMDQzNzI_f63191df-3b83-4f79-920f-578bacbd8078">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS0xLTEtMS0xMDQzNzI_238ac71a-7edc-4ff9-aa0d-a258d5589ecc">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS0yLTEtMS0xMDQzNzI_54449842-c80a-44cf-9010-0a17c77ee9fb">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS00LTEtMS0xMDQzNzI_1e942b3e-7874-4386-beab-affe648d16e9">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS01LTEtMS0xMDQzNzI_e2dc83b8-b5cc-404c-873d-32aa20951895">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtMS0xLTEtMTA0Mzcy_a1ac637e-8173-4c6f-95c6-dc2f6c18f8bd">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtMi0xLTEtMTA0Mzcy_b6652f0d-03d3-48bd-8699-04e0e483939e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtNC0xLTEtMTA0Mzcy_93f550fd-cef5-4964-96c1-fbb6f5ff522c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtNS0xLTEtMTA0Mzcy_4a71d9e0-bd77-4521-a3ca-a8a48413f565">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtMS0xLTEtMTA0Mzcy_ae7338e8-8fec-41de-a171-499bac292d92">2,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtMi0xLTEtMTA0Mzcy_e2f58c95-f696-4cd1-b8ea-9735bb27a44c">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtNC0xLTEtMTA0Mzcy_45c18c98-77f7-4ad5-85ca-af2d956fc33e">2,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtNS0xLTEtMTA0Mzcy_ec9aac07-055b-401e-89c3-e357e2547de1">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItMS0xLTEtMTA0Mzcy_473e5a46-40f4-4cda-8403-d7fd06841e5f">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItMi0xLTEtMTA0Mzcy_fec463da-9436-47b4-a3ad-cd348d25daf3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItNC0xLTEtMTA0Mzcy_f2b1b6dc-d63f-4707-b2a1-70a686dcd4f7">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItNS0xLTEtMTA0Mzcy_6b9d44b3-b293-42da-abb2-220a5e67e580">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtMS0xLTEtMTA0Mzcy_4895294e-023b-48a3-9ac9-e20a4b017624">2,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtMi0xLTEtMTA0Mzcy_a49ac0d9-6ef3-40f1-b290-f31439e65f64">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtNC0xLTEtMTA0Mzcy_cc6492db-5688-4e8b-a11b-89f4b72396c1">2,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtNS0xLTEtMTA0Mzcy_52f060ee-d7e1-47eb-83c4-b04ed1cf2f96">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtMS0xLTEtMTA0Mzcy_e9f362fc-cc1b-4a04-b359-2e5e818787a3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtMi0xLTEtMTA0Mzcy_e21a9b57-dea4-4716-813f-0fd2b1bfe0de">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtNC0xLTEtMTA0Mzcy_39687437-efe8-4b61-95d7-f6ee2e20b6ac">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtNS0xLTEtMTA0Mzcy_1c352f19-b979-402e-a5d0-92c7793e1531">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Baxter stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtMS0xLTEtMTA0Mzcy_4d45a6b2-2be7-4c95-bff9-ff70a248b791">2,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtMi0xLTEtMTA0Mzcy_4d618057-f572-4fe2-a22c-23658b220151">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtNC0xLTEtMTA0Mzcy_45923742-1751-432d-9ce7-712c8cb64750">2,614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtNS0xLTEtMTA0Mzcy_94481bf9-92b3-4dda-9c83-0b0794e28008">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="18" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (loss) per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctMS0xLTEtMTA0Mzcy_c30f2ba2-6f9a-4530-9521-335cc8feae00">5.83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctMi0xLTEtMTA0Mzcy_2d7ef048-4372-4b9e-8b64-0703906ccd50">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctNC0xLTEtMTA0Mzcy_205f33a5-0242-4759-83b5-bde710174ecd">5.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctNS0xLTEtMTA0Mzcy_3afcb556-4d40-4de8-a855-8c2b3ab1adfb">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtMS0xLTEtMTA0Mzcy_014c3dd6-0c35-4034-a634-e756e9edfef2">5.83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtMi0xLTEtMTA0Mzcy_cac625d8-297c-4d19-a1e3-0a6da85f48b1">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtNC0xLTEtMTA0Mzcy_92f18427-fe29-4676-a1fc-163935d7af56">5.20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtNS0xLTEtMTA0Mzcy_769f65eb-0529-4dea-bf83-bd80bb7640cc">2.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="18" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of shares outstanding</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtMS0xLTEtMTA0Mzcy_e5e770e1-5ed8-4467-9b5c-d5f50af945a1">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtMi0xLTEtMTA0Mzcy_1a04acb2-7024-4f50-b81a-b8e98344b1d9">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtNC0xLTEtMTA0Mzcy_9fb88fa5-8645-436f-bd5f-40a8e63baa7a">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtNS0xLTEtMTA0Mzcy_54dcf96b-d3e3-4d18-8f18-09aea75bdd54">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtMS0xLTEtMTA0Mzcy_af40bd4f-7ac2-45b2-a607-d129d75a9ded">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtMi0xLTEtMTA0Mzcy_7d2050fe-7306-4ad1-95b3-565110da335e">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtNC0xLTEtMTA0Mzcy_8f4135fa-78b8-4b80-b15f-b4b9773d85a4">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtNS0xLTEtMTA0Mzcy_218c91d3-fe89-45d3-b4fa-8ebf5d28bfcb">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi0xLTEtMS0xMDQzNzI_05defe6d-f337-421b-a8ee-d7559ed5ecc2">2,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi0yLTEtMS0xMDQzNzI_c005be19-b755-4cd1-8ada-9ef1b64d50b9">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi00LTEtMS0xMDQzNzI_5c6e95b1-17ec-485c-ac97-88d387b3db04">2,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi01LTEtMS0xMDQzNzI_00023cdd-4e3b-4cda-8f82-0afccffebc25">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl83MA_a122c5f5-12e2-4542-845c-c6ddfc598ec3">16</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl83Nw_46287a7c-fb79-4c1f-b2cb-3b1ebbcc6312">3</ix:nonFraction> for the three months ended September 30, 2022 and 2021, respectively, and ($<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl8xMzk_b67fbf00-808b-43c3-b956-1d38e7ea4bcd">25</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl8xNDY_ffed2eef-fb78-4d6a-8fdc-fb56df5d86b6">16</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0xLTEtMS0xMDQzNzI_e94e5e96-6c80-44ca-9dc2-9eb80a4d41da">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0yLTEtMS0xMDQzNzI_71fc56d1-4df5-4db9-936b-db643c21a4eb">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC00LTEtMS0xMDQzNzI_8ae07fa6-4986-4776-bdcc-5579a2028e02">751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC01LTEtMS0xMDQzNzI_67d32dda-a6ad-4a3d-9631-12ea809caa8f">257</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV82OQ_7845e3b9-92d3-40f3-8913-9f44bed5ac0f">5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV83Ng_d15da44c-4959-4fcd-9fb1-c9e9a8e30331">8</ix:nonFraction> for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV8xMzg_f28db72a-e7bd-4dc0-9122-34c3b0c7e06b">13</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV8xNDU_d86eb627-a26e-42c0-bfc4-833201c9ec11">19</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0xLTEtMS0xMDQzNzI_ef0e8511-e2f2-4f9b-b786-5ba337793056">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0yLTEtMS0xMDQzNzI_7425b20d-4829-400d-b681-f8b805ad3fa8">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS00LTEtMS0xMDQzNzI_19d755e8-3185-4ab2-ab82-ab288019a606">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS01LTEtMS0xMDQzNzI_8f4fab3d-68db-4ad7-86be-21041ef2bf90">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging activities, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM180Ng_502eaca6-9b0b-41a9-b494-f3c797151b6a">5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM181Mw_5d44e5ef-64a5-4788-a20a-067c579f1657">3</ix:nonFraction> for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM18xMTU_68d38b4a-7cb7-4907-aec4-cf4c2f108e4d">8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM18xMjI_29d0d1f5-f90c-488f-bb13-6bbefb656f05">8</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0xLTEtMS0xMDQzNzI_dd0910aa-9ab3-47bd-9f13-1ccd922c2d43">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0yLTEtMS0xMDQzNzI_5fab5be4-46b8-4e7c-90f6-206d8d70040e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi00LTEtMS0xMDQzNzI_89c84e52-b59f-4b44-9c8c-98d00101b8ba">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi01LTEtMS0xMDQzNzI_1deb5d90-8a46-442b-9dc5-67e37de7e553">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities, net of tax expense of <ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN182Mg_5a546094-59e4-4fee-8b3f-a61f67d0bef5"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN182Mg_9c130a44-12e6-4eea-aaff-c2ffa2e54531">zero</ix:nonFraction></ix:nonFraction> for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN18xMjQ_3b51d062-cf2e-443b-8df8-dc00a8c295b5">1</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN18xMzE_b8301442-bd94-4924-9a6d-e67ac76453f5">zero</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0xLTEtMS0xMDQzNzI_8d654ed7-188b-46b5-b95e-a5882d38c704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0yLTEtMS0xMDQzNzI_e39c7c79-a83a-46d1-be50-92772426c2d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy00LTEtMS0xMDQzNzI_522eb42b-d12f-4041-92d8-0bc30f2b271c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy01LTEtMS0xMDQzNzI_f99b2227-8adf-4820-84f4-a4e81a86895e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC0xLTEtMS0xMDQzNzI_633b0d4b-8ab2-4d5e-8fc4-545e53218c47">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC0yLTEtMS0xMDQzNzI_1a2d06b2-4c81-4afb-908f-464823df0437">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC00LTEtMS0xMDQzNzI_a0859fcb-47d7-4555-a15a-1ca70ecb11e0">674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC01LTEtMS0xMDQzNzI_adfcf55c-8d21-48a6-a131-d10f909e9a43">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS0xLTEtMS0xMDQzNzI_fb8de53f-6524-4968-8f05-b242dd975ebe">3,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS0yLTEtMS0xMDQzNzI_5b553d9b-7833-477e-b656-fb044e0b1b9e">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS00LTEtMS0xMDQzNzI_f7263ad4-3722-406f-b8ed-ddb9628e7b5f">3,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS01LTEtMS0xMDQzNzI_7ecabb3f-0d66-4d6f-8d63-e223c257ca66">885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtMS0xLTEtMTA0Mzcy_bc4cf602-ff0c-4b1c-96d3-8b17e4330016">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtMi0xLTEtMTA0Mzcy_5d61479d-19fb-4630-b4f2-c68f76841263">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtNC0xLTEtMTA0Mzcy_204f9609-6ced-463e-a238-20ca48a47134">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtNS0xLTEtMTA0Mzcy_e9d2b701-91a0-47a3-b228-92fbd9e482a6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to Baxter stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtMS0xLTEtMTA0Mzcy_e5cf2126-8d51-4e55-8f38-40f96f9b8f3d">3,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtMi0xLTEtMTA0Mzcy_aa1fed5c-0c36-4101-ba50-7e13df4eeb58">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtNC0xLTEtMTA0Mzcy_b198e005-20d3-4073-a9b8-32fd3f51c2b8">3,288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtNS0xLTEtMTA0Mzcy_1a5a350c-7bf3-45c6-a6aa-ebee86669893">878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Changes in Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares<br/>in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in<br/>treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of July 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55c7f3edeed8429db78b4f553fc45026_I20220630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0xLTEtMS0xMDQzNzI_246891eb-6b8e-4a92-90d0-74fffbc6687a">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c7f3edeed8429db78b4f553fc45026_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0yLTEtMS0xMDQzNzI_cfab1966-5942-489a-b572-404b5c9ce260">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50bf025855184ac89338332505bcf37e_I20220630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0zLTEtMS0xMDQzNzI_676ea41c-5254-4190-b99d-67414de47b3a">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50bf025855184ac89338332505bcf37e_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy00LTEtMS0xMDQzNzI_d7dd25d7-0444-4037-b338-97afd0cf97ca">11,409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a454fa8809c487b8e3d6d81416aaf44_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy01LTEtMS0xMDQzNzI_dc52f008-71b2-4b84-9509-6eba49d43065">6,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a76885f3de4448b4fffc6a3b402755_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy02LTEtMS0xMDQzNzI_d69212e0-7b8b-44cd-a3b6-64c888f3e3c4">17,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id320e76e08184ad18e0d44a027eb0e44_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy03LTEtMS0xMDQzNzI_be624cd2-6352-43eb-9099-b88a046d24b4">3,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc7215575114c6e9c9229e98fc5c182_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy04LTEtMS0xMDQzNzI_5978c92c-f295-49c9-83a2-16ae6f591581">8,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150a460e6b5240cf942785db873b20e0_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy05LTEtMS0xMDQzNzI_8515450a-f78f-4a3b-a3dd-4896d04332d4">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2ec04c98ba4de6aac9364b884a768f_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0xMC0xLTEtMTA0Mzcy_cca06fec-94c6-4e66-84a5-e42659a8602c">8,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaafa26dc685d48499145e063e9e41701_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS02LTEtMS0xMDQzNzI_9ac52281-5318-4b57-a585-605d7ca1f0ff">2,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS04LTEtMS0xMDQzNzI_89a2d8fa-c623-4f67-ae36-3b77f2de0e68">2,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS05LTEtMS0xMDQzNzI_27da035c-fcb0-4cbe-8382-091e5fdfe757">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS0xMC0xLTEtMTA0Mzcy_fc9b942a-d63e-4a69-b8c8-27ea59aaf089">2,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68bb769194c44702bc4f210eb327fd47_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi03LTEtMS0xMDQzNzI_0e2d286e-2e56-4e77-affc-e5534a26dbe2">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi04LTEtMS0xMDQzNzI_90c1fa78-ab38-408a-b1c4-a67bf522cacd">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi0xMC0xLTEtMTA0Mzcy_b3b5ed57-7b3b-48a9-9a75-7d6bc21cc721">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy00LTEtMS0xMDQzNzI_21464846-594d-4b7c-a04f-edb86e75daa9">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy04LTEtMS0xMDQzNzI_a652ad7c-a818-4c66-a8a0-5159827c3323">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy0xMC0xLTEtMTA0Mzcy_ea605a52-667f-41be-b6e8-c79c216ecbc1">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC0zLTEtMS0xMDQzNzI_d0eeef0c-35ae-4a52-9219-9e5d7832a28b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC00LTEtMS0xMDQzNzI_d83674f5-3aa5-4aad-a375-4e4cc8ad9f54">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5b6addca054a8c977547a71a11eb9d_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC01LTEtMS0xMDQzNzI_f8abbdf3-5aa5-4ae0-afe8-a46e0bd0eff5">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC04LTEtMS0xMDQzNzI_940934a0-19db-4a3b-95d2-350cc3dea840">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC0xMC0xLTEtMTA0Mzcy_f9b25fa9-b6a1-4822-ade7-1197af700aba">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaafa26dc685d48499145e063e9e41701_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS02LTEtMS0xMDQzNzI_24187408-200c-4164-b21e-aa9070764755">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS04LTEtMS0xMDQzNzI_bf434427-9589-4b14-949e-7c0ee75012aa">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS0xMC0xLTEtMTA0Mzcy_f01a149b-40de-4b9f-a465-4270701e2737">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTAtOS0xLTEtMTA0Mzcy_41385d2f-2602-4db3-8797-938b12e7f6ef">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTAtMTAtMS0xLTEwNDM3Mg_b80834f7-06c3-484c-b5a0-addb91100949">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMS0xLTEtMTA0Mzcy_25972cb5-1eea-4bdc-9ae1-667b5a0406f6">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMi0xLTEtMTA0Mzcy_83832a12-665a-4628-9711-9590f38d8576">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46185672532c493c87739cf7e9615db2_I20220930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMy0xLTEtMTA0Mzcy_0133bb22-e485-466a-9055-564d776f193e">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46185672532c493c87739cf7e9615db2_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNC0xLTEtMTA0Mzcy_6dabdfd3-5c32-4d2d-a9cf-fe910c2e323b">11,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNS0xLTEtMTA0Mzcy_c3c80fb7-d2ab-424b-a0d1-c4b862ee84ec">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b2f4c215a4c959a65859e3605344e_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNi0xLTEtMTA0Mzcy_0d9c02b8-9dd0-44ff-9c25-233eb27fbf14">14,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e06fdeb2414477d921f3587f0c89a44_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNy0xLTEtMTA0Mzcy_9554d697-0425-4693-b4eb-a83149123236">4,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0218eda155249b4a4da75408a661f78_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtOC0xLTEtMTA0Mzcy_26b67a39-3ade-4a4e-9b8d-7c66b658e7ee">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315357d813df434ea52bc4a2bd057649_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtOS0xLTEtMTA0Mzcy_ff7d0fa6-6494-42d0-8b1c-bdace61e8bd9">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMTAtMS0xLTEwNDM3Mg_53949b90-1a4b-42e7-ae65-234528d0b022">5,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the nine months ended September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares in treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0xLTEtMS0xMDQzNzI_e79ecd11-546e-4ca4-b33c-82e0bdda5941">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0yLTEtMS0xMDQzNzI_5d5f532e-9a08-42e2-84e9-c09398c4ec0f">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ebdd308c0aa480ab3f408048666bc96_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0zLTEtMS0xMDQzNzI_7adbfe20-6761-43dd-94f8-ea5066f52243">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ebdd308c0aa480ab3f408048666bc96_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy00LTEtMS0xMDQzNzI_0e159d79-7a30-42f0-8513-acc1d67d271d">11,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725b88481fef4b7db4a008b05245cf1f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy01LTEtMS0xMDQzNzI_73b6fe99-78a3-4868-9ab4-e0762491161f">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb99534e9ac74a81934e5e38cb02f00f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy02LTEtMS0xMDQzNzI_bba2ae77-aa7b-4c5d-9203-63e33f5442a1">17,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2915afd9c994936a8dd5af0ce476706_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy03LTEtMS0xMDQzNzI_2c882b06-2341-4158-8433-894404436bc9">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i701c21dcb04e48f6873a3307cf046c39_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy04LTEtMS0xMDQzNzI_c0d70416-6f28-4547-823d-2787db3c5f79">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7717dccf2b6422d90b12fdb9dc4ce69_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy05LTEtMS0xMDQzNzI_fb68fadf-a5e6-4fde-977e-aee21e4f14f4">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0xMC0xLTEtMTA0Mzcy_2444058d-22e7-4297-af7a-61328420e55e">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS02LTEtMS0xMDQzNzI_59d34c1f-f818-4a7b-913a-aad12eac3a8d">2,614</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS04LTEtMS0xMDQzNzI_33c0082b-5282-4066-9698-a7212ad1ce3f">2,614</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS05LTEtMS0xMDQzNzI_d57b428e-f6d1-4e5f-b727-6ffae97f85ab">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS0xMC0xLTEtMTA0Mzcy_b4579838-279c-491f-a493-a8724fcb7819">2,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7267511ecf06427ca86cc16435200efe_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi03LTEtMS0xMDQzNzI_4fa20db7-43a9-468b-b27e-5d7fb90e1651">674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi04LTEtMS0xMDQzNzI_888263a2-f8ff-49e9-a844-9ea042f08d05">674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi0xMC0xLTEtMTA0Mzcy_40689a65-3f3a-4f74-b384-36da94f9c263">674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy00LTEtMS0xMDQzNzI_9c5b0886-f3ae-423c-88c6-85176a30daca">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy04LTEtMS0xMDQzNzI_540c3089-b124-485b-a99b-16b1225302b2">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy0xMC0xLTEtMTA0Mzcy_7f19fb1e-02d9-4ad9-a463-6de6b054bb3c">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC0zLTEtMS0xMDQzNzI_7f32c196-c9b8-4e78-bbd1-ab091aaea375">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC00LTEtMS0xMDQzNzI_ae0c9dd1-bfbf-4684-82be-a97f21492814">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07aa4a40cec3445b9b7c2eae2471f420_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC01LTEtMS0xMDQzNzI_676bb5ff-d7a0-4363-b209-75bc65a9140c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC04LTEtMS0xMDQzNzI_e8214d6e-9703-46c2-9234-0b2df876d7f9">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC0xMC0xLTEtMTA0Mzcy_54fc64b7-8d96-4a93-9194-37349f25e5c4">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS02LTEtMS0xMDQzNzI_42226a3e-77e6-47e0-b548-79594b1dddc0">436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS04LTEtMS0xMDQzNzI_50d75864-4b3f-45e5-826b-234a5df9de29">436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS0xMC0xLTEtMTA0Mzcy_07bb002e-1769-4bb5-88fa-49dee69e882f">436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTAtOS0xLTEtMTA0Mzcy_03b5e3e3-3caa-4658-8d00-f0d040436753">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTAtMTAtMS0xLTEwNDM3Mg_02fc4e52-05c2-4c4c-809f-4b1b22cf912d">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMS0xLTEtMTA0Mzcy_d0c22252-9747-441c-919b-5e34be30a1aa">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMi0xLTEtMTA0Mzcy_5005597e-7f91-4d0d-a411-33ed22c32d30">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46185672532c493c87739cf7e9615db2_I20220930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMy0xLTEtMTA0Mzcy_71917695-23f4-4f44-af40-8ed318eaa671">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46185672532c493c87739cf7e9615db2_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNC0xLTEtMTA0Mzcy_8de18fc3-4d86-4045-b0d5-edf8fe820235">11,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNS0xLTEtMTA0Mzcy_b0d7d6c3-1a4b-4ae5-98eb-61454acf344f">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b2f4c215a4c959a65859e3605344e_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNi0xLTEtMTA0Mzcy_bbba24dd-6db8-4c85-9a9c-5fbc51d4f97b">14,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e06fdeb2414477d921f3587f0c89a44_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNy0xLTEtMTA0Mzcy_fa77342b-6e9c-4444-9fbd-84d3fd4e7037">4,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0218eda155249b4a4da75408a661f78_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtOC0xLTEtMTA0Mzcy_cfd6607b-b33d-4adb-9ea8-b827d488c22c">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315357d813df434ea52bc4a2bd057649_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtOS0xLTEtMTA0Mzcy_cd79cd48-2459-4284-b037-95eb31d0495a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMTAtMS0xLTEwNDM3Mg_5b48e04c-8adc-4880-81b2-8f966c5cde96">5,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of July 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i445ba8e9550344a6a0934d07c688931b_I20210630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0xLTEtMS0xMDQzNzI_4ea53c8f-d2fe-4147-957f-6055afa9b519">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445ba8e9550344a6a0934d07c688931b_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0yLTEtMS0xMDQzNzI_0d577808-5713-462c-891a-0c703a973d6e">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if779e104e4c64cb0b90cbb72e25d9c25_I20210630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0zLTEtMS0xMDQzNzI_ecbb2a20-f01b-44dd-900f-da79151d1e96">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if779e104e4c64cb0b90cbb72e25d9c25_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy00LTEtMS0xMDQzNzI_f6ee132a-0328-49f5-9d91-baf8d80882c5">11,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfa5f433f3c41f4ad813f18db07aeb6_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy01LTEtMS0xMDQzNzI_e27d5862-ac88-465d-b967-1efb508821e4">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1097bf8723ad4d40980c7a8684d82542_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy02LTEtMS0xMDQzNzI_88f5e261-0211-475a-b32d-5902483516c5">16,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9566c813807f46f9bca41a6a1eab60fd_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy03LTEtMS0xMDQzNzI_1d248d2d-95f9-42f1-af93-30385a4a141b">3,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i923c5d6629ac43938dde7322bca7a94f_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy04LTEtMS0xMDQzNzI_1698f430-a68e-4acb-a93b-ee711a384c25">8,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7adec63f56fe475aa13f80a829a783e3_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy05LTEtMS0xMDQzNzI_e62d987d-e397-4758-93ba-9a8746c70b7f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378c9497bb354eda8c5fec775c27e410_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0xMC0xLTEtMTA0Mzcy_f4d26b77-993b-4ee2-889b-8b05d306a1af">8,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS02LTEtMS0xMDQzNzI_6f4f9939-1dca-47ce-af6a-f4f89fd6f173">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS04LTEtMS0xMDQzNzI_b3812e40-b402-44ab-bdbf-ad04352cc47c">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS05LTEtMS0xMDQzNzI_75ee5bae-3c05-4984-a8f4-91737cdb3210">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS0xMC0xLTEtMTA0Mzcy_2c37945e-872d-4351-872f-8e25a19ecf99">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46300513cafe40bc8da05e9ae619e87d_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi03LTEtMS0xMDQzNzI_e55b1892-ddd4-4203-b012-343ae2c59716">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi04LTEtMS0xMDQzNzI_b75f2007-0b8d-4611-9ac1-a677ed806c7e">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi0xMC0xLTEtMTA0Mzcy_36993f9a-b050-49bf-9163-111d94cd5702">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC0zLTEtMS0xMDQzNzI_a7580a46-e809-4b2b-a759-35b3a18b17ae">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC00LTEtMS0xMDQzNzI_6c71523e-f579-4ac7-810d-ac7d4cf08d6b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cbf6e7717b42ed8cd2f03aefaa9a00_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC01LTEtMS0xMDQzNzI_120f71d1-167e-4a4a-8a08-29c971a6ba34">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC04LTEtMS0xMDQzNzI_2943e475-45fa-43a3-9402-3eff6ce7bb55">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC0xMC0xLTEtMTA0Mzcy_f7b18b12-05e0-471a-8596-99384048d369">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS02LTEtMS0xMDQzNzI_22f69143-40a3-4991-88fd-d3a0aaf43f0d">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS04LTEtMS0xMDQzNzI_f50bcf32-9f31-4f49-8e5e-563376a57685">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS0xMC0xLTEtMTA0Mzcy_55a88f10-5cb7-41ca-a67f-27990bdd2d95">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTAtOS0xLTEtMTA0Mzcy_6fdc263b-d282-41a8-8e9d-a0ca4bb65d7e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTAtMTAtMS0xLTEwNDM3Mg_0b0baf40-232d-4f51-8dcd-1f4abadd83a1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMS0xLTEtMTA0Mzcy_7dab8110-d10c-4182-a5fb-0e900f55dcd6">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMi0xLTEtMTA0Mzcy_64e55094-e7ad-4a34-a4ed-95ede5f915b0">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMy0xLTEtMTA0Mzcy_d66a1bbe-2868-42bc-b127-c040a6e5b7bb">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNC0xLTEtMTA0Mzcy_8a4b2dc4-39fa-4551-ae27-39885de8e7c1">11,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebeb40172e54d468de1bba6e61fded4_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNS0xLTEtMTA0Mzcy_dd6f6fd4-3a3e-4664-884a-68717be491d0">6,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNi0xLTEtMTA0Mzcy_f118383a-dff3-455c-ad03-0144ddc8ac07">16,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie27b36ac02ab451db59daf7bc158e8b3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNy0xLTEtMTA0Mzcy_e5e5ab4f-f30c-4486-be1e-9f9b12699f44">3,482</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i741c91bea17b416e8523648018b62817_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtOC0xLTEtMTA0Mzcy_fa5713c3-f3ed-4165-880f-5d1526c75e7b">8,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtOS0xLTEtMTA0Mzcy_7ea1f8d4-6e9d-4aea-a1d6-cc3426238a6f">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMTAtMS0xLTEwNDM3Mg_db56bd84-f09b-47e4-8c44-19a7b6b6aecf">8,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the nine months ended September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7deaf997b8b04e419ae489df558eb400_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0xLTEtMS0xMDQzNzI_58f99f4c-3e63-4cc4-b015-20db7bff7c54">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7deaf997b8b04e419ae489df558eb400_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0yLTEtMS0xMDQzNzI_63684317-3a35-42c8-8142-134d3dbc6b9b">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0zLTEtMS0xMDQzNzI_08fc1b5e-f41b-40d0-bec6-2de706f6d6ce">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy00LTEtMS0xMDQzNzI_bf250cea-01e6-479d-aaa7-e4f77c99961d">11,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9bdd01dd21457c955deb29629dbb05_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy01LTEtMS0xMDQzNzI_0dc2f896-58a3-4848-bcfc-2b9803505166">6,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bbc2059dee49748a9fb82ccedc2cc5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy02LTEtMS0xMDQzNzI_516dc841-dbd3-401d-9925-731562771f69">16,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i260874a837714dd18b6d85c063e738f4_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy03LTEtMS0xMDQzNzI_c6cf52ef-926f-4978-98f1-5adad15ac12a">3,314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061c707fc46f4796a51c7a57108a7be4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy04LTEtMS0xMDQzNzI_752a1d19-4aec-45b0-a67c-968910fa4055">8,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87069b641164461ea1d9c503986a6adb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy05LTEtMS0xMDQzNzI_4d702fec-7645-4352-8475-194e5acbe5fb">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0xMC0xLTEtMTA0Mzcy_c2e5cc40-6b7c-4be0-acba-a68bd2f90bc9">8,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b50155674434910931b52027a356924_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS02LTEtMS0xMDQzNzI_e3a942af-c191-4df5-ba78-e27c301a18a5">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS04LTEtMS0xMDQzNzI_0677493d-61a3-401f-b80c-a880f7e5e98a">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS05LTEtMS0xMDQzNzI_869bbe78-ca2f-4d1c-980e-03732fb5fd26">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS0xMC0xLTEtMTA0Mzcy_42a2d4b8-e399-4b9c-837f-f01dd3929201">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a04eb3f97aa454290cf5576bef8ba31_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi03LTEtMS0xMDQzNzI_dda0ecac-33d2-4a5b-ab85-fd3e0d4b7788">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi04LTEtMS0xMDQzNzI_3848c640-ebe2-4ae4-8688-57af2bdd1d8e">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi0xMC0xLTEtMTA0Mzcy_3be45ea8-2ff9-4215-96dd-707106147262">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy0zLTEtMS0xMDQzNzI_313c96b3-ccc0-4403-ae31-02a09c5740ad">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy00LTEtMS0xMDQzNzI_a0b53c41-a561-4e5e-8614-7c451542799f">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy04LTEtMS0xMDQzNzI_4ee792bf-4123-42e6-b57e-09baa22de22f">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy0xMC0xLTEtMTA0Mzcy_6fb3a87c-5006-4252-8c6a-4583851b7e8d">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC0zLTEtMS0xMDQzNzI_018f1e4c-0ac3-4490-8074-0df043c3ea95">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC00LTEtMS0xMDQzNzI_781debe4-290c-4f8e-8d12-e06e06da6f3d">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc9d6f153964e0d89122d5270df88f6_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC01LTEtMS0xMDQzNzI_98c8fb8d-d997-4b28-b566-53c315b1565e">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC04LTEtMS0xMDQzNzI_9676fa95-c2d3-45ea-90fd-7b14db602f15">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC0xMC0xLTEtMTA0Mzcy_b18aa0bf-2863-4ae2-be19-f979129125d6">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b50155674434910931b52027a356924_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS02LTEtMS0xMDQzNzI_5d837491-6973-4ade-9ce6-5568ed5b1965">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS04LTEtMS0xMDQzNzI_ca98c3a7-57fc-4dd0-b187-ef4d882dcc39">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS0xMC0xLTEtMTA0Mzcy_40bdcc74-c150-4407-9def-b80377b75d86">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTAtOS0xLTEtMTA0Mzcy_742cab01-6440-48c5-a83e-3709a4888777">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTAtMTAtMS0xLTEwNDM3Mg_9b41724c-f8d4-47d6-a15c-770666b79b2e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMS0xLTEtMTA0Mzcy_72e9c838-7aea-426c-a585-c8e1e686d9fa">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMi0xLTEtMTA0Mzcy_2ec462bd-bb54-4659-98ac-9c9c5822ebf9">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMy0xLTEtMTA0Mzcy_7793f20d-f8cc-49ea-b991-db921510300b">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNC0xLTEtMTA0Mzcy_00e24390-1ece-459e-aab4-4a9f7fb49fef">11,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebeb40172e54d468de1bba6e61fded4_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNS0xLTEtMTA0Mzcy_c0b838b1-fcf4-4c44-8f21-2176469a86f8">6,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNi0xLTEtMTA0Mzcy_41d12b3f-168c-489e-b148-7a6d79878ea7">16,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie27b36ac02ab451db59daf7bc158e8b3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNy0xLTEtMTA0Mzcy_63358d59-d35d-40f5-8935-13a3ef05ba9f">3,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i741c91bea17b416e8523648018b62817_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtOC0xLTEtMTA0Mzcy_6fc4fdbb-f797-493c-bfc7-55836b1c93c8">8,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtOS0xLTEtMTA0Mzcy_236e176c-2a71-4066-a749-1eaa620bcf21">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMTAtMS0xLTEwNDM3Mg_c0f6e130-dc7f-4ff7-98d9-a4b44d090ca9">8,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMy0xLTEtMS0xMDQzNzI_9fc390c1-aeff-481a-bb68-00f6b14dc560">2,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMy0yLTEtMS0xMDQzNzI_915acc20-cfad-4e04-ae3a-d5537b172b30">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash flows from operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNS0xLTEtMS0xMDQzNzI_33b88599-ec8c-412f-ac4a-6e0a28d03f06">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNS0yLTEtMS0xMDQzNzI_c759890d-d057-4825-83e1-9768172702c7">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNi0xLTEtMS0xMDQzNzI_2447208f-d5ca-403c-aac3-20dcbc883a55">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNi0yLTEtMS0xMDQzNzI_25baa92d-24c7-495e-9533-649e38acaaca">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNy0xLTEtMS0xMDQzNzI_40b499eb-a414-4f5a-bbe2-7ef1073c846d">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNy0yLTEtMS0xMDQzNzI_12983cca-4142-493d-9ee9-2a9a232b7064">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension and other postretirement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOC0xLTEtMS0xMDQzNzI_11106aec-7f65-4bba-aa1a-cd47574b50d5">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOC0yLTEtMS0xMDQzNzI_3c8d52e5-8498-41b9-9bfb-6a36af0b2871">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOS0xLTEtMS0xMDQzNzI_d90745e7-b07c-4288-9145-3f64aaa89e61">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOS0yLTEtMS0xMDQzNzI_5fb47d66-3e7e-4678-9197-c8646263c4c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTE0MjAy_5f9c9e07-8ace-4104-9c22-7a89e0844f5c">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTE0MjAy_7930858c-124c-467c-aa7c-fd7d97abe755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on product divestiture arrangement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTEtMS0xLTEtMTE3ODcx_077b9241-af2b-4072-80fc-255ebafa9fc7">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTEtMi0xLTEtMTE3ODcx_4b612670-c022-4a14-a1f3-ade970d6993b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTEyNzg5_8bd10948-46e5-4af9-aae2-2e89a11644e3">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTEyNzk3_9bf694ff-706e-457f-8442-1627af8f17e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTA0Mzcy_4b746919-2d7f-4b52-9a9a-9440404e59e8">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTA0Mzcy_212b93ad-34e8-4966-8279-3ce1022897c2">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in balance sheet items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTItMS0xLTEtMTA0Mzcy_68bb8b47-1308-4eda-94be-0a88c1fdb00e">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTItMi0xLTEtMTA0Mzcy_43bf4398-4c63-44f6-ba6d-44218d777aa8">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTMtMS0xLTEtMTA0Mzcy_eb9b3f1b-641b-45b9-933b-2d8f5b29e1ff">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTMtMi0xLTEtMTA0Mzcy_b3559316-da3f-43ef-ad31-ae3b49aa9efe">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTQtMS0xLTEtMTA0Mzcy_b1d038e9-a049-4015-af49-50a7251dad13">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTQtMi0xLTEtMTA0Mzcy_868bfaa6-2078-45d9-b7a5-57576437ea09">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTUtMS0xLTEtMTA0Mzcy_7809fba0-f8ee-40cb-892a-ae644135585a">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTUtMi0xLTEtMTA0Mzcy_41b3aab2-7647-4df3-8947-43fd385b6b76">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTYtMS0xLTEtMTA0Mzcy_3af4d443-ce95-4f20-8102-bdb5ad0abf81">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTYtMi0xLTEtMTA0Mzcy_db429e1d-151f-4d87-8ade-e39d9587fabc">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTctMS0xLTEtMTA0Mzcy_23188747-5e53-43a7-a063-858b0536afa6">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTctMi0xLTEtMTA0Mzcy_f85315f6-4d3e-41ae-9187-e6a726bf832a">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjAtMS0xLTEtMTA0Mzcy_abd538da-f71c-4c29-833f-9376f8220bfc">772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjAtMi0xLTEtMTA0Mzcy_b0ff1270-596b-4cd8-95d4-197845fcc9f6">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjItMS0xLTEtMTA0Mzcy_d9b04a16-412f-4a3a-80f0-98126283acef">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjItMi0xLTEtMTA0Mzcy_3fdda4a3-154d-466e-b03e-bd64522afd53">508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired, and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjMtMS0xLTEtMTA0Mzcy_995b181e-4bfe-43af-ad58-1e33b1286594">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjMtMi0xLTEtMTA0Mzcy_3385d0f5-1060-48c7-91f8-8877aa4b835a">463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjQtMS0xLTEtMTA0Mzcy_aa32e23f-97e2-4197-9dd7-7546577bfed6">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjQtMi0xLTEtMTA0Mzcy_027f5f54-20c7-4312-9c95-acab53193089">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjUtMS0xLTEtMTA0Mzcy_2e3ad559-d2d3-49d5-af14-f26a5ddd4931">675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjUtMi0xLTEtMTA0Mzcy_818d0d49-6eff-4021-91d3-042bec57d7b2">933</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjctMS0xLTEtMTA0Mzcy_d24881e9-40ba-4e75-92ea-63373f65dbd8">953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjctMi0xLTEtMTA0Mzcy_ebcc768c-221d-496a-a6d4-4140a21ee844">407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjgtMS0xLTEtMTA0Mzcy_f393e2eb-07d7-4235-b6fe-bf364f4dc9e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjgtMi0xLTEtMTA0Mzcy_b0f39b84-9e1f-4c3d-8ac3-ddb9ca1ba28a">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increases (decreases) in debt with original maturities of three months or less</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjktMS0xLTEtMTA0Mzcy_69e314c0-d12b-49be-a5d5-580935478bce">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjktMi0xLTEtMTA0Mzcy_e9f956ed-8c60-4161-b8d5-b913efdd0101">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzAtMS0xLTEtMTA0Mzcy_b45c20f0-d899-4684-898f-a4317586954f">427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzAtMi0xLTEtMTA0Mzcy_fc85ff2d-9bda-4239-9297-ca3bbd8301c3">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock issued under employee benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzEtMS0xLTEtMTA0Mzcy_a2a99bdc-0763-4df8-86f4-2b28f0fb4014">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzEtMi0xLTEtMTA0Mzcy_2bdf0422-a276-45a1-b5ba-2c77762d9543">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzItMS0xLTEtMTA0Mzcy_c0bf8637-5d3a-4b91-a3b6-50a66d2750f7">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzItMi0xLTEtMTA0Mzcy_70925401-501b-4a4e-b900-962f30e9f437">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzMtMS0xLTEtMTA0Mzcy_d4df023b-57d5-47f7-aed9-7f5a52be6fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzMtMi0xLTEtMTA0Mzcy_dd069585-f2a8-4e60-8ad9-fd4dedd70b22">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzQtMS0xLTEtMTA0Mzcy_f5b58cc9-8683-406d-bcd6-30a52f7d708a">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzQtMi0xLTEtMTA0Mzcy_f532a139-f50d-405c-8a9b-4d2fde4c532d">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzUtMS0xLTEtMTA0Mzcy_38d7968c-2d41-4fbe-ae5d-b54426e083bc">1,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzUtMi0xLTEtMTA0Mzcy_b0bdba8a-9188-4fd1-96ab-6867ac6fd640">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzYtMS0xLTEtMTA0Mzcy_b59c290f-44af-4716-aa7b-693f7e612f86">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzYtMi0xLTEtMTA0Mzcy_94ea6e08-025f-4ec6-9d49-db92c5213c34">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzctMS0xLTEtMTA0Mzcy_eb1ab64a-eafa-4d00-b2e2-61990a38b870">1,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzctMi0xLTEtMTA0Mzcy_a6923045-1e29-47b4-9733-210ab7e470cf">475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4" continuedAt="i61b727f6f3c34bbcba8aacc03552a3a8" footnoteRole="http://www.xbrl.org/2003/role/footnote"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of September&#160;30, 2022, December&#160;31, 2021, and September&#160;30, 2021 (in millions):</ix:footnote></span><ix:continuation id="i61b727f6f3c34bbcba8aacc03552a3a8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0xLTEtMS0xMDQzNzI_079b2a9f-e3d0-4398-ad2b-4eda308fa062">1,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0yLTEtMS0xMDQzNzI_94be0923-ef82-4105-8b52-979c5113b072">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0zLTEtMS0xMDQzNzI_d9b75a5b-2e5e-460c-af3f-b3984e875d92">3,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0xLTEtMS0xMDQzNzI_f7768519-bb2c-4e22-a7dc-277667826608">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0yLTEtMS0xMDQzNzI_5e1d6043-4a4b-458d-ac81-c3c669ff86e7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0zLTEtMS0xMDQzNzI_280b5e1e-bfdb-489d-b491-54a69f2bf6e5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0xLTEtMS0xMDQzNzI_cd719667-030b-4e29-b488-f57d01b83b88">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0yLTEtMS0xMDQzNzI_9307193b-a534-4e08-acdc-53dda8ac5ddd">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0zLTEtMS0xMDQzNzI_3ba24496-0d9e-431d-ac4c-2b7b19ff4ff6">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div id="iaef9f667721343c48067444506cf55c3_34"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">1. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4NA_f4ff3dd0-b722-4660-8e36-af69364c4abb" continuedAt="idb92a345830d4c1d8e3262426a056e7f" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="idb92a345830d4c1d8e3262426a056e7f"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4Ng_d51aa983-d1d1-4ef1-89a2-3eb8f9b4471b" continuedAt="icc74418f0aeb44dd8618dc800d8dca27" escape="true">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icc74418f0aeb44dd8618dc800d8dca27">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</ix:continuation> </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="bax:RisksAndUncertaintiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI5Mg_1a933d06-bdc6-4867-b69b-541a37cafc09" continuedAt="i129e88b84a4948a2b5e33c61201d4c9b" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future. </span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i129e88b84a4948a2b5e33c61201d4c9b">We expect that the challenges caused by the pandemic as well as global economic conditions, among other factors, may continue to have an adverse effect on our business.</ix:continuation>  </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4Nw_44bd1175-c37c-4e69-b638-2a7063eadf0a" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNg_aab3340a-8c0c-4cb0-b134-70b23fec9ee5" continuedAt="i451c9f317ae746beadd86af8e7b6bf68" escape="true">ACQUISITIONS AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><ix:continuation id="i451c9f317ae746beadd86af8e7b6bf68" continuedAt="i35a156fd35764e6196b4d7283c5cc7a4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjAw_969b9b64-847d-4a52-b5c9-e2c46cf0dfac">10.5</ix:nonFraction>&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $<ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-8" name="bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzE5_56e1ffc9-2fa9-4814-8ab4-c8e494a42bb5">12.8</ix:nonFraction>&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $<ix:nonFraction unitRef="usdPerShare" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNDAw_00e8c3c2-3c74-4ce3-8a4a-d01c2fa663c5">156.00</ix:nonFraction> in cash per outstanding Hillrom common share. </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNw_8311c9f2-bb34-4cde-b0a3-87f6b7ad9fc7" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMS0xLTEtMS0xMDQzNzI_48f234ff-4f79-4b4e-901f-f124e76f52c4">10,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMi0xLTEtMS0xMDQzNzI_1b6d5efa-289a-4d0b-a9ff-85e523c4741c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMy0xLTEtMS0xMDQzNzI_0f3be8f0-ad36-424e-912a-3693ec7a89b7">10,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $<ix:nonFraction unitRef="usdPerShare" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTgw_ec23b5f6-893c-4dfe-a0db-827038add4d7">156.00</ix:nonFraction> per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of <ix:nonFraction unitRef="shares" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfODAz_24ea6343-35b8-41c3-b17c-5d9a0a9440cd">668</ix:nonFraction>&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of assets acquired and liabilities assumed has not yet been finalized as of September 30, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwOA_7290780f-a649-461e-88d5-518eaa4e7e43" continuedAt="i5d08333d91b84a54a2f9a6dfdb2aa5bc" escape="true">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:</ix:nonNumeric></span></div><div style="margin-top:3pt"><ix:continuation id="i5d08333d91b84a54a2f9a6dfdb2aa5bc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMi0xLTEtMS0xMDQzNzI_7914b354-9a22-4899-838c-dc3b5e3d65f2">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMy0xLTEtMS0xMDQzNzI_21e4e285-47e4-45ec-8a4c-d9c1ab2e788a">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNC0xLTEtMS0xMDQzNzI_6e62039b-a888-4efd-bbd0-d00751dadbc0">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNS0xLTEtMS0xMDQzNzI_746adf99-c778-404d-95f8-8f04f74c29cc">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNi0xLTEtMS0xMDQzNzI_cfd399e1-717e-43d3-a176-eca48f9c0ec6">514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNy0xLTEtMS0xMDQzNzI_43c25794-2db1-49b4-a29c-68df30ed6fed">6,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfOC0xLTEtMS0xMDQzNzI_de45e4d4-5143-408f-834c-0530ed602341">6,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfOS0xLTEtMS0xMDQzNzI_7c6d79a7-c9cf-4bba-b30f-19bce2af8f6a">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTAtMS0xLTEtMTA0Mzcy_109a9a81-8ea8-4a12-94fe-744b8138d708">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTEtMS0xLTEtMTA0Mzcy_30b1905e-33f2-452a-946e-8d91c44423e3">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTItMS0xLTEtMTA0Mzcy_b7b36bd1-b50b-4c90-a21d-5cf8c4c03982">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTMtMS0xLTEtMTA0Mzcy_50734356-c730-4c20-b409-20fef9ebb9e7">558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTQtMS0xLTEtMTA0Mzcy_89424b89-d6e3-4104-8450-5bdd6debfb96">2,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTUtMS0xLTEtMTA0Mzcy_205930af-1ff5-4750-bb9f-415feb7ca825">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTYtMS0xLTEtMTA0Mzcy_b2738c6c-d2a2-4b0f-8527-aa5d76815657">1,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTctMS0xLTEtMTA0Mzcy_2fec46ea-777e-434c-9704-39f65bb93fff">10,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022 we recorded measurement period adjustments, primarily impacting accounts receivable, property, plant and equipment, other intangible assets, and deferred income tax liabilities. Individually the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i35a156fd35764e6196b4d7283c5cc7a4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement period adjustments were not material and in total increased goodwill by $<ix:nonFraction unitRef="usd" contextRef="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMTY4Ng_db47b8e4-5755-4083-8fe8-7117f630bfb0">25</ix:nonFraction>&#160;million. The measurement period adjustments did not have a significant impact to our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill from the Hillrom acquisition, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. See Note 4 for additional information about impairments recognized in the third quarter of 2022 related to goodwill and certain intangible assets acquired in the Hillrom acquisition. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, we recognized $<ix:nonFraction unitRef="usd" contextRef="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930" decimals="-6" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjA5MA_1d2c4748-b4fe-4141-b6c1-4af68ab19886">159</ix:nonFraction>&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the first quarter. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Other Business Development Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Celerity Pharmaceuticals, LLC</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2013, we entered into an agreement with Celerity Pharmaceuticals, LLC (Celerity) to develop certain acute care generic injectable premix and oncolytic products through regulatory approval. We transferred our rights in these products to Celerity and Celerity assumed ownership and responsibility for development of the products. We are obligated to purchase the individual product rights from Celerity if the products obtain regulatory approval. In December 2020, we entered into an agreement with a third party to divest our rights to one of the products that was being developed by Celerity, a generic version of liposomal doxorubicin, for less than $<ix:nonFraction unitRef="usd" contextRef="i773f5845d4754661b8aab38716b10554_D20200101-20201231" decimals="-6" name="bax:ProceedsFromDivestitureOfProductRights" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTQ5NzU1ODE5MTEz_5794c376-250b-48ee-b3e1-c31eca37acb7">1</ix:nonFraction>&#160;million if that product were to receive regulatory approval in the U.S. and European Union in 2022. Liposomal doxorubicin is a chemotherapy medicine used to treat various types of cancer and we entered into this transaction to divest our rights to this generic version of that product after we had separately entered into a transaction to acquire the branded version. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related regulatory approvals were subsequently obtained for the generic version of liposomal doxorubicin and we recognized a loss of approximately $<ix:nonFraction unitRef="usd" contextRef="i1d01f750794044e794ffffe67feb1dcf_D20220701-20220930" decimals="-6" sign="-" name="bax:GainLossOnDispositionOfProductDivestitureArrangement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTQ5NzU1ODE5MTI2_dae593fe-c1d0-4511-8024-83a32608bdf7">54</ix:nonFraction>&#160;million in the third quarter of 2022, representing the difference between the amount we owe Celerity following those regulatory approvals and the proceeds that we will receive from our divestiture of those product rights. That loss is reported within other operating expense (income), net in our condensed consolidated statements of operations for the three and nine months ended September 30, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Zosyn</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $<ix:nonFraction unitRef="usd" contextRef="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjY5MA_b100e751-9b6e-4efa-881b-8b0c8be050ae">122</ix:nonFraction> million currently, received specified intellectual property, including patent rights, in the first quarter and will receive additional intellectual property, including the product rights to Zosyn, in the first quarter of 2023.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $<ix:nonFraction unitRef="usd" contextRef="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzM1Ng_b100e751-9b6e-4efa-881b-8b0c8be050ae">122</ix:nonFraction> million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of <ix:nonNumeric contextRef="ic8a3ba76ddc34ac9b96c72e99f2225b5_D20220301-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNA_ffb94eed-e1a1-44e7-90d2-c04d0fcab328">9</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">3. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQy_3aa7ca60-715c-4bd9-9d6b-6909561ec61a" continuedAt="iadb6c14515a84cf9966a7d03275b8b20" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="iadb6c14515a84cf9966a7d03275b8b20" continuedAt="i14a874ec242e410289875357655da93a"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQz_6f90f232-1e4e-4ce8-944e-6b0072d99c5d" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2ec04c98ba4de6aac9364b884a768f_I20220630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0xLTEtMS0xMDQzNzI_57ea95b3-b76d-4179-b8e1-5e52b4cf5303">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378c9497bb354eda8c5fec775c27e410_I20210630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0yLTEtMS0xMDQzNzI_0094a29e-d91f-4587-b348-1ef0b50608a4">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0zLTEtMS0xMDQzNzI_1300aaa3-f4e5-4462-8da7-ca375102e2e7">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi00LTEtMS0xMDQzNzI_99626930-c62e-46b2-ab78-df7d4b7298fb">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0xLTEtMS0xMDQzNzI_89f5d7a9-0f27-42e8-91f0-edb264dab8a7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0yLTEtMS0xMDQzNzI_18f8a758-d050-4c27-b133-a8bb1082e1eb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0zLTEtMS0xMDQzNzI_ce2f677f-014a-45a7-8d75-905a07fd4580">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC00LTEtMS0xMDQzNzI_de2f990e-d0e2-4f44-99cd-5ebbd4cbeaa5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0xLTEtMS0xMDQzNzI_92a97827-e026-42dd-af02-55cba607ca1e">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0yLTEtMS0xMDQzNzI_a6dcedbf-7d00-4f87-82c5-3571418e5fba">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0zLTEtMS0xMDQzNzI_a726502c-e7c1-4228-9af3-ed67e66f237b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS00LTEtMS0xMDQzNzI_41e03a05-eb5c-4627-bdb0-9c4b629ad477">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0xLTEtMS0xMDQzNzI_07f3cb8e-711b-4d21-8893-b3e284851c17">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0yLTEtMS0xMDQzNzI_0c0a334f-dc73-4428-84f6-339809a88256">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0zLTEtMS0xMDQzNzI_efaf1a2e-c2a5-4960-b150-5b16b2926e75">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi00LTEtMS0xMDQzNzI_40f2ba37-fe11-4d93-b532-184321d2ebfc">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0xLTEtMS0xMDQzNzI_1fc62eb1-8bdc-4276-b265-5ebab150e915">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0yLTEtMS0xMDQzNzI_54a01577-f795-478b-ba5a-842be9b36d90">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0zLTEtMS0xMDQzNzI_8623cfaf-d684-4ed6-b76a-7e377ee95594">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy00LTEtMS0xMDQzNzI_f385fa95-7185-4cf3-8992-a72277644ca4">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ0_9c2d7c54-df6f-40fb-9f22-02511a37a14c" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMS0xLTEtMS0xMDQzNzI_a378d7ef-ba21-4eef-8ec3-60127de62773">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMS0yLTEtMS0xMDQzNzI_0195a4dc-dcb7-420d-aa76-1dc17ae3e4ab">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMi0xLTEtMS0xMDQzNzI_f83309f9-cc8f-4c27-8c37-e0ef9636e1aa">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMi0yLTEtMS0xMDQzNzI_80e9599c-46d7-42a4-9591-6b38773571fe">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMy0xLTEtMS0xMDQzNzI_3d71fce6-befd-4f42-b988-9eb9b7e8e65e">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMy0yLTEtMS0xMDQzNzI_53ea4f94-ec89-4281-84f8-24fce978acad">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfNC0xLTEtMS0xMDQzNzI_b7722255-cc4b-4738-a0d7-236d203b7fe7">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfNC0yLTEtMS0xMDQzNzI_cdbbb413-1b2d-468a-b4bf-b540e061a342">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ1_46f18d0b-9ab3-455d-b5bc-bb942128fbe7" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMS0xLTEtMS0xMDQzNzI_4d212620-df93-492e-82c2-b42877f7c426">11,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMS0yLTEtMS0xMDQzNzI_9408e352-c61e-469b-8dd7-3e32a10a584a">11,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMi0xLTEtMS0xMDQzNzI_92d445c0-b325-45e1-9272-b905f9fad524">6,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMi0yLTEtMS0xMDQzNzI_85cff3f6-7a05-471b-948c-fb112ac264a9">6,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMy0xLTEtMS0xMDQzNzI_4aca5a63-95f5-408f-a757-400b33118462">4,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMy0yLTEtMS0xMDQzNzI_4cc6b0da-728b-4fa3-9604-a15807fc88d3">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we signed a purchase agreement with a buyer to sell our corporate headquarters in Deerfield, Illinois for $<ix:nonFraction unitRef="usd" contextRef="ia8299eafa68647eaaa8620f38dec5bf4_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfMTA5OTUxMTYyOTEzOA_6b272f13-c758-4d19-aedb-a9eec7fb012f">52</ix:nonFraction>&#160;million. The related assets are classified as held-for-sale and are presented within prepaid expenses and other current assets in the accompanying consolidated balance sheet as of September 30, 2022. While the closing remains subject to the satisfaction of various closing conditions (including satisfactory completion of municipal diligence by the buyer), we expect the transaction to close in 2023 and the net book value of the assets approximates the transaction price net of estimated selling costs. </span></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ2_51cc1836-9786-46f0-af6f-8f4ef0b710d4" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi0xLTEtMS0xMDQzNzI_11eb792c-b8fa-422d-8d33-556f5330dec6">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi0yLTEtMS0xMDQzNzI_2e1a0b58-f32e-4080-890d-61485437f5b5">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi00LTEtMS0xMDQzNzI_80328a69-bc5f-4eeb-80bd-d0feed938a38">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi01LTEtMS0xMDQzNzI_ce6c39d7-1acf-4c8c-93d8-42f1642f087e">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy0xLTEtMS0xMDQzNzI_42c98f4b-0187-4987-a028-01f08607a468">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy0yLTEtMS0xMDQzNzI_241619c1-9811-48fc-b5c8-91d5446130d7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy00LTEtMS0xMDQzNzI_3601a9a1-06ca-4db0-98de-cee6bc932202">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy01LTEtMS0xMDQzNzI_92f19882-fee1-4ef3-afd3-300fefe0487e">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC0xLTEtMS0xMDQzNzI_80cc3d81-31a5-4dec-9f43-ae61f515936d">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC0yLTEtMS0xMDQzNzI_1ac508f1-ddaa-4a1b-aa5d-3d1a4398fd24">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC00LTEtMS0xMDQzNzI_497bea1e-49bc-43cd-acf9-44700fe710bf">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC01LTEtMS0xMDQzNzI_0eff3dfd-2daa-476c-8ba8-a819f04c7cbd">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i14a874ec242e410289875357655da93a" continuedAt="i93356f0a08b24cecacfc881cc481a689"><div style="margin-top:13pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQw_793f0bfe-9372-44ab-98ca-356232ecd2eb" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi0xLTEtMS0xMDQzNzI_c86be3b1-4ff8-456a-a799-18df349bf2ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi0yLTEtMS0xMDQzNzI_5432be90-7f6c-42a9-ad14-c35592ebc150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi00LTEtMS0xMDQzNzI_cb99e362-746c-44e4-af55-86aaa60c1ea9">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi01LTEtMS0xMDQzNzI_4ab327d6-d26a-427f-b814-411db864bba5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy0xLTEtMS0xMDQzNzI_a1490333-b350-4d2f-a979-390baceacf32">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy0yLTEtMS0xMDQzNzI_c5793760-c5bb-46af-b788-c3e11e26668f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy00LTEtMS0xMDQzNzI_0fa2d3ce-6fa4-4742-97e0-816a23d5ceac">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy01LTEtMS0xMDQzNzI_399a0bc1-444e-469c-bc31-4fc970f2fad4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC0xLTEtMS0xMDQzNzI_5ef30a6f-79b3-4e68-9dbb-84fb972d710d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC0yLTEtMS0xMDQzNzI_7784546c-6ceb-4b84-b205-aa5b4c9b48b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC00LTEtMS0xMDQzNzI_5866a565-a190-494a-b00c-46463d3b239c">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC01LTEtMS0xMDQzNzI_2d4a17b5-bdc4-4d8e-a256-b2c88141b115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS0xLTEtMS0xMDQzNzI_ec3bc19f-2b8d-485c-81f8-ce94a944e95e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS0yLTEtMS0xMDQzNzI_1937e009-f386-42e8-ac08-354dfc1ca0b9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS00LTEtMS0xMDQzNzI_cb25c5aa-9f72-44a9-8745-e3ba733d1aba">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS01LTEtMS0xMDQzNzI_dc4e4371-07ef-4440-88ea-3c2ff5683dca">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0xLTEtMS0xMTA3ODI_93a21c7d-e67a-4e17-9da7-856264a25d6f">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0yLTEtMS0xMTA3ODI_64d54a9d-75ff-4144-b536-7ec6ea946d2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi00LTEtMS0xMTA3ODI_aa51dbd3-43e6-4733-9b95-2cfeedebe2cf">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi01LTEtMS0xMTA3ODI_07d272cc-9573-4c4c-a5b3-d92a2de5d0df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0xLTEtMS0xMDQzNzI_8161345d-9a40-45e6-a464-fb8c3f5612b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0yLTEtMS0xMDQzNzI_fb2dff7a-0448-4451-83ac-47533730f439">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi00LTEtMS0xMDQzNzI_f39415ec-b02d-46cb-8d42-341acc16a2a0">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi01LTEtMS0xMDQzNzI_87efdafe-2919-4913-8314-8d636022bc56">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy0xLTEtMS0xMDQzNzI_55e8d7e9-4e46-4792-b9c8-d2064087046a">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy0yLTEtMS0xMDQzNzI_7a34a423-4fff-4e18-8871-89bfe3845d96">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy00LTEtMS0xMDQzNzI_d48ebda5-a9cc-41b6-b664-9f68b9d1a9f4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy01LTEtMS0xMDQzNzI_23189de1-75cd-416e-9ccd-0446f2690428">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have been winding down our operations in Argentina since early 2021 and we determined that the net assets of the related entities were substantially liquidated during the third quarter of 2022. As a result of that determination, we reclassified their $<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTQ5NzU1ODE2NDc5_b66916a1-f727-4f97-934c-9297edcad602">65</ix:nonFraction>&#160;million cumulative translation loss from accumulated other comprehensive income (loss) to other (income) expense, net.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the nine months ended September&#160;30, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNDYz_8a5c3565-d61c-4548-8c96-e951fe8027e3">59</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNDcw_6124d3c2-f048-4592-a84e-7af918cff25e">69</ix:nonFraction>&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i93356f0a08b24cecacfc881cc481a689">Purchases of property, plant and equipment included in accounts payable as of September&#160;30, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i4fe91520413b489ba3c114405e761908_D20220101-20220930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTgz_d3c84ea0-9eaa-4d5a-9bb3-72c6fa975a2c">65</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b30b6e6d2764728a8fb09e3396c5922_D20210101-20210930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTkw_bc1e4e40-c852-4d70-a93c-4dcb38fa613a">49</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="iaef9f667721343c48067444506cf55c3_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">4. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDQ2_bb04a4ad-5b00-41e2-ad0c-b011b186c60f" continuedAt="id0161ee3a1fd418a93dcfe8e85e314a6" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ix:nonNumeric></span></div><ix:continuation id="id0161ee3a1fd418a93dcfe8e85e314a6" continuedAt="i900bb65c087f4e1e976bb7047fd0cb56"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDUy_19853c3b-c66b-41cf-be3e-3eb5d010c2c9" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b2b5d983114aa88c2446e0dcc3de3a_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0xLTEtMS0xMDQzNzI_82c5c0f1-8022-4c46-9d8d-c27fdc4d16ab">2,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481a24f4e9cf4e4caadc1f417ed82ed5_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0yLTEtMS0xMDQzNzI_5628c13a-1723-430f-a22c-fdd67712adc1">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic475be483d5d490b9d25f69465a3e693_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0zLTEtMS0xMDQzNzI_14d530c7-19d3-4f0a-b9b9-3972318104ae">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0372e6d36f45fc821dbc1d47cc6ea9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS00LTEtMS0xMDQzNzI_494be6f0-2b76-45a8-8b9b-023993048659">6,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS01LTEtMS0xMDQzNzI_6435b849-8329-47fe-8159-bd092e42c661">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0xLTEtMS0xMDQzNzI_cb0b6965-d859-4c35-9c5d-aaf9ef1f6aa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0yLTEtMS0xMDQzNzI_657885c6-7b3d-4c19-ae76-ba94acc1e120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0zLTEtMS0xMDQzNzI_507f7f87-c708-4892-87d3-8147e2cab0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC00LTEtMS0xMDQzNzI_89cafbde-35c6-4372-bafd-e3e4b3eab84d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC01LTEtMS0xMDQzNzI_2e60e147-26c5-4855-9701-d3a04cfada94">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0xLTEtMS0xMTQyMjI_21ee9b4e-c8e1-4c1a-ac0c-ad7be69ec4e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0yLTEtMS0xMTQyMjI_a623587d-3be2-4d49-97db-6429112407f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0zLTEtMS0xMTQyMjI_4ba11c24-ad35-40b2-8407-05f7b3fae956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS00LTEtMS0xMTQyMjI_8e3d65dc-3645-4b03-87c2-9944de69e755">2,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS01LTEtMS0xMTQyMjI_d802659a-0833-4463-b086-bb4b0ca6467b">2,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0xLTEtMS0xMDQzNzI_cd7efa81-ebc9-473c-9253-e8198afda5f7">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0yLTEtMS0xMDQzNzI_bc2d2bf1-7478-4e49-8b0b-78df705c97b4">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0zLTEtMS0xMDQzNzI_fa7d81a5-8ddb-441b-9d0d-906b39db6f51">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS00LTEtMS0xMDQzNzI_9ca19517-40d5-4785-9bba-119c8fa144c0">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS01LTEtMS0xMDQzNzI_105c58e4-b708-494e-9450-3ba0fbb7b672">437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de2ca57ce45464ca01c64bb1f88e3b2_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0xLTEtMS0xMDQzNzI_5598da2d-1585-41e2-8460-bfde003e564c">2,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff51ea445a5436dae75f76b782ecd31_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0yLTEtMS0xMDQzNzI_6a5422af-8ff5-4e17-b6df-839e57f507a3">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a571604800242eeb2e7147c026d48b7_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0zLTEtMS0xMDQzNzI_9b4639df-5d02-4e83-bf72-7d55456fda95">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5aa4d680b44ec86fe26cdcf3bf099_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi00LTEtMS0xMDQzNzI_36ca9ccd-a17c-416c-ab44-d18ec4406dda">3,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi01LTEtMS0xMDQzNzI_11d1843f-3654-4bc9-a94a-b6e7d581b15c">6,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.  We recognize a goodwill impairment charge for the amount by which a reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill Impairments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 2, we acquired Hillrom on December 13, 2021 and recognized $<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzE0_9691eaf1-8901-4d6d-bb84-25ca683f00b0">6.8</ix:nonFraction>&#160;billion of goodwill and $<ix:nonFraction unitRef="usd" contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213" decimals="-8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzI4_7345faa2-7417-4afa-a2b5-8aa4a467b630">6.0</ix:nonFraction>&#160;billion of other intangible assets, including $<ix:nonFraction unitRef="usd" contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213" decimals="-8" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzQx_2d932555-a2cc-47bc-932e-d07c9e475da8">1.9</ix:nonFraction>&#160;billion of indefinite-lived intangible assets, in connection with that acquisition. Our Hillrom segment includes the following three reporting units: Patient Support Systems, Front Line Care and Surgical Solutions. During the third quarter of 2022, we performed trigger-based impairment tests of the goodwill of each of those three reporting units, as well as the indefinite-lived intangible assets, consisting primarily of trade names, that we acquired in connection with the Hillrom acquisition. We performed those tests as of September 30, 2022 due to (a) current macroeconomic conditions, including the rising interest rate environment and broad declines in equity valuations, and (b) reduced earnings forecasts for our three Hillrom reporting units, driven primarily by current shortages of certain component parts used in our products, raw materials inflation and increased supply chain costs. The impairment tests resulted in total pre-tax goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i75b9dbb2b9e54f9aa29cbe19d1203ee2_D20220701-20220930" decimals="-8" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzg1_21a8cd08-abd0-4e47-8100-6d96804c8f56">2.8</ix:nonFraction> billion in the third quarter of 2022, consisting of a $<ix:nonFraction unitRef="usd" contextRef="i890c2ffd49774bcdb114954d3d319644_D20220701-20220930" decimals="-8" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDA3_2d0e6a38-99d7-49a0-b497-3a8625fd425c">1.4</ix:nonFraction> billion goodwill impairment for our Patient Support Systems reporting unit, a $<ix:nonFraction unitRef="usd" contextRef="i3c3675597e4b41a9a723718dced98975_D20220701-20220930" decimals="-8" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDI5_c17bbb62-fafb-4212-a9c4-55ef729afd0a">1.0</ix:nonFraction> billion goodwill impairment for our Front Line Care reporting unit and a $<ix:nonFraction unitRef="usd" contextRef="i2fd9fa99362a4b3da7f2454b0437871b_D20220701-20220930" decimals="-8" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDQ1_65cc92a0-070d-47f9-b4d1-9e9f978794e9">0.4</ix:nonFraction> billion goodwill impairment for our Surgical </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i900bb65c087f4e1e976bb7047fd0cb56"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions reporting unit. See further discussion below for information regarding intangible asset impairment charges recognized during the third quarter of 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the reporting units tested for impairment during the third quarter of 2022 were determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples. Our reporting unit fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDQ4_827e4e4f-d8e0-4875-a2dc-d97b6bee04a1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0xLTEtMS0xMDQzNzI_b7ca0edb-4c6f-4da2-85c4-c72c211ce9a6">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0yLTEtMS0xMDQzNzI_c17f605e-35e2-4aef-8e39-dc6824ecb4d0">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ad5d55916c462eabe316458610941a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0zLTEtMS0xMDQzNzI_c6f4b663-7313-4bc5-82b1-b9be6e0a5f9f">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy00LTEtMS0xMDQzNzI_382e7b2b-4323-473b-96e8-d12c31784fdc">1,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a9b9c3e62944d59dd3f29abbe86694_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy01LTEtMS0xMDQzNzI_a673c850-b126-4f68-9e34-b703022fdc58">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy02LTEtMS0xMDQzNzI_3498530f-cdb4-4022-b230-da99c53314bc">9,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0xLTEtMS0xMDQzNzI_90e6893b-865f-4f4b-9e1a-715d3f382642">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0yLTEtMS0xMDQzNzI_8af8c826-f1f6-4aca-901c-427e7878ccf2">1,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20ad5d55916c462eabe316458610941a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0zLTEtMS0xMDQzNzI_d698d2d1-2d46-424d-b969-a59df71fb7e2">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC02LTEtMS0xMDQzNzI_70cda62c-4c3e-461c-aec0-c178176a6529">2,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0xLTEtMS0xMDQzNzI_7ff162ab-626c-415b-b11e-ebb0688ce5bf">3,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0yLTEtMS0xMDQzNzI_8b4afe5d-3056-47d4-bdbf-6f3a32c8350b">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ad5d55916c462eabe316458610941a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0zLTEtMS0xMDQzNzI_dea6b0b3-864f-47ec-9f4b-2139922ab785">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS00LTEtMS0xMDQzNzI_7b3f5046-71a9-4097-bad6-c9647a9b2127">1,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a9b9c3e62944d59dd3f29abbe86694_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS01LTEtMS0xMDQzNzI_0b0f8fc2-0d41-4702-bcdb-2cb153d93ed8">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS02LTEtMS0xMDQzNzI_827f14fd-986b-4049-8eda-2e7e7d689827">6,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0xLTEtMS0xMDQzNzI_45223d60-9166-4703-9a5c-60f12d15c815">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0yLTEtMS0xMDQzNzI_59af69f8-ec52-41a1-b923-498423f5e0b2">3,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0zLTEtMS0xMDQzNzI_a228b034-e944-4320-abcb-4e0f82da0269">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a672818e934149a401c70ac3c8e194_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy00LTEtMS0xMDQzNzI_0fc4eed5-f769-45f5-b1e0-ae2837257325">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8d99be5dd04810814673d9bb23b794_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy01LTEtMS0xMDQzNzI_a7fa6d40-54cb-4257-9259-9ab81cecab3a">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy02LTEtMS0xMDQzNzI_45a875ca-88a4-429c-9272-20c8a3a66711">9,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0xLTEtMS0xMDQzNzI_17a21d56-bad4-429b-9e51-02cc3a7eab57">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0yLTEtMS0xMDQzNzI_59008bf4-ba0f-4fe0-91f2-88566ffbbdbc">1,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0zLTEtMS0xMDQzNzI_916f9f4e-40c7-4ff0-8a46-df9a1743a624">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC02LTEtMS0xMDQzNzI_07091e57-2a1e-46f7-acbc-45729f5fa32e">1,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0xLTEtMS0xMDQzNzI_bab41b5f-4b77-4534-8c52-8d8dcc014183">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0yLTEtMS0xMDQzNzI_cf687db0-64c1-499b-9cb8-55ab556c0f82">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0zLTEtMS0xMDQzNzI_9cdc6cd0-2cb9-47de-9bd4-c1b15d2c63de">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a672818e934149a401c70ac3c8e194_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS00LTEtMS0xMDQzNzI_f5e91a91-3b27-49ba-94f0-9b9825610704">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8d99be5dd04810814673d9bb23b794_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS01LTEtMS0xMDQzNzI_2b760635-7090-4e50-9f5e-8b9348955a2b">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS02LTEtMS0xMDQzNzI_90df9b2d-1d30-4cc3-9b10-a61bf368b0a5">7,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfMzM2_2b594fc9-3481-4833-8475-628389237fbe">168</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfMzQz_dd449737-138f-4766-a72c-44036f82c5b5">68</ix:nonFraction> million for the three months ended September&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDAy_36d5b869-df31-41e2-acb3-f58cc9b4d79e">578</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDA5_43ea3d49-c6df-4b6b-a61b-f5ab601a7354">199</ix:nonFraction> million for the nine months ended September&#160;30, 2022 and 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indefinite-lived Intangible Asset Impairments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the goodwill impairments discussed above, we recognized pre-tax impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i8a7528b6cc67470689971a1b5911d02a_D20220701-20220930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMxMTQ3_1522c515-c457-4c74-b7f6-7ea908d81e9d">332</ix:nonFraction>&#160;million in the third quarter of 2022 to reduce the carrying amounts of certain indefinite-lived intangible assets, which related to trade names acquired in the Hillrom acquisition, to their estimated fair values. Those intangible asset impairment charges are classified within cost of sales in the accompanying condensed consolidated statements of income (loss) for the three and nine months ended September 30, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the indefinite-lived intangible assets tested for impairment were determined using a discounted cash flow model and significant inputs included forecasted cash flows, royalty rates and discount rates. Our indefinite-lived intangible asset fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">5. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTk4NQ_c87a7183-3adb-4482-a305-57bce1cb7203" continuedAt="i22ccb8515603435888520c72129a7e59" escape="true">FINANCING ARRANGEMENTS</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i22ccb8515603435888520c72129a7e59" continuedAt="i58ace939d4794fa8a79dbf44d230d18b"> </ix:continuation></span></div><ix:continuation id="i58ace939d4794fa8a79dbf44d230d18b" continuedAt="i7327554fe00c4ad89720777e389dc5a1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Debt Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we issued $<ix:nonFraction unitRef="usd" contextRef="i1e434fa298bb4e53b1687deba4d7259d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTQ3_f1e4fc4d-2a32-498d-9e77-2794a287ceee">800</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i1e434fa298bb4e53b1687deba4d7259d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTU0_d24247a9-b7b8-4dd2-90eb-d4a777cf592c">0.868</ix:nonFraction>% senior notes due in 2023, $<ix:nonFraction unitRef="usd" contextRef="i95d99d7448924622bdb9f324debce4d9_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTg0_4d19a3b2-aae0-4bd0-a7e9-605f7c54af16">1.4</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i95d99d7448924622bdb9f324debce4d9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTkx_18894c64-55a8-49a2-afd7-ddcb43f3cabd">1.322</ix:nonFraction>% senior notes due in 2024, $<ix:nonFraction unitRef="usd" contextRef="ie77337e4ad4e498c948df7b374666865_I20211231" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjIx_09b22a99-3a5f-4ab7-8fb4-7edd9ef22555">1.45</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="ie77337e4ad4e498c948df7b374666865_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjI4_675ae5ab-8e7f-4791-ad97-818aca8acbed">1.915</ix:nonFraction>% senior notes due in 2027, $<ix:nonFraction unitRef="usd" contextRef="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjU4_f99ec1b9-32bc-451b-9d3b-6c31bd0249da">1.25</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjY1_ac14b8dc-9fbc-4af4-b7df-dbf8ac314fcf">2.272</ix:nonFraction>% senior notes due in 2028, $<ix:nonFraction unitRef="usd" contextRef="i94dc1bd163de40399e15f75a2e3785a4_I20211231" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjk1_9f197e3a-b946-4b38-b7dd-d78b37dc193a">1.55</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i94dc1bd163de40399e15f75a2e3785a4_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzAy_e3a7e73b-2161-4119-8f33-72bb3acb3ba8">2.539</ix:nonFraction>% senior notes due in 2032, $<ix:nonFraction unitRef="usd" contextRef="i265508560c8841b293b5f093e5c37039_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzMy_5fac7c4e-f4a9-4518-9f64-306f9646aff2">750</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i265508560c8841b293b5f093e5c37039_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzM5_2c6e482d-34d6-4bad-8bce-24b4e0e94d12">3.132</ix:nonFraction>% senior notes due in 2051, $<ix:nonFraction unitRef="usd" contextRef="iae499f05266f4e6fb214cdc0ec19a38d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzY5_c8744004-9f23-46c7-b111-01a52b99e336">300</ix:nonFraction>&#160;million of floating rate senior notes due in 2023 and $<ix:nonFraction unitRef="usd" contextRef="i33078f73774943f3a2ca47a51219a873_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwODE5_9035d244-8675-42b1-8b54-341e50802b3b">300</ix:nonFraction>&#160;million of floating rate senior notes due in 2024 (collectively, the Hillrom notes) to fund a portion of the consideration for the Hillrom acquisition, repay certain indebtedness of Hillrom and to pay fees and expenses related to the foregoing. In conjunction with the issuances of the Hillrom notes, we entered into a registration rights agreement in which we agreed to file a registration statement with the SEC with respect to an offer to exchange the Hillrom notes for new issues of notes with the same terms registered under the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7327554fe00c4ad89720777e389dc5a1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities Act of 1933, as amended. Those exchange offers with respect to the Hillrom notes were completed in the second quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first half of 2022, we repaid $<ix:nonFraction unitRef="usd" contextRef="i3ed75a5ce2af4878b5a7a6a8436619f1_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfOTU_99701dcd-3696-44c0-be68-e8c220f4bce6">335</ix:nonFraction>&#160;million of our $<ix:nonFraction unitRef="usd" contextRef="i841d5a6c0ef8487fa19e286f23e59976_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTA1_f79c9ed2-21f1-46e7-a3b2-a6ce10f0c841">2.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i841d5a6c0ef8487fa19e286f23e59976_I20220930" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTA4_1b154f65-4258-4438-ba42-761ad3b3653d">three-year</ix:nonNumeric> term loan facility and $<ix:nonFraction unitRef="usd" contextRef="i772c3c7e174041f7bcc4ae5236f20052_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM0_59a438fc-5096-4937-adcf-880e6277df9d">355</ix:nonFraction>&#160;million of our $<ix:nonFraction unitRef="usd" contextRef="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTQ0_cad58d0f-0d25-4574-8b02-59d9b7255a2d">2.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTQ3_22bfe922-5cde-40a2-803d-78a68f3627d5">five-year</ix:nonNumeric> term loan facility. The loss from the early extinguishment of this debt was not significant. In the third quarter of 2022, we amended the credit agreements governing our term loan facility and our U.S. dollar-denominated revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to delay the commencement of our net leverage ratio covenant step-down schedule until June 30, 2024. We also amended the credit agreements governing our term loan facility and our U.S. dollar denominated revolving credit facility to transition the benchmark rate from LIBOR to the Secured Overnight Financing Rate (SOFR).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, we repaid $<ix:nonFraction unitRef="usd" contextRef="if16f417d337d49449cd42abe3f0b4ff1_D20220801-20220831" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODE2MDAw_81735cc4-86b7-4bc1-a251-d722a36e830a">203</ix:nonFraction>&#160;million of our <ix:nonFraction unitRef="number" contextRef="i54f8b3d4953342d7bb449d644860faac_I20220831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODE2MDE0_1ee4d022-2e8d-4406-bd3a-0df28dd58a25">2.4</ix:nonFraction>% senior dues due in 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930" decimals="-8" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTI3Mg_24abb568-7f21-4be4-afc2-3a9c9662a8e5">2.5</ix:nonFraction>&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM0NA_67391840-266f-4a95-a977-8e93b94d3406">200</ix:nonFraction> million. Each of the facilities matures in 2026. There were <ix:nonFraction unitRef="usd" contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM5OQ_1650fc20-9244-49a9-8678-ee69536a2dbb"><ix:nonFraction unitRef="usd" contextRef="i33bf0a8e536c465a9ba65e612d25078b_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM5OQ_78e89211-edba-4dec-aad6-8761ff7a662d">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under these credit facilities as of September&#160;30, 2022 or December&#160;31, 2021.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTcyMQ_9a87e01a-86bd-40be-ab88-88411dc19e1f">275</ix:nonFraction>&#160;million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="ib88bc321114a41c986908d3eab85ded7_I20220930" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTc5Nw_1423cca1-5af0-43a4-a3db-e267c0c0cc14">3.02</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTg0MQ_6c32e53d-1f89-4772-9049-7b2ff050a416">49</ix:nonNumeric> days. As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTg2Mg_4493687f-d527-43fd-9e27-0dfb0a4fce97">300</ix:nonFraction> million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="i3a0c4ec3de054eb99dbb0c9ef6f2e0a9_I20211231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTkzOA_8f842c4a-2b68-4095-941e-a77564e54b2c">0.27</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTk4Mg_9caf398e-1e2e-4a68-a353-d60d09bdd3ab">88</ix:nonNumeric> days.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">6. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfODYyMA_39d5f4d8-446d-40f4-85aa-9423300aab82" continuedAt="i02f8e374e20a4c4eb498f874e404ceb2" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i02f8e374e20a4c4eb498f874e404ceb2" continuedAt="i97bd5e4820fb4b308ca1364b155fdf68"> </ix:continuation></span></div><ix:continuation id="i97bd5e4820fb4b308ca1364b155fdf68" continuedAt="i7b1c35d5b2d447adba67417ac4d95876"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of September&#160;30, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjI3_eff30ca8-2ae1-4d3a-aeb7-3bc1867c9e7f">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjM0_228c9502-0614-48a1-88fd-c9431a29b321">72</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at <ix:nonFraction unitRef="site" contextRef="ie39c0ccc2d9f48b29fd18d7536c85b21_D20220101-20220930" decimals="INF" name="bax:SiteContingencyNumberOfSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfMjI0NQ_305d4804-87b9-4d3b-9be7-32ddb2152eee">six</ix:nonFraction> Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of September&#160;30, 2022 and December&#160;31, 2021, our </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7b1c35d5b2d447adba67417ac4d95876" continuedAt="ibd4c284861134b9ea0a4de61efccbe09"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">environmental reserves, which are measured on an undiscounted basis, were $<ix:nonFraction unitRef="usd" contextRef="icc5868a9f710403f8ce9e04bed2c6144_I20220930" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNTQ5NzU1ODIyNTE3_00c5d14a-9468-4a6d-b855-0f6957dd6991">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i167491d201974a2aaaea593456c7da9b_I20211231" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfMjg3OA_ea472607-893c-4238-a411-8df505ba9cb0">18</ix:nonFraction> million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, we and certain of our officers were named in a class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Ethan E. Silverman et al. v. Baxter International Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $<ix:nonFraction unitRef="usd" contextRef="ida0404dc815a4d388b3b0b1abd15f103_D20210112-20210112" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNTI0Ng_0bbaadfe-9a92-40e5-b2e1-43f9c5673c6e">16</ix:nonFraction>&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $<ix:nonFraction unitRef="usd" contextRef="ia6f8ffc989484986a6b2a7277800a496_D20220218-20220218" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjE0NA_93d2c88c-db9c-4f97-b51b-15de0eb786df">18</ix:nonFraction>&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#8217;s cooperation. We paid the penalty in the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, <ix:nonFraction unitRef="lawsuit" contextRef="iac075bc7be734ce28e3cd0ade633f46d_I20200331" decimals="INF" name="bax:LossContingencyNumberOfLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjM4OA_11937049-23f3-4a47-be22-db36a6d014d6">two</ix:nonFraction> lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd4c284861134b9ea0a4de61efccbe09">allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022 and filed on May 27, 2022, a motion challenging certain aspects of plaintiff's case.</ix:continuation></span></div><div id="iaef9f667721343c48067444506cf55c3_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">7. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNzky_31b4e946-012d-4dda-99e7-21dfeedf045b" continuedAt="ic69f288444dc409eb0f641524b1ebe38" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="ic69f288444dc409eb0f641524b1ebe38" continuedAt="i188a6cc5b88e49098a838a0f56a0352c"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three and nine months ended September&#160;30, 2022 were $<ix:nonFraction unitRef="usdPerShare" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTEw_544343b6-b3e6-4a48-8424-70932e82dee9">0.29</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTE3_4d003cd1-39e6-410e-9efb-180995a0f324">0.86</ix:nonFraction>. Cash dividends declared per share for the three and nine months ended September&#160;30, 2021 were $<ix:nonFraction unitRef="usdPerShare" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTg3_d4aed948-e4ac-45f7-869d-5bbda7939d5f">0.280</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTk0_004fbed3-56fa-4c5a-8c29-8540de84398d">0.805</ix:nonFraction>. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i188a6cc5b88e49098a838a0f56a0352c">In July 2012, our Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ida6a352adaf74291ac8418e13556460b_I20120731" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMjk3_2fceea92-6eed-459c-a4a8-ce10a519de5d">2.0</ix:nonFraction> billion of our common stock. Our Board of Directors increased this authority by an additional $<ix:nonFraction unitRef="usd" contextRef="ib2cfefd9411642a986838426ebc5fd65_I20180228" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMzg2_f1b9cf1c-5da1-4e60-b8f8-343f0b1afe80"><ix:nonFraction unitRef="usd" contextRef="i501f33331ff24934a4e311776d6b568e_I20161130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMzg2_f38cfb40-05a1-421e-850a-26bb2b9ea1e3">1.5</ix:nonFraction></ix:nonFraction> billion in each of November 2016 and February 2018, by an additional $<ix:nonFraction unitRef="usd" contextRef="i0e2c054b1e504ee491a43864f0b9a4f1_I20181130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNDUw_a301714a-cfa7-4cc7-8459-fb828ef23470">2.0</ix:nonFraction> billion in November 2018 and by an additional $<ix:nonFraction unitRef="usd" contextRef="i8c321d55d39c46389f13acfac44288a1_I20201031" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNDkx_dd23d68d-be19-422e-82ad-7943cfbf9ba9">1.5</ix:nonFraction>&#160;billion in October 2020. During the first nine months of 2022, we repurchased <ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNTQ5NzU1ODE0NzYw_bf6de12c-f8b9-4131-b823-d099bfa93f41">0.5</ix:nonFraction> million shares under this authority pursuant to a Rule 10b5-1 plan.  During the first nine months of 2021, we repurchased <ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNjY1_503638b8-25b8-4f13-8a60-6dfed5b839ca">7.3</ix:nonFraction>&#160;million shares under this authority pursuant to Rule 10b5-1 plans. We had $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNzM0_255c8c00-ead9-463d-8667-cb239a2cd97f">1.3</ix:nonFraction> billion remaining available under the authorization as of September&#160;30, 2022.</ix:continuation>  </span></div><div id="iaef9f667721343c48067444506cf55c3_58"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">8. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTQ2_96c27063-0dd1-47eb-9be7-e11e6e1f21c1" continuedAt="id4c696530f184a55ab3a41f14679e274" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="id4c696530f184a55ab3a41f14679e274" continuedAt="i8e6d34e3228a4bd0868576a34a7b802a"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income (loss), cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTQ3_bb19f128-e6f6-42b3-9803-f7c2ebb07efe" escape="true"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d2d3147ec91465dbab5eeb7b6a2cd5a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0xLTEtMS0xMDQzNzI_f23b33c6-1598-47e1-a954-b3c182056ba7">2,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31930c2af24645f49542738fff75d982_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0yLTEtMS0xMDQzNzI_76cb51ed-8610-4945-9057-8ac29c35400d">347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i552ac44c09dc4a709b2712f92ae94231_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0zLTEtMS0xMDQzNzI_1d12f4de-73b3-4a3a-89c3-7f9e91d7374d">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c2074ab131415892f8da221a18971e_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi00LTEtMS0xMDQzNzI_17230c30-f6cc-4859-b957-8c02c38fe02b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6a288994bf043d8a63aa03aaa1625a2_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi01LTEtMS0xMDQzNzI_1cb74fb5-d673-491e-ada3-994ba03a63a8">3,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0xLTEtMS0xMDQzNzI_c2f80d98-86c9-4995-b5fc-8810e96b8670">816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0yLTEtMS0xMDQzNzI_603bbbb5-fbe9-4ee5-9852-3d53943a19ba">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0zLTEtMS0xMDQzNzI_eaa1b09a-6060-43ae-806e-e7da2c56098b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy00LTEtMS0xMDQzNzI_af25713d-f031-4d27-957d-618fd1d4592f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy01LTEtMS0xMDQzNzI_f768eaef-91a0-475a-bf7a-0063e09b97dc">752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0xLTEtMS0xMDQzNzI_9e35dcc2-07ba-4744-adc2-78b9c050d5e0">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0yLTEtMS0xMDQzNzI_a48420f8-3b05-4c2d-96f8-f14ac1810bb7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0zLTEtMS0xMDQzNzI_10c69ed7-a3d1-4b0f-8bb9-16d39defa95b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC00LTEtMS0xMDQzNzI_590ca64f-6d67-4b27-84cb-cd089dbbdb86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC01LTEtMS0xMDQzNzI_4d752467-54b7-4967-9759-0e69524ac447">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0xLTEtMS0xMDQzNzI_9caae3d6-e11c-409b-ac25-63db644ef044">751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0yLTEtMS0xMDQzNzI_03f00df6-a366-4dc8-b30d-c8fe2e354dc8">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0zLTEtMS0xMDQzNzI_6f247066-b8d8-4509-83a4-906b27562b65">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS00LTEtMS0xMDQzNzI_df0c56f7-af59-4828-b4f3-18ad6a534ff4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS01LTEtMS0xMDQzNzI_88ae344a-5873-4213-9629-f9e40d9c72e3">674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63982438af89413496b321655eab4612_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0xLTEtMS0xMDQzNzI_1fa7226d-70ce-4d1e-b9e1-98866cac3fe7">3,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5823aeb3309544349e7a762d49f924ed_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0yLTEtMS0xMDQzNzI_631b07f1-f888-4d8b-aa76-a01be63acacb">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2621eddb6c8b4e35b45d30c5f4117f8c_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0zLTEtMS0xMDQzNzI_3303ab61-ae5c-4c94-b5c8-5d8491d62e88">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if77599f5408a4c88933df293d51078a0_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi00LTEtMS0xMDQzNzI_7ef2ca9b-5bd3-4b9d-88fc-b31d93a23c37">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7853bfd3a3f14931bd7a5fb8616f0070_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi01LTEtMS0xMDQzNzI_662ce71e-367e-487a-b60e-907fc498e630">4,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifec0e1e2b8494b57a02dabe89c9521c1_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0xLTEtMS0xMDQzNzI_e6f47832-6493-4de2-a007-98c773d8eb21">2,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i589024ff3b0647f4aed88a63568cfbf3_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0yLTEtMS0xMDQzNzI_4486604a-587e-475e-9b8c-465afd4f9894">574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib62950f4131d42f3b649b1a20703c62d_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0zLTEtMS0xMDQzNzI_824af702-7332-41c6-8bfc-bac0c949cb76">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0f53d52d2574f558f655a52b076f148_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi00LTEtMS0xMDQzNzI_c9d5a355-812b-4e8d-83ee-fdc24c0badc5">3,314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0xLTEtMS0xMDQzNzI_ceb3133f-4927-4092-85a5-5d4275a1ed29">257</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0yLTEtMS0xMDQzNzI_c50fbc39-3ef2-48d9-aae3-c8e10285f9d1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0zLTEtMS0xMDQzNzI_d240c154-7fe4-45b1-a20d-7941745b35dd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC00LTEtMS0xMDQzNzI_115213ca-2570-43de-92af-3d96ccd8148f">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0xLTEtMS0xMDQzNzI_40b6bb4e-c323-42a9-a4cb-cc4126ad7af0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0yLTEtMS0xMDQzNzI_716d7d58-b640-48bf-888e-16a5dfd2f71e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0zLTEtMS0xMDQzNzI_b14ec1dc-3869-40cc-bbd3-09316cda10e7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS00LTEtMS0xMDQzNzI_a3600c76-bdc7-4cb8-9b98-921367cb0c88">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0xLTEtMS0xMDQzNzI_283e2284-59d3-41d1-8589-49af313fa1a0">257</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0yLTEtMS0xMDQzNzI_e0d2574f-3022-4b88-b87c-3761910c9585">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0zLTEtMS0xMDQzNzI_2e8ae987-b241-4b18-b4c2-86b54b1ddc56">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi00LTEtMS0xMDQzNzI_e556e9fb-788b-4003-baa4-ed92c66e2761">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic37683e51faa4ef3a8d7fa7bd5e019f9_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0xLTEtMS0xMDQzNzI_1dc03244-9935-4702-b2b1-37f6278b6826">2,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6c55956d7c449a997855468c8753478_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0yLTEtMS0xMDQzNzI_54a2c3ae-850c-4496-a708-431841dbf1fd">511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e127d53ca94f5cbd11265d1621e42b_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0zLTEtMS0xMDQzNzI_8724da14-97d9-469e-b11b-811d2be987de">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18bdd75685a84d6ea4c661c64683c09b_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy00LTEtMS0xMDQzNzI_c565d961-faa1-48ff-b5aa-ab7245ece709">3,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8e6d34e3228a4bd0868576a34a7b802a" continuedAt="icbac702712fa4d9c82e636e349c9e72b"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTUx_9eec5c2e-5514-4b18-a2ad-d0115d62795d" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0xLTEtMS0xMTY0MzA_df288697-8332-4341-9b64-a60cbee22a2b">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0yLTEtMS0xMTY0MzA_948af9f8-8b25-4c66-9298-a44f89614e56">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0xLTEtMS0xMTY0MzA_5596f6e8-0cd3-46a6-b42d-d683363e948c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0yLTEtMS0xMTY0MzA_ffcae407-0cb7-4636-b2b9-0f39479e0b47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0xLTEtMS0xMTY0MzA_acf0b35b-ba8e-4869-aaff-be728167c905">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0yLTEtMS0xMTY0MzA_3617861c-4d71-4429-814c-944487a8eb65">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0xLTEtMS0xMDQzNzI_16eb1aa6-f2b7-49d4-9943-2e1fd6487825">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0yLTEtMS0xMDQzNzI_7203f051-8d1a-4bef-a895-1514422eec23">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0xLTEtMS0xMDQzNzI_a2682e67-38ba-435f-830d-d9ba3c9b3550">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0yLTEtMS0xMDQzNzI_553cae15-9bef-44c5-9226-f712d0166335">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0xLTEtMS0xMDQzNzI_4af66a0d-87e9-4cf2-beb2-f405418fbbb1">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0yLTEtMS0xMDQzNzI_90538d30-6bf8-4b86-84f8-96e2c3adcbf7">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc60984e5ff401591292f61763183a1_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNy0xLTEtMS0xMDQzNzI_13cccafb-2c7f-4ca9-894e-25e65e8ab63d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4e1f314d994197aa920eacb9a953ff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNy0yLTEtMS0xMDQzNzI_fd1fa43c-e1c5-4b7b-9f91-de1be381dab2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4477b37e0684b1584a8e138855d9585_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOC0xLTEtMS0xMDQzNzI_f8af3d43-cb29-4592-8fc7-d251fcfe19fa">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6ca2d911f1c41fdbc37513b3ecf53c8_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOC0yLTEtMS0xMDQzNzI_3eb72b34-f81f-40dd-96d7-f18f4cf794d7">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOS0xLTEtMS0xMDQzNzI_d4722c46-2e96-4073-a81c-b4f471769c6a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOS0yLTEtMS0xMDQzNzI_ad7c7326-d930-4e26-aa22-78499288cfe6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTAtMS0xLTEtMTA0Mzcy_8fa3e1ca-918b-4f06-b901-be52d6e7df40">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTAtMi0xLTEtMTA0Mzcy_bc37d424-1844-4b1c-ab97-65ddfcbb865a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTEtMS0xLTEtMTA0Mzcy_7897b5d7-2d20-448d-b527-ec778317e344">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTEtMi0xLTEtMTA0Mzcy_f1ab6267-0fc1-4ffa-bb8b-49c19fe6c54a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f7d5ccda5424cd6a7bd67a5706e35ce_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTItMS0xLTEtMTA0Mzcy_8125e22f-3c89-49ed-af8f-da6c23a36583">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119bfe21f51144d990801b60bfeb8623_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTItMi0xLTEtMTA0Mzcy_962ae6d3-9323-4819-8028-fe77aedfe025">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNC0xLTEtMS0xMDQzNzI_b653667d-9b24-416a-a747-27f715fdae96">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i559c50c17138442d8746383974831721_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNC0yLTEtMS0xMDQzNzI_833d9a3a-05c6-46f8-b510-f9abfdc248ad">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNS0xLTEtMS0xMDQzNzI_fe401265-2572-41af-bd11-1a8be74bb1ad">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i559c50c17138442d8746383974831721_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNS0yLTEtMS0xMDQzNzI_0f70623f-caa1-4750-8fe5-22752611ddc4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNi0xLTEtMS0xMDQzNzI_0a0e6acc-0f83-4a6e-9dd6-d5119d3abf06">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i559c50c17138442d8746383974831721_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNi0yLTEtMS0xMDQzNzI_9da85529-e269-407b-9632-04f669d4bea7">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81178378904d4536bccf75c0f969a644_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOC0xLTEtMS0xMDQzNzI_aef061ae-a872-456c-990e-7f86dc61cf93">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i033de94989d94ca29ea116ebb6e361e7_D20210101-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOC0yLTEtMS0xMDQzNzI_56aec4e5-4c3c-43d2-b606-f75afbfc3e81">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4901a3b8cbbd4579a3d8a09a6999f89c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOS0xLTEtMS0xMDQzNzI_c52bfb2c-43c6-47da-b1e8-0fd968a76812">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57d95941b3e84f7fbc4fd9c0e2f0ecf5_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOS0yLTEtMS0xMDQzNzI_8b141531-6e55-4b46-9f81-e12c1ce96eec">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTAtMS0xLTEtMTA0Mzcy_9656a2f9-d319-4f00-89d8-8c51b1d13cbe">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTAtMi0xLTEtMTA0Mzcy_bbec37f9-cd65-4b62-8dac-fbc1a8958a96">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTEtMS0xLTEtMTA0Mzcy_c36a1f24-ea18-4ba0-ab3c-a261ddca5c4a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTEtMi0xLTEtMTA0Mzcy_5b52058c-bfcc-4693-aa31-1b41d019d8f2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTItMS0xLTEtMTA0Mzcy_569bb2bf-ace8-48b7-9419-04866f9562a2">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTItMi0xLTEtMTA0Mzcy_47e91b15-fca4-4396-a1cd-ea1d71471103">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie18534aa529c45f286ef075afba0cf7b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTMtMS0xLTEtMTA0Mzcy_689f1a72-a150-43d3-84e9-2ed4836ae74c">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i013b33b74c04418da6c7b638e5d50da1_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTMtMi0xLTEtMTA0Mzcy_3320ab40-b748-4290-b0ec-80a4d5b7a288">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icbac702712fa4d9c82e636e349c9e72b">Refer to Note 3 for additional information regarding the reclassification of a cumulative translation loss to earnings, Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity</ix:continuation>.</span></div><div id="iaef9f667721343c48067444506cf55c3_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">9. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2OQ_e4f94451-1c67-4509-8657-7e2a56e64df9" continuedAt="i17963a04d4f847ef867e1e20ab280875" escape="true">REVENUES</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i17963a04d4f847ef867e1e20ab280875" continuedAt="id7aaf40b902e450e96fcf97884d457c6">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id7aaf40b902e450e96fcf97884d457c6" continuedAt="i6b4bfc0adcc9435d95d8e25ef8a5d055"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between <ix:nonNumeric contextRef="iac7b594f1d824d129657241335c72a8e_D20220101-20220930" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfODA1_41e5969b-895a-43f2-b8e5-0ad7b1eb8bc2">30</ix:nonNumeric>-<ix:nonNumeric contextRef="if0df1ff8a1a54c22872aa4b7544e0a23_D20220101-20220930" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfODA4_3090b234-1de7-4e2b-9d92-45adb81314f4">90</ix:nonNumeric> days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjI1NQ_379bcaf2-d789-4c1f-ba2a-e191d22c831e">10.9</ix:nonFraction> billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately <ix:nonFraction unitRef="number" contextRef="icbf3c6c583244c2fab2e8204429785e0_I20220930" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjYzMQ_f4e4e470-81d1-41b1-b6b0-5c188f3aa9a0">10</ix:nonFraction>% of this amount as revenue over the remainder of 2022, <ix:nonFraction unitRef="number" contextRef="i5e89a0afa4d441e69b487b51d995257f_I20220930" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjY4Ng_07ed8732-32a1-4cdf-b0a6-14ee8a869fbb"><ix:nonFraction unitRef="number" contextRef="if80d7ff3511a426c8ccbb5d590033061_I20220930" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjY4Ng_198694e4-8687-4c6a-b8be-cd9e1e308530">30</ix:nonFraction></ix:nonFraction>% in each of 2023 and 2024, <ix:nonFraction unitRef="number" contextRef="i70cf6c6b94e648fab5b4e530b9597a22_I20220930" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjcwNg_3f4593e5-0ddd-4cb1-8bd6-d6037cd97d3f">15</ix:nonFraction>% in 2025 and <ix:nonFraction unitRef="number" contextRef="i6114d388ab3d4e49b91f718263e65571_I20220930" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjcxOQ_a10dd354-18b2-4559-af42-05b4f5f820f6">15</ix:nonFraction>% thereafter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three and nine months ended September&#160;30, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDYwNA_fa32923f-444e-4e6d-a2aa-aa8f9812eb37">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDYxMQ_67762e10-799c-43fb-9074-9da89aa04fd8">2.4</ix:nonFraction> billion as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to <ix:nonNumeric contextRef="i2a2c21ee9026460f83c4f80341476ca8_D20220101-20220930" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDc3OQ_6eafa9d0-ba33-4b65-a80d-5d3c9f5924af">90</ix:nonNumeric> days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE4NA_4b48d30d-ec79-4a92-a7cd-7e8e20511e7a">one</span> to <ix:nonNumeric contextRef="i59f2aeeaddd4434b899181df93dd41d4_D20220101-20220930" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE5MA_bbb62c7f-0688-4e03-ab0a-7b3037eed3d4">five years</ix:nonNumeric>. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6b4bfc0adcc9435d95d8e25ef8a5d055" continuedAt="i49349bd70a504e58a00938735762a890"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3MQ_ecb681a4-8097-4734-b0f9-9c8160b702fe">one</span> to <ix:nonNumeric contextRef="id0750513067f4915aeadf4ccac6ac536_D20220101-20220930" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3Nw_7041a13d-93e8-4c4f-be5b-4c93c13ed4ea">seven years</ix:nonNumeric>. </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk3MA_58f80f0d-61ed-401c-81bd-9f3ce19e215f" continuedAt="ic63fa94604e044b187b1bda29a46c8b4" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a7066ec33c5413cb82aa1ff74f91430_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMS0xLTEtMS0xMDQzNzI_3863bf3c-5356-4af5-a526-5675186d812b">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25f331f9c16441697383aa057d1019d_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMS0yLTEtMS0xMDQzNzI_7f73fadd-3d75-4798-a6fc-c31808f838eb">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8cc01f04c94d908c036d3fb2209bf1_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMi0xLTEtMS0xMDQzNzI_96cb0270-5cc9-47ca-9d3b-f2194d451ddb">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ea711e6f845c490f196eb8f645359_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMi0yLTEtMS0xMDQzNzI_c8634e0b-90df-4dc7-8f0e-fd325c52c2fd">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3dbd2a395345e89bf32cdbb4960ffd_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMy0xLTEtMS0xMDQzNzI_3f30e22f-af0d-45f5-82da-b074e47885e8">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9584798cd648e6b0f68b8de0c67383_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMy0yLTEtMS0xMDQzNzI_8e01aefd-e594-4a45-a856-5db069e11ba6">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfNC0xLTEtMS0xMDQzNzI_650edcbf-b01f-46b8-98a3-737493c994fa">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfNC0yLTEtMS0xMDQzNzI_807fb070-dd6c-47e4-aaac-e72e0e607ef5">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae4355d68e2490daec9fa91cb0e265a_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMS0xLTEtMS0xMDQzNzI_06d3bb03-d3a3-4b11-9cf3-cf065d0b0219">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397c997d2efa40a4914ea6ada16e1c97_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMS0yLTEtMS0xMDQzNzI_38765ac0-c362-4315-b73f-6d85772728e3">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9100d979f2541629d90815696db7ff7_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMi0xLTEtMS0xMDQzNzI_377f906a-19a1-45b2-a61e-9376b626373d">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e238159a98e4530b36025474376c7c8_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMi0yLTEtMS0xMDQzNzI_99948ff4-70ef-4c36-932f-ab6e990bd2d5">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMy0xLTEtMS0xMDQzNzI_650edcbf-b01f-46b8-98a3-737493c994fa">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMy0yLTEtMS0xMDQzNzI_807fb070-dd6c-47e4-aaac-e72e0e607ef5">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc83d9ed3ee4a2ba978e5473f9f7841_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNS0xLTEtMS0xMDQzNzI_52f9e8cd-eb63-4ff1-8964-3006f054d879">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f24bfa3aee44280868c18852f2add00_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNS0yLTEtMS0xMDQzNzI_160e5a6f-8539-443f-93fd-8dfc8fea4ed6">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fb2acc48954eb78b81311475eb5154_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNi0xLTEtMS0xMDQzNzI_a0a452ff-797f-4be5-9726-4ff6ecd05b8a">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fcc59e0f14e4f539af996b7ddacaf81_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNi0yLTEtMS0xMDQzNzI_aa3f624a-13cf-43ad-aa2f-02fd4e3f810c">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNy0xLTEtMS0xMDQzNzI_88af4a7d-6383-429e-a03e-31fe9bbc823e">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNy0yLTEtMS0xMDQzNzI_6fb90805-2a31-4d0a-8916-2bc5bd0c9e88">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div><ix:continuation id="ic63fa94604e044b187b1bda29a46c8b4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the nine months ended September&#160;30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMS0xLTEtMS0xMDQzNzI_0d4a13b5-d144-43a2-a02d-00cde2acfd0d">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:ContractWithCustomerLiabilityDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMi0xLTEtMS0xMDQzNzI_e1a8da8e-c4cb-4cc5-9648-ca2ba8d565ee">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:ContractWithCustomerLiabilityTotalRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMy0xLTEtMS0xMDQzNzI_16de8d4c-533f-4b8a-8db9-c039057a5922">463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:ContractWithCustomerLiabilityCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfNC0xLTEtMS0xMDQzNzI_6a23ee70-8153-40be-ba40-6fe3b2753bd9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfNS0xLTEtMS0xMDQzNzI_d4896523-9129-4fb6-b5bc-75eb20b429b7">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Hillrom in December 2021, we added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i49349bd70a504e58a00938735762a890" continuedAt="ifab500feef2d4493908f6af5ec6d80af"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2MQ_dd8de6b4-5ba2-4c27-8a2f-ac06efc454f3" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00f9b1190024fc69e527ab0f26e42ae_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0xLTEtMS0xMDQzNzI_25015f2a-c034-4f3c-b9d9-57d815acf3cd">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1427edc253df478ab7767e33fbd20045_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0yLTEtMS0xMDQzNzI_d585cc54-1f93-446f-85e0-95e8b1e15853">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83d13706d9146a79d73c772426d5ff8_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0zLTEtMS0xMDQzNzI_8c3f389d-3ce2-4603-a825-96f946a3c5c9">942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f249df241c94811b66eb3658e39ec2d_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy00LTEtMS0xMDQzNzI_25d3300b-7b0d-4e00-babf-c16fe7629b8d">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if188a3e6d22a4b7db65d00970ac38a45_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy01LTEtMS0xMDQzNzI_7ad023f6-5cc5-46c6-92f1-f1a2a78ab77c">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d172fc6220427c9f12e31cf1f52b80_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy02LTEtMS0xMDQzNzI_6763a1aa-aa22-404c-9c46-fe79e1a67f72">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7eefbfc31c346bca35521fabb975893_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0xLTEtMS0xMDQzNzI_2e4d9e55-1216-4b6c-80e7-3899b537ccb8">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0cd3ff62c945c9ad487c37b3fd49a4_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0yLTEtMS0xMDQzNzI_dd6d879f-202d-4b6a-94d9-26ba018676b3">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ec5023912a4ca5bfbb4e7fca74a490_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0zLTEtMS0xMDQzNzI_6eaceca0-5f03-4945-8b9a-6fa1f21a6df8">725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie96abd97590140b0860c8ae2063b3fc2_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC00LTEtMS0xMDQzNzI_fe3f2d87-fb3a-4d46-abcd-842250ce23d8">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee44477cbc4457bba565114bc45fa23_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC01LTEtMS0xMDQzNzI_a209523c-1e21-4049-82bd-c9c38ada28cb">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3907c853c6419a870b4ed9a47ea65c_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC02LTEtMS0xMDQzNzI_f39fbe15-d8ed-46df-8d49-702f1260a28a">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id84f4faab40b4939b60934146442e110_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0xLTEtMS0xMDQzNzI_e4660b40-6ebc-4b90-9211-8fb2604124c4">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36134bef524d47339914de17640d4657_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0yLTEtMS0xMDQzNzI_5d047177-8565-4e42-ada2-a3feb5aba89b">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c190988faf34c569ba539990a780979_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0zLTEtMS0xMDQzNzI_2ea990c8-2435-4674-afd8-a97d0ff1e6d9">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7778b658da74dfc820fa45dffe480a5_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS00LTEtMS0xMDQzNzI_302c38dd-8533-49b7-99cd-06c261c224e0">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4c4e29d280497495f987d4c7046864_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS01LTEtMS0xMDQzNzI_e4ff5a87-c0c0-476a-8fc1-c56bf371b2b3">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994b7b3bd9824fcb955199e80b3d015d_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS02LTEtMS0xMDQzNzI_83e56dff-95d6-46d5-8a33-f04a519fe02a">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1684b3656ff54e7b88a81aa5ed514327_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0xLTEtMS0xMDQzNzI_3fc3194b-b4d2-4ff7-9782-09bad81a7d72">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8650d0802a0f4458b2b63e441989ada7_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0yLTEtMS0xMDQzNzI_aa5bc89b-be9a-4ecc-a93f-b7f6452328d8">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa64b17a72543409df08e6edf8f9be4_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0zLTEtMS0xMDQzNzI_4cdb69ed-ad50-4a29-a5fa-8e0310cc99e5">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0a55b7d81042cebc2597b4a7828ec0_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi00LTEtMS0xMDQzNzI_58918824-a51f-42ba-ae8a-8a8b8cfc641f">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e39a58bafcf47698fa18eba3fd53f41_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi01LTEtMS0xMDQzNzI_fe5c0393-7aa2-4be3-89cc-a5743c4423fe">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf94a6be0e1f4c53a69e7cae23297b88_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi02LTEtMS0xMDQzNzI_da03da4e-4436-4b14-b25d-9b8885011ebb">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be404ce95e74ed18104ee0224861b9c_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0xLTEtMS0xMDQzNzI_42bab010-42b4-4495-8fcf-f2c7da279ea9">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e142953703144db8673afd8a319673d_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0yLTEtMS0xMDQzNzI_676712ca-a894-4500-87bb-b137a4458c87">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3f619d2fc04691841709d7853758c3_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0zLTEtMS0xMDQzNzI_e4d8ed4e-bcc5-4a7f-b04c-efeff9084dd0">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f7b3b26880741cc9326ad463d4a8fb2_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy00LTEtMS0xMDQzNzI_bcd3a65a-add3-4fab-8ab3-07526d38a8a3">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9f8959592c42928f31e74aadef1a94_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy01LTEtMS0xMDQzNzI_69052608-9a3a-4d3f-8173-563dd0225e18">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5dd465f33414595a6a158c4dafd368f_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy02LTEtMS0xMDQzNzI_38d7fde5-b2ae-42dd-8722-0bbe35c9ff28">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b61cb16ec84ff397f4193ae43dab64_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0xLTEtMS0xMDQzNzI_9fd221f8-da62-4173-976f-e3c13cdfc128">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic197cd11b20542f99e6be323e290d337_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0yLTEtMS0xMDQzNzI_9902b4a7-9dbb-493f-acba-d1e68f260351">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c4e28760c8541dfbabc414285380144_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0zLTEtMS0xMDQzNzI_e6b4cb45-6653-42a6-8d73-8b8fb17254fd">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib35b235ca2534a9eb3695accabe2e56a_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC00LTEtMS0xMDQzNzI_2c38f638-8a7a-4c28-8098-594f0d77a85d">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bea95b582841779004ba9afa0dcbd3_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC01LTEtMS0xMDQzNzI_6715798f-f713-4202-b9f2-7cd16b4d20d4">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50557c7d0a314ffd949e64496b2989ec_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC02LTEtMS0xMDQzNzI_0b2e676b-da36-43ad-bca1-b61c5d4714ed">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c71d0b092845d79272052bbb18994f_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0xLTEtMS0xMDQzNzI_441f4796-54ce-4909-b4c9-f5073251fc18">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic727ea9150bc4dc391144e09e7d7e042_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0yLTEtMS0xMDQzNzI_72847410-8999-4946-991d-834434f1687b">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e66a2f3c8844b989c39e0f132489b7_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0zLTEtMS0xMDQzNzI_47c1059f-9199-4412-9ed4-d5a283980e62">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ee9e3ed488431ebb9c796f6637ad99_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS00LTEtMS0xMDQzNzI_feabf6c3-84eb-4d5a-abe5-e2c6f54885ff">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c1f1c2c43254a579e54a9790105bb7a_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS01LTEtMS0xMDQzNzI_d16d549b-9334-4750-a9e0-a93ba7f3ce4d">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c1df1cfb0e4a7695077dcdae7a8904_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS02LTEtMS0xMDQzNzI_57b04219-81e3-48c4-bb4f-5455625e1ad7">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a234e26b18540b7940a2ea492897975_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMS0xLTEtMTA0Mzcy_7fd545d9-2bb9-40d8-868f-277a0d974807">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a8ba54205549e490a8217b028c1dd2_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMi0xLTEtMTA0Mzcy_55ccd809-b554-4dbe-9e2a-cf4610e77f13">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78097a5d3545484eb624e2a51be21d04_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMy0xLTEtMTA0Mzcy_5cbea42b-d034-4e91-97cc-e8a67d0dec65">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112482d56c394f9c98ec73cd18cf2fef_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNC0xLTEtMTA0Mzcy_2439adfc-43cb-4ee9-aec7-32e380de628e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc9b003385e4853a584b34e1fa30b4c_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNS0xLTEtMTA0Mzcy_aee51662-a03a-4d6a-8aee-942434a1ca1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e1509f4a144b719b8606c6c5a8753b_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNi0xLTEtMTA0Mzcy_8eb51474-78c6-423b-9589-0af207ba4de9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if689fbf349b341a9ac5411f4ddb65c4e_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMS0xLTEtMTA0Mzcy_be57bf37-f012-4a4d-9772-03ca85de7fc9">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad592254e2654405a98370ac967c8207_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMi0xLTEtMTA0Mzcy_760cbab9-57aa-4ba2-a213-9da173047ca4">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb64aca6929b495da3e77fc1aa3d032c_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMy0xLTEtMTA0Mzcy_7e9e62dc-753e-4a1b-aebc-9c8e2084957e">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7295ea739c464a789ba0766d968ab158_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNC0xLTEtMTA0Mzcy_cb7d9824-d66d-49fb-9fea-4235d0a8eb10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc030e4ae0fb4916827ef25e38848ee5_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNS0xLTEtMTA0Mzcy_680f9a91-fff2-4969-aebf-af42b950a7de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i856404b99b8647e39c3633d9d681e346_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNi0xLTEtMTA0Mzcy_9f9a3e1b-c947-4af1-aea0-0bdcb51198b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cf322b7dcd4b9db7fcc6ee06d209ea_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMS0xLTEtMTA0Mzcy_5370c0b0-e795-4f3d-aa98-222fc8f1fd64">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0aab70eb4c4d9b9357a0f16a10420e_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMi0xLTEtMTA0Mzcy_dddb14bc-3316-44ee-ad85-fe43dea221e2">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e357fe9d2f4d669a14180154d0f6de_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMy0xLTEtMTA0Mzcy_efccc9c1-f1f6-4279-8d78-97277888bd85">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7156ab3665b4bd7a5933b82974deaeb_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNC0xLTEtMTA0Mzcy_3022cf31-e715-47a3-bcd9-127dc6d82451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia78721827a43497b8d32a902112bb683_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNS0xLTEtMTA0Mzcy_feef362a-acc8-4037-b907-f357118c258e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eea894996f475286c69c6085cb047b_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNi0xLTEtMTA0Mzcy_7eeca726-a935-4d5c-908a-89c161241271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if602b15a04ab4cee94de3cc0404d3169_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMS0xLTEtMTA0Mzcy_10452609-654d-4a73-85f2-eb19089ec226">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ca6e4d1f814edb8b3dceb8cc93f246_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMi0xLTEtMTA0Mzcy_01162595-6c1f-4015-a3a0-a58c4f5cc5dd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c44836865d447f5a235810c1d8e5421_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMy0xLTEtMTA0Mzcy_0097e88e-b784-4293-b9ac-fa571546027b">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae27fa4503e943d882c2b6fc4fd1b5e1_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNC0xLTEtMTA0Mzcy_82aa87e8-a89b-4d3a-bd31-a5cb731b8283">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced73c5c9a5c41689687660c8f52e324_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNS0xLTEtMTA0Mzcy_b0501894-9a60-453b-838d-98dfdb70911d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdfecd8a92a84c1ea9f18f5a8cf72dca_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNi0xLTEtMTA0Mzcy_344d4bac-01e0-4370-bce5-652ef0b1fe37">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36501cc5b8c1437bac9367d0d934737d_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMS0xLTEtMTA0Mzcy_a3308d4a-ea2c-4a27-91ea-d0221e54d7fe">1,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db8852c6a2a477c9de7a28fc85b2e0e_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMi0xLTEtMTA0Mzcy_11d4de79-4f65-4e7c-8956-8a188f9586e2">1,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMy0xLTEtMTA0Mzcy_c8155edb-3634-4500-897f-5e8ddb61fdbd">3,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445016d775dd4f209e977cbc25ca6e43_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNC0xLTEtMTA0Mzcy_09359873-80b8-4937-8ca9-9e70aba27784">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f18b4486f2427c843d513b40f25523_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNS0xLTEtMTA0Mzcy_516bd0bb-ffab-41f1-904c-485a1a92f653">1,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNi0xLTEtMTA0Mzcy_ed77b74a-767b-4095-88bd-cb7b2d660db1">3,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5414e1e552e04f9f8c6d1c6c4b4a4fe6_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0xLTEtMS0xMDQzNzI_6a4dff6a-2119-4994-b4e7-d113480b48da">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d34e28fa284f1ba780f48fa13f0b66_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0yLTEtMS0xMDQzNzI_042c1345-391a-4009-9d3a-0084628fa7ac">2,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e6724e55eb34d1790b308a597a419d2_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0zLTEtMS0xMDQzNzI_c20b8213-b0c6-402c-8083-5a258f490b67">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ec2539711d4ce5b8b8fed40d4c1deb_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy00LTEtMS0xMDQzNzI_ef3331de-03e9-4eaf-b342-9f3d4324961f">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffaa8df2c61540d0bb50ac46d4160159_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy01LTEtMS0xMDQzNzI_cd592302-1db5-4ced-bd81-1a5540f7851d">2,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b435d25b05043a6aaa5dba29add366d_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy02LTEtMS0xMDQzNzI_87d3a1f4-1267-4900-a3df-4f9e833fd18b">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68152a8599574507a548fc0ac92e4967_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0xLTEtMS0xMDQzNzI_798ad5c9-a406-4bcb-b9d8-26f6be78f917">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id817c0101ced4d6f99e8860b7bbf49e3_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0yLTEtMS0xMDQzNzI_850064f3-3d00-4c47-94da-df4f7ac4e955">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6624a35872d9468488b80d9b5c5a3bbf_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0zLTEtMS0xMDQzNzI_8ef5ffb0-9742-40e9-b9ee-3e4aaecd9a27">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifacde500ddb74a838f3cc9af62684d7c_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC00LTEtMS0xMDQzNzI_c7a4956d-6d3f-4af8-b9c2-9e4affc39681">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e1514aa7fc443080c274bc42357af8_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC01LTEtMS0xMDQzNzI_bf80f62c-ec60-4eb5-95bd-ec85065e7701">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idde5b46f7b324236890c317a7886f38b_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC02LTEtMS0xMDQzNzI_2a739add-2cec-4257-b20a-5d390b7e214c">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08864ae1bda84a668fd39b3a4061c26c_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0xLTEtMS0xMDQzNzI_5474598d-6245-4885-ab44-fadd45b24282">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c06aa2c44648eaa7913d094f119852_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0yLTEtMS0xMDQzNzI_bdfb48a1-0da8-444e-9ab8-30a0acdb5c7d">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cda3b1cb17849b68369df08696e2ff8_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0zLTEtMS0xMDQzNzI_be1cd0d6-e87b-4166-b8d1-5aa7717047a2">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6887a94e2824849a970f1b2b7ac88a8_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS00LTEtMS0xMDQzNzI_a73c014b-4e83-44e0-965a-3ba5bc09eaee">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2305248e0ec7423c9ec651a058186ca2_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS01LTEtMS0xMDQzNzI_1dbf1fb8-bb6e-4acc-9c22-a70f4b643fb5">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae35539042854319b592f855a1b59d31_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS02LTEtMS0xMDQzNzI_d820d11f-cbc2-4595-8580-e5449195f019">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206b2c76cea3434e9b38f340fb7d619a_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0xLTEtMS0xMDQzNzI_55ab6457-4803-445f-8b6d-81b4bdd49fa8">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bd891890ba45da8085b5e18a6d0c2d_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0yLTEtMS0xMDQzNzI_aeca8624-b32d-4bbd-b19a-b3addfb073bf">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b1d5114e8a40e58ad899a25fd25a78_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0zLTEtMS0xMDQzNzI_2f7c29b2-16b0-4574-87af-2a4937d993e4">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48883a929c674841b54b15a5dfa052c9_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi00LTEtMS0xMDQzNzI_81198801-e2bd-46bd-8ccb-e51f7cd6f2f9">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic709cdea2757418ba8d3eba64ac18cd3_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi01LTEtMS0xMDQzNzI_c1fb7738-e5e2-4ac9-80d7-19d55ff49c20">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd006e5337d34042a30f9b2fadf77562_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi02LTEtMS0xMDQzNzI_ebf83d34-e0c2-40ed-a167-64556de3b97c">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe1019e59b241e586669181c4ed2172_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0xLTEtMS0xMDQzNzI_824f6069-e58e-40bc-a658-83d1a272c44c">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8f1f99c44f4480975af6d8192015a8_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0yLTEtMS0xMDQzNzI_1e50dd59-098b-4d25-ad7e-7938aa3f062e">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b82b81097954a6dbe91e74a172c38a0_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0zLTEtMS0xMDQzNzI_e0cbd8a2-0d8d-49bf-b2d8-ec4fee53c22b">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996157eb8f024336abb632e6241bd77b_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy00LTEtMS0xMDQzNzI_b34c20d9-f1f1-4e76-a99a-71fead009162">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c72c96c8e434f6ca045344246edcf0d_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy01LTEtMS0xMDQzNzI_d5a881d8-038f-402c-90e6-67dbd68c449b">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5d4575471c419c84ba4bf97ce903ce_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy02LTEtMS0xMDQzNzI_1c9b0f38-abf7-471e-9dbb-2ad30d1633f8">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdae4e4c5a5242a1b88940fdea051045_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0xLTEtMS0xMDQzNzI_00e04b5d-60a4-4b41-928f-124ce3901b56">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia250b656d037452f82c80809f1305d0e_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0yLTEtMS0xMDQzNzI_dbfad7d7-bb96-49f3-9121-c73aaf4b371b">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b4ff6ffd414f62bb45cf05a387070d_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0zLTEtMS0xMDQzNzI_b148f43b-39c6-4c63-97e1-40f9ae2b6f1f">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1240a78f95a245e8a86128ad258992e2_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC00LTEtMS0xMDQzNzI_6fb7170d-0330-43f0-b29e-d344e7ed59aa">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4c7a30b47c41748e6634ad3c972b6a_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC01LTEtMS0xMDQzNzI_c497809e-119b-4e15-ad0b-e8a9c4b242ff">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3ae3d6aa2b4d09a6a8a1fd463caf0c_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC02LTEtMS0xMDQzNzI_0617ad95-0083-4bf0-b5ee-cc8825384917">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda2e702c6e44df89b96f76ad8d15ab_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0xLTEtMS0xMDQzNzI_218d274a-23c7-4a27-934a-a90800c04099">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08ebd120d464decaaf14ac1fb137424_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0yLTEtMS0xMDQzNzI_e84d81f9-484a-4be7-958c-4776c90e771e">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2d778f29a0499e8266532cb33dc627_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0zLTEtMS0xMDQzNzI_3d2568f3-64a5-4352-b749-61777be7fe7d">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3090e8c3fda94423a0d0912d50961819_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS00LTEtMS0xMDQzNzI_3a9dcad8-6953-4262-9854-7e114683ba28">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e3034fc19a412ea43aa1cfb0412fc7_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS01LTEtMS0xMDQzNzI_b7a59e63-9742-4bda-8757-81f9b209b202">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dae84b5f6a4563bdf623ffa56038af_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS02LTEtMS0xMDQzNzI_df3a70c5-75fe-4fe2-92d9-2cd316005d8d">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df3f4f4414c4f44918ed058594a3a6d_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMS0xLTEtMTA0Mzcy_320decb3-1b02-48b2-83a6-50877ea817d6">880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaddecfa588c45dbbd695699ea74db2e_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMi0xLTEtMTA0Mzcy_68bb2de5-b678-42e1-abba-483e302b32d3">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a0261aa0654089bb88fbb3d2a3a069_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMy0xLTEtMTA0Mzcy_3ce0db28-cb34-41b2-8bb1-8dcdc06cc1e9">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b80e53eaaf246c0a006f99d6c332ef9_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNC0xLTEtMTA0Mzcy_98ea20d1-5d0c-4299-b002-2429b283a7f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82485fb2469a47ecbb6c7c2217dbedb5_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNS0xLTEtMTA0Mzcy_667f511d-f077-4c12-aec6-4928ee0e5498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c244391ad84185a8d527720e081a70_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNi0xLTEtMTA0Mzcy_0e9da41d-0773-4602-9e81-c20fc9e43c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i428120bbc00c4484801fe373fa42a492_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMS0xLTEtMTA0Mzcy_a189b3ea-3f34-4644-8d49-9efbf8c6ec09">618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9603e0fe354ab996f5149cb7753360_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMi0xLTEtMTA0Mzcy_ac72e75a-4eb0-42b9-af7a-071e90eaecd8">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b0d89fe81948dbad94f24b2081b1fd_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMy0xLTEtMTA0Mzcy_d929f84a-6344-4b98-a607-069e2546ddbd">855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddbc08f9e34a4424a04357d4ff58fd2b_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNC0xLTEtMTA0Mzcy_2dc3cda3-7c63-4e65-8e2f-6163aa1e66a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34ea41012e54e3a8847c03a4116d7c5_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNS0xLTEtMTA0Mzcy_c5239733-72e1-448e-b4d2-c81fdef8bfb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983f956742e148cd9935461bf9c57d85_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNi0xLTEtMTA0Mzcy_8545d7d0-f853-46fc-9a31-5821ea6f29a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa57853da33460a929d418073a4e5ef_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMS0xLTEtMTA0Mzcy_e65c97aa-221d-4227-8f15-f4857b41f40c">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7764dcb4d84344eab48a05c00972e9ca_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMi0xLTEtMTA0Mzcy_856ca449-3761-4fe7-9176-2537c4ad6d23">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79060a21825446f68e990e404b003293_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMy0xLTEtMTA0Mzcy_672bd16d-a0fa-484f-a300-3c0f0bb81e57">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e5727a5d734abc8a8eceb71d05ff40_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNC0xLTEtMTA0Mzcy_d7bd95f7-5b9a-4241-80a0-f79706cb2da7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e28f51eca1f4bd9b296c01f4220bd6a_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNS0xLTEtMTA0Mzcy_4a134f79-9a31-49f1-8154-317ea8785042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia374726d39fe4c0c815368587eed129e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNi0xLTEtMTA0Mzcy_8594901c-0e84-49c3-9ff5-670e434aef58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000aac4b4eb74546bf63b572c100248c_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMS0xLTEtMTA0Mzcy_ca184bfa-ca57-41be-ae3b-437ccfb44d5c">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic27396433bf44b738da6b78bd6987adc_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMi0xLTEtMTA0Mzcy_c6bfc022-c87a-4f89-9658-686eddc58ba4">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd580e555ab485aa20157d901745b91_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMy0xLTEtMTA0Mzcy_e24da694-7a6d-4751-bc6b-eaa62e654be2">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ee0893dd9643fdbf0354b01a632557_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNC0xLTEtMTA0Mzcy_57806091-f010-4c45-9f30-91009481d933">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadc946e2caf484fa6388e999c80bef3_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNS0xLTEtMTA0Mzcy_a87f82cc-d6a4-4e0a-a01d-041066fde523">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3361742ed1c42fbbb2de2275dd10be2_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNi0xLTEtMTA0Mzcy_a894111a-e49f-4f6a-b35f-dc4f01a5c8c3">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7dc69941344244b7589680ec54ee1d_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMS0xLTEtMTA0Mzcy_97a79fba-cf65-4487-833e-8979a30226d6">5,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe952d9c345f44f88320bf99c72fbf4b_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMi0xLTEtMTA0Mzcy_8775565c-4480-4b37-9879-d251dc27e899">5,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMy0xLTEtMTA0Mzcy_03893772-8d75-431c-b31a-5fbe72069d9a">11,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice50f6d87c71414ca4f9c37b27e16086_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNC0xLTEtMTA0Mzcy_ec47bd61-d5fe-4e72-998f-1ef60ea395b5">3,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c354156cd54db0bdb335313ca518aa_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNS0xLTEtMTA0Mzcy_63f2a3e6-fb60-4417-8e80-76edc6cb6075">5,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNi0xLTEtMTA0Mzcy_9333efce-8e1c-4b15-a6da-ce7859af51a3">9,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifab500feef2d4493908f6af5ec6d80af"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2Mw_50981d4d-e5b2-4496-af48-034839d5dca9" escape="true"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2Mw_df27d8ca-e235-43af-acdd-bfe9a1ad86d2" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMS0xLTEtMS0xMDQzNzI_8533dfec-e020-400e-a1b9-5a7c3e26ef8a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMS0yLTEtMS0xMDQzNzI_dd7dd0b6-74da-4140-b429-b09b21ae72d3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMi0xLTEtMS0xMDQzNzI_cea9b107-807c-4df3-b029-84626054d9dc">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMi0yLTEtMS0xMDQzNzI_53c60cd5-4f76-4e98-a4d2-21abed7fe3d3">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMy0xLTEtMS0xMDQzNzI_44fe5695-5fff-40a1-b9f1-ff5098905373">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMy0yLTEtMS0xMDQzNzI_4fe0e633-f604-4642-abf7-bf833a160cfb">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfNC0xLTEtMS0xMDQzNzI_5dd6f741-8af0-4e80-af2c-a9c0578fc370">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfNC0yLTEtMS0xMDQzNzI_19ec945e-1b70-4710-a1d3-c39610dc30e7">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMS0xLTEtMS0xMDQzNzI_289e9a11-b5ac-49b5-bd6b-92d7fd62c86f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMS0yLTEtMS0xMDQzNzI_f96238e3-e41f-4ce0-8d6f-f9e0515fec06">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMi0xLTEtMS0xMDQzNzI_1bf9fd10-950a-44d9-bb68-620122f24f8c">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMi0yLTEtMS0xMDQzNzI_b4ecd74b-0220-4760-9666-5031174bd3a9">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMy0xLTEtMS0xMDQzNzI_a87bd469-ab24-417e-bfdf-274ac20fcdb3">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMy0yLTEtMS0xMDQzNzI_7263bf0a-0cdf-456c-8e46-eb444b4a6256">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfNC0xLTEtMS0xMDQzNzI_cb7386aa-9119-420e-83b2-ccb63a192092">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfNC0yLTEtMS0xMDQzNzI_80fdfd41-4873-4ef0-9d96-f884a1ad6eae">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTg1NQ_5d83e405-5b05-439e-8295-cd8ce93ee0ca">95</ix:nonFraction> million as of September&#160;30, 2022, of which $<ix:nonFraction unitRef="usd" contextRef="ia15c872355344ae39ce7dd39d2d327e4_I20181231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTg3Nw_20bd2d43-6472-4a5d-a72d-cd52e34f6a63">18</ix:nonFraction> million originated in 2018 and prior, $<ix:nonFraction unitRef="usd" contextRef="if78a45e31e0c4f4d810fb14d428a91ce_I20191231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkxMA_ec0e0fe8-12d6-4f1e-9bd4-db981173e252">19</ix:nonFraction> million in 2019, $<ix:nonFraction unitRef="usd" contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkyMg_0630a25e-f294-413c-9a4f-9f168ba596f9">26</ix:nonFraction>&#160;million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkzNA_b75244ea-e685-446d-aba9-b550510a20a4">24</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk1MA_c0766c85-2eae-4c16-8b2b-2c5ec742d6d7">8</ix:nonFraction>&#160;million in 2022.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_67"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">10. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxNg_e0719b4a-cb4e-4a70-b608-66d245913b65" continuedAt="i6f340c16988b47009583d706e4d91061" escape="true">BUSINESS OPTIMIZATION CHARGES</ix:nonNumeric></span></div><ix:continuation id="i6f340c16988b47009583d706e4d91061" continuedAt="i05b77136c0df4345817bc33803d5d224"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through September&#160;30, 2022, we have incurred cumulative pre-tax costs of $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfNjQ2_83c40e17-d4d1-4b1f-9875-cedb96200d96">1.4</ix:nonFraction> billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfOTc3_5ef009b2-c53c-44e6-8705-f76cb3ff0820">14</ix:nonFraction> million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related to our integration of Hillrom, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="bax:BusinessOptimizationChargeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxMQ_4d7930ee-8f8e-4a44-a699-d7369785e967" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi0xLTEtMS0xMDQzNzI_10286021-9a5c-4783-be64-b933dc9f2656">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi0yLTEtMS0xMDQzNzI_cff95e95-3d53-4dcd-bd2c-e5f6e87a5871">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi00LTEtMS0xMDQzNzI_5cd5db9b-4a5f-4377-8c9f-f72175e09e3a">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi01LTEtMS0xMDQzNzI_370dd891-1fbe-40bd-aae0-0bd11b3e51b8">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy0xLTEtMS0xMDQzNzI_1638836e-6845-4283-a6f1-e80ee193b4dd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy0yLTEtMS0xMDQzNzI_7b6844e9-0d2e-4b1c-b345-48feb7d8c0d9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy00LTEtMS0xMDQzNzI_382f9ce3-c5c6-4d72-9ca0-0d4ef63b03bd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy01LTEtMS0xMDQzNzI_e3ea35d4-d53f-4e4f-8e2b-64bf0cad4f33">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS0xLTEtMS0xMDQzNzI_096170c8-2abc-47f3-9b58-af3599ddcfd9">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS0yLTEtMS0xMDQzNzI_7696429b-bc28-4a07-b0cc-a3739ac30aff">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS00LTEtMS0xMDQzNzI_3a51371f-2af9-4f87-a7ad-88cfe82cbfda">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS01LTEtMS0xMDQzNzI_d18a757b-343b-4c2d-8bcb-a8296a4c51bc">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i05b77136c0df4345817bc33803d5d224"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three and nine months ended September&#160;30, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxMw_ce05f7ca-44fe-4e85-8008-696edddb20a0" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a632ba481346bdaf99d141baafe749_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0xLTEtMS0xMDQzNzI_a466f7f0-3725-405e-b4c3-ee9b82b46894">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17907bd75b564e249364985141865dee_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0yLTEtMS0xMDQzNzI_236b520f-3d14-4da4-8588-6625703b487d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66df73b2bcb44c6ab4532b0c9ab728b_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0zLTEtMS0xMDQzNzI_89185888-85e5-4355-9a65-77b70f0e705f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea336d5c32bc4861902104cb153044f3_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi00LTEtMS0xMDQzNzI_79199f57-4a19-41cb-8af0-1366991e2459">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697542fa1b0a4a98875df15a602c28ec_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0xLTEtMS0xMDQzNzI_9fb23a9f-6bbc-48b7-9d4f-ccdfbe3cadf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09cba0015a754f508a844041cd9e4b69_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0yLTEtMS0xMDQzNzI_5d7ab0bd-5043-4eab-a556-3b6f7b0cb8a9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f3be8e44b4bfa864a27180b621ed9_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0zLTEtMS0xMDQzNzI_2c763b8e-cde3-4d09-8850-9d999eb989c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e1f45adb51d457aa5725c517e737b84_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy00LTEtMS0xMDQzNzI_5ee1c5c7-afa4-4ae5-9cf1-6d8f1e1539e8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2588cc62cb4d48b7a46b738e92f4072f_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0xLTEtMS0xMDQzNzI_5950e29c-5767-47fa-bbf6-684adcb29398">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d230df90c142c884206af10ef9f8fc_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0yLTEtMS0xMDQzNzI_41a09ccf-cb4b-4fee-a8d1-e083185ae258">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7199ae522f2f43f4ae0239522889f703_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0zLTEtMS0xMDQzNzI_d7932ea3-5709-45d9-8b89-3b0b247af112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2312799038e14136a66c60426b4cb5f9_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC00LTEtMS0xMDQzNzI_a08a2b83-055a-4858-a67c-12a6da3e7629">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4632e8764241ee9398872757d10f8e_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0xLTEtMS0xMDQzNzI_c683c0c2-cb1f-4ee1-b4dc-f7ba940f4e25">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4990d1e08a374066a38fe1c66495a71f_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0yLTEtMS0xMDQzNzI_33be822b-fbb6-439c-87ac-d05a0a094617">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbfdfaa0e8ef4d4790f5cacb41fbc6d5_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0zLTEtMS0xMDQzNzI_21b66400-6456-4b9f-90bc-0349af1a69bc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS00LTEtMS0xMDQzNzI_08375b77-0a8f-40cd-b7b1-214b322925c9">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c145ad188b4727a0ff9e2d211c6b95_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi0xLTEtMS0xMDQzNzI_7d22f288-97ac-4ed5-9cc4-eb5a56ae4bba">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c83749cf3d4a26b1b79ffab6bc6042_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi0yLTEtMS0xMDQzNzI_b0ad37da-8c4a-47d0-b8de-b1d01a278f22">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i115a2bff9c784ab99914fe29be8d2d98_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi00LTEtMS0xMDQzNzI_9f0a5e5f-95bf-443f-bbe6-7e8a48a80c0b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e6c07c99ae4e90bc9ff4f65a602520_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy0xLTEtMS0xMDQzNzI_268f5032-2088-4c17-aa3a-6ce1c8bd2d5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida458b6715084e3a96aa191749dc91fd_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy0yLTEtMS0xMDQzNzI_c785afa8-947a-40df-a781-2a74e307dd88">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bdf1fc538624d7d9910380d7d77b626_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy00LTEtMS0xMDQzNzI_2622ab86-53bb-4522-b7de-f9b0e4856ea2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95260f0037d846208bd14cc3ba8adffb_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC0xLTEtMS0xMDQzNzI_95c95d6e-b153-46ca-b394-17c9008feed8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff550217f2b4a8f8d4ae65fe153a1ff_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC0yLTEtMS0xMDQzNzI_5d88cb02-e76f-41b4-81a2-d4240d0c566e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbdf433bfc67461d8114a92c13283325_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC00LTEtMS0xMDQzNzI_8251e380-e7ae-401d-b3b2-a932b5df28d7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0679fb1835b4c7795bcea38cf0b9886_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS0xLTEtMS0xMDQzNzI_cdb44ff9-f722-4527-aadd-820b43264aed">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e2ab4fa4974f7889612beb65ce8d19_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS0yLTEtMS0xMDQzNzI_f3e1f96d-ea72-4ddf-946a-66beca62c17f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS00LTEtMS0xMDQzNzI_0ad4123b-68e5-42ab-bcca-65e2d6b27dd5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491168a2923441709f7ed1cbfe6c88ad_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0xLTEtMS0xMDQzNzI_30dba572-cc6b-4acc-b316-64a926d6e888">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59821c1a37b043dd8a8397a39a3d0bd4_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0yLTEtMS0xMDQzNzI_2cb7ae1c-53fe-4b72-a7df-9fa342f65e30">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f65613766e4c30bdf4b47df7bb28b8_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0zLTEtMS0xMDQzNzI_0e3d7d07-1e06-4e63-af1a-5d9e42ce36ae">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a5054d010e43e2bb824d4b0a88a448_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi00LTEtMS0xMDQzNzI_4f7b6b7a-b53f-403e-811a-41272fa397f5">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3df95dfd2c54aaea21d90d6cd142885_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0xLTEtMS0xMDQzNzI_2271d00c-c9d8-4fc9-a4e2-b8d4ba47fbc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ff276cb874486b9ea8a16dad3d507f_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0yLTEtMS0xMDQzNzI_83ee1d4e-727f-4e9c-b79b-38a6568b97fa">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee715bdb374f4d0fb135cd9a90024cb7_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0zLTEtMS0xMDQzNzI_df58d06b-6ac9-444e-b809-6805414522f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bdd528aa2f43d699d93d6730eaadc0_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy00LTEtMS0xMDQzNzI_a59dcf4b-0656-429c-b4f5-c7518415c2d1">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4eaef49d9cb47cfa238b4be07c3c11e_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0xLTEtMS0xMDQzNzI_a1f8c019-c993-481c-aa4e-72954f9d22d2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7daf0d45954200a36a140244cfa8c3_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0yLTEtMS0xMDQzNzI_b8b6cc34-c46d-4f60-906c-1cc97dce1ad8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e760ae3df749d7a28496170682fcdb_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0zLTEtMS0xMDQzNzI_89668683-f9e7-4c70-a810-8cb5411d286a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9092a352dc419ebd9202ad5227d8e1_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC00LTEtMS0xMDQzNzI_0a1099c9-6cec-4087-9690-d3fe93c8fda1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa41f2bd185d4f35992a88175bd33816_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0xLTEtMS0xMDQzNzI_1246fe8d-6f3d-47be-a22b-2b05f1158fc6">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f72f4b6a78548e09b7e4a30258e2a66_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0yLTEtMS0xMDQzNzI_60d68744-6464-4b67-b723-e096e9c17bb2">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f4353d73fc0409094a9382a8f5b35ed_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0zLTEtMS0xMDQzNzI_5233c16e-a258-456e-b506-59bbb4b4d048">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS00LTEtMS0xMDQzNzI_45970d4c-1fc8-4497-aa42-eac109aa5a2f">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f7b3dac88f4fdeb34925d2fd733bd2_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi0xLTEtMS0xMDQzNzI_17d8df1a-8d79-4832-a203-9b0ba57f7c39">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f085c0375204e3d928fcb8db88faac6_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi0yLTEtMS0xMDQzNzI_fd1073df-2294-4991-b73e-03cd243cea10">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087c22c00b8342649cb73bf0310b7e9e_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi00LTEtMS0xMDQzNzI_e9e322b7-ea59-4855-bd43-b2eb9f8c3d32">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89294089c022435cbb391734e7e95a77_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy0xLTEtMS0xMDQzNzI_e985286c-0eee-468f-8597-5ac02ec46763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c1cd55ef43406fb28e3516e8bed426_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy0yLTEtMS0xMDQzNzI_ed1113df-d2be-4315-aeb1-1d256b68d016">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f66dbec955f46ba8e2a9f09b30f4234_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy00LTEtMS0xMDQzNzI_ef629cfa-934e-4f34-a746-de4d8ee2c033">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dda49a9d7704da6860a7855a38b3484_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC0xLTEtMS0xMDQzNzI_be347cad-3b9f-41aa-9fcf-8b11ba4675e7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3dbfedff62414dbc6b3c751ec05d46_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC0yLTEtMS0xMDQzNzI_20034022-9d3b-452c-8af1-b7fc8664ba88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a28025718c7422987d5e9a1bb04a33f_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC00LTEtMS0xMDQzNzI_c97c7d8e-5898-48ef-9162-51875938528b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie76d49105fd64d3fbed5c1bb08359728_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS0xLTEtMS0xMDQzNzI_485a736e-2c17-42e0-9395-b08194fd4f39">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0522de9f5b144d58800dd0fd0f71c6a_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS0yLTEtMS0xMDQzNzI_19b59635-2f6f-440d-822c-3d5e0019afa9">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS00LTEtMS0xMDQzNzI_f44cd1d4-88ce-4d7d-8b50-81301f6978b7">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxNA_66f9fee6-6b03-41f2-9032-d275c53530d4" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2166896cc67640a7ae96d097acab1f25_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMS0xLTEtMS0xMDQzNzI_4949f85a-442d-48ed-9d04-a80d49121b1f">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMi0xLTEtMS0xMDQzNzI_b48180c6-2e2f-4bde-a517-84d06f6cbb30">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMy0xLTEtMS0xMDQzNzI_b158d64c-db18-47af-a794-d72d67a581d8">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNC0xLTEtMS0xMDQzNzI_12fe75d4-812e-4880-afac-8ba6774e456d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNS0xLTEtMS0xMDQzNzI_51b36bd2-8503-45be-a5e7-55581ddc87bd">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950523c03d0e465a8db7b9c48b7e0e3e_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNi0xLTEtMS0xMDQzNzI_d8b39a32-2e79-4944-abe6-4f24f16226b2">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of September&#160;30, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">11. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfODQ3_ed177bcd-0400-4cb7-8e13-ee57f9ab60d2" continuedAt="i37f4c1b9478b411484517aee941e36ff" escape="true">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ix:nonNumeric></span></div><ix:continuation id="i37f4c1b9478b411484517aee941e36ff" continuedAt="i50d9ca69a7604b5883464dd9a59e5539"><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfODQ5_cfb5a055-1f6d-4e82-b916-6a512fbb03de" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy0xLTEtMS0xMDQzNzI_0f777b56-4919-48d7-ae09-3000cbe3bd76">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy0yLTEtMS0xMDQzNzI_4d6475c1-60c6-40cb-9e37-bd5c12f66a2e">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy00LTEtMS0xMDQzNzI_909080d4-42eb-4645-b95f-813d350e6d45">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy01LTEtMS0xMDQzNzI_1c68c110-e85d-40e3-b991-35c95f7b9fff">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC0xLTEtMS0xMDQzNzI_f16e948e-9134-44aa-9d2d-8d08f901421b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC0yLTEtMS0xMDQzNzI_37b5f16e-32e5-4400-b1ea-7261d14d3b7f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC00LTEtMS0xMDQzNzI_fe35db7b-8655-4d95-a5b4-693a6e02f98a">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC01LTEtMS0xMDQzNzI_c4e6fc45-09ca-4f53-9512-f33d9cd43caa">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS0xLTEtMS0xMDQzNzI_a6e5b1ad-8b3a-4833-834c-59de074e6eea">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS0yLTEtMS0xMDQzNzI_3d51bbb7-3ee9-4cf4-9184-8486e71aee75">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS00LTEtMS0xMDQzNzI_357c9bcd-ce19-4fc4-8fb1-3b7211690898">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS01LTEtMS0xMDQzNzI_b7ad82d4-64a1-434b-87a2-231bb8b37770">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi0xLTEtMS0xMDQzNzI_a42b6451-674c-40e8-8e15-eb7b06aa32e4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi0yLTEtMS0xMDQzNzI_3d3c68ed-32b7-4269-b5cc-066dc6f2da0b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi00LTEtMS0xMDQzNzI_7f54ab79-f9a1-4dc4-a097-3a9626dbc987">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi01LTEtMS0xMDQzNzI_da345049-430a-4e0d-95c6-17e9a2d763cd">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy0xLTEtMS0xMDQzNzI_38f8a3a5-e2f3-4feb-8458-3977f982bf05">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy0yLTEtMS0xMDQzNzI_cc0a4727-9169-44bf-b6ce-021eef0fdede">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy00LTEtMS0xMDQzNzI_3515988a-8409-4380-a856-d7d0166058b7">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy01LTEtMS0xMDQzNzI_b82f2a23-5dd9-4253-9c75-a9cb1ef130a5">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS0xLTEtMS0xMDQzNzI_df7be1d5-979b-4d5b-89d7-9084bbe7fc94">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS0yLTEtMS0xMDQzNzI_a7ebde4d-e6f6-4541-9eda-d00260b0f331">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS00LTEtMS0xMDQzNzI_63fdef21-56cc-43fd-9e4f-8db294fc71a3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS01LTEtMS0xMDQzNzI_b321e46a-2194-497e-b002-06997fa4fa9f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtMS0xLTEtMTA0Mzcy_e8ceb2bf-629c-4100-ba1c-fa6b66af9260">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtMi0xLTEtMTA0Mzcy_a4307799-fd43-4685-a9a9-4de74df8eb02">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtNC0xLTEtMTA0Mzcy_86a7340d-0206-4ca7-aaf2-03dbce6cf5d4">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtNS0xLTEtMTA0Mzcy_9a4e65e5-3756-40ff-bdc1-f6ca16c79b9c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtMS0xLTEtMTA0Mzcy_3d94f4a0-4fd7-44cd-a227-4264b1a98ef1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtMi0xLTEtMTA0Mzcy_97fee40d-79a2-4fc6-853c-d007827a0438">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtNC0xLTEtMTA0Mzcy_8b185d57-e73e-432c-b603-8e41f46809ba">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtNS0xLTEtMTA0Mzcy_32f39c5e-3c6b-4b1f-9019-e57c1f38f429">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Hillrom Pension Plan Amendment</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i50d9ca69a7604b5883464dd9a59e5539">In May 2022, we announced that the pay and service amounts used to calculate pension benefits for active non-bargaining participants in our U.S. Hillrom pension plan will freeze as of December 31, 2022. Years of additional service earned and eligible compensation received after December 31, 2022 will not be included in the determination of the benefits payable to those participants. This change resulted in an $<ix:nonFraction unitRef="usd" contextRef="i8ace5ff2293146d4bf055d7cb9bcf636_I20220531" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfNjA1_5f6945fa-2554-4fb9-9a16-1a9f31512133">11</ix:nonFraction>&#160;million decline in the projected benefit obligation (PBO) with an offsetting curtailment gain included within other (income) expense, net on the condensed consolidated statements of income (loss) for the nine months ended September 30, 2022.</ix:continuation> </span></div><div id="iaef9f667721343c48067444506cf55c3_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> 12. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTIyNA_b7d4c6c9-c169-4ddf-bce9-0f5c57495e8f" continuedAt="iea481d500f7a441a99c645710dd2cd06" escape="true">INCOME TAXES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="iea481d500f7a441a99c645710dd2cd06" continuedAt="i04d5106a0e1b461f92a48bcfad326be6"> </ix:continuation></span></div><ix:continuation id="i04d5106a0e1b461f92a48bcfad326be6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTg_ddf753e8-6b98-43f6-991a-ce52fb97d505">1.1</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNjU_70ca4eb4-3736-422a-8918-c408020cae6c">0.2</ix:nonFraction>)% for the three months ended September 30, 2022 and 2021, respectively, and (<ix:nonFraction unitRef="number" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTA1_1161ce48-e256-4f7c-8f75-2151f5273452">1.1</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTEy_4527c6df-0ec8-4baf-9df8-f40715bf784b">11.8</ix:nonFraction>% for the nine months ended September&#160;30, 2022 and 2021, respectively. Our effective income tax rate can differ from the <ix:nonFraction unitRef="number" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMjE0_37cb6443-38c0-4130-8464-494d18ae0d5e">21</ix:nonFraction>% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to non-deductible goodwill impairments.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTQ5NzU1ODE2MDc1_689edbee-9f1a-4364-93df-7a8cbdee7c8b">58</ix:nonFraction>&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTQ5NzU1ODE2MjQ0_4a9e5d65-0fb4-4bae-9646-cd4039e7475a">58</ix:nonFraction>&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as a favorable geographic earnings mix and changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_76"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">13. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfOTUy_71ec7b52-2560-4b69-a266-a98ff1f4ceee" continuedAt="i97234c9fd6234cf685e1d40b2ea69a65" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i97234c9fd6234cf685e1d40b2ea69a65" continuedAt="ie7572f1228c640b6a9a076edf7c0152d">The numerator for both basic and diluted earnings per share (EPS) is net income (loss) attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie7572f1228c640b6a9a076edf7c0152d"><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfOTUz_b1cc8053-83e0-4b77-aee2-208df0d9eb17" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi0xLTEtMS0xMDQzNzI_7be37722-501e-49d8-ad44-70e6c5a50cd3">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi0yLTEtMS0xMDQzNzI_bee903e0-982f-427d-8ae8-f23461508617">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi00LTEtMS0xMDQzNzI_021d1468-f6ed-4eb7-9b5d-189fc358e227">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi01LTEtMS0xMDQzNzI_48395e4d-a26e-4801-9189-2c9de1a64048">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy0xLTEtMS0xMDQzNzI_0abee681-86c3-4b1b-9459-e5a7d736607c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy0yLTEtMS0xMDQzNzI_b876ca17-c792-49c1-8231-689c826fc489">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy00LTEtMS0xMDQzNzI_a60ea63b-21b7-41b9-8ce4-59069b29c955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy01LTEtMS0xMDQzNzI_f97b7201-79b2-4b03-bd55-fca0911771b5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC0xLTEtMS0xMDQzNzI_9bd3ca87-0830-4db4-9786-90f5d27bb3c3">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC0yLTEtMS0xMDQzNzI_2f69d6c8-4671-4048-91ed-1d25abcc6412">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC00LTEtMS0xMDQzNzI_11e4e4f3-8e88-4d32-a4dc-0769446deac7">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC01LTEtMS0xMDQzNzI_b6cd943c-3170-4aeb-b800-3e92abd336c7">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted shares are the same for the three and nine months ended September 30, 2022 due to our net losses for those periods. The effect of dilutive securities for the three and nine months ended September 30, 2021 includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS excludes <ix:nonFraction unitRef="shares" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNjUw_31155439-b4db-4d48-aa6b-045506a16860">23</ix:nonFraction> million shares issuable under equity awards for the three and nine months ended September&#160;30, 2022, respectively, and <ix:nonFraction unitRef="shares" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNzIw_9729b0e0-1ec6-4eb0-a353-d68c88f8a074"><ix:nonFraction unitRef="shares" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNzIw_aadd23ce-6153-4a32-99ac-85f1d11304f7">7</ix:nonFraction></ix:nonFraction> million shares issuable under equity awards for the three and nine months ended September&#160;30, 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS. Refer to Note 7 for additional information regarding items impacting basic and diluted shares.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">14. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNA_e73d6979-b499-406d-a5a2-5d3e87dc7c9d" continuedAt="if60e877e6bbe4039982612e3cd9d3d92" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="if60e877e6bbe4039982612e3cd9d3d92" continuedAt="ia59889ffb6c24013bcfaa4151e20de71"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia59889ffb6c24013bcfaa4151e20de71" continuedAt="i0609391cf202410c80d94a4d552a0825"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $<ix:nonFraction unitRef="usd" contextRef="i2a9b0b9cb7944866bf75d223bb4c8fea_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzU1Ng_9ff0cdd6-3d70-4b13-86d9-0af95870d9b9">407</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0a10b05f8c504eaea705b787746ae15b_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzU2Mw_6215412f-583e-4ca4-8adc-4d6f438cb4e1">377</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at September&#160;30, 2022 is <ix:nonNumeric contextRef="i33b44d74805841d2ac389e7934b1a17f_D20220101-20220930" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzcxMg_6986c92d-4443-418a-a1e8-8205bc9dcd67">12</ix:nonNumeric> months for foreign exchange contracts. There were <ix:nonFraction unitRef="usd" contextRef="i1111c82205474cdda375e71c5738d55b_I20220930" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzc1OA_7f04c015-401f-459f-be7e-af5a2e827c28"><ix:nonFraction unitRef="usd" contextRef="if77e3cf538fe4a19a12e07001222f635_I20211231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzc1OA_cc5a787d-c958-4f85-b88b-8462c6cb32b9">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as cash flow hedges as of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i01b9c1c44ba84e60af09ae0057af5a4e_I20220930" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDY1Mg_563ac7e7-f37c-4777-a22c-e1d888b43ddb"><ix:nonFraction unitRef="usd" contextRef="i4fd80b73ae2b420ca679db0cac3a60ba_I20211231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDY1Mg_6b25a2b3-6237-45f0-9388-44d3a2831c2a">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as fair value hedges as of September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i55e4dbb5ee80417da9485fdfabbcc12b_I20170531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDc4NQ_513c6461-19c0-423a-8a85-7ce418911ad5">600</ix:nonFraction> million of senior notes due May 2025. In May 2019, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i9812ba731b464628b9581ec75cb13f21_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDgzNQ_b61772c4-1892-4f65-8539-3f0cbf5c7587">750</ix:nonFraction> million of senior notes due May 2024 and &#8364;<ix:nonFraction unitRef="eur" contextRef="if0c7cce9faa64129b1ddac611011830c_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDg2NQ_921387be-2e8d-4254-b616-1eeef609037c">750</ix:nonFraction> million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of September&#160;30, 2022, we had an accumulated pre-tax unrealized translation gain in AOCI of $<ix:nonFraction unitRef="usd" contextRef="i4219ab86c67549bfa1e56276605a8990_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTE5MA_39273513-8a64-45cb-9f8a-ea9f97073301">265</ix:nonFraction> million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTc5Mg_a2ff41c5-eb15-47f5-8b1c-277589ad5d71"><ix:nonFraction unitRef="usd" contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTc5Mg_ac4b8740-64e7-4f4c-afef-9109e77a7d1e">no</ix:nonFraction></ix:nonFraction> hedge dedesignations in the first nine months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were <ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjE4Mg_2fc0994c-c056-47b3-a46d-ae7e0b498444"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjE4Mg_bc2d0e5e-7224-4090-8abd-cfe8c54f9816">no</ix:nonFraction></ix:nonFraction> fair value hedges terminated during the first nine months of 2022 or 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were <ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjQ3OA_490d19c9-150f-44da-8a2b-41b6371adaab"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjQ3OA_842eeb01-4b39-4387-be93-7fa685353a89">no</ix:nonFraction></ix:nonFraction> net investment hedges terminated during the first nine months of 2022 or 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $<ix:nonFraction unitRef="usd" contextRef="ic762452cc4494022a233acfc178ebafa_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzAwMw_be1845f5-57ec-49aa-8af2-9950c02384b3">548</ix:nonFraction>&#160;million as of September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="if03565d5005c4f898506b8c013da1feb_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzAxOQ_7499cc4a-0dbd-46a0-8c54-75072d933624">851</ix:nonFraction> million as of December&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0609391cf202410c80d94a4d552a0825" continuedAt="ia07fdc2c1fdc4f399f8b3ec97a6333f0"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNQ_7dadb8ad-1235-4bab-8d98-c79d66bf7bde" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4b212abcc54d02b74cb18b61508e58_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy0xLTEtMS0xMDQzNzI_61b09942-0811-43ab-aabb-a10427226e43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0045fb1e0941df98e20a283f36d227_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy0zLTEtMS0xMDQzNzI_b0406203-a9e8-4b79-aa7b-2e3852d99694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idec3801c7613438c8124f3cde7757903_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy02LTEtMS0xMDQzNzI_94d59750-7825-4744-a24f-db81b7a9f179">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i524f33dedfef49de9b3bc2b5e9c14c87_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy04LTEtMS0xMDQzNzI_ae570b65-8ec0-402c-9244-0d2ad0c30d04">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeaa8f4aa8c140688f7b460b580b43ed_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC0xLTEtMS0xMDQzNzI_c00346bb-fd90-4483-9b5b-a1fdb03a232f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf0aac0647045d5aa67667953993c07_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC0zLTEtMS0xMDQzNzI_c9fcc96c-13d8-48bd-9dbd-941564ae625e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d171c4e6be042278f782461c977f45c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC02LTEtMS0xMDQzNzI_150b1733-c6c1-4978-808e-ab748b7fce93">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2542bc7a65744214aae79ec882f3c054_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC04LTEtMS0xMDQzNzI_d0dbce56-39ae-44f2-83bc-9dea7696e59a">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0e3547cbe442938da56027d6f100e8_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS0xLTEtMS0xMDQzNzI_9cf3e206-8e0c-451f-9589-095df6672062">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaa95bf889d043f38f60a617e70b40d3_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS0zLTEtMS0xMDQzNzI_da29f570-d775-4b9f-ab31-4092561b650b">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57bc193f1088457fb04394f5af366882_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS02LTEtMS0xMDQzNzI_96cfaaad-bf3a-474c-965d-d9bce4a93768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4402f6cfbe44c7a47198d315febe1d_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS04LTEtMS0xMDQzNzI_90402676-2ad6-45a1-8f1a-d2758faed049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi0xLTEtMS0xMDQzNzI_93982453-fa22-4d79-a7ef-579cda6bf207">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi0zLTEtMS0xMDQzNzI_c0885ccf-1633-4097-bf1b-16aa07ff1a5e">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi02LTEtMS0xMDQzNzI_a9cd370d-7f13-4565-b84d-8748bc6e861a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi04LTEtMS0xMDQzNzI_ef7cc1c4-2d54-4e34-9773-084390adbf47">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b054901d62649cdb8f927a96ce91ace_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjI0N2ZjNmVjZDFkMTRhOTA5ZjUxOTNjNzk0ZjQ1NTg1L3RhYmxlcmFuZ2U6MjQ3ZmM2ZWNkMWQxNGE5MDlmNTE5M2M3OTRmNDU1ODVfMy0yLTEtMS0xMDQzNzI_0140def1-766b-4800-8615-191bfd6c9faf">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bd9a491ccff4bbda2839a7be1c36b74_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjI0N2ZjNmVjZDFkMTRhOTA5ZjUxOTNjNzk0ZjQ1NTg1L3RhYmxlcmFuZ2U6MjQ3ZmM2ZWNkMWQxNGE5MDlmNTE5M2M3OTRmNDU1ODVfMy00LTEtMS0xMDQzNzI_acd44f9a-9d66-4594-a423-11cc9d5d548d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI<br/>into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef3027bf73d4dc6910053458adbcef3_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy0xLTEtMS0xMDQzNzI_4cda827f-21d7-4d4e-b751-fcb9f7cf87c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7c0055bf4040c381b494fe4307540c_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy0yLTEtMS0xMDQzNzI_5e6fac9c-fc7c-40ad-a23c-78d4d88b815c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3c83643aa4f4d08a36b0e3403f878e7_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy00LTEtMS0xMDQzNzI_53189aee-0dd8-4a34-9b51-a0170033efda">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3597ba90139f4ad88f34ea14d4c322e4_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy01LTEtMS0xMDQzNzI_c231f289-b36c-4b9b-9255-162865143d7d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23c6ae90b5e43f18f128140d9efd7b9_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC0xLTEtMS0xMDQzNzI_8074f4b6-0714-47c6-be34-a306a1438d37">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f6cdaf8a75405295f0a68abbdc904e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC0yLTEtMS0xMDQzNzI_8f9e5c5d-32e0-4189-b32a-b40974667e0d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b78a3fb7ef44f86a0bd6a81e7c2f5eb_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC00LTEtMS0xMDQzNzI_b5570550-d36e-4d68-a03f-d2f4df381c6d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b24494d1e54bcb900d94e60f0b8ac7_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC01LTEtMS0xMDQzNzI_223f35a7-029f-4d7e-8eb7-18f0e6133b41">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4159e70eae1c4a779c9b692aaa4cf78c_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS0xLTEtMS0xMDQzNzI_ea2273f3-0a4d-40b0-a7f9-07ddcb2a7312">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a752302cfc64472917c0dcdd2903e89_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS0yLTEtMS0xMDQzNzI_75d50524-1b8a-43e0-a06c-b62bfadcfdbf">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e74411bec474aaea6b669ed608cdde3_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS00LTEtMS0xMDQzNzI_3a07ba1b-da2d-4a5f-8a37-82e81c12d51f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia96f099a1e7d4398a154facff7209588_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS01LTEtMS0xMDQzNzI_4fe323c4-0070-4227-b849-84ee3a849fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi0xLTEtMS0xMDQzNzI_cfe799d2-c4ec-43d0-896f-fbf5e916d2dc">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi0yLTEtMS0xMDQzNzI_d5a64238-f277-457d-a746-019326a593c5">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi00LTEtMS0xMDQzNzI_9dad71ea-36b6-4b94-9fb3-e09b353a606e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi01LTEtMS0xMDQzNzI_77fe43ea-ddc3-4749-a1cc-cd05363fa756">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie089f3302f66450796c1dff4135d452a_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI3MjI2YWE1OWVhZTRlZDFhNTJjZDliNzFjZTMxNzdhL3RhYmxlcmFuZ2U6YjcyMjZhYTU5ZWFlNGVkMWE1MmNkOWI3MWNlMzE3N2FfNS0yLTEtMS0xMDQzNzI_dafa3471-ccc0-416c-9c3d-cce4b2945396">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1528a977db6d4b2599de78b0fafe3502_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI3MjI2YWE1OWVhZTRlZDFhNTJjZDliNzFjZTMxNzdhL3RhYmxlcmFuZ2U6YjcyMjZhYTU5ZWFlNGVkMWE1MmNkOWI3MWNlMzE3N2FfNS0zLTEtMS0xMDQzNzI_4e6248e1-8d47-4eb8-82b7-b8d188c19c36">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, $<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzU2OA_ab74d345-b14f-4a7f-9b92-7189fdf0e332">22</ix:nonFraction> million of deferred, net after-tax gains on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia07fdc2c1fdc4f399f8b3ec97a6333f0" continuedAt="i66377756bc254e1cbb4a685b8dab4b9d"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgxMQ_a255cfca-747c-466b-9b36-f5fe4abda382" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of September&#160;30, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1abbbcb680d54d358fcfea6c93ecb0b7_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNC0yLTEtMS0xMDQzNzI_05622444-cb5a-4b22-a9f9-69e1e9379b8c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de69187ee1449e690027dd9b5781e35_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNC01LTEtMS0xMDQzNzI_b58c2dec-41b3-4917-b15d-aa6008492977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNi0yLTEtMS0xMDQzNzI_128287e9-6c17-47d8-8155-6bcc515e9d0b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNi01LTEtMS0xMDQzNzI_57bdd540-e81e-4aa1-a7e8-306b599e4485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468b5d6abb97433c8ced58e53154b575_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOC0yLTEtMS0xMDQzNzI_2a955ca9-d4dd-4a4c-b3d9-5f93e62a0092">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cc534a76f6479cb41d07feb73fe749_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOC01LTEtMS0xMDQzNzI_99a06a67-b293-4e8a-b1eb-2c07401eea66">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOS0yLTEtMS0xMDQzNzI_a6037313-1625-437c-84d1-970509e73605">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOS01LTEtMS0xMDQzNzI_6873fcbf-1a91-4c27-94de-df13067fe3cd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3173187680714658978b04838fce40b9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNC0yLTEtMS0xMDQzNzI_4fb63edc-7a75-4147-b100-4fc1acb06cd1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe54a153e4a40e4a1a669f98ab1f673_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNC01LTEtMS0xMDQzNzI_6fbdcedf-75ad-49ca-b9bc-53979408bca9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af24cb81eb1423ab102ead43ce324f2_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNi0yLTEtMS0xMDQzNzI_33844452-71ce-48a9-8eea-e86d0eda22d9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af24cb81eb1423ab102ead43ce324f2_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNi01LTEtMS0xMDQzNzI_32e81af5-512a-4f28-90d5-b52287246572">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d91b9084444f99a2a267da216d851d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOC0yLTEtMS0xMDQzNzI_be59314a-cc96-4a85-b22a-1d59584f7a21">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i821cd3c29b904c40826ea7cf9fc530c6_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOC01LTEtMS0xMDQzNzI_87bb6cf7-06e6-40e5-aa13-651ae6781536">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOS0yLTEtMS0xMDQzNzI_2c08a7ce-2f01-4d00-96b7-0698970de7a9">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOS01LTEtMS0xMDQzNzI_16812219-af81-45ee-9e44-279c0dfa7b60">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwMg_4a3eee09-689b-4a75-9058-130d1847bb37" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi0xLTEtMS0xMDQzNzI_a979e4c2-3443-4674-8a07-b26e2359722a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi0yLTEtMS0xMDQzNzI_afb987b0-0a9c-40d7-92a2-f73c6a0321ff">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi00LTEtMS0xMDQzNzI_1af441a8-fa79-41ea-b09a-26bb40f0e629">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi01LTEtMS0xMDQzNzI_dbdf1c27-5a83-4e5e-ad80-fb3ca3e65fa4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy0xLTEtMS0xMDQzNzI_eafc41e5-adae-4c91-8f48-6ef71ccd0657">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy0yLTEtMS0xMDQzNzI_c718934a-0cf3-4319-a21d-58287cfa72df">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy00LTEtMS0xMDQzNzI_970065c9-5a0b-4ff6-b53c-4c3d7970d90b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy01LTEtMS0xMDQzNzI_0b6fe556-7f02-4aec-aed7-1531736cd521">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC0xLTEtMS0xMDQzNzI_c6b2df1e-c59a-4910-98f5-8009e302d782">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC0yLTEtMS0xMDQzNzI_bbeac79c-2121-44b3-836b-a613fd341d0d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC00LTEtMS0xMDQzNzI_c9d44093-5590-4f04-a4fc-1dc9af7cf542">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC01LTEtMS0xMDQzNzI_e05b168d-4343-4a68-bccb-c4e7f460cb4e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i66377756bc254e1cbb4a685b8dab4b9d"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNg_83a09c07-b588-4e2e-a4a3-24098b8eb4ce" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e5214316a649e3860c819c556c69d4_I20220930" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi0xLTEtMS0xMDQzNzI_b2b4fdbc-aff5-4415-a1a9-bbeabc3d733a">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi0yLTEtMS0xMDQzNzI_0037d422-2b6f-4de3-bd2f-c3f44c0b3e64">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e5214316a649e3860c819c556c69d4_I20220930" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi00LTEtMS0xMDQzNzI_5f09f96c-6b48-45a5-986f-714e371407be">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi01LTEtMS0xMDQzNzI_8581d9b6-81dc-4afe-9e67-5718eee9b138">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div></ix:nonNumeric></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">15. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMxOA_34deee1e-b2d5-4cf0-831d-529299531f15" continuedAt="i0304065f2ba64db4a9e60e65a22425ef" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i0304065f2ba64db4a9e60e65a22425ef" continuedAt="i82cb74561dea438b92d02ccfeb4e1a65"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMA_e60200ce-1a07-4a0b-aa71-6ed1f96ca01e" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0xLTEtMS0xMDQzNzI_360ad04b-2095-413f-ad0a-828bfcdc2eab">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0yLTEtMS0xMDQzNzI_41ab5885-d85f-419c-9f60-a75dbca3ce3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0zLTEtMS0xMDQzNzI_18e7cca7-1147-42be-ba5d-ea5158f54421">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy00LTEtMS0xMDQzNzI_dcfa6bfd-12fc-4274-a032-26073c35fdf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0xLTEtMS0xMDQzNzI_dafffb65-72c0-43cd-b548-b337dd756d12">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0yLTEtMS0xMDQzNzI_4b73b73c-4462-424c-ac0e-f59b5bc87d50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0zLTEtMS0xMDQzNzI_6a18ac1f-98c1-40ed-879e-555a3cbebcfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS00LTEtMS0xMDQzNzI_4eb1c614-802a-4f1b-ad97-7b6ea274471f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0xLTEtMS0xMDQzNzI_03a7ca10-d1f0-44f6-b969-a1bbb9a10504">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0yLTEtMS0xMDQzNzI_b6a3f9f6-a41d-40b6-ad09-8a87532a4b7b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0zLTEtMS0xMDQzNzI_cd74746b-8208-4a5b-8918-811e245b2003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi00LTEtMS0xMDQzNzI_36871a65-112a-4826-9ea7-02c725a76748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0xLTEtMS0xMDQzNzI_7d205d3a-33c6-4fe4-bda1-07000f2c2101">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0yLTEtMS0xMDQzNzI_a8136d4c-c7d6-4f3a-9426-79de2b9de98f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0zLTEtMS0xMDQzNzI_e820bca4-9c5a-4216-8c75-f972855aacad">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy00LTEtMS0xMDQzNzI_15663606-f535-4fce-b519-152a6c3f583c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0xLTEtMS0xMDQzNzI_e202c09d-544c-4a2f-b9d2-773727f93a5a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0yLTEtMS0xMDQzNzI_a99a4d4a-bead-4a33-aea8-7531e7f0268b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0zLTEtMS0xMDQzNzI_949833db-7fca-4a57-ba17-c967bd09c45b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS00LTEtMS0xMDQzNzI_8796b756-4840-46c4-a010-830f0afc64cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMS0xLTEtMTA0Mzcy_1dfdfffe-0b18-479b-ab56-ee30a817fb90">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMi0xLTEtMTA0Mzcy_30733f54-3b43-4286-9e13-5afcccade8f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMy0xLTEtMTA0Mzcy_2d806447-cec2-4b77-9704-40940bf9d253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtNC0xLTEtMTA0Mzcy_5cbeb108-863a-4d9e-abc9-ff29d7bcc8ac">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMS0xLTEtMTA0Mzcy_0a070fa5-9c42-432f-9c32-6168a89d238a">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMi0xLTEtMTA0Mzcy_0dfb1808-1e37-4ea5-bd2d-c73264453efb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMy0xLTEtMTA0Mzcy_ebb9c1e8-3c79-41f4-800a-32792a073c28">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItNC0xLTEtMTA0Mzcy_7a4d55f1-b8dc-4b89-9e3d-02bf9dd83352">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:49.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0xLTEtMS0xMDQzNzI_341efff3-505b-4679-b816-a209cf4e596c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0yLTEtMS0xMDQzNzI_03004984-60ca-423a-8cbe-4f77138e7ca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0zLTEtMS0xMDQzNzI_75ef0743-cabd-4a81-87a6-a865dff8204c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy00LTEtMS0xMDQzNzI_37dce4b1-5f14-4c42-bab1-cc331d654023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0xLTEtMS0xMDQzNzI_990c3950-4a73-4280-9c25-2b46b887658a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0yLTEtMS0xMDQzNzI_5ff6f8af-bbd1-4e1f-961c-4b6e8e7272eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0zLTEtMS0xMDQzNzI_d53a4c07-3e7d-4e8d-ab34-6912fdb8acc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS00LTEtMS0xMDQzNzI_3e8ffb56-c536-4a5f-ba8a-dee72769c14a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0xLTEtMS0xMDQzNzI_cfdb6027-0082-4acc-8693-0b173a241157">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0yLTEtMS0xMDQzNzI_4dfb186d-3aa6-4ec6-8d2b-7238a0eafea4">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0zLTEtMS0xMDQzNzI_bcde13e2-4d3e-47b2-8786-6ebb452d2d5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi00LTEtMS0xMDQzNzI_6040f90a-54f3-4472-a65f-5da01bc87c92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0xLTEtMS0xMDQzNzI_5c342883-6601-45ce-9af0-67d213590db1">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0yLTEtMS0xMDQzNzI_9919e451-ae5d-4fe9-a0e9-67de6aa08f7f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0zLTEtMS0xMDQzNzI_eb7f2174-341f-4d91-98a0-b7f31eb036a2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy00LTEtMS0xMDQzNzI_88566e8a-eee2-4a90-819b-c2faccef6737">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0xLTEtMS0xMDQzNzI_4a5581b1-e471-402d-b09a-207ad5afb415">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0yLTEtMS0xMDQzNzI_01f61d29-a653-4681-9508-639e63de67fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0zLTEtMS0xMDQzNzI_373e602e-359f-41c7-bc0d-4ccbfeaf6fef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS00LTEtMS0xMDQzNzI_d76022d7-ff33-4b28-a38e-e38f15d8b6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMS0xLTEtMTA0Mzcy_18ff9a8c-2f7c-48b0-95e7-40af6035241a">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMi0xLTEtMTA0Mzcy_55455d63-eaf7-497b-b772-f3c5ee283c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMy0xLTEtMTA0Mzcy_d6c780c8-ae23-4bb6-9790-d32a2d24906d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtNC0xLTEtMTA0Mzcy_76a71337-6cb7-4bb4-9d57-e3c049ff7a31">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655add2ac3494884b74da98ed4989459_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMS0xLTEtMTA0Mzcy_0effa21b-40d7-4671-a7f6-728daee7224c">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMi0xLTEtMTA0Mzcy_2b277216-c706-4c46-94dd-1c6be5143b5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMy0xLTEtMTA0Mzcy_efd43a77-0742-45b8-aa5e-f6d69095c08c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItNC0xLTEtMTA0Mzcy_1ba7d368-7efc-4007-b637-fa31d0be5810">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i100fa316fc12492f84183e5383c3e332_I20220930" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMTk0_ede5df97-6235-43b9-b0f4-febfd7018f65">1.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjAx_bb77843b-7643-489a-be15-9c0be0b8abd8">3.0</ix:nonFraction> billion, respectively, included money market and other short-term funds of approximately $<ix:nonFraction unitRef="usd" contextRef="i8db585f6be0041fdbc967569ee16766a_I20220930" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjg1_2a6c8a8a-cfe7-4084-86b6-d432914ee6b0">161</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie775ab37506340ba914ddb80c6e46611_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjky_6b89c679-5f64-49f6-b4f6-a12b19b429e7">816</ix:nonFraction> million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i82cb74561dea438b92d02ccfeb4e1a65" continuedAt="i9da7a407d5e447f9b3d2715ced8f50e1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMQ_b950f00f-3b2a-4c46-b633-5738e1813021" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bef60de6abe41cebf0448519a3ac267_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy0xLTEtMS0xMDQzNzI_ac84b08e-10c4-4e84-80dc-94a4faed7c89">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e06ddc9fdd4a0295e9c0705d568e98_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy0yLTEtMS0xMDQzNzI_a6dc4685-da75-4f7b-b7be-951a4e5b4bfe">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcd1a7cef434b938b81d5633355bbf5_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy00LTEtMS0xMDQzNzI_b2288c9a-82b8-4c21-b23f-cc5a6a63f757">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC0xLTEtMS0xMDQzNzI_5123c3ae-78ed-4cc9-9980-8cb28f7257aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC0yLTEtMS0xMDQzNzI_58e34ccb-9da3-45cf-8f8f-e9e813575979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC00LTEtMS0xMDQzNzI_8424185b-cd59-4575-8166-87f786deae58">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi0xLTEtMS0xMDQzNzI_00686b8b-8b1f-4346-bf7f-3a7374d5bfec">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi0yLTEtMS0xMDQzNzI_76c847c6-5d92-4a95-8bb3-d9d46132683f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi00LTEtMS0xMDQzNzI_2641d333-5a15-4efa-a850-dd53270c3507">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS0xLTEtMS0xMDQzNzI_c99c4564-0918-4401-975a-e6da88ed92f1">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS0yLTEtMS0xMDQzNzI_6b2ed3cd-db9f-4516-a94f-7bf22a71bca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS00LTEtMS0xMDQzNzI_b9d79db5-22e1-4e1c-8d5c-b26eb1442e36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34110c3d1d548c099e33f7257520862_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtMS0xLTEtMTA0Mzcy_2838a7a5-51e7-492e-a4e8-4cfe06d20f48">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5785042f0a0a48b2a89a8d5e5292f378_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtMi0xLTEtMTA0Mzcy_d6d414e0-9db3-4f68-aebe-c11b457a602e">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c975de3f94448528111a2732f5ff183_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtNC0xLTEtMTA0Mzcy_58e7b400-c538-4001-831e-def057598f54">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b320ae27de4e16915e55e2cea04c39_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy0xLTEtMS0xMDQzNzI_18e9c7ca-81de-4e15-a126-23aac1d8476c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af787ce477145f395b6c47dad80c78d_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy0yLTEtMS0xMDQzNzI_3fbac21d-757f-4495-aa52-c4793282d9b5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib401981a72924d8cb4fa3b85e149335f_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy00LTEtMS0xMDQzNzI_400526fe-8d72-4ccf-ade2-2c35c6d2830d">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC0xLTEtMS0xMDQzNzI_f51019da-d156-4186-8b33-a7e1260ad5c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC0yLTEtMS0xMDQzNzI_5bbf1f67-e64c-4cc0-a4a2-2ce48c5db9c0">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC00LTEtMS0xMDQzNzI_6aaab8bc-39ed-492f-98a9-6934073cfb74">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi0xLTEtMS0xMDQzNzI_0c2abf33-167c-4d52-8ca7-f636e3d6cd3b">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi0yLTEtMS0xMDQzNzI_22a71d88-87fa-4bc9-beab-15262e9d2097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi00LTEtMS0xMDQzNzI_d10f2fec-8274-4c42-9cba-c03e00b376cf">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy0xLTEtMS0xMDQzNzI_2fd98492-6b31-4c63-9097-d70965e3bdeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy0yLTEtMS0xMDQzNzI_0d44d00b-5725-40fd-9b26-fe75aadbd8d7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy00LTEtMS0xMDQzNzI_1cc4ee67-399e-442b-8e00-835674d95cb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC0xLTEtMS0xMDQzNzI_a14136de-a9bb-4505-aac8-cbcaedd68131">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC0yLTEtMS0xMDQzNzI_5eda0211-6929-447a-b88c-902c80df7e93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC00LTEtMS0xMDQzNzI_5d72a587-8a32-4bbe-b939-1d731b3b61b5">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS0xLTEtMS0xMDQzNzI_4144424f-a7c9-40ca-b7ce-4eef5650ef1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS0yLTEtMS0xMDQzNzI_6195946f-64d4-4875-92f9-ed0edfde0efa">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS00LTEtMS0xMDQzNzI_95ca1fe5-baa5-4bc4-ad8d-1a4641e392a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930" decimals="-6" name="bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtMS0xLTEtMTA0Mzcy_a08169da-3af0-42c5-9656-66bb6cd009ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtMi0xLTEtMTA0Mzcy_df148535-2127-4c78-93ee-4c233b4ba4a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930" decimals="-6" name="bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtNC0xLTEtMTA0Mzcy_404d4da7-72df-4f01-b106-115a4fd33942">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34110c3d1d548c099e33f7257520862_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtMS0xLTEtMTA0Mzcy_f4377d98-a560-4482-a52f-29519075e76b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5785042f0a0a48b2a89a8d5e5292f378_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtMi0xLTEtMTA0Mzcy_212a0102-838d-4d72-bc9d-f435518a744c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c975de3f94448528111a2732f5ff183_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtNC0xLTEtMTA0Mzcy_5d5ea404-56db-4560-a86d-5eb35d40c954">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, $<ix:nonFraction unitRef="usd" contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjU5NA_34762a21-67ea-4e16-b687-5553480c6e21"><ix:nonFraction unitRef="usd" contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjU5NA_ff8d4b04-207e-4dfc-a278-025bb5170026">8</ix:nonFraction></ix:nonFraction>&#160;million of available-for-sale debt securities that were previously classified as Level 3 converted to marketable equity securities, which are classified as Level 1 in the fair value hierarchy, upon the initial public offering of the investee.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9da7a407d5e447f9b3d2715ced8f50e1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMg_ca389571-d819-4095-907a-dea0a4fbd72d" continuedAt="ie2a0ef88d50a44ca9d826c852b2081fb" escape="true">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of September&#160;30, 2022 and December&#160;31, 2021.</ix:nonNumeric></span></div><ix:continuation id="ie2a0ef88d50a44ca9d826c852b2081fb"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy0xLTEtMS0xMDQzNzI_9999009d-f3f9-4ff6-a0c5-249757195f8b">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy0yLTEtMS0xMDQzNzI_c0281551-4b5b-40ac-96be-94593038710f">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy00LTEtMS0xMDQzNzI_ab7f20e9-8e11-4dc0-8413-c353c7816abf">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy01LTEtMS0xMDQzNzI_e44ab0a9-fdc6-47fa-8b5a-d6637817f197">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC0xLTEtMS0xMDQzNzI_e2716af6-2f22-4eef-bf2e-33ef375fc028">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC0yLTEtMS0xMDQzNzI_cd60e316-0b7a-4834-a76c-4c6ba73a861b">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC00LTEtMS0xMDQzNzI_aa2bc9e5-7c37-48de-80c5-645a103048cd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC01LTEtMS0xMDQzNzI_786a4dc2-6e9e-4ce3-9837-99afb8974934">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS0xLTEtMS0xMDQzNzI_e5855417-d3d8-4b68-ace5-8ca58a75ba64">16,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS0yLTEtMS0xMDQzNzI_61ec7bf2-518a-4cc8-a1a8-8c338f91d2fd">17,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS00LTEtMS0xMDQzNzI_1f5c2bb9-643f-4891-9359-4a257f59c831">14,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS01LTEtMS0xMDQzNzI_08b200ce-eef6-4ee4-a399-090ddf7b3534">17,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $<ix:nonFraction unitRef="usd" contextRef="i5f7ae0b172974bf08be1404801ce8bf3_I20220930" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDE4NQ_660fb92b-eddd-4b7a-aed0-5bed02fab9e3">102</ix:nonFraction> million as of September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i672fe12465f04ed1ac1c17454ce41b89_I20211231" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDIwMQ_612d3009-363c-4108-bad5-6c84c4e5ae32">114</ix:nonFraction> million as of December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</span></div></ix:continuation><div id="iaef9f667721343c48067444506cf55c3_85"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">16. <ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyNw_7513a5a0-208e-4dd2-8888-7ec19b8249c0" continuedAt="ia7e17f9980ef4d548d7aefdbb7856b91" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ia7e17f9980ef4d548d7aefdbb7856b91" continuedAt="i1c538f080d2948d6939cc36d07e5275b"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on <ix:nonFraction unitRef="segment" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfNjE_471fa98a-60d6-4c58-b4a1-659e2a556301">four</ix:nonFraction> segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $<ix:nonFraction unitRef="usd" contextRef="if8cdf58384f44554b6f0c7ae5b485465_D20220701-20220930" decimals="-8" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjE4MQ_471d9fce-e310-4147-ae7c-b21a90dfbffb">3.0</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ibd833938b8fd43d887495cb1fa7f7edd_D20220101-20220930" decimals="-8" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjE4OA_681d94b5-3f47-4dc1-b517-4178f13ba485">3.3</ix:nonFraction> billion for the three and nine months ended September&#160;30, 2022, respectively, and primarily related to goodwill and intangible asset impairments are now presented within Corporate as well. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1c538f080d2948d6939cc36d07e5275b"><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyOA_8cc5af04-71c9-4eae-abc5-ebf78b2826c0" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy0xLTEtMS0xMDQzNzI_20a12824-a0af-4c0b-a50e-4e158ce441ba">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4917de1dd954a059d60387d14e89f10_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy0yLTEtMS0xMDQzNzI_4d3acc43-e543-4c04-81f7-0c19376a93f1">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy00LTEtMS0xMDQzNzI_3a23fff2-980c-4b7b-85e1-bb7505735325">4,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy01LTEtMS0xMDQzNzI_482ae491-70b2-4e1a-a476-c3ebf9bc173d">4,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC0xLTEtMS0xMDQzNzI_aef8e04d-3925-4912-aa81-9a857d544582">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC0yLTEtMS0xMDQzNzI_083aecc8-79f7-4778-a6e3-714e60d552a0">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC00LTEtMS0xMDQzNzI_e7b09c4b-5878-49b7-a93d-75d3bbe10b3c">2,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6123385e384e4137985445ff7eee59cb_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC01LTEtMS0xMDQzNzI_a2ef80e0-089a-4726-ab3c-9eb22f4aa3aa">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS0xLTEtMS0xMDQzNzI_545173b1-db48-4778-97b8-82a36e1a7469">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS0yLTEtMS0xMDQzNzI_c4cdcbde-93ff-44f6-b59f-8decacc98838">720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS00LTEtMS0xMDQzNzI_0a5c33e7-da1a-42d0-8b9c-92d042d4a816">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS01LTEtMS0xMDQzNzI_c6d74ac8-2d0f-452d-95c1-3f75abedc634">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327518eb465544d693c28e6cd73f5736_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi0xLTEtMS0xMDQzNzI_4ce4b5d4-c8e1-451d-a7ce-d5a1ef4c580c">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi0yLTEtMS0xMDQzNzI_3125a5bb-1fc1-4535-9caa-780d40641b85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi00LTEtMS0xMDQzNzI_546d5291-c4f4-4aea-b16c-9fed251f14e4">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi01LTEtMS0xMDQzNzI_de4c10e7-0fc7-47b2-af5b-8eeec9067877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy0xLTEtMS0xMDQzNzI_a60b0f81-a41d-48d7-812b-f44ff177c83d">3,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy0yLTEtMS0xMDQzNzI_90a7fd30-4b24-4f29-ad8e-df4679971d70">3,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy00LTEtMS0xMDQzNzI_6b0b03e2-24a9-44a6-97cd-50027dae2b56">11,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy01LTEtMS0xMDQzNzI_37e395c3-647c-4b96-92cb-e2d75678e1be">9,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS0xLTEtMS0xMDQzNzI_d42f7b12-4275-4252-b10e-2849300222fd">588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4917de1dd954a059d60387d14e89f10_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS0yLTEtMS0xMDQzNzI_794a0cc0-9e2d-4706-8d9f-a4446760dd50">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS00LTEtMS0xMDQzNzI_b83d2f8b-8720-4e09-8c4b-d2f67f93bdbc">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS01LTEtMS0xMDQzNzI_ee3b5e41-fd19-4f6d-9237-27027b3d4c5e">1,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtMS0xLTEtMTA0Mzcy_15f1abca-79ef-4e15-8d8a-7b8069a3d09a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtMi0xLTEtMTA0Mzcy_330f5519-f58c-4b67-afb8-18b8da208686">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtNC0xLTEtMTA0Mzcy_6abeafab-1d53-4ba4-8be6-aa4837f3f89c">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6123385e384e4137985445ff7eee59cb_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtNS0xLTEtMTA0Mzcy_6a91c3de-45a7-4ce3-8207-2411a41c57a1">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtMS0xLTEtMTA0Mzcy_e90f7a45-9743-47cf-8d6b-dc61bcfa16c1">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtMi0xLTEtMTA0Mzcy_5a3ad458-72e1-4c39-8a4c-6bb5b02cc3c6">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtNC0xLTEtMTA0Mzcy_546aec7d-39a0-4e17-8b3d-f05c9e764890">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtNS0xLTEtMTA0Mzcy_d16492b0-0ac2-49d6-a626-054c0f408177">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327518eb465544d693c28e6cd73f5736_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItMS0xLTEtMTA0Mzcy_93809774-d590-41fe-8325-e283bc319ad2">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItMi0xLTEtMTA0Mzcy_f33c4fb2-0949-445f-a573-26f46fd1be49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItNC0xLTEtMTA0Mzcy_3db8ea8e-b48c-4e6c-97d2-d22bbe9b82e2">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItNS0xLTEtMTA0Mzcy_a0e0ceab-f076-49c1-ac32-282f1f5aa086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtMS0xLTEtMTA0Mzcy_bafeb035-381e-4054-ac12-a5ab3c1921a6">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtMi0xLTEtMTA0Mzcy_e2b2c18b-bbc5-4b28-abaa-8d7ecff8f38b">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtNC0xLTEtMTA0Mzcy_540b55af-a0dc-4bfc-a892-ed4c5e6807b0">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtNS0xLTEtMTA0Mzcy_9f4953ed-e63e-4806-ac26-b8643bdb4347">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyNQ_f8a5bf39-6667-46cf-8600-820c1a9600c4" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi0xLTEtMS0xMDQzNzI_2c4bd6c7-531e-4682-90aa-57927f9205f2">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi0yLTEtMS0xMDQzNzI_6d783f58-35f2-4c47-864e-19b47ed4dbd9">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi00LTEtMS0xMDQzNzI_989b2886-9560-432f-a65d-6cfaed0373c9">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi01LTEtMS0xMDQzNzI_ed1a51e2-bd4f-4861-898b-60a13d6dc4fe">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca18a38e7b24b8b99d1fe4106969b7b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy0xLTEtMS0xMDQzNzI_32dadca0-c8ec-4e6e-9bad-c011df829de4">3,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if51f0dd41ec94f6b858c4933e0bd444b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy0yLTEtMS0xMDQzNzI_c1fe9af4-8c77-4699-b131-eb0a242563a1">496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07947bacb9de439897e75f3c619d0f5b_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy00LTEtMS0xMDQzNzI_5334d169-c39d-46eb-8a64-70694665b1ea">5,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a9d785c00c479d87a0bf2f015e7811_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy01LTEtMS0xMDQzNzI_d7e06d72-5a8a-44e5-91a1-30b4bd7dd6c5">1,497</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC0xLTEtMS0xMDQzNzI_07593cd9-bb5d-43c3-9014-3db7bb6826f0">2,799</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC0yLTEtMS0xMDQzNzI_d3a9452d-4e97-4d76-89bb-661e1c2ce025">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC00LTEtMS0xMDQzNzI_df2d9042-3d20-4da7-be5d-d369ecc31153">2,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC01LTEtMS0xMDQzNzI_c0d2f332-8b3e-415f-9ca1-ece768506538">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS0xLTEtMS0xMDQzNzI_75aba368-f1d0-4226-8cad-42d99f50bb92">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS0yLTEtMS0xMDQzNzI_4572a194-24f7-4081-b01e-8067d894df9c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS00LTEtMS0xMDQzNzI_4630d202-4239-48c1-ad81-6d68100859a6">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS01LTEtMS0xMDQzNzI_07fedbea-8460-4613-9ee3-568891f27170">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi0xLTEtMS0xMDQzNzI_75dc57cf-c235-4f2f-b165-4d1f3a0f1fc2">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi0yLTEtMS0xMDQzNzI_9c89ef21-f6dd-4b80-97ef-2e1621b94620">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi00LTEtMS0xMDQzNzI_6bd7caf2-34e2-4675-a33c-e8d8f93b569a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi01LTEtMS0xMDQzNzI_e9f19069-5b0c-42a3-ac85-fbe23c95ab2b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy0xLTEtMS0xMDQzNzI_f5980f4c-9f35-4ab5-85c7-4a478ed4a541">2,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy0yLTEtMS0xMDQzNzI_d2bd3133-bb33-479b-9bdf-f5a7058cb1e5">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy00LTEtMS0xMDQzNzI_124ab603-cd74-435d-903a-b497a6b331ad">2,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy01LTEtMS0xMDQzNzI_c543f461-6b02-450d-ad8e-3b1b32c53c0c">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 for additional information on Net Sales by product category.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to our Annual Report on Form 10-K for the year ended December&#160;31, 2021 for management&#8217;s discussion and analysis of our financial condition and results of operations. The following is management&#8217;s discussion and analysis of our financial condition and results of operations for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div id="iaef9f667721343c48067444506cf55c3_91"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $10.5 billion. Including the assumption of Hillrom&#8217;s outstanding debt, the enterprise value of the transaction was approximately $12.8 billion. While the current year periods include the results of operations and cash flows of Hillrom, the prior year periods do not as they preceded the acquisition date. In the third quarter of 2022, we recognized impairments of goodwill and certain indefinite-lived intangible assets that arose from the Hillrom acquisition. See Note 4, Goodwill and Other Intangible Assets, Net, of the accompanying condensed consolidated financial statements for additional information about those impairments. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Baxter stockholders for the three and nine months ended September&#160;30, 2022 totaled $(2,937) million, or $(5.83) per diluted share, and $(2,614) million, or $(5.20) per diluted share, compared to $450 million, or $0.89 per diluted share, and $1,046 million, or $2.06 per diluted share, for the three and nine months ended September&#160;30, 2021. Net income (loss) for the three and nine months ended September&#160;30, 2022 included special items which decreased net income by $3.4&#160;billion and $3.9 billion, respectively, or $6.65 and $7.81 per diluted share, respectively, as further discussed below. Net income (loss) for the three and nine months ended September&#160;30, 2021 included special items which decreased net income by $66&#160;million and $265 million, respectively, or $0.13 and $0.52 per diluted share, respectively, as further discussed below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our special items and the related impact by line item on our results for the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Margin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product-related items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Gross Margin Ratio</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9 pts)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1 pts)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5 pts)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0 pts)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, General and Administrative (SG&amp;A) Expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation and related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on SG&amp;A Ratio</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 pts</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 pts</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 pts</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 pts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and Development (R&amp;D) Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on R&amp;D Ratio</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 pts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill Impairments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Operating Expense (Income), net</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on product divestiture arrangement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Income (Expense), net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension curtailment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Tax Expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effects of special items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Effective Tax Rate</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7 pts)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0 pts)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2 pts)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3 pts)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense, which increased significantly from the prior year due to the Hillrom acquisition, is identified as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and our Board of Directors assess performance. Additional special items are identified above because they are highly variable, difficult to predict and of a size that may substantially impact our reported results of operations for the period. Management believes that providing the separate impact of those items may provide a more complete understanding and facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">In 2022 and 2021, our results were impacted by costs associated with our execution of programs to optimize our organization and cost structure. These actions included streamlining our international operations, rationalizing our manufacturing and distribution facilities, reducing our general and administrative infrastructure, re-aligning certain R&amp;D activities and cancelling certain R&amp;D programs. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom, which we acquired in December 2021. Our results in 2022 included business optimization charges of $73 million in the third quarter and $196 million in the first nine months. Our results in 2021 included business optimization charges of $36 million in the third quarter and $81 million in the first nine months. Refer to Note 10 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding these charges and related liabilities. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included $4 million in the third quarter and $193 million in the first nine months of acquisition and integration-related expenses. Those costs included $10 million in the third quarter and $227 million in the first nine months related to our acquisition of Hillrom, primarily reflecting $159 million of incremental costs of sales in the first nine months from the fair value step-ups on acquired Hillrom inventory that was sold in the first quarter.  We have not incurred and we do not expect to incur significant incremental cost of sales from those inventory fair value step-ups beyond what was recognized in the first quarter 2022. Other integration expenses in the current period included third party consulting costs related to our integration and related cost savings activities. Those acquisition and integration-related expenses related to Hillrom were partially offset by a $6 million benefit in the third quarter and a $34 million benefit in the first nine months from changes in the estimated fair value of contingent consideration liabilities. Our results in 2021 included acquisition, integration and related financing expenses of $39 million in the third quarter and $36 million in the first nine months. This included acquisition, integration and related financing expenses for our acquisition of Hillrom and the acquisition to the rights to Caelyx and Doxil for specified territories outside of the U.S. These expenses were partially offset by benefits in the third quarter and first nine months from changes in the estimated fair value of contingent consideration liabilities. Refer to Note 2 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding business development activities.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included $12 million in the third quarter and $35 million in the first nine months of costs related to updating our quality systems and product labeling to comply with the new medical device reporting regulation and other requirements of the European Union&#8217;s regulations for medical devices that became effective in stages beginning in 2021. Our results in 2021 included $11 million in the third quarter and $30 million in the first nine months of costs related to these requirements.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2021 included charges of $3 million in the third quarter and $31 million in the first nine months for investigation and related cost for matters associated with our previously announced investigation of foreign exchange gains and losses. Refer to Note 6 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding the investigation.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included charges of $20 million in the third quarter and $43 million in the first nine months related to warranty and remediation activities arising from two field corrective actions on certain of our infusion pumps.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included charges of $3.1 billion in the third quarter and first nine months for goodwill and indefinite-lived intangible asset impairments.  Refer to Note 4 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding the impairments. </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.44pt">Our results in 2022 included a loss of $54 million in the third quarter and first nine months under an arrangement to divest certain product rights for an amount that is less than our cost of those product rights, which was triggered by U.S. and European Union regulatory approvals of the related products. Refer to Note 2 in Item 1 of this Quarterly Report on Form 10-Q for further information about the related transactions.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included a curtailment gain of $11 million in the first nine months related to an announced change for active non-bargaining participants in our U.S. Hillrom pension plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included a charge of $65 million in the third quarter and first nine months for cumulative translation adjustments (CTA) reclassified from accumulated other comprehensive income (loss) as a result of the substantial liquidation of our operations in Argentina. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:24.88pt">Our results in the third quarter and first nine months of 2021 included a $58 million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary. Our results in the first nine months of 2021 also included a charge of $22 million related to an unfavorable court ruling for an uncertain tax position.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:24.88pt">Reflected in this item is the income tax impact of the special items identified in this table. The tax effect of each special item is based on the jurisdiction in which the item was incurred and the tax laws in effect for each such jurisdiction.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FACTORS AFFECTING OUR RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties Related to COVID-19</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9 in Item 1 of this Quarterly Report on Form 10-Q. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic. Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Constraints, Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations are also affected by macroeconomic conditions and levels of business confidence. The war in Ukraine and the sanctions and other measures being imposed in response to this conflict have increased the levels of economic and political uncertainty. In response, we continue to monitor the developing situation with respect to ongoing business in Russia and are working on appropriate contingency plans that will support our desire to serving existing, chronically ill patient populations while remaining compliant with all applicable U.S. and European Union sanctions and regulations. While Russia and Ukraine do not constitute a material portion of our business, a significant escalation or expansion of economic disruption or the conflict&#8217;s current scope could have an adverse effect on our business. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the existence of inflation in the United States and in many of the countries where we conduct business has resulted in, and may continue to result in, higher interest rates and capital costs, shipping costs, increased costs of labor, weakening exchange rates and other similar effects. We have experienced and may continue to experience inflationary increases in manufacturing costs and operating expenses as well as negative impacts from weakening exchange rates, caused by the COVID-19 pandemic or as a result of general macroeconomic factors, and may not be able to pass these cost increases on to our customers in a timely manner or at all, which could have a material adverse impact on our profitability and results of operations. Inflation may also cause our customers to reduce or delay orders for our products and services, which could have a material adverse impact on our sales and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to acquisitions and organic reinvestment, we consistently look for opportunities to optimize our portfolio. As such, we may divest businesses, discontinue products or exit markets (in a manner consistent with our commitments to patient safety and quality) to create value and drive enhanced future performance in line with our strategic objectives.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Environment</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and products, and those of our customers, are subject to regulation globally by numerous government agencies. We, like other businesses in our industry, face challenges inherent in product development, including the potential inability to obtain and maintain regulatory approvals and registrations in the United States and abroad, which could preclude or delay commercialization of a product and increase development costs. New or changing laws and regulations, or changes in enforcement practices in response to requests from various regulatory authorities, could also affect our domestic and foreign operations. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials (including DEHP and polyvinyl chloride) that may require us to re-register products already on the market or change product formulations or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world. Product efficacy or safety concerns regarding products could result in regulatory action on the part of the FDA or foreign counterparts, declining sales and product liability claims, and damage to our reputation. For example, manufacturers across the pharmaceutical industry, including us, are evaluating their product portfolios for the potential presence or formation of nitrosamines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We expect that these challenges and conditions, among other factors, may continue to have an adverse effect on our business.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, please refer to Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET SALES</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual<br/>currency rates</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual<br/>currency rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisition of Hillrom favorably impacted net sales by 23 and 24 percentage points during the third quarter and first nine months of 2022, respectively, compared to the prior year periods. Foreign currency unfavorably impacted net sales by 6 and 5 percentage points during the third quarter and first nine months of 2022, respectively, compared to the prior-year periods, principally due to the strengthening of the U.S. Dollar relative to the Euro, British Pound, Turkish Lira, Australian Dollar and Japanese Yen.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparisons presented at constant currency rates reflect local currency sales at the prior period&#8217;s foreign exchange rates. This measure provides information on the change in net sales assuming that foreign currency exchange rates had remained constant between the prior and the current period. We believe that the non-GAAP measure of change in net sales at constant currency rates, when used in conjunction with the U.S. GAAP measure of change in net sales at actual currency rates, may provide a more complete understanding and facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Product Category Net Sales Reporting </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon our acquisition of Hillrom, we added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions. Our product categories include the following:</span></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BioPharma Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patient Support Systems</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Front Line Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment. </span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Surgical Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of other miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:42.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual currency rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual currency rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care net sales decreased 4% in the third quarter and 3% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter and first nine months was driven by an 8% and 5%, respectively, negative impact from foreign exchange rate changes, as compared to the prior-year periods, and lower in-center HD sales, partially offset by global patient growth in PD.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery net sales decreased 3% in the third quarter and increased 2% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter was driven by a 3% negative impact from foreign exchange rates as compared to the prior-year period. The increase in the first nine months was driven by increased demand for IV administration sets and solutions, reflecting a recovery in hospital admission rates and surgical procedures. The first nine months of 2022 was also favorably impacted by lower U.S. customer rebates in the current year period. Those items were partially offset by lower sales of infusion pumps, a 2% negative impact in the first nine months of 2022 from foreign exchange rates as compared to the prior-year period and sales headwinds in China driven by COVID-related lockdowns. Supply chain constraints, including constraints related to the availability of semiconductor components and other components used in the production of our infusion pumps, and the fact that our new infusion pump platform has not yet received FDA clearance in the U.S. have contributed to lower sales of infusion pumps in the current year periods. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals net sales decreased 11% in the third quarter and 7% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter and first nine months was primarily driven by a 8% and 6%, respectively, negative impact from foreign exchange rates, as compared to the prior-year periods. Additionally, pharmaceuticals net sales were adversely impacted by new market entrants increasing competition and supply constraints for certain molecules. Those items were partially offset by increased sales internationally for inhaled anesthesia products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition net sales decreased 5% in the third quarter and 4% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter and first nine months was driven by a 9% and 7%, respectively, negative impact from foreign exchange rate changes, as compared to the prior-year periods, and lower sales of vitamins resulting from ongoing supply constraints. Those decreases were partially offset by growth in the U.S. for our PN therapies and related products, including our PN multi-chamber bags.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery net sales decreased 1% in the third quarter and increased 2% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter was driven by a 7% negative impact from foreign exchange rate changes, as compared to the prior-year period, partially offset by continued recovery in surgical procedures. The increase in the first nine months was driven by the continued recovery in surgical procedures, particularly in EMEA, and benefits from competitor supply constraints, partially offset by a 5% negative impact from foreign exchange rates, as compared to the prior-year period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies net sales decreased 15% in the third quarter and 11% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter and first nine months was driven by lower COVID-related </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand for our CRRT systems and a 6% and 4%, respectively, negative impact from foreign exchange rate changes, as compared to the prior-year periods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions net sales decreased 17% in the third quarter and 6% in the first nine months of 2022, as compared to the prior-year periods. The decrease in the third quarter and first nine months includes a 7% and 6%, respectively, negative impact from foreign exchange rates, as compared to the prior-year periods. The decrease in the third quarter was also driven by lower sales from manufacturing services and supply packaging related to the production of COVID-19 vaccines on behalf of multiple pharmaceutical companies, reflecting a challenging comparison against a strong prior-year period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Support Systems, Front Line Care and Surgical Solutions product categories were added in connection with our acquisition of Hillrom in December of 2021. Net sales of those product categories have been adversely impacted in the current year periods by ongoing supply chain constraints, particularly related to components used in our Front Line Care product offerings, and by delays in product installations for Patient Support Systems and Surgical Solutions resulting from limitations on hospital access due, in part, to staffing challenges being experienced by those customers. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin and Expense Ratios</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Margin</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross margin ratio was 30.0% and 35.0% in the third quarter and first nine months of 2022, respectively. The special items identified above had an unfavorable impact of approximately 12.9 and 8.5 percentage points on the gross margin ratio in the third quarter and first nine months of 2022, respectively. The gross margin ratio was 40.9% and 39.9% in the third quarter and first nine months of 2021, respectively. The special items identified above had an unfavorable impact of approximately 3.1 and 3.0 percentage points on the gross margin ratio in the third quarter and first nine months of 2021, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the gross margin ratio decreased in the third quarter and increased in the first nine months of 2022 compared to the prior-year periods. The decrease in the third quarter was primarily driven by raw materials inflation and increased supply chain costs, partially offset by a favorable product mix that was primarily driven by our acquisition of Hillrom and lower bonus accruals under our annual employee incentive compensation plans. The increase in the first nine months resulted from a favorable product mix that was that was primarily driven by our acquisition of Hillrom and lower bonus accruals under our annual employee incentive compensation plans, which exceeded the adverse impacts of raw materials inflation and increased supply chain costs for the year-to-date period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SG&amp;A</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SG&amp;A expenses ratio was 25.1% and 26.5% in the third quarter and first nine months of 2022, respectively. The special items identified above had an unfavorable impact of approximately 3.3 and 4.1 percentage points on the SG&amp;A expenses ratio in the third quarter and first nine months of 2022, respectively. The SG&amp;A expenses ratio was 21.1% and 21.4% in the third quarter and first nine months of 2021, respectively. The special items identified above had an unfavorable impact of approximately 1.3 and 0.9 percentage points on the SG&amp;A expenses ratio in the third quarter and first nine months of 2021, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the SG&amp;A expenses ratio increased in the third quarter and first nine months of 2022 compared to the prior-year periods primarily due to the acquisition of Hillrom and increased outbound freight costs, partially offset by lower bonus accruals under our annual employee incentive compensation plans. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The R&amp;D expenses ratio was 4.0% in the third quarter and first nine months of 2022. The R&amp;D expenses ratio was 4.0% and 4.3% in the third quarter and first nine months of 2021, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The R&amp;D expenses ratio remained relatively flat in the third quarter and first nine months of 2022 compared to the prior-year periods, with the increase in total spend primarily driven by the Hillrom acquisition, partially offset by lower bonus accruals under our annual employee incentive compensation plans. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Optimization Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing our manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current year periods, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization actions in the second half of 2015 through September&#160;30, 2022, we have incurred cumulative pre-tax costs of $1.4 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments, and accelerated depreciation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect to incur additional pre-tax costs, primarily related to the implementation of business optimization programs, of approximately $14&#160;million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related to our integration of Hillrom, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill Impairments </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.  We recognize a goodwill impairment charge for the amount by which a reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, we acquired Hillrom on December 13, 2021 and recognized $6.8 billion of goodwill and $6.0 billion of other intangible assets, including $1.9 billion of indefinite-lived intangible assets, in connection with that acquisition. Our Hillrom segment includes the following three reporting units: Patient Support Systems, Front Line Care and Surgical Solutions. During the third quarter of 2022, we performed trigger-based impairment tests of the goodwill of each of those three reporting units, as well as the indefinite-lived intangible assets, consisting primarily of trade names, that we acquired in connection with the Hillrom acquisition. We performed those tests as of September 30, 2022 due to (a) current macroeconomic conditions, including the rising interest rate environment and broad declines in equity valuations, and (b) reduced earnings forecasts for our three Hillrom reporting units, driven primarily by current shortages of certain component parts used in our products, raw materials inflation and increased supply chain costs. The impairment tests resulted in total pre-tax goodwill impairment charges of $2.8 billion in the third quarter of 2022, consisting of a $1.4 billion goodwill impairment for our Patient Support Systems reporting unit, a $1.0 billion goodwill impairment for our Front Line Care reporting unit and a $0.4 billion goodwill impairment for our Surgical Solutions reporting unit. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further adverse changes to macroeconomic conditions or our earnings forecasts could lead to additional goodwill or intangible asset impairment charges in future periods and such charges could be material to our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Operating Expense (Income), Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense (income), net was $48 million and $20 million in the third quarter and first nine months of 2022, respectively. The current year periods include a loss of $54 million under an arrangement to divest certain product rights for an amount that is less than our cost of those product rights, which was triggered by U.S. and European Union regulatory approvals of the related products. Refer to Note 2 in Item 1 of this Quarterly Report on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 10-Q for further information about the related transactions. That loss was partially offset by gains from net decreases in the estimated fair values of contingent consideration liabilities of $6 million and $34 million in the third quarter and first nine months of 2022, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense (income), net was $1 million and $6 million in the third quarter and first nine months of 2021, respectively, which consisted of gains from net decreases in the estimated fair values of contingent consideration liabilities. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $104 million and $278 million in the third quarter and first nine months of 2022, respectively, and $50 million and $118 million in the third quarter and first nine months of 2021, respectively. The increases in the third quarter and first nine months of 2022 were primarily driven by higher average debt outstanding in connection with the Hillrom acquisition. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (Income) Expense, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income) expense, net was an expense of $63 million and $3 million in the third quarter and first nine months of 2022, respectively, and an expense of $12 million and $15 million in the third quarter and first nine months of 2021, respectively. The increases in the third quarter of 2022 compared to the prior year period was primarily due to the reclassification of a cumulative translation loss from accumulated other comprehensive income (loss) to earnings due to the substantial liquidation of our operations in Argentina, partially offset by pension benefits in the current-year period. The decrease in the first nine months of 2022 compared to the prior year was primarily due to foreign exchange gains in the current-year period versus losses in the prior-year period, pension benefits in the current-year period versus expenses in the prior-year period and a pension curtailment gain in the current-year period, partially offset by the reclassification of the Argentina cumulative translation loss to earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was 1.1% and (0.2)% in the third quarter, and (1.1)% and 11.8% in the first nine months of 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to non-deductible goodwill impairments.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as a favorable geographic earnings mix and changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Segment Results</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our global operations based on four segments, consisting of the following geographic segments related to legacy Baxter business: Americas, EMEA and APAC, and a new global segment for our recently acquired Hillrom business. We use net sales and operating income on a segment basis to make resource allocation decisions and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assess the ongoing performance of our segments. The following is a summary of financial information for our reportable segments:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating income (loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,296)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $1.7 billion and $588 million, respectively, in the third quarter and $5.0 billion and $1.8 billion, respectively, in the first nine months of 2022. Segment net sales and operating income were $1.7 billion and $676 million, respectively, in the third quarter and $4.9 billion and $1.9 billion, respectively, in the first nine months of 2021. The decrease in operating income in the third quarter of 2022 was due to higher supply chain costs and lower sales in our BioPharma Solutions, Pharmaceuticals and Acute Therapies product categories, partially offset by higher sales in our Renal Care and Advanced Surgery product categories. The decrease in operating income in the first nine months of 2022 was due to raw materials inflation, higher supply chain costs and lower sales in our Pharmaceuticals, Acute Therapies and BioPharma Solutions product categories, partially offset by higher sales in our Medication Delivery, Renal Care and Advanced Surgery product categories.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EMEA</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $692 million and $145 million, respectively, in the third quarter and $2.1 billion and $433 million, respectively, in the first nine months of 2022. Segment net sales and operating income were $779 million and $167 million, respectively, in the third quarter and $2.3 billion and $461 million, respectively, in the first nine months of 2021. The decrease in operating income in the third quarter and first nine months of 2022 was primarily due to an unfavorable impact of foreign exchange rates on results as compared to the prior-year period, lower sales in our Acute Therapies and BioPharma Solutions product categories and higher supply chain costs, partially offset by lower operating expenses and improved gross margin, driven by a favorable product mix. For the first nine months of 2022, the decrease in operating income was partially offset by having a full nine months of sales from our February 2021 acquisition of the rights to Caelyx and Doxil for specified territories outside the U.S. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">APAC</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $643 million and $152 million, respectively, in the third quarter and $1.9 billion and $459 million, respectively, in the first nine months of 2022. Segment net sales and operating income were $720 million and $166 million, respectively, in the third quarter and $2.1 billion and $456 million, respectively, in the first nine months of 2021. The decrease in operating income in the third quarter of 2022 was driven by the unfavorable impact of foreign exchange rates on results as compared to the prior-year period. The increase in operating income in the first nine months of 2022 was due to lower operating expenses and an improved gross margin, driven by a favorable product mix, partially offset by the unfavorable impact of foreign exchange rates on results as compared to the prior-year period, higher supply chain costs and sales headwinds in China driven by COVID-related lockdowns. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $735 million and $215 million, respectively, in the third quarter and $2.2 billion and $564 million, respectively, in the first nine months of 2022. The increases in net sales and operating income in the third quarter and first nine months of 2022, from zero in the prior year periods, were due to our acquisition of Hillrom in December 2021.    </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $3.0&#160;billion and $3.3 billion for the three and nine months ended September&#160;30, 2022, respectively, are now presented within Corporate as well.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate operating loss in the third quarter was significantly higher than the prior-year period primarily due to goodwill and intangible asset impairments, higher intangible asset amortization expense, acquisition and integration-related expenses and business optimization charges and increased manufacturing variances and centrally managed supply chain costs, partially offset by lower bonus accruals under our annual employee incentive compensation plans.  </span></div><div id="iaef9f667721343c48067444506cf55c3_94"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the statement of cash flows for the nine-month periods ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022, cash provided by operating activities was $772 million, as compared to cash provided by operating activities of $1.5 billion in the first nine months of 2021, a decrease of $757 million. The decrease was primarily due to a decrease in our net income in 2022, increases in inventory levels and higher annual payouts under our employee incentive compensation plans in the current year period compared to the prior year period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022, cash used for investing activities included payments for acquisitions and investments of $206 million, primarily related to our payment to acquire the rights to Zosyn, and capital expenditures of $479 million. In the first nine months of 2021, cash used for investing activities included payments for acquisitions and investments of $463 million, primarily related to Caelyx and Doxil, Transderm Scop and PerClot Polysaccharide Hemostatic System (PerClot), and capital expenditures of $508 million. See Note 2 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding business development activities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022, cash used in financing activities included debt repayments of $953 million and dividend payments of $427 million, partially offset by a net increase in commercial paper borrowings of $30 million and proceeds from stock issued under employee benefit plans of $114 million. In the first nine months of 2021, cash used for financing activities included payments for treasury stock repurchases of $600 million, debt repayments of $407 million and dividend payments of $390 million, partially offset by proceeds from stock issued under employee benefit plans of $135 million and the net proceeds from commercial paper borrowings of $300 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As authorized by our Board of Directors, we repurchase our stock depending upon our cash flows, net debt levels and market conditions. In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2022, we repurchased 0.5 million shares under this authority pursuant to a Rule 10b5-1 plan. We had $1.3 billion remaining available under this authorization as of September&#160;30, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities and Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Facilities</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, our U.S. dollar-denominated revolving credit facility and Euro-denominated revolving credit facility had a maximum capacity of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 billion and &#8364;200 million, respectively. There were no borrowings outstanding under these credit facilities as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or December&#160;31, 2021. Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we were in compliance with the financial covenants in these agreements. In the third quarter of 2022, we amended the credit agreement governing our U.S. dollar-denominated revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to delay the commencement of our net leverage ratio covenant step-down schedule until June 30, 2024. The non-performance of any financial institution supporting either of the credit facilities would reduce the maximum capacity of these facilities by the institution&#8217;s respective commitment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We intend to fund short-term and long-term obligations as they mature through cash on hand, future cash flows from operations or by issuing additional debt. We had $1.6 billion of cash and cash equivalents as of September&#160;30, 2022, with adequate cash available to meet operating requirements in each jurisdiction in which we operate. We invest our excess cash in money market and other funds and diversify the concentration of cash among different financial institutions. As of September&#160;30, 2022, we had approximately $16.4 billion of long-term debt and finance lease obligations, including current maturities, and short-term debt. Subject to market conditions, we regularly evaluate opportunities with respect to our capital structure.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions, including global economic conditions. However, we believe we have sufficient financial flexibility to issue debt, enter into other financing arrangements and attract long-term capital on acceptable terms to support our growth objectives. Although our outlook was downgraded from stable to negative by two of the rating agencies during the third quarter of 2022, there have been no changes to our investment grade credit ratings that we disclosed in our 2021 Annual Report. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LIBOR Reform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the United Kingdom&#8217;s Financial Conduct Authority announced that after 2021 it would no longer compel banks to submit the rates required to calculate the London Interbank Offered Rate (LIBOR) and other interbank offered rates, which have been widely used as reference rates for various securities and financial contracts, including loans, debt and derivatives. This announcement indicated that the continuation of LIBOR on the current basis was not guaranteed after 2021. Regulators in the U.S. and other jurisdictions have been working to replace these rates with alternative reference interest rates that are supported by transactions in liquid and observable markets, such as the Secured Overnight Financing Rate (SOFR). In 2020, it was announced that certain U.S. dollar LIBOR tenors would not cease until 2023. In September 2022, our $2.5 billion U.S. dollar-denominated revolving credit facility and our $4.0 billion Term Loan Credit Agreement were amended to reference SOFR-based rates. Currently, our &#8364;200 million Euro-denominated revolving credit facility references LIBOR-based rates. The discontinuation of LIBOR will require this arrangement to be modified in order to replace LIBOR with an alternative reference interest rate, which could impact our cost of funds. That credit facility agreement includes provisions related to the determination of a successor LIBOR rate.</span></div><div id="iaef9f667721343c48067444506cf55c3_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CRITICAL ACCOUNTING POLICIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and   judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 1 to our consolidated financial statements in our 2021 Annual Report. Certain </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our accounting policies are considered critical, as these policies are the most important to the depiction of our financial statements and require significant, difficult or complex judgments by us, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in our 2021 Annual Report. We identified the Valuation of Intangible Assets, Including IPR&amp;D, as one of our critical accounting policies in our 2021 Annual Report. We currently consider the valuation of goodwill to be a part of that critical accounting policy. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is initially measured as the excess of the purchase price over the fair value (or other measurement attribute required by U.S. GAAP) of acquired assets and liabilities in a business combination. Goodwill is not amortized but is subject to an impairment review annually and whenever indicators of impairment exist. We have the option to assess goodwill for impairment by initially performing a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. If we determine that it is not more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, then the quantitative goodwill impairment test is not required to be performed. If we determine that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, or if we do not elect the option to perform an initial qualitative assessment, we perform a quantitative goodwill impairment test. In the quantitative impairment test, we calculate the estimated fair value of the reporting unit. If the carrying amount of the reporting unit exceeds the estimated fair value, an impairment charge is recorded for the amount that the reporting unit&#8217;s carrying amount, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. In a quantitative goodwill impairment test, the fair values of our reporting units are generally determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to reporting unit fair value measurements generally include forecasted cash flows, discount rates, terminal growth rates and earnings multiples. Each of those inputs can significantly affect the fair values of our reporting units. During the third quarter of 2022, we recognized $2.8 billion of goodwill impairment charges and $332 million of indefinite-lived intangible asset impairment charges. See Note 4, Goodwill and Other Intangible Assets, Net in Item 1 of this Quarterly Report on Form 10-Q for further information about those impairments.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other updates to our critical accounting policies and no significant changes in the application of our critical accounting policies during the first nine months of 2022. </span></div><div id="iaef9f667721343c48067444506cf55c3_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sales Restrictions, which (1) clarifies the guidance in Topic 820 on the fair value measurement of an equity security that is subject to contractual restrictions that prohibit the sale of an equity security and (2) requires specific disclosures related to such an equity security. The standard is effective for our financial statements beginning in 2024. The impact of the adoption of this ASU is not expected to have a material effect on our condensed consolidated financial statements.</span></div><div id="iaef9f667721343c48067444506cf55c3_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LEGAL CONTINGENCIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6 within Item 1 for a discussion of our legal contingencies. Upon resolution of any of these uncertainties, we may incur charges in excess of presently established liabilities. While our liability in connection with certain claims cannot be estimated with any certainty, and although the resolution in any reporting period of one or more of these matters could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in these matters, litigation is inherently uncertain, excessive verdicts do occur, and we may in the future incur material judgments or enter into material settlements of claims.</span></div><div id="iaef9f667721343c48067444506cf55c3_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTAIN REGULATORY MATTERS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration (FDA) commenced an inspection of Claris&#8217; facilities in Ahmedabad, India in July 2017, immediately prior to the closing of our acquisition of Claris Injectables Limited (Claris). FDA completed the inspection and subsequently issued a Warning Letter based on observations identified in the 2017 inspection (Claris Warning Letter).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> FDA re-inspected the facilities and issued a Form 483 on May 17, 2022. On September 1, 2022, FDA notified the company that the inspection had been classified as voluntary action indicated (VAI). Since the issuance of the Claris Warning Letter, we have implemented corrective and preventive actions to address FDA&#8217;s prior </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observations and other items we identified and management has begun working with other manufacturing locations, including contract manufacturing organizations, to support the production of new products for distribution in the U.S. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Available online at https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm613538.htm</span></div><div id="iaef9f667721343c48067444506cf55c3_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FORWARD-LOOKING INFORMATION</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q includes forward-looking statements. Use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;evaluates,&#8221; &#8220;pursues,&#8221; &#8220;anticipates,&#8221; &#8220;continues,&#8221; &#8220;designs,&#8221; &#8220;impacts,&#8221; &#8220;affects,&#8221; &#8220;forecasts,&#8221; &#8220;target,&#8221; &#8220;outlook,&#8221; &#8220;initiative,&#8221; &#8220;objective,&#8221; &#8220;designed,&#8221; &#8220;priorities,&#8221; &#8220;goal,&#8221; or the negative of those words or other similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. These forward-looking statements may include statements with respect to accounting estimates and assumptions, impacts of the COVID-19 pandemic and global economic conditions, litigation-related matters including outcomes, impacts of the internal investigation related to foreign exchange gains and losses, future regulatory filings and our R&amp;D pipeline, strategic objectives, sales from new product offerings, credit exposure to foreign governments, potential developments with respect to credit ratings, investment of foreign earnings, estimates of liabilities including those related to uncertain tax positions, contingent payments, future pension plan contributions, costs, discount rates and rates of return, our exposure to financial market volatility and foreign currency and interest rate risks, the impact of competition, future sales growth, business development activities (including the acquisitions of Cheetah, Seprafilm, certain outside of the U.S. (OUS) rights to Caelyx and Doxil, full U.S. and specific OUS rights to Transderm Scop, PerClot, Hillrom and certain rights to Zosyn in the U.S. and Canada), business optimization and portfolio rationalization initiatives, cost saving initiatives, future capital and R&amp;D expenditures, future debt issuances, manufacturing expansion, the adequacy of credit facilities, tax provisions and reserves, the effective tax rate and all other statements that do not relate to historical facts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These forward-looking statements are based on certain assumptions and analyses made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate in the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. Whether actual future results and developments will conform to expectations and predictions is subject to a number of risks and uncertainties, including the following factors, many of which are beyond our control:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">demand for and market acceptance risks for and competitive pressures related to new and existing products (including challenges with our ability to accurately predict changing customer preferences, which has led to and may continue to lead to increased inventory levels, and needs and advances in technology and the resulting impact on customer inventory levels and the impact of reduced hospital admission rates and elective surgery volumes), and the impact of those products on quality and patient safety concerns;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the continuity, availability and pricing of acceptable raw materials and component parts (and our ability to pass some or all of these costs on to our customers), and the related continuity of our manufacturing and distribution (including impacts from COVID-19) and those of our suppliers;</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">inability to create additional production capacity in a timely manner or the occurrence of other manufacturing, sterilization or supply difficulties (including as a result of natural disaster, public health crises and epidemics/pandemics, regulatory actions or otherwise);</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product development risks, including satisfactory clinical performance and obtaining required regulatory approvals (including as a result of evolving regulatory requirements), the ability to manufacture at appropriate scale, and the general unpredictability associated with the product development cycle;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to finance and develop new products or enhancements on commercially acceptable terms or at all;</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the impact of global economic conditions (including, among other things, the ongoing war in Ukraine, the related economic sanctions being imposed globally in response to the conflict and potential trade wars and global inflationary pressures) and continuing public health crises, pandemics and epidemics, such as the ongoing COVID-19 pandemic, on us and our employees, customers and suppliers, including foreign governments in countries in which we operate;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to identify business development, portfolio rationalization and growth opportunities and to successfully execute on these strategies (including the Hillrom acquisition and related integration and restructuring activities);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product quality or patient safety issues, leading to product recalls, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation, or declining sales, including the focus on evaluating product portfolios for the potential presence or formation of nitrosamines;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">breaches or failures of our information technology systems or products, including by cyber-attack, data leakage, unauthorized access or theft (as a result of increased remote working arrangements or otherwise);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of (or failures to act or delays in acting by) FDA, the European Medicines Agency or any other regulatory body or government authority (including the SEC, DOJ or the Attorney General of any State) that could delay, limit or suspend product development, manufacturing or sale or result in seizures, recalls, injunctions, monetary sanctions or criminal or civil liabilities, including the continued delay in lifting the warning letter at our Ahmedabad facility;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failures with respect to our quality, compliance or ethics programs;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of third parties, including third-party payers and our customers and distributors (including group purchasing organizations and formed integrated delivery networks), the impact of healthcare reform and its implementation, suspension, repeal, replacement, amendment, modification and other similar actions undertaken by the United States or foreign governments, including with respect to pricing, reimbursement, taxation and rebate policies; legislation, regulation and other governmental pressures in the United States or globally, including the cost of compliance and potential penalties for purported noncompliance thereof, all of which may affect pricing, reimbursement, taxation and rebate policies of government agencies and private payers or other elements of our business, including new or amended laws, rules and regulations (such as the California Consumer Privacy Act of 2018, the European Union&#8217;s General Data Protection Regulation and proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multi-year capital expenditures, which are difficult to estimate in advance);</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the outcome of pending or future litigation, including the opioid litigation and ethylene oxide litigation or other claims;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failure to achieve our short- and long-term financial goals;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">global regulatory, trade and tax policies (including with respect to climate change and other sustainability matters);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the ability to protect or enforce our owned or in-licensed patent or other proprietary rights (including trademarks, copyrights, trade secrets and know-how) or patents of third parties preventing or restricting our manufacture, sale or use of affected products or technology;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.367%"><tr><td style="width:1.0%"></td><td style="width:3.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of any goodwill or other intangible asset impairments on our operating results;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fluctuations in foreign exchange and interest rates;</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">any changes in law concerning the taxation of income (whether with respect to current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax or the Build Back Better framework;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">actions by tax authorities in connection with ongoing tax audits;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">loss of key employees, the occurrence of labor disruptions or the inability to identify and recruit new employees;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other factors identified elsewhere in this report and other filings with the SEC, including those factors described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, all of which are available on our website.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Actual results may differ materially from those projected in the forward-looking statements. We do not undertake to update our forward-looking statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to revenues generated outside of the United States denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative financial instruments to further reduce the net exposure to foreign exchange. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and stockholders&#8217; equity volatility relating to foreign exchange. However, we don't hedge our entire foreign exchange exposure and are still subject to earnings and stockholders' equity volatility relating to foreign exchange risk.  Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use options and forwards to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities denominated in foreign currencies. The maximum term over which we have cash flow hedge contracts in place related to foreign exchange risk on forecasted transactions as of September&#160;30, 2022 is 12 months. We also enter into derivative instruments to hedge foreign exchange risk on certain intra-company and third-party receivables and payables and debt denominated in foreign currencies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk-management program, we perform sensitivity analyses to assess potential changes in the fair value of our foreign exchange instruments relating to hypothetical and reasonably possible near-term movements in foreign exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of changes in the fair value of foreign exchange contracts outstanding as of September&#160;30, 2022, while not predictive in nature, indicated that if the U.S. Dollar uniformly weakened by 10% against all currencies, the net pre-tax asset balance of $26 million with respect to those contracts would change by $70 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity analysis model recalculates the fair value of the foreign exchange contracts outstanding as of September&#160;30, 2022 by replacing the actual exchange rates as of September&#160;30, 2022 with exchange rates that are 10% weaker compared to the actual exchange rates for each applicable currency. All other factors are held constant. These sensitivity analyses disregard the possibility that currency exchange rates can move in opposite directions and that gains from one currency may or may not be offset by losses from another currency. The analyses also disregard the offsetting change in value of the underlying hedged transactions and balances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the three-year cumulative inflation rate in Turkey exceeded 100 percent.  As a result, on April 1, 2022, we began reporting the results of our subsidiary in that jurisdiction using highly inflationary accounting, which requires that the functional currency of the entity be changed to the reporting currency of its parent.  As of September&#160;30, 2022, our subsidiary in Turkey had net monetary assets of $40 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate and Other Risks</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the caption &#8220;Interest Rate and Other Risks&#8221; in the &#8220;Financial Instrument Market Risk&#8221; section of the 2021 Annual Report. There were no significant changes during the quarter ended September&#160;30, 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of September&#160;30, 2022. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September&#160;30, 2022. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Chan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es in Internal Control over Financial Reporting</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our finance transformation and process optimization initiatives, during the quarter ended September 30, 2022 we transferred certain accounting and finance activities to new Baxter global business service centers located in Kuala Lumpur, Malaysia, and Warsaw, Poland. These transitions followed several months of knowledge transfer and training programs and included modifications to the design and operation of our internal controls over financial reporting in some cases. Additional transitions of accounting and finance activities to our global business service centers are planned over the coming year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described in the preceding paragraph, there have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="iaef9f667721343c48067444506cf55c3_121"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Part I, Item 1, Note 6 is incorporated herein by reference.</span></div><div id="iaef9f667721343c48067444506cf55c3_124"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1A.  Risk Factors  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We do not believe that there have been any material changes to the risk factors previously disclosed in our 2021 Annual Report. </span></div><div id="iaef9f667721343c48067444506cf55c3_127"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.574%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total number of shares purchased </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average price paid per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total number of shares purchased as part of publicly announced program</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Approximate dollar value of shares that may yet be purchased under the program</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2022 through July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2022 through August 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 through September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.80&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264,718,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) In July 2012, we announced that our Board of Directors authorized us to repurchase up to $2.0 billion of our common stock on the open market or in private transactions. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. During the third quarter of 2022, we repurchased approximately 0.4 million shares for $24 million pursuant to this authority through a Rule 10b5-1 purchase plan. We had $1.3 billion remaining under this program as of September&#160;30, 2022. This program does not have an expiration date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312522255523/d378856dex101.htm">First Amendment, dated as of September 28, 2022, to the Credit Agreement, dated as of September 30, 2021, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed on September 30, 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312522255523/d378856dex102.htm">Second Amendment, dated as of September 28, 2022, to the Credit Agreement, dated as of September 30, 2021, as amended by the First Amendment, dated as of September 28, 2022, amount Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K, filed on September 30, 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312522255523/d378856dex103.htm">First Amendment, dated as of September 28, 2022, to the Five-Year Credit Agreement, dated as of September 30, 2021, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K, filed on September 30, 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312522255523/d378856dex104.htm">Second Amendment, dated as of September 28, 2022, to the Five-Year Credit Agreement, dated as of September 30, 2021, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K, filed on September 30, 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312522255523/d378856dex105.htm">Second Amendment, dated as of September 28, 2022, to the Credit Agreement, dated as of December 20, 2019, as amended by the First Amendment, dated as of October 1, 2021, among Baxter Healthcare SA and Baxter World Trade SRL, as Borrowers, JPMorgan SE, as Administrative Agent and certain other financial institutions named therein (incorporated by reference to Exhibit 10.5 to the Company's Current Report on Form 8-K, filed on September 30, 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220930xex311.htm">Certification of Chief Executive Officer Pursuant to Rules 13a-14 (a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220930xex312.htm">Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220930ex321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220930xex322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained within the Inline XBRL Instance Document in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="iaef9f667721343c48067444506cf55c3_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BAXTER INTERNATIONAL INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: October 27, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro<br/>Executive Vice President and Chief Financial Officer<br/>(duly authorized officer and principal financial officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>bax-20220930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9d95262e3e5c4f5cbbebecd521e92be0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jos&#233; E. Almeida, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; October&#160;27, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>bax-20220930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6e7159370db64c72aec322b072e2da5f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James K. Saccaro, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Date&#58; October&#160;27, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>bax-20220930ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i08d364999c72437fa1b54cb819caaa7c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jos&#233; E. Almeida, as Chairman of the Board and Chief Executive Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>bax-20220930xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i084cb851a2c346d7a2487031be7fc6ca_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James K. Saccaro, as Executive Vice President and Chief Financial Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bax-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.baxter.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.baxter.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeLossunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Income (Loss) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.baxter.com/role/BASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTS" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS">
        <link:definition>2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNET" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET">
        <link:definition>2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTS" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS">
        <link:definition>2122105 - Disclosure - FINANCING ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2126107 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME">
        <link:definition>2128108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUES" roleURI="http://www.baxter.com/role/REVENUES">
        <link:definition>2132109 - Disclosure - REVENUES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGES" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES">
        <link:definition>2138110 - Disclosure - BUSINESS OPTIMIZATION CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS">
        <link:definition>2144111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.baxter.com/role/INCOMETAXES">
        <link:definition>2147112 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.baxter.com/role/EARNINGSPERSHARE">
        <link:definition>2149113 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>2153114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2160115 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.baxter.com/role/SEGMENTINFORMATION">
        <link:definition>2166116 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSTables" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables">
        <link:definition>2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONTables" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables">
        <link:definition>2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETTables" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables">
        <link:definition>2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables">
        <link:definition>2329304 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESTables" roleURI="http://www.baxter.com/role/REVENUESTables">
        <link:definition>2333305 - Disclosure - REVENUES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESTables" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables">
        <link:definition>2339306 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables">
        <link:definition>2345307 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables">
        <link:definition>2350308 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>2354309 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2361310 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables">
        <link:definition>2367311 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails">
        <link:definition>2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails">
        <link:definition>2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails">
        <link:definition>2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails">
        <link:definition>2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails">
        <link:definition>2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails">
        <link:definition>2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails">
        <link:definition>2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails">
        <link:definition>2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails">
        <link:definition>2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
        <link:definition>2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
        <link:definition>2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails">
        <link:definition>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
        <link:definition>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSDetails" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails">
        <link:definition>2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2427416 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails">
        <link:definition>2430417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
        <link:definition>2431418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails">
        <link:definition>2434419 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails_1" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1">
        <link:definition>2434419 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESContractAssetsandContractLiabilitiesDetails" roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails">
        <link:definition>2435420 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
        <link:definition>2436421 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESLeaseRevenueDetails" roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails">
        <link:definition>2437422 - Disclosure - REVENUES - Lease Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails">
        <link:definition>2440423 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
        <link:definition>2441424 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
        <link:definition>2442425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
        <link:definition>2443426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
        <link:definition>2446427 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.baxter.com/role/INCOMETAXESDetails">
        <link:definition>2448428 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails">
        <link:definition>2451429 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREAdditionalInformationDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails">
        <link:definition>2452430 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
        <link:definition>2455431 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
        <link:definition>2456432 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
        <link:definition>2457433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails">
        <link:definition>2458434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
        <link:definition>2459435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2462436 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>2463437 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
        <link:definition>2464438 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
        <link:definition>2465439 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
        <link:definition>2468440 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
        <link:definition>2469441 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bax_ClinicalNutritionMember" abstract="true" name="ClinicalNutritionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillTable" abstract="true" name="IntangibleAssetExcludingGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_A2539NotesDue2032Member" abstract="true" name="A2539NotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenueRecognizedContractPeriod" abstract="false" name="RevenueRecognizedContractPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_A13SeniorNotesDueMay2029Member" abstract="true" name="A13SeniorNotesDueMay2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessOptimizationChargeTableTextBlock" abstract="false" name="BusinessOptimizationChargeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_PatientSupportSystemsReportingUnitMember" abstract="true" name="PatientSupportSystemsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_CommonStock100PerValueMember" abstract="true" name="CommonStock100PerValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A2272SeniorNotesDue2028Member" abstract="true" name="A2272SeniorNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2025Member" abstract="true" name="GlobalNotes13Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_FrontLineCareReportingUnitMember" abstract="true" name="FrontLineCareReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AcquisitionsAndCollaborationsTable" abstract="true" name="AcquisitionsAndCollaborationsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" abstract="false" name="ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_AssetImpairmentMember" abstract="true" name="AssetImpairmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_CelerityMember" abstract="true" name="CelerityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ConsumableMedicalProductsMember" abstract="true" name="ConsumableMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" abstract="true" name="BundledEquipmentAndConsumableMedicalProductsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" abstract="false" name="IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_A3132SeniorNotesDue2051Member" abstract="true" name="A3132SeniorNotesDue2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_LossContingencyNumberOfLawsuits" abstract="false" name="LossContingencyNumberOfLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_BioPharmaSolutionsMember" abstract="true" name="BioPharmaSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityDeferredRevenue" abstract="false" name="ContractWithCustomerLiabilityDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_GlobalNotes04Due2024Member" abstract="true" name="GlobalNotes04Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SeniorFiveYearTermLoanMember" abstract="true" name="SeniorFiveYearTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SeveranceAndOtherEmployeeRelatedCostsMember" abstract="true" name="SeveranceAndOtherEmployeeRelatedCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SiteContingencyNumberOfSites" abstract="false" name="SiteContingencyNumberOfSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_MedicationDeliveryMember" abstract="true" name="MedicationDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ProceedsFromDivestitureOfProductRights" abstract="false" name="ProceedsFromDivestitureOfProductRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AsiaPacificSegmentMember" abstract="true" name="AsiaPacificSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2029Member" abstract="true" name="GlobalNotes13Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" abstract="false" name="BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_A1322SeniorNotesDue2024Member" abstract="true" name="A1322SeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_FrontLineCareMember" abstract="true" name="FrontLineCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A130SeniorNotesDueMay2025Member" abstract="true" name="A130SeniorNotesDueMay2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_EnviromentalCleanUpMember" abstract="true" name="EnviromentalCleanUpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A24SeniorNotesDue2022Member" abstract="true" name="A24SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" abstract="false" name="AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AcquisitionsAndCollaborationsLineItems" abstract="true" name="AcquisitionsAndCollaborationsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_AdvancedSurgeryMember" abstract="true" name="AdvancedSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OriginalWeightedAverageTerm" abstract="false" name="OriginalWeightedAverageTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityTotalRevenueRecognized" abstract="false" name="ContractWithCustomerLiabilityTotalRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ContractTerminationAndOtherCostsMember" abstract="true" name="ContractTerminationAndOtherCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ManufacturingArrangementsMember" abstract="true" name="ManufacturingArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PatientSupportSystemsMember" abstract="true" name="PatientSupportSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SeniorThreeYearTermLoanMember" abstract="true" name="SeniorThreeYearTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FloatingRateNotesDue2024Member" abstract="true" name="FloatingRateNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ZosynMember" abstract="true" name="ZosynMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SurgicalSolutionsMember" abstract="true" name="SurgicalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_DerivativeFairValueTerminated" abstract="false" name="DerivativeFairValueTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_RenalMember" abstract="true" name="RenalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PharmaceuticalsMember" abstract="true" name="PharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_DevelopedTechnologyIncludingPatentsMember" abstract="true" name="DevelopedTechnologyIncludingPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AcuteTherapiesMember" abstract="true" name="AcuteTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A04SeniorNotesDueMay2024Member" abstract="true" name="A04SeniorNotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_A0868SeniorNotesDueMay2023Member" abstract="true" name="A0868SeniorNotesDueMay2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_HillromMember" abstract="true" name="HillromMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueDisclosuresTable" abstract="true" name="FairValueDisclosuresTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_SurgicalSolutionsReportingUnitMember" abstract="true" name="SurgicalSolutionsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SuperfundSitesMember" abstract="true" name="SuperfundSitesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_FloatingRateNotesDue2023Member" abstract="true" name="FloatingRateNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AvailableForSaleDebtSecuritiesMember" abstract="true" name="AvailableForSaleDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SoftwareArrangementsMember" abstract="true" name="SoftwareArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GainLossOnDispositionOfProductDivestitureArrangement" abstract="false" name="GainLossOnDispositionOfProductDivestitureArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_StockRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="StockRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_A1915DebenturesDue2027Member" abstract="true" name="A1915DebenturesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenuePerformanceObligationPaymentTerms" abstract="false" name="RevenuePerformanceObligationPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_OtherProductOrServicesMember" abstract="true" name="OtherProductOrServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessOptimizationProgramsMember" abstract="true" name="BusinessOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillLineItems" abstract="true" name="IntangibleAssetExcludingGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_RevenueFromContractWithCustomerRollForward" abstract="true" name="RevenueFromContractWithCustomerRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_AmericasSegmentMember" abstract="true" name="AmericasSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_DerivativeNetInvestmentTerminated" abstract="false" name="DerivativeNetInvestmentTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_FairValueDisclosuresLineItems" abstract="true" name="FairValueDisclosuresLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_EMEASegmentMember" abstract="true" name="EMEASegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bax-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_33d6a192-9777-48fa-8dca-e9ddd3a60d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fb130650-3d4c-4743-a150-d282b0729c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_33d6a192-9777-48fa-8dca-e9ddd3a60d5c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fb130650-3d4c-4743-a150-d282b0729c09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_93aa48a5-7e74-4c80-acb0-ff6cdf695aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_33d6a192-9777-48fa-8dca-e9ddd3a60d5c" xlink:to="loc_us-gaap_AccountsPayableCurrent_93aa48a5-7e74-4c80-acb0-ff6cdf695aae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_587f4fb6-9987-4311-a9f1-dd39b3e66210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_33d6a192-9777-48fa-8dca-e9ddd3a60d5c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_587f4fb6-9987-4311-a9f1-dd39b3e66210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_0a414ee4-449d-4dbb-98fa-4077f6d38bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_33d6a192-9777-48fa-8dca-e9ddd3a60d5c" xlink:to="loc_us-gaap_ShortTermBorrowings_0a414ee4-449d-4dbb-98fa-4077f6d38bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_01f519bb-423c-4084-9ae7-0d8c1395fb40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_01f519bb-423c-4084-9ae7-0d8c1395fb40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c82de5d-1f74-401c-a5a3-6b82d57f36d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c82de5d-1f74-401c-a5a3-6b82d57f36d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4a54f56a-40e3-4afa-89fb-00dc671ae361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:to="loc_us-gaap_CommonStockValue_4a54f56a-40e3-4afa-89fb-00dc671ae361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a5f6628e-a2d1-4766-a24f-a05098e98111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a5f6628e-a2d1-4766-a24f-a05098e98111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_063d7424-1238-45d9-a51e-7990ee503007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cbadd374-40b8-4fbd-bb16-4caced32ad48" xlink:to="loc_us-gaap_TreasuryStockCommonValue_063d7424-1238-45d9-a51e-7990ee503007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0344f397-7ce8-4251-ab93-02a79a0f74db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_AssetsCurrent_0344f397-7ce8-4251-ab93-02a79a0f74db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6c8b1c1d-2911-4318-994f-d4e7ff01e3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6c8b1c1d-2911-4318-994f-d4e7ff01e3e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebd6b79f-2604-4721-aa50-7fd520a062eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_Goodwill_ebd6b79f-2604-4721-aa50-7fd520a062eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da3aea5c-e57b-4bee-be2c-1b5c29c6f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da3aea5c-e57b-4bee-be2c-1b5c29c6f7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3ce3509f-672f-4fec-8334-1578ff364561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3ce3509f-672f-4fec-8334-1578ff364561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e036d86b-57fa-42be-b585-d97366884fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d5fdb84a-01be-46bc-ae8e-8ba92d50a797" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e036d86b-57fa-42be-b585-d97366884fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c6ebef1-4e4b-464f-aab1-9fbb840b38d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_189a93fd-9965-40c4-8656-c756df746716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c6ebef1-4e4b-464f-aab1-9fbb840b38d0" xlink:to="loc_us-gaap_Liabilities_189a93fd-9965-40c4-8656-c756df746716" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f51a314c-dd4d-4d83-9928-79a3305ef124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c6ebef1-4e4b-464f-aab1-9fbb840b38d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f51a314c-dd4d-4d83-9928-79a3305ef124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_03290852-6b2f-4996-8673-882bfa8c89c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c6ebef1-4e4b-464f-aab1-9fbb840b38d0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_03290852-6b2f-4996-8673-882bfa8c89c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b0709d7-e6ed-4ef8-b50d-ca4f650bae55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab0f6cfd-d87d-49a5-b7ef-26f7d4c17270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4b0709d7-e6ed-4ef8-b50d-ca4f650bae55" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab0f6cfd-d87d-49a5-b7ef-26f7d4c17270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6c3b5544-28af-4863-baa2-64ce779ac612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4b0709d7-e6ed-4ef8-b50d-ca4f650bae55" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6c3b5544-28af-4863-baa2-64ce779ac612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6b4572ce-d8ef-4dfd-9bfb-b7451fb0c3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4b0709d7-e6ed-4ef8-b50d-ca4f650bae55" xlink:to="loc_us-gaap_InventoryNet_6b4572ce-d8ef-4dfd-9bfb-b7451fb0c3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e6e9dd40-a2db-4810-9cec-1f2214cb92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4b0709d7-e6ed-4ef8-b50d-ca4f650bae55" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e6e9dd40-a2db-4810-9cec-1f2214cb92a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f791ad37-4eb5-4ffb-a54c-63431315877d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3a98abf4-8ff5-419c-8568-db24796bb070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f791ad37-4eb5-4ffb-a54c-63431315877d" xlink:to="loc_us-gaap_StockholdersEquity_3a98abf4-8ff5-419c-8568-db24796bb070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e9406a6c-ca4a-4075-930e-09cbdc24d509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f791ad37-4eb5-4ffb-a54c-63431315877d" xlink:to="loc_us-gaap_MinorityInterest_e9406a6c-ca4a-4075-930e-09cbdc24d509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ebd87883-61f2-45f4-9711-4721537919ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e9547a34-0958-4ffe-8db7-b3041bdd3117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ebd87883-61f2-45f4-9711-4721537919ac" xlink:to="loc_us-gaap_LiabilitiesCurrent_e9547a34-0958-4ffe-8db7-b3041bdd3117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b75f11b9-d95d-464d-9b4e-01cab01d2f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ebd87883-61f2-45f4-9711-4721537919ac" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b75f11b9-d95d-464d-9b4e-01cab01d2f63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67e4f236-b7f0-47e6-875b-f38f97cbb89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ebd87883-61f2-45f4-9711-4721537919ac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67e4f236-b7f0-47e6-875b-f38f97cbb89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1f3ca1a2-b441-4dd1-8de3-d4f29c734f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ebd87883-61f2-45f4-9711-4721537919ac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1f3ca1a2-b441-4dd1-8de3-d4f29c734f20" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofIncomeLossunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cdfca044-da60-4b37-a6f5-d8e05cd12682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_13f863d5-566c-485e-8d5c-a850f78704db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cdfca044-da60-4b37-a6f5-d8e05cd12682" xlink:to="loc_us-gaap_OperatingIncomeLoss_13f863d5-566c-485e-8d5c-a850f78704db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_93052858-626a-4970-84e4-36a7e2fb7b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cdfca044-da60-4b37-a6f5-d8e05cd12682" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_93052858-626a-4970-84e4-36a7e2fb7b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_886ff5d6-21f3-4d33-a2b4-a5eab44ffe1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cdfca044-da60-4b37-a6f5-d8e05cd12682" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_886ff5d6-21f3-4d33-a2b4-a5eab44ffe1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_339f823b-4c75-45d8-9097-2dd93742a34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_36ff02a6-fdd9-4fa7-a9eb-6664bc8d3cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_339f823b-4c75-45d8-9097-2dd93742a34b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_36ff02a6-fdd9-4fa7-a9eb-6664bc8d3cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6270645f-9cfc-48fd-a2d6-7a88d71e7db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_339f823b-4c75-45d8-9097-2dd93742a34b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6270645f-9cfc-48fd-a2d6-7a88d71e7db4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0956de33-107a-49a4-8262-a2d75baff3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e55009f-1812-4495-98f9-5f1c9f3f300e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0956de33-107a-49a4-8262-a2d75baff3a8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e55009f-1812-4495-98f9-5f1c9f3f300e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_94a93b6e-4595-44a4-b45b-032f8bb255e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0956de33-107a-49a4-8262-a2d75baff3a8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_94a93b6e-4595-44a4-b45b-032f8bb255e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0195797e-f428-44a7-ba47-ce2853328ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:to="loc_us-gaap_GrossProfit_0195797e-f428-44a7-ba47-ce2853328ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ceba4b6-d9bd-4be9-8713-64e80c2c4359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ceba4b6-d9bd-4be9-8713-64e80c2c4359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ce46e865-0203-4681-b6e9-d2b3a65c7c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ce46e865-0203-4681-b6e9-d2b3a65c7c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c29988e7-5879-4733-9026-aa1da828a2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c29988e7-5879-4733-9026-aa1da828a2e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_6afeccdc-0b9c-4e8b-9d79-d09df537a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_748dcfe7-65fe-4a10-a5c6-30eb257744c5" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_6afeccdc-0b9c-4e8b-9d79-d09df537a6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_607955e9-936e-457b-9a9e-5c29cb80f5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c6ea78b9-8788-485d-a9f1-d3a103dc132a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_607955e9-936e-457b-9a9e-5c29cb80f5c5" xlink:to="loc_us-gaap_ProfitLoss_c6ea78b9-8788-485d-a9f1-d3a103dc132a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1dbdf230-e626-44f8-8b1e-bb8664bd5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_607955e9-936e-457b-9a9e-5c29cb80f5c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1dbdf230-e626-44f8-8b1e-bb8664bd5c76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c776a3f7-3bd8-4d87-a91c-3a519ffd2b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b9621bd5-ce31-4832-b299-fc77820a5a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c776a3f7-3bd8-4d87-a91c-3a519ffd2b5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b9621bd5-ce31-4832-b299-fc77820a5a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_316628b1-b834-480a-af1f-0f710887edff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c776a3f7-3bd8-4d87-a91c-3a519ffd2b5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_316628b1-b834-480a-af1f-0f710887edff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a1f7ea82-94d0-4ab4-bf30-c25fece092dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c776a3f7-3bd8-4d87-a91c-3a519ffd2b5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a1f7ea82-94d0-4ab4-bf30-c25fece092dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45f06b25-072a-4a52-a060-6dfeaea1ed4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c776a3f7-3bd8-4d87-a91c-3a519ffd2b5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45f06b25-072a-4a52-a060-6dfeaea1ed4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53418304-d565-430e-87e5-bd87d6304cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f56b921a-95c5-4678-827b-ad7082434431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53418304-d565-430e-87e5-bd87d6304cf7" xlink:to="loc_us-gaap_ProfitLoss_f56b921a-95c5-4678-827b-ad7082434431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_352b4e07-03fe-4fea-a2d5-6b8d9a04a363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53418304-d565-430e-87e5-bd87d6304cf7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_352b4e07-03fe-4fea-a2d5-6b8d9a04a363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a3f8ccda-6b12-424b-9822-732b037f7b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_71658bf8-6ed8-46b7-b1b7-91aaf8eab143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a3f8ccda-6b12-424b-9822-732b037f7b52" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_71658bf8-6ed8-46b7-b1b7-91aaf8eab143" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b9c57acf-71a3-4719-a7f7-684803f5fd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a3f8ccda-6b12-424b-9822-732b037f7b52" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b9c57acf-71a3-4719-a7f7-684803f5fd41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_083372d1-739d-4575-962f-131079d90669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_083372d1-739d-4575-962f-131079d90669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e33f4fe3-c1fa-4cc1-a19d-4bcc9a31f7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_ShareBasedCompensation_e33f4fe3-c1fa-4cc1-a19d-4bcc9a31f7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_be332d63-cd8d-4e1b-b25c-5ae6f59c172a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_be332d63-cd8d-4e1b-b25c-5ae6f59c172a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_eedd6773-c8cf-4cb5-bb95-9a4db97768cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_eedd6773-c8cf-4cb5-bb95-9a4db97768cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_580c0742-a2e4-4f2e-bece-c6bfcc1bba71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_580c0742-a2e4-4f2e-bece-c6bfcc1bba71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9a271134-bb2b-4348-915c-32e6fbb1273a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9a271134-bb2b-4348-915c-32e6fbb1273a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d102aa5e-c4a3-4411-888b-15fed3dbbe71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d102aa5e-c4a3-4411-888b-15fed3dbbe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f5bccdc4-90c2-4550-b527-80ae12e39e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f5bccdc4-90c2-4550-b527-80ae12e39e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8feee37d-41ab-4258-afbb-6fd5f9236d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_ProfitLoss_8feee37d-41ab-4258-afbb-6fd5f9236d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_fd8c60b3-7bed-4e63-beea-2b9bdaf477ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_fd8c60b3-7bed-4e63-beea-2b9bdaf477ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_d4299c2a-d78c-48a3-92c3-d42bd5b8ca92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_d4299c2a-d78c-48a3-92c3-d42bd5b8ca92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_beeabe2b-a669-4c37-b233-5322ecbf26fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_beeabe2b-a669-4c37-b233-5322ecbf26fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_bf47a17d-f221-4a13-bba6-bc40e2dd4fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_bf47a17d-f221-4a13-bba6-bc40e2dd4fd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_497bb8d0-7e66-4349-8fc0-5acdbe842cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_497bb8d0-7e66-4349-8fc0-5acdbe842cca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_7ce02a79-b969-430b-a73f-048093686a2b" xlink:href="bax-20220930.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_7ce02a79-b969-430b-a73f-048093686a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_fdbdf2f4-bf5e-4c3f-8e63-d950eee78947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be6e175f-8609-4c65-b880-f5ecfb3c1473" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_fdbdf2f4-bf5e-4c3f-8e63-d950eee78947" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff1a4df3-aa29-480f-ba3a-7f2c9a350035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_59fb035f-2521-4128-b717-fd5933ed6d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff1a4df3-aa29-480f-ba3a-7f2c9a350035" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_59fb035f-2521-4128-b717-fd5933ed6d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b95328f-22b3-4e15-82be-501488e1d85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff1a4df3-aa29-480f-ba3a-7f2c9a350035" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b95328f-22b3-4e15-82be-501488e1d85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c57b8c08-a668-4fab-a937-624735d75624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff1a4df3-aa29-480f-ba3a-7f2c9a350035" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c57b8c08-a668-4fab-a937-624735d75624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5d8d2560-1a62-455d-9f99-7a142905c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5d8d2560-1a62-455d-9f99-7a142905c3ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a9c399bf-6194-46d3-919d-ec18867065e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a9c399bf-6194-46d3-919d-ec18867065e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3a8a8872-aca1-4016-ac2f-315e2a0abbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3a8a8872-aca1-4016-ac2f-315e2a0abbaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_851b96b7-8154-4eb5-9fe9-e4d0769afc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_851b96b7-8154-4eb5-9fe9-e4d0769afc2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_7f8c4ac2-42a1-421f-a7f5-bc0d8bb2eb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_7f8c4ac2-42a1-421f-a7f5-bc0d8bb2eb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_89435732-2b01-4558-ac9c-6429148efc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_RepaymentsOfDebt_89435732-2b01-4558-ac9c-6429148efc76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e9c689d9-cdb6-4952-8283-78ca209d384a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e9c689d9-cdb6-4952-8283-78ca209d384a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e7e173fe-9fe4-4c06-9b72-738894bf304d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dce42f07-6d30-4a47-8f6e-2866f944358e" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e7e173fe-9fe4-4c06-9b72-738894bf304d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6178f9a2-e663-47b9-9340-1d5eb29fba75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_570f1267-0ce5-407f-84b3-399786834715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6178f9a2-e663-47b9-9340-1d5eb29fba75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_570f1267-0ce5-407f-84b3-399786834715" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaed3122-75b9-4108-a32e-279d5ef15098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6178f9a2-e663-47b9-9340-1d5eb29fba75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaed3122-75b9-4108-a32e-279d5ef15098" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c14a47d-382f-43db-8431-38a47cd5928a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6178f9a2-e663-47b9-9340-1d5eb29fba75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c14a47d-382f-43db-8431-38a47cd5928a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fadbd4ca-12f7-4e88-a3fe-db22fa118ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6178f9a2-e663-47b9-9340-1d5eb29fba75" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fadbd4ca-12f7-4e88-a3fe-db22fa118ed0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_796ccecd-4ff0-49e3-9204-e89de5968d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cb1ce151-1f08-4b13-93e7-7246c20277f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_796ccecd-4ff0-49e3-9204-e89de5968d53" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cb1ce151-1f08-4b13-93e7-7246c20277f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7fb81682-b92d-4ff1-8bb8-46773fa8668f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_796ccecd-4ff0-49e3-9204-e89de5968d53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7fb81682-b92d-4ff1-8bb8-46773fa8668f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_3435fceb-7d7d-46f5-8e3f-6ac9fe8dc3b8" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_3435fceb-7d7d-46f5-8e3f-6ac9fe8dc3b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_2a9318b2-b0e8-4ab8-9a40-a1c520c38c01" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_2a9318b2-b0e8-4ab8-9a40-a1c520c38c01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e91e0d41-dbc6-43f0-b8e1-d62ee82604d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e91e0d41-dbc6-43f0-b8e1-d62ee82604d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_08793593-4e9f-4e54-b175-103f5ea16c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_08793593-4e9f-4e54-b175-103f5ea16c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bafb914b-e8e9-4e08-a689-4ed7ad2eade7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bafb914b-e8e9-4e08-a689-4ed7ad2eade7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9082ddb3-49b3-441f-b7c7-f246e5026267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_Goodwill_9082ddb3-49b3-441f-b7c7-f246e5026267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e3a14570-e713-48c8-b419-2c023b17d0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e3a14570-e713-48c8-b419-2c023b17d0af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbfd1a62-e31c-439d-8512-57fa09235d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbfd1a62-e31c-439d-8512-57fa09235d90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fb34bd81-4f8d-4e9a-8378-f4a8c539f8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fb34bd81-4f8d-4e9a-8378-f4a8c539f8b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_109bc5e1-6012-419c-8e88-c4fd78053a7b" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_109bc5e1-6012-419c-8e88-c4fd78053a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d218249f-5a31-4a87-9dc5-f23f198d7dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d218249f-5a31-4a87-9dc5-f23f198d7dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_1a16a854-2b30-49c5-b7aa-9cdb08de05d9" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_1a16a854-2b30-49c5-b7aa-9cdb08de05d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_8574dd05-2094-49a4-b055-7ccbf11ae777" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_8574dd05-2094-49a4-b055-7ccbf11ae777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9d2e4605-8ac7-4eec-82af-c85947353e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9d2e4605-8ac7-4eec-82af-c85947353e25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baf9e6f5-80d6-4ea2-91d1-bf6381f925a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f8d3d343-3de9-461c-9776-d058f777c50f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_baf9e6f5-80d6-4ea2-91d1-bf6381f925a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f6adcfaa-545b-4c91-a781-e475d281cb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_59667576-ea56-423a-9be2-578194d2c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f6adcfaa-545b-4c91-a781-e475d281cb9d" xlink:to="loc_us-gaap_InventoryRawMaterials_59667576-ea56-423a-9be2-578194d2c0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_5199f254-5a27-43c4-9527-c6534da76dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f6adcfaa-545b-4c91-a781-e475d281cb9d" xlink:to="loc_us-gaap_InventoryWorkInProcess_5199f254-5a27-43c4-9527-c6534da76dbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_5a34ca03-521b-4211-9ca7-36833ea7031d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f6adcfaa-545b-4c91-a781-e475d281cb9d" xlink:to="loc_us-gaap_InventoryFinishedGoods_5a34ca03-521b-4211-9ca7-36833ea7031d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4fe808f5-af34-40b4-8fbf-8c99b6aca575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_bc24d9e9-6fc2-4f41-9e22-566a6e6f1e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4fe808f5-af34-40b4-8fbf-8c99b6aca575" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_bc24d9e9-6fc2-4f41-9e22-566a6e6f1e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_abbbffb7-6191-437e-8c66-9bedd4ad6ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4fe808f5-af34-40b4-8fbf-8c99b6aca575" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_abbbffb7-6191-437e-8c66-9bedd4ad6ec3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_c70c30a7-c64e-4370-92af-5a099a472fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7866217a-98ef-485e-ac3c-77c30ef578a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_c70c30a7-c64e-4370-92af-5a099a472fc1" xlink:to="loc_us-gaap_InterestExpense_7866217a-98ef-485e-ac3c-77c30ef578a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_418b172b-99b9-4761-80ab-d98f772a0a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_c70c30a7-c64e-4370-92af-5a099a472fc1" xlink:to="loc_us-gaap_InterestIncomeOperating_418b172b-99b9-4761-80ab-d98f772a0a4f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_fcb2aca3-205d-4556-9549-9c2d70ce796e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_fcb2aca3-205d-4556-9549-9c2d70ce796e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_9c97e918-1480-4cb8-928a-3ec9b7365ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_9c97e918-1480-4cb8-928a-3ec9b7365ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d6d98e4-7aa7-4caa-a124-d49216ae3052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d6d98e4-7aa7-4caa-a124-d49216ae3052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c0773304-8210-422d-ba64-2d4454c39559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c0773304-8210-422d-ba64-2d4454c39559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_db1d5ec0-ed6f-4e6a-b0ac-c1e20ed55c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_db1d5ec0-ed6f-4e6a-b0ac-c1e20ed55c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_33116fd9-3fc2-4505-ab6b-cc9908dfd89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_4231c553-8bab-4e0c-b09b-275e6702553c" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_33116fd9-3fc2-4505-ab6b-cc9908dfd89d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_df6907ae-f046-4369-9c96-cb1b4f207d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bdb356d1-d6ae-4384-b7b3-e7b054f79416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_df6907ae-f046-4369-9c96-cb1b4f207d18" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bdb356d1-d6ae-4384-b7b3-e7b054f79416" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_218fe372-8b40-4a51-91eb-0cd48f07b6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_df6907ae-f046-4369-9c96-cb1b4f207d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_218fe372-8b40-4a51-91eb-0cd48f07b6c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_daebb08c-2c37-469d-861c-396aa6412da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8d697f50-8da0-4e27-9353-3947d9854f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_daebb08c-2c37-469d-861c-396aa6412da3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8d697f50-8da0-4e27-9353-3947d9854f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b7dd8803-18a2-46d8-9ec4-517f9ac0a577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_daebb08c-2c37-469d-861c-396aa6412da3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b7dd8803-18a2-46d8-9ec4-517f9ac0a577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2da62d22-08bb-4eb6-a034-c29272b56f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a25cf6de-3df0-4ea6-b967-5c9e883a94ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2da62d22-08bb-4eb6-a034-c29272b56f1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a25cf6de-3df0-4ea6-b967-5c9e883a94ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_564e33ca-6850-4203-84fd-60fb424879fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2da62d22-08bb-4eb6-a034-c29272b56f1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_564e33ca-6850-4203-84fd-60fb424879fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESLeaseRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_74650a7a-afe0-4154-bfdb-1338157cb6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_bafdaf19-c03b-4604-b992-89c5cb2c5c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_74650a7a-afe0-4154-bfdb-1338157cb6a1" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_bafdaf19-c03b-4604-b992-89c5cb2c5c30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_374f0986-6756-4b61-a266-620fde133432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_74650a7a-afe0-4154-bfdb-1338157cb6a1" xlink:to="loc_us-gaap_VariableLeaseIncome_374f0986-6756-4b61-a266-620fde133432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_bc87411f-33ef-418c-b50b-b1d4cb76fea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_74650a7a-afe0-4154-bfdb-1338157cb6a1" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_bc87411f-33ef-418c-b50b-b1d4cb76fea1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_898a804f-d66a-4731-9294-cc806bef57c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_231e609d-28ce-4544-beeb-92ae79749524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_898a804f-d66a-4731-9294-cc806bef57c4" xlink:to="loc_us-gaap_RestructuringCharges_231e609d-28ce-4544-beeb-92ae79749524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_3f3ab894-3b30-4777-981d-302738b4e00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_898a804f-d66a-4731-9294-cc806bef57c4" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_3f3ab894-3b30-4777-981d-302738b4e00d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9bde2f74-1456-4146-aa94-8340e5904390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4a68c817-0198-4c4e-a7a5-08ad8424fd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9bde2f74-1456-4146-aa94-8340e5904390" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4a68c817-0198-4c4e-a7a5-08ad8424fd74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_93deb641-35fd-4da5-939b-9007b9a9a73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9bde2f74-1456-4146-aa94-8340e5904390" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_93deb641-35fd-4da5-939b-9007b9a9a73a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0b5ca751-fecc-4873-aa4e-b44c405533c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9bde2f74-1456-4146-aa94-8340e5904390" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0b5ca751-fecc-4873-aa4e-b44c405533c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f8f05a50-ebf0-4b4e-a794-91718be92497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9bde2f74-1456-4146-aa94-8340e5904390" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f8f05a50-ebf0-4b4e-a794-91718be92497" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dd126869-e483-42ca-9c65-835599714328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3b08e945-7985-4d14-b18d-6ec724bdcaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dd126869-e483-42ca-9c65-835599714328" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3b08e945-7985-4d14-b18d-6ec724bdcaa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e1c025d1-d518-4b99-be16-39ae0c7a45f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dd126869-e483-42ca-9c65-835599714328" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e1c025d1-d518-4b99-be16-39ae0c7a45f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_df3f5521-5f92-4933-8561-bbce5a5a1d43" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_cc493e4d-adee-4e2d-8d04-9e5f7e73f8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_df3f5521-5f92-4933-8561-bbce5a5a1d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_cc493e4d-adee-4e2d-8d04-9e5f7e73f8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_e08dd97b-e9be-46ed-841d-bc5b0fdfbf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_df3f5521-5f92-4933-8561-bbce5a5a1d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_e08dd97b-e9be-46ed-841d-bc5b0fdfbf51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_c671d414-f692-4d29-9b92-8d6cb06e4464" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_940bd7dd-2cc4-4b77-b701-25a31fc69490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_c671d414-f692-4d29-9b92-8d6cb06e4464" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_940bd7dd-2cc4-4b77-b701-25a31fc69490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_ae7a2bbb-ded6-4983-bf87-9bbaccfbb015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_c671d414-f692-4d29-9b92-8d6cb06e4464" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_ae7a2bbb-ded6-4983-bf87-9bbaccfbb015" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5d879fe6-bd41-4417-8413-b1dd3895158d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_a04f349f-fcca-4ec0-9dee-48b176ca989e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5d879fe6-bd41-4417-8413-b1dd3895158d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_a04f349f-fcca-4ec0-9dee-48b176ca989e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cf23448a-48de-4355-a4e3-8676e0297cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5d879fe6-bd41-4417-8413-b1dd3895158d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cf23448a-48de-4355-a4e3-8676e0297cf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec88cdba-da7a-4139-b694-c72a5d668f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5d879fe6-bd41-4417-8413-b1dd3895158d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec88cdba-da7a-4139-b694-c72a5d668f88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_14be6cb4-b799-4e88-85a4-ece9ee9b1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_76e38ef5-5716-4ef4-9a0b-6d52da45401c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_14be6cb4-b799-4e88-85a4-ece9ee9b1e33" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_76e38ef5-5716-4ef4-9a0b-6d52da45401c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1463335d-da43-4506-bafb-fafc22b4fb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_14be6cb4-b799-4e88-85a4-ece9ee9b1e33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1463335d-da43-4506-bafb-fafc22b4fb67" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bax-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20220930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended" id="i18320c9debb54a4ab430dd01a6ab20a1_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ef2fed95-0de9-4188-b171-d24eafe8d12b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentType_ef2fed95-0de9-4188-b171-d24eafe8d12b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4ba03b08-d0f8-40cb-8a84-57f873997fcd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentQuarterlyReport_4ba03b08-d0f8-40cb-8a84-57f873997fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e5b27de4-3fc5-4a94-b168-8c46857b69e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentPeriodEndDate_e5b27de4-3fc5-4a94-b168-8c46857b69e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_37c8f989-42ef-43c4-a61a-c5a2ac4e1d90" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentTransitionReport_37c8f989-42ef-43c4-a61a-c5a2ac4e1d90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6f3c8079-d63a-4385-8ee5-d3c82c60e361" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityFileNumber_6f3c8079-d63a-4385-8ee5-d3c82c60e361" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_80768720-5027-40b5-9eda-68d57d707422" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityRegistrantName_80768720-5027-40b5-9eda-68d57d707422" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c6c4d940-3e30-4437-a425-2db36e2b3dca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c6c4d940-3e30-4437-a425-2db36e2b3dca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0188b50f-d040-431d-bc95-d00f7297bff9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityTaxIdentificationNumber_0188b50f-d040-431d-bc95-d00f7297bff9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2ee7ed02-015f-426c-a52c-a3468ac1b39f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressAddressLine1_2ee7ed02-015f-426c-a52c-a3468ac1b39f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0b42b01c-c016-4a1a-8202-fb73adae1036" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressCityOrTown_0b42b01c-c016-4a1a-8202-fb73adae1036" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_67814071-c9d7-43f9-a780-128c50e61e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressStateOrProvince_67814071-c9d7-43f9-a780-128c50e61e22" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_34db3425-650a-4d37-addf-08d343c4a8fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressPostalZipCode_34db3425-650a-4d37-addf-08d343c4a8fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3a006500-0705-46c9-983b-e23e953721c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_CityAreaCode_3a006500-0705-46c9-983b-e23e953721c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5345f590-42e4-426a-b327-3545dd45e5dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_LocalPhoneNumber_5345f590-42e4-426a-b327-3545dd45e5dc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9b9408d8-134c-468e-bbd4-3d4de6db07e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_Security12bTitle_9b9408d8-134c-468e-bbd4-3d4de6db07e1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf20c362-376c-44bf-af00-e3cd3455aba4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_TradingSymbol_cf20c362-376c-44bf-af00-e3cd3455aba4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_98ed0d19-6f7c-4d62-93dc-dd1f9e85bda4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_SecurityExchangeName_98ed0d19-6f7c-4d62-93dc-dd1f9e85bda4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7074b274-f40a-4786-bb03-5289832e7a33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCurrentReportingStatus_7074b274-f40a-4786-bb03-5289832e7a33" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dbbe0ff3-d609-4c17-b69c-3eb6a4410a97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityInteractiveDataCurrent_dbbe0ff3-d609-4c17-b69c-3eb6a4410a97" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d6576131-6690-49a7-90cf-4f2654759055" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityFilerCategory_d6576131-6690-49a7-90cf-4f2654759055" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_69210710-e589-4180-96af-bb171373cb3b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntitySmallBusiness_69210710-e589-4180-96af-bb171373cb3b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_93c66744-46e5-4a96-8d7c-99de762c9a20" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityEmergingGrowthCompany_93c66744-46e5-4a96-8d7c-99de762c9a20" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cd1bd7cc-b2bc-446d-9793-728072ff4a54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityShellCompany_cd1bd7cc-b2bc-446d-9793-728072ff4a54" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_513a81b7-a5f1-49bf-9ab6-5c52f01a9af1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_513a81b7-a5f1-49bf-9ab6-5c52f01a9af1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0856611b-c460-41fc-b4b3-7bdee9252afb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_AmendmentFlag_0856611b-c460-41fc-b4b3-7bdee9252afb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9f3c87e4-686e-49c7-954a-9d54b95d7ad4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentFiscalYearFocus_9f3c87e4-686e-49c7-954a-9d54b95d7ad4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c286f33c-b18a-4804-9ffa-e6e593932b18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c286f33c-b18a-4804-9ffa-e6e593932b18" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_96660611-5b49-423e-94e7-09d66396802f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCentralIndexKey_96660611-5b49-423e-94e7-09d66396802f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a6559414-1faf-4776-b673-a6d0784d0e68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_CurrentFiscalYearEndDate_a6559414-1faf-4776-b673-a6d0784d0e68" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3ddd5cfb-cdb6-495c-884a-ab188754f4bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:to="loc_us-gaap_ClassOfStockDomain_3ddd5cfb-cdb6-495c-884a-ab188754f4bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:to="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_fc6b15e1-47e8-4ff8-9e7f-50cff3432f8b" xlink:href="bax-20220930.xsd#bax_CommonStock100PerValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_CommonStock100PerValueMember_fc6b15e1-47e8-4ff8-9e7f-50cff3432f8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_ef41751a-d74a-4ed7-888d-f55444f538a6" xlink:href="bax-20220930.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes04Due2024Member_ef41751a-d74a-4ed7-888d-f55444f538a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_a6d96800-a606-48ca-ad27-2e3b0cace847" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes13Due2025Member_a6d96800-a606-48ca-ad27-2e3b0cace847" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_90001d63-8104-439d-b886-65d59ce04bbc" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes13Due2029Member_90001d63-8104-439d-b886-65d59ce04bbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:to="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_24f275c6-c345-4801-a7bd-ca1dd486c14e_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:to="loc_dei_ExchangeDomain_24f275c6-c345-4801-a7bd-ca1dd486c14e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:to="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_654ab5cb-b8a3-4b3f-b838-a6b5063ef4de" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:to="loc_exch_XNYS_654ab5cb-b8a3-4b3f-b838-a6b5063ef4de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_e3fa9af0-272d-4158-aae1-34cd833c0cde" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:to="loc_exch_XCHI_e3fa9af0-272d-4158-aae1-34cd833c0cde" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended" id="id103c9ba91454068a1470ddb1e4c07d3_CondensedConsolidatedStatementsofChangesinEquityunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a41194de-7f86-4057-aa58-f6b2adbcb837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a41194de-7f86-4057-aa58-f6b2adbcb837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_08df425a-58dc-43f0-8a3e-6817f9cdd0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_08df425a-58dc-43f0-8a3e-6817f9cdd0f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_50df1d01-eb64-4fd7-9c58-a0b91eb8f68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_50df1d01-eb64-4fd7-9c58-a0b91eb8f68a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7fd669d0-aa62-45e4-83fd-001ee9fffb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_ProfitLoss_7fd669d0-aa62-45e4-83fd-001ee9fffb1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d0c51c6-7dc7-413d-b2d2-fa104fb6e81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d0c51c6-7dc7-413d-b2d2-fa104fb6e81d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_aec7e1f0-0df4-42cd-8683-792e6d7df65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_aec7e1f0-0df4-42cd-8683-792e6d7df65f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c074ce06-9e33-4f1c-84fc-65a895568977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c074ce06-9e33-4f1c-84fc-65a895568977" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7c2b26ff-8f18-4b34-beba-bcb5a1765eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7c2b26ff-8f18-4b34-beba-bcb5a1765eff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d0f78477-11f8-426f-a03d-f78cfba8c958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d0f78477-11f8-426f-a03d-f78cfba8c958" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1207e4bd-2714-4551-a4e9-f3a62ea84a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_DividendsCommonStock_1207e4bd-2714-4551-a4e9-f3a62ea84a99" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_fb40fe5a-ec9e-4b39-ba4e-3a17ea2e6b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_fb40fe5a-ec9e-4b39-ba4e-3a17ea2e6b95" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_880aa984-b2a3-444c-ad67-5f26cb10a349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5a2a52c-45dd-4895-8526-0254b51b7b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:to="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dee1873b-7c0a-465d-b949-41e038473799_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:to="loc_us-gaap_EquityComponentDomain_dee1873b-7c0a-465d-b949-41e038473799_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:to="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:to="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2625051d-4f78-491c-8014-f9a307cb1d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_CommonStockMember_2625051d-4f78-491c-8014-f9a307cb1d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_8cc2da0e-5227-48dc-9018-7ef786b0b7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_8cc2da0e-5227-48dc-9018-7ef786b0b7b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_152cb684-ad5b-49e6-a73c-6dcf1cf0dc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_152cb684-ad5b-49e6-a73c-6dcf1cf0dc56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_aeeef198-9fdb-4c12-a8a6-44a5281bd3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_RetainedEarningsMember_aeeef198-9fdb-4c12-a8a6-44a5281bd3af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f67f8f-e4cf-4067-9b0a-b15446d3a8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f67f8f-e4cf-4067-9b0a-b15446d3a8b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_51ab6851-60b5-42d5-a2c7-609c1b174e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_51ab6851-60b5-42d5-a2c7-609c1b174e06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="ie4e5e77b3d474db48daa649e55feae19_ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2982d483-2d7b-4dcc-8322-ab0a4fc9fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2982d483-2d7b-4dcc-8322-ab0a4fc9fbc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_97ed32a2-c4f2-43d2-b267-9a87a7134403" xlink:href="bax-20220930.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_97ed32a2-c4f2-43d2-b267-9a87a7134403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_c8ff9480-b134-4f97-9b38-85d5e6fe0369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_c8ff9480-b134-4f97-9b38-85d5e6fe0369" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7a5c9c38-9367-4f01-a856-3d3ae8d74652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7a5c9c38-9367-4f01-a856-3d3ae8d74652" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4fdfb7b2-1cbf-4975-85b5-7c32daf1a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4fdfb7b2-1cbf-4975-85b5-7c32daf1a7ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_843e8409-903d-4438-bb4c-559ab6f00cbd" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:to="loc_bax_HillromMember_843e8409-903d-4438-bb4c-559ab6f00cbd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended" id="iea201986f2ac4cfda2593813594dde5c_ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6c747a28-3317-49af-8bec-7ca9650949eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6c747a28-3317-49af-8bec-7ca9650949eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_27fbe4a6-2aba-4b88-a027-c12e9d81135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_27fbe4a6-2aba-4b88-a027-c12e9d81135c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6e6c5c5d-32c9-484a-96c7-ee0762cae097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6e6c5c5d-32c9-484a-96c7-ee0762cae097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_d5faf281-6a04-4b3c-9a1e-52eda34b47cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_d5faf281-6a04-4b3c-9a1e-52eda34b47cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5f8a0869-9c87-4110-8c30-1a8821c0b403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5f8a0869-9c87-4110-8c30-1a8821c0b403" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f75ee2-eeea-4fd0-879e-35f4850ae694_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2f75ee2-eeea-4fd0-879e-35f4850ae694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_245b2313-d666-4f4e-8be1-61db9f3aac0e" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:to="loc_bax_HillromMember_245b2313-d666-4f4e-8be1-61db9f3aac0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended" id="i94a7a26d7ba44f889ef34eb706e9be21_ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_31c93c47-d941-4b83-af48-ac34ad81bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_31c93c47-d941-4b83-af48-ac34ad81bf36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_41b9d16b-6e14-4815-b4fb-a3c4061de954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_41b9d16b-6e14-4815-b4fb-a3c4061de954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4cab86a8-8b41-4c20-8cbd-413c0f470ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4cab86a8-8b41-4c20-8cbd-413c0f470ddf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0f2db462-c7d8-4e6a-b8b4-11c0dae548ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0f2db462-c7d8-4e6a-b8b4-11c0dae548ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b542134d-b966-4dfb-b839-32c9abd4dbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b542134d-b966-4dfb-b839-32c9abd4dbb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4b5377e1-d71e-4f18-a769-e68e1099798c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_Goodwill_4b5377e1-d71e-4f18-a769-e68e1099798c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7a018bba-bfb1-47bc-bfd6-bb8edf57c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7a018bba-bfb1-47bc-bfd6-bb8edf57c726" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_88fb3945-be80-4719-a207-c6fcb69966aa" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_88fb3945-be80-4719-a207-c6fcb69966aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1463e48e-5453-4ed3-9c5e-05d07dfa4294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1463e48e-5453-4ed3-9c5e-05d07dfa4294" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_05c518e6-705e-4779-b156-33d7fc94a20e" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_05c518e6-705e-4779-b156-33d7fc94a20e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_15e3f11e-ecea-4c8a-9536-ee37fe2aa7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_15e3f11e-ecea-4c8a-9536-ee37fe2aa7a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_e5824a33-c84f-48e5-8e9c-27a45663e0f8" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_e5824a33-c84f-48e5-8e9c-27a45663e0f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_24531d6f-7cb2-4321-b428-53fc15f397dd" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_24531d6f-7cb2-4321-b428-53fc15f397dd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_97e837c4-83d5-44c6-b62c-079d00c68c33" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_97e837c4-83d5-44c6-b62c-079d00c68c33" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3a89dfa6-99af-4528-9dbf-e0fcf5f9e697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3a89dfa6-99af-4528-9dbf-e0fcf5f9e697" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa548e67-fc8b-4083-bfab-d086a051f817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa548e67-fc8b-4083-bfab-d086a051f817" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216eff8e-9a64-436b-aa8b-fcc4e36b7a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_216eff8e-9a64-436b-aa8b-fcc4e36b7a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_4fea3ab9-daf8-4821-a8a6-cbe688cad08e" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:to="loc_bax_HillromMember_4fea3ab9-daf8-4821-a8a6-cbe688cad08e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="extended" id="idc85c1b643244843a73f168d4bcf93b6_ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d4f4ad5-65d3-4829-8441-b580ea3796bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d4f4ad5-65d3-4829-8441-b580ea3796bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d53dcb7c-1c99-4a01-b57f-3b28a7398232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d53dcb7c-1c99-4a01-b57f-3b28a7398232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ProceedsFromDivestitureOfProductRights_595754bd-a66a-4ec6-af89-e86e984138d6" xlink:href="bax-20220930.xsd#bax_ProceedsFromDivestitureOfProductRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_bax_ProceedsFromDivestitureOfProductRights_595754bd-a66a-4ec6-af89-e86e984138d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement_062a0d35-6833-43b9-b1b8-e1304bc338dc" xlink:href="bax-20220930.xsd#bax_GainLossOnDispositionOfProductDivestitureArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement_062a0d35-6833-43b9-b1b8-e1304bc338dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_dc2cf336-98df-4599-8730-8b7d22b2d129_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:to="loc_us-gaap_AssetAcquisitionDomain_dc2cf336-98df-4599-8730-8b7d22b2d129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:to="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_35e5a4ac-673b-43e9-aaa2-82f1fee93f19" xlink:href="bax-20220930.xsd#bax_ZosynMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:to="loc_bax_ZosynMember_35e5a4ac-673b-43e9-aaa2-82f1fee93f19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ead7f6-9384-48ee-b12c-05b7d75dddd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ead7f6-9384-48ee-b12c-05b7d75dddd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9935187c-7b87-4759-8348-57caadb07220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9935187c-7b87-4759-8348-57caadb07220" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_74d0acfd-0e30-4d8f-a599-152c194952ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:to="loc_us-gaap_LicensingAgreementsMember_74d0acfd-0e30-4d8f-a599-152c194952ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91686043-d87e-4eae-a6f0-5d748d8c179d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91686043-d87e-4eae-a6f0-5d748d8c179d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CelerityMember_bbb0fe82-63cf-4afe-a024-9a3c770f73ad" xlink:href="bax-20220930.xsd#bax_CelerityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:to="loc_bax_CelerityMember_bbb0fe82-63cf-4afe-a024-9a3c770f73ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended" id="ibd37ba824b2e4ba78dd1359e16acf3eb_SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1045319a-9725-4a8a-9d5f-91a47b5f8299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1045319a-9725-4a8a-9d5f-91a47b5f8299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_755189c1-8c40-4cf5-b264-4410cd27c988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_755189c1-8c40-4cf5-b264-4410cd27c988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_435111be-06d3-46f9-b463-ed558c6b51a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_435111be-06d3-46f9-b463-ed558c6b51a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6ae5d08-b009-4303-98f8-39e70e955eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6ae5d08-b009-4303-98f8-39e70e955eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b201116d-0c96-47d9-a985-c360c0d0a996_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b201116d-0c96-47d9-a985-c360c0d0a996_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_d889e1ec-969f-4f73-918c-1389f053c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_d889e1ec-969f-4f73-918c-1389f053c72a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_b2eb0b8d-f283-4f4b-8b99-1dd1c6f56a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_GeographicBasisCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:to="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_b2eb0b8d-f283-4f4b-8b99-1dd1c6f56a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a524029b-987b-47cc-b415-6cf43ce1fdc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a524029b-987b-47cc-b415-6cf43ce1fdc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_1b4b9528-4532-49bc-9c6f-030db4f0c57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_1b4b9528-4532-49bc-9c6f-030db4f0c57a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended" id="ib1c0a374c68a48448adece3b4c3b8076_GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:to="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6ebd173d-33cb-4a45-abb1-5ae047427798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_Goodwill_6ebd173d-33cb-4a45-abb1-5ae047427798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c1dfe359-979a-43c9-b4af-556e05963a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c1dfe359-979a-43c9-b4af-556e05963a9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9e0515fa-da56-4849-8cdc-c0487e227458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9e0515fa-da56-4849-8cdc-c0487e227458" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c18e91cd-4501-4b0a-9081-996922fb5ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c18e91cd-4501-4b0a-9081-996922fb5ab4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c5d6fdea-6ba3-4f33-b747-9cf3678f7202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:to="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_25698fd6-b2a2-4c7d-acbb-40663570b058_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:to="loc_srt_SegmentGeographicalDomain_25698fd6-b2a2-4c7d-acbb-40663570b058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:to="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_c9bc6b2b-e7e8-4d0a-ad3c-840b3c5380c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_srt_AmericasMember_c9bc6b2b-e7e8-4d0a-ad3c-840b3c5380c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_24bf9398-0c54-4ac2-9840-f3385cc363a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_us-gaap_EMEAMember_24bf9398-0c54-4ac2-9840-f3385cc363a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e7f67e6d-8da9-472c-8357-8ade33342e4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_srt_AsiaPacificMember_e7f67e6d-8da9-472c-8357-8ade33342e4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_9748e1b7-96f4-4159-8c0d-a2664474617b" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_bax_HillromMember_9748e1b7-96f4-4159-8c0d-a2664474617b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="extended" id="i114fab4e36fc4397a26b82941a0802fc_GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bfbe2e69-6ea8-461d-bf68-44e1c5238829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_Goodwill_bfbe2e69-6ea8-461d-bf68-44e1c5238829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b95fc440-97fb-4e20-b3b6-ee543d9f813a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b95fc440-97fb-4e20-b3b6-ee543d9f813a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_65bdfbd3-f337-4de3-b6b8-980464ac3a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_65bdfbd3-f337-4de3-b6b8-980464ac3a0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_16867b73-75a2-4037-88a7-35c2d8fe9685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_16867b73-75a2-4037-88a7-35c2d8fe9685" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_17deb471-fe01-4fcf-98f0-ec4c58ddb159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_17deb471-fe01-4fcf-98f0-ec4c58ddb159" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3360e6f5-b4d0-4bd5-961a-1d0da26a5754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3360e6f5-b4d0-4bd5-961a-1d0da26a5754" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8fd89f9-6bf9-4e5a-babe-df79feb5d918_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8fd89f9-6bf9-4e5a-babe-df79feb5d918_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_b3a39155-08ae-417a-b4d1-5dcef5c3963b" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:to="loc_bax_HillromMember_b3a39155-08ae-417a-b4d1-5dcef5c3963b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_229ddd96-c868-48e1-a983-e3c369504316_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:to="loc_us-gaap_ReportingUnitDomain_229ddd96-c868-48e1-a983-e3c369504316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:to="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsReportingUnitMember_592666f9-42bb-40bc-b253-ea6f56203333" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_PatientSupportSystemsReportingUnitMember_592666f9-42bb-40bc-b253-ea6f56203333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareReportingUnitMember_adfd7eb9-60ed-46c6-8398-b42cca5b6f3a" xlink:href="bax-20220930.xsd#bax_FrontLineCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_FrontLineCareReportingUnitMember_adfd7eb9-60ed-46c6-8398-b42cca5b6f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsReportingUnitMember_dc26f4b7-fa62-4092-832f-0abee9cf5672" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_SurgicalSolutionsReportingUnitMember_dc26f4b7-fa62-4092-832f-0abee9cf5672" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_74811172-dc4c-4539-b236-2a017c496cde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_74811172-dc4c-4539-b236-2a017c496cde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c77c04e5-2130-4e34-857b-b20c36c7af4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:to="loc_us-gaap_TradeNamesMember_c77c04e5-2130-4e34-857b-b20c36c7af4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended" id="i9e180558bfc642738eb45d9516cf7bf6_GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_afe980cf-ca93-4bfa-9636-d5390148907b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_afe980cf-ca93-4bfa-9636-d5390148907b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9a57e0e8-7285-4519-b600-bc73fa336cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9a57e0e8-7285-4519-b600-bc73fa336cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1d86580c-8800-407a-8ac9-b987ed2cf1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1d86580c-8800-407a-8ac9-b987ed2cf1ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_704743e2-a7cb-4b7a-826f-2b22d2dd548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_704743e2-a7cb-4b7a-826f-2b22d2dd548d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5128a88e-64c2-45b6-8f16-7ff265d4d865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5128a88e-64c2-45b6-8f16-7ff265d4d865" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f60487f-1845-4b49-9295-432a37d6d254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f60487f-1845-4b49-9295-432a37d6d254" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72dc7828-0ce3-4009-8d22-17c7d1c63d5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_72dc7828-0ce3-4009-8d22-17c7d1c63d5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1e6c339c-4f34-4648-9141-4a7584d7fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1e6c339c-4f34-4648-9141-4a7584d7fb64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_5cfab835-e126-4a3f-98d4-57c041a3346b" xlink:href="bax-20220930.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_5cfab835-e126-4a3f-98d4-57c041a3346b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_6547c4da-c7ea-46b4-b3b5-f11621b8edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_6547c4da-c7ea-46b4-b3b5-f11621b8edfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b6fdfdef-4502-412e-b706-ce6a634b988d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b6fdfdef-4502-412e-b706-ce6a634b988d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_93d2a189-c250-4d9f-ae1f-062d521a7f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:to="loc_us-gaap_TradeNamesMember_93d2a189-c250-4d9f-ae1f-062d521a7f61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_2dad93c2-2640-46a8-a6ce-3a7b5ef25c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_2dad93c2-2640-46a8-a6ce-3a7b5ef25c20" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended" id="if77073e144164d31ac52a9677b4f1df9_FINANCINGARRANGEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_bb266fe4-d483-4439-b5a8-49d77020ee10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_RepaymentsOfDebt_bb266fe4-d483-4439-b5a8-49d77020ee10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f0bcc4d2-d2d6-4ede-8b2f-f9595a5563c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f0bcc4d2-d2d6-4ede-8b2f-f9595a5563c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_787788a3-cdff-4f9e-a138-ca192016a4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LongTermDebtTerm_787788a3-cdff-4f9e-a138-ca192016a4f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1cc9ac24-5b55-4d15-b96b-fdbae2fc80f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1cc9ac24-5b55-4d15-b96b-fdbae2fc80f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7b911c7e-d609-4b31-a049-86269777418b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7b911c7e-d609-4b31-a049-86269777418b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5b5d2c6a-41f3-47f9-8030-9b1ce621a7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LineOfCredit_5b5d2c6a-41f3-47f9-8030-9b1ce621a7ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_14faf498-95fe-4a74-b6fc-24cd8ff858bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_14faf498-95fe-4a74-b6fc-24cd8ff858bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_54bd3e47-e086-4313-a2e1-860b22970868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_54bd3e47-e086-4313-a2e1-860b22970868" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_f282da7c-d202-47cf-a39a-37397b98a73f" xlink:href="bax-20220930.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_bax_OriginalWeightedAverageTerm_f282da7c-d202-47cf-a39a-37397b98a73f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_40f34091-a6ae-4fc2-885a-91de318e79ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_40f34091-a6ae-4fc2-885a-91de318e79ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember_7c5a5a5c-e4a0-4d62-ac78-d7c0ae739b81" xlink:href="bax-20220930.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_SeniorThreeYearTermLoanMember_7c5a5a5c-e4a0-4d62-ac78-d7c0ae739b81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember_f62e710f-342d-4bb2-bb5d-72b11bf5f89b" xlink:href="bax-20220930.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_SeniorFiveYearTermLoanMember_f62e710f-342d-4bb2-bb5d-72b11bf5f89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A24SeniorNotesDue2022Member_9074d759-f0ad-4612-ab59-6739cae6820a" xlink:href="bax-20220930.xsd#bax_A24SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A24SeniorNotesDue2022Member_9074d759-f0ad-4612-ab59-6739cae6820a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A0868SeniorNotesDueMay2023Member_8e6fca6d-1754-4520-9837-73c78f8b336d" xlink:href="bax-20220930.xsd#bax_A0868SeniorNotesDueMay2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A0868SeniorNotesDueMay2023Member_8e6fca6d-1754-4520-9837-73c78f8b336d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1322SeniorNotesDue2024Member_0469415f-868a-4cf2-ab46-171548abcfd6" xlink:href="bax-20220930.xsd#bax_A1322SeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A1322SeniorNotesDue2024Member_0469415f-868a-4cf2-ab46-171548abcfd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1915DebenturesDue2027Member_bdd066c9-e922-44a9-ad65-aaa93608a977" xlink:href="bax-20220930.xsd#bax_A1915DebenturesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A1915DebenturesDue2027Member_bdd066c9-e922-44a9-ad65-aaa93608a977" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2272SeniorNotesDue2028Member_90e0bbae-7f44-4525-8299-07166a86a30f" xlink:href="bax-20220930.xsd#bax_A2272SeniorNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A2272SeniorNotesDue2028Member_90e0bbae-7f44-4525-8299-07166a86a30f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2539NotesDue2032Member_a736575e-556f-4fe4-b590-f935e0d3e419" xlink:href="bax-20220930.xsd#bax_A2539NotesDue2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A2539NotesDue2032Member_a736575e-556f-4fe4-b590-f935e0d3e419" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A3132SeniorNotesDue2051Member_0cb1ed51-bde0-482a-87f0-4698b1e02c44" xlink:href="bax-20220930.xsd#bax_A3132SeniorNotesDue2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A3132SeniorNotesDue2051Member_0cb1ed51-bde0-482a-87f0-4698b1e02c44" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2023Member_40b17e34-e315-4d1d-8d18-1aabbf18d265" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_FloatingRateNotesDue2023Member_40b17e34-e315-4d1d-8d18-1aabbf18d265" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2024Member_da118bca-d4ae-47f2-bae6-28781f8a8afa" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_FloatingRateNotesDue2024Member_da118bca-d4ae-47f2-bae6-28781f8a8afa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4a49312-4956-4d15-b46f-f77a6b56fe06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4a49312-4956-4d15-b46f-f77a6b56fe06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_b0fa83f3-be5c-4638-b2d6-4cacd1798b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:to="loc_us-gaap_SeniorNotesMember_b0fa83f3-be5c-4638-b2d6-4cacd1798b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1db045f2-1cda-4889-9466-68c44c5b3e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:to="loc_us-gaap_CommercialPaperMember_1db045f2-1cda-4889-9466-68c44c5b3e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_90766080-f2ca-406a-9446-fc48a996ae7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:to="loc_us-gaap_CreditFacilityDomain_90766080-f2ca-406a-9446-fc48a996ae7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:to="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d6fd4f6a-647a-486b-a598-ac10b5aa32ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d6fd4f6a-647a-486b-a598-ac10b5aa32ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i49717a79491d4405b8df4175e0e2ff29_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_4f846f35-9556-4ce8-a845-54d7e105c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationReserve_4f846f35-9556-4ce8-a845-54d7e105c64b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_eb590b58-6538-49b4-a237-5c8a04f8732a" xlink:href="bax-20220930.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_bax_SiteContingencyNumberOfSites_eb590b58-6538-49b4-a237-5c8a04f8732a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_408e7cb8-b53a-43a7-8224-dd02f6050ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_408e7cb8-b53a-43a7-8224-dd02f6050ddf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9c06e898-2d3f-4ec9-b5f5-5ad3308d22d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9c06e898-2d3f-4ec9-b5f5-5ad3308d22d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_00e5c704-dc10-425e-ad48-d7a09c9a28b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationSettlementExpense_00e5c704-dc10-425e-ad48-d7a09c9a28b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_247d2914-f21e-4eba-a30a-ee5dd6c225bb" xlink:href="bax-20220930.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_247d2914-f21e-4eba-a30a-ee5dd6c225bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_e73bf653-6bd4-4d45-8bb4-aad301bb0e97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_e73bf653-6bd4-4d45-8bb4-aad301bb0e97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_bb0cb25d-a92c-446c-a618-1d831a10b1e3" xlink:href="bax-20220930.xsd#bax_SuperfundSitesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:to="loc_bax_SuperfundSitesMember_bb0cb25d-a92c-446c-a618-1d831a10b1e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_caf2b72e-89e2-45c3-9d8c-5abfed0824bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_caf2b72e-89e2-45c3-9d8c-5abfed0824bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_248623c0-32bc-458d-aed8-e816a71485a5" xlink:href="bax-20220930.xsd#bax_EnviromentalCleanUpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:to="loc_bax_EnviromentalCleanUpMember_248623c0-32bc-458d-aed8-e816a71485a5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="extended" id="ie56fbf7b0a674e968b375630b1249025_ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_085b9604-37e6-41fc-8404-741277d461e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_085b9604-37e6-41fc-8404-741277d461e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88c9c43a-1ad2-4c18-bfe2-ad2c1012898f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88c9c43a-1ad2-4c18-bfe2-ad2c1012898f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_28d98a8c-05b6-4df4-a638-65a7f02b6a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_28d98a8c-05b6-4df4-a638-65a7f02b6a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ac9f32d-a3c1-4ef5-99c9-35ecbd8a8e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ac9f32d-a3c1-4ef5-99c9-35ecbd8a8e0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b2e2cb9-6100-4d5e-87b2-e9431f070f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0362cd92-e692-439b-9209-fefdc1c5c2e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:to="loc_us-gaap_EquityComponentDomain_0362cd92-e692-439b-9209-fefdc1c5c2e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:to="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_68f4dc60-303b-4e6c-aa6b-6305e8f3c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_68f4dc60-303b-4e6c-aa6b-6305e8f3c80e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_39d1b5c9-73d2-436f-9962-8b1384c40367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_39d1b5c9-73d2-436f-9962-8b1384c40367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_c0ea4ece-a839-4aa3-875e-99d8de110211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_c0ea4ece-a839-4aa3-875e-99d8de110211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c841844f-91dd-42b3-8ed1-5504f0f1f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c841844f-91dd-42b3-8ed1-5504f0f1f3f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c2150079-fabd-4dbb-8488-156039647e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c2150079-fabd-4dbb-8488-156039647e54" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended" id="i23866cb64b5a4c63b7ad35ad5df7e6dc_ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_44d0d67f-857d-499d-9536-a4b59c307e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_44d0d67f-857d-499d-9536-a4b59c307e25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1e4df5fc-ef02-4035-99c6-a936a6a828d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1e4df5fc-ef02-4035-99c6-a936a6a828d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2828c8af-30e9-4ee9-b9c2-5b7dc7dcba53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2828c8af-30e9-4ee9-b9c2-5b7dc7dcba53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5bb6f0b9-f703-4077-b014-a0561c561bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5bb6f0b9-f703-4077-b014-a0561c561bbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f82633ca-a5f6-407a-8f74-6eb1520c8c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f82633ca-a5f6-407a-8f74-6eb1520c8c5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2555f809-b16d-4c2c-b578-e44e5d116381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_NetIncomeLoss_2555f809-b16d-4c2c-b578-e44e5d116381" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1db14c62-d879-4e71-b68e-09bf30db6f0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1db14c62-d879-4e71-b68e-09bf30db6f0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_74997078-da6f-43e9-95a7-6a14dd655a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_74997078-da6f-43e9-95a7-6a14dd655a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_79daf9dd-8cb4-469a-b9e4-bcb4f778637b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:to="loc_us-gaap_EquityComponentDomain_79daf9dd-8cb4-469a-b9e4-bcb4f778637b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:to="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_06c2d20f-6a1c-4f43-9efb-df6da58e2b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_06c2d20f-6a1c-4f43-9efb-df6da58e2b39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_666f0108-b8b2-4017-a960-c839caf90ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_666f0108-b8b2-4017-a960-c839caf90ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_95bba750-1b12-4285-8d0d-254ede942bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_95bba750-1b12-4285-8d0d-254ede942bc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4e527278-0ac5-4cda-9323-59a96563dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4e527278-0ac5-4cda-9323-59a96563dfda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_5b091a0f-34e6-489b-b2a5-fd15e9d4ded4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:to="loc_us-gaap_InterestRateContractMember_5b091a0f-34e6-489b-b2a5-fd15e9d4ded4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended" id="i2945c676f2b143c0a394efb2e2469491_REVENUESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:href="bax-20220930.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:href="bax-20220930.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_bdb9a3eb-1fec-4c3b-bb95-0008594cb82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_bdb9a3eb-1fec-4c3b-bb95-0008594cb82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ee9a782-83b7-4f03-8c4b-48f6e0268be2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:to="loc_srt_RangeMember_1ee9a782-83b7-4f03-8c4b-48f6e0268be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:to="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_27f89abb-4aba-4545-8360-97bd24685233_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_27f89abb-4aba-4545-8360-97bd24685233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:href="bax-20220930.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended" id="i593481fba85a48daaec23aa1a8880157_REVENUESAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:href="bax-20220930.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:href="bax-20220930.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ee9a782-83b7-4f03-8c4b-48f6e0268be2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:to="loc_srt_RangeMember_1ee9a782-83b7-4f03-8c4b-48f6e0268be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:to="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_27f89abb-4aba-4545-8360-97bd24685233_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_27f89abb-4aba-4545-8360-97bd24685233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:href="bax-20220930.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended" id="ie23d32f79f95498284e336ba249775d2_REVENUESContractAssetsandContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_cd4ffd46-1979-4283-9076-575379a855d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_cd4ffd46-1979-4283-9076-575379a855d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_20996c02-4ec6-4679-8fcb-50b875cd7000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_20996c02-4ec6-4679-8fcb-50b875cd7000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:href="bax-20220930.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_431c448f-baed-4835-8b52-7c2a3194cbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_bfbf8310-cb23-4d9c-8c39-804e06c58d20" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_bfbf8310-cb23-4d9c-8c39-804e06c58d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_66a2a338-cd0b-45df-88c0-8ffb22e92b46" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_66a2a338-cd0b-45df-88c0-8ffb22e92b46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_7cafddb4-7412-4748-8cdd-cdf58be550f3" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_7cafddb4-7412-4748-8cdd-cdf58be550f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_86bd2e59-a8ec-46dc-86ac-986acd244bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_2d863413-8b66-47cc-8cce-eadb8cda40ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_2d863413-8b66-47cc-8cce-eadb8cda40ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_1f7d8cbc-1395-47c7-b94b-36ed338c46d6" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_ManufacturingArrangementsMember_1f7d8cbc-1395-47c7-b94b-36ed338c46d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_6f9318b0-f333-44fc-ae1c-3be4e3ed50f3" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_SoftwareArrangementsMember_6f9318b0-f333-44fc-ae1c-3be4e3ed50f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_c64eaaac-4467-4f25-905f-0157c7e7fc2b" xlink:href="bax-20220930.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_c64eaaac-4467-4f25-905f-0157c7e7fc2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c066e38a-95e9-4419-874b-0911f419bc83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c066e38a-95e9-4419-874b-0911f419bc83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0886adea-f2f5-433e-b1d0-7629258b13e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0886adea-f2f5-433e-b1d0-7629258b13e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b451a2d6-121b-4e3a-9580-e69a981510e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b451a2d6-121b-4e3a-9580-e69a981510e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_d71cba96-1d94-4611-ac9c-75cc26decf30" xlink:href="bax-20220930.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_d71cba96-1d94-4611-ac9c-75cc26decf30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_785b2d52-2506-4e9e-9d04-605b6ded8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_785b2d52-2506-4e9e-9d04-605b6ded8f09" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended" id="ic4ff5e7774734bf2ac16aee6379062e3_REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac0af49b-57e3-43b3-b12f-ad7d78614c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac0af49b-57e3-43b3-b12f-ad7d78614c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:to="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9c92d2e-996a-4821-b036-00e08c6fe877_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:to="loc_srt_ProductsAndServicesDomain_a9c92d2e-996a-4821-b036-00e08c6fe877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:to="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_fad2fe8c-6c3a-4d2b-8d96-e20623224648" xlink:href="bax-20220930.xsd#bax_RenalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_RenalMember_fad2fe8c-6c3a-4d2b-8d96-e20623224648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_3f468ee5-9189-4fe6-966e-96b24b9a8e69" xlink:href="bax-20220930.xsd#bax_MedicationDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_MedicationDeliveryMember_3f468ee5-9189-4fe6-966e-96b24b9a8e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_3a8ce107-2166-4f04-a989-70e39ee0f627" xlink:href="bax-20220930.xsd#bax_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_PharmaceuticalsMember_3a8ce107-2166-4f04-a989-70e39ee0f627" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_224edf8a-e274-4eaa-a970-e2a089cdfe11" xlink:href="bax-20220930.xsd#bax_ClinicalNutritionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_ClinicalNutritionMember_224edf8a-e274-4eaa-a970-e2a089cdfe11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_6e883828-3e3a-43d9-aaf7-891400354120" xlink:href="bax-20220930.xsd#bax_AdvancedSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_AdvancedSurgeryMember_6e883828-3e3a-43d9-aaf7-891400354120" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_ade1f047-cbfe-4595-a3cd-1565870d30fd" xlink:href="bax-20220930.xsd#bax_AcuteTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_AcuteTherapiesMember_ade1f047-cbfe-4595-a3cd-1565870d30fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_e1f0e1b5-3e47-409c-abcc-072f2df13ce7" xlink:href="bax-20220930.xsd#bax_BioPharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_BioPharmaSolutionsMember_e1f0e1b5-3e47-409c-abcc-072f2df13ce7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_d7ee817d-5260-4f64-8c9b-6178dcfe8e49" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_PatientSupportSystemsMember_d7ee817d-5260-4f64-8c9b-6178dcfe8e49" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_82cd02b0-f0d8-4aaa-9e2c-5f35bbeea4fb" xlink:href="bax-20220930.xsd#bax_FrontLineCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_FrontLineCareMember_82cd02b0-f0d8-4aaa-9e2c-5f35bbeea4fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_e59be87b-257d-42f8-96a5-023d7029c488" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_SurgicalSolutionsMember_e59be87b-257d-42f8-96a5-023d7029c488" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_a108fbd9-e161-453d-8357-a28112b2ac1a" xlink:href="bax-20220930.xsd#bax_OtherProductOrServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_OtherProductOrServicesMember_a108fbd9-e161-453d-8357-a28112b2ac1a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:to="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fceaf144-0e7b-42e8-a3f1-695420913b74_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:to="loc_srt_SegmentGeographicalDomain_fceaf144-0e7b-42e8-a3f1-695420913b74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:to="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_324e9151-6601-409c-af28-f734946ef52f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:to="loc_country_US_324e9151-6601-409c-af28-f734946ef52f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cf042600-0525-4eaf-9408-0c0aa96f05be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:to="loc_us-gaap_NonUsMember_cf042600-0525-4eaf-9408-0c0aa96f05be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended" id="ib5ccfe6c390440bd85b2235117ab6b12_BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_433fe207-22d9-4ca7-9596-4d40ececeec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringCharges_433fe207-22d9-4ca7-9596-4d40ececeec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_885838a9-a998-4180-8bf3-82c24b442d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_885838a9-a998-4180-8bf3-82c24b442d0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_94df4cc2-caf6-4fe4-af17-b0788522ce38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringCosts_94df4cc2-caf6-4fe4-af17-b0788522ce38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:to="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9f96913e-6066-4929-9a3e-21a5e1e60a85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:to="loc_us-gaap_RestructuringPlanDomain_9f96913e-6066-4929-9a3e-21a5e1e60a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:to="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_f2351cf1-fd80-4d00-84b5-7800a1122f80" xlink:href="bax-20220930.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:to="loc_bax_BusinessOptimizationProgramsMember_f2351cf1-fd80-4d00-84b5-7800a1122f80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended" id="i9e03af5141af4c8d90b2d3797ec999ca_BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c0f51c19-adb4-42bf-b0a4-6256fd801b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:to="loc_us-gaap_RestructuringCharges_c0f51c19-adb4-42bf-b0a4-6256fd801b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5addae6d-de61-4213-9320-2c0b8c4adde6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5addae6d-de61-4213-9320-2c0b8c4adde6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_522ce68c-5547-4a46-bb7d-5990e0833f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_us-gaap_EmployeeSeveranceMember_522ce68c-5547-4a46-bb7d-5990e0833f38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_ff1a6a38-ec37-4de6-a27f-12f1d95b9391" xlink:href="bax-20220930.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_ff1a6a38-ec37-4de6-a27f-12f1d95b9391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_55d001f5-84c6-4cc6-8f79-3765e93d9802" xlink:href="bax-20220930.xsd#bax_AssetImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_bax_AssetImpairmentMember_55d001f5-84c6-4cc6-8f79-3765e93d9802" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bac2f98a-7f85-4485-a38d-b5986118208e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bac2f98a-7f85-4485-a38d-b5986118208e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bd972d05-42d9-4a0e-a172-306fc0b3385d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_CostOfSalesMember_bd972d05-42d9-4a0e-a172-306fc0b3385d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5f639ba3-458a-4c83-8a20-43b4c0f0e8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5f639ba3-458a-4c83-8a20-43b4c0f0e8b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_92819c5b-e114-41e9-a351-daa146f40f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_92819c5b-e114-41e9-a351-daa146f40f4f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended" id="i46b82dbb155944d68d0639d915083104_BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:to="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_477e2b94-5d8a-40ad-a1ae-7218785a9648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserve_477e2b94-5d8a-40ad-a1ae-7218785a9648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_969ce326-5193-4964-90bd-5f63718f43c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringCharges_969ce326-5193-4964-90bd-5f63718f43c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_01f3406e-7e12-454a-9e68-ea06d3f23794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_PaymentsForRestructuring_01f3406e-7e12-454a-9e68-ea06d3f23794" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1d898ff7-2536-4c91-a632-94b917a5c696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1d898ff7-2536-4c91-a632-94b917a5c696" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_6c036c61-63a2-4189-abc2-01acecd83efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_6c036c61-63a2-4189-abc2-01acecd83efd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b8457e5f-32f2-458b-9f88-6af7c6d5fa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_27879c65-3c08-42d4-9e71-7e0d67ab97c9" xlink:href="bax-20220930.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_27879c65-3c08-42d4-9e71-7e0d67ab97c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended" id="i3c8140b4ad98462ab434fa72e0009e13_PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e53ca8f4-7fb2-4499-964d-ed5fd0d81fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e53ca8f4-7fb2-4499-964d-ed5fd0d81fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_05b03ade-ec03-44bc-9afe-61ceedefb222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_05b03ade-ec03-44bc-9afe-61ceedefb222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_eeafdca2-9c8b-4ed4-8bef-886c2e5688e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_eeafdca2-9c8b-4ed4-8bef-886c2e5688e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_89644ce8-0b7d-4958-9073-b0224c3f2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_89644ce8-0b7d-4958-9073-b0224c3f2850" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fe5d157a-3d65-4ff1-ad62-dd5f26bb0240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fe5d157a-3d65-4ff1-ad62-dd5f26bb0240" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_68ad1e9f-5c32-4749-bfe1-0081fc08484d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_68ad1e9f-5c32-4749-bfe1-0081fc08484d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_045613ab-2970-4464-8490-7314379c3766_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_045613ab-2970-4464-8490-7314379c3766_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7b18e660-285a-4d8d-b82a-d14de62f970d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7b18e660-285a-4d8d-b82a-d14de62f970d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d62dd36-d40b-4b9d-a14c-3d5b26125b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d62dd36-d40b-4b9d-a14c-3d5b26125b11" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended" id="i5f7464a2adfa408484b2faf66bb492db_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c10b18c0-df13-435a-bd11-e7b1f2be1a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c10b18c0-df13-435a-bd11-e7b1f2be1a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_d00b223f-c790-4dd2-920c-528d1f239ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_d00b223f-c790-4dd2-920c-528d1f239ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64190024-c0a8-409c-8e0d-3022d5c82d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64190024-c0a8-409c-8e0d-3022d5c82d1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0b467346-e04f-48ae-bd29-027152d95eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0b467346-e04f-48ae-bd29-027152d95eae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da458a45-fc7c-4aa2-87b8-e93b1ffebe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da458a45-fc7c-4aa2-87b8-e93b1ffebe4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_b36d7bbf-9d66-451e-a89b-3d6cd48bc37d" xlink:href="bax-20220930.xsd#bax_DerivativeFairValueTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_bax_DerivativeFairValueTerminated_b36d7bbf-9d66-451e-a89b-3d6cd48bc37d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_89562093-c6c5-43eb-9299-a1f93c40a8b3" xlink:href="bax-20220930.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_89562093-c6c5-43eb-9299-a1f93c40a8b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_43e6ef32-113d-40c5-820c-1094e221ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_43e6ef32-113d-40c5-820c-1094e221ce1e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7d945cd6-f339-4251-af8d-15686eb8134d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7d945cd6-f339-4251-af8d-15686eb8134d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8e34906e-2d70-436e-8c5b-9fc3eb888e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_InterestRateContractMember_8e34906e-2d70-436e-8c5b-9fc3eb888e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3c9728dc-f1cf-4058-868b-4454fb656bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_InterestRateSwapMember_3c9728dc-f1cf-4058-868b-4454fb656bd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9d0c85d-4409-4500-a245-f2f6910ada16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9d0c85d-4409-4500-a245-f2f6910ada16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member_0e696462-c4aa-4482-9e20-f883dba0f026" xlink:href="bax-20220930.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A130SeniorNotesDueMay2025Member_0e696462-c4aa-4482-9e20-f883dba0f026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member_c5a51874-6617-4a0e-b927-5c8c2958c63e" xlink:href="bax-20220930.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A04SeniorNotesDueMay2024Member_c5a51874-6617-4a0e-b927-5c8c2958c63e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member_25f7cb99-2a9c-4506-8470-1003ce32f52b" xlink:href="bax-20220930.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A13SeniorNotesDueMay2029Member_25f7cb99-2a9c-4506-8470-1003ce32f52b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6842cb22-1e19-45d5-8315-07d9ff28af5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6842cb22-1e19-45d5-8315-07d9ff28af5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9b1a7c6b-4171-478c-bd45-a91d14ecd02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9b1a7c6b-4171-478c-bd45-a91d14ecd02e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0abe996-3743-44ba-ba04-2470b845bf3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0abe996-3743-44ba-ba04-2470b845bf3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:to="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e55be0d0-5743-41bf-837c-228af58e1867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:to="loc_us-gaap_NondesignatedMember_e55be0d0-5743-41bf-837c-228af58e1867" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended" id="i1cc8cfb488e84fdeb8f428528c8aca0b_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_dd58db01-e768-4dca-b3ad-d959bf3cfb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_dd58db01-e768-4dca-b3ad-d959bf3cfb1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_7e939cf5-2771-46b8-a7ec-376e9f678b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_7e939cf5-2771-46b8-a7ec-376e9f678b9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_6fe96e24-b377-4363-ac0a-cd6156cc3002" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_6fe96e24-b377-4363-ac0a-cd6156cc3002" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ef234909-741d-4698-9d00-38ce2cf00a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ef234909-741d-4698-9d00-38ce2cf00a40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_2492b49f-fe7c-4097-9c98-38b6bffe40d7" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_2492b49f-fe7c-4097-9c98-38b6bffe40d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c6d41bea-5a76-49f4-92d6-2b72e1aef2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c6d41bea-5a76-49f4-92d6-2b72e1aef2e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b503ba86-ce84-48e4-836a-7446852c62dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b503ba86-ce84-48e4-836a-7446852c62dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7eff95f5-ef4d-4227-9cd3-70aa2bff236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:to="loc_us-gaap_InterestRateContractMember_7eff95f5-ef4d-4227-9cd3-70aa2bff236f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d84143d8-e2b7-4d12-9026-1ffd8de968d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d84143d8-e2b7-4d12-9026-1ffd8de968d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_edc5b62a-f34b-4ecd-b1ea-ed5b5dae5be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:to="loc_us-gaap_CashFlowHedgingMember_edc5b62a-f34b-4ecd-b1ea-ed5b5dae5be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_33cd654a-0d14-4c81-bd15-82db2d8dbfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_33cd654a-0d14-4c81-bd15-82db2d8dbfac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_997d4298-ce4b-4b26-a821-fec6e8a83e2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_997d4298-ce4b-4b26-a821-fec6e8a83e2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ea1198f2-fed6-429c-9965-97717fde7033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_InterestExpenseMember_ea1198f2-fed6-429c-9965-97717fde7033" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6520b26e-cb36-432d-b12d-7dd6cba55e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_CostOfSalesMember_6520b26e-cb36-432d-b12d-7dd6cba55e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2176482f-6c7e-4c57-a946-f0b3a14061f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2176482f-6c7e-4c57-a946-f0b3a14061f9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended" id="i88b0c9e38f9b44a7817b26d4e798749a_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0b09d243-80a3-4adc-b0a2-ea9d663f4c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0b09d243-80a3-4adc-b0a2-ea9d663f4c1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6787e086-8064-4d0a-a249-b6f671b2bec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6787e086-8064-4d0a-a249-b6f671b2bec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fb486ab1-ea84-479c-8f72-18bde9f36442_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:to="loc_us-gaap_HedgingDesignationDomain_fb486ab1-ea84-479c-8f72-18bde9f36442_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b5c40daf-243c-429e-8006-adf65a86d610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b5c40daf-243c-429e-8006-adf65a86d610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_27924fb1-7c9b-4fb7-ba74-ed29ad650f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:to="loc_us-gaap_NondesignatedMember_27924fb1-7c9b-4fb7-ba74-ed29ad650f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e39fca32-2ef3-4ce8-975c-116d97ec1f4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e39fca32-2ef3-4ce8-975c-116d97ec1f4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5bc41228-2c13-46ac-b9bb-5d0ead6c42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5bc41228-2c13-46ac-b9bb-5d0ead6c42ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_52dfc424-2019-44dc-99de-5c785f7e9e66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_52dfc424-2019-44dc-99de-5c785f7e9e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a8958824-b572-407e-93ee-508b4e779ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a8958824-b572-407e-93ee-508b4e779ecd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_4b6b1be3-97ea-4f4e-9c63-d55573bce5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_4b6b1be3-97ea-4f4e-9c63-d55573bce5e7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended" id="ib03050dac7bc4d1aa3a8db2d17cad35c_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_98ef6e27-b89b-434e-a75e-0b31e459f909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_98ef6e27-b89b-434e-a75e-0b31e459f909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3425cb8c-78b3-4129-a254-d80bf3b92024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3425cb8c-78b3-4129-a254-d80bf3b92024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04db8d55-5186-45f2-ae90-dd4d6225527f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04db8d55-5186-45f2-ae90-dd4d6225527f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c893b3fa-e9e2-49fa-8386-9fcc50ad68ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:to="loc_us-gaap_LongTermDebtMember_c893b3fa-e9e2-49fa-8386-9fcc50ad68ff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i4cb1664e0bd44ee897ad702948ec00f4_FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_62c44182-ead1-4735-88cd-d22ba683ed88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_62c44182-ead1-4735-88cd-d22ba683ed88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6c06e303-b1d0-4146-9d81-1c65990086df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6c06e303-b1d0-4146-9d81-1c65990086df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_bf8cffaa-e442-4eae-a067-57c82d559335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_bf8cffaa-e442-4eae-a067-57c82d559335" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b5f59742-4525-4960-bbcc-24ba891a0583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b5f59742-4525-4960-bbcc-24ba891a0583" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_cb5f9e33-cf04-4fbc-a16f-72a31034c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_cb5f9e33-cf04-4fbc-a16f-72a31034c1f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7d487cad-a0f7-497e-9989-870c97846be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7d487cad-a0f7-497e-9989-870c97846be3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_0abf9a0b-3660-4092-b844-213e4811f432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_0abf9a0b-3660-4092-b844-213e4811f432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6610fccd-593f-4095-945c-3682720b9d73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6610fccd-593f-4095-945c-3682720b9d73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_32540b12-0a07-40ae-b735-89eccddb238d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_32540b12-0a07-40ae-b735-89eccddb238d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1052fed-86fa-4d59-8667-e05003aaf6c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1052fed-86fa-4d59-8667-e05003aaf6c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_039f09b9-26db-46f4-b0aa-1234701c9b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_039f09b9-26db-46f4-b0aa-1234701c9b87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_008d8f99-52cf-4117-bd35-5ec08e471388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_008d8f99-52cf-4117-bd35-5ec08e471388" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_42da0503-fa29-4370-ae02-804fb0a44ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_42da0503-fa29-4370-ae02-804fb0a44ade" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="i0d47cf92e5a6496ebee291ffc0aa494c_FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f7cad95-406b-4e37-bb09-8f03397b8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f7cad95-406b-4e37-bb09-8f03397b8b86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_786f0f39-7cc5-4f93-9063-159a0d84a159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_786f0f39-7cc5-4f93-9063-159a0d84a159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_7ad62e80-0ce8-4a46-8e28-3c18a140067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_7ad62e80-0ce8-4a46-8e28-3c18a140067b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_11fd2957-c04c-4217-927e-4864d7b247bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_11fd2957-c04c-4217-927e-4864d7b247bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b75289fa-da0f-4f42-83a4-47f0c7aa41a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b75289fa-da0f-4f42-83a4-47f0c7aa41a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a01ee632-dbbb-4f7f-a391-07106f410040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a01ee632-dbbb-4f7f-a391-07106f410040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_28f45b99-8b75-4e14-837b-fdd92487c0e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_28f45b99-8b75-4e14-837b-fdd92487c0e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_aed55ec0-b189-4be6-a817-5b8693df619d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:to="loc_us-gaap_OtherAssetsMember_aed55ec0-b189-4be6-a817-5b8693df619d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14753cb8-f4d4-4ddb-bff2-c32728eaf02b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14753cb8-f4d4-4ddb-bff2-c32728eaf02b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_81bc7093-a9f1-40d1-be8a-03c42a2049f3" xlink:href="bax-20220930.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_81bc7093-a9f1-40d1-be8a-03c42a2049f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended" id="i5dba1f7a5cee49009f45aae02a91d626_FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73e49793-a326-4fa4-b7a7-2faee2071629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73e49793-a326-4fa4-b7a7-2faee2071629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_95d2878f-3d3c-4ad1-8d5f-34bb3b69ec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_95d2878f-3d3c-4ad1-8d5f-34bb3b69ec5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_69c2f4dd-fcac-46c0-8e16-8fcc9f5c18c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_69c2f4dd-fcac-46c0-8e16-8fcc9f5c18c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_413e19da-d886-465e-8e6e-f1f180513af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_413e19da-d886-465e-8e6e-f1f180513af6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5c8ac255-4ef5-4002-aae6-5185278b11f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5c8ac255-4ef5-4002-aae6-5185278b11f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_fe13470e-b068-4c86-8b7b-e54e63f3c145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_fe13470e-b068-4c86-8b7b-e54e63f3c145" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_8f6b91bd-e99f-4ddf-adaf-3ccc808b1fcb" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_8f6b91bd-e99f-4ddf-adaf-3ccc808b1fcb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1612982d-942e-4191-a7b2-ea09de833001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_207e2ce6-1f7f-4729-bfb0-d369db2898ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_207e2ce6-1f7f-4729-bfb0-d369db2898ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_d44944cd-8668-4bb2-915d-0f1cc433d3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_d44944cd-8668-4bb2-915d-0f1cc433d3d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_65e0d2aa-d40f-4e44-a386-58b7ce33a84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_65e0d2aa-d40f-4e44-a386-58b7ce33a84b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_89bcc425-2135-4c5e-ba59-aea7c3beab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_89bcc425-2135-4c5e-ba59-aea7c3beab4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_63b5fd96-f770-45bd-b509-03eb4ef29506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_63b5fd96-f770-45bd-b509-03eb4ef29506" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_051d6475-c692-4903-ab8c-a926cc31a073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_051d6475-c692-4903-ab8c-a926cc31a073" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_eb3b6bfa-ae12-4686-b514-fed4b95c3302" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_eb3b6bfa-ae12-4686-b514-fed4b95c3302" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d5df50a6-97fa-4d33-801d-df085855c4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:to="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_997eb1b8-5c5c-4f2f-bc35-060bd001bb74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_997eb1b8-5c5c-4f2f-bc35-060bd001bb74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_a47093d4-a8d6-4aa7-8f08-ec87fd191090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_a47093d4-a8d6-4aa7-8f08-ec87fd191090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_b8cb35f6-f27d-4519-866c-91815fbbcc38" xlink:href="bax-20220930.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_b8cb35f6-f27d-4519-866c-91815fbbcc38" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended" id="ic3204413d9d54b1eb7e7857bc09c74b8_FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_1a592819-6768-4231-a6f5-b594321490a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_us-gaap_ShorttermDebtFairValue_1a592819-6768-4231-a6f5-b594321490a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_b5171933-7ad9-4188-b58d-1ccbf4ff4c98" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_b5171933-7ad9-4188-b58d-1ccbf4ff4c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_0ead18f2-cc28-43d3-8bdc-b91b72c45271" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_0ead18f2-cc28-43d3-8bdc-b91b72c45271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_51a14352-6611-471f-89ad-2a6de53d2ab3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_51a14352-6611-471f-89ad-2a6de53d2ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4aed391e-cdda-4c38-b6f0-97e043e06722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4aed391e-cdda-4c38-b6f0-97e043e06722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dce5b743-8229-4e37-a8fd-6bd853c3dbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dce5b743-8229-4e37-a8fd-6bd853c3dbe4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended" id="i5b6d86ec8c064ab2a20601f7242d2a20_SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5ce84891-f5c8-4f97-a6dc-695fe1f50500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5ce84891-f5c8-4f97-a6dc-695fe1f50500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce8bf403-8719-495c-bbee-1c0d25939ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce8bf403-8719-495c-bbee-1c0d25939ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_832b2326-f4cf-441b-b9a1-9b0d72c24afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_OperatingIncomeLoss_832b2326-f4cf-441b-b9a1-9b0d72c24afe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:to="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_65ef0d82-4309-4489-84bc-17e297722b3f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:to="loc_srt_ConsolidationItemsDomain_65ef0d82-4309-4489-84bc-17e297722b3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:to="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_addd5b11-cd3d-46e2-9216-41eb96a5a196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_addd5b11-cd3d-46e2-9216-41eb96a5a196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_89553d12-c0db-4d6d-baa7-08f8078c68ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:to="loc_us-gaap_OperatingSegmentsMember_89553d12-c0db-4d6d-baa7-08f8078c68ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e39e3e67-e5a7-43a6-885b-48ea444627b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:to="loc_us-gaap_SegmentDomain_e39e3e67-e5a7-43a6-885b-48ea444627b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:to="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_bf280369-4f4a-4712-9da2-608201823bb3" xlink:href="bax-20220930.xsd#bax_AmericasSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_AmericasSegmentMember_bf280369-4f4a-4712-9da2-608201823bb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_4a468b0d-186a-4065-ba91-84fbe44e860d" xlink:href="bax-20220930.xsd#bax_EMEASegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_EMEASegmentMember_4a468b0d-186a-4065-ba91-84fbe44e860d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_7d7706d9-ed1e-4b41-8cb1-ef67d450fb62" xlink:href="bax-20220930.xsd#bax_AsiaPacificSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_AsiaPacificSegmentMember_7d7706d9-ed1e-4b41-8cb1-ef67d450fb62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_60cce5ad-e68b-4838-9aa5-5d7a481a8179" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_HillromMember_60cce5ad-e68b-4838-9aa5-5d7a481a8179" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended" id="iacc9a9bd3e18463d9efa2459a7ea6808_SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97be5b8f-324a-4137-bb86-42a8844d5c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_OperatingIncomeLoss_97be5b8f-324a-4137-bb86-42a8844d5c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_522233b5-279f-4e81-8b2e-cc303c971aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_522233b5-279f-4e81-8b2e-cc303c971aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eca1eb68-b78c-4934-9940-cd8324f71aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eca1eb68-b78c-4934-9940-cd8324f71aeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b551365f-7868-4fc8-b67f-2935f74669ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b551365f-7868-4fc8-b67f-2935f74669ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:to="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5ac7d17d-8936-4951-8108-452c6d121432_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:to="loc_srt_ConsolidationItemsDomain_5ac7d17d-8936-4951-8108-452c6d121432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:to="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7b1b4de-2bc8-43fc-8445-71e6fa477453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7b1b4de-2bc8-43fc-8445-71e6fa477453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7696ab78-cc74-4f0b-8385-75b77299175c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7696ab78-cc74-4f0b-8385-75b77299175c" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bax-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_0c8a44e4-1445-4bfc-81b8-8c45430c97df_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_0516dc24-e62d-45ea-98c6-71bd8cece013_terseLabel_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="bax-20220930.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c9eb5c61-949a-4aa5-94c3-58d117db1a9c_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_15a3a28c-321d-4be7-896f-e3da84de2ee5_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_label_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosure Line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresLineItems" xlink:to="lab_bax_FairValueDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_141ed259-1790-4a92-813b-00e87b1551d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_057ae0d6-6eb5-415f-bfcf-feb920ee73eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d4a4c77e-0c27-4755-a4fb-f35137867c12_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3cce53bc-e373-427c-bc40-1a24f0a67c13_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_8a66a958-493a-41b3-a993-aeb19f2d4005_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsMember_c95312ab-f493-4a78-980b-ceb488b2816d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process Research and Development</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_79f8bdb9-92c4-444e-942a-eaa3d2e9099a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_37302dfc-7ae3-4179-838a-bd69810d94f1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_22ad87f3-18d8-4dc9-92bb-59b9842af8a3_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_label_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member" xlink:href="bax-20220930.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes04Due2024Member" xlink:to="lab_bax_GlobalNotes04Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_9edce8c9-90ee-4771-b1b2-aa47ef936f48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_b4ada3ff-07ea-42ef-8ce5-580d6f3e6c9d_terseLabel_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology, including patents</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_label_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Including Patents [Member]</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_documentation_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology including patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:href="bax-20220930.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:to="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_e93c1f1e-4e38-4c5b-9561-60045ea4fe3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_f5ec8e50-a407-4321-9263-98dc48803ac8_terseLabel_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and Other Employee Related Costs</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_label_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance And Other Employee Related Costs [Member]</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_documentation_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and other employee related costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:href="bax-20220930.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:to="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_31c65239-5c66-43a3-b7dc-9ba55d1af2ef_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and carrying value by balance sheet grouping.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2764d3ae-cf19-40f1-9b7c-2565a7ee70fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_75a0de47-255b-4b69-83d6-425fd72258e3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_f5094e89-7750-4f77-bca6-c5f5afc444a2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0658796a-66e2-4760-8302-d807e790bae2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_92c3229f-16c7-4c11-92ca-3c9af260c752_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7f32d6e4-9f80-4a5c-a274-aee22672af97_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_15528905-305c-4bd6-acdc-fb7826d93eff_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_57069a97-54a0-4f77-a018-edddb5edc376_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_42b88825-848b-4354-ba92-86b7eccd2bcd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseIncome_32d4d7a6-18bd-4a4a-979d-5555bc6ed9c1_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease revenue</link:label>
    <link:label id="lab_us-gaap_LeaseIncome_label_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseIncome" xlink:to="lab_us-gaap_LeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_bcd19d89-3fdd-45c8-a3ce-604747374f88_terseLabel_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled equipment and consumable medical products contracts</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_label_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts [Member]</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_documentation_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:href="bax-20220930.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:to="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_1a629e8d-6d83-41f7-846e-b804e566872e_terseLabel_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, additional authorized amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program additional authorized amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="bax-20220930.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_19bd79d6-ad35-45cb-9662-f83c6ce76b77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income) Expense, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11087580-b2ad-438f-b4ed-afaddff66ae9_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_63f12b9f-2f5f-42dc-8ab2-f0c29f32ea75_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:href="bax-20220930.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:to="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_aa9010cd-bb74-478b-9ff6-afb08d2974b8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_79baa222-7c5d-42d2-8877-44b1e664283b_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_036afa39-deea-4473-a620-5923168c13aa_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_16ffe7be-ffcc-4155-b5d5-63d55f9daff0_terseLabel_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original weighted-average term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_label_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_documentation_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm" xlink:href="bax-20220930.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OriginalWeightedAverageTerm" xlink:to="lab_bax_OriginalWeightedAverageTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c11dba57-f6c7-441a-8ad4-1477fa908e95_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_105cea5f-612b-4a5d-a462-5ffb3fe2dfad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gains and Losses on Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ebd9d292-002b-4d24-b151-a195cae12337_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4a7d3398-7c30-40d3-ab5a-5fc6640b79be_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e824f524-c2de-4888-b55b-8047a6ad2f48_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_7a400496-8017-4eae-a36c-7113d1802f0a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_8b4b52a3-4fc8-4c2f-ad86-d460323838f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b74e2365-37ba-46e1-a10a-e63129c74ce4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_d96afec8-8277-4284-96c8-92ad8afe729d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_5733a62c-1180-4f70-9a25-2b39eeb017ba_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ecb4fa67-3ff0-4598-a981-efbf25afbe37_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6a8ff573-2202-4023-8fa8-646b0d9336d0_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4649dca5-02ee-4004-a563-fa17db043cba_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_96a8a891-75fe-4ef4-80d3-84c42fe198f2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_6823c4a4-e864-4996-9d1c-3eaa29e442da_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_16eea08c-fb09-475e-985d-07c0bf841675_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AmericasSegmentMember_6a088576-ae7e-49f6-9f42-bee3db2acb56_terseLabel_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_label_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment [Member]</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_documentation_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember" xlink:href="bax-20220930.xsd#bax_AmericasSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AmericasSegmentMember" xlink:to="lab_bax_AmericasSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_1fc1e7df-42d8-4e45-9e56-209caf84b814_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other amortized intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SurgicalSolutionsReportingUnitMember_81d368e1-514b-4754-b406-4d8d46f5d3dc_terseLabel_en-US" xlink:label="lab_bax_SurgicalSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions Reporting Unit</link:label>
    <link:label id="lab_bax_SurgicalSolutionsReportingUnitMember_label_en-US" xlink:label="lab_bax_SurgicalSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions Reporting Unit [Member]</link:label>
    <link:label id="lab_bax_SurgicalSolutionsReportingUnitMember_documentation_en-US" xlink:label="lab_bax_SurgicalSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsReportingUnitMember" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SurgicalSolutionsReportingUnitMember" xlink:to="lab_bax_SurgicalSolutionsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_e55dc75c-92d6-4c0f-a015-e2387c3633af_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_a12fc988-6ecf-427e-827b-e8fb0d67722f_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0a0c2b5e-87db-45e9-979c-798ff78b6e28_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_fc5a176c-44d3-40e5-9bcb-af2fd73a8d1d_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_5e3ef4a3-0546-4d24-b34f-0f590cd7467a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6f06a632-c19d-4376-85f1-91c2de923281_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_c15f2eda-5819-45e8-bde7-b5961048be2d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_3f2b5dfa-a732-4709-8f45-000cf4ec0140_terseLabel_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_label_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Translation</link:label>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_documentation_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:to="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_64e5bb95-3f0e-4623-8b5d-7b9035fa598b_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_d50eb87a-6d05-4948-a7ff-48481e5980bd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_b29631d0-4493-4561-b18c-a4a950dd6367_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2029Member" xlink:to="lab_bax_GlobalNotes13Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ffaffe02-1dea-40be-bb4d-b2a4b23b293b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_6c0e34e5-2177-4491-b293-f44322451ed9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration transferred (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_95a62a05-7c33-427e-8e5d-2aa5ec0d190d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f11646ae-1b11-4c7d-99b3-963d4f9ddac2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d498e1a5-6e66-4ff2-918c-02fe42c3273d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_45021f32-ab18-4650-a049-c98631e6809e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7a6f4c9e-b9eb-43b3-a151-d417724a5022_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_ef137f44-b7f9-45bd-a915-9fce49a91e97_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_efcc7164-76b0-4563-87cf-b63dcad84278_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_c034048b-f838-4240-aa25-0ab0b2b20ca0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0b9aa5c6-6594-4f83-8b8a-068fee64b247_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active markets for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_00c729a7-1059-42db-8085-4035e0b77153_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A24SeniorNotesDue2022Member_697b7a6b-3179-4365-9bf2-090db40e20fc_terseLabel_en-US" xlink:label="lab_bax_A24SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Senior Notes Due 2022</link:label>
    <link:label id="lab_bax_A24SeniorNotesDue2022Member_label_en-US" xlink:label="lab_bax_A24SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A24SeniorNotesDue2022Member" xlink:href="bax-20220930.xsd#bax_A24SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A24SeniorNotesDue2022Member" xlink:to="lab_bax_A24SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_80546c4b-739b-47ed-8b40-61b7c7a743f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_89b7eeec-9ba1-4d60-87d2-0683ebf49dce_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_8af7a549-02c3-42a9-aec8-ee93bd966a67_terseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7aa1ab74-99a7-4c29-90b7-af3a42044bf2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_820ed6b2-aac8-4f62-9db5-4e29866e5b59_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total business optimization charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseIncome_23a4df2f-d2b8-4fe3-ad8a-0f90e2764251_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease revenue</link:label>
    <link:label id="lab_us-gaap_VariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseIncome" xlink:to="lab_us-gaap_VariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_8d382fea-526c-4856-ab9d-bf70570dc6b1_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_06a00c74-d509-457e-832e-e9f20c0a76f2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_feda9221-1da3-4e80-bf10-c0f77d4445f0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected additional pre-tax costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_771a1945-6f96-4196-ac52-e381530b745b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_61f19b26-7100-4f6f-9836-b4ca374b6500_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_d979cf67-764a-476a-928f-bb2ad7b8e3f1_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_5df76d14-0529-46f7-81f0-6d0a0fe6f05d_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_105a7edd-4a66-41e2-b30e-27db6cc428c4_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_51e2a4d1-6630-4d09-bf96-197dcb901abc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_832b0569-1c72-4df9-b0aa-77ce26742d3e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_5f7769ad-f4a7-487a-8cea-6beb257cb92b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62b4b49f-7545-4bf7-bfb4-e27d16b85b49_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_dc2f9e84-e23d-4d12-8bb4-854938d6fc9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_c8cb813e-98ed-468c-9c5f-00a0bcd97d11_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Reclassification from AOCI to Net Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f73d0ecd-8143-4dfc-97f7-232cb91d5d21_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2c20d64-4e55-4cac-9563-140d3b8ffef4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_46992af4-7ebc-4898-8e2d-3dd6f11088d8_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_3a868a82-1288-4a24-95b3-9085a2329851_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ZosynMember_efffaa6e-3943-4a83-b3e1-e2ccf508724a_terseLabel_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn</link:label>
    <link:label id="lab_bax_ZosynMember_label_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn [Member]</link:label>
    <link:label id="lab_bax_ZosynMember_documentation_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember" xlink:href="bax-20220930.xsd#bax_ZosynMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ZosynMember" xlink:to="lab_bax_ZosynMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_df860e3d-5eb1-4324-80b5-3ce154535760_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_185f2aa7-f880-451d-9d21-07daf6741b7c_terseLabel_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan</link:label>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_label_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan [Member]</link:label>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_documentation_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember" xlink:href="bax-20220930.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeniorThreeYearTermLoanMember" xlink:to="lab_bax_SeniorThreeYearTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4f10a7b-0480-4503-ab6e-7db5476e4578_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_17eae925-3c4e-4a25-833c-ac7b9a553880_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_9a591402-58d3-48ca-b04d-e8313e2e77c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_1e264a78-3b3c-4775-997d-46b2db2ebac1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636337dd-a5fa-4201-9b38-894f4dbc5803_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5ebf73d7-ca02-4269-adeb-7fbaada62b5b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ce1081e5-d911-4b4c-9004-741909c94502_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8d4d280c-5e07-4741-a9db-cacebfd3394b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_da7a5e1b-0523-4211-bbdf-4285b5d3463a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_21d4cd52-42cf-473e-a022-f5965f5f3205_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_656751b3-e73d-4693-8fb5-420562ca899e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_04186691-ea8f-4e78-a136-655d46d2399e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_6d21737d-a42c-4918-9ed4-cef4b8615512_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Intangible Asset</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_cb8f2994-ec90-49dc-8c4d-005d8a6a69e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8b33f865-fe60-4b54-98ba-5e3780c93182_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_62446e82-eda6-4429-b3ab-7a077faaa940_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8d829420-4c85-4655-baf7-34e56fa73b45_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6415ba77-352f-424d-a784-2e3dffc1279c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b9df918a-6b48-4bc1-97d2-ab952853e798_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in AOCI by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4f2fbfce-96d2-4d8e-ba9b-913b48320707_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1ba4f45e-6c49-42bc-b153-a2f964f81365_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3f195aab-d9eb-42d0-be87-5075573fbf63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_97dae443-c490-4317-8f8a-eb4ac0860449_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_379c3207-e26d-4cf1-8db2-0448aa38b2ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_105edfb3-5c02-4603-b88c-ecbe9698213e_terseLabel_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_label_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognized Contract Period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_documentation_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod" xlink:href="bax-20220930.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueRecognizedContractPeriod" xlink:to="lab_bax_RevenueRecognizedContractPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_de7948d0-3ca1-40fa-a011-7f9889a95daa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_fda991a0-7188-4864-8224-29633e269555_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_bdb3efb0-d0f2-46bd-b0a3-a9c895a1ba3d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_16f86a5b-abdd-4919-aa37-65d6d260b9e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_2bd49b66-edd0-405d-86a1-83b5f241e102_totalLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8724ee09-e879-4fda-837c-df36b35c0214_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_722467a5-fc53-4b50-987a-8c506cb3cfef_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_091b9614-50f2-4ea9-be46-d3f651ef1c8b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_54db386b-7a9a-4174-b1d0-e50657475b26_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_48502f3e-5eed-42e6-b223-d420d13c068f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of cumulative translation loss to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5e6f9d9-b88a-4e02-bfa6-f07798fb7561_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b15ca34d-a737-406d-a83f-5d9ba804eaa6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_11937f8f-c604-4aaa-ae05-64a3e333b527_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb338139-c459-4481-972d-1f56fde8deff_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0e748d3a-1c95-44d0-b0b0-40e54bf38401_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9f887d49-7fda-4894-80dc-1750a1560907_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_19367c49-9d9f-4c49-a133-04c691592ed2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_dfd44971-1d5e-4766-a47b-e025b8601b9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0f8fa010-85ab-404d-86ea-01f24b70807a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_283b50d2-04d8-4c4a-ae3c-3c4e8cf55583_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CTA</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_9ae56359-6d90-47f3-bd87-9f76bb9e4f05_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_052acc99-f005-4b2c-ae5f-b59fd188bf63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b40d46dd-c748-4272-a657-f021b749ba1d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_7672a77d-dbf4-45e2-9ff1-c8a83abe04be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8f21d103-db73-4b16-a2cd-c614daf1ba09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and Fair Values of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_83d15242-327a-40db-9fdf-b96d6ebb045f_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, less current portion</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Debt and Finance Lease Obligations, Noncurrent</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_94f423b5-68b0-4643-a2e1-38f0c5b4ecc9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SurgicalSolutionsMember_44055daa-8de9-4b95-9ef9-9c1631b904f5_terseLabel_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_label_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions [Member]</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_documentation_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SurgicalSolutionsMember" xlink:to="lab_bax_SurgicalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e549ab65-611d-466c-926e-8de1e675e95e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d2e1fe38-d29b-4a81-8109-24543770777b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_a87a922a-c94b-4ac2-95d0-4aae023d5b98_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration paid to Hillrom shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_28ef8e86-26dd-4567-9433-f1b70de6b932_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition price</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7223b866-d370-45d1-98d9-54681ceb5828_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Values and Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ad0d3fc7-f2b4-4649-8d2e-e1be704e5268_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_2190dcdc-6d69-4ddc-b702-5555b5de94a6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_ef4ee3d8-25fe-473a-a427-0521df598d99_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_92ad4f6e-7809-4b54-8a44-e4935ea7911d_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9a279ab3-9e83-470e-9a44-f989397a397d_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_9b9b0613-c8b3-4b18-8208-4a3f28c359ca_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum length of time hedge in cash flow hedge</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ae6e294f-d6f0-4007-a3b1-6c7c718db34a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible_fa725ee5-721f-4fd7-a159-14b3ac741b28_terseLabel_en-US" xlink:label="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible_label_en-US" xlink:label="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Foreign Statutory Loss on Foreign Subsidiary Investment, Tax Deductible</link:label>
    <link:label id="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible_documentation_en-US" xlink:label="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Foreign Statutory Loss on Foreign Subsidiary Investment, Tax Deductible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:href="bax-20220930.xsd#bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:to="lab_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_cdedd4b0-6677-4159-86e1-4339e0200dc3_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_5d8de51b-8cd1-40f8-a9a5-7d13b5692c5d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_85ff8342-2e46-4ebf-8e36-d58ac4160e36_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3d566684-7551-4a03-8ef5-82802224e205_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_9efd0758-8266-4abc-bd4e-38e9ab830b10_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2faf6536-22b7-4c9c-8dfd-942ff994901c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_61ee5c07-7606-413b-b485-7875d2d8cdcb_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_8db7595d-3a19-416b-875d-953d8df2017d_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_91d8acc3-da23-49d6-9c21-acb1ce8827e5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_0c85069b-9e23-4cc7-aa8e-544b18cdad06_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_702e9270-58b4-43fd-9152-900bf4bf6f0e_terseLabel_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise value</link:label>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_label_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</link:label>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_documentation_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:href="bax-20220930.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:to="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_3ad15a90-ae7a-42c9-84d3-7d5aeb39497c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average term</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9936f21e-a30a-4257-9d09-fbadd5d8c054_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97b4d22f-fef7-4bc8-be01-a875ef666e14_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c9810c4-c5b9-47ad-8701-fb28b259d366_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_10131479-5f4b-45a9-a9c4-8e94a1468b79_terseLabel_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, net investment terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_label_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated" xlink:href="bax-20220930.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeNetInvestmentTerminated" xlink:to="lab_bax_DerivativeNetInvestmentTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_e3d6cdd3-25ab-4975-9ee5-93ee92d17493_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ClinicalNutritionMember_9fe01159-5cfd-42ef-b2e2-fc45d2ee5415_terseLabel_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_label_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition [Member]</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_documentation_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical nutrition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember" xlink:href="bax-20220930.xsd#bax_ClinicalNutritionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ClinicalNutritionMember" xlink:to="lab_bax_ClinicalNutritionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_8a76e150-9ca8-4411-8705-e901ddcd44b3_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt and Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3845f7df-d66f-44b5-9b19-da3fce58541d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_34380912-90d2-42e1-a577-bbd64d9532e1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6f51843a-01fc-4b3f-b9a9-1e572224f467_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3a4ed0e9-7020-4390-b2cf-768174e05739_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_00f9a606-6057-4da5-88d7-0ab4444e5ca5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_edaf990a-e25c-440f-96e1-b5499646d689_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4100879f-0d7a-4e1b-95ce-983b2c376004_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5d933092-a509-437e-a436-b762c751c5fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_6c3c9ea4-a741-4210-97d3-1e4b44e5dea5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_22b12464-5028-4234-ad95-832a2c29fda2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_45f34cae-306b-4d54-93b1-7cfaa28af65b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_64eee12f-26cf-494e-8fee-00a7b418fa9c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_47957fe2-ec8a-4b74-bb09-bbe36144b6dc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_54ad3146-322d-49bf-a973-783960b07ac5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_aa3d0308-0ee9-4e58-b268-4bb272de7826_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_53c8c728-b815-4ede-b43a-3fb5fffda19d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2fe8f9fa-be92-446a-9a03-cf20209cef2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8ace4392-d797-47c7-b47c-da97031fffff_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c9c702d5-6ca3-4249-8624-1c9930ad8753_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dd44d191-24ef-4d00-a299-d820f6c907eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_dddd50d4-8b54-4484-a0c5-9791562f4c2c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d50feaf-f2fd-46b7-98b0-d0bd5178dfcd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_7414ccfc-0dc2-4cbe-b0fb-d9dd48c1ddff_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_18e4f201-fcff-47d1-94c8-9cd79e14a6ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_8c7932d3-5831-41bf-b54a-d239991d0f8d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND OTHER ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_94c153a1-1380-40dc-aac3-0306c54c0198_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_301a8140-9b33-4ba2-830d-8af4fd171c92_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_4d43a51f-8005-4367-8dd5-4b08d88e062f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8f14f81f-1885-41d7-ab26-654ffd1b7701_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a320e2ae-05ff-41f4-9be5-6be1fc933782_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d4177216-67e3-4f98-b592-7e26ee098150_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_50d6c675-85cb-49bf-913e-56751a486e85_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, net of tax expense of $5 and $3 for the three months ended September 30, 2022 and 2021, respectively, and $8 and $8 for the nine months ended September&#160;30, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_0365871c-a3a4-4a07-ba90-34716510517d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative pre-tax costs incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A1915DebenturesDue2027Member_ba622d32-0197-4e3b-835a-13334aa711d8_terseLabel_en-US" xlink:label="lab_bax_A1915DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.915% Debentures Due 2027</link:label>
    <link:label id="lab_bax_A1915DebenturesDue2027Member_label_en-US" xlink:label="lab_bax_A1915DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.915% Debentures Due 2027 [Member]</link:label>
    <link:label id="lab_bax_A1915DebenturesDue2027Member_documentation_en-US" xlink:label="lab_bax_A1915DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.915% Debentures Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1915DebenturesDue2027Member" xlink:href="bax-20220930.xsd#bax_A1915DebenturesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A1915DebenturesDue2027Member" xlink:to="lab_bax_A1915DebenturesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_1f6b8ac9-ac1b-4f4d-a3a0-1faa1e37ff30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_af3bf148-d001-4994-8e5e-c279ffd7ebae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_f86e7b7a-55ae-4e0f-88cf-f4f53368d529_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_5d014939-8199-49e8-9785-f75ecc610459_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on product divestiture arrangement</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a3bfa5ff-a215-43d7-aede-bce1139d60bc_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2d7ac301-dd38-41ee-9a31-f627696b3ca8_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_dc7b7409-3467-42bc-8530-7b5ece43b9c0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a875d03e-ace4-4bba-9693-b5b9caf3b2c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b6ef7fb3-41d6-4287-b3b7-b10166f607f9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_2c12133e-fbd3-4acb-83ed-fd2de3e25bf8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_8d18e1ff-ae7d-4261-8fcd-a9f8f2783c8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_d3d69349-0e44-4c88-8c70-4ac2aa3e2b7a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcuteTherapiesMember_57ee872b-cc3b-47d6-a9da-baec0e33c447_terseLabel_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_label_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies [Member]</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_documentation_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember" xlink:href="bax-20220930.xsd#bax_AcuteTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcuteTherapiesMember" xlink:to="lab_bax_AcuteTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b7703e62-f8f4-492f-8bbc-2782f6e426e2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ef22926b-ac11-4d4a-b128-2bf4db6bc8fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_89dbf7f4-b73d-4380-9cf6-ae7fa1afb15d_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Finance Lease Obligations, Current Fair Value Disclosure</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, current, fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_bff20f8a-675e-400c-9bce-e51bd671ee8d_terseLabel_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_label_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_documentation_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:href="bax-20220930.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:to="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_a8f98be8-8453-4010-b21b-10081efb8544_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e23a37a3-c29e-472b-8c79-d68c6747c9e8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fdb2d3b4-d374-408a-8a1a-1ae26506426f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1e6bee9c-8d61-4968-baaf-2f44a7e90c10_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommonStock100PerValueMember_0f18a1be-3b42-474b-a13e-dd424bc80fb1_terseLabel_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 par value</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_label_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value [Member]</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_documentation_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember" xlink:href="bax-20220930.xsd#bax_CommonStock100PerValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommonStock100PerValueMember" xlink:to="lab_bax_CommonStock100PerValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_ef92210a-1790-4c65-8109-5afe023c5c4a_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, average outstanding</link:label>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_label_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Average Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:to="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_40aa56ca-d348-4d83-a8e7-8656b29b3767_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_d134bc1d-960c-4818-a9ca-118622e2fda9_terseLabel_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_label_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency Number Of Sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_documentation_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site contingency, number of sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites" xlink:href="bax-20220930.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SiteContingencyNumberOfSites" xlink:to="lab_bax_SiteContingencyNumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_076869df-d7ad-4f85-a163-76f2afc4a287_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_54b74e05-d6fd-4ad0-91db-c587c7ae0660_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5d141cec-fc68-4f24-8c0e-a262cea03a4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b469871-c443-42a1-8500-e6cc2d6909ac_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f16edf1-65f3-4a58-b687-571c3250dd16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_78a7b349-9a51-4f33-b74d-212b651691f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed93a492-7b2f-46a7-8baf-56648f48eefd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in balance sheet items:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ManufacturingArrangementsMember_50d6e878-68cb-4a0e-be91-557362b58553_terseLabel_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract manufacturing services</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_label_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Arrangements [Member]</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_documentation_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ManufacturingArrangementsMember" xlink:to="lab_bax_ManufacturingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7babed32-1dd6-4c18-97ee-b116329bc861_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_f587a06c-19c7-4505-a8f5-c88d61661523_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_9b80a4d1-dacb-4c8d-b210-9f8a36d1deb4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c0643a7f-49db-4b14-b000-460d869aef40_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_294333b5-fe17-4ba4-80a4-07c7c306981f_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds, at carrying value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d484bcc8-ad12-435c-b73f-b3dca2f29f46_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_356e84c1-2956-4bd1-8be0-449d27e3b552_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_8b50fd7a-62c6-40ee-9a14-382b3bc844ac_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_577a877e-417b-4b56-bfec-f5e0bf786088_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_6286170b-b87e-4561-8263-4872f3f2c10a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ce33f012-3e4c-4ffa-ab75-e29b51192921_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ProceedsFromDivestitureOfProductRights_0f35cc6d-8f49-4623-a98f-91de45a3f9ef_terseLabel_en-US" xlink:label="lab_bax_ProceedsFromDivestitureOfProductRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of product rights</link:label>
    <link:label id="lab_bax_ProceedsFromDivestitureOfProductRights_label_en-US" xlink:label="lab_bax_ProceedsFromDivestitureOfProductRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Product Rights</link:label>
    <link:label id="lab_bax_ProceedsFromDivestitureOfProductRights_documentation_en-US" xlink:label="lab_bax_ProceedsFromDivestitureOfProductRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Product Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ProceedsFromDivestitureOfProductRights" xlink:href="bax-20220930.xsd#bax_ProceedsFromDivestitureOfProductRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ProceedsFromDivestitureOfProductRights" xlink:to="lab_bax_ProceedsFromDivestitureOfProductRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_8fd2e6cd-3eb2-4031-83db-3af3af77acde_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_efe82979-17f4-4957-a99a-c930bfdf7019_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_c858aa8d-0e88-4e37-b0c1-e50982b704d7_negatedTerseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized upon satisfaction of performance obligations</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Total Revenue Recognized</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Total Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:to="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d6f69f4a-6377-43da-9fd9-80bc65d7b96f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_2e9a1d19-d3d6-48c8-b45d-91911c11de9e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_889a1a44-ffeb-4e07-b037-db93ef63d7ff_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_15ca4ae9-ab85-44bc-ac3b-cd44402d30c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_aa825157-47d0-4b51-a120-0ba23e2e1b42_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_796d2a8f-260e-49c4-b133-001a41daa44c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ac4d5cfa-cc3f-47ee-9bc4-e5a74bfbea2c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c05c15d0-405f-405f-8670-f0d810422623_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_ca9cb055-0c4e-46e9-8bc9-46bad2d886d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f598c891-a88f-497d-a9f8-73c6bf6bce6b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $120 in 2022 and $122 in 2021</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_1c25b88a-f39e-4c13-b9be-cda3ef843d09_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_2188523a-7874-4148-85cd-3f63f388dde9_negatedTerseLabel_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:href="bax-20220930.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_db4d761f-ea0e-4ad2-98d0-2604057828be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_a3eacc58-8d43-417a-9705-39ac1c9fce61_terseLabel_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_label_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Termination And Other Costs [Member]</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_documentation_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember" xlink:href="bax-20220930.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractTerminationAndOtherCostsMember" xlink:to="lab_bax_ContractTerminationAndOtherCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_9fa942f9-2338-46a4-b3ad-6fc768e61ce1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_dc689dd7-15fd-4891-b0b0-907a6e3b257a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fead7ccd-3f85-46b8-aca7-694cbaf88fdc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b1074be1-7a1b-4d3d-bae0-3a6b043bf941_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_765315eb-885d-4cee-b4e4-3dc784fd716b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_43690917-44b9-4c92-82d4-18aefb7ddb83_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreed purchase price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_50802b39-9fc9-466c-832a-1f97003b6085_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5302351a-8920-41eb-b92c-42e3f874b95c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AssetImpairmentMember_edc3d464-968f-463b-a0b7-f083480223e2_terseLabel_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_label_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment [Member]</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_documentation_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember" xlink:href="bax-20220930.xsd#bax_AssetImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AssetImpairmentMember" xlink:to="lab_bax_AssetImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_40268c2b-86bd-4244-801b-e7eca400def8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_fdbf18af-76dd-4286-88d8-babbe6ed3660_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_8abd1aaf-207d-4a7e-aa6e-3997f77323a7_negatedTerseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Currency Translation</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:to="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a2a35041-703d-44cb-a681-9cc4532eb1d8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_ebe3ac45-08a5-44f1-a287-1a0377bf0435_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension and other postretirement costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ba6efd52-0992-4c1a-a640-4a97d96848f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bd7325a5-86d9-4eaf-a485-5af56b72606b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_ece7db75-ba40-44ec-ba4a-ba07d8505e71_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_7acf5008-c839-4254-9694-104da21d39b8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_373a3be8-67d4-4bc7-bb35-42c098772734_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cecad295-86ad-4cb6-84a1-19ad6b37f8bc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_73d18a06-8c8d-4ed2-8eeb-c5e0cf4a4a3a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_996c0a09-cff0-4b38-8ad6-b55dbe5e0724_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b66adb8a-cafe-40af-a69e-a9dc3cc39094_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9d0bd3fc-90c1-4727-81a6-9d1875af227b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_5ce53087-be85-41b8-aff9-6a950e9aadfe_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_10e80e7f-0abd-4d1c-9cce-5a8758892bae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_462777d0-9b7e-4a2d-992f-8fa7d3cc8d4e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_1a5caf62-8e48-4c37-8cff-e4086acd86b0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c785a989-f3ae-4e4d-8e85-91e475c6f802_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_72667515-4ada-40dc-b41e-6d135c95101c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8d923d1f-e347-4814-bae1-d9566cb55288_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_135799a8-d077-4b27-a530-74f474c18e84_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b032d35a-8e5c-4035-9562-379fb0b85f4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_8f1a1fe2-cf86-414a-bdac-031191b903e8_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_67986567-1fbb-42dc-ac93-5cb8e9718142_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_1bfbb07f-cb6a-4623-ab74-0947c049e819_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_6a1787f6-5954-4b90-9a65-3bf72e92ccd1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value, total</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Security Sold under Agreement to Repurchase, and Security Loaned, Subject to Master Netting Arrangement, after Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RenalMember_7e184060-614a-46f3-bd9f-11765b94ff5d_terseLabel_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care</link:label>
    <link:label id="lab_bax_RenalMember_label_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal [Member]</link:label>
    <link:label id="lab_bax_RenalMember_documentation_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember" xlink:href="bax-20220930.xsd#bax_RenalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RenalMember" xlink:to="lab_bax_RenalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_92035807-a763-4f3e-aa55-8f71037ba995_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5208163-8b55-4c80-9054-265afdc9cf5e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_e98034ef-7450-49f4-821f-91277da11437_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_3d1bcc76-bc4a-4c37-b830-701406968854_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_c10c7563-1e62-42df-bc69-13ac268d23c1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_afe7d2cb-3452-4abf-aed1-503cfaac545b_terseLabel_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_label_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_documentation_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits" xlink:href="bax-20220930.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LossContingencyNumberOfLawsuits" xlink:to="lab_bax_LossContingencyNumberOfLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_49305499-fc06-40c1-a0e7-bb27940f4794_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to cash flows from operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BioPharmaSolutionsMember_717fc508-353d-46fd-8c8d-e4e61a909032_terseLabel_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_label_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions [Member]</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_documentation_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember" xlink:href="bax-20220930.xsd#bax_BioPharmaSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BioPharmaSolutionsMember" xlink:to="lab_bax_BioPharmaSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_14fd89b6-9b9e-4a64-a61c-df41fb198f9a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_24341240-b2f2-4d65-a3ec-33c9c0368b09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a1aadbc8-92c3-4b13-af32-48031eddb37f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8a9b06fa-6355-4383-bbf9-159c6228d18a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement_a94060d0-81b2-4652-8102-6e6d04500f63_negatedTerseLabel_en-US" xlink:label="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on product divestiture arrangement</link:label>
    <link:label id="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement_label_en-US" xlink:label="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Product Divestiture Arrangement</link:label>
    <link:label id="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement_documentation_en-US" xlink:label="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Product Divestiture Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:href="bax-20220930.xsd#bax_GainLossOnDispositionOfProductDivestitureArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:to="lab_bax_GainLossOnDispositionOfProductDivestitureArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a7b32495-bd35-4260-aa7f-26fd9776bac2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d68b64eb-2617-48d3-9935-97c98d1b4608_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresTable_74180ac8-1830-48c1-8cfe-5f9bc90039b4_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_label_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosures table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresTable" xlink:to="lab_bax_FairValueDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_43d5012f-929d-48e0-bb17-c10a70b9f56e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_2fd28854-3d48-42b1-ba39-275dcb8175f2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_342a1a8d-e699-4b6f-bb92-1f4166539227_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_accaefc7-78a7-4dce-8488-6a757eb4c5da_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SuperfundSitesMember_7e64cc8a-54cb-45e7-aa2b-81ca641eadad_terseLabel_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_label_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites [Member]</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_documentation_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember" xlink:href="bax-20220930.xsd#bax_SuperfundSitesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SuperfundSitesMember" xlink:to="lab_bax_SuperfundSitesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_3b31e765-0843-4f12-a9f9-2ee1e935f65a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_819ac977-7f11-42f7-88dc-d5abac583d4f_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_46760caf-3fd6-4c2c-b99c-02ab27eb27d6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4894763d-659e-410b-a0ca-7235b9f205f3_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e136a20d-b55b-4896-80bf-53d6934ce24e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ba4f7e44-8384-41f0-9fa5-3845dc8cc160_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_66143865-3c36-4c0b-b7e6-7fd445d49960_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_905f70e7-3130-4f36-ae6e-f56ffe143980_terseLabel_en-US" xlink:label="lab_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Basis, Corporate Headquarters</link:label>
    <link:label id="lab_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_label_en-US" xlink:label="lab_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Basis, Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_GeographicBasisCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember" xlink:to="lab_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_57e796ff-4006-4bcc-bb9e-605b740223fb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_031a1a51-dbae-4a53-ad21-67d8deb1ed38_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_1ef0b70e-0948-44bb-9e23-d50d9280ffca_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_6c7f6b63-61e5-45da-a047-b1df8046fe33_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Short-Term Debt</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0f40aec3-6ad1-4118-90c4-ccd2b12aeb0b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c4cbfe3c-a5e3-4a86-8300-32eb3f170bd7_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book values</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a369bb8d-d935-4a12-9082-61fc6d0fd317_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_0a48a6e9-38a3-4ea2-b109-b4d128cdc8e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_d4843f91-b255-4f36-a238-12d361a0a9cc_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseRevenue" xlink:to="lab_us-gaap_SalesTypeLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_67f4025e-8289-49bb-b15c-9b7f4c3d09c6_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_0f098a60-a13a-4945-bb9e-d45cb0e15183_terseLabel_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Senior Notes Due May 2024</link:label>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_label_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Senior Notes Due May 2024 [Member]</link:label>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_documentation_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero point four percentage senior notes due May two thousand twenty four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member" xlink:href="bax-20220930.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A04SeniorNotesDueMay2024Member" xlink:to="lab_bax_A04SeniorNotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_8ba9ab24-812f-4bdc-99e7-b15a63c1ec70_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_2fe62201-dc66-4230-98d9-8a3838c8dd77_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c04f863c-2a6d-46f9-9361-e558f4f89b68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_7109d74f-bf52-4d52-9152-d6c0c75dbf8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_cf2c9fd2-6765-4962-94ba-d10f77bffd2b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred, net after-tax gains on derivative instruments</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_22f2aa61-636e-4e1a-80fa-27c50768237c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_f3d24a87-0c61-4155-abba-0225bc26d521_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of marketable equity securities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54156a1f-3f10-4d51-898c-aa502033115e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d4c53ff-b349-4e3e-b532-6d540bfe0b93_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_dcd1a207-cecf-4e95-a9b7-b486f3d96b53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, net of tax expense (benefit) of ($16) and $3 for the three months ended September 30, 2022 and 2021, respectively, and ($25) and $16 for the nine months ended September&#160;30, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_d054f3d1-0906-4d87-916c-22ecdbca171c_terseLabel_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Senior Notes Due May 2029</link:label>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_label_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Senior Notes Due May 2029 [Member]</link:label>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_documentation_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One point three percentage senior notes due May two thousand twenty nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member" xlink:href="bax-20220930.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A13SeniorNotesDueMay2029Member" xlink:to="lab_bax_A13SeniorNotesDueMay2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9327ab4a-3139-4ed5-94ff-e7db637842cf_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e387e2bf-f57d-48b1-a698-bc62b872f55a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_85e07abc-4dcf-4fef-b420-92adfa986284_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_bcef7dd4-b376-4ef7-91b1-b93a6d3f3a6c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_323377fb-c8a5-46c8-a319-d3e352f3dc5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension curtailment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b2f84088-d7f9-455c-94c0-46eaa33bb30e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_ac190654-ec1b-4061-9b38-7ca022012b2c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_97fe4893-29f5-4c61-8257-c2a5c8d5ead2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures incurred but not yet paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_fad9f5c9-28a9-4ad8-8af5-196fbc70c988_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders' equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_226488b2-86d2-497a-80b3-3fa2adb1cd37_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_526cff6c-da19-4015-843e-d028e8b101a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3ce36241-4acb-4f41-80eb-a658c58fc36a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cc237839-1fc5-4db8-a0d3-55f5a6163a2b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_90d10192-b65e-42bd-9945-68b4ca23d959_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c70f424e-599d-4835-a0f8-6e79263f54ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PharmaceuticalsMember_11b4cd3a-c22e-4247-908d-b25ebe0cc2bd_terseLabel_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_label_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_documentation_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember" xlink:href="bax-20220930.xsd#bax_PharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PharmaceuticalsMember" xlink:to="lab_bax_PharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f7c56705-1370-4f1c-af5a-78372bc20fc9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a11d7b3-6a4e-4861-8f45-544ea840b061_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_e0bf8691-b600-4b28-817e-e2407c03dd79_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, total</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SoftwareArrangementsMember_f6f41984-5aab-4db9-aad9-bcd4059224ae_terseLabel_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software sales</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_label_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Arrangements [Member]</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_documentation_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SoftwareArrangementsMember" xlink:to="lab_bax_SoftwareArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_60027601-c88c-459a-9894-ace09e4a46e6_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8eace3e4-00d1-4c2d-9540-cb24d94d49d8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c5aff4e2-cb80-4119-9a57-e5733f152c79_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_691e7156-e434-41b7-a709-367d16739d4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d8152932-ddbd-495d-91f6-93d515c56c51_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_75b755a3-2309-4a5a-9868-bc42701aa4af_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_b31a6b03-254f-4fef-8845-fe442e2ef229_terseLabel_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_label_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Currency Translation</link:label>
    <link:label id="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_documentation_en-US" xlink:label="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:to="lab_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherProductOrServicesMember_6cc92f38-c9c3-49af-aae6-2e0f79d1c8c0_terseLabel_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_label_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Product Or Services [Member]</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_documentation_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other product or services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember" xlink:href="bax-20220930.xsd#bax_OtherProductOrServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherProductOrServicesMember" xlink:to="lab_bax_OtherProductOrServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ed17caed-a071-49f8-bfc1-58640828bb04_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock issued under employee benefit plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e7328e13-2c08-499e-a7a3-b6ddf67cea11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information for Our Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_683c5598-fde8-4e06-8604-da8fd05ce3df_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated pre-tax unrealized translation gain in AOCI</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_05a69b80-1203-45fd-9435-efd7efda13b1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8dcf8b60-8eca-4841-bbfa-8eb5d802b6d3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12d45e09-508f-4c04-a9f0-9a951cddec4c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_20aa3ac8-325d-48d3-8db9-80d1cee581a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_5175cdfb-47be-4a4d-8ca0-866188ea8c7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeFairValueTerminated_e292a4d1-f038-4081-8040-976d591f6d74_terseLabel_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_label_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated" xlink:href="bax-20220930.xsd#bax_DerivativeFairValueTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeFairValueTerminated" xlink:to="lab_bax_DerivativeFairValueTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_3373600f-aa88-4737-9494-2148d1675f55_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Business Optimization Charges</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_label_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Charge [Table Text Block]</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business optimization charge.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:href="bax-20220930.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:to="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_7563bb88-8835-46d9-a926-b2ab94634049_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_MedicationDeliveryMember_8c2f72d6-574b-4291-9d9a-5cce870640f1_terseLabel_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_label_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery [Member]</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_documentation_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication delivery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember" xlink:href="bax-20220930.xsd#bax_MedicationDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_MedicationDeliveryMember" xlink:to="lab_bax_MedicationDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_0d17d617-b6bc-4b0d-9d05-e917053990b1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increases (decreases) in debt with original maturities of three months or less</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_1f0cf87b-3f18-4941-ae7c-bb6f0e1c5873_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type leases, receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_73634681-2aca-4d03-8e40-56e0e1b4954a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_cbadfdae-abc5-4add-81db-a5da65ebcf87_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_cd5870f3-4bb4-4d67-a18b-4ec91e7a53f7_terseLabel_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy [Policy Text Block]</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="bax-20220930.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8bac2345-c01b-4e5a-8738-d144d92aa00d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_fca6c6ff-4a31-4746-8963-d44262f18fab_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3893ea1c-d63f-4269-84c4-3acb2429a881_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5a9cb609-1cc0-40b4-af14-17e6011e7d3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f71d38b4-4d94-4289-b74f-c48b9ad13b50_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_78919196-c415-4c60-84b9-1e28e162fa43_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_27485e43-c038-41a1-94c3-6b72ce715ba6_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A0868SeniorNotesDueMay2023Member_9521f2a9-ce79-4c7c-99a8-cfbf225bfd90_terseLabel_en-US" xlink:label="lab_bax_A0868SeniorNotesDueMay2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.868% Senior Notes Due May 2023</link:label>
    <link:label id="lab_bax_A0868SeniorNotesDueMay2023Member_label_en-US" xlink:label="lab_bax_A0868SeniorNotesDueMay2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.868% Senior Notes Due May 2023 [Member]</link:label>
    <link:label id="lab_bax_A0868SeniorNotesDueMay2023Member_documentation_en-US" xlink:label="lab_bax_A0868SeniorNotesDueMay2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.868% Senior Notes Due May 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A0868SeniorNotesDueMay2023Member" xlink:href="bax-20220930.xsd#bax_A0868SeniorNotesDueMay2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A0868SeniorNotesDueMay2023Member" xlink:to="lab_bax_A0868SeniorNotesDueMay2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_991938ca-9566-40f2-ae66-075141d62dbb_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_dd3cccaf-34b1-4b91-ad9a-508bd7e3d099_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a3040811-87f0-4aac-9df3-7a144040ad8a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_20f1bf62-ae5d-4022-97a5-30d5a27727c0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A1322SeniorNotesDue2024Member_a9baae84-0edc-4e52-a363-adb10c869b9f_terseLabel_en-US" xlink:label="lab_bax_A1322SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.322% Senior Notes Due 2024</link:label>
    <link:label id="lab_bax_A1322SeniorNotesDue2024Member_label_en-US" xlink:label="lab_bax_A1322SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.322% Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_bax_A1322SeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_bax_A1322SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.322% Senior Notes Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1322SeniorNotesDue2024Member" xlink:href="bax-20220930.xsd#bax_A1322SeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A1322SeniorNotesDue2024Member" xlink:to="lab_bax_A1322SeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2b2c7f1a-f7a8-4649-827c-e7f2fde7fec9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_6404c07d-e215-4166-bb70-0abeba050605_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_63dc30b5-e272-4e8c-87bf-26de7853f45b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EnviromentalCleanUpMember_1d5c0731-4199-42aa-84a5-fd6639d43594_terseLabel_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Clean-up</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_label_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental Clean Up [Member]</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_documentation_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental clean-up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember" xlink:href="bax-20220930.xsd#bax_EnviromentalCleanUpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EnviromentalCleanUpMember" xlink:to="lab_bax_EnviromentalCleanUpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4ef9328e-ec71-4470-8696-4e71c43f9857_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, net of tax expense of $5 and $8 for the three months ended September 30, 2022 and 2021, respectively, and $13 and $19 for the nine months ended September&#160;30, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_2dca45b6-b33d-4289-a402-f104ac7da96c_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_f65a6375-f2c6-4f6d-a226-7d82c826ec6a_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_label_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs [Member]</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember" xlink:href="bax-20220930.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationProgramsMember" xlink:to="lab_bax_BusinessOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_feee4ab6-de99-4fd8-af56-be9db421410e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_b4debf2b-7896-4747-8f91-3eec829f1013_terseLabel_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global payment terms</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_label_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_documentation_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:href="bax-20220930.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:to="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_72638192-d91a-42cf-9013-11a537ba5fe8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9b24d06b-5499-4d95-8a23-a8225a08e27e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e9ab8eee-4d2a-420e-84ef-8d03e328467c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_17164fed-59a7-4778-b22a-ae34fb944b3e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A2539NotesDue2032Member_43a9b7b2-11bc-4b17-9d23-01727a341140_terseLabel_en-US" xlink:label="lab_bax_A2539NotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.539% Senior Notes Due 2032</link:label>
    <link:label id="lab_bax_A2539NotesDue2032Member_label_en-US" xlink:label="lab_bax_A2539NotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.539% Notes Due 2032 [Member]</link:label>
    <link:label id="lab_bax_A2539NotesDue2032Member_documentation_en-US" xlink:label="lab_bax_A2539NotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.539% Senior Notes Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2539NotesDue2032Member" xlink:href="bax-20220930.xsd#bax_A2539NotesDue2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A2539NotesDue2032Member" xlink:to="lab_bax_A2539NotesDue2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9cee379f-abf8-40bf-aece-3ac8d4592ed1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities, net of tax expense of zero for the three months ended September 30, 2022 and 2021, respectively, and $1 and zero for the nine months ended September&#160;30, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_03b7e6c9-99b0-4a71-a8d0-39ca29ba7ec5_totalLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e7d639e4-2b3a-4fca-a795-0f0d2f6cdbe2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS OPTIMIZATION CHARGES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7f62deea-3c2a-485b-9616-41e37e0dae66_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_388ad0a9-00d9-4dcc-9d97-3772bc53a438_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in income, undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_85eb205d-01b2-40f9-a258-c44ff3bef5f2_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c3494eb-1366-4c0c-aeae-03f8e17f9c4b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_697f2bc5-f1f4-4cdd-9223-a7daf84033f1_terseLabel_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_label_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products [Member]</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_documentation_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable medical products [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember" xlink:href="bax-20220930.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ConsumableMedicalProductsMember" xlink:to="lab_bax_ConsumableMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6dd4ea89-87ec-419c-a6ec-b5171b9637f6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2f4220e1-ebf3-4cef-b393-e5537e9e2e4b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_a5e69614-f1eb-41cd-8df9-57cb4c146385_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales from Contracts with Customers by Global Business Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2c7a884a-d749-4732-9c5e-8f583c915fe5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a44f86f5-b5c2-40b3-9e61-296f1dbde8ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0a67d6e1-515e-43c9-941b-ad3f262da87e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_e8f7ddf6-ccc9-4c2f-9f74-ce42ca292375_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5c52eef8-ae40-4e14-9bbf-c002299c7a0c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4d72c284-b529-4fc8-a2af-a2e8d79780cf_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments designated as hedges</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_aaa4308c-2210-4c94-ac16-bb9b6b943545_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4adaa02c-816b-4206-a8d5-31d7b783ff2d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_bb44d406-0aba-4eab-a826-0139e993fb26_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7131bf8d-d30f-4b86-8b7c-25ef450fc8ba_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_0d1099b7-9964-4ed4-bd2a-8ceca2a5083f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_e37e5770-840d-4b4c-ab56-63c8ada82d76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7c2ce3f1-4c06-4642-a2f8-e01bb4a3025c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9aaee827-f057-4e55-9c67-e2267391388d_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net, finite-lived</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_44ca53e8-eb61-4a79-bd8c-7aee153c0892_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_83265642-15bd-4078-96a4-0869df468854_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_af3a8a96-cc6b-4886-b12a-0c87dfbe791e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of cumulative translation loss to earnings</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_c393893b-ee09-431e-aa31-3d753f1feea8_terseLabel_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_label_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_documentation_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems" xlink:to="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_777f1b08-aaaf-4247-99e3-e25f8c93a02e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0e3f11e-ee6b-4e97-b959-c261cfe6e8ba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_36fd54db-375c-4a38-a4e8-27b2eb2d8816_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental costs of sales</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a98875d3-ffd5-4a56-9376-99ecc600a54f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_1f6df72f-f628-4c5a-a526-b2689e62621d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8e30f81c-6c36-4cef-a4a9-b5fe96a9bb81_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0689ff8-a814-49d3-96ae-b3fef932167e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2fd4fbc5-07a5-4095-83ba-72efed8ac1c6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_acdc43bb-9679-4afc-b34b-aa2840973e46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7f7d027e-f646-4ebb-817e-720d8d8260b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_ffc08540-abe2-4b92-92b0-36cd1af4b189_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_20ca926f-4cc4-459b-b444-5fe1c39ab454_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7a725c9b-8f4d-4972-8247-dee8aeae5110_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_002ea1c6-c1ff-4aff-afd2-f48cf47e29c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2b643133-72f6-4b45-8535-e35f1ab60d69_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0a314dac-ca33-46e2-901e-a5e0d93d939a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_bc2c0d2d-4580-4f37-adf8-04431517a314_terseLabel_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_label_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_documentation_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable" xlink:to="lab_bax_AcquisitionsAndCollaborationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e5aa6804-caf1-4121-8efc-425aa5ee6130_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair values</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_1077541c-a7fe-4be7-a4e5-f2da5bfab3b8_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Stock Exchange</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a9178a47-7426-40c1-8451-46c40229feb0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_fd7ece08-88f8-4791-9366-b93956f90dc3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to settle the case</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_61e35e14-8611-4cb4-8329-17aa81c03307_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e7a0cc6e-469a-4bc2-9f8e-a28e5509028c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_e6f4f840-3008-4bae-aff6-5c6254678a3c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_83cb5ec5-fd81-4297-b73c-6b35f4de11e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_7cc1b0d0-0bc8-48da-a19d-23fe74533c57_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_5dda8b4d-1952-49d5-a524-eb4d0f04dbab_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_098b0578-4bfe-49e6-aab1-635f03c7790c_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental reserves</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_67f7b415-a7ab-4170-84ab-905198446a58_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_ae745f50-634d-4e0b-9359-3453105c5419_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_cd3eb816-d148-4e0e-9bc1-f6d9dc060e3a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cfe1f41-bc01-4657-80ea-b80618f966b2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a67dfc7b-4b29-4382-9071-74c2d5243e65_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c439b467-1c3b-4fa2-819b-47830aed28f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_359fbf9a-da3e-4220-9faf-3ed023acb46a_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_41f75618-1e49-4b35-a687-b4318fb67f19_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2025Member" xlink:to="lab_bax_GlobalNotes13Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_8bb62352-c9da-4ae1-9ef3-b0955af77a75_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XCHI_d22d79ab-bfb1-466d-86d6-9bc8041037a1_terseLabel_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago Stock Exchange</link:label>
    <link:label id="lab_exch_XCHI_label_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NYSE CHICAGO, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XCHI" xlink:to="lab_exch_XCHI" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_d534d390-94a1-4263-9e4a-18dca08fa032_terseLabel_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan</link:label>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_label_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan [Member]</link:label>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_documentation_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember" xlink:href="bax-20220930.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeniorFiveYearTermLoanMember" xlink:to="lab_bax_SeniorFiveYearTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ec828e86-19e6-4f6d-8c7d-9c1b85f005dd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_978374c4-908f-4ca1-a4da-352afa8d3ab3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_b701d49d-c09f-4637-be0b-87fca6409c2e_negatedLabel_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:href="bax-20220930.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:to="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_HillromMember_6c0e58c4-45a9-4906-8bc7-3919428f9028_terseLabel_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom</link:label>
    <link:label id="lab_bax_HillromMember_label_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom [Member]</link:label>
    <link:label id="lab_bax_HillromMember_documentation_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_HillromMember" xlink:to="lab_bax_HillromMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_64e436de-571b-4f76-8bbc-18e17e8119fb_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_a7afeb56-0c30-41ab-826f-2548dce87c1e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_49d849e7-c001-48da-b87f-94ec3246ca97_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A3132SeniorNotesDue2051Member_c415413b-a809-4ca3-9102-7d9ff4af913e_terseLabel_en-US" xlink:label="lab_bax_A3132SeniorNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.132% Senior Notes Due 2051</link:label>
    <link:label id="lab_bax_A3132SeniorNotesDue2051Member_label_en-US" xlink:label="lab_bax_A3132SeniorNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.132% Senior Notes Due 2051 [Member]</link:label>
    <link:label id="lab_bax_A3132SeniorNotesDue2051Member_documentation_en-US" xlink:label="lab_bax_A3132SeniorNotesDue2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.132% Senior Notes Due 2051</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A3132SeniorNotesDue2051Member" xlink:href="bax-20220930.xsd#bax_A3132SeniorNotesDue2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A3132SeniorNotesDue2051Member" xlink:to="lab_bax_A3132SeniorNotesDue2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b3b0fd25-7fe3-4d97-9dbf-87b31dd4f7dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_799938da-c185-4550-a716-70c4fec46d62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30b2245b-fe51-4727-b23e-46d77480ff85_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_17f29952-ac3c-44d1-a378-b8c9a71f5141_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_cdb8eaad-64dd-4972-8a98-f94d5aa78b50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PatientSupportSystemsReportingUnitMember_3b4d6efb-ca9b-479b-ba6a-3a255eeb5e51_terseLabel_en-US" xlink:label="lab_bax_PatientSupportSystemsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems Reporting Unit</link:label>
    <link:label id="lab_bax_PatientSupportSystemsReportingUnitMember_label_en-US" xlink:label="lab_bax_PatientSupportSystemsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems Reporting Unit [Member]</link:label>
    <link:label id="lab_bax_PatientSupportSystemsReportingUnitMember_documentation_en-US" xlink:label="lab_bax_PatientSupportSystemsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsReportingUnitMember" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PatientSupportSystemsReportingUnitMember" xlink:to="lab_bax_PatientSupportSystemsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_816aaedf-097e-4fd1-93f4-d852ff55c9af_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity awards issued to Hillrom equity award holders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_486fd889-e17f-464a-8ee2-ad84a5514e2d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FrontLineCareReportingUnitMember_97b9a499-f309-4dcb-9213-6f62d6237cf3_terseLabel_en-US" xlink:label="lab_bax_FrontLineCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care Reporting Unit</link:label>
    <link:label id="lab_bax_FrontLineCareReportingUnitMember_label_en-US" xlink:label="lab_bax_FrontLineCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care Reporting Unit [Member]</link:label>
    <link:label id="lab_bax_FrontLineCareReportingUnitMember_documentation_en-US" xlink:label="lab_bax_FrontLineCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareReportingUnitMember" xlink:href="bax-20220930.xsd#bax_FrontLineCareReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FrontLineCareReportingUnitMember" xlink:to="lab_bax_FrontLineCareReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0b55de60-0bc9-4b79-b380-3ffed90668dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_c955a023-d2e8-464d-b9ab-0d03a00dc08e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4ab2c885-8f3c-4f54-b95e-8164189d2eed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1aac2dd4-7ed4-41a6-9e0a-4d8091ece2d9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_b1a208cc-21f0-47ea-b67c-b1d5de796d5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_41305ba5-792f-4323-8acb-f5e5ed71552c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_01912f36-05be-49eb-96b4-daebcb54be37_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_95d54b4e-9203-49be-9e64-e748e511c35e_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8881f18d-6485-410e-a913-2c95c56be8ab_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_510447b8-c7ba-4481-8993-ca886f3649f5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_68daa221-4c18-4ef1-977b-9e16a93533f2_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Positions Presented On Net Basis</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of derivative positions presented on net basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:href="bax-20220930.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:to="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_ab203682-73c1-4c58-97c3-d7c81dab2086_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_50e2d556-4e8c-40e8-a29e-85cdae35df3a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs to implement business optimization programs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_0dcef89e-7a5c-48a8-8f16-713d8f1f7c8b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease, net of investment in lease</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_b11ba316-5f9f-4ca3-a05f-476dfb88ba7d_terseLabel_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025</link:label>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_label_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025 [Member]</link:label>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_documentation_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member" xlink:href="bax-20220930.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A130SeniorNotesDueMay2025Member" xlink:to="lab_bax_A130SeniorNotesDueMay2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_c043afb9-600d-4aaa-8f91-16e3279a704b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_9cfb23f7-46e1-483b-add5-5a835680957f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_7bb3911e-8e27-4b88-8bee-4ecb2b0d25bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_374c0377-bde8-48f9-aa4e-a3c666794449_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net losses and prior service costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_49cb4bdd-0aa4-4b14-807a-877385c4db45_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FrontLineCareMember_9c94248c-d661-4271-8539-77d9d2b79c4b_terseLabel_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care</link:label>
    <link:label id="lab_bax_FrontLineCareMember_label_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care [Member]</link:label>
    <link:label id="lab_bax_FrontLineCareMember_documentation_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember" xlink:href="bax-20220930.xsd#bax_FrontLineCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FrontLineCareMember" xlink:to="lab_bax_FrontLineCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_76fb5422-d7bd-479e-be72-99ce141ade63_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gains) losses, net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_180073aa-eeb9-4f43-ad31-9a5904243ac5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ddd1de55-71e8-40dc-a60d-5787f41f806d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_6b6335ed-9e63-41bd-b8bd-67111073007d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_56a284d9-e0cb-4688-becc-a1da63047a24_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining value available under stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c7fee856-99bb-4232-8f53-ee2487efbb20_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities excluded from the computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_c38bf39c-c96e-4d8d-a0f0-d0047f1e0ec1_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_459b9f54-a346-43c5-8365-5a5339cbbd7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_26536b2f-6761-419c-b4c9-b6b49ae7b24d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_51898248-69f0-467f-a542-bbb39c9e688b_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64393ecd-d3e1-4c41-823b-1614f8fd5244_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired, and investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_5e4aab49-0a45-4929-b6c4-c87fb3ef7cdc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3f69169c-461f-49f4-9876-8a8240d3dd47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_f5b02ef9-32e2-4eb4-8b9c-a2769d454b98_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income to Income Before Income Taxes Reconciliation</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_8909c248-5680-418b-a0ca-e7eb454d8cbb_terseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New revenue deferrals</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:to="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c6f17bc0-7649-4838-bb6e-48b7c6834d62_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5190082d-8d2c-4d92-aed9-447aae395c1d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8365d5ec-cf54-4685-b4b3-03089f2faa0f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ec825a5d-f111-407c-86e2-26d67c263e37_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_811aef33-2421-43b5-8189-7e93ba22aafe_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PatientSupportSystemsMember_8de7128c-692c-41ef-9ef3-a1af731c4586_terseLabel_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_label_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems [Member]</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_documentation_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PatientSupportSystemsMember" xlink:to="lab_bax_PatientSupportSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a06cdc3f-6656-43b1-934f-589bf62cf43e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AsiaPacificSegmentMember_8e2feb21-6433-45b1-b1fa-2ee1d0198b2a_terseLabel_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_label_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment [Member]</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_documentation_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember" xlink:href="bax-20220930.xsd#bax_AsiaPacificSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AsiaPacificSegmentMember" xlink:to="lab_bax_AsiaPacificSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9515eca4-4611-4b91-858c-e822a17f6262_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EMEASegmentMember_d8f862aa-28d2-4167-95b2-78656a4cc63f_terseLabel_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_bax_EMEASegmentMember_label_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment [Member]</link:label>
    <link:label id="lab_bax_EMEASegmentMember_documentation_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember" xlink:href="bax-20220930.xsd#bax_EMEASegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EMEASegmentMember" xlink:to="lab_bax_EMEASegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_8bc7d57d-cef1-43b9-8661-b95e398390d5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9b975d5c-348b-4f21-8ae0-3e45c6db6dd9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_b211bb2b-a21e-410d-9ec7-bcebc7381f18_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_9898c270-2d7e-4c78-b920-96ce8ce5b5d8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:to="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_833b076f-c625-48d1-934f-ce6d9ff59ba9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_8c0c1e17-c6f8-4be5-a0fd-7360484db10b_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_d83c4ad2-de8e-4cde-b99f-c3f8463ed13a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0ec0510a-64c7-437e-9e20-4f6f2e6cc0b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_15c7c750-1afe-4ebc-97d5-9d2c77a8f13b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_3f22c49a-f78a-49ec-a9ac-c772952da523_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_168c94c1-eb58-4db4-9ad8-944e809ccc29_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6d4b750b-1cf8-4ace-b104-34b97c4abf02_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2d722cc2-5677-4edf-960a-2df12ef44181_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_a5857c55-28f8-4cd5-8f66-191a482b95d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_a54aa3fd-4bf6-49d6-a3aa-d031625af20c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_4249e217-d8fe-4c51-af40-8255777c54d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_49ed2604-802f-4e1c-b45a-1b6e9e619f08_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c65c696e-15c2-49b1-8179-048fd2ecc183_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9f9bf8b6-5930-45eb-94bd-06088a8f25f7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_982822fa-dd85-47bb-a61b-24852c6be1f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7465b988-4733-43db-95c9-0d440b33d031_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9eff20d5-347e-4432-a232-aa22aa0af838_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_14f9648e-9569-4504-902c-6552a1732014_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f9a1da2c-4600-41f4-a97c-ba39e14c66fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4c9dc0a1-2237-433d-9fd4-f3e8a95e5174_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_59f47b3e-7c64-41c3-b35c-ff757aa3124e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_b476e7f8-49ab-4307-9cbf-8974a9beb907_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_ca04881c-57b4-48d6-ad2d-5d6f7876dad0_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_87304135-a7ca-4216-b2a8-0346c5acc727_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_322cd87f-d1fe-41e8-9f9a-97d5ea331d8b_terseLabel_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_label_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale, Debt Securities [Member]</link:label>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_documentation_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale, Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember" xlink:href="bax-20220930.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AvailableForSaleDebtSecuritiesMember" xlink:to="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_cbbd425e-2290-4d9a-bac6-da95537a364f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_55861ade-3e14-43c6-b31c-c23f4c23922f_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_20fd2d4f-8a30-4548-9488-de7ad1acd2ab_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_59c8a242-13c1-48a8-a113-6b716274d9c6_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_866da92c-19eb-4084-95f2-01b7801fbcf4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bdcc67b2-9103-4f56-bf87-3bc99244e281_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_00a1eac9-7b18-493f-9d9b-bacec2d426db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_aad1096a-3745-45d8-a27b-30c34fc5cd19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_1646cb62-4328-465a-95fa-bd1f666f1f96_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_04ae1721-1de3-444a-bfa6-5196705bbb29_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1c794c8d-126f-42f6-b7dc-5f3b55e80adf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_12c47462-55ad-41bf-9657-53840545d466_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_29552842-80fb-427b-bf6f-213a3d9a417b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil settlement amount</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c45320d-6164-441c-8dd4-f55d1f8976e4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A2272SeniorNotesDue2028Member_c28239eb-3b01-4407-bd40-f0aad48b0536_terseLabel_en-US" xlink:label="lab_bax_A2272SeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.272% Senior Notes Due 2028</link:label>
    <link:label id="lab_bax_A2272SeniorNotesDue2028Member_label_en-US" xlink:label="lab_bax_A2272SeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.272% Senior Notes Due 2028 [Member]</link:label>
    <link:label id="lab_bax_A2272SeniorNotesDue2028Member_documentation_en-US" xlink:label="lab_bax_A2272SeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.272% Senior Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2272SeniorNotesDue2028Member" xlink:href="bax-20220930.xsd#bax_A2272SeniorNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A2272SeniorNotesDue2028Member" xlink:to="lab_bax_A2272SeniorNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_40909d1a-521e-4c14-b6da-e06da4fbd6a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity in Reserves Related to Restructuring Initiatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f2c08a75-2a06-43f5-a662-9b21fe854462_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fad542d4-6bda-4586-bc06-9d71b5f4c4c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_eaec3089-4f79-4608-be2f-fb6f26769a81_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0afb680c-91e5-4618-b0a7-10fc9d4dcced_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_dffefc9c-6955-4bfb-84ad-9ccc3db00e19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CelerityMember_77089f5a-1533-400d-a41b-e891e3320a10_terseLabel_en-US" xlink:label="lab_bax_CelerityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celerity</link:label>
    <link:label id="lab_bax_CelerityMember_label_en-US" xlink:label="lab_bax_CelerityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celerity [Member]</link:label>
    <link:label id="lab_bax_CelerityMember_documentation_en-US" xlink:label="lab_bax_CelerityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celerity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CelerityMember" xlink:href="bax-20220930.xsd#bax_CelerityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CelerityMember" xlink:to="lab_bax_CelerityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8fdb1f63-7ee0-478b-a1ee-3f65e8d0bc96_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_d8579469-a1a0-49ed-94b3-643161f83f03_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_4c19e9f6-4ce7-4496-bcfa-4479b6f5fb1f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FloatingRateNotesDue2024Member_9de4376c-54a1-476c-a01e-6dc351431de8_terseLabel_en-US" xlink:label="lab_bax_FloatingRateNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate Notes Due 2024</link:label>
    <link:label id="lab_bax_FloatingRateNotesDue2024Member_label_en-US" xlink:label="lab_bax_FloatingRateNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate notes due 2024 [Member]</link:label>
    <link:label id="lab_bax_FloatingRateNotesDue2024Member_documentation_en-US" xlink:label="lab_bax_FloatingRateNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2024Member" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FloatingRateNotesDue2024Member" xlink:to="lab_bax_FloatingRateNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_c35dc10d-9535-47f7-81ba-28b9016a285c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_46b5c643-86e2-4049-98ec-6d0345046054_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserve</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8350c341-752a-4cde-b231-13206a5a30f5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AdvancedSurgeryMember_d8074564-e86d-40b4-afa3-d750b6266272_terseLabel_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_label_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery [Member]</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_documentation_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced surgery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember" xlink:href="bax-20220930.xsd#bax_AdvancedSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AdvancedSurgeryMember" xlink:to="lab_bax_AdvancedSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_9ec2faa1-0ede-4723-8e13-fbe30d094d24_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_307c8d21-8fda-4808-ab44-9cba07c02fd0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_4b4ee0d0-acdd-4608-aea4-9850094206a9_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_cb028dca-c4cd-4b41-9d12-3bbfd2230db5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a550ed3f-8c50-42ae-8a7a-733a9fe51cee_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a448bf52-0355-46f8-bf9e-fb6725f9d047_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_e7b2f7d2-6a73-41b0-b61c-05604af18ef0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining revenue performance obligation, percentage of revenue expected to be recognized</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0c4e45d-9aa3-413b-9d1a-3986b09eb66d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FloatingRateNotesDue2023Member_27f78b30-b3c4-42fb-bae4-403bf744515b_terseLabel_en-US" xlink:label="lab_bax_FloatingRateNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate Notes Due 2023</link:label>
    <link:label id="lab_bax_FloatingRateNotesDue2023Member_label_en-US" xlink:label="lab_bax_FloatingRateNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate notes due 2023 [Member]</link:label>
    <link:label id="lab_bax_FloatingRateNotesDue2023Member_documentation_en-US" xlink:label="lab_bax_FloatingRateNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2023Member" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FloatingRateNotesDue2023Member" xlink:to="lab_bax_FloatingRateNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e8446be3-8758-435e-affa-d0660047f6a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9047d4db-f336-4065-96a4-8b23b792fa76_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_b2b2c421-c412-4ce9-b386-66437d5c3f43_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_92e0a56b-2d74-4a9f-877b-febc1608f824_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_aa2d23b1-288c-4ec8-b220-f3a5dfa78b07_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5990d919-644a-4cdc-ade2-26ae34f08ca9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_e0cf6aa8-f6d8-4eb7-a1b1-5a2ac413fa26_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b5d31604-4fcc-4529-9d56-daf614baf8a7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_53521753-1473-4657-8cd0-980bbd617536_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COGS</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_989a0b38-beab-40a2-be8c-f637d07ab431_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_98eec76a-5bf6-4bd3-ac3e-91c874ab2934_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPEB</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bax-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3d630b4a-7e32-41e0-b836-b9431d7ca0cb,g:b2be7303-c1c1-4516-95db-2d027e756aa2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2a1fb1a2-ad2a-4be3-adfd-0220dc3d60ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a1fb1a2-ad2a-4be3-adfd-0220dc3d60ba" xlink:to="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ddd5cfb-cdb6-495c-884a-ab188754f4bf" xlink:to="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_fc6b15e1-47e8-4ff8-9e7f-50cff3432f8b" xlink:href="bax-20220930.xsd#bax_CommonStock100PerValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_CommonStock100PerValueMember_fc6b15e1-47e8-4ff8-9e7f-50cff3432f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_ef41751a-d74a-4ed7-888d-f55444f538a6" xlink:href="bax-20220930.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes04Due2024Member_ef41751a-d74a-4ed7-888d-f55444f538a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_a6d96800-a606-48ca-ad27-2e3b0cace847" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes13Due2025Member_a6d96800-a606-48ca-ad27-2e3b0cace847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_90001d63-8104-439d-b886-65d59ce04bbc" xlink:href="bax-20220930.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fae722a9-b686-4782-aa25-032d12b0c2e0" xlink:to="loc_bax_GlobalNotes13Due2029Member_90001d63-8104-439d-b886-65d59ce04bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:to="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_24f275c6-c345-4801-a7bd-ca1dd486c14e" xlink:to="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_654ab5cb-b8a3-4b3f-b838-a6b5063ef4de" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:to="loc_exch_XNYS_654ab5cb-b8a3-4b3f-b838-a6b5063ef4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_e3fa9af0-272d-4158-aae1-34cd833c0cde" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_cffd728e-074d-4ae4-91fb-4ab434120010" xlink:to="loc_exch_XCHI_e3fa9af0-272d-4158-aae1-34cd833c0cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_aa2a67f4-e562-4c7c-9924-7a2dad8568a5" xlink:to="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ef2fed95-0de9-4188-b171-d24eafe8d12b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentType_ef2fed95-0de9-4188-b171-d24eafe8d12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4ba03b08-d0f8-40cb-8a84-57f873997fcd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentQuarterlyReport_4ba03b08-d0f8-40cb-8a84-57f873997fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e5b27de4-3fc5-4a94-b168-8c46857b69e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentPeriodEndDate_e5b27de4-3fc5-4a94-b168-8c46857b69e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_37c8f989-42ef-43c4-a61a-c5a2ac4e1d90" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentTransitionReport_37c8f989-42ef-43c4-a61a-c5a2ac4e1d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6f3c8079-d63a-4385-8ee5-d3c82c60e361" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityFileNumber_6f3c8079-d63a-4385-8ee5-d3c82c60e361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_80768720-5027-40b5-9eda-68d57d707422" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityRegistrantName_80768720-5027-40b5-9eda-68d57d707422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c6c4d940-3e30-4437-a425-2db36e2b3dca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c6c4d940-3e30-4437-a425-2db36e2b3dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0188b50f-d040-431d-bc95-d00f7297bff9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityTaxIdentificationNumber_0188b50f-d040-431d-bc95-d00f7297bff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2ee7ed02-015f-426c-a52c-a3468ac1b39f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressAddressLine1_2ee7ed02-015f-426c-a52c-a3468ac1b39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0b42b01c-c016-4a1a-8202-fb73adae1036" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressCityOrTown_0b42b01c-c016-4a1a-8202-fb73adae1036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_67814071-c9d7-43f9-a780-128c50e61e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressStateOrProvince_67814071-c9d7-43f9-a780-128c50e61e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_34db3425-650a-4d37-addf-08d343c4a8fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityAddressPostalZipCode_34db3425-650a-4d37-addf-08d343c4a8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3a006500-0705-46c9-983b-e23e953721c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_CityAreaCode_3a006500-0705-46c9-983b-e23e953721c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5345f590-42e4-426a-b327-3545dd45e5dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_LocalPhoneNumber_5345f590-42e4-426a-b327-3545dd45e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9b9408d8-134c-468e-bbd4-3d4de6db07e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_Security12bTitle_9b9408d8-134c-468e-bbd4-3d4de6db07e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf20c362-376c-44bf-af00-e3cd3455aba4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_TradingSymbol_cf20c362-376c-44bf-af00-e3cd3455aba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_98ed0d19-6f7c-4d62-93dc-dd1f9e85bda4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_SecurityExchangeName_98ed0d19-6f7c-4d62-93dc-dd1f9e85bda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7074b274-f40a-4786-bb03-5289832e7a33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCurrentReportingStatus_7074b274-f40a-4786-bb03-5289832e7a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dbbe0ff3-d609-4c17-b69c-3eb6a4410a97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityInteractiveDataCurrent_dbbe0ff3-d609-4c17-b69c-3eb6a4410a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d6576131-6690-49a7-90cf-4f2654759055" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityFilerCategory_d6576131-6690-49a7-90cf-4f2654759055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_69210710-e589-4180-96af-bb171373cb3b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntitySmallBusiness_69210710-e589-4180-96af-bb171373cb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_93c66744-46e5-4a96-8d7c-99de762c9a20" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityEmergingGrowthCompany_93c66744-46e5-4a96-8d7c-99de762c9a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cd1bd7cc-b2bc-446d-9793-728072ff4a54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityShellCompany_cd1bd7cc-b2bc-446d-9793-728072ff4a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_513a81b7-a5f1-49bf-9ab6-5c52f01a9af1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_513a81b7-a5f1-49bf-9ab6-5c52f01a9af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0856611b-c460-41fc-b4b3-7bdee9252afb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_AmendmentFlag_0856611b-c460-41fc-b4b3-7bdee9252afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9f3c87e4-686e-49c7-954a-9d54b95d7ad4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentFiscalYearFocus_9f3c87e4-686e-49c7-954a-9d54b95d7ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c286f33c-b18a-4804-9ffa-e6e593932b18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c286f33c-b18a-4804-9ffa-e6e593932b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_96660611-5b49-423e-94e7-09d66396802f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_EntityCentralIndexKey_96660611-5b49-423e-94e7-09d66396802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a6559414-1faf-4776-b673-a6d0784d0e68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_0c4227e0-fd04-4f4b-8a20-12da1e7130e2" xlink:to="loc_dei_CurrentFiscalYearEndDate_a6559414-1faf-4776-b673-a6d0784d0e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_93dcd1c7-e747-4794-8c32-6a3d68214a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_93dcd1c7-e747-4794-8c32-6a3d68214a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bc66b96c-d6e9-4b83-94b2-ef4c62b42e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bc66b96c-d6e9-4b83-94b2-ef4c62b42e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3462a7a8-8bb8-46f3-a969-6710f1dd9137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:to="loc_us-gaap_InventoryNet_3462a7a8-8bb8-46f3-a969-6710f1dd9137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5ea7737b-ba5f-4cbf-b3ab-34b234f9de18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5ea7737b-ba5f-4cbf-b3ab-34b234f9de18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2ff26cdd-dc39-422f-b113-9898425cedd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_68bd8698-f45e-49f8-830e-331c77a3b2f6" xlink:to="loc_us-gaap_AssetsCurrent_2ff26cdd-dc39-422f-b113-9898425cedd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c8df42f9-2c0f-4190-b434-e6cb365fc824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c8df42f9-2c0f-4190-b434-e6cb365fc824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_61ba0e7f-5e1c-44c0-8e65-7ba4a838c0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_Goodwill_61ba0e7f-5e1c-44c0-8e65-7ba4a838c0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd6b108b-d8d5-46cd-a273-296ddbf6f570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd6b108b-d8d5-46cd-a273-296ddbf6f570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_794d90ae-8963-4c06-9542-95915383ddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_794d90ae-8963-4c06-9542-95915383ddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c360e87c-29c0-42be-b743-ec7da7ff8f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c360e87c-29c0-42be-b743-ec7da7ff8f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_da1d56a0-b477-41b3-b56d-a2569e0d2f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_Assets_da1d56a0-b477-41b3-b56d-a2569e0d2f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_34c4c40e-8686-4a43-80a4-92c67be8eb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:to="loc_us-gaap_ShortTermBorrowings_34c4c40e-8686-4a43-80a4-92c67be8eb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_51e9758e-f473-43b4-97e3-f45f26ad6bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_51e9758e-f473-43b4-97e3-f45f26ad6bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4661ad6a-d867-41cc-9059-31c720c55d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:to="loc_us-gaap_AccountsPayableCurrent_4661ad6a-d867-41cc-9059-31c720c55d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f4155898-b9d4-4163-9256-bd8bef4b4943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f4155898-b9d4-4163-9256-bd8bef4b4943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3d33f521-e1f6-488e-b3ea-6c9b5655e351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f52ed4c-3ca2-4063-aecf-f5be48733ce2" xlink:to="loc_us-gaap_LiabilitiesCurrent_3d33f521-e1f6-488e-b3ea-6c9b5655e351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dbb98ede-00e1-4229-92d0-94d4cdebab45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dbb98ede-00e1-4229-92d0-94d4cdebab45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f78d82aa-c4b2-4838-b807-f9923034c8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f78d82aa-c4b2-4838-b807-f9923034c8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3f9cd723-1fac-46a0-a036-d3625bd39caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3f9cd723-1fac-46a0-a036-d3625bd39caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a49ec718-589a-48dc-bc59-59dcf1e0a1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_Liabilities_a49ec718-589a-48dc-bc59-59dcf1e0a1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_64c7eee4-3a3c-46bb-b3d3-89f619231a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_CommitmentsAndContingencies_64c7eee4-3a3c-46bb-b3d3-89f619231a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_70eadadc-d12c-4dd8-b12a-2a54da147abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_CommonStockValue_70eadadc-d12c-4dd8-b12a-2a54da147abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_6e88edfb-04a9-4aa7-aaa5-eb9a031f5f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_TreasuryStockCommonValue_6e88edfb-04a9-4aa7-aaa5-eb9a031f5f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_03bb663c-de7e-43b0-ac9f-89a99af703b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_03bb663c-de7e-43b0-ac9f-89a99af703b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6a31cea4-43fd-4edb-9cab-e06d1c90d5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6a31cea4-43fd-4edb-9cab-e06d1c90d5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fbce7045-62fe-47a6-81a7-76aea967b784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fbce7045-62fe-47a6-81a7-76aea967b784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d25600c9-c771-43c3-a5a0-3ac85e29b3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_StockholdersEquity_d25600c9-c771-43c3-a5a0-3ac85e29b3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7c3fd842-1563-4b4d-806d-030c1a52355d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_MinorityInterest_7c3fd842-1563-4b4d-806d-030c1a52355d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4efc8895-367c-4390-a9be-4a6e099bbe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_dca517d7-e5c9-404c-a80f-aede305955a0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4efc8895-367c-4390-a9be-4a6e099bbe8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce92ac25-2a3b-49f2-aa92-ca64bf5100f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe815f6e-4f4e-4f72-9f15-25801f7e4077" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce92ac25-2a3b-49f2-aa92-ca64bf5100f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_821728ce-2178-4776-b6ed-5a4fb6158da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_821728ce-2178-4776-b6ed-5a4fb6158da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_40cf9c79-5fc4-4970-8803-54ac3562aa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_40cf9c79-5fc4-4970-8803-54ac3562aa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_db9932ed-7433-4d1b-8201-176fe30d5554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_db9932ed-7433-4d1b-8201-176fe30d5554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e4a3d0e0-4314-4c37-a979-b109750b9a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:to="loc_us-gaap_CommonStockSharesIssued_e4a3d0e0-4314-4c37-a979-b109750b9a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_ca2c2eaa-ac5f-47cf-8d20-65c431e9a5be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5fb30535-9fe5-4e95-89d4-12ca98486f19" xlink:to="loc_us-gaap_TreasuryStockCommonShares_ca2c2eaa-ac5f-47cf-8d20-65c431e9a5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofIncomeLossunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4288256e-3d07-42e0-a454-ff502f00f1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4288256e-3d07-42e0-a454-ff502f00f1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9303e1b3-0845-4102-ac9e-c28136ff464b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9303e1b3-0845-4102-ac9e-c28136ff464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_44dd9dd3-2b13-4541-8889-bf5fc7ca7169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_GrossProfit_44dd9dd3-2b13-4541-8889-bf5fc7ca7169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_282d5531-f417-4d48-97ff-63be73f19808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_282d5531-f417-4d48-97ff-63be73f19808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8993bd79-ba58-4d2a-a5e8-94072dedf3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8993bd79-ba58-4d2a-a5e8-94072dedf3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_96e804c3-0771-429e-86ab-66af5a9c8c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_96e804c3-0771-429e-86ab-66af5a9c8c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_db65d85b-b69b-452a-8858-2fae212885c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_db65d85b-b69b-452a-8858-2fae212885c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_338cd206-8ebf-4465-8cff-ca1f06225b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_OperatingIncomeLoss_338cd206-8ebf-4465-8cff-ca1f06225b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_72f26a66-fe24-4ee5-868d-82972b4f5ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_72f26a66-fe24-4ee5-868d-82972b4f5ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d614914d-1f70-495c-8c21-e961a1217489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d614914d-1f70-495c-8c21-e961a1217489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5aa721dd-0ac2-4076-8e6e-55aeccce1025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5aa721dd-0ac2-4076-8e6e-55aeccce1025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a27e8b0d-3b87-457c-a0c1-37c90ccf2f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a27e8b0d-3b87-457c-a0c1-37c90ccf2f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0aaea1f8-8a02-4b38-a7c1-45a6a282f409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_ProfitLoss_0aaea1f8-8a02-4b38-a7c1-45a6a282f409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_17cf2a51-d1d5-4429-ab67-3dd4664b34c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_17cf2a51-d1d5-4429-ab67-3dd4664b34c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5de9592-1509-44aa-8da2-828c287f79ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_NetIncomeLoss_d5de9592-1509-44aa-8da2-828c287f79ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_229e4069-219b-44a9-942e-6dd760e75863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_EarningsPerShareAbstract_229e4069-219b-44a9-942e-6dd760e75863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_35b1471d-5c5c-4925-a984-f83dd0813974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_229e4069-219b-44a9-942e-6dd760e75863" xlink:to="loc_us-gaap_EarningsPerShareBasic_35b1471d-5c5c-4925-a984-f83dd0813974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5ccec551-7928-4423-b84d-cd4f7f52427a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_229e4069-219b-44a9-942e-6dd760e75863" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5ccec551-7928-4423-b84d-cd4f7f52427a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_da52fa78-f888-4e03-b1ff-1c5cdb780151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_61a59a57-c13a-4a54-9dad-9f7a148f4481" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_da52fa78-f888-4e03-b1ff-1c5cdb780151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7254f312-c8b7-4cff-a84c-58ca6650d5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_da52fa78-f888-4e03-b1ff-1c5cdb780151" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7254f312-c8b7-4cff-a84c-58ca6650d5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1c019977-5c94-4ae0-a81b-77838fb7d4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_da52fa78-f888-4e03-b1ff-1c5cdb780151" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1c019977-5c94-4ae0-a81b-77838fb7d4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_170d2f8f-64d2-4775-89c1-37559f08f770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:to="loc_us-gaap_ProfitLoss_170d2f8f-64d2-4775-89c1-37559f08f770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45ea3826-82c5-4309-8638-4773ce541d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45ea3826-82c5-4309-8638-4773ce541d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7cc015a4-1a15-46a7-bb71-d2f15f2d8acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7cc015a4-1a15-46a7-bb71-d2f15f2d8acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5677b032-8acd-4b54-a981-d3d25945dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5677b032-8acd-4b54-a981-d3d25945dcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67c99642-9d38-4309-984c-9af27ee0b08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67c99642-9d38-4309-984c-9af27ee0b08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bf23d3e-b41b-46f6-bdf5-b302a127eff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_94e2bbbc-6319-4a6e-a58f-2734aa5a5185" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bf23d3e-b41b-46f6-bdf5-b302a127eff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f7849cd9-0f44-4138-9b78-d3c2994783e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f7849cd9-0f44-4138-9b78-d3c2994783e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_045e5163-e02a-4231-a0dc-3d959b4183dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_045e5163-e02a-4231-a0dc-3d959b4183dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7eef1f5a-9812-4ff1-8873-9ee795a13c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b9ea3f3-9b97-43f2-8fe7-6502e9765f18" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7eef1f5a-9812-4ff1-8873-9ee795a13c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b6cc16c9-eb1a-4961-b3b1-2cdfc5d1e2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6e4b75ed-95e0-4392-8f40-8a5cd42bd946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b6cc16c9-eb1a-4961-b3b1-2cdfc5d1e2ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6e4b75ed-95e0-4392-8f40-8a5cd42bd946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4d4d52a9-9194-4807-af05-52c875e530d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b6cc16c9-eb1a-4961-b3b1-2cdfc5d1e2ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4d4d52a9-9194-4807-af05-52c875e530d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_492871ed-84ee-4810-a3b0-27b0ee1a0d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b6cc16c9-eb1a-4961-b3b1-2cdfc5d1e2ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_492871ed-84ee-4810-a3b0-27b0ee1a0d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_205157d6-dd51-4b76-9608-5c482eba2895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b6cc16c9-eb1a-4961-b3b1-2cdfc5d1e2ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_205157d6-dd51-4b76-9608-5c482eba2895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b5be22e0-2768-4219-b2c8-6236a062b15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b5be22e0-2768-4219-b2c8-6236a062b15a" xlink:to="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dee1873b-7c0a-465d-b949-41e038473799" xlink:to="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:to="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2625051d-4f78-491c-8014-f9a307cb1d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_CommonStockMember_2625051d-4f78-491c-8014-f9a307cb1d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_8cc2da0e-5227-48dc-9018-7ef786b0b7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_8cc2da0e-5227-48dc-9018-7ef786b0b7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_152cb684-ad5b-49e6-a73c-6dcf1cf0dc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_152cb684-ad5b-49e6-a73c-6dcf1cf0dc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_aeeef198-9fdb-4c12-a8a6-44a5281bd3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_RetainedEarningsMember_aeeef198-9fdb-4c12-a8a6-44a5281bd3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f67f8f-e4cf-4067-9b0a-b15446d3a8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d2401214-bd56-424c-99d2-8b9ec367105d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f67f8f-e4cf-4067-9b0a-b15446d3a8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_51ab6851-60b5-42d5-a2c7-609c1b174e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0d85d94-633a-4e29-a2b7-9658b9fc4de6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_51ab6851-60b5-42d5-a2c7-609c1b174e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c425a30e-339a-45fa-ae5d-4979b1a680ff" xlink:to="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94b6fa22-f93d-4321-b27f-af2a376a7c1b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a41194de-7f86-4057-aa58-f6b2adbcb837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a41194de-7f86-4057-aa58-f6b2adbcb837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_08df425a-58dc-43f0-8a3e-6817f9cdd0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_08df425a-58dc-43f0-8a3e-6817f9cdd0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_50df1d01-eb64-4fd7-9c58-a0b91eb8f68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_50df1d01-eb64-4fd7-9c58-a0b91eb8f68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7fd669d0-aa62-45e4-83fd-001ee9fffb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_ProfitLoss_7fd669d0-aa62-45e4-83fd-001ee9fffb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d0c51c6-7dc7-413d-b2d2-fa104fb6e81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d0c51c6-7dc7-413d-b2d2-fa104fb6e81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_aec7e1f0-0df4-42cd-8683-792e6d7df65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_aec7e1f0-0df4-42cd-8683-792e6d7df65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c074ce06-9e33-4f1c-84fc-65a895568977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c074ce06-9e33-4f1c-84fc-65a895568977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7c2b26ff-8f18-4b34-beba-bcb5a1765eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7c2b26ff-8f18-4b34-beba-bcb5a1765eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d0f78477-11f8-426f-a03d-f78cfba8c958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d0f78477-11f8-426f-a03d-f78cfba8c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1207e4bd-2714-4551-a4e9-f3a62ea84a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_DividendsCommonStock_1207e4bd-2714-4551-a4e9-f3a62ea84a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_fb40fe5a-ec9e-4b39-ba4e-3a17ea2e6b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_fb40fe5a-ec9e-4b39-ba4e-3a17ea2e6b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_880aa984-b2a3-444c-ad67-5f26cb10a349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_880aa984-b2a3-444c-ad67-5f26cb10a349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5a2a52c-45dd-4895-8526-0254b51b7b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c7504ff-8529-4084-92d9-d584e73c363f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5a2a52c-45dd-4895-8526-0254b51b7b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20220930.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c84c0544-6cb7-446c-a958-325020494667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c84c0544-6cb7-446c-a958-325020494667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d7a14741-9304-4fab-9eb6-85bb44662138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c84c0544-6cb7-446c-a958-325020494667" xlink:to="loc_us-gaap_ProfitLoss_d7a14741-9304-4fab-9eb6-85bb44662138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c84c0544-6cb7-446c-a958-325020494667" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_51b31533-15a0-4932-a300-d9754a1c2cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_51b31533-15a0-4932-a300-d9754a1c2cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_91c7e5e1-c2ec-4ff6-95a3-c5b64b54e3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_91c7e5e1-c2ec-4ff6-95a3-c5b64b54e3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8033da62-27d3-4268-8344-aa9e8363e80c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_ShareBasedCompensation_8033da62-27d3-4268-8344-aa9e8363e80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_f1fe9545-8988-4b16-a2bb-2e23c6e603df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_f1fe9545-8988-4b16-a2bb-2e23c6e603df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_f47d4364-4225-4ccc-ad50-87f7746516ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_f47d4364-4225-4ccc-ad50-87f7746516ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f1490d80-ac33-4ef9-a5c8-0487d853b3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f1490d80-ac33-4ef9-a5c8-0487d853b3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_e65428b4-c816-412d-ae76-04768f149e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_e65428b4-c816-412d-ae76-04768f149e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e712e3fb-4488-4c5c-a694-ada67b038bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e712e3fb-4488-4c5c-a694-ada67b038bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7e7d2dde-b58f-4b92-87a5-e7735290722f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7e7d2dde-b58f-4b92-87a5-e7735290722f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_790f534c-26ef-40eb-8a2b-f42351995b29" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3e9fa550-20b2-41f3-850f-a2d6cf5e69e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3e9fa550-20b2-41f3-850f-a2d6cf5e69e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3bd923ab-3a0e-4db6-9faf-cff6d5e28cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3bd923ab-3a0e-4db6-9faf-cff6d5e28cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_26bf94be-ced2-4c99-b476-d116dc7b0206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_26bf94be-ced2-4c99-b476-d116dc7b0206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a598109-e484-405a-90f6-3edd0268429e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a598109-e484-405a-90f6-3edd0268429e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_d4dc477a-e543-4b3f-8ede-2eb2ca7875f3" xlink:href="bax-20220930.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_d4dc477a-e543-4b3f-8ede-2eb2ca7875f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a32e9046-a765-43de-9369-527034e1fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ec5dc3-786e-4398-bee8-c479fcbee41c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a32e9046-a765-43de-9369-527034e1fcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7c24c41-4083-4d65-849b-c61452ab2bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c84c0544-6cb7-446c-a958-325020494667" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7c24c41-4083-4d65-849b-c61452ab2bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_581ac018-1f2c-403e-9254-0716d62f1504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_581ac018-1f2c-403e-9254-0716d62f1504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5ee9216a-bfa7-40f8-9619-310a8f82e165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5ee9216a-bfa7-40f8-9619-310a8f82e165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41d22a9e-5497-4e51-bd96-ea2851882441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41d22a9e-5497-4e51-bd96-ea2851882441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2db40b31-4577-473c-8874-e02315f43698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_57db94de-2d60-463e-ac1e-3413804859fc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2db40b31-4577-473c-8874-e02315f43698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2ca0c11d-23ae-4d85-a786-5688a031e2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_RepaymentsOfDebt_2ca0c11d-23ae-4d85-a786-5688a031e2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4eee0bff-77df-4111-9212-8bdb3e17557e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4eee0bff-77df-4111-9212-8bdb3e17557e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_e7c25f2f-087b-462d-9106-c0af201f2280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_e7c25f2f-087b-462d-9106-c0af201f2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_c925962a-7018-4a22-bfd3-c231798ef719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_c925962a-7018-4a22-bfd3-c231798ef719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d4459cec-cde8-499a-99ee-83322b8124ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d4459cec-cde8-499a-99ee-83322b8124ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2e184ba7-2177-4641-bb28-b50dff34b82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2e184ba7-2177-4641-bb28-b50dff34b82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_01a5274d-21e3-4a94-8c54-8520f311efac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_01a5274d-21e3-4a94-8c54-8520f311efac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e5be8437-40e1-47f8-8856-b28de1ac74be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e5be8437-40e1-47f8-8856-b28de1ac74be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_10b850ac-df79-4ff8-a3c2-491b0f80ba40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6317fb7-842b-4643-8969-f34f7b826bf5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_10b850ac-df79-4ff8-a3c2-491b0f80ba40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2d9ba965-153c-42c4-810c-a166f151bd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2d9ba965-153c-42c4-810c-a166f151bd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd918a08-8811-472c-b599-d7af4a2ad143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd918a08-8811-472c-b599-d7af4a2ad143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_344a5340-0f7b-44d5-bc86-bd54850a1353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_344a5340-0f7b-44d5-bc86-bd54850a1353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5868a440-288b-4aa3-a4bc-f4682571caba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5868a440-288b-4aa3-a4bc-f4682571caba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5295073f-5eee-4d9f-ba0f-40c327574f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5295073f-5eee-4d9f-ba0f-40c327574f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_144fce7a-3d83-4d74-9387-acf06f5a4dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6988eae1-e303-44a3-93ca-e3615b162410" xlink:to="loc_us-gaap_RestrictedCash_144fce7a-3d83-4d74-9387-acf06f5a4dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="bax-20220930.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75752764-cc0a-40a4-a814-a1da703601e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_85d2843f-93e9-4fd2-aaa2-c3bd86b2f23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75752764-cc0a-40a4-a814-a1da703601e1" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_85d2843f-93e9-4fd2-aaa2-c3bd86b2f23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1af43e3f-c689-4de0-8e27-f880fa439445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_56925acc-d542-4328-9307-ca081da61aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1af43e3f-c689-4de0-8e27-f880fa439445" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_56925acc-d542-4328-9307-ca081da61aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_594fa50a-487f-4dea-b84b-e3e514cced12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_698acd6c-31e3-469f-8dc2-0ae101fc338d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_594fa50a-487f-4dea-b84b-e3e514cced12" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_698acd6c-31e3-469f-8dc2-0ae101fc338d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNET"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a75094b9-6c7d-4b7c-80b2-ab6257c8f355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d98195f1-cae6-48d0-9163-119f3929978e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a75094b9-6c7d-4b7c-80b2-ab6257c8f355" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d98195f1-cae6-48d0-9163-119f3929978e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="simple" xlink:href="bax-20220930.xsd#FINANCINGARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_85209fa7-0a23-496f-8d11-cb4abe725c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e3ad17cb-ec05-4068-9a39-eba9a81aa8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_85209fa7-0a23-496f-8d11-cb4abe725c50" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e3ad17cb-ec05-4068-9a39-eba9a81aa8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bax-20220930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a2e4de76-1623-4cc4-84aa-4079c90f56e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fb059fcb-ab09-40ea-8626-187c5f106133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a2e4de76-1623-4cc4-84aa-4079c90f56e8" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fb059fcb-ab09-40ea-8626-187c5f106133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bax-20220930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afb11456-7a42-402f-8bed-7209159dd0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ca1d8a70-da83-4bfd-8090-6df19b0a4284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afb11456-7a42-402f-8bed-7209159dd0f5" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ca1d8a70-da83-4bfd-8090-6df19b0a4284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9debb221-e915-41b6-bc76-b476caeac9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6db1deec-8c76-4bee-a2a9-d3421d8d6c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9debb221-e915-41b6-bc76-b476caeac9f3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6db1deec-8c76-4bee-a2a9-d3421d8d6c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUES" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_411164e4-e4bd-49de-b4d6-4048039b2cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_2882c993-5ac1-4b2c-9dea-dea46421d525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_411164e4-e4bd-49de-b4d6-4048039b2cbf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_2882c993-5ac1-4b2c-9dea-dea46421d525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0bf89d9a-9f36-4843-b967-e4c3be64f904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_078d3f9e-3809-43ed-a54f-1ceefdf0887b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0bf89d9a-9f36-4843-b967-e4c3be64f904" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_078d3f9e-3809-43ed-a54f-1ceefdf0887b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="simple" xlink:href="bax-20220930.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d468f2c2-9c97-4b92-a7d9-23b407636c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_90abc248-2a70-4413-b35d-ababc2d37b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d468f2c2-9c97-4b92-a7d9-23b407636c2d" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_90abc248-2a70-4413-b35d-ababc2d37b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bax-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2e43c88d-00e8-4812-a54c-d5cf75d4166f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6483b016-322f-40ce-9ce7-68d356445a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2e43c88d-00e8-4812-a54c-d5cf75d4166f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6483b016-322f-40ce-9ce7-68d356445a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bax-20220930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d2cf17a-49ac-41e5-91d3-f9f7051594a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_23a53b7a-91c5-42c9-b52e-e8cb9f38eadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d2cf17a-49ac-41e5-91d3-f9f7051594a4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_23a53b7a-91c5-42c9-b52e-e8cb9f38eadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f4bb8b8d-cc73-4a01-aea8-26f51f5168e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ebd7791c-e19b-400f-b5b8-687ceb0b2611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f4bb8b8d-cc73-4a01-aea8-26f51f5168e4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ebd7791c-e19b-400f-b5b8-687ceb0b2611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_78de1d02-dd14-435f-9479-aea8c1b961c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_01dda387-6861-4820-8ac2-b9c34fccf1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_78de1d02-dd14-435f-9479-aea8c1b961c0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_01dda387-6861-4820-8ac2-b9c34fccf1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_979d42b3-2a28-4501-9faf-3df9dcdb341c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1eb0e847-0b7b-48f8-af2a-2865c89dfc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_979d42b3-2a28-4501-9faf-3df9dcdb341c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1eb0e847-0b7b-48f8-af2a-2865c89dfc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="bax-20220930.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a4b3563-74c4-49d1-87bc-559b4803f1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2567bc71-6096-408a-9486-591786797760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a4b3563-74c4-49d1-87bc-559b4803f1e7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2567bc71-6096-408a-9486-591786797760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_895a8857-32f9-4349-ad11-05f3f709c8ec" xlink:href="bax-20220930.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a4b3563-74c4-49d1-87bc-559b4803f1e7" xlink:to="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_895a8857-32f9-4349-ad11-05f3f709c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_01f5dbf7-d3f6-473b-8fc1-6faa7f0d86d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a4b3563-74c4-49d1-87bc-559b4803f1e7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_01f5dbf7-d3f6-473b-8fc1-6faa7f0d86d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac2b7b19-0021-4036-805e-37d4d9ea844e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f3f9bbb8-2e55-4bcb-8510-63dd96bb5e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac2b7b19-0021-4036-805e-37d4d9ea844e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f3f9bbb8-2e55-4bcb-8510-63dd96bb5e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9a326a56-cdc2-48f2-95fe-e974d4bbf1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac2b7b19-0021-4036-805e-37d4d9ea844e" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9a326a56-cdc2-48f2-95fe-e974d4bbf1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_9be8f403-7a3a-495d-9404-97c452095f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_9be8f403-7a3a-495d-9404-97c452095f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_402732be-3216-4e4c-b25b-0a285961df9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_402732be-3216-4e4c-b25b-0a285961df9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3a03efa3-9831-4acc-9a06-6c5d4e7e39ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3a03efa3-9831-4acc-9a06-6c5d4e7e39ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_a6e9e960-849b-4eaf-8ac1-5fb027428b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_a6e9e960-849b-4eaf-8ac1-5fb027428b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1ea050e6-14ff-40c6-b927-bce8834b5010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03bc2345-ef76-47e5-94e3-b8f402e9dd2a" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1ea050e6-14ff-40c6-b927-bce8834b5010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7789901-aa72-4a5f-95bc-a93134305a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_efb69fdb-28f1-45ce-8ed5-f587a616020b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7789901-aa72-4a5f-95bc-a93134305a0f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_efb69fdb-28f1-45ce-8ed5-f587a616020b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_bffc9ab5-9028-4f62-8dac-4dbf163c6b92" xlink:href="bax-20220930.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7789901-aa72-4a5f-95bc-a93134305a0f" xlink:to="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_bffc9ab5-9028-4f62-8dac-4dbf163c6b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_87c029cd-4957-47ca-a08c-b3f370ed7806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_17ee2601-16a7-41c7-a70e-8d481cf20ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_87c029cd-4957-47ca-a08c-b3f370ed7806" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_17ee2601-16a7-41c7-a70e-8d481cf20ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_75678283-a56e-4e49-adb4-dccca56c2385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_87c029cd-4957-47ca-a08c-b3f370ed7806" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_75678283-a56e-4e49-adb4-dccca56c2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESTables" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_da06d025-4a60-4321-9652-33ed12ab84eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d710b69e-5868-445f-9540-b058221150db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_da06d025-4a60-4321-9652-33ed12ab84eb" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d710b69e-5868-445f-9540-b058221150db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_00eee5a7-4629-44fd-a1e4-7bfeb5f21e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_da06d025-4a60-4321-9652-33ed12ab84eb" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_00eee5a7-4629-44fd-a1e4-7bfeb5f21e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_742e6bcb-923d-4df7-93c7-d94740c384b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_da06d025-4a60-4321-9652-33ed12ab84eb" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_742e6bcb-923d-4df7-93c7-d94740c384b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_834e8118-4780-402b-807d-7c6db12c6e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_da06d025-4a60-4321-9652-33ed12ab84eb" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_834e8118-4780-402b-807d-7c6db12c6e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4aad5f15-4aae-4fd1-a6fc-167925da6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock_4b3ba88e-3bf2-4794-9041-4459a98898d5" xlink:href="bax-20220930.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4aad5f15-4aae-4fd1-a6fc-167925da6f28" xlink:to="loc_bax_BusinessOptimizationChargeTableTextBlock_4b3ba88e-3bf2-4794-9041-4459a98898d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_18e29141-84ca-4843-bd2e-4ba90eec622e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4aad5f15-4aae-4fd1-a6fc-167925da6f28" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_18e29141-84ca-4843-bd2e-4ba90eec622e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_90eac6d2-5758-4e73-89c9-b57531549b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4aad5f15-4aae-4fd1-a6fc-167925da6f28" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_90eac6d2-5758-4e73-89c9-b57531549b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="simple" xlink:href="bax-20220930.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_30e23c73-f986-41db-a837-17893dd48c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_18cb5202-55f2-4633-bd6a-acaa9bdaad91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_30e23c73-f986-41db-a837-17893dd48c06" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_18cb5202-55f2-4633-bd6a-acaa9bdaad91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bax-20220930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cd9804bd-600a-469e-b3ef-9eccf04ae88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_95df7a9e-1063-4cac-8501-156b54598d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd9804bd-600a-469e-b3ef-9eccf04ae88f" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_95df7a9e-1063-4cac-8501-156b54598d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ecbc2ed-b40c-46bb-ab6e-40cc7438bb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c99a05e8-86e8-412e-885b-602185cd940e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ecbc2ed-b40c-46bb-ab6e-40cc7438bb73" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c99a05e8-86e8-412e-885b-602185cd940e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_24c95488-e006-4479-8f7f-3f48c338e98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ecbc2ed-b40c-46bb-ab6e-40cc7438bb73" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_24c95488-e006-4479-8f7f-3f48c338e98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_65e514ca-9425-4800-853a-51c8ef6b0ade" xlink:href="bax-20220930.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ecbc2ed-b40c-46bb-ab6e-40cc7438bb73" xlink:to="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_65e514ca-9425-4800-853a-51c8ef6b0ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9fce0616-77d5-4a22-9434-3acb44c6fcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ecbc2ed-b40c-46bb-ab6e-40cc7438bb73" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9fce0616-77d5-4a22-9434-3acb44c6fcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cb2658ea-0cad-404d-9cbb-9a67fd17eee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_aad3a373-d14f-4cae-a41f-6fc9c364e3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb2658ea-0cad-404d-9cbb-9a67fd17eee1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_aad3a373-d14f-4cae-a41f-6fc9c364e3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f599020b-4e64-431e-b7ca-d40feb76cb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb2658ea-0cad-404d-9cbb-9a67fd17eee1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f599020b-4e64-431e-b7ca-d40feb76cb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_425d909f-5856-4a81-bc45-8edda08c09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb2658ea-0cad-404d-9cbb-9a67fd17eee1" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_425d909f-5856-4a81-bc45-8edda08c09f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7269b301-19ac-4620-ba8d-3ce7af4885ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bf489add-00a7-4016-985c-51ab9c26899d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7269b301-19ac-4620-ba8d-3ce7af4885ff" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bf489add-00a7-4016-985c-51ab9c26899d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_f85e3664-163b-4e89-8041-f57db780a85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7269b301-19ac-4620-ba8d-3ce7af4885ff" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_f85e3664-163b-4e89-8041-f57db780a85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7727c14a-fa08-4c37-960b-38e0e7b0e992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7727c14a-fa08-4c37-960b-38e0e7b0e992" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d21f453-041c-4b43-ab9f-62b4bc7a3dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_843e8409-903d-4438-bb4c-559ab6f00cbd" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98a3dce5-a521-46c0-be27-efd1cc0f736a" xlink:to="loc_bax_HillromMember_843e8409-903d-4438-bb4c-559ab6f00cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d3e82c1-0ef2-48b1-a9b5-19019d093455" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2982d483-2d7b-4dcc-8322-ab0a4fc9fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2982d483-2d7b-4dcc-8322-ab0a4fc9fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_97ed32a2-c4f2-43d2-b267-9a87a7134403" xlink:href="bax-20220930.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_97ed32a2-c4f2-43d2-b267-9a87a7134403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_c8ff9480-b134-4f97-9b38-85d5e6fe0369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_c8ff9480-b134-4f97-9b38-85d5e6fe0369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7a5c9c38-9367-4f01-a856-3d3ae8d74652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7a5c9c38-9367-4f01-a856-3d3ae8d74652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4fdfb7b2-1cbf-4975-85b5-7c32daf1a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03794359-f592-42ff-8896-945cda76eb3d" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4fdfb7b2-1cbf-4975-85b5-7c32daf1a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0788c5e0-981d-4596-b739-aada46d2e632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0788c5e0-981d-4596-b739-aada46d2e632" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2f75ee2-eeea-4fd0-879e-35f4850ae694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_245b2313-d666-4f4e-8be1-61db9f3aac0e" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa0595c9-7a20-4757-8a09-6b4cdaae8ad6" xlink:to="loc_bax_HillromMember_245b2313-d666-4f4e-8be1-61db9f3aac0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_cf3de3e8-ecd9-4e70-9a1c-b7a46c29d4bf" xlink:to="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6c747a28-3317-49af-8bec-7ca9650949eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6c747a28-3317-49af-8bec-7ca9650949eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_27fbe4a6-2aba-4b88-a027-c12e9d81135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_27fbe4a6-2aba-4b88-a027-c12e9d81135c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6e6c5c5d-32c9-484a-96c7-ee0762cae097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6e6c5c5d-32c9-484a-96c7-ee0762cae097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_d5faf281-6a04-4b3c-9a1e-52eda34b47cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_d5faf281-6a04-4b3c-9a1e-52eda34b47cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5f8a0869-9c87-4110-8c30-1a8821c0b403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_729417a9-567d-4c9a-afd3-389d3aea6943" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5f8a0869-9c87-4110-8c30-1a8821c0b403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5a216eeb-12e8-49c9-93a2-04ca5a5bd860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5a216eeb-12e8-49c9-93a2-04ca5a5bd860" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_216eff8e-9a64-436b-aa8b-fcc4e36b7a26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_4fea3ab9-daf8-4821-a8a6-cbe688cad08e" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03920aa2-d86b-445f-aabe-e437f6427db6" xlink:to="loc_bax_HillromMember_4fea3ab9-daf8-4821-a8a6-cbe688cad08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:href="bax-20220930.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_f623c62a-ef85-44b2-b35f-42ba1cf53bae" xlink:to="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_31c93c47-d941-4b83-af48-ac34ad81bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_31c93c47-d941-4b83-af48-ac34ad81bf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_41b9d16b-6e14-4815-b4fb-a3c4061de954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_41b9d16b-6e14-4815-b4fb-a3c4061de954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4cab86a8-8b41-4c20-8cbd-413c0f470ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4cab86a8-8b41-4c20-8cbd-413c0f470ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0f2db462-c7d8-4e6a-b8b4-11c0dae548ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0f2db462-c7d8-4e6a-b8b4-11c0dae548ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b542134d-b966-4dfb-b839-32c9abd4dbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b542134d-b966-4dfb-b839-32c9abd4dbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4b5377e1-d71e-4f18-a769-e68e1099798c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_Goodwill_4b5377e1-d71e-4f18-a769-e68e1099798c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7a018bba-bfb1-47bc-bfd6-bb8edf57c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7a018bba-bfb1-47bc-bfd6-bb8edf57c726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_88fb3945-be80-4719-a207-c6fcb69966aa" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_88fb3945-be80-4719-a207-c6fcb69966aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1463e48e-5453-4ed3-9c5e-05d07dfa4294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1463e48e-5453-4ed3-9c5e-05d07dfa4294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_05c518e6-705e-4779-b156-33d7fc94a20e" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_05c518e6-705e-4779-b156-33d7fc94a20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_15e3f11e-ecea-4c8a-9536-ee37fe2aa7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_15e3f11e-ecea-4c8a-9536-ee37fe2aa7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_e5824a33-c84f-48e5-8e9c-27a45663e0f8" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_e5824a33-c84f-48e5-8e9c-27a45663e0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_24531d6f-7cb2-4321-b428-53fc15f397dd" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations_24531d6f-7cb2-4321-b428-53fc15f397dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_97e837c4-83d5-44c6-b62c-079d00c68c33" xlink:href="bax-20220930.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation_97e837c4-83d5-44c6-b62c-079d00c68c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3a89dfa6-99af-4528-9dbf-e0fcf5f9e697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3a89dfa6-99af-4528-9dbf-e0fcf5f9e697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa548e67-fc8b-4083-bfab-d086a051f817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_01a17022-3f8d-4d0c-8038-3ac2117a4172" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa548e67-fc8b-4083-bfab-d086a051f817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3bd08514-02e9-4b8d-9017-d1ae9679ece9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3bd08514-02e9-4b8d-9017-d1ae9679ece9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dc2cf336-98df-4599-8730-8b7d22b2d129" xlink:to="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_35e5a4ac-673b-43e9-aaa2-82f1fee93f19" xlink:href="bax-20220930.xsd#bax_ZosynMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_e7c42441-9250-428b-8677-888c058a1dea" xlink:to="loc_bax_ZosynMember_35e5a4ac-673b-43e9-aaa2-82f1fee93f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08ead7f6-9384-48ee-b12c-05b7d75dddd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9935187c-7b87-4759-8348-57caadb07220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9935187c-7b87-4759-8348-57caadb07220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_74d0acfd-0e30-4d8f-a599-152c194952ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55d92a-4457-4c7d-8be1-8b35f9389b91" xlink:to="loc_us-gaap_LicensingAgreementsMember_74d0acfd-0e30-4d8f-a599-152c194952ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_91686043-d87e-4eae-a6f0-5d748d8c179d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CelerityMember_bbb0fe82-63cf-4afe-a024-9a3c770f73ad" xlink:href="bax-20220930.xsd#bax_CelerityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cbd58a3a-0775-4835-a5fe-ff8ac55fe5aa" xlink:to="loc_bax_CelerityMember_bbb0fe82-63cf-4afe-a024-9a3c770f73ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6213c04-1b55-4b1e-bf66-a5332b0e9b0e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d4f4ad5-65d3-4829-8441-b580ea3796bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d4f4ad5-65d3-4829-8441-b580ea3796bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d53dcb7c-1c99-4a01-b57f-3b28a7398232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d53dcb7c-1c99-4a01-b57f-3b28a7398232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ProceedsFromDivestitureOfProductRights_595754bd-a66a-4ec6-af89-e86e984138d6" xlink:href="bax-20220930.xsd#bax_ProceedsFromDivestitureOfProductRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_bax_ProceedsFromDivestitureOfProductRights_595754bd-a66a-4ec6-af89-e86e984138d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement_062a0d35-6833-43b9-b1b8-e1304bc338dc" xlink:href="bax-20220930.xsd#bax_GainLossOnDispositionOfProductDivestitureArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e4e9c32b-dd74-4de1-bd6c-4171385d1cf8" xlink:to="loc_bax_GainLossOnDispositionOfProductDivestitureArrangement_062a0d35-6833-43b9-b1b8-e1304bc338dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbc9eab9-1db5-43c8-a89a-5ed8aefe6792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbc9eab9-1db5-43c8-a89a-5ed8aefe6792" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_99d11e39-5f3e-407d-99c4-6766808611ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_99d11e39-5f3e-407d-99c4-6766808611ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2bd8bad7-86ee-4cbb-a8d7-120f1bfa8437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2bd8bad7-86ee-4cbb-a8d7-120f1bfa8437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2fb92b0e-e9e2-41ad-ba45-8989763623ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2fb92b0e-e9e2-41ad-ba45-8989763623ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_f09ba534-53ed-413d-83c6-0805030e0e04" xlink:href="bax-20220930.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:to="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_f09ba534-53ed-413d-83c6-0805030e0e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_786c7e37-71a2-4b9b-80e3-037bdb4dccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ca681bfa-22ff-4fd0-97fe-f17c060ba96a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_786c7e37-71a2-4b9b-80e3-037bdb4dccaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25284386-2e2c-4d3f-931e-b449e4f65aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_a44f0dcf-8e47-4ce1-a6b1-8df9cb0240bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25284386-2e2c-4d3f-931e-b449e4f65aea" xlink:to="loc_us-gaap_InventoryRawMaterials_a44f0dcf-8e47-4ce1-a6b1-8df9cb0240bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_0c4fac62-72e3-4e4c-8531-a219739538ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25284386-2e2c-4d3f-931e-b449e4f65aea" xlink:to="loc_us-gaap_InventoryWorkInProcess_0c4fac62-72e3-4e4c-8531-a219739538ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_a09be17b-1730-4fc5-b8cb-dbff371f8dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25284386-2e2c-4d3f-931e-b449e4f65aea" xlink:to="loc_us-gaap_InventoryFinishedGoods_a09be17b-1730-4fc5-b8cb-dbff371f8dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_40867087-f0fb-4ab7-8cda-99eca0766e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25284386-2e2c-4d3f-931e-b449e4f65aea" xlink:to="loc_us-gaap_InventoryNet_40867087-f0fb-4ab7-8cda-99eca0766e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e07d872-4262-4b1b-8650-9a9cf20f701b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ce5a8f59-b916-4f27-9ac7-29a85ddabc86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e07d872-4262-4b1b-8650-9a9cf20f701b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ce5a8f59-b916-4f27-9ac7-29a85ddabc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3c6772e8-e084-4c9c-9fe4-0ecaeeac5b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e07d872-4262-4b1b-8650-9a9cf20f701b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3c6772e8-e084-4c9c-9fe4-0ecaeeac5b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a2e0a1bf-f4a4-4836-81ea-9e69aee536c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e07d872-4262-4b1b-8650-9a9cf20f701b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a2e0a1bf-f4a4-4836-81ea-9e69aee536c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c01cc2-4f3a-40c5-9439-436ab95ad39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_a07f4a46-c538-4059-b5db-e4e1d6454e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c01cc2-4f3a-40c5-9439-436ab95ad39f" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_a07f4a46-c538-4059-b5db-e4e1d6454e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a839ad4f-945b-495b-b9ee-ab54e9990155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_a07f4a46-c538-4059-b5db-e4e1d6454e3f" xlink:to="loc_us-gaap_InterestExpense_a839ad4f-945b-495b-b9ee-ab54e9990155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_c5c817e5-8190-45d8-b34e-e67d78347846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_a07f4a46-c538-4059-b5db-e4e1d6454e3f" xlink:to="loc_us-gaap_InterestIncomeOperating_c5c817e5-8190-45d8-b34e-e67d78347846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_d9492871-cd9f-4eb4-98c0-730c7044bc18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_a07f4a46-c538-4059-b5db-e4e1d6454e3f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_d9492871-cd9f-4eb4-98c0-730c7044bc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e0149eb4-1c78-4bc3-814c-370f15ee1f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e0149eb4-1c78-4bc3-814c-370f15ee1f19" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_ef335fd9-c0eb-4b54-a92a-3aa53c746d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_ef335fd9-c0eb-4b54-a92a-3aa53c746d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_176b8bea-c9eb-4d8e-9c72-754f201f2870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_176b8bea-c9eb-4d8e-9c72-754f201f2870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_59573d00-d14c-4c4e-9480-d807bf6a6145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_59573d00-d14c-4c4e-9480-d807bf6a6145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_bdcceff4-fd2c-48e2-8c25-bf82b26e1085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_bdcceff4-fd2c-48e2-8c25-bf82b26e1085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_06c16e54-17eb-4490-82d4-39e8a73f1851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_06c16e54-17eb-4490-82d4-39e8a73f1851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_16cdff17-7c7a-4f66-95b1-c87138f7e6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_16cdff17-7c7a-4f66-95b1-c87138f7e6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5a6505a5-156a-404f-80b6-9968b83102e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_85b95b27-0405-4fb5-bf8c-49b2c85b8e3e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5a6505a5-156a-404f-80b6-9968b83102e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1df413fd-ee5e-415a-bb75-0f7203b4bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1df413fd-ee5e-415a-bb75-0f7203b4bdbb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b201116d-0c96-47d9-a985-c360c0d0a996" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_d889e1ec-969f-4f73-918c-1389f053c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_d889e1ec-969f-4f73-918c-1389f053c72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_b2eb0b8d-f283-4f4b-8b99-1dd1c6f56a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_GeographicBasisCorporateHeadquartersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de67d87e-11f1-4bd3-86ee-b89de4c4c107" xlink:to="loc_us-gaap-supplement_GeographicBasisCorporateHeadquartersMember_b2eb0b8d-f283-4f4b-8b99-1dd1c6f56a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a524029b-987b-47cc-b415-6cf43ce1fdc1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_1b4b9528-4532-49bc-9c6f-030db4f0c57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_198967da-9df0-40f6-8357-4422e0fd8aa1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationsMember_1b4b9528-4532-49bc-9c6f-030db4f0c57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_128b5475-e653-4b4a-833c-b0e78ecca118" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1045319a-9725-4a8a-9d5f-91a47b5f8299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1045319a-9725-4a8a-9d5f-91a47b5f8299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_755189c1-8c40-4cf5-b264-4410cd27c988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_755189c1-8c40-4cf5-b264-4410cd27c988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_435111be-06d3-46f9-b463-ed558c6b51a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_435111be-06d3-46f9-b463-ed558c6b51a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6ae5d08-b009-4303-98f8-39e70e955eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_033d8bfe-665e-42c2-8412-575f6e5ec14d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d6ae5d08-b009-4303-98f8-39e70e955eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_469ee99c-9904-44d4-9be8-1a24a5925446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_469ee99c-9904-44d4-9be8-1a24a5925446" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:to="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_25698fd6-b2a2-4c7d-acbb-40663570b058" xlink:to="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_c9bc6b2b-e7e8-4d0a-ad3c-840b3c5380c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_srt_AmericasMember_c9bc6b2b-e7e8-4d0a-ad3c-840b3c5380c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_24bf9398-0c54-4ac2-9840-f3385cc363a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_us-gaap_EMEAMember_24bf9398-0c54-4ac2-9840-f3385cc363a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e7f67e6d-8da9-472c-8357-8ade33342e4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_srt_AsiaPacificMember_e7f67e6d-8da9-472c-8357-8ade33342e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_9748e1b7-96f4-4159-8c0d-a2664474617b" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e1f3044-f0d9-4b30-a5de-6c40ad7d5dc9" xlink:to="loc_bax_HillromMember_9748e1b7-96f4-4159-8c0d-a2664474617b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bc32b06-9980-4982-a450-641c400db19f" xlink:to="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e03b3169-e5de-41aa-aa73-6aab97aa2642" xlink:to="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6ebd173d-33cb-4a45-abb1-5ae047427798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_Goodwill_6ebd173d-33cb-4a45-abb1-5ae047427798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c1dfe359-979a-43c9-b4af-556e05963a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c1dfe359-979a-43c9-b4af-556e05963a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9e0515fa-da56-4849-8cdc-c0487e227458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9e0515fa-da56-4849-8cdc-c0487e227458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c18e91cd-4501-4b0a-9081-996922fb5ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c18e91cd-4501-4b0a-9081-996922fb5ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c5d6fdea-6ba3-4f33-b747-9cf3678f7202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_867dc9ed-25e0-44d0-b8c8-dad76b435063" xlink:to="loc_us-gaap_Goodwill_c5d6fdea-6ba3-4f33-b747-9cf3678f7202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5969a14-9026-46eb-9a17-70c0e77028d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5969a14-9026-46eb-9a17-70c0e77028d4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a8fd89f9-6bf9-4e5a-babe-df79feb5d918" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_b3a39155-08ae-417a-b4d1-5dcef5c3963b" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_418b3c8e-2f18-4dc2-8ecc-a7e85c7e76c3" xlink:to="loc_bax_HillromMember_b3a39155-08ae-417a-b4d1-5dcef5c3963b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_229ddd96-c868-48e1-a983-e3c369504316" xlink:to="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsReportingUnitMember_592666f9-42bb-40bc-b253-ea6f56203333" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_PatientSupportSystemsReportingUnitMember_592666f9-42bb-40bc-b253-ea6f56203333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareReportingUnitMember_adfd7eb9-60ed-46c6-8398-b42cca5b6f3a" xlink:href="bax-20220930.xsd#bax_FrontLineCareReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_FrontLineCareReportingUnitMember_adfd7eb9-60ed-46c6-8398-b42cca5b6f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsReportingUnitMember_dc26f4b7-fa62-4092-832f-0abee9cf5672" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fdb571c3-777f-4e53-8086-fbae136fe7fb" xlink:to="loc_bax_SurgicalSolutionsReportingUnitMember_dc26f4b7-fa62-4092-832f-0abee9cf5672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_74811172-dc4c-4539-b236-2a017c496cde" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c77c04e5-2130-4e34-857b-b20c36c7af4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2147178b-fb75-4d09-afdc-faafa2fc6174" xlink:to="loc_us-gaap_TradeNamesMember_c77c04e5-2130-4e34-857b-b20c36c7af4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d776aee1-5833-4fec-b02a-ef273d964313" xlink:to="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bfbe2e69-6ea8-461d-bf68-44e1c5238829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_Goodwill_bfbe2e69-6ea8-461d-bf68-44e1c5238829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b95fc440-97fb-4e20-b3b6-ee543d9f813a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b95fc440-97fb-4e20-b3b6-ee543d9f813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_65bdfbd3-f337-4de3-b6b8-980464ac3a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_65bdfbd3-f337-4de3-b6b8-980464ac3a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_16867b73-75a2-4037-88a7-35c2d8fe9685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_16867b73-75a2-4037-88a7-35c2d8fe9685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_17deb471-fe01-4fcf-98f0-ec4c58ddb159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_17deb471-fe01-4fcf-98f0-ec4c58ddb159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3360e6f5-b4d0-4bd5-961a-1d0da26a5754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9f3eeb95-505b-474c-b84b-6e704d6569c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3360e6f5-b4d0-4bd5-961a-1d0da26a5754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fef10c7-b7a0-4e92-b76e-597b16662561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4fef10c7-b7a0-4e92-b76e-597b16662561" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_72dc7828-0ce3-4009-8d22-17c7d1c63d5d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1e6c339c-4f34-4648-9141-4a7584d7fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1e6c339c-4f34-4648-9141-4a7584d7fb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_5cfab835-e126-4a3f-98d4-57c041a3346b" xlink:href="bax-20220930.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_5cfab835-e126-4a3f-98d4-57c041a3346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_6547c4da-c7ea-46b4-b3b5-f11621b8edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ec625ad-f9f0-4dad-962b-b0f838e5db16" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_6547c4da-c7ea-46b4-b3b5-f11621b8edfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b6fdfdef-4502-412e-b706-ce6a634b988d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_93d2a189-c250-4d9f-ae1f-062d521a7f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:to="loc_us-gaap_TradeNamesMember_93d2a189-c250-4d9f-ae1f-062d521a7f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_2dad93c2-2640-46a8-a6ce-3a7b5ef25c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d09a925-52f2-47bb-b2e7-6593553ed877" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_2dad93c2-2640-46a8-a6ce-3a7b5ef25c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:href="bax-20220930.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_e6caf056-9e26-4d48-b5ba-5401fc38c0bf" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_afe980cf-ca93-4bfa-9636-d5390148907b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_afe980cf-ca93-4bfa-9636-d5390148907b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9a57e0e8-7285-4519-b600-bc73fa336cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9a57e0e8-7285-4519-b600-bc73fa336cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1d86580c-8800-407a-8ac9-b987ed2cf1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1d86580c-8800-407a-8ac9-b987ed2cf1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_704743e2-a7cb-4b7a-826f-2b22d2dd548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_704743e2-a7cb-4b7a-826f-2b22d2dd548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5128a88e-64c2-45b6-8f16-7ff265d4d865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5128a88e-64c2-45b6-8f16-7ff265d4d865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f60487f-1845-4b49-9295-432a37d6d254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f9af830c-788e-4165-aea0-c8f8f520040e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f60487f-1845-4b49-9295-432a37d6d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f94acebf-a841-4129-b2b7-6980542137c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f94acebf-a841-4129-b2b7-6980542137c6" xlink:to="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_40f34091-a6ae-4fc2-885a-91de318e79ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember_7c5a5a5c-e4a0-4d62-ac78-d7c0ae739b81" xlink:href="bax-20220930.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_SeniorThreeYearTermLoanMember_7c5a5a5c-e4a0-4d62-ac78-d7c0ae739b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember_f62e710f-342d-4bb2-bb5d-72b11bf5f89b" xlink:href="bax-20220930.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_SeniorFiveYearTermLoanMember_f62e710f-342d-4bb2-bb5d-72b11bf5f89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A24SeniorNotesDue2022Member_9074d759-f0ad-4612-ab59-6739cae6820a" xlink:href="bax-20220930.xsd#bax_A24SeniorNotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A24SeniorNotesDue2022Member_9074d759-f0ad-4612-ab59-6739cae6820a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A0868SeniorNotesDueMay2023Member_8e6fca6d-1754-4520-9837-73c78f8b336d" xlink:href="bax-20220930.xsd#bax_A0868SeniorNotesDueMay2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A0868SeniorNotesDueMay2023Member_8e6fca6d-1754-4520-9837-73c78f8b336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1322SeniorNotesDue2024Member_0469415f-868a-4cf2-ab46-171548abcfd6" xlink:href="bax-20220930.xsd#bax_A1322SeniorNotesDue2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A1322SeniorNotesDue2024Member_0469415f-868a-4cf2-ab46-171548abcfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A1915DebenturesDue2027Member_bdd066c9-e922-44a9-ad65-aaa93608a977" xlink:href="bax-20220930.xsd#bax_A1915DebenturesDue2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A1915DebenturesDue2027Member_bdd066c9-e922-44a9-ad65-aaa93608a977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2272SeniorNotesDue2028Member_90e0bbae-7f44-4525-8299-07166a86a30f" xlink:href="bax-20220930.xsd#bax_A2272SeniorNotesDue2028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A2272SeniorNotesDue2028Member_90e0bbae-7f44-4525-8299-07166a86a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A2539NotesDue2032Member_a736575e-556f-4fe4-b590-f935e0d3e419" xlink:href="bax-20220930.xsd#bax_A2539NotesDue2032Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A2539NotesDue2032Member_a736575e-556f-4fe4-b590-f935e0d3e419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A3132SeniorNotesDue2051Member_0cb1ed51-bde0-482a-87f0-4698b1e02c44" xlink:href="bax-20220930.xsd#bax_A3132SeniorNotesDue2051Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_A3132SeniorNotesDue2051Member_0cb1ed51-bde0-482a-87f0-4698b1e02c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2023Member_40b17e34-e315-4d1d-8d18-1aabbf18d265" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_FloatingRateNotesDue2023Member_40b17e34-e315-4d1d-8d18-1aabbf18d265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FloatingRateNotesDue2024Member_da118bca-d4ae-47f2-bae6-28781f8a8afa" xlink:href="bax-20220930.xsd#bax_FloatingRateNotesDue2024Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_614b3e41-f5d4-468e-b41c-34ba718e5d55" xlink:to="loc_bax_FloatingRateNotesDue2024Member_da118bca-d4ae-47f2-bae6-28781f8a8afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4a49312-4956-4d15-b46f-f77a6b56fe06" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_b0fa83f3-be5c-4638-b2d6-4cacd1798b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:to="loc_us-gaap_SeniorNotesMember_b0fa83f3-be5c-4638-b2d6-4cacd1798b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1db045f2-1cda-4889-9466-68c44c5b3e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c91bb274-6987-4bed-a596-4365766c397a" xlink:to="loc_us-gaap_CommercialPaperMember_1db045f2-1cda-4889-9466-68c44c5b3e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_90766080-f2ca-406a-9446-fc48a996ae7d" xlink:to="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d6fd4f6a-647a-486b-a598-ac10b5aa32ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_08d190cf-361d-4090-8f0e-4ad3d887aeb4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d6fd4f6a-647a-486b-a598-ac10b5aa32ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6e9163a8-5710-4144-b867-5638418c18db" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_bb266fe4-d483-4439-b5a8-49d77020ee10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_RepaymentsOfDebt_bb266fe4-d483-4439-b5a8-49d77020ee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f0bcc4d2-d2d6-4ede-8b2f-f9595a5563c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f0bcc4d2-d2d6-4ede-8b2f-f9595a5563c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_787788a3-cdff-4f9e-a138-ca192016a4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LongTermDebtTerm_787788a3-cdff-4f9e-a138-ca192016a4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1cc9ac24-5b55-4d15-b96b-fdbae2fc80f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1cc9ac24-5b55-4d15-b96b-fdbae2fc80f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7b911c7e-d609-4b31-a049-86269777418b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7b911c7e-d609-4b31-a049-86269777418b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5b5d2c6a-41f3-47f9-8030-9b1ce621a7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_LineOfCredit_5b5d2c6a-41f3-47f9-8030-9b1ce621a7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_14faf498-95fe-4a74-b6fc-24cd8ff858bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_14faf498-95fe-4a74-b6fc-24cd8ff858bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_54bd3e47-e086-4313-a2e1-860b22970868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_54bd3e47-e086-4313-a2e1-860b22970868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_f282da7c-d202-47cf-a39a-37397b98a73f" xlink:href="bax-20220930.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a88f6594-8dbd-45a3-bf10-6bb113d796d9" xlink:to="loc_bax_OriginalWeightedAverageTerm_f282da7c-d202-47cf-a39a-37397b98a73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ba55574-666d-46e5-99b1-86261221db44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9ba55574-666d-46e5-99b1-86261221db44" xlink:to="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_e73bf653-6bd4-4d45-8bb4-aad301bb0e97" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_bb0cb25d-a92c-446c-a618-1d831a10b1e3" xlink:href="bax-20220930.xsd#bax_SuperfundSitesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_d4d539d6-fd38-47b9-bf44-49ef1c41c15f" xlink:to="loc_bax_SuperfundSitesMember_bb0cb25d-a92c-446c-a618-1d831a10b1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_caf2b72e-89e2-45c3-9d8c-5abfed0824bb" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_248623c0-32bc-458d-aed8-e816a71485a5" xlink:href="bax-20220930.xsd#bax_EnviromentalCleanUpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_518f3272-07df-4913-8d32-6bf36287880d" xlink:to="loc_bax_EnviromentalCleanUpMember_248623c0-32bc-458d-aed8-e816a71485a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bd0c9ce9-3383-4787-9ced-5334311b9e08" xlink:to="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_4f846f35-9556-4ce8-a845-54d7e105c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationReserve_4f846f35-9556-4ce8-a845-54d7e105c64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_eb590b58-6538-49b4-a237-5c8a04f8732a" xlink:href="bax-20220930.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_bax_SiteContingencyNumberOfSites_eb590b58-6538-49b4-a237-5c8a04f8732a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_408e7cb8-b53a-43a7-8224-dd02f6050ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_408e7cb8-b53a-43a7-8224-dd02f6050ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9c06e898-2d3f-4ec9-b5f5-5ad3308d22d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9c06e898-2d3f-4ec9-b5f5-5ad3308d22d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_00e5c704-dc10-425e-ad48-d7a09c9a28b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_us-gaap_LitigationSettlementExpense_00e5c704-dc10-425e-ad48-d7a09c9a28b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_247d2914-f21e-4eba-a30a-ee5dd6c225bb" xlink:href="bax-20220930.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3c14ef5a-e384-4b8c-ad2e-045914487f33" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_247d2914-f21e-4eba-a30a-ee5dd6c225bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_13b0e42c-28b7-4d28-9d01-cb3c95116be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_13b0e42c-28b7-4d28-9d01-cb3c95116be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_111c4af3-3952-4699-bc6f-7372331529f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_111c4af3-3952-4699-bc6f-7372331529f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_a9abccec-62c7-4d47-a347-fd9166b1ee7e" xlink:href="bax-20220930.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:to="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_a9abccec-62c7-4d47-a347-fd9166b1ee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_fdf32f6e-ebbd-4a71-9d9b-4f2e3bab56a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_fdf32f6e-ebbd-4a71-9d9b-4f2e3bab56a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b915ed81-3636-43b3-98a3-f3dc3eb8c982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e71befcf-f4ee-4a33-b90e-9fa2b319273e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b915ed81-3636-43b3-98a3-f3dc3eb8c982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ff3dd03a-91e1-430b-9415-8e16678b9fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ff3dd03a-91e1-430b-9415-8e16678b9fe7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0362cd92-e692-439b-9209-fefdc1c5c2e4" xlink:to="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_68f4dc60-303b-4e6c-aa6b-6305e8f3c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_68f4dc60-303b-4e6c-aa6b-6305e8f3c80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_39d1b5c9-73d2-436f-9962-8b1384c40367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_39d1b5c9-73d2-436f-9962-8b1384c40367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_c0ea4ece-a839-4aa3-875e-99d8de110211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_c0ea4ece-a839-4aa3-875e-99d8de110211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c841844f-91dd-42b3-8ed1-5504f0f1f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c841844f-91dd-42b3-8ed1-5504f0f1f3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c2150079-fabd-4dbb-8488-156039647e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a64c4343-9f87-473f-b5af-9c1e0e293df1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c2150079-fabd-4dbb-8488-156039647e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bac4639f-7b80-49d7-989c-a156dc50a8cc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d2aae25-c479-4567-98ff-aa75984883af" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_085b9604-37e6-41fc-8404-741277d461e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_085b9604-37e6-41fc-8404-741277d461e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88c9c43a-1ad2-4c18-bfe2-ad2c1012898f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_88c9c43a-1ad2-4c18-bfe2-ad2c1012898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_28d98a8c-05b6-4df4-a638-65a7f02b6a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_28d98a8c-05b6-4df4-a638-65a7f02b6a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ac9f32d-a3c1-4ef5-99c9-35ecbd8a8e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ac9f32d-a3c1-4ef5-99c9-35ecbd8a8e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b2e2cb9-6100-4d5e-87b2-e9431f070f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36a6cf0d-42e9-46ac-963f-64081439cf5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b2e2cb9-6100-4d5e-87b2-e9431f070f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ebbc2a8a-4b2c-4f79-8533-6ba50af5eaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ebbc2a8a-4b2c-4f79-8533-6ba50af5eaab" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1db14c62-d879-4e71-b68e-09bf30db6f0f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_74997078-da6f-43e9-95a7-6a14dd655a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d530c4fc-a3a7-4055-aada-6cefa98ecd39" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_74997078-da6f-43e9-95a7-6a14dd655a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79daf9dd-8cb4-469a-b9e4-bcb4f778637b" xlink:to="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_06c2d20f-6a1c-4f43-9efb-df6da58e2b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_06c2d20f-6a1c-4f43-9efb-df6da58e2b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_666f0108-b8b2-4017-a960-c839caf90ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_666f0108-b8b2-4017-a960-c839caf90ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_95bba750-1b12-4285-8d0d-254ede942bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_79b0003f-1c2a-4318-bafd-33eee004b98c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_95bba750-1b12-4285-8d0d-254ede942bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_167bdc4f-871f-4dfa-a55c-1f91e5df5ad4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4e527278-0ac5-4cda-9323-59a96563dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4e527278-0ac5-4cda-9323-59a96563dfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_5b091a0f-34e6-489b-b2a5-fd15e9d4ded4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07f634ce-be1d-48e5-bd24-8192a664e9f6" xlink:to="loc_us-gaap_InterestRateContractMember_5b091a0f-34e6-489b-b2a5-fd15e9d4ded4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_afd65837-914d-477f-aade-054e2e4aae83" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_44d0d67f-857d-499d-9536-a4b59c307e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_44d0d67f-857d-499d-9536-a4b59c307e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1e4df5fc-ef02-4035-99c6-a936a6a828d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1e4df5fc-ef02-4035-99c6-a936a6a828d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2828c8af-30e9-4ee9-b9c2-5b7dc7dcba53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2828c8af-30e9-4ee9-b9c2-5b7dc7dcba53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5bb6f0b9-f703-4077-b014-a0561c561bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5bb6f0b9-f703-4077-b014-a0561c561bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f82633ca-a5f6-407a-8f74-6eb1520c8c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f82633ca-a5f6-407a-8f74-6eb1520c8c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2555f809-b16d-4c2c-b578-e44e5d116381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_18bb5914-c31f-4019-9b50-2256f3f5c286" xlink:to="loc_us-gaap_NetIncomeLoss_2555f809-b16d-4c2c-b578-e44e5d116381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e14d147-1c55-4b56-a717-18af55ff6ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e14d147-1c55-4b56-a717-18af55ff6ae9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_bdb9a3eb-1fec-4c3b-bb95-0008594cb82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_bdb9a3eb-1fec-4c3b-bb95-0008594cb82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ee9a782-83b7-4f03-8c4b-48f6e0268be2" xlink:to="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MinimumMember_15eaf5e4-9246-4ba4-af4c-cb37b8ef690e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5e1c6769-962d-43eb-968d-26b5a3a7d125" xlink:to="loc_srt_MaximumMember_189c1a13-edc6-4f59-a878-228e09f3d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_27f89abb-4aba-4545-8360-97bd24685233" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ManufacturingArrangementsMember_43813d26-ac11-4655-b578-fc0fca3830f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_SoftwareArrangementsMember_138eed56-1544-40b8-92d8-aaad605b0f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:href="bax-20220930.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_7d76b28e-b675-4494-a36e-5973813db5b7" xlink:to="loc_bax_ConsumableMedicalProductsMember_4b14460f-63be-4b82-ba58-77687871c809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b28ed8ae-276a-41e6-a667-34136d5deb1e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:href="bax-20220930.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_968d15ad-1ed3-4757-aa0b-b116f88949f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_329f3433-b434-441c-a6ee-e2ce2cb5f480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_98a39e6c-2222-40fc-a7ef-6f792bf1d574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_AccountsReceivableNet_c88a3a76-37a6-424b-9b72-99ed255faa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:href="bax-20220930.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_6d55b8ec-507f-40ec-b3f8-e0029df8eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_45978a2c-d9b6-4e55-b64d-f76b4df08e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_6b6fe068-ae0f-4f08-9042-ba96b9e69944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a43e1b4b-fca7-4870-831a-16357450ec9e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e33a98ba-cff2-4aa1-b6db-ab1d8e34912f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b1c09451-5476-44ff-bc7e-ef7432222de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b1c09451-5476-44ff-bc7e-ef7432222de4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_2d863413-8b66-47cc-8cce-eadb8cda40ec" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_1f7d8cbc-1395-47c7-b94b-36ed338c46d6" xlink:href="bax-20220930.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_ManufacturingArrangementsMember_1f7d8cbc-1395-47c7-b94b-36ed338c46d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_6f9318b0-f333-44fc-ae1c-3be4e3ed50f3" xlink:href="bax-20220930.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_SoftwareArrangementsMember_6f9318b0-f333-44fc-ae1c-3be4e3ed50f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_c64eaaac-4467-4f25-905f-0157c7e7fc2b" xlink:href="bax-20220930.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_4208db7e-6157-44ba-bb7c-475a87331e83" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_c64eaaac-4467-4f25-905f-0157c7e7fc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c066e38a-95e9-4419-874b-0911f419bc83" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0886adea-f2f5-433e-b1d0-7629258b13e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0886adea-f2f5-433e-b1d0-7629258b13e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b451a2d6-121b-4e3a-9580-e69a981510e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b451a2d6-121b-4e3a-9580-e69a981510e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_d71cba96-1d94-4611-ac9c-75cc26decf30" xlink:href="bax-20220930.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_d71cba96-1d94-4611-ac9c-75cc26decf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_785b2d52-2506-4e9e-9d04-605b6ded8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b01a431-a189-4f3a-af82-ed650ab73bd2" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_785b2d52-2506-4e9e-9d04-605b6ded8f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc9b8eec-41ee-49a2-9930-a49da4ba4677" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_cd4ffd46-1979-4283-9076-575379a855d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_cd4ffd46-1979-4283-9076-575379a855d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_20996c02-4ec6-4679-8fcb-50b875cd7000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_20996c02-4ec6-4679-8fcb-50b875cd7000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:href="bax-20220930.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d6dafec-aa0b-43e2-b76b-d83123e8841a" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_431c448f-baed-4835-8b52-7c2a3194cbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_431c448f-baed-4835-8b52-7c2a3194cbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_bfbf8310-cb23-4d9c-8c39-804e06c58d20" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_bfbf8310-cb23-4d9c-8c39-804e06c58d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_66a2a338-cd0b-45df-88c0-8ffb22e92b46" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_66a2a338-cd0b-45df-88c0-8ffb22e92b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_7cafddb4-7412-4748-8cdd-cdf58be550f3" xlink:href="bax-20220930.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_7cafddb4-7412-4748-8cdd-cdf58be550f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_86bd2e59-a8ec-46dc-86ac-986acd244bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_5366700f-b52e-4ccb-94e9-ff930f0cc6b9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_86bd2e59-a8ec-46dc-86ac-986acd244bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7ae7854f-074f-4a0f-8643-1d0b4928b617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7ae7854f-074f-4a0f-8643-1d0b4928b617" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:to="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a9c92d2e-996a-4821-b036-00e08c6fe877" xlink:to="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_fad2fe8c-6c3a-4d2b-8d96-e20623224648" xlink:href="bax-20220930.xsd#bax_RenalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_RenalMember_fad2fe8c-6c3a-4d2b-8d96-e20623224648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_3f468ee5-9189-4fe6-966e-96b24b9a8e69" xlink:href="bax-20220930.xsd#bax_MedicationDeliveryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_MedicationDeliveryMember_3f468ee5-9189-4fe6-966e-96b24b9a8e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_3a8ce107-2166-4f04-a989-70e39ee0f627" xlink:href="bax-20220930.xsd#bax_PharmaceuticalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_PharmaceuticalsMember_3a8ce107-2166-4f04-a989-70e39ee0f627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_224edf8a-e274-4eaa-a970-e2a089cdfe11" xlink:href="bax-20220930.xsd#bax_ClinicalNutritionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_ClinicalNutritionMember_224edf8a-e274-4eaa-a970-e2a089cdfe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_6e883828-3e3a-43d9-aaf7-891400354120" xlink:href="bax-20220930.xsd#bax_AdvancedSurgeryMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_AdvancedSurgeryMember_6e883828-3e3a-43d9-aaf7-891400354120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_ade1f047-cbfe-4595-a3cd-1565870d30fd" xlink:href="bax-20220930.xsd#bax_AcuteTherapiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_AcuteTherapiesMember_ade1f047-cbfe-4595-a3cd-1565870d30fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_e1f0e1b5-3e47-409c-abcc-072f2df13ce7" xlink:href="bax-20220930.xsd#bax_BioPharmaSolutionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_BioPharmaSolutionsMember_e1f0e1b5-3e47-409c-abcc-072f2df13ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_d7ee817d-5260-4f64-8c9b-6178dcfe8e49" xlink:href="bax-20220930.xsd#bax_PatientSupportSystemsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_PatientSupportSystemsMember_d7ee817d-5260-4f64-8c9b-6178dcfe8e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_82cd02b0-f0d8-4aaa-9e2c-5f35bbeea4fb" xlink:href="bax-20220930.xsd#bax_FrontLineCareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_FrontLineCareMember_82cd02b0-f0d8-4aaa-9e2c-5f35bbeea4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_e59be87b-257d-42f8-96a5-023d7029c488" xlink:href="bax-20220930.xsd#bax_SurgicalSolutionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_SurgicalSolutionsMember_e59be87b-257d-42f8-96a5-023d7029c488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_a108fbd9-e161-453d-8357-a28112b2ac1a" xlink:href="bax-20220930.xsd#bax_OtherProductOrServicesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f28e5ad-a025-45c1-96fe-53e539c14493" xlink:to="loc_bax_OtherProductOrServicesMember_a108fbd9-e161-453d-8357-a28112b2ac1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:to="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fceaf144-0e7b-42e8-a3f1-695420913b74" xlink:to="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_324e9151-6601-409c-af28-f734946ef52f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:to="loc_country_US_324e9151-6601-409c-af28-f734946ef52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cf042600-0525-4eaf-9408-0c0aa96f05be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7fed0b91-de23-4dca-b821-b1ac939656a6" xlink:to="loc_us-gaap_NonUsMember_cf042600-0525-4eaf-9408-0c0aa96f05be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5efedf8c-2235-47d8-b06e-3e5817dc6c6a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac0af49b-57e3-43b3-b12f-ad7d78614c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8880a65-2a32-4a2e-90dc-ad6da9991bc5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac0af49b-57e3-43b3-b12f-ad7d78614c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#REVENUESLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a74f1797-32f0-4af8-91e3-1be10ef77cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_cd8a71f7-869a-4293-b9d1-f92c3f212083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a74f1797-32f0-4af8-91e3-1be10ef77cdb" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_cd8a71f7-869a-4293-b9d1-f92c3f212083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_1e4f5035-8a21-42a9-a362-aefb120606c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a74f1797-32f0-4af8-91e3-1be10ef77cdb" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_1e4f5035-8a21-42a9-a362-aefb120606c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_973e83c2-d4d8-4bcc-b06b-96c845ffd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a74f1797-32f0-4af8-91e3-1be10ef77cdb" xlink:to="loc_us-gaap_VariableLeaseIncome_973e83c2-d4d8-4bcc-b06b-96c845ffd13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_9d398474-3464-42da-8a09-aa7d4f08a8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a74f1797-32f0-4af8-91e3-1be10ef77cdb" xlink:to="loc_us-gaap_LeaseIncome_9d398474-3464-42da-8a09-aa7d4f08a8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2e61bf6-f018-4001-aaaf-f83ab25ff9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_495718ea-6fa5-4c86-bb56-a7c7c3dbee3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2e61bf6-f018-4001-aaaf-f83ab25ff9aa" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_495718ea-6fa5-4c86-bb56-a7c7c3dbee3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_90e4168c-c18e-4e8b-95be-2784e4b65b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2e61bf6-f018-4001-aaaf-f83ab25ff9aa" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_90e4168c-c18e-4e8b-95be-2784e4b65b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_74ebbde5-91b8-42d8-83a0-de3bd6bb5334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_74ebbde5-91b8-42d8-83a0-de3bd6bb5334" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:to="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_9f96913e-6066-4929-9a3e-21a5e1e60a85" xlink:to="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_f2351cf1-fd80-4d00-84b5-7800a1122f80" xlink:href="bax-20220930.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_f16ab55e-9e41-4abc-b751-333f5253da8a" xlink:to="loc_bax_BusinessOptimizationProgramsMember_f2351cf1-fd80-4d00-84b5-7800a1122f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c96b5924-9807-4bb3-9a41-671f990e6d78" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_433fe207-22d9-4ca7-9596-4d40ececeec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringCharges_433fe207-22d9-4ca7-9596-4d40ececeec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_885838a9-a998-4180-8bf3-82c24b442d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_885838a9-a998-4180-8bf3-82c24b442d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_94df4cc2-caf6-4fe4-af17-b0788522ce38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_050d9ba2-8b48-4a8e-affc-6f65c226ac16" xlink:to="loc_us-gaap_RestructuringCosts_94df4cc2-caf6-4fe4-af17-b0788522ce38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_87ccbb75-bfb2-4db4-8f24-80dd435e094c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_87ccbb75-bfb2-4db4-8f24-80dd435e094c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5addae6d-de61-4213-9320-2c0b8c4adde6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_522ce68c-5547-4a46-bb7d-5990e0833f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_us-gaap_EmployeeSeveranceMember_522ce68c-5547-4a46-bb7d-5990e0833f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_ff1a6a38-ec37-4de6-a27f-12f1d95b9391" xlink:href="bax-20220930.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_ff1a6a38-ec37-4de6-a27f-12f1d95b9391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_55d001f5-84c6-4cc6-8f79-3765e93d9802" xlink:href="bax-20220930.xsd#bax_AssetImpairmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_789b396a-2b75-44bd-8bc2-51e0f698fa34" xlink:to="loc_bax_AssetImpairmentMember_55d001f5-84c6-4cc6-8f79-3765e93d9802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bac2f98a-7f85-4485-a38d-b5986118208e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bd972d05-42d9-4a0e-a172-306fc0b3385d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_CostOfSalesMember_bd972d05-42d9-4a0e-a172-306fc0b3385d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5f639ba3-458a-4c83-8a20-43b4c0f0e8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5f639ba3-458a-4c83-8a20-43b4c0f0e8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_92819c5b-e114-41e9-a351-daa146f40f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f3b915f7-102c-4f96-9af4-ded59b025692" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_92819c5b-e114-41e9-a351-daa146f40f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_02b4d170-ab62-41ea-be40-240daff0dec3" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c0f51c19-adb4-42bf-b0a4-6256fd801b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bc9dfc25-4c81-4994-b100-8d97c99ec294" xlink:to="loc_us-gaap_RestructuringCharges_c0f51c19-adb4-42bf-b0a4-6256fd801b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_52d99eeb-3599-4936-a86c-671276dc3b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_52d99eeb-3599-4936-a86c-671276dc3b28" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_549d0a6a-c1b3-4c73-9b24-c22e6265b8a7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_27879c65-3c08-42d4-9e71-7e0d67ab97c9" xlink:href="bax-20220930.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d5a58f29-2c09-46c0-8cca-b17e6e90ca89" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_27879c65-3c08-42d4-9e71-7e0d67ab97c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f89af54-93f2-4fe8-af4f-db3d28ccafbb" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_610c6411-39ee-4ceb-916f-0079782b8093" xlink:to="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_477e2b94-5d8a-40ad-a1ae-7218785a9648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserve_477e2b94-5d8a-40ad-a1ae-7218785a9648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_969ce326-5193-4964-90bd-5f63718f43c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringCharges_969ce326-5193-4964-90bd-5f63718f43c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_01f3406e-7e12-454a-9e68-ea06d3f23794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_PaymentsForRestructuring_01f3406e-7e12-454a-9e68-ea06d3f23794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1d898ff7-2536-4c91-a632-94b917a5c696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1d898ff7-2536-4c91-a632-94b917a5c696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_6c036c61-63a2-4189-abc2-01acecd83efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_6c036c61-63a2-4189-abc2-01acecd83efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b8457e5f-32f2-458b-9f88-6af7c6d5fa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3c888435-4a88-4419-b7e6-627466b3ce90" xlink:to="loc_us-gaap_RestructuringReserve_b8457e5f-32f2-458b-9f88-6af7c6d5fa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_20ab010d-596c-440e-a4da-8b9ba3714357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_20ab010d-596c-440e-a4da-8b9ba3714357" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_045613ab-2970-4464-8490-7314379c3766" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7b18e660-285a-4d8d-b82a-d14de62f970d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7b18e660-285a-4d8d-b82a-d14de62f970d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d62dd36-d40b-4b9d-a14c-3d5b26125b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1e23bbb-e3fa-4b0b-893a-65a19e4addec" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d62dd36-d40b-4b9d-a14c-3d5b26125b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f1dd88f-79dd-4be8-ac9b-263ec7bda901" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e53ca8f4-7fb2-4499-964d-ed5fd0d81fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e53ca8f4-7fb2-4499-964d-ed5fd0d81fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_05b03ade-ec03-44bc-9afe-61ceedefb222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_05b03ade-ec03-44bc-9afe-61ceedefb222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_eeafdca2-9c8b-4ed4-8bef-886c2e5688e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_eeafdca2-9c8b-4ed4-8bef-886c2e5688e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_89644ce8-0b7d-4958-9073-b0224c3f2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_89644ce8-0b7d-4958-9073-b0224c3f2850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fe5d157a-3d65-4ff1-ad62-dd5f26bb0240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b62e1c46-ebbb-4b03-9381-89634f6ad417" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fe5d157a-3d65-4ff1-ad62-dd5f26bb0240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_68ad1e9f-5c32-4749-bfe1-0081fc08484d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4eff6e73-d402-4ef8-84c1-e0b14a77620f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_68ad1e9f-5c32-4749-bfe1-0081fc08484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_74d4dde9-915f-43e7-b01e-e9e32f65eb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d59c30e4-c4cd-4c7e-a725-2790524c1200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_74d4dde9-915f-43e7-b01e-e9e32f65eb9e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d59c30e4-c4cd-4c7e-a725-2790524c1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e6e025d9-6e57-4a1a-b9a9-5569794251b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_74d4dde9-915f-43e7-b01e-e9e32f65eb9e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e6e025d9-6e57-4a1a-b9a9-5569794251b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible_abcbb010-badb-43d5-9b92-4f399e13290d" xlink:href="bax-20220930.xsd#bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_74d4dde9-915f-43e7-b01e-e9e32f65eb9e" xlink:to="loc_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible_abcbb010-badb-43d5-9b92-4f399e13290d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a7ce980b-44ad-4b3f-a3fe-3eba5e94c473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_adea6756-9225-4fdb-9525-207a64244744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a7ce980b-44ad-4b3f-a3fe-3eba5e94c473" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_adea6756-9225-4fdb-9525-207a64244744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0fe9d6f-fc53-4840-9d76-73b920ebd438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_adea6756-9225-4fdb-9525-207a64244744" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0fe9d6f-fc53-4840-9d76-73b920ebd438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d2519546-83da-461e-8ea1-a5e674b0d16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_adea6756-9225-4fdb-9525-207a64244744" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d2519546-83da-461e-8ea1-a5e674b0d16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_370fd9b9-ed07-41aa-b3cd-edb453fcdbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_adea6756-9225-4fdb-9525-207a64244744" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_370fd9b9-ed07-41aa-b3cd-edb453fcdbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#EARNINGSPERSHAREAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43b54cf4-6075-429c-87cd-6cdd4b1f709a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6803c5e9-cbd9-4e54-acaa-6240dce7f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43b54cf4-6075-429c-87cd-6cdd4b1f709a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6803c5e9-cbd9-4e54-acaa-6240dce7f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d11dbf79-3b6f-46f4-a7fc-ba4d838d9006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43b54cf4-6075-429c-87cd-6cdd4b1f709a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d11dbf79-3b6f-46f4-a7fc-ba4d838d9006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68540e2f-127c-4075-b67a-66a73d594e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68540e2f-127c-4075-b67a-66a73d594e96" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_698cf90d-f2d0-4adf-a29f-e0d240d8f4e3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7d945cd6-f339-4251-af8d-15686eb8134d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7d945cd6-f339-4251-af8d-15686eb8134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8e34906e-2d70-436e-8c5b-9fc3eb888e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_InterestRateContractMember_8e34906e-2d70-436e-8c5b-9fc3eb888e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3c9728dc-f1cf-4058-868b-4454fb656bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87563bc8-24a2-4488-bdee-5d7aa8fff43b" xlink:to="loc_us-gaap_InterestRateSwapMember_3c9728dc-f1cf-4058-868b-4454fb656bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9d0c85d-4409-4500-a245-f2f6910ada16" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member_0e696462-c4aa-4482-9e20-f883dba0f026" xlink:href="bax-20220930.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A130SeniorNotesDueMay2025Member_0e696462-c4aa-4482-9e20-f883dba0f026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member_c5a51874-6617-4a0e-b927-5c8c2958c63e" xlink:href="bax-20220930.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A04SeniorNotesDueMay2024Member_c5a51874-6617-4a0e-b927-5c8c2958c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member_25f7cb99-2a9c-4506-8470-1003ce32f52b" xlink:href="bax-20220930.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_02853074-4260-428c-bc52-48d9a35a93d1" xlink:to="loc_bax_A13SeniorNotesDueMay2029Member_25f7cb99-2a9c-4506-8470-1003ce32f52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6842cb22-1e19-45d5-8315-07d9ff28af5d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9b1a7c6b-4171-478c-bd45-a91d14ecd02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8be4826c-7637-4250-8639-2054a75938ab" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9b1a7c6b-4171-478c-bd45-a91d14ecd02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0abe996-3743-44ba-ba04-2470b845bf3a" xlink:to="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e55be0d0-5743-41bf-837c-228af58e1867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_472fe876-a09e-43f7-b65e-9b761d2b2289" xlink:to="loc_us-gaap_NondesignatedMember_e55be0d0-5743-41bf-837c-228af58e1867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_748abe57-1f38-40d9-aea3-b81089cf4fcc" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c10b18c0-df13-435a-bd11-e7b1f2be1a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c10b18c0-df13-435a-bd11-e7b1f2be1a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_d00b223f-c790-4dd2-920c-528d1f239ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_d00b223f-c790-4dd2-920c-528d1f239ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64190024-c0a8-409c-8e0d-3022d5c82d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64190024-c0a8-409c-8e0d-3022d5c82d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0b467346-e04f-48ae-bd29-027152d95eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0b467346-e04f-48ae-bd29-027152d95eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da458a45-fc7c-4aa2-87b8-e93b1ffebe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da458a45-fc7c-4aa2-87b8-e93b1ffebe4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_b36d7bbf-9d66-451e-a89b-3d6cd48bc37d" xlink:href="bax-20220930.xsd#bax_DerivativeFairValueTerminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_bax_DerivativeFairValueTerminated_b36d7bbf-9d66-451e-a89b-3d6cd48bc37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_89562093-c6c5-43eb-9299-a1f93c40a8b3" xlink:href="bax-20220930.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_89562093-c6c5-43eb-9299-a1f93c40a8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_43e6ef32-113d-40c5-820c-1094e221ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94b4ca13-4ee1-4b16-b6a1-37576154e205" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_43e6ef32-113d-40c5-820c-1094e221ce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_05ec08d2-09be-409b-b0a4-7f742d0cafbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_05ec08d2-09be-409b-b0a4-7f742d0cafbd" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b503ba86-ce84-48e4-836a-7446852c62dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7eff95f5-ef4d-4227-9cd3-70aa2bff236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:to="loc_us-gaap_InterestRateContractMember_7eff95f5-ef4d-4227-9cd3-70aa2bff236f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d84143d8-e2b7-4d12-9026-1ffd8de968d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5b1be4e-faac-4700-8995-83f3ad7234ca" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d84143d8-e2b7-4d12-9026-1ffd8de968d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_bee5b8f9-c6eb-4eb4-9a75-e9ed223e8b42" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_edc5b62a-f34b-4ecd-b1ea-ed5b5dae5be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:to="loc_us-gaap_CashFlowHedgingMember_edc5b62a-f34b-4ecd-b1ea-ed5b5dae5be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_33cd654a-0d14-4c81-bd15-82db2d8dbfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d2613052-f17d-45b1-9004-8825bae6282a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_33cd654a-0d14-4c81-bd15-82db2d8dbfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_997d4298-ce4b-4b26-a821-fec6e8a83e2b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ea1198f2-fed6-429c-9965-97717fde7033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_InterestExpenseMember_ea1198f2-fed6-429c-9965-97717fde7033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6520b26e-cb36-432d-b12d-7dd6cba55e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_CostOfSalesMember_6520b26e-cb36-432d-b12d-7dd6cba55e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2176482f-6c7e-4c57-a946-f0b3a14061f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19bebdb0-b68b-4091-9920-dd7a4e785d34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2176482f-6c7e-4c57-a946-f0b3a14061f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1adb6717-cb8d-4973-9c36-083f2a472c6d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_dd58db01-e768-4dca-b3ad-d959bf3cfb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_dd58db01-e768-4dca-b3ad-d959bf3cfb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_7e939cf5-2771-46b8-a7ec-376e9f678b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_7e939cf5-2771-46b8-a7ec-376e9f678b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_6fe96e24-b377-4363-ac0a-cd6156cc3002" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_6fe96e24-b377-4363-ac0a-cd6156cc3002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ef234909-741d-4698-9d00-38ce2cf00a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ef234909-741d-4698-9d00-38ce2cf00a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_2492b49f-fe7c-4097-9c98-38b6bffe40d7" xlink:href="bax-20220930.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_2492b49f-fe7c-4097-9c98-38b6bffe40d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c6d41bea-5a76-49f4-92d6-2b72e1aef2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_44879a06-7d5e-4cc7-b0a1-dc6a3163d47d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c6d41bea-5a76-49f4-92d6-2b72e1aef2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b6e74440-9c57-4e29-ab0d-5319c9bc8954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b6e74440-9c57-4e29-ab0d-5319c9bc8954" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_fb486ab1-ea84-479c-8f72-18bde9f36442" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b5c40daf-243c-429e-8006-adf65a86d610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b5c40daf-243c-429e-8006-adf65a86d610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_27924fb1-7c9b-4fb7-ba74-ed29ad650f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8168b7-1f41-45cb-99f9-bd14a2ed8ea7" xlink:to="loc_us-gaap_NondesignatedMember_27924fb1-7c9b-4fb7-ba74-ed29ad650f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e39fca32-2ef3-4ce8-975c-116d97ec1f4c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5bc41228-2c13-46ac-b9bb-5d0ead6c42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_83c9569e-511d-4501-b086-da6c083ed1e0" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5bc41228-2c13-46ac-b9bb-5d0ead6c42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52dfc424-2019-44dc-99de-5c785f7e9e66" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a8958824-b572-407e-93ee-508b4e779ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a8958824-b572-407e-93ee-508b4e779ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_4b6b1be3-97ea-4f4e-9c63-d55573bce5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_39db75fe-06b6-456a-a174-f148e6a09c22" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_4b6b1be3-97ea-4f4e-9c63-d55573bce5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ccab29cf-2800-4cf2-917c-6fef47114370" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0b09d243-80a3-4adc-b0a2-ea9d663f4c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0b09d243-80a3-4adc-b0a2-ea9d663f4c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6787e086-8064-4d0a-a249-b6f671b2bec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9356833d-33bd-4268-8bbe-cdd6eb424635" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_6787e086-8064-4d0a-a249-b6f671b2bec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c82c9ea-2abc-4b67-b17c-f85a5ed26cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_66f1537d-182c-4e9d-aa7a-dbbbc4ba2db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c82c9ea-2abc-4b67-b17c-f85a5ed26cda" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_66f1537d-182c-4e9d-aa7a-dbbbc4ba2db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fed67f6a-162a-4801-9243-42f820ba9a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_66f1537d-182c-4e9d-aa7a-dbbbc4ba2db8" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fed67f6a-162a-4801-9243-42f820ba9a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_1f8871f7-e1cd-48f6-a88c-4fbe72aa0622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_66f1537d-182c-4e9d-aa7a-dbbbc4ba2db8" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_1f8871f7-e1cd-48f6-a88c-4fbe72aa0622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_0617070b-0bca-4cb9-88ec-d36fbd2e3819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_66f1537d-182c-4e9d-aa7a-dbbbc4ba2db8" xlink:to="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_0617070b-0bca-4cb9-88ec-d36fbd2e3819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_bda68fb4-0c47-47f2-8110-89170a770e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c82c9ea-2abc-4b67-b17c-f85a5ed26cda" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_bda68fb4-0c47-47f2-8110-89170a770e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc9b3331-9f00-4043-bdbe-ec93b96e0e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_bda68fb4-0c47-47f2-8110-89170a770e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_dc9b3331-9f00-4043-bdbe-ec93b96e0e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_327cb914-21ca-4766-bd63-6dc87179dbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_bda68fb4-0c47-47f2-8110-89170a770e5c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_327cb914-21ca-4766-bd63-6dc87179dbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_3b4f5e91-8d3d-427c-8045-ed7e4e4fe470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_bda68fb4-0c47-47f2-8110-89170a770e5c" xlink:to="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_3b4f5e91-8d3d-427c-8045-ed7e4e4fe470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_07535ac8-afdc-4f5b-861f-d45c6253adf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_07535ac8-afdc-4f5b-861f-d45c6253adf2" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_04db8d55-5186-45f2-ae90-dd4d6225527f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c893b3fa-e9e2-49fa-8386-9fcc50ad68ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3848165e-b5e8-4aa4-b1cc-350de6d822e5" xlink:to="loc_us-gaap_LongTermDebtMember_c893b3fa-e9e2-49fa-8386-9fcc50ad68ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c1958c90-26f9-4d31-9034-f3deb6a3dc9b" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_98ef6e27-b89b-434e-a75e-0b31e459f909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_98ef6e27-b89b-434e-a75e-0b31e459f909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3425cb8c-78b3-4129-a254-d80bf3b92024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_23c9f1c7-c3fe-434b-a025-0f4052eb7548" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3425cb8c-78b3-4129-a254-d80bf3b92024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_671299f8-c1c5-4cac-9369-1fe694856ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_671299f8-c1c5-4cac-9369-1fe694856ff5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6610fccd-593f-4095-945c-3682720b9d73" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_32540b12-0a07-40ae-b735-89eccddb238d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9803624-b721-4893-818e-2b5f61bb026a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_32540b12-0a07-40ae-b735-89eccddb238d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1052fed-86fa-4d59-8667-e05003aaf6c8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_039f09b9-26db-46f4-b0aa-1234701c9b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_039f09b9-26db-46f4-b0aa-1234701c9b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_008d8f99-52cf-4117-bd35-5ec08e471388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_008d8f99-52cf-4117-bd35-5ec08e471388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_42da0503-fa29-4370-ae02-804fb0a44ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e909c24-47dd-4f32-a734-52d4f4bcaf7c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_42da0503-fa29-4370-ae02-804fb0a44ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6edb4a9-68f7-4e85-9063-308b2682fb96" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_62c44182-ead1-4735-88cd-d22ba683ed88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_62c44182-ead1-4735-88cd-d22ba683ed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6c06e303-b1d0-4146-9d81-1c65990086df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6c06e303-b1d0-4146-9d81-1c65990086df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_bf8cffaa-e442-4eae-a067-57c82d559335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_bf8cffaa-e442-4eae-a067-57c82d559335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b5f59742-4525-4960-bbcc-24ba891a0583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7c1e8e2e-9b22-40ba-bbbd-3f9f35b068b6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b5f59742-4525-4960-bbcc-24ba891a0583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_21b86c15-0968-4f03-8231-0f921a44fb02" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_cb5f9e33-cf04-4fbc-a16f-72a31034c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_cb5f9e33-cf04-4fbc-a16f-72a31034c1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7d487cad-a0f7-497e-9989-870c97846be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7d487cad-a0f7-497e-9989-870c97846be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_0abf9a0b-3660-4092-b844-213e4811f432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1e5397b6-29cc-40e6-9ea1-29dee51f215a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_0abf9a0b-3660-4092-b844-213e4811f432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bb6dea7e-0af8-4b34-b379-ce264794a07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bb6dea7e-0af8-4b34-b379-ce264794a07a" xlink:to="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b75289fa-da0f-4f42-83a4-47f0c7aa41a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a01ee632-dbbb-4f7f-a391-07106f410040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fc78aa9-4acd-4546-ba1c-b5d85991d520" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a01ee632-dbbb-4f7f-a391-07106f410040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_28f45b99-8b75-4e14-837b-fdd92487c0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_aed55ec0-b189-4be6-a817-5b8693df619d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5f2e37bc-53ef-455b-9728-1045b90fc18d" xlink:to="loc_us-gaap_OtherAssetsMember_aed55ec0-b189-4be6-a817-5b8693df619d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_14753cb8-f4d4-4ddb-bff2-c32728eaf02b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_81bc7093-a9f1-40d1-be8a-03c42a2049f3" xlink:href="bax-20220930.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc0283ad-fd7d-4820-91af-9660ba40a7b8" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_81bc7093-a9f1-40d1-be8a-03c42a2049f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_f4d58098-9e88-4d75-8b01-37ba51302900" xlink:to="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f7cad95-406b-4e37-bb09-8f03397b8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f7cad95-406b-4e37-bb09-8f03397b8b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_786f0f39-7cc5-4f93-9063-159a0d84a159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_786f0f39-7cc5-4f93-9063-159a0d84a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_7ad62e80-0ce8-4a46-8e28-3c18a140067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_7ad62e80-0ce8-4a46-8e28-3c18a140067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_11fd2957-c04c-4217-927e-4864d7b247bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_ea8d224b-969b-40cb-aefd-5cf7ab7a2d03" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_11fd2957-c04c-4217-927e-4864d7b247bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bf1d7a4b-e630-4e57-9954-86fb9b16c952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bf1d7a4b-e630-4e57-9954-86fb9b16c952" xlink:to="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_997eb1b8-5c5c-4f2f-bc35-060bd001bb74" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_a47093d4-a8d6-4aa7-8f08-ec87fd191090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_a47093d4-a8d6-4aa7-8f08-ec87fd191090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_b8cb35f6-f27d-4519-866c-91815fbbcc38" xlink:href="bax-20220930.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f9c18816-b9ac-48b2-b3ed-2017821f75c0" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_b8cb35f6-f27d-4519-866c-91815fbbcc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:href="bax-20220930.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_75f50672-be00-498a-a234-33b565437aa7" xlink:to="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73e49793-a326-4fa4-b7a7-2faee2071629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73e49793-a326-4fa4-b7a7-2faee2071629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_95d2878f-3d3c-4ad1-8d5f-34bb3b69ec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_95d2878f-3d3c-4ad1-8d5f-34bb3b69ec5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_69c2f4dd-fcac-46c0-8e16-8fcc9f5c18c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_69c2f4dd-fcac-46c0-8e16-8fcc9f5c18c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_413e19da-d886-465e-8e6e-f1f180513af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_413e19da-d886-465e-8e6e-f1f180513af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5c8ac255-4ef5-4002-aae6-5185278b11f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5c8ac255-4ef5-4002-aae6-5185278b11f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_fe13470e-b068-4c86-8b7b-e54e63f3c145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_fe13470e-b068-4c86-8b7b-e54e63f3c145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_8f6b91bd-e99f-4ddf-adaf-3ccc808b1fcb" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation_8f6b91bd-e99f-4ddf-adaf-3ccc808b1fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1612982d-942e-4191-a7b2-ea09de833001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8cbe3e83-c172-47a3-89ba-5aff570b1e7a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1612982d-942e-4191-a7b2-ea09de833001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_936f7d0e-8977-49dd-ae8b-9be99a76f036" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_207e2ce6-1f7f-4729-bfb0-d369db2898ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_207e2ce6-1f7f-4729-bfb0-d369db2898ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_d44944cd-8668-4bb2-915d-0f1cc433d3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_d44944cd-8668-4bb2-915d-0f1cc433d3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_65e0d2aa-d40f-4e44-a386-58b7ce33a84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_65e0d2aa-d40f-4e44-a386-58b7ce33a84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_89bcc425-2135-4c5e-ba59-aea7c3beab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_89bcc425-2135-4c5e-ba59-aea7c3beab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_63b5fd96-f770-45bd-b509-03eb4ef29506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_63b5fd96-f770-45bd-b509-03eb4ef29506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_051d6475-c692-4903-ab8c-a926cc31a073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_051d6475-c692-4903-ab8c-a926cc31a073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_eb3b6bfa-ae12-4686-b514-fed4b95c3302" xlink:href="bax-20220930.xsd#bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation_eb3b6bfa-ae12-4686-b514-fed4b95c3302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d5df50a6-97fa-4d33-801d-df085855c4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1fc20abb-2380-4f93-b50a-c4aa183a26c6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d5df50a6-97fa-4d33-801d-df085855c4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d7e43bfe-9f31-4ba9-8a9a-e465eb29d70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d7e43bfe-9f31-4ba9-8a9a-e465eb29d70f" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a14352-6611-471f-89ad-2a6de53d2ab3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4aed391e-cdda-4c38-b6f0-97e043e06722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4aed391e-cdda-4c38-b6f0-97e043e06722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dce5b743-8229-4e37-a8fd-6bd853c3dbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8c5f3473-3dc2-42c3-a38e-f81592782d8b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dce5b743-8229-4e37-a8fd-6bd853c3dbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:href="bax-20220930.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_6694d86c-ef4b-4a7f-8a6f-e34f450fd985" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_1a592819-6768-4231-a6f5-b594321490a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_us-gaap_ShorttermDebtFairValue_1a592819-6768-4231-a6f5-b594321490a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_b5171933-7ad9-4188-b58d-1ccbf4ff4c98" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_b5171933-7ad9-4188-b58d-1ccbf4ff4c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_0ead18f2-cc28-43d3-8bdc-b91b72c45271" xlink:href="bax-20220930.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_4f025827-7ccb-4942-85cb-1ae6afe8fd7a" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_0ead18f2-cc28-43d3-8bdc-b91b72c45271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7430f882-9c1c-48b6-8c6b-9dac56b2e52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7430f882-9c1c-48b6-8c6b-9dac56b2e52c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:to="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_65ef0d82-4309-4489-84bc-17e297722b3f" xlink:to="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_addd5b11-cd3d-46e2-9216-41eb96a5a196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_addd5b11-cd3d-46e2-9216-41eb96a5a196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_89553d12-c0db-4d6d-baa7-08f8078c68ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7fafb17e-d942-47dd-83b4-a3cda05c982d" xlink:to="loc_us-gaap_OperatingSegmentsMember_89553d12-c0db-4d6d-baa7-08f8078c68ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e39e3e67-e5a7-43a6-885b-48ea444627b1" xlink:to="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_bf280369-4f4a-4712-9da2-608201823bb3" xlink:href="bax-20220930.xsd#bax_AmericasSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_AmericasSegmentMember_bf280369-4f4a-4712-9da2-608201823bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_4a468b0d-186a-4065-ba91-84fbe44e860d" xlink:href="bax-20220930.xsd#bax_EMEASegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_EMEASegmentMember_4a468b0d-186a-4065-ba91-84fbe44e860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_7d7706d9-ed1e-4b41-8cb1-ef67d450fb62" xlink:href="bax-20220930.xsd#bax_AsiaPacificSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_AsiaPacificSegmentMember_7d7706d9-ed1e-4b41-8cb1-ef67d450fb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_60cce5ad-e68b-4838-9aa5-5d7a481a8179" xlink:href="bax-20220930.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_46c9c63d-49a9-4200-9f7f-7d5ee22cb960" xlink:to="loc_bax_HillromMember_60cce5ad-e68b-4838-9aa5-5d7a481a8179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b6fa8ca7-35e1-4c47-9211-01023604eaf6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5ce84891-f5c8-4f97-a6dc-695fe1f50500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5ce84891-f5c8-4f97-a6dc-695fe1f50500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce8bf403-8719-495c-bbee-1c0d25939ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce8bf403-8719-495c-bbee-1c0d25939ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_832b2326-f4cf-441b-b9a1-9b0d72c24afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4afa122c-9e3a-4c36-8606-a62ce3630212" xlink:to="loc_us-gaap_OperatingIncomeLoss_832b2326-f4cf-441b-b9a1-9b0d72c24afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20220930.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3fe5347c-043b-4fac-920b-de0a78adac10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3fe5347c-043b-4fac-920b-de0a78adac10" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:to="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5ac7d17d-8936-4951-8108-452c6d121432" xlink:to="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7b1b4de-2bc8-43fc-8445-71e6fa477453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7b1b4de-2bc8-43fc-8445-71e6fa477453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7696ab78-cc74-4f0b-8385-75b77299175c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_85c77331-5b57-4eb6-8130-b53e734ad6a8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7696ab78-cc74-4f0b-8385-75b77299175c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6e6c3f65-ffa3-4692-b86d-cc0ecaad5fa9" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97be5b8f-324a-4137-bb86-42a8844d5c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_OperatingIncomeLoss_97be5b8f-324a-4137-bb86-42a8844d5c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_522233b5-279f-4e81-8b2e-cc303c971aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_522233b5-279f-4e81-8b2e-cc303c971aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eca1eb68-b78c-4934-9940-cd8324f71aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eca1eb68-b78c-4934-9940-cd8324f71aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b551365f-7868-4fc8-b67f-2935f74669ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8b6a455d-9003-4446-824d-24bb01612343" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b551365f-7868-4fc8-b67f-2935f74669ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853598896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BAXTER INTERNATIONAL INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">224.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948.2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,120,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | Chicago Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member', window );">0.4% Global Notes due 2024 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.4% Global Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member', window );">1.3% Global Notes due 2025 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member', window );">1.3% Global Notes due 2029 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850839488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,601<span></span>
</td>
<td class="nump">$ 2,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $120 in 2022 and $122 in 2021</a></td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">2,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">979<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,810<span></span>
</td>
<td class="nump">8,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,799<span></span>
</td>
<td class="nump">5,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,639<span></span>
</td>
<td class="nump">9,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,927<span></span>
</td>
<td class="nump">7,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">27,965<span></span>
</td>
<td class="nump">33,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">2,195<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,708<span></span>
</td>
<td class="nump">4,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">16,153<span></span>
</td>
<td class="nump">17,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">2,493<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">22,386<span></span>
</td>
<td class="nump">24,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021</a></td>
<td class="num">(11,406)<span></span>
</td>
<td class="num">(11,488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional contributed capital</a></td>
<td class="nump">6,297<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">14,015<span></span>
</td>
<td class="nump">17,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(4,054)<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Baxter stockholders&#8217; equity</a></td>
<td class="nump">5,535<span></span>
</td>
<td class="nump">9,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">9,121<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 27,965<span></span>
</td>
<td class="nump">$ 33,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853544320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for accounts receivable, current</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">683,494,944<span></span>
</td>
<td class="nump">683,494,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">179,451,293<span></span>
</td>
<td class="nump">181,879,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850314784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 3,226<span></span>
</td>
<td class="nump">$ 11,226<span></span>
</td>
<td class="nump">$ 9,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,640<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
<td class="nump">7,292<span></span>
</td>
<td class="nump">5,571<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">3,934<span></span>
</td>
<td class="nump">3,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">947<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="nump">2,975<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense (income), net</a></td>
<td class="nump">48<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(2,799)<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="num">(2,296)<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(2,966)<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(2,577)<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,934)<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="num">(2,606)<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Baxter stockholders</a></td>
<td class="num">$ (2,937)<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="num">$ (2,614)<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (5.83)<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="num">$ (5.20)<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (5.83)<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="num">$ (5.20)<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850273744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (2,934)<span></span>
</td>
<td class="nump">$ 452<span></span>
</td>
<td class="num">$ (2,606)<span></span>
</td>
<td class="nump">$ 1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments, net of tax expense (benefit) of ($16) and $3 for the three months ended September 30, 2022 and 2021, respectively, and ($25) and $16 for the nine months ended September&#160;30, 2022 and 2021, respectively.</a></td>
<td class="num">(319)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="num">(751)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits, net of tax expense of $5 and $8 for the three months ended September 30, 2022 and 2021, respectively, and $13 and $19 for the nine months ended September&#160;30, 2022 and 2021, respectively.</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Hedging activities, net of tax expense of $5 and $3 for the three months ended September 30, 2022 and 2021, respectively, and $8 and $8 for the nine months ended September&#160;30, 2022 and 2021, respectively.</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Available-for-sale debt securities, net of tax expense of zero for the three months ended September 30, 2022 and 2021, respectively, and $1 and zero for the nine months ended September&#160;30, 2022 and 2021, respectively.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(287)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(674)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(3,221)<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="num">(3,280)<span></span>
</td>
<td class="nump">885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to Baxter stockholders</a></td>
<td class="num">$ (3,224)<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
<td class="num">$ (3,288)<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850828464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Currency translation adjustments, tax</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and other postretirement benefits, tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Hedging activities, tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Debt securities, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846444000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Baxter stockholders' equity</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Common stock in treasury</div></th>
<th class="th"><div>Additional contributed capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Noncontrolling interests</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2020</a></td>
<td class="nump">$ 8,726<span></span>
</td>
<td class="nump">$ 8,689<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,051)<span></span>
</td>
<td class="nump">$ 6,043<span></span>
</td>
<td class="nump">$ 16,328<span></span>
</td>
<td class="num">$ (3,314)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (168)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (600)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Sep. 30, 2021</a></td>
<td class="nump">8,815<span></span>
</td>
<td class="nump">8,770<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,529)<span></span>
</td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">16,967<span></span>
</td>
<td class="num">(3,482)<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Jun. 30, 2021</a></td>
<td class="nump">8,535<span></span>
</td>
<td class="nump">8,494<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,561)<span></span>
</td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">16,658<span></span>
</td>
<td class="num">(3,376)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(141)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Sep. 30, 2021</a></td>
<td class="nump">$ 8,815<span></span>
</td>
<td class="nump">8,770<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,529)<span></span>
</td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">16,967<span></span>
</td>
<td class="num">(3,482)<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">181,879,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2021</a></td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">9,077<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,488)<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
<td class="nump">17,065<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,606)<span></span>
</td>
<td class="num">(2,614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (674)<span></span>
</td>
<td class="num">(674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(436)<span></span>
</td>
<td class="num">(436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Sep. 30, 2022</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">5,535<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,406)<span></span>
</td>
<td class="nump">6,297<span></span>
</td>
<td class="nump">14,015<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Jun. 30, 2022</a></td>
<td class="nump">8,903<span></span>
</td>
<td class="nump">8,859<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,409)<span></span>
</td>
<td class="nump">6,253<span></span>
</td>
<td class="nump">17,099<span></span>
</td>
<td class="num">(3,767)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,934)<span></span>
</td>
<td class="num">(2,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(287)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Sep. 30, 2022</a></td>
<td class="nump">$ 5,579<span></span>
</td>
<td class="nump">$ 5,535<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,406)<span></span>
</td>
<td class="nump">$ 6,297<span></span>
</td>
<td class="nump">$ 14,015<span></span>
</td>
<td class="num">$ (4,054)<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">179,451,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853996176">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operations</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,606)<span></span>
</td>
<td class="nump">$ 1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to cash flows from operations:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,069<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">122<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Net periodic pension and other postretirement costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">332<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss on product divestiture arrangement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Reclassification of cumulative translation loss to earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in balance sheet items:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">84<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(250)<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">772<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired, and investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows from investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(675)<span></span>
</td>
<td class="num">(933)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(953)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuances of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Net increases (decreases) in debt with original maturities of three months or less</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends on common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(427)<span></span>
</td>
<td class="num">(390)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock issued under employee benefit plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">114<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,319)<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(130)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,352)<span></span>
</td>
<td class="num">(475)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">3,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">3,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash included in prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of September&#160;30, 2022, December&#160;31, 2021, and September&#160;30, 2021 (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses And Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851537840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the challenges caused by the pandemic as well as global economic conditions, among other factors, may continue to have an adverse effect on our business.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851605600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND OTHER ARRANGEMENTS</a></td>
<td class="text">ACQUISITIONS AND OTHER ARRANGEMENTS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $10.5&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $12.8&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $156.00 in cash per outstanding Hillrom common share. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of assets acquired and liabilities assumed has not yet been finalized as of September 30, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date. The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022 we recorded measurement period adjustments, primarily impacting accounts receivable, property, plant and equipment, other intangible assets, and deferred income tax liabilities. Individually the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement period adjustments were not material and in total increased goodwill by $25&#160;million. The measurement period adjustments did not have a significant impact to our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill from the Hillrom acquisition, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. See Note 4 for additional information about impairments recognized in the third quarter of 2022 related to goodwill and certain intangible assets acquired in the Hillrom acquisition. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, we recognized $159&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the first quarter. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Other Business Development Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Celerity Pharmaceuticals, LLC</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2013, we entered into an agreement with Celerity Pharmaceuticals, LLC (Celerity) to develop certain acute care generic injectable premix and oncolytic products through regulatory approval. We transferred our rights in these products to Celerity and Celerity assumed ownership and responsibility for development of the products. We are obligated to purchase the individual product rights from Celerity if the products obtain regulatory approval. In December 2020, we entered into an agreement with a third party to divest our rights to one of the products that was being developed by Celerity, a generic version of liposomal doxorubicin, for less than $1&#160;million if that product were to receive regulatory approval in the U.S. and European Union in 2022. Liposomal doxorubicin is a chemotherapy medicine used to treat various types of cancer and we entered into this transaction to divest our rights to this generic version of that product after we had separately entered into a transaction to acquire the branded version. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related regulatory approvals were subsequently obtained for the generic version of liposomal doxorubicin and we recognized a loss of approximately $54&#160;million in the third quarter of 2022, representing the difference between the amount we owe Celerity following those regulatory approvals and the proceeds that we will receive from our divestiture of those product rights. That loss is reported within other operating expense (income), net in our condensed consolidated statements of operations for the three and nine months ended September 30, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Zosyn</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $122 million currently, received specified intellectual property, including patent rights, in the first quarter and will receive additional intellectual property, including the product rights to Zosyn, in the first quarter of 2023.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $122 million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of 9 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851764128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">SUPPLEMENTAL FINANCIAL INFORMATION</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we signed a purchase agreement with a buyer to sell our corporate headquarters in Deerfield, Illinois for $52&#160;million. The related assets are classified as held-for-sale and are presented within prepaid expenses and other current assets in the accompanying consolidated balance sheet as of September 30, 2022. While the closing remains subject to the satisfaction of various closing conditions (including satisfactory completion of municipal diligence by the buyer), we expect the transaction to close in 2023 and the net book value of the assets approximates the transaction price net of estimated selling costs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have been winding down our operations in Argentina since early 2021 and we determined that the net assets of the related entities were substantially liquidated during the third quarter of 2022. As a result of that determination, we reclassified their $65&#160;million cumulative translation loss from accumulated other comprehensive income (loss) to other (income) expense, net.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the nine months ended September&#160;30, 2022 and 2021 were $59 million and $69&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div>Purchases of property, plant and equipment included in accounts payable as of September&#160;30, 2022 and 2021 were $65 million and $49 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851572256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS, NET<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.  We recognize a goodwill impairment charge for the amount by which a reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill Impairments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 2, we acquired Hillrom on December 13, 2021 and recognized $6.8&#160;billion of goodwill and $6.0&#160;billion of other intangible assets, including $1.9&#160;billion of indefinite-lived intangible assets, in connection with that acquisition. Our Hillrom segment includes the following three reporting units: Patient Support Systems, Front Line Care and Surgical Solutions. During the third quarter of 2022, we performed trigger-based impairment tests of the goodwill of each of those three reporting units, as well as the indefinite-lived intangible assets, consisting primarily of trade names, that we acquired in connection with the Hillrom acquisition. We performed those tests as of September 30, 2022 due to (a) current macroeconomic conditions, including the rising interest rate environment and broad declines in equity valuations, and (b) reduced earnings forecasts for our three Hillrom reporting units, driven primarily by current shortages of certain component parts used in our products, raw materials inflation and increased supply chain costs. The impairment tests resulted in total pre-tax goodwill impairment charges of $2.8 billion in the third quarter of 2022, consisting of a $1.4 billion goodwill impairment for our Patient Support Systems reporting unit, a $1.0 billion goodwill impairment for our Front Line Care reporting unit and a $0.4 billion goodwill impairment for our Surgical </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions reporting unit. See further discussion below for information regarding intangible asset impairment charges recognized during the third quarter of 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the reporting units tested for impairment during the third quarter of 2022 were determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples. Our reporting unit fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,930)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $168 million and $68 million for the three months ended September&#160;30, 2022 and 2021, respectively, and $578 million and $199 million for the nine months ended September&#160;30, 2022 and 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indefinite-lived Intangible Asset Impairments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the goodwill impairments discussed above, we recognized pre-tax impairment charges of $332&#160;million in the third quarter of 2022 to reduce the carrying amounts of certain indefinite-lived intangible assets, which related to trade names acquired in the Hillrom acquisition, to their estimated fair values. Those intangible asset impairment charges are classified within cost of sales in the accompanying condensed consolidated statements of income (loss) for the three and nine months ended September 30, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the indefinite-lived intangible assets tested for impairment were determined using a discounted cash flow model and significant inputs included forecasted cash flows, royalty rates and discount rates. Our indefinite-lived intangible asset fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851490736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">FINANCING ARRANGEMENTS</a></td>
<td class="text">FINANCING ARRANGEMENTS <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Debt Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we issued $800&#160;million of 0.868% senior notes due in 2023, $1.4&#160;billion of 1.322% senior notes due in 2024, $1.45&#160;billion of 1.915% senior notes due in 2027, $1.25&#160;billion of 2.272% senior notes due in 2028, $1.55&#160;billion of 2.539% senior notes due in 2032, $750&#160;million of 3.132% senior notes due in 2051, $300&#160;million of floating rate senior notes due in 2023 and $300&#160;million of floating rate senior notes due in 2024 (collectively, the Hillrom notes) to fund a portion of the consideration for the Hillrom acquisition, repay certain indebtedness of Hillrom and to pay fees and expenses related to the foregoing. In conjunction with the issuances of the Hillrom notes, we entered into a registration rights agreement in which we agreed to file a registration statement with the SEC with respect to an offer to exchange the Hillrom notes for new issues of notes with the same terms registered under the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities Act of 1933, as amended. Those exchange offers with respect to the Hillrom notes were completed in the second quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first half of 2022, we repaid $335&#160;million of our $2.0&#160;billion three-year term loan facility and $355&#160;million of our $2.0&#160;billion five-year term loan facility. The loss from the early extinguishment of this debt was not significant. In the third quarter of 2022, we amended the credit agreements governing our term loan facility and our U.S. dollar-denominated revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to delay the commencement of our net leverage ratio covenant step-down schedule until June 30, 2024. We also amended the credit agreements governing our term loan facility and our U.S. dollar denominated revolving credit facility to transition the benchmark rate from LIBOR to the Secured Overnight Financing Rate (SOFR).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, we repaid $203&#160;million of our 2.4% senior dues due in 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2.5&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of September&#160;30, 2022 or December&#160;31, 2021.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $275&#160;million of commercial paper outstanding with a weighted-average interest rate of 3.02% and an original weighted-average term of 49 days. As of December&#160;31, 2021, we had $300 million of commercial paper outstanding with a weighted-average interest rate of 0.27% and an original weighted-average term of 88 days.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851596016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of September&#160;30, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $31 million and $72 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of September&#160;30, 2022 and December&#160;31, 2021, our </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">environmental reserves, which are measured on an undiscounted basis, were $17 million and $18 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, we and certain of our officers were named in a class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Ethan E. Silverman et al. v. Baxter International Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $16&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $18&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#8217;s cooperation. We paid the penalty in the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by </span></div>allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022 and filed on May 27, 2022, a motion challenging certain aspects of plaintiff's case.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851786464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three and nine months ended September&#160;30, 2022 were $0.29 and $0.86. Cash dividends declared per share for the three and nine months ended September&#160;30, 2021 were $0.280 and $0.805. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div>In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first nine months of 2022, we repurchased 0.5 million shares under this authority pursuant to a Rule 10b5-1 plan.  During the first nine months of 2021, we repurchased 7.3&#160;million shares under this authority pursuant to Rule 10b5-1 plans. We had $1.3 billion remaining available under the authorization as of September&#160;30, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851570256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income (loss), cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. </span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,054)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,844)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,482)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div>Refer to Note 3 for additional information regarding the reclassification of a cumulative translation loss to earnings, Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851689184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES</a></td>
<td class="text">REVENUESRevenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $10.9 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 10% of this amount as revenue over the remainder of 2022, 30% in each of 2023 and 2024, 15% in 2025 and 15% thereafter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three and nine months ended September&#160;30, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3 billion and $2.4 billion as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE4NA_4b48d30d-ec79-4a92-a7cd-7e8e20511e7a">one</span> to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3MQ_ecb681a4-8097-4734-b0f9-9c8160b702fe">one</span> to seven years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the nine months ended September&#160;30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Hillrom in December 2021, we added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.137%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $95 million as of September&#160;30, 2022, of which $18 million originated in 2018 and prior, $19 million in 2019, $26&#160;million in 2020, $24 million in 2021, and $8&#160;million in 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851752144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">BUSINESS OPTIMIZATION CHARGES</a></td>
<td class="text">BUSINESS OPTIMIZATION CHARGES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through September&#160;30, 2022, we have incurred cumulative pre-tax costs of $1.4 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $14 million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related to our integration of Hillrom, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three and nine months ended September&#160;30, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of September&#160;30, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851848592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</a></td>
<td class="text">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Hillrom Pension Plan Amendment</span></div>In May 2022, we announced that the pay and service amounts used to calculate pension benefits for active non-bargaining participants in our U.S. Hillrom pension plan will freeze as of December 31, 2022. Years of additional service earned and eligible compensation received after December 31, 2022 will not be included in the determination of the benefits payable to those participants. This change resulted in an $11&#160;million decline in the projected benefit obligation (PBO) with an offsetting curtailment gain included within other (income) expense, net on the condensed consolidated statements of income (loss) for the nine months ended September 30, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851688368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 1.1% and (0.2)% for the three months ended September 30, 2022 and 2021, respectively, and (1.1)% and 11.8% for the nine months ended September&#160;30, 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to non-deductible goodwill impairments.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as a favorable geographic earnings mix and changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851602176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHAREThe numerator for both basic and diluted earnings per share (EPS) is net income (loss) attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted shares are the same for the three and nine months ended September 30, 2022 due to our net losses for those periods. The effect of dilutive securities for the three and nine months ended September 30, 2021 includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS excludes 23 million shares issuable under equity awards for the three and nine months ended September&#160;30, 2022, respectively, and 7 million shares issuable under equity awards for the three and nine months ended September&#160;30, 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS. Refer to Note 7 for additional information regarding items impacting basic and diluted shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851602176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $407 million and $377 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at September&#160;30, 2022 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no outstanding interest rate contracts designated as fair value hedges as of September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;600 million of senior notes due May 2025. In May 2019, we issued &#8364;750 million of senior notes due May 2024 and &#8364;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of September&#160;30, 2022, we had an accumulated pre-tax unrealized translation gain in AOCI of $265 million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no hedge dedesignations in the first nine months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first nine months of 2022 or 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first nine months of 2022 or 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $548&#160;million as of September&#160;30, 2022 and $851 million as of December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI<br/>into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, $22 million of deferred, net after-tax gains on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of September&#160;30, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851596016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, cash and cash equivalents of $1.6 billion and $3.0 billion, respectively, included money market and other short-term funds of approximately $161 million and $816 million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, $8&#160;million of available-for-sale debt securities that were previously classified as Level 3 converted to marketable equity securities, which are classified as Level 1 in the fair value hierarchy, upon the initial public offering of the investee.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,153&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $102 million as of September&#160;30, 2022 and $114 million as of December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409855713456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $3.0&#160;billion and $3.3 billion for the three and nine months ended September&#160;30, 2022, respectively, and primarily related to goodwill and intangible asset impairments are now presented within Corporate as well. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,296)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,966)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,577)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 for additional information on Net Sales by product category.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853598368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future. </span></div>We expect that the challenges caused by the pandemic as well as global economic conditions, among other factors, may continue to have an adverse effect on our business.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks and Uncertainties Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851506128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850946016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Interest Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Other (Income) Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851582480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock', window );">Other Intangible Assets, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,930)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409852822048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Changes in AOCI by Component</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(752)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,054)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,844)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,482)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Summary of Reclassification from AOCI to Net Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three and nine months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative translation loss to earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846373008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Contract Asset</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the nine months ended September&#160;30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Net Sales from Contracts with Customers by Global Business Unit</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock', window );">Sales-type Lease, Lease Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.137%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.137%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850187216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessOptimizationChargeTableTextBlock', window );">Summary of Business Optimization Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Components of Restructuring Charges</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Activity in Reserves Related to Restructuring Initiatives</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessOptimizationChargeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business optimization charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessOptimizationChargeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851605600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851698976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Basic Shares to Diluted Shares</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853346560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Gains and Losses on Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended September&#160;30, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI<br/>into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Classification and Fair Values of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of September&#160;30, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock', window );">Derivative Positions Presented On Net Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of derivative positions presented on net basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851599040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Book Values and Fair Values of Financial Instruments</a></td>
<td class="text">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of September&#160;30, 2022 and December&#160;31, 2021.<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,153&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850945424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Information for Our Segments</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Operating Income to Income Before Income Taxes Reconciliation</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,296)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,966)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,577)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850145504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total Consideration</a></td>
<td class="nump">$ 10,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations', window );">Enterprise value</a></td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash consideration transferred (in usd per share)</a></td>
<td class="nump">$ 156.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Incremental costs of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409847305792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details) - Hillrom<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 13, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid to Hillrom shareholders</a></td>
<td class="nump">$ 10,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of equity awards issued to Hillrom equity award holders</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total Consideration</a></td>
<td class="nump">$ 10,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash consideration transferred (in usd per share) | $ / shares</a></td>
<td class="nump">$ 156.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares) | shares</a></td>
<td class="nump">668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AcquisitionsAndCollaborationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions And Collaborations [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AcquisitionsAndCollaborationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853416816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,639<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and finance lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,527)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total assets acquired and liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AcquisitionsAndCollaborationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions And Collaborations [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AcquisitionsAndCollaborationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt and Capital Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850281296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Celerity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ProceedsFromDivestitureOfProductRights', window );">Proceeds from divestiture of product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_GainLossOnDispositionOfProductDivestitureArrangement', window );">Loss on product divestiture arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=bax_ZosynMember', window );">Zosyn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisition price</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=bax_ZosynMember', window );">Zosyn | Developed Technology Intangible Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average useful life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_GainLossOnDispositionOfProductDivestitureArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Product Divestiture Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_GainLossOnDispositionOfProductDivestitureArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ProceedsFromDivestitureOfProductRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Divestiture of Product Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ProceedsFromDivestitureOfProductRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bax_CelerityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bax_CelerityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=bax_ZosynMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=bax_ZosynMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853440944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Charged to costs and expenses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments', window );">Currency translation adjustments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409855598816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 690<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,680<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 2,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846878400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 11,084<span></span>
</td>
<td class="nump">$ 11,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(6,285)<span></span>
</td>
<td class="num">(6,550)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 4,799<span></span>
</td>
<td class="nump">$ 5,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846844160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income Expense Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of capitalized interest</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850116720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange (gains) losses, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Pension and other postretirement benefit plans</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Change in fair value of marketable equity securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Reclassification of cumulative translation loss to earnings</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846397424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification of cumulative translation loss to earnings</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset obtained in exchange for operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures incurred but not yet paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap-supplement_GeographicBasisCorporateHeadquartersMember', window );">Geographic Basis, Corporate Headquarters | Disposal Group, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Agreed purchase price</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap-supplement_GeographicBasisCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap-supplement_GeographicBasisCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850678896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="num">$ (2,785)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(2,785)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">6,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,785)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 3,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845805664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=bax_PatientSupportSystemsReportingUnitMember', window );">Patient Support Systems Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=bax_FrontLineCareReportingUnitMember', window );">Front Line Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=bax_SurgicalSolutionsReportingUnitMember', window );">Surgical Solutions Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">6,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=bax_PatientSupportSystemsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=bax_PatientSupportSystemsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=bax_FrontLineCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=bax_FrontLineCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=bax_SurgicalSolutionsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=bax_SurgicalSolutionsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845736048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="nump">$ 9,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(2,373)<span></span>
</td>
<td class="num">(1,930)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,927<span></span>
</td>
<td class="nump">7,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">1,578<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">In process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">3,447<span></span>
</td>
<td class="nump">3,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">3,037<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember', window );">Developed technology, including patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="nump">3,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(1,743)<span></span>
</td>
<td class="num">(1,556)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other amortized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(220)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IntangibleAssetExcludingGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Asset Excluding Goodwill [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IntangibleAssetExcludingGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846514448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 953,000,000<span></span>
</td>
<td class="nump">$ 407,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaperAverageOutstanding', window );">Commercial paper, average outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OriginalWeightedAverageTerm', window );">Original weighted-average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">88 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit, current borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaperAverageOutstanding', window );">Commercial paper, average outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.27%<span></span>
</td>
<td class="nump">3.02%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OriginalWeightedAverageTerm', window );">Original weighted-average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">49 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember', window );">Senior Three Year Term Loan | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Weighted-average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember', window );">Senior Five Year Term Loan | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Weighted-average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A24SeniorNotesDue2022Member', window );">2.4% Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A0868SeniorNotesDueMay2023Member', window );">0.868% Senior Notes Due May 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.868%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A1322SeniorNotesDue2024Member', window );">1.322% Senior Notes Due 2024 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.322%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A1915DebenturesDue2027Member', window );">1.915% Debentures Due 2027 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.915%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A2272SeniorNotesDue2028Member', window );">2.272% Senior Notes Due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.272%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A2539NotesDue2032Member', window );">2.539% Senior Notes Due 2032 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.539%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A3132SeniorNotesDue2051Member', window );">3.132% Senior Notes Due 2051 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.132%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2023Member', window );">Floating-rate Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2024Member', window );">Floating-rate Notes Due 2024 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OriginalWeightedAverageTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original Weighted-Average Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OriginalWeightedAverageTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaperAverageOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average amount outstanding of commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaperAverageOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A24SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A24SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A0868SeniorNotesDueMay2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A0868SeniorNotesDueMay2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A1322SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A1322SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A1915DebenturesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A1915DebenturesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A2272SeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A2272SeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A2539NotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A2539NotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A3132SeniorNotesDue2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A3132SeniorNotesDue2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_FloatingRateNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846472128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>site</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>lawsuit</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Agreement to settle the case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Civil settlement amount</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LossContingencyNumberOfLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember', window );">Superfund Sites | Environmental Clean-up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_SiteContingencyNumberOfSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Environmental reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LossContingencyNumberOfLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LossContingencyNumberOfLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_SiteContingencyNumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Site contingency, number of sites.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_SiteContingencyNumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13703-110860<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850117312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Jul. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.280<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount', window );">Stock repurchase program, additional authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining value available under stock repurchase programs</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock repurchase program additional authorized amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_StockRepurchaseProgramAdditionalAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853786880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="nump">$ 8,903<span></span>
</td>
<td class="nump">$ 8,535<span></span>
</td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">$ 8,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(752)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(287)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(674)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">8,815<span></span>
</td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">8,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">CTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,907)<span></span>
</td>
<td class="num">(2,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(816)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(751)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(3,658)<span></span>
</td>
<td class="num">(2,844)<span></span>
</td>
<td class="num">(3,658)<span></span>
</td>
<td class="num">(2,844)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(299)<span></span>
</td>
<td class="num">(511)<span></span>
</td>
<td class="num">(299)<span></span>
</td>
<td class="num">(511)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Hedging activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Available-for-sale Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
<td class="num">(3,314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">$ (4,054)<span></span>
</td>
<td class="num">$ (3,482)<span></span>
</td>
<td class="num">$ (4,054)<span></span>
</td>
<td class="num">$ (3,482)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853024192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">$ (63)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(2,640)<span></span>
</td>
<td class="num">(1,905)<span></span>
</td>
<td class="num">(7,292)<span></span>
</td>
<td class="num">(5,571)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="num">(2,966)<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(2,577)<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">(2,937)<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="num">(2,614)<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Pension and OPEB items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities | Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | CTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">$ (65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853653824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Net trade accounts receivable</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Sales-type lease, net of investment in lease</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable', window );">Sales-type leases, receivables</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenuePerformanceObligationPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenuePerformanceObligationPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueRecognizedContractPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue recognized contract period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueRecognizedContractPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853795392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Contract Assets and Contract Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityDeferredRevenue', window );">New revenue deferrals</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityTotalRevenueRecognized', window );">Revenue recognized upon satisfaction of performance obligations</a></td>
<td class="num">(463)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityCurrencyTranslation', window );">Currency translation</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember', window );">Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember', window );">Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember', window );">Bundled equipment and consumable medical products contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityTotalRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability, Total Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityTotalRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845230880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 3,226<span></span>
</td>
<td class="nump">$ 11,226<span></span>
</td>
<td class="nump">$ 9,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,849<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">5,370<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,924<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
<td class="nump">5,856<span></span>
</td>
<td class="nump">5,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">690<span></span>
</td>
<td class="nump">655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">759<span></span>
</td>
<td class="nump">2,077<span></span>
</td>
<td class="nump">2,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">725<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">2,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="nump">1,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">589<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">1,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">422<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="nump">722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_RenalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_RenalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_MedicationDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_ClinicalNutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AcuteTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_FrontLineCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853430000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Lease Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Sales-type lease revenue</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseIncome', window );">Variable lease revenue</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseIncome', window );">Total lease revenue</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409855797552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cumulative pre-tax costs incurred</a></td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected additional pre-tax costs</a></td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409847320864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember', window );">Business Optimization Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Costs to implement business optimization programs</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Total business optimization charges</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853162048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846302784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember', window );">Severance and Other Employee Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Reserve adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, ending balance</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850289456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost (income)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">OPEB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost (income)</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409852776160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation, Foreign Statutory Loss on Foreign Subsidiary Investment, Tax Deductible</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409850124800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Reconciliation of Basic Shares to Diluted Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846337824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845641168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DerivativeFairValueTerminated', window );">Derivative, fair value, terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DerivativeNetInvestmentTerminated', window );">Derivative, net investment terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Deferred, net after-tax gains on derivative instruments</a></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">548,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 851,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Accumulated pre-tax unrealized translation gain in AOCI</a></td>
<td class="nump">265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member', window );">1.30% Senior Notes Due May 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member', window );">0.4% Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member', window );">1.3% Senior Notes Due May 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 407,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum length of time hedge in cash flow hedge</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeFairValueTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Fair Value, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeFairValueTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeNetInvestmentTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Net Investment Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeNetInvestmentTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409847278480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 353<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax', window );">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts | Cash Flow Hedging | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) recognized in income, undesignated derivative instruments</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Cash Flow Hedging | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845757872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846375952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Derivative asset, fair value, total</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement', window );">Derivative liability, fair value, total</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of master netting arrangement, of derivative liability, security sold under agreement to repurchase, and security loaned. Includes financial instrument subject to master netting arrangement not elected or qualified to offset. Excludes liability not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851560896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details) - Long-term debt - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Carrying amount of hedged item</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845111440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted prices in active markets for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853418464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,601<span></span>
</td>
<td class="nump">$ 1,601<span></span>
</td>
<td class="nump">$ 2,951<span></span>
</td>
<td class="nump">$ 3,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue', window );">Other equity investments without readily determinable fair values</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds, at carrying value</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value disclosure Line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 820<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35710923&amp;loc=d3e45360-110995<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409845673376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Contingent payments related to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Contingent payments related to acquisitions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning of period</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in earnings</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Change in fair value recognized in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfers out of Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at end of period</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Contingent payments related to acquisitions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Available-for-sale debt securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at beginning of period</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Change in fair value recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Change in fair value recognized in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation', window );">Currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at end of period</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409852817328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Book values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">16,153<span></span>
</td>
<td class="nump">17,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">$ 14,402<span></span>
</td>
<td class="nump">$ 17,568<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value and carrying value by balance sheet grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations, current, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409853860448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 3,226<span></span>
</td>
<td class="nump">$ 11,226<span></span>
</td>
<td class="nump">$ 9,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="num">(2,799)<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="num">(2,296)<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="num">(3,899)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
<td class="num">(5,517)<span></span>
</td>
<td class="num">(1,497)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">3,773<span></span>
</td>
<td class="nump">3,226<span></span>
</td>
<td class="nump">11,226<span></span>
</td>
<td class="nump">9,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">3,221<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="nump">4,975<span></span>
</td>
<td class="nump">4,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">2,129<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">720<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">459<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409846411616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="num">$ (2,799)<span></span>
</td>
<td class="nump">$ 513<span></span>
</td>
<td class="num">$ (2,296)<span></span>
</td>
<td class="nump">$ 1,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(2,966)<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(2,577)<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">3,221<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="num">$ (3,899)<span></span>
</td>
<td class="num">$ (496)<span></span>
</td>
<td class="num">$ (5,517)<span></span>
</td>
<td class="num">$ (1,497)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140409851824864">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>bax-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20220930"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bax-20220930.xsd" xlink:type="simple"/>
    <context id="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39976b84175d43efbe32f5536a21818c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifc165b9e144140309b5f09674a899d54_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2e4d13c497514386a72aa4814ef8a1c0_I20221020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-10-20</instant>
        </period>
    </context>
    <context id="i100fa316fc12492f84183e5383c3e332_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4b539be2fbed438e9e118c2cdb3604d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id53ca5df30f04301a9054d72614b728c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i55c7f3edeed8429db78b4f553fc45026_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i50bf025855184ac89338332505bcf37e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2a454fa8809c487b8e3d6d81416aaf44_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i25a76885f3de4448b4fffc6a3b402755_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id320e76e08184ad18e0d44a027eb0e44_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6dc7215575114c6e9c9229e98fc5c182_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i150a460e6b5240cf942785db873b20e0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ida2ec04c98ba4de6aac9364b884a768f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaafa26dc685d48499145e063e9e41701_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68bb769194c44702bc4f210eb327fd47_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idc5b6addca054a8c977547a71a11eb9d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i46185672532c493c87739cf7e9615db2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8b2b2f4c215a4c959a65859e3605344e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9e06fdeb2414477d921f3587f0c89a44_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie0218eda155249b4a4da75408a661f78_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i315357d813df434ea52bc4a2bd057649_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ebdd308c0aa480ab3f408048666bc96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i725b88481fef4b7db4a008b05245cf1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb99534e9ac74a81934e5e38cb02f00f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2915afd9c994936a8dd5af0ce476706_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i701c21dcb04e48f6873a3307cf046c39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7717dccf2b6422d90b12fdb9dc4ce69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7267511ecf06427ca86cc16435200efe_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i07aa4a40cec3445b9b7c2eae2471f420_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i445ba8e9550344a6a0934d07c688931b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if779e104e4c64cb0b90cbb72e25d9c25_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2cfa5f433f3c41f4ad813f18db07aeb6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1097bf8723ad4d40980c7a8684d82542_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9566c813807f46f9bca41a6a1eab60fd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i923c5d6629ac43938dde7322bca7a94f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7adec63f56fe475aa13f80a829a783e3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i378c9497bb354eda8c5fec775c27e410_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46300513cafe40bc8da05e9ae619e87d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95cbf6e7717b42ed8cd2f03aefaa9a00_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7bfaa62f2344760ae28e0bcef715667_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i73ce590d6794464d8f48b6882ce9967b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifebeb40172e54d468de1bba6e61fded4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie27b36ac02ab451db59daf7bc158e8b3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i741c91bea17b416e8523648018b62817_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7deaf997b8b04e419ae489df558eb400_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b9bdd01dd21457c955deb29629dbb05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7bbc2059dee49748a9fb82ccedc2cc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i260874a837714dd18b6d85c063e738f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i061c707fc46f4796a51c7a57108a7be4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87069b641164461ea1d9c503986a6adb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife1a4f269c63413dab2f7eff8c7b4525_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b50155674434910931b52027a356924_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a04eb3f97aa454290cf5576bef8ba31_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifcc9d6f153964e0d89122d5270df88f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="if52624140cdd4ab390ee1ab86fa1bf13_I20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-13</instant>
        </period>
    </context>
    <context id="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i773f5845d4754661b8aab38716b10554_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bax:CelerityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d01f750794044e794ffffe67feb1dcf_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bax:CelerityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic8a3ba76ddc34ac9b96c72e99f2225b5_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia8299eafa68647eaaa8620f38dec5bf4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap-supplement:GeographicBasisCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4fe91520413b489ba3c114405e761908_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b30b6e6d2764728a8fb09e3396c5922_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i64b2b5d983114aa88c2446e0dcc3de3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i481a24f4e9cf4e4caadc1f417ed82ed5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic475be483d5d490b9d25f69465a3e693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a0372e6d36f45fc821dbc1d47cc6ea9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16877dc9c8664898918e2920216cd8db_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3de2ca57ce45464ca01c64bb1f88e3b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ff51ea445a5436dae75f76b782ecd31_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a571604800242eeb2e7147c026d48b7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4ee5aa4d680b44ec86fe26cdcf3bf099_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i75b9dbb2b9e54f9aa29cbe19d1203ee2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i890c2ffd49774bcdb114954d3d319644_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:PatientSupportSystemsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3c3675597e4b41a9a723718dced98975_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:FrontLineCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2fd9fa99362a4b3da7f2454b0437871b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">bax:SurgicalSolutionsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7b25966c2f794fccbcda61130bacdf1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if7a5cf2a666444178c784c2a4e45771e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i20ad5d55916c462eabe316458610941a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i74a9b9c3e62944d59dd3f29abbe86694_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2130e393d1145f1b34fd256df79921e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i895aace70e0d4238a25f2489179fc9a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6865ca49209e4856bbee3881f270f09a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54a672818e934149a401c70ac3c8e194_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec8d99be5dd04810814673d9bb23b794_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a7528b6cc67470689971a1b5911d02a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1e434fa298bb4e53b1687deba4d7259d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A0868SeniorNotesDueMay2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95d99d7448924622bdb9f324debce4d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A1322SeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie77337e4ad4e498c948df7b374666865_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A1915DebenturesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A2272SeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94dc1bd163de40399e15f75a2e3785a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A2539NotesDue2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i265508560c8841b293b5f093e5c37039_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A3132SeniorNotesDue2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae499f05266f4e6fb214cdc0ec19a38d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:FloatingRateNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33078f73774943f3a2ca47a51219a873_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:FloatingRateNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ed75a5ce2af4878b5a7a6a8436619f1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i841d5a6c0ef8487fa19e286f23e59976_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i772c3c7e174041f7bcc4ae5236f20052_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if16f417d337d49449cd42abe3f0b4ff1_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A24SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i54f8b3d4953342d7bb449d644860faac_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A24SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i0b888e2815b64c00a744bce83922eec7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33bf0a8e536c465a9ba65e612d25078b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib88bc321114a41c986908d3eab85ded7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a0c4ec3de054eb99dbb0c9ef6f2e0a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie39c0ccc2d9f48b29fd18d7536c85b21_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc5868a9f710403f8ce9e04bed2c6144_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i167491d201974a2aaaea593456c7da9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida0404dc815a4d388b3b0b1abd15f103_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="ia6f8ffc989484986a6b2a7277800a496_D20220218-20220218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-02-18</startDate>
            <endDate>2022-02-18</endDate>
        </period>
    </context>
    <context id="iac075bc7be734ce28e3cd0ade633f46d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ida6a352adaf74291ac8418e13556460b_I20120731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2012-07-31</instant>
        </period>
    </context>
    <context id="ib2cfefd9411642a986838426ebc5fd65_I20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="i501f33331ff24934a4e311776d6b568e_I20161130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2016-11-30</instant>
        </period>
    </context>
    <context id="i0e2c054b1e504ee491a43864f0b9a4f1_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i8c321d55d39c46389f13acfac44288a1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i7d2d3147ec91465dbab5eeb7b6a2cd5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31930c2af24645f49542738fff75d982_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i552ac44c09dc4a709b2712f92ae94231_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5c2074ab131415892f8da221a18971e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6a288994bf043d8a63aa03aaa1625a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1edf5496290547488b6fb150515ee067_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i63982438af89413496b321655eab4612_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5823aeb3309544349e7a762d49f924ed_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2621eddb6c8b4e35b45d30c5f4117f8c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if77599f5408a4c88933df293d51078a0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7853bfd3a3f14931bd7a5fb8616f0070_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifec0e1e2b8494b57a02dabe89c9521c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i589024ff3b0647f4aed88a63568cfbf3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib62950f4131d42f3b649b1a20703c62d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0f53d52d2574f558f655a52b076f148_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic37683e51faa4ef3a8d7fa7bd5e019f9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6c55956d7c449a997855468c8753478_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1e127d53ca94f5cbd11265d1621e42b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i18bdd75685a84d6ea4c661c64683c09b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f7c3783e84d45838caeead615497da4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibfc60984e5ff401591292f61763183a1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3f4e1f314d994197aa920eacb9a953ff_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie4477b37e0684b1584a8e138855d9585_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia6ca2d911f1c41fdbc37513b3ecf53c8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f7d5ccda5424cd6a7bd67a5706e35ce_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i119bfe21f51144d990801b60bfeb8623_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i559c50c17138442d8746383974831721_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i81178378904d4536bccf75c0f969a644_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i033de94989d94ca29ea116ebb6e361e7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4901a3b8cbbd4579a3d8a09a6999f89c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i57d95941b3e84f7fbc4fd9c0e2f0ecf5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie18534aa529c45f286ef075afba0cf7b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i013b33b74c04418da6c7b638e5d50da1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iac7b594f1d824d129657241335c72a8e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if0df1ff8a1a54c22872aa4b7544e0a23_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icbf3c6c583244c2fab2e8204429785e0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5e89a0afa4d441e69b487b51d995257f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if80d7ff3511a426c8ccbb5d590033061_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70cf6c6b94e648fab5b4e530b9597a22_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6114d388ab3d4e49b91f718263e65571_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2a2c21ee9026460f83c4f80341476ca8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39edd3b053b44656ba6ef1db52a30967_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i59f2aeeaddd4434b899181df93dd41d4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4f552247b7024defa099434103c396e8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id0750513067f4915aeadf4ccac6ac536_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a7066ec33c5413cb82aa1ff74f91430_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if25f331f9c16441697383aa057d1019d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c8cc01f04c94d908c036d3fb2209bf1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i409ea711e6f845c490f196eb8f645359_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b3dbd2a395345e89bf32cdbb4960ffd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1d9584798cd648e6b0f68b8de0c67383_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibae4355d68e2490daec9fa91cb0e265a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i397c997d2efa40a4914ea6ada16e1c97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9100d979f2541629d90815696db7ff7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3e238159a98e4530b36025474376c7c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbc83d9ed3ee4a2ba978e5473f9f7841_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1f24bfa3aee44280868c18852f2add00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if4fb2acc48954eb78b81311475eb5154_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9fcc59e0f14e4f539af996b7ddacaf81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic00f9b1190024fc69e527ab0f26e42ae_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1427edc253df478ab7767e33fbd20045_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id83d13706d9146a79d73c772426d5ff8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5f249df241c94811b66eb3658e39ec2d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if188a3e6d22a4b7db65d00970ac38a45_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17d172fc6220427c9f12e31cf1f52b80_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7eefbfc31c346bca35521fabb975893_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9b0cd3ff62c945c9ad487c37b3fd49a4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i82ec5023912a4ca5bfbb4e7fca74a490_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie96abd97590140b0860c8ae2063b3fc2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ee44477cbc4457bba565114bc45fa23_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iac3907c853c6419a870b4ed9a47ea65c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id84f4faab40b4939b60934146442e110_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i36134bef524d47339914de17640d4657_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4c190988faf34c569ba539990a780979_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if7778b658da74dfc820fa45dffe480a5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3a4c4e29d280497495f987d4c7046864_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i994b7b3bd9824fcb955199e80b3d015d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1684b3656ff54e7b88a81aa5ed514327_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8650d0802a0f4458b2b63e441989ada7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2aa64b17a72543409df08e6edf8f9be4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d0a55b7d81042cebc2597b4a7828ec0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8e39a58bafcf47698fa18eba3fd53f41_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf94a6be0e1f4c53a69e7cae23297b88_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3be404ce95e74ed18104ee0224861b9c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8e142953703144db8673afd8a319673d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iec3f619d2fc04691841709d7853758c3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4f7b3b26880741cc9326ad463d4a8fb2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c9f8959592c42928f31e74aadef1a94_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5dd465f33414595a6a158c4dafd368f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i99b61cb16ec84ff397f4193ae43dab64_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic197cd11b20542f99e6be323e290d337_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1c4e28760c8541dfbabc414285380144_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib35b235ca2534a9eb3695accabe2e56a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6bea95b582841779004ba9afa0dcbd3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i50557c7d0a314ffd949e64496b2989ec_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i87c71d0b092845d79272052bbb18994f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic727ea9150bc4dc391144e09e7d7e042_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie1e66a2f3c8844b989c39e0f132489b7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i00ee9e3ed488431ebb9c796f6637ad99_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c1f1c2c43254a579e54a9790105bb7a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36c1df1cfb0e4a7695077dcdae7a8904_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5a234e26b18540b7940a2ea492897975_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i23a8ba54205549e490a8217b028c1dd2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i78097a5d3545484eb624e2a51be21d04_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i112482d56c394f9c98ec73cd18cf2fef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7fc9b003385e4853a584b34e1fa30b4c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48e1509f4a144b719b8606c6c5a8753b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if689fbf349b341a9ac5411f4ddb65c4e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad592254e2654405a98370ac967c8207_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb64aca6929b495da3e77fc1aa3d032c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7295ea739c464a789ba0766d968ab158_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifc030e4ae0fb4916827ef25e38848ee5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i856404b99b8647e39c3633d9d681e346_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73cf322b7dcd4b9db7fcc6ee06d209ea_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf0aab70eb4c4d9b9357a0f16a10420e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16e357fe9d2f4d669a14180154d0f6de_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia7156ab3665b4bd7a5933b82974deaeb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia78721827a43497b8d32a902112bb683_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5eea894996f475286c69c6085cb047b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if602b15a04ab4cee94de3cc0404d3169_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id8ca6e4d1f814edb8b3dceb8cc93f246_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4c44836865d447f5a235810c1d8e5421_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iae27fa4503e943d882c2b6fc4fd1b5e1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iced73c5c9a5c41689687660c8f52e324_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibdfecd8a92a84c1ea9f18f5a8cf72dca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36501cc5b8c1437bac9367d0d934737d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6db8852c6a2a477c9de7a28fc85b2e0e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i445016d775dd4f209e977cbc25ca6e43_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if9f18b4486f2427c843d513b40f25523_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5414e1e552e04f9f8c6d1c6c4b4a4fe6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia8d34e28fa284f1ba780f48fa13f0b66_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6e6724e55eb34d1790b308a597a419d2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i05ec2539711d4ce5b8b8fed40d4c1deb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iffaa8df2c61540d0bb50ac46d4160159_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b435d25b05043a6aaa5dba29add366d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68152a8599574507a548fc0ac92e4967_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id817c0101ced4d6f99e8860b7bbf49e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6624a35872d9468488b80d9b5c5a3bbf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifacde500ddb74a838f3cc9af62684d7c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id0e1514aa7fc443080c274bc42357af8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idde5b46f7b324236890c317a7886f38b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i08864ae1bda84a668fd39b3a4061c26c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i82c06aa2c44648eaa7913d094f119852_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7cda3b1cb17849b68369df08696e2ff8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie6887a94e2824849a970f1b2b7ac88a8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2305248e0ec7423c9ec651a058186ca2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iae35539042854319b592f855a1b59d31_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i206b2c76cea3434e9b38f340fb7d619a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5bd891890ba45da8085b5e18a6d0c2d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic5b1d5114e8a40e58ad899a25fd25a78_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i48883a929c674841b54b15a5dfa052c9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic709cdea2757418ba8d3eba64ac18cd3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd006e5337d34042a30f9b2fadf77562_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbe1019e59b241e586669181c4ed2172_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f8f1f99c44f4480975af6d8192015a8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1b82b81097954a6dbe91e74a172c38a0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i996157eb8f024336abb632e6241bd77b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c72c96c8e434f6ca045344246edcf0d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc5d4575471c419c84ba4bf97ce903ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifdae4e4c5a5242a1b88940fdea051045_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia250b656d037452f82c80809f1305d0e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i59b4ff6ffd414f62bb45cf05a387070d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1240a78f95a245e8a86128ad258992e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifc4c7a30b47c41748e6634ad3c972b6a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a3ae3d6aa2b4d09a6a8a1fd463caf0c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5bda2e702c6e44df89b96f76ad8d15ab_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id08ebd120d464decaaf14ac1fb137424_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4e2d778f29a0499e8266532cb33dc627_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3090e8c3fda94423a0d0912d50961819_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8e3034fc19a412ea43aa1cfb0412fc7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9dae84b5f6a4563bdf623ffa56038af_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6df3f4f4414c4f44918ed058594a3a6d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idaddecfa588c45dbbd695699ea74db2e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i26a0261aa0654089bb88fbb3d2a3a069_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0b80e53eaaf246c0a006f99d6c332ef9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i82485fb2469a47ecbb6c7c2217dbedb5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i87c244391ad84185a8d527720e081a70_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i428120bbc00c4484801fe373fa42a492_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7e9603e0fe354ab996f5149cb7753360_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2b0d89fe81948dbad94f24b2081b1fd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iddbc08f9e34a4424a04357d4ff58fd2b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia34ea41012e54e3a8847c03a4116d7c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i983f956742e148cd9935461bf9c57d85_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iafa57853da33460a929d418073a4e5ef_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7764dcb4d84344eab48a05c00972e9ca_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79060a21825446f68e990e404b003293_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id2e5727a5d734abc8a8eceb71d05ff40_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e28f51eca1f4bd9b296c01f4220bd6a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia374726d39fe4c0c815368587eed129e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i000aac4b4eb74546bf63b572c100248c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic27396433bf44b738da6b78bd6987adc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2cd580e555ab485aa20157d901745b91_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18ee0893dd9643fdbf0354b01a632557_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icadc946e2caf484fa6388e999c80bef3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3361742ed1c42fbbb2de2275dd10be2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe7dc69941344244b7589680ec54ee1d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe952d9c345f44f88320bf99c72fbf4b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ice50f6d87c71414ca4f9c37b27e16086_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i04c354156cd54db0bdb335313ca518aa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia15c872355344ae39ce7dd39d2d327e4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if78a45e31e0c4f4d810fb14d428a91ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifc06387a4f544444a7bbab606971c606_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i918c71be12f94ae78f91f363866ba727_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45a632ba481346bdaf99d141baafe749_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i17907bd75b564e249364985141865dee_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id66df73b2bcb44c6ab4532b0c9ab728b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iea336d5c32bc4861902104cb153044f3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i697542fa1b0a4a98875df15a602c28ec_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i09cba0015a754f508a844041cd9e4b69_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if55f3be8e44b4bfa864a27180b621ed9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2e1f45adb51d457aa5725c517e737b84_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2588cc62cb4d48b7a46b738e92f4072f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i99d230df90c142c884206af10ef9f8fc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7199ae522f2f43f4ae0239522889f703_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2312799038e14136a66c60426b4cb5f9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe4632e8764241ee9398872757d10f8e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4990d1e08a374066a38fe1c66495a71f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idbfdfaa0e8ef4d4790f5cacb41fbc6d5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i87c145ad188b4727a0ff9e2d211c6b95_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i39c83749cf3d4a26b1b79ffab6bc6042_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i115a2bff9c784ab99914fe29be8d2d98_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21e6c07c99ae4e90bc9ff4f65a602520_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida458b6715084e3a96aa191749dc91fd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8bdf1fc538624d7d9910380d7d77b626_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95260f0037d846208bd14cc3ba8adffb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icff550217f2b4a8f8d4ae65fe153a1ff_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idbdf433bfc67461d8114a92c13283325_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0679fb1835b4c7795bcea38cf0b9886_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23e2ab4fa4974f7889612beb65ce8d19_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i491168a2923441709f7ed1cbfe6c88ad_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i59821c1a37b043dd8a8397a39a3d0bd4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i53f65613766e4c30bdf4b47df7bb28b8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i11a5054d010e43e2bb824d4b0a88a448_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id3df95dfd2c54aaea21d90d6cd142885_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id7ff276cb874486b9ea8a16dad3d507f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee715bdb374f4d0fb135cd9a90024cb7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16bdd528aa2f43d699d93d6730eaadc0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia4eaef49d9cb47cfa238b4be07c3c11e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a7daf0d45954200a36a140244cfa8c3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id0e760ae3df749d7a28496170682fcdb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife9092a352dc419ebd9202ad5227d8e1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaa41f2bd185d4f35992a88175bd33816_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6f72f4b6a78548e09b7e4a30258e2a66_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8f4353d73fc0409094a9382a8f5b35ed_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i32f7b3dac88f4fdeb34925d2fd733bd2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f085c0375204e3d928fcb8db88faac6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i087c22c00b8342649cb73bf0310b7e9e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89294089c022435cbb391734e7e95a77_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i03c1cd55ef43406fb28e3516e8bed426_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5f66dbec955f46ba8e2a9f09b30f4234_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9dda49a9d7704da6860a7855a38b3484_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d3dbfedff62414dbc6b3c751ec05d46_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a28025718c7422987d5e9a1bb04a33f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie76d49105fd64d3fbed5c1bb08359728_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie0522de9f5b144d58800dd0fd0f71c6a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2166896cc67640a7ae96d097acab1f25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i950523c03d0e465a8db7b9c48b7e0e3e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ace5ff2293146d4bf055d7cb9bcf636_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i2a9b0b9cb7944866bf75d223bb4c8fea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a10b05f8c504eaea705b787746ae15b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33b44d74805841d2ac389e7934b1a17f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1111c82205474cdda375e71c5738d55b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if77e3cf538fe4a19a12e07001222f635_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01b9c1c44ba84e60af09ae0057af5a4e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4fd80b73ae2b420ca679db0cac3a60ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55e4dbb5ee80417da9485fdfabbcc12b_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A130SeniorNotesDueMay2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i9812ba731b464628b9581ec75cb13f21_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A04SeniorNotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="if0c7cce9faa64129b1ddac611011830c_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A13SeniorNotesDueMay2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i4219ab86c67549bfa1e56276605a8990_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic762452cc4494022a233acfc178ebafa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if03565d5005c4f898506b8c013da1feb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd4b212abcc54d02b74cb18b61508e58_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b0045fb1e0941df98e20a283f36d227_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idec3801c7613438c8124f3cde7757903_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i524f33dedfef49de9b3bc2b5e9c14c87_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaeaa8f4aa8c140688f7b460b580b43ed_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8cf0aac0647045d5aa67667953993c07_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d171c4e6be042278f782461c977f45c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2542bc7a65744214aae79ec882f3c054_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c0e3547cbe442938da56027d6f100e8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifaa95bf889d043f38f60a617e70b40d3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i57bc193f1088457fb04394f5af366882_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d4402f6cfbe44c7a47198d315febe1d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b054901d62649cdb8f927a96ce91ace_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bd9a491ccff4bbda2839a7be1c36b74_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaef3027bf73d4dc6910053458adbcef3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1d7c0055bf4040c381b494fe4307540c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3c83643aa4f4d08a36b0e3403f878e7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3597ba90139f4ad88f34ea14d4c322e4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia23c6ae90b5e43f18f128140d9efd7b9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i20f6cdaf8a75405295f0a68abbdc904e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b78a3fb7ef44f86a0bd6a81e7c2f5eb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i02b24494d1e54bcb900d94e60f0b8ac7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4159e70eae1c4a779c9b692aaa4cf78c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5a752302cfc64472917c0dcdd2903e89_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e74411bec474aaea6b669ed608cdde3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia96f099a1e7d4398a154facff7209588_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie089f3302f66450796c1dff4135d452a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1528a977db6d4b2599de78b0fafe3502_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1abbbcb680d54d358fcfea6c93ecb0b7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6de69187ee1449e690027dd9b5781e35_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i468b5d6abb97433c8ced58e53154b575_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia6cc534a76f6479cb41d07feb73fe749_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3173187680714658978b04838fce40b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fe54a153e4a40e4a1a669f98ab1f673_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6af24cb81eb1423ab102ead43ce324f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32d91b9084444f99a2a267da216d851d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i821cd3c29b904c40826ea7cf9fc530c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6e5214316a649e3860c819c556c69d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f5e8ee945c84b1da96f6817955ff214_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b104e3d69714250a4d3b01b50f34773_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibec49a9c245a406cad720eaf5a91dba8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i655add2ac3494884b74da98ed4989459_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib38d2fefee4f4f3fb7ce25329d990772_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c384389756a4c369c17d835b9631cb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8db585f6be0041fdbc967569ee16766a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie775ab37506340ba914ddb80c6e46611_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bef60de6abe41cebf0448519a3ac267_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i16e06ddc9fdd4a0295e9c0705d568e98_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iefcd1a7cef434b938b81d5633355bbf5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic34110c3d1d548c099e33f7257520862_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5785042f0a0a48b2a89a8d5e5292f378_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c975de3f94448528111a2732f5ff183_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia4b320ae27de4e16915e55e2cea04c39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5af787ce477145f395b6c47dad80c78d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib401981a72924d8cb4fa3b85e149335f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36894205b57049ef997539ec21871c49_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if2ff000d306648239fede97f2055f01f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a8551f83b15496db276708fb0ec4cc2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie5748a1a16bd49a496f9c15a091112fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60e9daec1c784937b3bc084af4e7d546_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i60aa20a1204d41029dcdf01856f5131f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f7ae0b172974bf08be1404801ce8bf3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i672fe12465f04ed1ac1c17454ce41b89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8cdf58384f44554b6f0c7ae5b485465_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd833938b8fd43d887495cb1fa7f7edd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id4917de1dd954a059d60387d14e89f10_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6123385e384e4137985445ff7eee59cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i327518eb465544d693c28e6cd73f5736_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1ca18a38e7b24b8b99d1fe4106969b7b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if51f0dd41ec94f6b858c4933e0bd444b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07947bacb9de439897e75f3c619d0f5b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i44a9d785c00c479d87a0bf2f015e7811_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="site">
        <measure>bax:site</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bax:lawsuit</measure>
    </unit>
    <unit id="segment">
        <measure>bax:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml8yLTEtMS0xLTEwNDM3Mg_d6ac42d6-0a2f-4ab5-9008-5344fb84e62f">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml8zLTEtMS0xLTEwNDM3Mg_9b861277-42f5-401b-a293-4689496062ba">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml80LTEtMS0xLTEwNDM3Mg_d7ee9062-5f3b-4633-85fe-af44e40896ed">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml81LTEtMS0xLTEwNDM3Mg_3cfe00a2-1d59-494f-b7d0-422b4da499f8">0000010456</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180L2ZyYWc6ZjhjMDcyYTYxNGYzNGVjNmI1OTM2OTVkNzYxMmZiZDYvdGFibGU6OTkwNjNlNTk4MjI0NDg1Yzk5OWEyYTBjZjVjNTIyNDIvdGFibGVyYW5nZTo5OTA2M2U1OTgyMjQ0ODVjOTk5YTJhMGNmNWM1MjI0Ml82LTEtMS0xLTEwNDM3Mg_e9428987-8bc8-483a-b128-00052f5b57ed">--12-31</dei:CurrentFiscalYearEndDate>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i39edd3b053b44656ba6ef1db52a30967_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE4NA_4b48d30d-ec79-4a92-a7cd-7e8e20511e7a">P1Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i4f552247b7024defa099434103c396e8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3MQ_ecb681a4-8097-4734-b0f9-9c8160b702fe">P1Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="icbf3c6c583244c2fab2e8204429785e0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfNC0xLTEtMS0xMDQzNzI_a8bce7e7-7631-41a7-be44-fbd7caaf20e5">P3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i5e89a0afa4d441e69b487b51d995257f_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfOC0xLTEtMS0xMDQzNzI_b0a3db66-2c93-49b6-be60-7c8adfbeb870">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="if80d7ff3511a426c8ccbb5d590033061_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMTItMS0xLTEtMTA0Mzcy_c58d8b3f-d0e2-4015-a81f-8d6da27374e0">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i70cf6c6b94e648fab5b4e530b9597a22_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMTYtMS0xLTEtMTA0Mzcy_47a43be4-6183-4ab8-993a-630d1589a4e6">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6114d388ab3d4e49b91f718263e65571_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182NC9mcmFnOmQ1ZGMxZmU0MTE2ZjQyZGY4NTI5MDc5OWZmNDQzMjBlL3RhYmxlOmYwNzVmZDYwYjhjMjRkNDZiOWU4Njc0ZGZmNDI1OGJmL3RhYmxlcmFuZ2U6ZjA3NWZkNjBiOGMyNGQ0NmI5ZTg2NzRkZmY0MjU4YmZfMjAtMS0xLTEtMTA0Mzcy_0e6370ee-0b5f-4c4a-b795-965cbbe07276"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xNjY_c9a395cb-628b-4c57-8b99-b08feac3e318">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6YzcxNzQ1MGI5MDEzNGJiMWE2MmJiZmYyZmQ0OTllNDkvdGFibGVyYW5nZTpjNzE3NDUwYjkwMTM0YmIxYTYyYmJmZjJmZDQ5OWU0OV8wLTAtMS0xLTEwNDM3Mg_931e5ae4-47de-40c3-8780-f36aceb10ef9">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8yODM_5a2ccfc5-a484-48d6-b38c-4e7fd8278360">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NjdkZmVkZGQ5NmNmNDVhOGFmM2UwYjU0NjE3MjczYmYvdGFibGVyYW5nZTo2N2RmZWRkZDk2Y2Y0NWE4YWYzZTBiNTQ2MTcyNzNiZl8wLTAtMS0xLTEwNDM3Mg_9f2f8883-2e67-4cbd-88c0-736fcc23bf01">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8zNzA_fd0350db-3450-43c9-b7ec-58d1769a0eca">1-4448</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl80NTU_33a1c50d-587a-4d68-8ede-23d83e363570">BAXTER INTERNATIONAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18wLTAtMS0xLTEwNDM3Mg_cea67aae-0dc6-4ca4-ac0f-196948db78ae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18wLTQtMS0xLTEwNDM3Mg_64c44d35-a8bb-4962-ae15-9b878ac42fa7">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTAtMS0xLTEwNDM3Mg_6b003dba-b37d-4623-9cf2-f82074153bc1">One Baxter Parkway,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTEtMS0xLTEwNDM3Mg_93a9fd2a-c72a-46c9-b9c4-e1750d37a377">Deerfield,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTItMS0xLTEwNDM3Mg_7dedce80-6939-48ce-9127-48fa35d021ab">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NTYzZDBkMzFlM2FiNDcyMTkzZDU0NTNkOWU4NmYxYzMvdGFibGVyYW5nZTo1NjNkMGQzMWUzYWI0NzIxOTNkNTQ1M2Q5ZTg2ZjFjM18zLTQtMS0xLTEwNDM3Mg_02b4f1b6-c60c-4668-8b6b-4e3d65e73900">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NzNhMDhhYWY2ZTQxNDk0NzgyNWQ0MmM4YmE4MmFhNzYvdGFibGVyYW5nZTo3M2EwOGFhZjZlNDE0OTQ3ODI1ZDQyYzhiYTgyYWE3Nl8wLTItMS0xLTEwNDM3Mg_74f73d4b-99f9-49a3-9559-e8dd1f84e3a7">224.</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6NzNhMDhhYWY2ZTQxNDk0NzgyNWQ0MmM4YmE4MmFhNzYvdGFibGVyYW5nZTo3M2EwOGFhZjZlNDE0OTQ3ODI1ZDQyYzhiYTgyYWE3Nl8wLTMtMS0xLTEwNDM3Mg_42ee60de-703b-4846-9c96-202efdf88c80">948.2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTAtMS0xLTEwNDM3Mg_84004c69-a210-4e0f-a626-69e6f753e8e3">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTAtMS0xLTEwNDM3Mg_e7a59efc-7b8f-41b8-be43-24ed58395da8">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTItMS0xLTEwNDM3Mg_22a2eb1b-bd71-4cd8-80ac-f0855e016ecc">BAX (NYSE)</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTItMS0xLTEwNDM3Mg_d8f5514b-a03d-42d1-9338-601a50be8165">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6d80b7d261e94cf78251d9aec843e96d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8xLTQtMS0xLTEwNDM3Mg_19d1098b-b012-446b-9fc0-1b2dc073fc95">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="i3c7527cde1eb4b6f99506924392029b2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8yLTQtMS0xLTEwNDM3Mg_aca0fe32-6f5a-4dc2-ba36-b558471f2dbb">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTAtMS0xLTEwNDM3Mg_ffa0eca4-2647-4ca8-a743-ac6d60760e60">0.4% Global Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTItMS0xLTEwNDM3Mg_4f135dc2-7c41-468c-ae20-bc6876be955d">BAX 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id3e55bfbfbe74bf090eb96f68e58dc1e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF8zLTQtMS0xLTEwNDM3Mg_019d41ac-623d-4581-8a27-f2b776aa6fd5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTAtMS0xLTEwNDM3Mg_c32b0f31-ebda-4a2e-aa65-ffa781d63aa6">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTItMS0xLTEwNDM3Mg_26abfe3d-a4a2-4e61-9a75-8afa9de49071">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i39976b84175d43efbe32f5536a21818c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF80LTQtMS0xLTEwNDM3Mg_09ba9615-2558-4a4e-9c4d-5d06722567a1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTAtMS0xLTEwNDM3Mg_9e3b53b7-6aba-4330-8d5a-0ef817765b2d">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTItMS0xLTEwNDM3Mg_3cc3ce3b-d24f-4651-a712-e95c77f53432">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifc165b9e144140309b5f09674a899d54_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6ODE5MWI3MDY2OGU2NDY5MTk2NmYyMDI5ZTBmYTExODQvdGFibGVyYW5nZTo4MTkxYjcwNjY4ZTY0NjkxOTY2ZjIwMjllMGZhMTE4NF81LTQtMS0xLTEwNDM3Mg_16ff6852-513e-4508-8980-f6c375ab7ffd">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMDg2_cfa078dc-0095-4339-b291-dfb88b4b1cd7">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMzc4_6d576b59-d853-4757-ab90-163071b6b459">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8wLTAtMS0xLTEwNDM3Mg_017bacff-8d26-4757-9d09-04f37bac59ab">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8xLTQtMS0xLTEwNDM3Mg_d7394be0-a11f-4919-88eb-a283452f9bf3">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGFibGU6M2Y2OTZiZjQ2MjUwNGJhZjgwOTE5YzYyYjEzODE0YzUvdGFibGVyYW5nZTozZjY5NmJmNDYyNTA0YmFmODA5MTljNjJiMTM4MTRjNV8yLTEtMS0xLTEwNDM3Mg_20a0c6cd-80a2-4a7e-acd6-22a34a384e54">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8xMDk5NTExNjMwMDE3_737c672a-adc9-4280-8536-75f446af231a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2e4d13c497514386a72aa4814ef8a1c0_I20221020"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xL2ZyYWc6ODI0N2M5MWZjNDM4NDE4MWJiZDZkODAzOGRmNTY1OTYvdGV4dHJlZ2lvbjo4MjQ3YzkxZmM0Mzg0MTgxYmJkNmQ4MDM4ZGY1NjU5Nl8yMjI2_49699ce5-66b6-4724-9c2a-24af1bd5f0ec"
      unitRef="shares">504120759</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMi0xLTEtMS0xMDQzNzI_682d574d-2039-4309-a1a7-a17640035fd3"
      unitRef="usd">1601000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMi0yLTEtMS0xMDQzNzI_eb4671a6-91f8-4746-8667-c4d67fe8a911"
      unitRef="usd">2951000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo1ZTMyNWVkMjNmZTE0ZjU0YWI2YWMyNTk1YWRmNzlhMV80Ng_3e29f03c-d711-45cc-9949-39c28b1f543b"
      unitRef="usd">120000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo1ZTMyNWVkMjNmZTE0ZjU0YWI2YWMyNTk1YWRmNzlhMV81OQ_7c1be297-0be3-4236-be6b-9bc881103cb0"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0xLTEtMS0xMDQzNzI_8c7e8a59-0af9-4d9b-a80f-2a7f02cb4bb7"
      unitRef="usd">2555000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMy0yLTEtMS0xMDQzNzI_25b6a629-2ad8-43eb-aa44-da4079e4d501"
      unitRef="usd">2629000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNC0xLTEtMS0xMDQzNzI_2aa69a2b-7285-42ff-9ee2-cf1629e833d5"
      unitRef="usd">2675000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNC0yLTEtMS0xMDQzNzI_812bc7d2-29d6-4c2a-8bdf-ec386d82669d"
      unitRef="usd">2453000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNS0xLTEtMS0xMDQzNzI_0dcc13b4-4d00-48d1-aac3-e89b7e1fe666"
      unitRef="usd">979000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNS0yLTEtMS0xMDQzNzI_e9dc549d-0862-4159-9c7d-dc280ffe0155"
      unitRef="usd">839000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNi0xLTEtMS0xMDQzNzI_00b06f2d-b14d-444c-b09d-f4c44c8ad839"
      unitRef="usd">7810000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNi0yLTEtMS0xMDQzNzI_9fb0955a-8537-4dd5-a742-26b10398e00c"
      unitRef="usd">8872000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNy0xLTEtMS0xMDQzNzI_08e66666-b724-4d0f-9b71-7e0500606562"
      unitRef="usd">4799000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfNy0yLTEtMS0xMDQzNzI_3a6cb1de-1c08-42ac-9e58-6f80c6cf921d"
      unitRef="usd">5178000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOC0xLTEtMS0xMDQzNzI_9c77401f-c328-4867-9c6c-49df393fa0ed"
      unitRef="usd">6639000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOC0yLTEtMS0xMDQzNzI_e0775612-f81a-4619-a230-04008148a50c"
      unitRef="usd">9836000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOS0xLTEtMS0xMDQzNzI_bd941449-4217-4218-85c3-78c78490b072"
      unitRef="usd">6927000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfOS0yLTEtMS0xMDQzNzI_44b72655-5647-4ec6-930b-48f89ab226b2"
      unitRef="usd">7792000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTAtMS0xLTEtMTA0Mzcy_5300123a-0175-4cde-aff1-e92c9828609f"
      unitRef="usd">546000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTAtMi0xLTEtMTA0Mzcy_c8ae8644-e12c-4af6-95db-ea01a56367c2"
      unitRef="usd">630000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTEtMS0xLTEtMTA0Mzcy_5aa1d309-2860-4a06-8334-eb2cd9abe96c"
      unitRef="usd">1244000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTEtMi0xLTEtMTA0Mzcy_661fd90c-b924-4ad5-82f4-710d1346aa34"
      unitRef="usd">1213000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTItMS0xLTEtMTA0Mzcy_5b954511-1b49-4a68-a791-31805652977c"
      unitRef="usd">27965000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTItMi0xLTEtMTA0Mzcy_91535e40-cb90-482f-a01e-badbc2454356"
      unitRef="usd">33521000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTQtMS0xLTEtMTA0Mzcy_a764e534-a654-4a72-be2f-9a1b13e2ad54"
      unitRef="usd">275000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTQtMi0xLTEtMTA0Mzcy_30ea9d45-3fbe-40cc-9515-00f561007c11"
      unitRef="usd">301000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTUtMS0xLTEtMTA0Mzcy_33cb272c-caa2-4c69-86a2-46dd9f818d51"
      unitRef="usd">4000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTUtMi0xLTEtMTA0Mzcy_c42210d2-8cef-4957-8948-86ec92ca79d9"
      unitRef="usd">210000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTYtMS0xLTEtMTA0Mzcy_e4cf233d-5163-4671-82e2-bcc9e2120f0e"
      unitRef="usd">1234000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTYtMi0xLTEtMTA0Mzcy_48863e4b-b4f7-4098-a492-1e1525efd665"
      unitRef="usd">1246000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTctMS0xLTEtMTA0Mzcy_da050810-0328-4364-9858-72b0d6a583bb"
      unitRef="usd">2195000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTctMi0xLTEtMTA0Mzcy_9f8d5d79-7559-4bb2-a9bd-4bfea7fd3dfa"
      unitRef="usd">2479000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTgtMS0xLTEtMTA0Mzcy_7e3a7623-d0f2-44ac-899a-aeda9cd87ddb"
      unitRef="usd">3708000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTgtMi0xLTEtMTA0Mzcy_c1b79af3-f6ce-437c-8179-566aedd86f3b"
      unitRef="usd">4236000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTktMS0xLTEtMTA0Mzcy_93f53f6b-a530-47ee-a8bf-8401a9da9b5f"
      unitRef="usd">16153000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMTktMi0xLTEtMTA0Mzcy_2445a014-12e4-4ce6-b8c5-0bdc2582a263"
      unitRef="usd">17149000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjAtMS0xLTEtMTA0Mzcy_8f1ad878-8dbe-40ab-95e1-b10ed648f9b0"
      unitRef="usd">454000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjAtMi0xLTEtMTA0Mzcy_2e234b68-de1d-43b2-9f44-b858305cd075"
      unitRef="usd">522000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjEtMS0xLTEtMTA0Mzcy_fdf720fe-5a91-46c7-a087-091efdba9e7b"
      unitRef="usd">2071000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjEtMi0xLTEtMTA0Mzcy_f0a2d552-42d3-4db7-8437-df081d48837f"
      unitRef="usd">2493000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjItMS0xLTEtMTA0Mzcy_037ba1dc-99b9-4d83-9cb4-535ce994c8bb"
      unitRef="usd">22386000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjItMi0xLTEtMTA0Mzcy_dd683084-3a4d-4d08-8e4a-c3647086fc0c"
      unitRef="usd">24400000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjMtMS0xLTEtMTA0Mzcy_2926c4e5-cc36-417b-b402-954e6ae14927"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjMtMi0xLTEtMTA0Mzcy_2340f4b0-dab9-4a0e-a661-341c9a61c996"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfMTg_aa366660-5b82-4256-85ab-574886b34ff0"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfMTg_d6927bc4-363f-4719-a97b-454e79699355"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNDM_66ba282a-5a2e-41c4-a4f3-e6e749781796"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNDM_d56a0cca-9dc0-4e1c-8c3c-d4d9b7309088"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNjE_1c2a8e48-a023-4fa7-a749-2c850907724e"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246ZWM2ZGRhODQxNzg1NGI1NjkzZmM5NmVhYmMwMjVhZGZfNjE_d45baf24-8f96-40ba-b304-dd8b786eb391"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMS0xLTEtMTA0Mzcy_7104fb64-0b2b-44f7-af26-52cee97c14c6"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjUtMi0xLTEtMTA0Mzcy_78303c21-03aa-4a64-a436-efb69e7d22bd"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246MzA5MTczZDc1YmJkNGI2ZTk3NDllYWQ1ZTc1OTkzNmRfMzg_9d35a105-86ac-4b7d-aace-7b47966a43ee"
      unitRef="shares">179451293</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMC0xLTEtMTA0MzcyL3RleHRyZWdpb246MzA5MTczZDc1YmJkNGI2ZTk3NDllYWQ1ZTc1OTkzNmRfNTg_fff92f7f-eda4-4e4b-8fc8-0a11fd04a279"
      unitRef="shares">181879516</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMS0xLTEtMTA0Mzcy_0017b6b5-6858-49a5-98be-e5a35a561c85"
      unitRef="usd">11406000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjYtMi0xLTEtMTA0Mzcy_53e735a3-e097-4e74-a65f-6809f503bbde"
      unitRef="usd">11488000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjctMS0xLTEtMTA0Mzcy_7b9ec08f-a6cf-439b-91b6-9a3d7c0933e0"
      unitRef="usd">6297000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjctMi0xLTEtMTA0Mzcy_01ce8cf1-5177-49ae-bed6-bed1972a92ec"
      unitRef="usd">6197000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjgtMS0xLTEtMTA0Mzcy_4d57b544-93b4-49cf-97ff-240d3369a97b"
      unitRef="usd">14015000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjgtMi0xLTEtMTA0Mzcy_58cdd8db-3b7d-416c-9f54-e453fab47746"
      unitRef="usd">17065000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjktMS0xLTEtMTA0Mzcy_0d0d1803-7c9a-4a83-9177-97af263388ff"
      unitRef="usd">-4054000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMjktMi0xLTEtMTA0Mzcy_e904cc57-f44b-4845-92ae-7aa9167b4488"
      unitRef="usd">-3380000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzAtMS0xLTEtMTA0Mzcy_05601d1c-db3b-40b7-a15d-cecd58f4921b"
      unitRef="usd">5535000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzAtMi0xLTEtMTA0Mzcy_aabfb315-e71a-482b-918f-d33ce31b127a"
      unitRef="usd">9077000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzEtMS0xLTEtMTA0Mzcy_48585cdf-2477-4b1d-a79c-dc7ae55e4c8b"
      unitRef="usd">44000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzEtMi0xLTEtMTA0Mzcy_a2b4b80a-1b01-4f18-b15a-1701760a4348"
      unitRef="usd">44000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzItMS0xLTEtMTA0Mzcy_0c60f470-c9a9-4d82-a186-06c6ad5f8d8f"
      unitRef="usd">5579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzItMi0xLTEtMTA0Mzcy_12fa3226-e300-4823-b75c-3589f0d10f29"
      unitRef="usd">9121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzMtMS0xLTEtMTA0Mzcy_15b18a9a-57c9-4413-922a-d9966f4c4d57"
      unitRef="usd">27965000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xNi9mcmFnOmJlNWUzODYwODNkNjQ0ODZiY2MyYjY4OWQ4MmE5ZWI3L3RhYmxlOjVhYWYxOTM1ZDMxZTQwN2NiMDZlY2ViMTU5NGJlZTc4L3RhYmxlcmFuZ2U6NWFhZjE5MzVkMzFlNDA3Y2IwNmVjZWIxNTk0YmVlNzhfMzMtMi0xLTEtMTA0Mzcy_0b356f7d-5311-453e-ae49-2ba7c8408b46"
      unitRef="usd">33521000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi0xLTEtMS0xMDQzNzI_7ff1b7a5-c02c-4ef9-a3a3-1b2cec9352a4"
      unitRef="usd">3773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi0yLTEtMS0xMDQzNzI_098c9167-675e-4749-b581-26415a5ea07c"
      unitRef="usd">3226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi00LTEtMS0xMDQzNzI_b0a56fc0-1ba9-458b-9bdf-f8f463fc4d44"
      unitRef="usd">11226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMi01LTEtMS0xMDQzNzI_120e61e5-04d6-41f3-b259-6ea18ffb6e1b"
      unitRef="usd">9270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy0xLTEtMS0xMDQzNzI_394ae309-1962-42d0-a365-3d95924b0929"
      unitRef="usd">2640000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy0yLTEtMS0xMDQzNzI_3e40770f-5838-4100-a48d-477cb5f88ebe"
      unitRef="usd">1905000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy00LTEtMS0xMDQzNzI_2f534653-8024-4b6a-af0d-218a00c39151"
      unitRef="usd">7292000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMy01LTEtMS0xMDQzNzI_57761791-dd3b-4b9c-8b36-48b28ffa5d03"
      unitRef="usd">5571000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC0xLTEtMS0xMDQzNzI_7b4cd31b-e66c-4f1a-8568-020bf080bd1d"
      unitRef="usd">1133000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC0yLTEtMS0xMDQzNzI_cff86fd1-9776-4c06-888a-17d00166062b"
      unitRef="usd">1321000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC00LTEtMS0xMDQzNzI_c050ae4c-8643-4a9a-bbdf-f4a08b1f6c41"
      unitRef="usd">3934000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNC01LTEtMS0xMDQzNzI_83930e7d-c290-458b-801f-0aade1bced00"
      unitRef="usd">3699000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS0xLTEtMS0xMDQzNzI_2ae5afa6-217b-4af4-b541-d664a3e2c98b"
      unitRef="usd">947000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS0yLTEtMS0xMDQzNzI_2241fec6-d2e9-4ace-8902-0cef5ae0a57e"
      unitRef="usd">680000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS00LTEtMS0xMDQzNzI_ee2438f7-db68-45d3-bf9e-98bcc7d6ea43"
      unitRef="usd">2975000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNS01LTEtMS0xMDQzNzI_34b655d7-bb81-4c50-83d9-1f46681782da"
      unitRef="usd">1982000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi0xLTEtMS0xMDQzNzI_f2d43689-07d3-4eed-a486-e7bf1cbf49cb"
      unitRef="usd">152000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi0yLTEtMS0xMDQzNzI_fb9e3617-c68e-40dd-bba8-6b1b7b545dd1"
      unitRef="usd">129000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi00LTEtMS0xMDQzNzI_4fd8fa51-6de0-49ba-a1ad-a817f64c4d8c"
      unitRef="usd">450000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNi01LTEtMS0xMDQzNzI_268a710b-8cee-46fd-aa9b-1740eb5a62de"
      unitRef="usd">396000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0xLTEtMS0xMTQxNTk_7b47f1a4-49eb-4d2b-98d2-2adb93895eb1"
      unitRef="usd">2785000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0yLTEtMS0xMTQxNTk_3e7b83b7-1c31-4026-a86d-678a99c6dc5d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy00LTEtMS0xMTQxNjc_860eee1b-4b21-435b-a031-3660d0646d88"
      unitRef="usd">2785000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy01LTEtMS0xMTQxNjc_16a416f8-051c-40e8-ae3a-98e23a1ac695"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0xLTEtMS0xMDQzNzI_aedadce3-f0de-49e7-b777-1ee96b1a2d5d"
      unitRef="usd">-48000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy0yLTEtMS0xMDQzNzI_35696741-09fc-49ba-b32c-47ff547c9757"
      unitRef="usd">1000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy00LTEtMS0xMDQzNzI_4c56cbc4-d85b-4b06-98e2-e3f4a1f7390e"
      unitRef="usd">-20000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfNy01LTEtMS0xMDQzNzI_eb43c1de-1767-41a2-9dfc-f8ba552095fa"
      unitRef="usd">6000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC0xLTEtMS0xMDQzNzI_ef6c48ea-3a90-41f2-a644-f7a7cb87a2d6"
      unitRef="usd">-2799000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC0yLTEtMS0xMDQzNzI_48a7b177-77af-433d-88ea-ab3fecdf0445"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC00LTEtMS0xMDQzNzI_0cb76609-8a0f-4acf-a09a-66222502296a"
      unitRef="usd">-2296000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOC01LTEtMS0xMDQzNzI_f63191df-3b83-4f79-920f-578bacbd8078"
      unitRef="usd">1327000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS0xLTEtMS0xMDQzNzI_238ac71a-7edc-4ff9-aa0d-a258d5589ecc"
      unitRef="usd">-104000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS0yLTEtMS0xMDQzNzI_54449842-c80a-44cf-9010-0a17c77ee9fb"
      unitRef="usd">-50000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS00LTEtMS0xMDQzNzI_1e942b3e-7874-4386-beab-affe648d16e9"
      unitRef="usd">-278000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfOS01LTEtMS0xMDQzNzI_e2dc83b8-b5cc-404c-873d-32aa20951895"
      unitRef="usd">-118000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtMS0xLTEtMTA0Mzcy_a1ac637e-8173-4c6f-95c6-dc2f6c18f8bd"
      unitRef="usd">-63000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtMi0xLTEtMTA0Mzcy_b6652f0d-03d3-48bd-8699-04e0e483939e"
      unitRef="usd">-12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtNC0xLTEtMTA0Mzcy_93f550fd-cef5-4964-96c1-fbb6f5ff522c"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTAtNS0xLTEtMTA0Mzcy_4a71d9e0-bd77-4521-a3ca-a8a48413f565"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtMS0xLTEtMTA0Mzcy_ae7338e8-8fec-41de-a171-499bac292d92"
      unitRef="usd">-2966000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtMi0xLTEtMTA0Mzcy_e2f58c95-f696-4cd1-b8ea-9735bb27a44c"
      unitRef="usd">451000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtNC0xLTEtMTA0Mzcy_45c18c98-77f7-4ad5-85ca-af2d956fc33e"
      unitRef="usd">-2577000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTEtNS0xLTEtMTA0Mzcy_ec9aac07-055b-401e-89c3-e357e2547de1"
      unitRef="usd">1194000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItMS0xLTEtMTA0Mzcy_473e5a46-40f4-4cda-8403-d7fd06841e5f"
      unitRef="usd">-32000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItMi0xLTEtMTA0Mzcy_fec463da-9436-47b4-a3ad-cd348d25daf3"
      unitRef="usd">-1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItNC0xLTEtMTA0Mzcy_f2b1b6dc-d63f-4707-b2a1-70a686dcd4f7"
      unitRef="usd">29000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTItNS0xLTEtMTA0Mzcy_6b9d44b3-b293-42da-abb2-220a5e67e580"
      unitRef="usd">141000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtMS0xLTEtMTA0Mzcy_4895294e-023b-48a3-9ac9-e20a4b017624"
      unitRef="usd">-2934000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtMi0xLTEtMTA0Mzcy_a49ac0d9-6ef3-40f1-b290-f31439e65f64"
      unitRef="usd">452000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtNC0xLTEtMTA0Mzcy_cc6492db-5688-4e8b-a11b-89f4b72396c1"
      unitRef="usd">-2606000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTMtNS0xLTEtMTA0Mzcy_52f060ee-d7e1-47eb-83c4-b04ed1cf2f96"
      unitRef="usd">1053000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtMS0xLTEtMTA0Mzcy_e9f362fc-cc1b-4a04-b359-2e5e818787a3"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtMi0xLTEtMTA0Mzcy_e21a9b57-dea4-4716-813f-0fd2b1bfe0de"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtNC0xLTEtMTA0Mzcy_39687437-efe8-4b61-95d7-f6ee2e20b6ac"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTQtNS0xLTEtMTA0Mzcy_1c352f19-b979-402e-a5d0-92c7793e1531"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtMS0xLTEtMTA0Mzcy_4d45a6b2-2be7-4c95-bff9-ff70a248b791"
      unitRef="usd">-2937000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtMi0xLTEtMTA0Mzcy_4d618057-f572-4fe2-a22c-23658b220151"
      unitRef="usd">450000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtNC0xLTEtMTA0Mzcy_45923742-1751-432d-9ce7-712c8cb64750"
      unitRef="usd">-2614000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTUtNS0xLTEtMTA0Mzcy_94481bf9-92b3-4dda-9c83-0b0794e28008"
      unitRef="usd">1046000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctMS0xLTEtMTA0Mzcy_c30f2ba2-6f9a-4530-9521-335cc8feae00"
      unitRef="usdPerShare">-5.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctMi0xLTEtMTA0Mzcy_2d7ef048-4372-4b9e-8b64-0703906ccd50"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctNC0xLTEtMTA0Mzcy_205f33a5-0242-4759-83b5-bde710174ecd"
      unitRef="usdPerShare">-5.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTctNS0xLTEtMTA0Mzcy_3afcb556-4d40-4de8-a855-8c2b3ab1adfb"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtMS0xLTEtMTA0Mzcy_014c3dd6-0c35-4034-a634-e756e9edfef2"
      unitRef="usdPerShare">-5.83</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtMi0xLTEtMTA0Mzcy_cac625d8-297c-4d19-a1e3-0a6da85f48b1"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtNC0xLTEtMTA0Mzcy_92f18427-fe29-4676-a1fc-163935d7af56"
      unitRef="usdPerShare">-5.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMTgtNS0xLTEtMTA0Mzcy_769f65eb-0529-4dea-bf83-bd80bb7640cc"
      unitRef="usdPerShare">2.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtMS0xLTEtMTA0Mzcy_e5e770e1-5ed8-4467-9b5c-d5f50af945a1"
      unitRef="shares">504000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtMi0xLTEtMTA0Mzcy_1a04acb2-7024-4f50-b81a-b8e98344b1d9"
      unitRef="shares">500000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtNC0xLTEtMTA0Mzcy_9fb88fa5-8645-436f-bd5f-40a8e63baa7a"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjAtNS0xLTEtMTA0Mzcy_54dcf96b-d3e3-4d18-8f18-09aea75bdd54"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtMS0xLTEtMTA0Mzcy_af40bd4f-7ac2-45b2-a607-d129d75a9ded"
      unitRef="shares">504000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtMi0xLTEtMTA0Mzcy_7d2050fe-7306-4ad1-95b3-565110da335e"
      unitRef="shares">506000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtNC0xLTEtMTA0Mzcy_8f4135fa-78b8-4b80-b15f-b4b9773d85a4"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18xOS9mcmFnOjE5MzY4NWI5NWYyYjRkMDk5MDJhODRmMjdmOGQ3NjU4L3RhYmxlOmZkOWRmMDBkMzdlMDQzNTViYTc4NGFmMWZkZjVlNDBhL3RhYmxlcmFuZ2U6ZmQ5ZGYwMGQzN2UwNDM1NWJhNzg0YWYxZmRmNWU0MGFfMjEtNS0xLTEtMTA0Mzcy_218c91d3-fe89-45d3-b4fa-8ebf5d28bfcb"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi0xLTEtMS0xMDQzNzI_05defe6d-f337-421b-a8ee-d7559ed5ecc2"
      unitRef="usd">-2934000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi0yLTEtMS0xMDQzNzI_c005be19-b755-4cd1-8ada-9ef1b64d50b9"
      unitRef="usd">452000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi00LTEtMS0xMDQzNzI_5c6e95b1-17ec-485c-ac97-88d387b3db04"
      unitRef="usd">-2606000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMi01LTEtMS0xMDQzNzI_00023cdd-4e3b-4cda-8f82-0afccffebc25"
      unitRef="usd">1053000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl83MA_a122c5f5-12e2-4542-845c-c6ddfc598ec3"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl83Nw_46287a7c-fb79-4c1f-b2cb-3b1ebbcc6312"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl8xMzk_b67fbf00-808b-43c3-b956-1d38e7ea4bcd"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjo0NmMyMjllN2ZlYTg0ZWEzOGU1OGFlYjE0ZjY3MzBmZl8xNDY_ffed2eef-fb78-4d6a-8fdc-fb56df5d86b6"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0xLTEtMS0xMDQzNzI_e94e5e96-6c80-44ca-9dc2-9eb80a4d41da"
      unitRef="usd">-319000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC0yLTEtMS0xMDQzNzI_71fc56d1-4df5-4db9-936b-db643c21a4eb"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC00LTEtMS0xMDQzNzI_8ae07fa6-4986-4776-bdcc-5579a2028e02"
      unitRef="usd">-751000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNC01LTEtMS0xMDQzNzI_67d32dda-a6ad-4a3d-9631-12ea809caa8f"
      unitRef="usd">-257000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV82OQ_7845e3b9-92d3-40f3-8913-9f44bed5ac0f"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV83Ng_d15da44c-4959-4fcd-9fb1-c9e9a8e30331"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV8xMzg_f28db72a-e7bd-4dc0-9122-34c3b0c7e06b"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjphODE5OWNjYzIzZmQ0YWU4OGMxZjc0YTM5MmExODgwMV8xNDU_d86eb627-a26e-42c0-bfc4-833201c9ec11"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0xLTEtMS0xMDQzNzI_ef0e8511-e2f2-4f9b-b786-5ba337793056"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS0yLTEtMS0xMDQzNzI_7425b20d-4829-400d-b681-f8b805ad3fa8"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS00LTEtMS0xMDQzNzI_19d755e8-3185-4ab2-ab82-ab288019a606"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNS01LTEtMS0xMDQzNzI_8f4fab3d-68db-4ad7-86be-21041ef2bf90"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM180Ng_502eaca6-9b0b-41a9-b494-f3c797151b6a"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM181Mw_5d44e5ef-64a5-4788-a20a-067c579f1657"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM18xMTU_68d38b4a-7cb7-4907-aec4-cf4c2f108e4d"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjoxNDlkZjY1MTcyMTc0MDVhYmM5NzE0NzM2NjBiNjJlM18xMjI_29d0d1f5-f90c-488f-bb13-6bbefb656f05"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0xLTEtMS0xMDQzNzI_dd0910aa-9ab3-47bd-9f13-1ccd922c2d43"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi0yLTEtMS0xMDQzNzI_5fab5be4-46b8-4e7c-90f6-206d8d70040e"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi00LTEtMS0xMDQzNzI_89c84e52-b59f-4b44-9c8c-98d00101b8ba"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNi01LTEtMS0xMDQzNzI_1deb5d90-8a46-442b-9dc5-67e37de7e553"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN182Mg_5a546094-59e4-4fee-8b3f-a61f67d0bef5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN182Mg_9c130a44-12e6-4eea-aaff-c2ffa2e54531"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN18xMjQ_3b51d062-cf2e-443b-8df8-dc00a8c295b5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0wLTEtMS0xMDQzNzIvdGV4dHJlZ2lvbjplNWIyMDE0Yjk4Zjg0NTMwODRkYWEwYzYzYjIxOGQyN18xMzE_b8301442-bd94-4924-9a6d-e67ac76453f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0xLTEtMS0xMDQzNzI_8d654ed7-188b-46b5-b95e-a5882d38c704"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy0yLTEtMS0xMDQzNzI_e39c7c79-a83a-46d1-be50-92772426c2d0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy00LTEtMS0xMDQzNzI_522eb42b-d12f-4041-92d8-0bc30f2b271c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfNy01LTEtMS0xMDQzNzI_f99b2227-8adf-4820-84f4-a4e81a86895e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC0xLTEtMS0xMDQzNzI_633b0d4b-8ab2-4d5e-8fc4-545e53218c47"
      unitRef="usd">-287000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC0yLTEtMS0xMDQzNzI_1a2d06b2-4c81-4afb-908f-464823df0437"
      unitRef="usd">-106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC00LTEtMS0xMDQzNzI_a0859fcb-47d7-4555-a15a-1ca70ecb11e0"
      unitRef="usd">-674000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOC01LTEtMS0xMDQzNzI_adfcf55c-8d21-48a6-a131-d10f909e9a43"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS0xLTEtMS0xMDQzNzI_fb8de53f-6524-4968-8f05-b242dd975ebe"
      unitRef="usd">-3221000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS0yLTEtMS0xMDQzNzI_5b553d9b-7833-477e-b656-fb044e0b1b9e"
      unitRef="usd">346000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS00LTEtMS0xMDQzNzI_f7263ad4-3722-406f-b8ed-ddb9628e7b5f"
      unitRef="usd">-3280000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfOS01LTEtMS0xMDQzNzI_7ecabb3f-0d66-4d6f-8d63-e223c257ca66"
      unitRef="usd">885000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtMS0xLTEtMTA0Mzcy_bc4cf602-ff0c-4b1c-96d3-8b17e4330016"
      unitRef="usd">3000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtMi0xLTEtMTA0Mzcy_5d61479d-19fb-4630-b4f2-c68f76841263"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtNC0xLTEtMTA0Mzcy_204f9609-6ced-463e-a238-20ca48a47134"
      unitRef="usd">8000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTAtNS0xLTEtMTA0Mzcy_e9d2b701-91a0-47a3-b228-92fbd9e482a6"
      unitRef="usd">7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtMS0xLTEtMTA0Mzcy_e5cf2126-8d51-4e55-8f38-40f96f9b8f3d"
      unitRef="usd">-3224000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtMi0xLTEtMTA0Mzcy_aa1fed5c-0c36-4101-ba50-7e13df4eeb58"
      unitRef="usd">344000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtNC0xLTEtMTA0Mzcy_b198e005-20d3-4073-a9b8-32fd3f51c2b8"
      unitRef="usd">-3288000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yMi9mcmFnOmIwOWI3OGM2MDMzMjRiNDVhNzc3ZDhlNDk3YzMxZjVlL3RhYmxlOjhkMmEwODc3ZDc3YTQxMjY4OGM0OTg0ZjcxMDk3YTgzL3RhYmxlcmFuZ2U6OGQyYTA4NzdkNzdhNDEyNjg4YzQ5ODRmNzEwOTdhODNfMTEtNS0xLTEtMTA0Mzcy_1a5a350c-7bf3-45c6-a6aa-ebee86669893"
      unitRef="usd">878000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i55c7f3edeed8429db78b4f553fc45026_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0xLTEtMS0xMDQzNzI_246891eb-6b8e-4a92-90d0-74fffbc6687a"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55c7f3edeed8429db78b4f553fc45026_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0yLTEtMS0xMDQzNzI_cfab1966-5942-489a-b572-404b5c9ce260"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i50bf025855184ac89338332505bcf37e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0zLTEtMS0xMDQzNzI_676ea41c-5254-4190-b99d-67414de47b3a"
      unitRef="shares">180000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50bf025855184ac89338332505bcf37e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy00LTEtMS0xMDQzNzI_d7dd25d7-0444-4037-b338-97afd0cf97ca"
      unitRef="usd">-11409000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a454fa8809c487b8e3d6d81416aaf44_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy01LTEtMS0xMDQzNzI_dc52f008-71b2-4b84-9509-6eba49d43065"
      unitRef="usd">6253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25a76885f3de4448b4fffc6a3b402755_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy02LTEtMS0xMDQzNzI_d69212e0-7b8b-44cd-a3b6-64c888f3e3c4"
      unitRef="usd">17099000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id320e76e08184ad18e0d44a027eb0e44_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy03LTEtMS0xMDQzNzI_be624cd2-6352-43eb-9099-b88a046d24b4"
      unitRef="usd">-3767000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6dc7215575114c6e9c9229e98fc5c182_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy04LTEtMS0xMDQzNzI_5978c92c-f295-49c9-83a2-16ae6f591581"
      unitRef="usd">8859000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i150a460e6b5240cf942785db873b20e0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy05LTEtMS0xMDQzNzI_8515450a-f78f-4a3b-a3dd-4896d04332d4"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida2ec04c98ba4de6aac9364b884a768f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMy0xMC0xLTEtMTA0Mzcy_cca06fec-94c6-4e66-84a5-e42659a8602c"
      unitRef="usd">8903000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iaafa26dc685d48499145e063e9e41701_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS02LTEtMS0xMDQzNzI_9ac52281-5318-4b57-a585-605d7ca1f0ff"
      unitRef="usd">-2937000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS04LTEtMS0xMDQzNzI_89a2d8fa-c623-4f67-ae36-3b77f2de0e68"
      unitRef="usd">-2937000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS05LTEtMS0xMDQzNzI_27da035c-fcb0-4cbe-8382-091e5fdfe757"
      unitRef="usd">3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNS0xMC0xLTEtMTA0Mzcy_fc9b942a-d63e-4a69-b8c8-27ea59aaf089"
      unitRef="usd">-2934000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i68bb769194c44702bc4f210eb327fd47_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi03LTEtMS0xMDQzNzI_0e2d286e-2e56-4e77-affc-e5534a26dbe2"
      unitRef="usd">-287000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi04LTEtMS0xMDQzNzI_90c1fa78-ab38-408a-b1c4-a67bf522cacd"
      unitRef="usd">-287000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNi0xMC0xLTEtMTA0Mzcy_b3b5ed57-7b3b-48a9-9a75-7d6bc21cc721"
      unitRef="usd">-287000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy00LTEtMS0xMDQzNzI_21464846-594d-4b7c-a04f-edb86e75daa9"
      unitRef="usd">24000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy04LTEtMS0xMDQzNzI_a652ad7c-a818-4c66-a8a0-5159827c3323"
      unitRef="usd">24000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfNy0xMC0xLTEtMTA0Mzcy_ea605a52-667f-41be-b6e8-c79c216ecbc1"
      unitRef="usd">24000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC0zLTEtMS0xMDQzNzI_d0eeef0c-35ae-4a52-9219-9e5d7832a28b"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if47c71584f6640e2a6c54c2f0fc93b07_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC00LTEtMS0xMDQzNzI_d83674f5-3aa5-4aad-a375-4e4cc8ad9f54"
      unitRef="usd">27000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="idc5b6addca054a8c977547a71a11eb9d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC01LTEtMS0xMDQzNzI_f8abbdf3-5aa5-4ae0-afe8-a46e0bd0eff5"
      unitRef="usd">44000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC04LTEtMS0xMDQzNzI_940934a0-19db-4a3b-95d2-350cc3dea840"
      unitRef="usd">71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOC0xMC0xLTEtMTA0Mzcy_f9b25fa9-b6a1-4822-ade7-1197af700aba"
      unitRef="usd">71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="iaafa26dc685d48499145e063e9e41701_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS02LTEtMS0xMDQzNzI_24187408-200c-4164-b21e-aa9070764755"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ie5005979730d42aa98babd3091cd05ab_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS04LTEtMS0xMDQzNzI_bf434427-9589-4b14-949e-7c0ee75012aa"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfOS0xMC0xLTEtMTA0Mzcy_f01a149b-40de-4b9f-a465-4270701e2737"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i81b8962db4dc4d9da3e1356395e7450a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTAtOS0xLTEtMTA0Mzcy_41385d2f-2602-4db3-8797-938b12e7f6ef"
      unitRef="usd">-3000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTAtMTAtMS0xLTEwNDM3Mg_b80834f7-06c3-484c-b5a0-addb91100949"
      unitRef="usd">-3000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMS0xLTEtMTA0Mzcy_25972cb5-1eea-4bdc-9ae1-667b5a0406f6"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMi0xLTEtMTA0Mzcy_83832a12-665a-4628-9711-9590f38d8576"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i46185672532c493c87739cf7e9615db2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMy0xLTEtMTA0Mzcy_0133bb22-e485-466a-9055-564d776f193e"
      unitRef="shares">179000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46185672532c493c87739cf7e9615db2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNC0xLTEtMTA0Mzcy_6dabdfd3-5c32-4d2d-a9cf-fe910c2e323b"
      unitRef="usd">-11406000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNS0xLTEtMTA0Mzcy_c3c80fb7-d2ab-424b-a0d1-c4b862ee84ec"
      unitRef="usd">6297000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b2b2f4c215a4c959a65859e3605344e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNi0xLTEtMTA0Mzcy_0d9c02b8-9dd0-44ff-9c25-233eb27fbf14"
      unitRef="usd">14015000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e06fdeb2414477d921f3587f0c89a44_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtNy0xLTEtMTA0Mzcy_9554d697-0425-4693-b4eb-a83149123236"
      unitRef="usd">-4054000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0218eda155249b4a4da75408a661f78_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtOC0xLTEtMTA0Mzcy_26b67a39-3ade-4a4e-9b8d-7c66b658e7ee"
      unitRef="usd">5535000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i315357d813df434ea52bc4a2bd057649_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtOS0xLTEtMTA0Mzcy_ff7d0fa6-6494-42d0-8b1c-bdace61e8bd9"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjJlZDM4NzVhZTlkNTRlYjI4NDFlOThmYjIzOWI2YTdkL3RhYmxlcmFuZ2U6MmVkMzg3NWFlOWQ1NGViMjg0MWU5OGZiMjM5YjZhN2RfMTEtMTAtMS0xLTEwNDM3Mg_53949b90-1a4b-42e7-ae65-234528d0b022"
      unitRef="usd">5579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0xLTEtMS0xMDQzNzI_e79ecd11-546e-4ca4-b33c-82e0bdda5941"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7200af2a4e8c4cf3af40acbba5a15fea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0yLTEtMS0xMDQzNzI_5d5f532e-9a08-42e2-84e9-c09398c4ec0f"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i7ebdd308c0aa480ab3f408048666bc96_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0zLTEtMS0xMDQzNzI_7adbfe20-6761-43dd-94f8-ea5066f52243"
      unitRef="shares">182000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ebdd308c0aa480ab3f408048666bc96_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy00LTEtMS0xMDQzNzI_0e159d79-7a30-42f0-8513-acc1d67d271d"
      unitRef="usd">-11488000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i725b88481fef4b7db4a008b05245cf1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy01LTEtMS0xMDQzNzI_73b6fe99-78a3-4868-9ab4-e0762491161f"
      unitRef="usd">6197000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb99534e9ac74a81934e5e38cb02f00f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy02LTEtMS0xMDQzNzI_bba2ae77-aa7b-4c5d-9203-63e33f5442a1"
      unitRef="usd">17065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2915afd9c994936a8dd5af0ce476706_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy03LTEtMS0xMDQzNzI_2c882b06-2341-4158-8433-894404436bc9"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i701c21dcb04e48f6873a3307cf046c39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy04LTEtMS0xMDQzNzI_c0d70416-6f28-4547-823d-2787db3c5f79"
      unitRef="usd">9077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7717dccf2b6422d90b12fdb9dc4ce69_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy05LTEtMS0xMDQzNzI_fb68fadf-a5e6-4fde-977e-aee21e4f14f4"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMy0xMC0xLTEtMTA0Mzcy_2444058d-22e7-4297-af7a-61328420e55e"
      unitRef="usd">9121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS02LTEtMS0xMDQzNzI_59d34c1f-f818-4a7b-913a-aad12eac3a8d"
      unitRef="usd">-2614000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS04LTEtMS0xMDQzNzI_33c0082b-5282-4066-9698-a7212ad1ce3f"
      unitRef="usd">-2614000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS05LTEtMS0xMDQzNzI_d57b428e-f6d1-4e5f-b727-6ffae97f85ab"
      unitRef="usd">8000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNS0xMC0xLTEtMTA0Mzcy_b4579838-279c-491f-a493-a8724fcb7819"
      unitRef="usd">-2606000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7267511ecf06427ca86cc16435200efe_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi03LTEtMS0xMDQzNzI_4fa20db7-43a9-468b-b27e-5d7fb90e1651"
      unitRef="usd">-674000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi04LTEtMS0xMDQzNzI_888263a2-f8ff-49e9-a844-9ea042f08d05"
      unitRef="usd">-674000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNi0xMC0xLTEtMTA0Mzcy_40689a65-3f3a-4f74-b384-36da94f9c263"
      unitRef="usd">-674000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy00LTEtMS0xMDQzNzI_9c5b0886-f3ae-423c-88c6-85176a30daca"
      unitRef="usd">32000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy04LTEtMS0xMDQzNzI_540c3089-b124-485b-a99b-16b1225302b2"
      unitRef="usd">32000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfNy0xMC0xLTEtMTA0Mzcy_7f19fb1e-02d9-4ad9-a463-6de6b054bb3c"
      unitRef="usd">32000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC0zLTEtMS0xMDQzNzI_7f32c196-c9b8-4e78-bbd1-ab091aaea375"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7ee2e9d1cfe143c3b878d6425403ed7b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC00LTEtMS0xMDQzNzI_ae0c9dd1-bfbf-4684-82be-a97f21492814"
      unitRef="usd">114000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i07aa4a40cec3445b9b7c2eae2471f420_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC01LTEtMS0xMDQzNzI_676bb5ff-d7a0-4363-b209-75bc65a9140c"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC04LTEtMS0xMDQzNzI_e8214d6e-9703-46c2-9234-0b2df876d7f9"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOC0xMC0xLTEtMTA0Mzcy_54fc64b7-8d96-4a93-9194-37349f25e5c4"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i83f8ddc382224d118c084080b79bc67f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS02LTEtMS0xMDQzNzI_42226a3e-77e6-47e0-b548-79594b1dddc0"
      unitRef="usd">436000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ieb2a52ae15ce41be8177f3e9cd288fd7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS04LTEtMS0xMDQzNzI_50d75864-4b3f-45e5-826b-234a5df9de29"
      unitRef="usd">436000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfOS0xMC0xLTEtMTA0Mzcy_07bb002e-1769-4bb5-88fa-49dee69e882f"
      unitRef="usd">436000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i0bb203cb8c1f40e4abe4b132db42c858_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTAtOS0xLTEtMTA0Mzcy_03b5e3e3-3caa-4658-8d00-f0d040436753"
      unitRef="usd">-8000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTAtMTAtMS0xLTEwNDM3Mg_02fc4e52-05c2-4c4c-809f-4b1b22cf912d"
      unitRef="usd">-8000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMS0xLTEtMTA0Mzcy_d0c22252-9747-441c-919b-5e34be30a1aa"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f5f07b61ec4fb4a68c56aec5f32d5c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMi0xLTEtMTA0Mzcy_5005597e-7f91-4d0d-a411-33ed22c32d30"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i46185672532c493c87739cf7e9615db2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMy0xLTEtMTA0Mzcy_71917695-23f4-4f44-af40-8ed318eaa671"
      unitRef="shares">179000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46185672532c493c87739cf7e9615db2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNC0xLTEtMTA0Mzcy_8de18fc3-4d86-4045-b0d5-edf8fe820235"
      unitRef="usd">-11406000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e5271352bf34c8c8a7c566cc306c6f1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNS0xLTEtMTA0Mzcy_b0d7d6c3-1a4b-4ae5-98eb-61454acf344f"
      unitRef="usd">6297000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b2b2f4c215a4c959a65859e3605344e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNi0xLTEtMTA0Mzcy_bbba24dd-6db8-4c85-9a9c-5fbc51d4f97b"
      unitRef="usd">14015000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e06fdeb2414477d921f3587f0c89a44_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtNy0xLTEtMTA0Mzcy_fa77342b-6e9c-4444-9fbd-84d3fd4e7037"
      unitRef="usd">-4054000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0218eda155249b4a4da75408a661f78_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtOC0xLTEtMTA0Mzcy_cfd6607b-b33d-4adb-9ea8-b827d488c22c"
      unitRef="usd">5535000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i315357d813df434ea52bc4a2bd057649_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtOS0xLTEtMTA0Mzcy_cd79cd48-2459-4284-b037-95eb31d0495a"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjMwZmY2ODBhNDYzYjQ1N2VhMTViYzJiNzZkOTZhZjU2L3RhYmxlcmFuZ2U6MzBmZjY4MGE0NjNiNDU3ZWExNWJjMmI3NmQ5NmFmNTZfMTEtMTAtMS0xLTEwNDM3Mg_5b48e04c-8adc-4880-81b2-8f966c5cde96"
      unitRef="usd">5579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i445ba8e9550344a6a0934d07c688931b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0xLTEtMS0xMDQzNzI_4ea53c8f-d2fe-4147-957f-6055afa9b519"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i445ba8e9550344a6a0934d07c688931b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0yLTEtMS0xMDQzNzI_0d577808-5713-462c-891a-0c703a973d6e"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if779e104e4c64cb0b90cbb72e25d9c25_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0zLTEtMS0xMDQzNzI_ecbb2a20-f01b-44dd-900f-da79151d1e96"
      unitRef="shares">184000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if779e104e4c64cb0b90cbb72e25d9c25_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy00LTEtMS0xMDQzNzI_f6ee132a-0328-49f5-9d91-baf8d80882c5"
      unitRef="usd">-11561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cfa5f433f3c41f4ad813f18db07aeb6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy01LTEtMS0xMDQzNzI_e27d5862-ac88-465d-b967-1efb508821e4"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1097bf8723ad4d40980c7a8684d82542_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy02LTEtMS0xMDQzNzI_88f5e261-0211-475a-b32d-5902483516c5"
      unitRef="usd">16658000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9566c813807f46f9bca41a6a1eab60fd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy03LTEtMS0xMDQzNzI_1d248d2d-95f9-42f1-af93-30385a4a141b"
      unitRef="usd">-3376000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i923c5d6629ac43938dde7322bca7a94f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy04LTEtMS0xMDQzNzI_1698f430-a68e-4acb-a93b-ee711a384c25"
      unitRef="usd">8494000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7adec63f56fe475aa13f80a829a783e3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy05LTEtMS0xMDQzNzI_e62d987d-e397-4758-93ba-9a8746c70b7f"
      unitRef="usd">41000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i378c9497bb354eda8c5fec775c27e410_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMy0xMC0xLTEtMTA0Mzcy_f4d26b77-993b-4ee2-889b-8b05d306a1af"
      unitRef="usd">8535000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS02LTEtMS0xMDQzNzI_6f4f9939-1dca-47ce-af6a-f4f89fd6f173"
      unitRef="usd">450000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS04LTEtMS0xMDQzNzI_b3812e40-b402-44ab-bdbf-ad04352cc47c"
      unitRef="usd">450000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS05LTEtMS0xMDQzNzI_75ee5bae-3c05-4984-a8f4-91737cdb3210"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNS0xMC0xLTEtMTA0Mzcy_2c37945e-872d-4351-872f-8e25a19ecf99"
      unitRef="usd">452000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46300513cafe40bc8da05e9ae619e87d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi03LTEtMS0xMDQzNzI_e55b1892-ddd4-4203-b012-343ae2c59716"
      unitRef="usd">-106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi04LTEtMS0xMDQzNzI_b75f2007-0b8d-4611-9ac1-a677ed806c7e"
      unitRef="usd">-106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfNi0xMC0xLTEtMTA0Mzcy_36993f9a-b050-49bf-9163-111d94cd5702"
      unitRef="usd">-106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC0zLTEtMS0xMDQzNzI_a7580a46-e809-4b2b-a759-35b3a18b17ae"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i247e8e43b72c47d7b9caf6522b208c0f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC00LTEtMS0xMDQzNzI_6c71523e-f579-4ac7-810d-ac7d4cf08d6b"
      unitRef="usd">32000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i95cbf6e7717b42ed8cd2f03aefaa9a00_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC01LTEtMS0xMDQzNzI_120f71d1-167e-4a4a-8a08-29c971a6ba34"
      unitRef="usd">41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC04LTEtMS0xMDQzNzI_2943e475-45fa-43a3-9402-3eff6ce7bb55"
      unitRef="usd">73000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOC0xMC0xLTEtMTA0Mzcy_f7b18b12-05e0-471a-8596-99384048d369"
      unitRef="usd">73000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i8fa6df7b82d3471da850c157de3722ee_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS02LTEtMS0xMDQzNzI_22f69143-40a3-4991-88fd-d3a0aaf43f0d"
      unitRef="usd">141000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i928f073ec4e143dcbe723ae42043dbac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS04LTEtMS0xMDQzNzI_f50bcf32-9f31-4f49-8e5e-563376a57685"
      unitRef="usd">141000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfOS0xMC0xLTEtMTA0Mzcy_55a88f10-5cb7-41ca-a67f-27990bdd2d95"
      unitRef="usd">141000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i0df13047b0a14d1bbc3abe910e981cf4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTAtOS0xLTEtMTA0Mzcy_6fdc263b-d282-41a8-8e9d-a0ca4bb65d7e"
      unitRef="usd">2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTAtMTAtMS0xLTEwNDM3Mg_0b0baf40-232d-4f51-8dcd-1f4abadd83a1"
      unitRef="usd">2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMS0xLTEtMTA0Mzcy_7dab8110-d10c-4182-a5fb-0e900f55dcd6"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMi0xLTEtMTA0Mzcy_64e55094-e7ad-4a34-a4ed-95ede5f915b0"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMy0xLTEtMTA0Mzcy_d66a1bbe-2868-42bc-b127-c040a6e5b7bb"
      unitRef="shares">183000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNC0xLTEtMTA0Mzcy_8a4b2dc4-39fa-4551-ae27-39885de8e7c1"
      unitRef="usd">-11529000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifebeb40172e54d468de1bba6e61fded4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNS0xLTEtMTA0Mzcy_dd6f6fd4-3a3e-4664-884a-68717be491d0"
      unitRef="usd">6131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNi0xLTEtMTA0Mzcy_f118383a-dff3-455c-ad03-0144ddc8ac07"
      unitRef="usd">16967000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie27b36ac02ab451db59daf7bc158e8b3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtNy0xLTEtMTA0Mzcy_e5e5ab4f-f30c-4486-be1e-9f9b12699f44"
      unitRef="usd">-3482000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i741c91bea17b416e8523648018b62817_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtOC0xLTEtMTA0Mzcy_fa5713c3-f3ed-4165-880f-5d1526c75e7b"
      unitRef="usd">8770000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtOS0xLTEtMTA0Mzcy_7ea1f8d4-6e9d-4aea-a1d6-cc3426238a6f"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjFhNzRlYmU2MDQ2MjQxNWJhM2Q3ZjI1YjFlNDA3OWQ4L3RhYmxlcmFuZ2U6MWE3NGViZTYwNDYyNDE1YmEzZDdmMjViMWU0MDc5ZDhfMTEtMTAtMS0xLTEwNDM3Mg_db56bd84-f09b-47e4-8c44-19a7b6b6aecf"
      unitRef="usd">8815000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7deaf997b8b04e419ae489df558eb400_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0xLTEtMS0xMDQzNzI_58f99f4c-3e63-4cc4-b015-20db7bff7c54"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7deaf997b8b04e419ae489df558eb400_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0yLTEtMS0xMDQzNzI_63684317-3a35-42c8-8142-134d3dbc6b9b"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0zLTEtMS0xMDQzNzI_08fc1b5e-f41b-40d0-bec6-2de706f6d6ce"
      unitRef="shares">179000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8f53c6faca04460ad2c24de01d0c5f5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy00LTEtMS0xMDQzNzI_bf250cea-01e6-479d-aaa7-e4f77c99961d"
      unitRef="usd">-11051000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b9bdd01dd21457c955deb29629dbb05_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy01LTEtMS0xMDQzNzI_0dc2f896-58a3-4848-bcfc-2b9803505166"
      unitRef="usd">6043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7bbc2059dee49748a9fb82ccedc2cc5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy02LTEtMS0xMDQzNzI_516dc841-dbd3-401d-9925-731562771f69"
      unitRef="usd">16328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i260874a837714dd18b6d85c063e738f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy03LTEtMS0xMDQzNzI_c6cf52ef-926f-4978-98f1-5adad15ac12a"
      unitRef="usd">-3314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i061c707fc46f4796a51c7a57108a7be4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy04LTEtMS0xMDQzNzI_752a1d19-4aec-45b0-a67c-968910fa4055"
      unitRef="usd">8689000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87069b641164461ea1d9c503986a6adb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy05LTEtMS0xMDQzNzI_4d702fec-7645-4352-8475-194e5acbe5fb"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMy0xMC0xLTEtMTA0Mzcy_c2e5cc40-6b7c-4be0-acba-a68bd2f90bc9"
      unitRef="usd">8726000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4b50155674434910931b52027a356924_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS02LTEtMS0xMDQzNzI_e3a942af-c191-4df5-ba78-e27c301a18a5"
      unitRef="usd">1046000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS04LTEtMS0xMDQzNzI_0677493d-61a3-401f-b80c-a880f7e5e98a"
      unitRef="usd">1046000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS05LTEtMS0xMDQzNzI_869bbe78-ca2f-4d1c-980e-03732fb5fd26"
      unitRef="usd">7000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNS0xMC0xLTEtMTA0Mzcy_42a2d4b8-e399-4b9c-837f-f01dd3929201"
      unitRef="usd">1053000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9a04eb3f97aa454290cf5576bef8ba31_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi03LTEtMS0xMDQzNzI_dda0ecac-33d2-4a5b-ab85-fd3e0d4b7788"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi04LTEtMS0xMDQzNzI_3848c640-ebe2-4ae4-8688-57af2bdd1d8e"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNi0xMC0xLTEtMTA0Mzcy_3be45ea8-2ff9-4215-96dd-707106147262"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy0zLTEtMS0xMDQzNzI_313c96b3-ccc0-4403-ae31-02a09c5740ad"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy00LTEtMS0xMDQzNzI_a0b53c41-a561-4e5e-8614-7c451542799f"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy04LTEtMS0xMDQzNzI_4ee792bf-4123-42e6-b57e-09baa22de22f"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfNy0xMC0xLTEtMTA0Mzcy_6fb3a87c-5006-4252-8c6a-4583851b7e8d"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC0zLTEtMS0xMDQzNzI_018f1e4c-0ac3-4490-8074-0df043c3ea95"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibc3fc4929fcb42938f7b68635c878243_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC00LTEtMS0xMDQzNzI_781debe4-290c-4f8e-8d12-e06e06da6f3d"
      unitRef="usd">122000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifcc9d6f153964e0d89122d5270df88f6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC01LTEtMS0xMDQzNzI_98c8fb8d-d997-4b28-b566-53c315b1565e"
      unitRef="usd">88000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC04LTEtMS0xMDQzNzI_9676fa95-c2d3-45ea-90fd-7b14db602f15"
      unitRef="usd">210000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOC0xMC0xLTEtMTA0Mzcy_b18aa0bf-2863-4ae2-be19-f979129125d6"
      unitRef="usd">210000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i4b50155674434910931b52027a356924_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS02LTEtMS0xMDQzNzI_5d837491-6973-4ade-9ce6-5568ed5b1965"
      unitRef="usd">407000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3b165baa9abc495fb2dfc0556e9e01b2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS04LTEtMS0xMDQzNzI_ca98c3a7-57fc-4dd0-b187-ef4d882dcc39"
      unitRef="usd">407000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfOS0xMC0xLTEtMTA0Mzcy_40bdcc74-c150-4407-9def-b80377b75d86"
      unitRef="usd">407000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i005181a12f2840cabcbe5dfd395c612a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTAtOS0xLTEtMTA0Mzcy_742cab01-6440-48c5-a83e-3709a4888777"
      unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTAtMTAtMS0xLTEwNDM3Mg_9b41724c-f8d4-47d6-a15c-770666b79b2e"
      unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMS0xLTEtMTA0Mzcy_72e9c838-7aea-426c-a585-c8e1e686d9fa"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7bfaa62f2344760ae28e0bcef715667_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMi0xLTEtMTA0Mzcy_2ec462bd-bb54-4659-98ac-9c9c5822ebf9"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMy0xLTEtMTA0Mzcy_7793f20d-f8cc-49ea-b991-db921510300b"
      unitRef="shares">183000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ce590d6794464d8f48b6882ce9967b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNC0xLTEtMTA0Mzcy_00e24390-1ece-459e-aab4-4a9f7fb49fef"
      unitRef="usd">-11529000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifebeb40172e54d468de1bba6e61fded4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNS0xLTEtMTA0Mzcy_c0b838b1-fcf4-4c44-8f21-2176469a86f8"
      unitRef="usd">6131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1e468bc4ea24e26a8b0d8b0d9021554_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNi0xLTEtMTA0Mzcy_41d12b3f-168c-489e-b148-7a6d79878ea7"
      unitRef="usd">16967000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie27b36ac02ab451db59daf7bc158e8b3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtNy0xLTEtMTA0Mzcy_63358d59-d35d-40f5-8935-13a3ef05ba9f"
      unitRef="usd">-3482000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i741c91bea17b416e8523648018b62817_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtOC0xLTEtMTA0Mzcy_6fc4fdbb-f797-493c-bfc7-55836b1c93c8"
      unitRef="usd">8770000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a3f0e5027bf41a2b415bdc65fec1db5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtOS0xLTEtMTA0Mzcy_236e176c-2a71-4066-a749-1eaa620bcf21"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yNS9mcmFnOjhkODQzODJmYTA5OTQxNDY4ZDRlZDBiZmFmOTY1YmZlL3RhYmxlOjBiMzc4YjMzMTFkNTQzYTc5N2U5MGUzNWU4MmI4YzJjL3RhYmxlcmFuZ2U6MGIzNzhiMzMxMWQ1NDNhNzk3ZTkwZTM1ZTgyYjhjMmNfMTEtMTAtMS0xLTEwNDM3Mg_c0f6e130-dc7f-4ff7-98d9-a4b44d090ca9"
      unitRef="usd">8815000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMy0xLTEtMS0xMDQzNzI_9fc390c1-aeff-481a-bb68-00f6b14dc560"
      unitRef="usd">-2606000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMy0yLTEtMS0xMDQzNzI_915acc20-cfad-4e04-ae3a-d5537b172b30"
      unitRef="usd">1053000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNS0xLTEtMS0xMDQzNzI_33b88599-ec8c-412f-ac4a-6e0a28d03f06"
      unitRef="usd">1069000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNS0yLTEtMS0xMDQzNzI_c759890d-d057-4825-83e1-9768172702c7"
      unitRef="usd">645000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNi0xLTEtMS0xMDQzNzI_2447208f-d5ca-403c-aac3-20dcbc883a55"
      unitRef="usd">-174000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNi0yLTEtMS0xMDQzNzI_25baa92d-24c7-495e-9533-649e38acaaca"
      unitRef="usd">-98000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNy0xLTEtMS0xMDQzNzI_40b499eb-a414-4f5a-bbe2-7ef1073c846d"
      unitRef="usd">122000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfNy0yLTEtMS0xMDQzNzI_12983cca-4142-493d-9ee9-2a9a232b7064"
      unitRef="usd">93000000</us-gaap:ShareBasedCompensation>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOC0xLTEtMS0xMDQzNzI_11106aec-7f65-4bba-aa1a-cd47574b50d5"
      unitRef="usd">42000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOC0yLTEtMS0xMDQzNzI_3c8d52e5-8498-41b9-9bfb-6a36af0b2871"
      unitRef="usd">77000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOS0xLTEtMS0xMDQzNzI_d90745e7-b07c-4288-9145-3f64aaa89e61"
      unitRef="usd">332000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfOS0yLTEtMS0xMDQzNzI_5fb47d66-3e7e-4678-9197-c8646263c4c7"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTE0MjAy_5f9c9e07-8ace-4104-9c22-7a89e0844f5c"
      unitRef="usd">2785000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTE0MjAy_7930858c-124c-467c-aa7c-fd7d97abe755"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTEtMS0xLTEtMTE3ODcx_077b9241-af2b-4072-80fc-255ebafa9fc7"
      unitRef="usd">-54000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTEtMi0xLTEtMTE3ODcx_4b612670-c022-4a14-a1f3-ade970d6993b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTEyNzg5_8bd10948-46e5-4af9-aae2-2e89a11644e3"
      unitRef="usd">-65000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTEyNzk3_9bf694ff-706e-457f-8442-1627af8f17e3"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMS0xLTEtMTA0Mzcy_4b746919-2d7f-4b52-9a9a-9440404e59e8"
      unitRef="usd">35000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTAtMi0xLTEtMTA0Mzcy_212b93ad-34e8-4966-8279-3ce1022897c2"
      unitRef="usd">-46000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTItMS0xLTEtMTA0Mzcy_68bb8b47-1308-4eda-94be-0a88c1fdb00e"
      unitRef="usd">116000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTItMi0xLTEtMTA0Mzcy_43bf4398-4c63-44f6-ba6d-44218d777aa8"
      unitRef="usd">128000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTMtMS0xLTEtMTA0Mzcy_eb9b3f1b-641b-45b9-933b-2d8f5b29e1ff"
      unitRef="usd">410000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTMtMi0xLTEtMTA0Mzcy_b3559316-da3f-43ef-ad31-ae3b49aa9efe"
      unitRef="usd">149000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTQtMS0xLTEtMTA0Mzcy_b1d038e9-a049-4015-af49-50a7251dad13"
      unitRef="usd">98000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTQtMi0xLTEtMTA0Mzcy_868bfaa6-2078-45d9-b7a5-57576437ea09"
      unitRef="usd">51000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTUtMS0xLTEtMTA0Mzcy_7809fba0-f8ee-40cb-892a-ae644135585a"
      unitRef="usd">84000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTUtMi0xLTEtMTA0Mzcy_41b3aab2-7647-4df3-8947-43fd385b6b76"
      unitRef="usd">14000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTYtMS0xLTEtMTA0Mzcy_3af4d443-ce95-4f20-8102-bdb5ad0abf81"
      unitRef="usd">250000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTYtMi0xLTEtMTA0Mzcy_db429e1d-151f-4d87-8ade-e39d9587fabc"
      unitRef="usd">-91000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTctMS0xLTEtMTA0Mzcy_23188747-5e53-43a7-a063-858b0536afa6"
      unitRef="usd">-92000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMTctMi0xLTEtMTA0Mzcy_f85315f6-4d3e-41ae-9187-e6a726bf832a"
      unitRef="usd">-64000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjAtMS0xLTEtMTA0Mzcy_abd538da-f71c-4c29-833f-9376f8220bfc"
      unitRef="usd">772000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjAtMi0xLTEtMTA0Mzcy_b0ff1270-596b-4cd8-95d4-197845fcc9f6"
      unitRef="usd">1529000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjItMS0xLTEtMTA0Mzcy_d9b04a16-412f-4a3a-80f0-98126283acef"
      unitRef="usd">479000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjItMi0xLTEtMTA0Mzcy_3fdda4a3-154d-466e-b03e-bd64522afd53"
      unitRef="usd">508000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjMtMS0xLTEtMTA0Mzcy_995b181e-4bfe-43af-ad58-1e33b1286594"
      unitRef="usd">206000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjMtMi0xLTEtMTA0Mzcy_3385d0f5-1060-48c7-91f8-8877aa4b835a"
      unitRef="usd">463000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjQtMS0xLTEtMTA0Mzcy_aa32e23f-97e2-4197-9dd7-7546577bfed6"
      unitRef="usd">-10000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjQtMi0xLTEtMTA0Mzcy_027f5f54-20c7-4312-9c95-acab53193089"
      unitRef="usd">-38000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjUtMS0xLTEtMTA0Mzcy_2e3ad559-d2d3-49d5-af14-f26a5ddd4931"
      unitRef="usd">-675000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjUtMi0xLTEtMTA0Mzcy_818d0d49-6eff-4021-91d3-042bec57d7b2"
      unitRef="usd">-933000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjctMS0xLTEtMTA0Mzcy_d24881e9-40ba-4e75-92ea-63373f65dbd8"
      unitRef="usd">953000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjctMi0xLTEtMTA0Mzcy_ebcc768c-221d-496a-a6d4-4140a21ee844"
      unitRef="usd">407000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjgtMS0xLTEtMTA0Mzcy_f393e2eb-07d7-4235-b6fe-bf364f4dc9e4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjgtMi0xLTEtMTA0Mzcy_b0f39b84-9e1f-4c3d-8ac3-ddb9ca1ba28a"
      unitRef="usd">50000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjktMS0xLTEtMTA0Mzcy_69e314c0-d12b-49be-a5d5-580935478bce"
      unitRef="usd">30000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMjktMi0xLTEtMTA0Mzcy_e9f956ed-8c60-4161-b8d5-b913efdd0101"
      unitRef="usd">251000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzAtMS0xLTEtMTA0Mzcy_b45c20f0-d899-4684-898f-a4317586954f"
      unitRef="usd">427000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzAtMi0xLTEtMTA0Mzcy_fc85ff2d-9bda-4239-9297-ca3bbd8301c3"
      unitRef="usd">390000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzEtMS0xLTEtMTA0Mzcy_a2a99bdc-0763-4df8-86f4-2b28f0fb4014"
      unitRef="usd">114000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzEtMi0xLTEtMTA0Mzcy_2bdf0422-a276-45a1-b5ba-2c77762d9543"
      unitRef="usd">135000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzItMS0xLTEtMTA0Mzcy_c0bf8637-5d3a-4b91-a3b6-50a66d2750f7"
      unitRef="usd">32000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzItMi0xLTEtMTA0Mzcy_70925401-501b-4a4e-b900-962f30e9f437"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzMtMS0xLTEtMTA0Mzcy_d4df023b-57d5-47f7-aed9-7f5a52be6fce"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzMtMi0xLTEtMTA0Mzcy_dd069585-f2a8-4e60-8ad9-fd4dedd70b22"
      unitRef="usd">37000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzQtMS0xLTEtMTA0Mzcy_f5b58cc9-8683-406d-bcd6-30a52f7d708a"
      unitRef="usd">-51000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzQtMi0xLTEtMTA0Mzcy_f532a139-f50d-405c-8a9b-4d2fde4c532d"
      unitRef="usd">-33000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzUtMS0xLTEtMTA0Mzcy_38d7968c-2d41-4fbe-ae5d-b54426e083bc"
      unitRef="usd">-1319000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzUtMi0xLTEtMTA0Mzcy_b0bdba8a-9188-4fd1-96ab-6867ac6fd640"
      unitRef="usd">-1031000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzYtMS0xLTEtMTA0Mzcy_b59c290f-44af-4716-aa7b-693f7e612f86"
      unitRef="usd">-130000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzYtMi0xLTEtMTA0Mzcy_94ea6e08-025f-4ec6-9d49-db92c5213c34"
      unitRef="usd">-40000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzctMS0xLTEtMTA0Mzcy_eb1ab64a-eafa-4d00-b2e2-61990a38b870"
      unitRef="usd">-1352000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzctMi0xLTEtMTA0Mzcy_a6923045-1e29-47b4-9733-210ab7e470cf"
      unitRef="usd">-475000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2"
      unitRef="usd">2956000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df"
      unitRef="usd">3736000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619"
      unitRef="usd">1604000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca"
      unitRef="usd">3261000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0xLTEtMS0xMDQzNzI_079b2a9f-e3d0-4398-ad2b-4eda308fa062"
      unitRef="usd">1601000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0yLTEtMS0xMDQzNzI_94be0923-ef82-4105-8b52-979c5113b072"
      unitRef="usd">2951000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMS0zLTEtMS0xMDQzNzI_d9b75a5b-2e5e-460c-af3f-b3984e875d92"
      unitRef="usd">3258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0xLTEtMS0xMDQzNzI_f7768519-bb2c-4e22-a7dc-277667826608"
      unitRef="usd">3000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0yLTEtMS0xMDQzNzI_5e1d6043-4a4b-458d-ac81-c3c669ff86e7"
      unitRef="usd">5000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMi0zLTEtMS0xMDQzNzI_280b5e1e-bfdb-489d-b491-54a69f2bf6e5"
      unitRef="usd">3000000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0xLTEtMS0xMDQzNzI_cd719667-030b-4e29-b488-f57d01b83b88"
      unitRef="usd">1604000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0yLTEtMS0xMDQzNzI_9307193b-a534-4e08-acdc-53dda8ac5ddd"
      unitRef="usd">2956000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOmNmMWM3MTllZjJkODQzMDc4Mjc5YzAzYmM5ZmNjMDU1L3RhYmxlcmFuZ2U6Y2YxYzcxOWVmMmQ4NDMwNzgyNzljMDNiYzlmY2MwNTVfMy0zLTEtMS0xMDQzNzI_3ba24496-0d9e-431d-ac4c-2b7b19ff4ff6"
      unitRef="usd">3261000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4NA_f4ff3dd0-b722-4660-8e36-af69364c4abb">BASIS OF PRESENTATION&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect that the challenges caused by the pandemic as well as global economic conditions, among other factors, may continue to have an adverse effect on our business.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4Ng_d51aa983-d1d1-4ef1-89a2-3eb8f9b4471b">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</us-gaap:ConsolidationPolicyTextBlock>
    <bax:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI5Mg_1a933d06-bdc6-4867-b69b-541a37cafc09">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses. Over the course of the pandemic, our business has been impacted by shifting healthcare priorities and significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  Concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to moratoriums on elective procedures and mandatory quarantines and travel restrictions), resulting in higher levels of absenteeism, including at our manufacturing and distribution facilities. Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future. &lt;/span&gt;&lt;/div&gt;We expect that the challenges caused by the pandemic as well as global economic conditions, among other factors, may continue to have an adverse effect on our business.</bax:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNC9mcmFnOmIzODk2NjEyNWY1YTQxZGM5ODNiYzRlNzg2MTZjNjQwL3RleHRyZWdpb246YjM4OTY2MTI1ZjVhNDFkYzk4M2JjNGU3ODYxNmM2NDBfNTI4Nw_44bd1175-c37c-4e69-b638-2a7063eadf0a">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNg_aab3340a-8c0c-4cb0-b134-70b23fec9ee5">ACQUISITIONS AND OTHER ARRANGEMENTS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Hillrom&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $10.5&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $12.8&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $156.00 in cash per outstanding Hillrom common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the total consideration paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to Hillrom shareholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of equity awards issued to Hillrom equity award holders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation of assets acquired and liabilities assumed has not yet been finalized as of September 30, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date. The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first nine months of 2022 we recorded measurement period adjustments, primarily impacting accounts receivable, property, plant and equipment, other intangible assets, and deferred income tax liabilities. Individually the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measurement period adjustments were not material and in total increased goodwill by $25&#160;million. The measurement period adjustments did not have a significant impact to our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill from the Hillrom acquisition, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. See Note 4 for additional information about impairments recognized in the third quarter of 2022 related to goodwill and certain intangible assets acquired in the Hillrom acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September 30, 2022, we recognized $159&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the first quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Other Business Development Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Celerity Pharmaceuticals, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2013, we entered into an agreement with Celerity Pharmaceuticals, LLC (Celerity) to develop certain acute care generic injectable premix and oncolytic products through regulatory approval. We transferred our rights in these products to Celerity and Celerity assumed ownership and responsibility for development of the products. We are obligated to purchase the individual product rights from Celerity if the products obtain regulatory approval. In December 2020, we entered into an agreement with a third party to divest our rights to one of the products that was being developed by Celerity, a generic version of liposomal doxorubicin, for less than $1&#160;million if that product were to receive regulatory approval in the U.S. and European Union in 2022. Liposomal doxorubicin is a chemotherapy medicine used to treat various types of cancer and we entered into this transaction to divest our rights to this generic version of that product after we had separately entered into a transaction to acquire the branded version. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related regulatory approvals were subsequently obtained for the generic version of liposomal doxorubicin and we recognized a loss of approximately $54&#160;million in the third quarter of 2022, representing the difference between the amount we owe Celerity following those regulatory approvals and the proceeds that we will receive from our divestiture of those product rights. That loss is reported within other operating expense (income), net in our condensed consolidated statements of operations for the three and nine months ended September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Zosyn&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $122 million currently, received specified intellectual property, including patent rights, in the first quarter and will receive additional intellectual property, including the product rights to Zosyn, in the first quarter of 2023.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $122 million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of 9 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjAw_969b9b64-847d-4a52-b5c9-e2c46cf0dfac"
      unitRef="usd">10500000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzE5_56e1ffc9-2fa9-4814-8ab4-c8e494a42bb5"
      unitRef="usd">12800000000</bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNDAw_00e8c3c2-3c74-4ce3-8a4a-d01c2fa663c5"
      unitRef="usdPerShare">156.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNw_8311c9f2-bb34-4cde-b0a3-87f6b7ad9fc7">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the total consideration paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to Hillrom shareholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of equity awards issued to Hillrom equity award holders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMS0xLTEtMS0xMDQzNzI_48f234ff-4f79-4b4e-901f-f124e76f52c4"
      unitRef="usd">10474000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMi0xLTEtMS0xMDQzNzI_1b6d5efa-289a-4d0b-a9ff-85e523c4741c"
      unitRef="usd">2000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjA5ZTVlNDRhZjNiMjRlOWM5NGQ4MmJkODNlODE1Njc0L3RhYmxlcmFuZ2U6MDllNWU0NGFmM2IyNGU5Yzk0ZDgyYmQ4M2U4MTU2NzRfMy0xLTEtMS0xMDQzNzI_0f3be8f0-ad36-424e-912a-3693ec7a89b7"
      unitRef="usd">10476000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTgw_ec23b5f6-893c-4dfe-a0db-827038add4d7"
      unitRef="usdPerShare">156.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfODAz_24ea6343-35b8-41c3-b17c-5d9a0a9440cd"
      unitRef="shares">668000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwOA_7290780f-a649-461e-88d5-518eaa4e7e43">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMi0xLTEtMS0xMDQzNzI_7914b354-9a22-4899-838c-dc3b5e3d65f2"
      unitRef="usd">399000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMy0xLTEtMS0xMDQzNzI_21e4e285-47e4-45ec-8a4c-d9c1ab2e788a"
      unitRef="usd">562000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNC0xLTEtMS0xMDQzNzI_6e62039b-a888-4efd-bbd0-d00751dadbc0"
      unitRef="usd">557000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNS0xLTEtMS0xMDQzNzI_746adf99-c778-404d-95f8-8f04f74c29cc"
      unitRef="usd">49000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNi0xLTEtMS0xMDQzNzI_cfd399e1-717e-43d3-a176-eca48f9c0ec6"
      unitRef="usd">514000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfNy0xLTEtMS0xMDQzNzI_43c25794-2db1-49b4-a29c-68df30ed6fed"
      unitRef="usd">6810000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfOC0xLTEtMS0xMDQzNzI_de45e4d4-5143-408f-834c-0530ed602341"
      unitRef="usd">6029000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfOS0xLTEtMS0xMDQzNzI_7c6d79a7-c9cf-4bba-b30f-19bce2af8f6a"
      unitRef="usd">74000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTAtMS0xLTEtMTA0Mzcy_109a9a81-8ea8-4a12-94fe-744b8138d708"
      unitRef="usd">132000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTEtMS0xLTEtMTA0Mzcy_30b1905e-33f2-452a-946e-8d91c44423e3"
      unitRef="usd">250000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTItMS0xLTEtMTA0Mzcy_b7b36bd1-b50b-4c90-a21d-5cf8c4c03982"
      unitRef="usd">140000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTMtMS0xLTEtMTA0Mzcy_50734356-c730-4c20-b409-20fef9ebb9e7"
      unitRef="usd">558000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTQtMS0xLTEtMTA0Mzcy_89424b89-d6e3-4104-8450-5bdd6debfb96"
      unitRef="usd">2118000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations>
    <bax:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTUtMS0xLTEtMTA0Mzcy_205930af-1ff5-4750-bb9f-415feb7ca825"
      unitRef="usd">57000000</bax:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTYtMS0xLTEtMTA0Mzcy_b2738c6c-d2a2-4b0f-8527-aa5d76815657"
      unitRef="usd">1527000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RhYmxlOjVlMDNiYWFkNmEwZDQwYTZiMjRiNTdjNDM2MmM1ZTM2L3RhYmxlcmFuZ2U6NWUwM2JhYWQ2YTBkNDBhNmIyNGI1N2M0MzYyYzVlMzZfMTctMS0xLTEtMTA0Mzcy_2fec46ea-777e-434c-9704-39f65bb93fff"
      unitRef="usd">10476000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMTY4Ng_db47b8e4-5755-4083-8fe8-7117f630bfb0"
      unitRef="usd">25000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i8c3ac263681644d589d0fd2aa294c3e7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjA5MA_1d2c4748-b4fe-4141-b6c1-4af68ab19886"
      unitRef="usd">159000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <bax:ProceedsFromDivestitureOfProductRights
      contextRef="i773f5845d4754661b8aab38716b10554_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTQ5NzU1ODE5MTEz_5794c376-250b-48ee-b3e1-c31eca37acb7"
      unitRef="usd">1000000</bax:ProceedsFromDivestitureOfProductRights>
    <bax:GainLossOnDispositionOfProductDivestitureArrangement
      contextRef="i1d01f750794044e794ffffe67feb1dcf_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfNTQ5NzU1ODE5MTI2_dae593fe-c1d0-4511-8024-83a32608bdf7"
      unitRef="usd">-54000000</bax:GainLossOnDispositionOfProductDivestitureArrangement>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMjY5MA_b100e751-9b6e-4efa-881b-8b0c8be050ae"
      unitRef="usd">122000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5ad206ed8b1e4d819011ef5255327a42_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzM1Ng_b100e751-9b6e-4efa-881b-8b0c8be050ae"
      unitRef="usd">122000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic8a3ba76ddc34ac9b96c72e99f2225b5_D20220301-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18zNy9mcmFnOjhlZDk5YTFhNTg5MDQwZTQ5YTRhMWQzMzFhZmY0YjVhL3RleHRyZWdpb246OGVkOTlhMWE1ODkwNDBlNDlhNGExZDMzMWFmZjRiNWFfMzUwNA_ffb94eed-e1a1-44e7-90d2-c04d0fcab328">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQy_3aa7ca60-715c-4bd9-9d6b-6909561ec61a">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, we signed a purchase agreement with a buyer to sell our corporate headquarters in Deerfield, Illinois for $52&#160;million. The related assets are classified as held-for-sale and are presented within prepaid expenses and other current assets in the accompanying consolidated balance sheet as of September 30, 2022. While the closing remains subject to the satisfaction of various closing conditions (including satisfactory completion of municipal diligence by the buyer), we expect the transaction to close in 2023 and the net book value of the assets approximates the transaction price net of estimated selling costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other (Income) Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative translation loss to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We have been winding down our operations in Argentina since early 2021 and we determined that the net assets of the related entities were substantially liquidated during the third quarter of 2022. As a result of that determination, we reclassified their $65&#160;million cumulative translation loss from accumulated other comprehensive income (loss) to other (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Non-Cash Operating and Investing Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Right-of-use operating lease assets obtained in exchange for lease obligations for the nine months ended September&#160;30, 2022 and 2021 were $59 million and $69&#160;million, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;Purchases of property, plant and equipment included in accounts payable as of September&#160;30, 2022 and 2021 were $65 million and $49 million, respectively.</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQz_6f90f232-1e4e-4ce8-944e-6b0072d99c5d">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ida2ec04c98ba4de6aac9364b884a768f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0xLTEtMS0xMDQzNzI_57ea95b3-b76d-4179-b8e1-5e52b4cf5303"
      unitRef="usd">125000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i378c9497bb354eda8c5fec775c27e410_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0yLTEtMS0xMDQzNzI_0094a29e-d91f-4587-b348-1ef0b50608a4"
      unitRef="usd">117000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi0zLTEtMS0xMDQzNzI_1300aaa3-f4e5-4462-8da7-ca375102e2e7"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfMi00LTEtMS0xMDQzNzI_99626930-c62e-46b2-ab78-df7d4b7298fb"
      unitRef="usd">125000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0xLTEtMS0xMDQzNzI_89f5d7a9-0f27-42e8-91f0-edb264dab8a7"
      unitRef="usd">2000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0yLTEtMS0xMDQzNzI_18f8a758-d050-4c27-b133-a8bb1082e1eb"
      unitRef="usd">2000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC0zLTEtMS0xMDQzNzI_ce2f677f-014a-45a7-8d75-905a07fd4580"
      unitRef="usd">11000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNC00LTEtMS0xMDQzNzI_de2f990e-d0e2-4f44-99cd-5ebbd4cbeaa5"
      unitRef="usd">-1000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0xLTEtMS0xMDQzNzI_92a97827-e026-42dd-af02-55cba607ca1e"
      unitRef="usd">2000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0yLTEtMS0xMDQzNzI_a6dcedbf-7d00-4f87-82c5-3571418e5fba"
      unitRef="usd">2000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS0zLTEtMS0xMDQzNzI_a726502c-e7c1-4228-9af3-ed67e66f237b"
      unitRef="usd">4000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNS00LTEtMS0xMDQzNzI_41e03a05-eb5c-4627-bdb0-9c4b629ad477"
      unitRef="usd">3000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0xLTEtMS0xMDQzNzI_07f3cb8e-711b-4d21-8893-b3e284851c17"
      unitRef="usd">5000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0yLTEtMS0xMDQzNzI_0c0a334f-dc73-4428-84f6-339809a88256"
      unitRef="usd">2000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi0zLTEtMS0xMDQzNzI_efaf1a2e-c2a5-4960-b150-5b16b2926e75"
      unitRef="usd">9000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNi00LTEtMS0xMDQzNzI_40f2ba37-fe11-4d93-b532-184321d2ebfc"
      unitRef="usd">6000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0xLTEtMS0xMDQzNzI_1fc62eb1-8bdc-4276-b265-5ebab150e915"
      unitRef="usd">120000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0yLTEtMS0xMDQzNzI_54a01577-f795-478b-ba5a-842be9b36d90"
      unitRef="usd">115000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy0zLTEtMS0xMDQzNzI_8623cfaf-d684-4ed6-b76a-7e377ee95594"
      unitRef="usd">120000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk4ZTg3YmYwMDg1YjQ3NjU4NDdjZTFhNDNjZDliMWQ3L3RhYmxlcmFuZ2U6OThlODdiZjAwODViNDc2NTg0N2NlMWE0M2NkOWIxZDdfNy00LTEtMS0xMDQzNzI_f385fa95-7185-4cf3-8992-a72277644ca4"
      unitRef="usd">115000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ0_9c2d7c54-df6f-40fb-9f22-02511a37a14c">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMS0xLTEtMS0xMDQzNzI_a378d7ef-ba21-4eef-8ec3-60127de62773"
      unitRef="usd">690000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMS0yLTEtMS0xMDQzNzI_0195a4dc-dcb7-420d-aa76-1dc17ae3e4ab"
      unitRef="usd">591000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMi0xLTEtMS0xMDQzNzI_f83309f9-cc8f-4c27-8c37-e0ef9636e1aa"
      unitRef="usd">305000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMi0yLTEtMS0xMDQzNzI_80e9599c-46d7-42a4-9591-6b38773571fe"
      unitRef="usd">300000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMy0xLTEtMS0xMDQzNzI_3d71fce6-befd-4f42-b988-9eb9b7e8e65e"
      unitRef="usd">1680000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfMy0yLTEtMS0xMDQzNzI_53ea4f94-ec89-4281-84f8-24fce978acad"
      unitRef="usd">1562000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfNC0xLTEtMS0xMDQzNzI_b7722255-cc4b-4738-a0d7-236d203b7fe7"
      unitRef="usd">2675000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjUxNmNiMjY5NjEzZDQwMmFhMzM2ZTI5NWNmZmE0OWMzL3RhYmxlcmFuZ2U6NTE2Y2IyNjk2MTNkNDAyYWEzMzZlMjk1Y2ZmYTQ5YzNfNC0yLTEtMS0xMDQzNzI_cdbbb413-1b2d-468a-b4bf-b540e061a342"
      unitRef="usd">2453000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ1_46f18d0b-9ab3-455d-b5bc-bb942128fbe7">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMS0xLTEtMS0xMDQzNzI_4d212620-df93-492e-82c2-b42877f7c426"
      unitRef="usd">11084000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMS0yLTEtMS0xMDQzNzI_9408e352-c61e-469b-8dd7-3e32a10a584a"
      unitRef="usd">11728000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMi0xLTEtMS0xMDQzNzI_92d445c0-b325-45e1-9272-b905f9fad524"
      unitRef="usd">6285000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMi0yLTEtMS0xMDQzNzI_85cff3f6-7a05-471b-948c-fb112ac264a9"
      unitRef="usd">6550000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMy0xLTEtMS0xMDQzNzI_4aca5a63-95f5-408f-a757-400b33118462"
      unitRef="usd">4799000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOmVlNGZmMDM0MTUxOTRlZWViNzQ4MWI4ZmM0YzFjNTRmL3RhYmxlcmFuZ2U6ZWU0ZmYwMzQxNTE5NGVlZWI3NDgxYjhmYzRjMWM1NGZfMy0yLTEtMS0xMDQzNzI_4cc6b0da-728b-4fa3-9604-a15807fc88d3"
      unitRef="usd">5178000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ia8299eafa68647eaaa8620f38dec5bf4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfMTA5OTUxMTYyOTEzOA_6b272f13-c758-4d19-aedb-a9eec7fb012f"
      unitRef="usd">52000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQ2_51cc1836-9786-46f0-af6f-8f4ef0b710d4">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi0xLTEtMS0xMDQzNzI_11eb792c-b8fa-422d-8d33-556f5330dec6"
      unitRef="usd">109000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi0yLTEtMS0xMDQzNzI_2e1a0b58-f32e-4080-890d-61485437f5b5"
      unitRef="usd">54000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi00LTEtMS0xMDQzNzI_80328a69-bc5f-4eeb-80bd-d0feed938a38"
      unitRef="usd">290000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMi01LTEtMS0xMDQzNzI_ce6c39d7-1acf-4c8c-93d8-42f1642f087e"
      unitRef="usd">128000000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeOperating
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy0xLTEtMS0xMDQzNzI_42c98f4b-0187-4987-a028-01f08607a468"
      unitRef="usd">5000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy0yLTEtMS0xMDQzNzI_241619c1-9811-48fc-b5c8-91d5446130d7"
      unitRef="usd">4000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy00LTEtMS0xMDQzNzI_3601a9a1-06ca-4db0-98de-cee6bc932202"
      unitRef="usd">12000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfMy01LTEtMS0xMDQzNzI_92f19882-fee1-4ef3-afd3-300fefe0487e"
      unitRef="usd">10000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC0xLTEtMS0xMDQzNzI_80cc3d81-31a5-4dec-9f43-ae61f515936d"
      unitRef="usd">-104000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC0yLTEtMS0xMDQzNzI_1ac508f1-ddaa-4a1b-aa5d-3d1a4398fd24"
      unitRef="usd">-50000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC00LTEtMS0xMDQzNzI_497bea1e-49bc-43cd-acf9-44700fe710bf"
      unitRef="usd">-278000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjk1OWQ3NjM2MjYxMzQ1MDg4NTVjMzE5ZmQwNTMzYjA3L3RhYmxlcmFuZ2U6OTU5ZDc2MzYyNjEzNDUwODg1NWMzMTlmZDA1MzNiMDdfNC01LTEtMS0xMDQzNzI_0eff3dfd-2daa-476c-8ba8-a819f04c7cbd"
      unitRef="usd">-118000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNzQw_793f0bfe-9372-44ab-98ca-356232ecd2eb">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other (Income) Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative translation loss to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi0xLTEtMS0xMDQzNzI_c86be3b1-4ff8-456a-a799-18df349bf2ca"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi0yLTEtMS0xMDQzNzI_5432be90-7f6c-42a9-ad14-c35592ebc150"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi00LTEtMS0xMDQzNzI_cb99e362-746c-44e4-af55-86aaa60c1ea9"
      unitRef="usd">26000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMi01LTEtMS0xMDQzNzI_4ab327d6-d26a-427f-b814-411db864bba5"
      unitRef="usd">-5000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy0xLTEtMS0xMDQzNzI_a1490333-b350-4d2f-a979-390baceacf32"
      unitRef="usd">-5000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy0yLTEtMS0xMDQzNzI_c5793760-c5bb-46af-b788-c3e11e26668f"
      unitRef="usd">4000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy00LTEtMS0xMDQzNzI_0fa2d3ce-6fa4-4742-97e0-816a23d5ceac"
      unitRef="usd">-17000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfMy01LTEtMS0xMDQzNzI_399a0bc1-444e-469c-bc31-4fc970f2fad4"
      unitRef="usd">11000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC0xLTEtMS0xMDQzNzI_5ef30a6f-79b3-4e68-9dbb-84fb972d710d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC0yLTEtMS0xMDQzNzI_7784546c-6ceb-4b84-b205-aa5b4c9b48b9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC00LTEtMS0xMDQzNzI_5866a565-a190-494a-b00c-46463d3b239c"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNC01LTEtMS0xMDQzNzI_2d4a17b5-bdc4-4d8e-a256-b2c88141b115"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS0xLTEtMS0xMDQzNzI_ec3bc19f-2b8d-485c-81f8-ce94a944e95e"
      unitRef="usd">-3000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS0yLTEtMS0xMDQzNzI_1937e009-f386-42e8-ac08-354dfc1ca0b9"
      unitRef="usd">-9000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS00LTEtMS0xMDQzNzI_cb25c5aa-9f72-44a9-8745-e3ba733d1aba"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNS01LTEtMS0xMDQzNzI_dc4e4371-07ef-4440-88ea-3c2ff5683dca"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0xLTEtMS0xMTA3ODI_93a21c7d-e67a-4e17-9da7-856264a25d6f"
      unitRef="usd">-65000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0yLTEtMS0xMTA3ODI_64d54a9d-75ff-4144-b536-7ec6ea946d2e"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi00LTEtMS0xMTA3ODI_aa51dbd3-43e6-4733-9b95-2cfeedebe2cf"
      unitRef="usd">-65000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi01LTEtMS0xMTA3ODI_07d272cc-9573-4c4c-a5b3-d92a2de5d0df"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0xLTEtMS0xMDQzNzI_8161345d-9a40-45e6-a464-fb8c3f5612b6"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi0yLTEtMS0xMDQzNzI_fb2dff7a-0448-4451-83ac-47533730f439"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi00LTEtMS0xMDQzNzI_f39415ec-b02d-46cb-8d42-341acc16a2a0"
      unitRef="usd">3000000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNi01LTEtMS0xMDQzNzI_87efdafe-2919-4913-8314-8d636022bc56"
      unitRef="usd">3000000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy0xLTEtMS0xMDQzNzI_55e8d7e9-4e46-4792-b9c8-d2064087046a"
      unitRef="usd">-63000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy0yLTEtMS0xMDQzNzI_7a34a423-4fff-4e18-8871-89bfe3845d96"
      unitRef="usd">-12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy00LTEtMS0xMDQzNzI_d48ebda5-a9cc-41b6-b664-9f68b9d1a9f4"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RhYmxlOjEyNTAzNjY0ODhjZTQwNTliMDFjYzg1NzQzNDg4ZjdiL3RhYmxlcmFuZ2U6MTI1MDM2NjQ4OGNlNDA1OWIwMWNjODU3NDM0ODhmN2JfNy01LTEtMS0xMDQzNzI_23189de1-75cd-416e-9ccd-0446f2690428"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTQ5NzU1ODE2NDc5_b66916a1-f727-4f97-934c-9297edcad602"
      unitRef="usd">65000000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNDYz_8a5c3565-d61c-4548-8c96-e951fe8027e3"
      unitRef="usd">59000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNDcw_6124d3c2-f048-4592-a84e-7af918cff25e"
      unitRef="usd">69000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i4fe91520413b489ba3c114405e761908_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTgz_d3c84ea0-9eaa-4d5a-9bb3-72c6fa975a2c"
      unitRef="usd">65000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8b30b6e6d2764728a8fb09e3396c5922_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180MC9mcmFnOmFkMmYyMTQ5OGM1MjRmYzNiMDI1OWVlZmEwNWYwNDA5L3RleHRyZWdpb246YWQyZjIxNDk4YzUyNGZjM2IwMjU5ZWVmYTA1ZjA0MDlfNTkw_bc1e4e40-c852-4d70-a93c-4dcb38fa613a"
      unitRef="usd">49000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDQ2_bb04a4ad-5b00-41e2-ad0c-b011b186c60f">GOODWILL AND OTHER INTANGIBLE ASSETS, NET&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.  We recognize a goodwill impairment charge for the amount by which a reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Goodwill Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 2, we acquired Hillrom on December 13, 2021 and recognized $6.8&#160;billion of goodwill and $6.0&#160;billion of other intangible assets, including $1.9&#160;billion of indefinite-lived intangible assets, in connection with that acquisition. Our Hillrom segment includes the following three reporting units: Patient Support Systems, Front Line Care and Surgical Solutions. During the third quarter of 2022, we performed trigger-based impairment tests of the goodwill of each of those three reporting units, as well as the indefinite-lived intangible assets, consisting primarily of trade names, that we acquired in connection with the Hillrom acquisition. We performed those tests as of September 30, 2022 due to (a) current macroeconomic conditions, including the rising interest rate environment and broad declines in equity valuations, and (b) reduced earnings forecasts for our three Hillrom reporting units, driven primarily by current shortages of certain component parts used in our products, raw materials inflation and increased supply chain costs. The impairment tests resulted in total pre-tax goodwill impairment charges of $2.8 billion in the third quarter of 2022, consisting of a $1.4 billion goodwill impairment for our Patient Support Systems reporting unit, a $1.0 billion goodwill impairment for our Front Line Care reporting unit and a $0.4 billion goodwill impairment for our Surgical &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions reporting unit. See further discussion below for information regarding intangible asset impairment charges recognized during the third quarter of 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the reporting units tested for impairment during the third quarter of 2022 were determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples. Our reporting unit fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;In process Research and Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense was $168 million and $68 million for the three months ended September&#160;30, 2022 and 2021, respectively, and $578 million and $199 million for the nine months ended September&#160;30, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Indefinite-lived Intangible Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the goodwill impairments discussed above, we recognized pre-tax impairment charges of $332&#160;million in the third quarter of 2022 to reduce the carrying amounts of certain indefinite-lived intangible assets, which related to trade names acquired in the Hillrom acquisition, to their estimated fair values. Those intangible asset impairment charges are classified within cost of sales in the accompanying condensed consolidated statements of income (loss) for the three and nine months ended September 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the indefinite-lived intangible assets tested for impairment were determined using a discounted cash flow model and significant inputs included forecasted cash flows, royalty rates and discount rates. Our indefinite-lived intangible asset fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDUy_19853c3b-c66b-41cf-be3e-3eb5d010c2c9">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i64b2b5d983114aa88c2446e0dcc3de3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0xLTEtMS0xMDQzNzI_82c5c0f1-8022-4c46-9d8d-c27fdc4d16ab"
      unitRef="usd">2517000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i481a24f4e9cf4e4caadc1f417ed82ed5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0yLTEtMS0xMDQzNzI_5628c13a-1723-430f-a22c-fdd67712adc1"
      unitRef="usd">309000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic475be483d5d490b9d25f69465a3e693_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS0zLTEtMS0xMDQzNzI_14d530c7-19d3-4f0a-b9b9-3972318104ae"
      unitRef="usd">224000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3a0372e6d36f45fc821dbc1d47cc6ea9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS00LTEtMS0xMDQzNzI_494be6f0-2b76-45a8-8b9b-023993048659"
      unitRef="usd">6786000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfMS01LTEtMS0xMDQzNzI_6435b849-8329-47fe-8159-bd092e42c661"
      unitRef="usd">9836000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0xLTEtMS0xMDQzNzI_cb0b6965-d859-4c35-9c5d-aaf9ef1f6aa0"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0yLTEtMS0xMDQzNzI_657885c6-7b3d-4c19-ae76-ba94acc1e120"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC0zLTEtMS0xMDQzNzI_507f7f87-c708-4892-87d3-8147e2cab0fb"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC00LTEtMS0xMDQzNzI_89cafbde-35c6-4372-bafd-e3e4b3eab84d"
      unitRef="usd">25000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNC01LTEtMS0xMDQzNzI_2e60e147-26c5-4855-9701-d3a04cfada94"
      unitRef="usd">25000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0xLTEtMS0xMTQyMjI_21ee9b4e-c8e1-4c1a-ac0c-ad7be69ec4e6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0yLTEtMS0xMTQyMjI_a623587d-3be2-4d49-97db-6429112407f7"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0zLTEtMS0xMTQyMjI_4ba11c24-ad35-40b2-8407-05f7b3fae956"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS00LTEtMS0xMTQyMjI_8e3d65dc-3645-4b03-87c2-9944de69e755"
      unitRef="usd">2785000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS01LTEtMS0xMTQyMjI_d802659a-0833-4463-b086-bb4b0ca6467b"
      unitRef="usd">2785000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3d6b58bd30024750aabda6b735be9efa_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0xLTEtMS0xMDQzNzI_cd7efa81-ebc9-473c-9253-e8198afda5f7"
      unitRef="usd">-241000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib7d0f952641a47cfaa3691c2ce2515e9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0yLTEtMS0xMDQzNzI_bc2d2bf1-7478-4e49-8b0b-78df705c97b4"
      unitRef="usd">-29000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i16877dc9c8664898918e2920216cd8db_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS0zLTEtMS0xMDQzNzI_fa7d81a5-8ddb-441b-9d0d-906b39db6f51"
      unitRef="usd">-22000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ie608a1e3ee114ece89dbef0acb5fb7b0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS00LTEtMS0xMDQzNzI_9ca19517-40d5-4785-9bba-119c8fa144c0"
      unitRef="usd">-145000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNS01LTEtMS0xMDQzNzI_105c58e4-b708-494e-9450-3ba0fbb7b672"
      unitRef="usd">-437000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i3de2ca57ce45464ca01c64bb1f88e3b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0xLTEtMS0xMDQzNzI_5598da2d-1585-41e2-8460-bfde003e564c"
      unitRef="usd">2276000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8ff51ea445a5436dae75f76b782ecd31_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0yLTEtMS0xMDQzNzI_6a5422af-8ff5-4e17-b6df-839e57f507a3"
      unitRef="usd">280000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0a571604800242eeb2e7147c026d48b7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi0zLTEtMS0xMDQzNzI_9b4639df-5d02-4e83-bf72-7d55456fda95"
      unitRef="usd">202000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4ee5aa4d680b44ec86fe26cdcf3bf099_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi00LTEtMS0xMDQzNzI_36ca9ccd-a17c-416c-ab44-d18ec4406dda"
      unitRef="usd">3881000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjQxYjIxYTkyZWYwZDRjOTdiYWUwYWQxZDBmZTFmZmE4L3RhYmxlcmFuZ2U6NDFiMjFhOTJlZjBkNGM5N2JhZTBhZDFkMGZlMWZmYThfNi01LTEtMS0xMDQzNzI_11d1843f-3654-4bc9-a94a-b6e7d581b15c"
      unitRef="usd">6639000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzE0_9691eaf1-8901-4d6d-bb84-25ca683f00b0"
      unitRef="usd">6800000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="if52624140cdd4ab390ee1ab86fa1bf13_I20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzI4_7345faa2-7417-4afa-a2b5-8aa4a467b630"
      unitRef="usd">6000000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzQx_2d932555-a2cc-47bc-932e-d07c9e475da8"
      unitRef="usd">1900000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i75b9dbb2b9e54f9aa29cbe19d1203ee2_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwMzg1_21a8cd08-abd0-4e47-8100-6d96804c8f56"
      unitRef="usd">2800000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i890c2ffd49774bcdb114954d3d319644_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDA3_2d0e6a38-99d7-49a0-b497-3a8625fd425c"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c3675597e4b41a9a723718dced98975_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDI5_c17bbb62-fafb-4212-a9c4-55ef729afd0a"
      unitRef="usd">1000000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2fd9fa99362a4b3da7f2454b0437871b_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMwNDQ1_65cc92a0-070d-47f9-b4d1-9e9f978794e9"
      unitRef="usd">400000000</us-gaap:GoodwillImpairmentLoss>
    <bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDQ4_827e4e4f-d8e0-4875-a2dc-d97b6bee04a1">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;In process Research and Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0xLTEtMS0xMDQzNzI_b7ca0edb-4c6f-4da2-85c4-c72c211ce9a6"
      unitRef="usd">3447000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0yLTEtMS0xMDQzNzI_c17f605e-35e2-4aef-8e39-dc6824ecb4d0"
      unitRef="usd">3752000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i20ad5d55916c462eabe316458610941a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy0zLTEtMS0xMDQzNzI_c6f4b663-7313-4bc5-82b1-b9be6e0a5f9f"
      unitRef="usd">310000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy00LTEtMS0xMDQzNzI_382e7b2b-4323-473b-96e8-d12c31784fdc"
      unitRef="usd">1578000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i74a9b9c3e62944d59dd3f29abbe86694_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy01LTEtMS0xMDQzNzI_a673c850-b126-4f68-9e34-b703022fdc58"
      unitRef="usd">213000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfMy02LTEtMS0xMDQzNzI_3498530f-cdb4-4022-b230-da99c53314bc"
      unitRef="usd">9300000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0xLTEtMS0xMDQzNzI_90e6893b-865f-4f4b-9e1a-715d3f382642"
      unitRef="usd">410000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0yLTEtMS0xMDQzNzI_8af8c826-f1f6-4aca-901c-427e7878ccf2"
      unitRef="usd">1743000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i20ad5d55916c462eabe316458610941a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC0zLTEtMS0xMDQzNzI_d698d2d1-2d46-424d-b969-a59df71fb7e2"
      unitRef="usd">220000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNC02LTEtMS0xMDQzNzI_70cda62c-4c3e-461c-aec0-c178176a6529"
      unitRef="usd">2373000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7b25966c2f794fccbcda61130bacdf1a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0xLTEtMS0xMDQzNzI_7ff162ab-626c-415b-b11e-ebb0688ce5bf"
      unitRef="usd">3037000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if7a5cf2a666444178c784c2a4e45771e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0yLTEtMS0xMDQzNzI_8b4afe5d-3056-47d4-bdbf-6f3a32c8350b"
      unitRef="usd">2009000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i20ad5d55916c462eabe316458610941a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS0zLTEtMS0xMDQzNzI_dea6b0b3-864f-47ec-9f4b-2139922ab785"
      unitRef="usd">90000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2e437c5e3bc54b3aa7d77c3ded625481_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS00LTEtMS0xMDQzNzI_7b3f5046-71a9-4097-bad6-c9647a9b2127"
      unitRef="usd">1578000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i74a9b9c3e62944d59dd3f29abbe86694_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS01LTEtMS0xMDQzNzI_0b0f8fc2-0d41-4702-bcdb-2cb153d93ed8"
      unitRef="usd">213000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNS02LTEtMS0xMDQzNzI_827f14fd-986b-4049-8eda-2e7e7d689827"
      unitRef="usd">6927000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0xLTEtMS0xMDQzNzI_45223d60-9166-4703-9a5c-60f12d15c815"
      unitRef="usd">3437000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0yLTEtMS0xMDQzNzI_59af69f8-ec52-41a1-b923-498423f5e0b2"
      unitRef="usd">3801000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy0zLTEtMS0xMDQzNzI_a228b034-e944-4320-abcb-4e0f82da0269"
      unitRef="usd">344000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i54a672818e934149a401c70ac3c8e194_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy00LTEtMS0xMDQzNzI_0fc4eed5-f769-45f5-b1e0-ae2837257325"
      unitRef="usd">1910000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iec8d99be5dd04810814673d9bb23b794_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy01LTEtMS0xMDQzNzI_a7fa6d40-54cb-4257-9259-9ab81cecab3a"
      unitRef="usd">230000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfNy02LTEtMS0xMDQzNzI_45a875ca-88a4-429c-9272-20c8a3a66711"
      unitRef="usd">9722000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0xLTEtMS0xMDQzNzI_17a21d56-bad4-429b-9e51-02cc3a7eab57"
      unitRef="usd">162000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0yLTEtMS0xMDQzNzI_59008bf4-ba0f-4fe0-91f2-88566ffbbdbc"
      unitRef="usd">1556000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC0zLTEtMS0xMDQzNzI_916f9f4e-40c7-4ff0-8a46-df9a1743a624"
      unitRef="usd">212000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOC02LTEtMS0xMDQzNzI_07091e57-2a1e-46f7-acbc-45729f5fa32e"
      unitRef="usd">1930000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib2130e393d1145f1b34fd256df79921e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0xLTEtMS0xMDQzNzI_bab41b5f-4b77-4534-8c52-8d8dcc014183"
      unitRef="usd">3275000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i895aace70e0d4238a25f2489179fc9a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0yLTEtMS0xMDQzNzI_cf687db0-64c1-499b-9cb8-55ab556c0f82"
      unitRef="usd">2245000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6865ca49209e4856bbee3881f270f09a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS0zLTEtMS0xMDQzNzI_9cdc6cd0-2cb9-47de-9bd4-c1b15d2c63de"
      unitRef="usd">132000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i54a672818e934149a401c70ac3c8e194_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS00LTEtMS0xMDQzNzI_f5e91a91-3b27-49ba-94f0-9b9825610704"
      unitRef="usd">1910000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iec8d99be5dd04810814673d9bb23b794_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS01LTEtMS0xMDQzNzI_2b760635-7090-4e50-9f5e-8b9348955a2b"
      unitRef="usd">230000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RhYmxlOjk2ZWFiMWQyZGNiOTQzY2E5YjExMTgzNWNjOGJjN2I2L3RhYmxlcmFuZ2U6OTZlYWIxZDJkY2I5NDNjYTliMTExODM1Y2M4YmM3YjZfOS02LTEtMS0xMDQzNzI_90df9b2d-1d30-4cc3-9b10-a61bf368b0a5"
      unitRef="usd">7792000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfMzM2_2b594fc9-3481-4833-8475-628389237fbe"
      unitRef="usd">168000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfMzQz_dd449737-138f-4766-a72c-44036f82c5b5"
      unitRef="usd">68000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDAy_36d5b869-df31-41e2-acb3-f58cc9b4d79e"
      unitRef="usd">578000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNDA5_43ea3d49-c6df-4b6b-a61b-f5ab601a7354"
      unitRef="usd">199000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i8a7528b6cc67470689971a1b5911d02a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180My9mcmFnOmFiODE5MjkxMmRkNjQxNWRhN2QyMzk2M2I4ZDVhZDlmL3RleHRyZWdpb246YWI4MTkyOTEyZGQ2NDE1ZGE3ZDIzOTYzYjhkNWFkOWZfNTQ5NzU1ODMxMTQ3_1522c515-c457-4c74-b7f6-7ea908d81e9d"
      unitRef="usd">332000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTk4NQ_c87a7183-3adb-4482-a305-57bce1cb7203">FINANCING ARRANGEMENTS &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Debt Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, we issued $800&#160;million of 0.868% senior notes due in 2023, $1.4&#160;billion of 1.322% senior notes due in 2024, $1.45&#160;billion of 1.915% senior notes due in 2027, $1.25&#160;billion of 2.272% senior notes due in 2028, $1.55&#160;billion of 2.539% senior notes due in 2032, $750&#160;million of 3.132% senior notes due in 2051, $300&#160;million of floating rate senior notes due in 2023 and $300&#160;million of floating rate senior notes due in 2024 (collectively, the Hillrom notes) to fund a portion of the consideration for the Hillrom acquisition, repay certain indebtedness of Hillrom and to pay fees and expenses related to the foregoing. In conjunction with the issuances of the Hillrom notes, we entered into a registration rights agreement in which we agreed to file a registration statement with the SEC with respect to an offer to exchange the Hillrom notes for new issues of notes with the same terms registered under the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Securities Act of 1933, as amended. Those exchange offers with respect to the Hillrom notes were completed in the second quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first half of 2022, we repaid $335&#160;million of our $2.0&#160;billion three-year term loan facility and $355&#160;million of our $2.0&#160;billion five-year term loan facility. The loss from the early extinguishment of this debt was not significant. In the third quarter of 2022, we amended the credit agreements governing our term loan facility and our U.S. dollar-denominated revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to delay the commencement of our net leverage ratio covenant step-down schedule until June 30, 2024. We also amended the credit agreements governing our term loan facility and our U.S. dollar denominated revolving credit facility to transition the benchmark rate from LIBOR to the Secured Overnight Financing Rate (SOFR).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2022, we repaid $203&#160;million of our 2.4% senior dues due in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. dollar-denominated revolving credit facility has a capacity of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $2.5&#160;billion&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our Euro-denominated revolving credit facility has a capacity of &#x20ac;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of September&#160;30, 2022 or December&#160;31, 2021.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, we had $275&#160;million of commercial paper outstanding with a weighted-average interest rate of 3.02% and an original weighted-average term of 49 days. As of December&#160;31, 2021, we had $300 million of commercial paper outstanding with a weighted-average interest rate of 0.27% and an original weighted-average term of 88 days.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1e434fa298bb4e53b1687deba4d7259d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTQ3_f1e4fc4d-2a32-498d-9e77-2794a287ceee"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1e434fa298bb4e53b1687deba4d7259d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTU0_d24247a9-b7b8-4dd2-90eb-d4a777cf592c"
      unitRef="number">0.00868</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i95d99d7448924622bdb9f324debce4d9_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTg0_4d19a3b2-aae0-4bd0-a7e9-605f7c54af16"
      unitRef="usd">1400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i95d99d7448924622bdb9f324debce4d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNTkx_18894c64-55a8-49a2-afd7-ddcb43f3cabd"
      unitRef="number">0.01322</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie77337e4ad4e498c948df7b374666865_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjIx_09b22a99-3a5f-4ab7-8fb4-7edd9ef22555"
      unitRef="usd">1450000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie77337e4ad4e498c948df7b374666865_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjI4_675ae5ab-8e7f-4791-ad97-818aca8acbed"
      unitRef="number">0.01915</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjU4_f99ec1b9-32bc-451b-9d3b-6c31bd0249da"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6ea4649f6e22498aa5b93b14f6fb63ea_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjY1_ac14b8dc-9fbc-4af4-b7df-dbf8ac314fcf"
      unitRef="number">0.02272</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i94dc1bd163de40399e15f75a2e3785a4_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNjk1_9f197e3a-b946-4b38-b7dd-d78b37dc193a"
      unitRef="usd">1550000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i94dc1bd163de40399e15f75a2e3785a4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzAy_e3a7e73b-2161-4119-8f33-72bb3acb3ba8"
      unitRef="number">0.02539</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i265508560c8841b293b5f093e5c37039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzMy_5fac7c4e-f4a9-4518-9f64-306f9646aff2"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i265508560c8841b293b5f093e5c37039_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzM5_2c6e482d-34d6-4bad-8bce-24b4e0e94d12"
      unitRef="number">0.03132</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iae499f05266f4e6fb214cdc0ec19a38d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwNzY5_c8744004-9f23-46c7-b111-01a52b99e336"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i33078f73774943f3a2ca47a51219a873_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODIwODE5_9035d244-8675-42b1-8b54-341e50802b3b"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3ed75a5ce2af4878b5a7a6a8436619f1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfOTU_99701dcd-3696-44c0-be68-e8c220f4bce6"
      unitRef="usd">335000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i841d5a6c0ef8487fa19e286f23e59976_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTA1_f79c9ed2-21f1-46e7-a3b2-a6ce10f0c841"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTerm
      contextRef="i841d5a6c0ef8487fa19e286f23e59976_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTA4_1b154f65-4258-4438-ba42-761ad3b3653d">P3Y</us-gaap:LongTermDebtTerm>
    <us-gaap:RepaymentsOfDebt
      contextRef="i772c3c7e174041f7bcc4ae5236f20052_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM0_59a438fc-5096-4937-adcf-880e6277df9d"
      unitRef="usd">355000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTQ0_cad58d0f-0d25-4574-8b02-59d9b7255a2d"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTerm
      contextRef="i465c9821ce6f4ff8bca778cc146e1cc2_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTQ3_22bfe922-5cde-40a2-803d-78a68f3627d5">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:RepaymentsOfDebt
      contextRef="if16f417d337d49449cd42abe3f0b4ff1_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODE2MDAw_81735cc4-86b7-4bc1-a251-d722a36e830a"
      unitRef="usd">203000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54f8b3d4953342d7bb449d644860faac_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfNTQ5NzU1ODE2MDE0_1ee4d022-2e8d-4406-bd3a-0df28dd58a25"
      unitRef="number">0.024</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTI3Mg_24abb568-7f21-4be4-afc2-3a9c9662a8e5"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM0NA_67391840-266f-4a95-a977-8e93b94d3406"
      unitRef="eur">200000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i0b888e2815b64c00a744bce83922eec7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM5OQ_1650fc20-9244-49a9-8678-ee69536a2dbb"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i33bf0a8e536c465a9ba65e612d25078b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTM5OQ_78e89211-edba-4dec-aad6-8761ff7a662d"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTcyMQ_9a87e01a-86bd-40be-ab88-88411dc19e1f"
      unitRef="usd">275000000</us-gaap:CommercialPaperAverageOutstanding>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ib88bc321114a41c986908d3eab85ded7_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTc5Nw_1423cca1-5af0-43a4-a3db-e267c0c0cc14"
      unitRef="number">0.0302</us-gaap:DebtWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="i8e507739d3784995bc2e5831628ba6d8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTg0MQ_6c32e53d-1f89-4772-9049-7b2ff050a416">P49D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTg2Mg_4493687f-d527-43fd-9e27-0dfb0a4fce97"
      unitRef="usd">300000000</us-gaap:CommercialPaperAverageOutstanding>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i3a0c4ec3de054eb99dbb0c9ef6f2e0a9_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTkzOA_8f842c4a-2b68-4095-941e-a77564e54b2c"
      unitRef="number">0.0027</us-gaap:DebtWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="i3325a024108447b9bbfde3aa8794fded_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180Ni9mcmFnOmY3NTUxYzdkNGQwNDQ1ZTc4OGU1NzI2NWJkNGFhODFlL3RleHRyZWdpb246Zjc1NTFjN2Q0ZDA0NDVlNzg4ZTU3MjY1YmQ0YWE4MWVfMTk4Mg_9caf398e-1e2e-4a68-a353-d60d09bdd3ab">P88D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfODYyMA_39d5f4d8-446d-40f4-85aa-9423300aab82">COMMITMENTS AND CONTINGENCIES &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of September&#160;30, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $31 million and $72 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#x2019; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of September&#160;30, 2022 and December&#160;31, 2021, our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;environmental reserves, which are measured on an undiscounted basis, were $17 million and $18 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2019, we and certain of our officers were named in a class action complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Ethan E. Silverman et al. v. Baxter International Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $16&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $18&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#x2019;s cooperation. We paid the penalty in the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by &lt;/span&gt;&lt;/div&gt;allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022 and filed on May 27, 2022, a motion challenging certain aspects of plaintiff's case.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjI3_eff30ca8-2ae1-4d3a-aeb7-3bc1867c9e7f"
      unitRef="usd">31000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjM0_228c9502-0614-48a1-88fd-c9431a29b321"
      unitRef="usd">72000000</us-gaap:LitigationReserve>
    <bax:SiteContingencyNumberOfSites
      contextRef="ie39c0ccc2d9f48b29fd18d7536c85b21_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfMjI0NQ_305d4804-87b9-4d3b-9be7-32ddb2152eee"
      unitRef="site">6</bax:SiteContingencyNumberOfSites>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="icc5868a9f710403f8ce9e04bed2c6144_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNTQ5NzU1ODIyNTE3_00c5d14a-9468-4a6d-b855-0f6957dd6991"
      unitRef="usd">17000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i167491d201974a2aaaea593456c7da9b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfMjg3OA_ea472607-893c-4238-a411-8df505ba9cb0"
      unitRef="usd">18000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ida0404dc815a4d388b3b0b1abd15f103_D20210112-20210112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNTI0Ng_0bbaadfe-9a92-40e5-b2e1-43f9c5673c6e"
      unitRef="usd">16000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementExpense
      contextRef="ia6f8ffc989484986a6b2a7277800a496_D20220218-20220218"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjE0NA_93d2c88c-db9c-4f97-b51b-15de0eb786df"
      unitRef="usd">18000000</us-gaap:LitigationSettlementExpense>
    <bax:LossContingencyNumberOfLawsuits
      contextRef="iac075bc7be734ce28e3cd0ade633f46d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM180OS9mcmFnOmM1M2M2MjQ0Y2YyNjQzY2VhODVkNWU1MWUwZDRiYjAyL3RleHRyZWdpb246YzUzYzYyNDRjZjI2NDNjZWE4NWQ1ZTUxZTBkNGJiMDJfNjM4OA_11937049-23f3-4a47-be22-db36a6d014d6"
      unitRef="lawsuit">2</bax:LossContingencyNumberOfLawsuits>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNzky_31b4e946-012d-4dda-99e7-21dfeedf045b">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash dividends declared per share for the three and nine months ended September&#160;30, 2022 were $0.29 and $0.86. Cash dividends declared per share for the three and nine months ended September&#160;30, 2021 were $0.280 and $0.805. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs&lt;/span&gt;&lt;/div&gt;In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first nine months of 2022, we repurchased 0.5 million shares under this authority pursuant to a Rule 10b5-1 plan.  During the first nine months of 2021, we repurchased 7.3&#160;million shares under this authority pursuant to Rule 10b5-1 plans. We had $1.3 billion remaining available under the authorization as of September&#160;30, 2022.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTEw_544343b6-b3e6-4a48-8424-70932e82dee9"
      unitRef="usdPerShare">0.29</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTE3_4d003cd1-39e6-410e-9efb-180995a0f324"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTg3_d4aed948-e4ac-45f7-869d-5bbda7939d5f"
      unitRef="usdPerShare">0.280</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMTk0_004fbed3-56fa-4c5a-8c29-8540de84398d"
      unitRef="usdPerShare">0.805</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ida6a352adaf74291ac8418e13556460b_I20120731"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMjk3_2fceea92-6eed-459c-a4a8-ce10a519de5d"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="ib2cfefd9411642a986838426ebc5fd65_I20180228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMzg2_f1b9cf1c-5da1-4e60-b8f8-343f0b1afe80"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i501f33331ff24934a4e311776d6b568e_I20161130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfMzg2_f38cfb40-05a1-421e-850a-26bb2b9ea1e3"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i0e2c054b1e504ee491a43864f0b9a4f1_I20181130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNDUw_a301714a-cfa7-4cc7-8459-fb828ef23470"
      unitRef="usd">2000000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i8c321d55d39c46389f13acfac44288a1_I20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNDkx_dd23d68d-be19-422e-82ad-7943cfbf9ba9"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNTQ5NzU1ODE0NzYw_bf6de12c-f8b9-4131-b823-d099bfa93f41"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNjY1_503638b8-25b8-4f13-8a60-6dfed5b839ca"
      unitRef="shares">7300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181Mi9mcmFnOjUxNTg1YjJkNzRiNjQyMzFhZWNiNWYzMzM3YzRmZGM1L3RleHRyZWdpb246NTE1ODViMmQ3NGI2NDIzMWFlY2I1ZjMzMzdjNGZkYzVfNzM0_255c8c00-ead9-463d-8667-cb239a2cd97f"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTQ2_96c27063-0dd1-47eb-9be7-e11e6e1f21c1">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income includes all changes in stockholders&#x2019; equity that do not arise from transactions with stockholders, and consists of net income (loss), cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative translation loss to earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Note 3 for additional information regarding the reclassification of a cumulative translation loss to earnings, Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTQ3_bb19f128-e6f6-42b3-9803-f7c2ebb07efe">&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d2d3147ec91465dbab5eeb7b6a2cd5a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0xLTEtMS0xMDQzNzI_f23b33c6-1598-47e1-a954-b3c182056ba7"
      unitRef="usd">-2907000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31930c2af24645f49542738fff75d982_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0yLTEtMS0xMDQzNzI_76cb51ed-8610-4945-9057-8ac29c35400d"
      unitRef="usd">-347000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i552ac44c09dc4a709b2712f92ae94231_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi0zLTEtMS0xMDQzNzI_1d12f4de-73b3-4a3a-89c3-7f9e91d7374d"
      unitRef="usd">-126000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5c2074ab131415892f8da221a18971e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi00LTEtMS0xMDQzNzI_17230c30-f6cc-4859-b957-8c02c38fe02b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6a288994bf043d8a63aa03aaa1625a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMi01LTEtMS0xMDQzNzI_1cb74fb5-d673-491e-ada3-994ba03a63a8"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0xLTEtMS0xMDQzNzI_c2f80d98-86c9-4995-b5fc-8810e96b8670"
      unitRef="usd">-816000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0yLTEtMS0xMDQzNzI_603bbbb5-fbe9-4ee5-9852-3d53943a19ba"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy0zLTEtMS0xMDQzNzI_eaa1b09a-6060-43ae-806e-e7da2c56098b"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy00LTEtMS0xMDQzNzI_af25713d-f031-4d27-957d-618fd1d4592f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfMy01LTEtMS0xMDQzNzI_f768eaef-91a0-475a-bf7a-0063e09b97dc"
      unitRef="usd">-752000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0xLTEtMS0xMDQzNzI_9e35dcc2-07ba-4744-adc2-78b9c050d5e0"
      unitRef="usd">-65000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0yLTEtMS0xMDQzNzI_a48420f8-3b05-4c2d-96f8-f14ac1810bb7"
      unitRef="usd">-19000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC0zLTEtMS0xMDQzNzI_10c69ed7-a3d1-4b0f-8bb9-16d39defa95b"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC00LTEtMS0xMDQzNzI_590ca64f-6d67-4b27-84cb-cd089dbbdb86"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNC01LTEtMS0xMDQzNzI_4d752467-54b7-4967-9759-0e69524ac447"
      unitRef="usd">-78000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1c96bf68e10e4ecfac1a99f80dcb4931_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0xLTEtMS0xMDQzNzI_9caae3d6-e11c-409b-ac25-63db644ef044"
      unitRef="usd">-751000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia6a46fa1b2f34496974fc4ab006f03f0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0yLTEtMS0xMDQzNzI_03f00df6-a366-4dc8-b30d-c8fe2e354dc8"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bc72876db814554b7e92b7057cde4e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS0zLTEtMS0xMDQzNzI_6f247066-b8d8-4509-83a4-906b27562b65"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1edf5496290547488b6fb150515ee067_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS00LTEtMS0xMDQzNzI_df0c56f7-af59-4828-b4f3-18ad6a534ff4"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNS01LTEtMS0xMDQzNzI_88ae344a-5873-4213-9629-f9e40d9c72e3"
      unitRef="usd">-674000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i63982438af89413496b321655eab4612_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0xLTEtMS0xMDQzNzI_1fa7226d-70ce-4d1e-b9e1-98866cac3fe7"
      unitRef="usd">-3658000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5823aeb3309544349e7a762d49f924ed_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0yLTEtMS0xMDQzNzI_631b07f1-f888-4d8b-aa76-a01be63acacb"
      unitRef="usd">-299000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2621eddb6c8b4e35b45d30c5f4117f8c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi0zLTEtMS0xMDQzNzI_3303ab61-ae5c-4c94-b5c8-5d8491d62e88"
      unitRef="usd">-99000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if77599f5408a4c88933df293d51078a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi00LTEtMS0xMDQzNzI_7ef2ca9b-5bd3-4b9d-88fc-b31d93a23c37"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7853bfd3a3f14931bd7a5fb8616f0070_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjE1NDI2YzQ5MzZmMTQwZTBhZDZkOTI2NjRiM2NlYWZlL3RhYmxlcmFuZ2U6MTU0MjZjNDkzNmYxNDBlMGFkNmQ5MjY2NGIzY2VhZmVfNi01LTEtMS0xMDQzNzI_662ce71e-367e-487a-b60e-907fc498e630"
      unitRef="usd">-4054000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifec0e1e2b8494b57a02dabe89c9521c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0xLTEtMS0xMDQzNzI_e6f47832-6493-4de2-a007-98c773d8eb21"
      unitRef="usd">-2587000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i589024ff3b0647f4aed88a63568cfbf3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0yLTEtMS0xMDQzNzI_4486604a-587e-475e-9b8c-465afd4f9894"
      unitRef="usd">-574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib62950f4131d42f3b649b1a20703c62d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi0zLTEtMS0xMDQzNzI_824af702-7332-41c6-8bfc-bac0c949cb76"
      unitRef="usd">-153000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0f53d52d2574f558f655a52b076f148_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfMi00LTEtMS0xMDQzNzI_c9d5a355-812b-4e8d-83ee-fdc24c0badc5"
      unitRef="usd">-3314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0xLTEtMS0xMDQzNzI_ceb3133f-4927-4092-85a5-5d4275a1ed29"
      unitRef="usd">-257000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0yLTEtMS0xMDQzNzI_c50fbc39-3ef2-48d9-aae3-c8e10285f9d1"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC0zLTEtMS0xMDQzNzI_d240c154-7fe4-45b1-a20d-7941745b35dd"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNC00LTEtMS0xMDQzNzI_115213ca-2570-43de-92af-3d96ccd8148f"
      unitRef="usd">-239000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0xLTEtMS0xMDQzNzI_40b6bb4e-c323-42a9-a4cb-cc4126ad7af0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0yLTEtMS0xMDQzNzI_716d7d58-b640-48bf-888e-16a5dfd2f71e"
      unitRef="usd">-50000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS0zLTEtMS0xMDQzNzI_b14ec1dc-3869-40cc-bbd3-09316cda10e7"
      unitRef="usd">-21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNS00LTEtMS0xMDQzNzI_a3600c76-bdc7-4cb8-9b98-921367cb0c88"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9230bd2c0f154f0c9b4fc5a15d354f46_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0xLTEtMS0xMDQzNzI_283e2284-59d3-41d1-8589-49af313fa1a0"
      unitRef="usd">-257000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e155f7998e54116862a41fe3e90094a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0yLTEtMS0xMDQzNzI_e0d2574f-3022-4b88-b87c-3761910c9585"
      unitRef="usd">63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7df5fe4000fa4bc7baebf848f7289eb3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi0zLTEtMS0xMDQzNzI_2e8ae987-b241-4b18-b4c2-86b54b1ddc56"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNi00LTEtMS0xMDQzNzI_e556e9fb-788b-4003-baa4-ed92c66e2761"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic37683e51faa4ef3a8d7fa7bd5e019f9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0xLTEtMS0xMDQzNzI_1dc03244-9935-4702-b2b1-37f6278b6826"
      unitRef="usd">-2844000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6c55956d7c449a997855468c8753478_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0yLTEtMS0xMDQzNzI_54a2c3ae-850c-4496-a708-431841dbf1fd"
      unitRef="usd">-511000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1e127d53ca94f5cbd11265d1621e42b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy0zLTEtMS0xMDQzNzI_8724da14-97d9-469e-b11b-811d2be987de"
      unitRef="usd">-127000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18bdd75685a84d6ea4c661c64683c09b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjc2NmE0MmI0MDhlMDQyMGY4NDg2MzNlMmY1M2YyNDZmL3RhYmxlcmFuZ2U6NzY2YTQyYjQwOGUwNDIwZjg0ODYzM2UyZjUzZjI0NmZfNy00LTEtMS0xMDQzNzI_c565d961-faa1-48ff-b5aa-ab7245ece709"
      unitRef="usd">-3482000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RleHRyZWdpb246ZjMyZWU1ODRkOTE1NDhjYzkxYTY2ZTBhNTc5NmI1MDNfOTUx_9eec5c2e-5514-4b18-a2ad-d0115d62795d">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative translation loss to earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0xLTEtMS0xMTY0MzA_df288697-8332-4341-9b64-a60cbee22a2b"
      unitRef="usd">-65000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0yLTEtMS0xMTY0MzA_948af9f8-8b25-4c66-9298-a44f89614e56"
      unitRef="usd">-65000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0xLTEtMS0xMTY0MzA_5596f6e8-0cd3-46a6-b42d-d683363e948c"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0yLTEtMS0xMTY0MzA_ffcae407-0cb7-4636-b2b9-0f39479e0b47"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i183ec29eb9814c8aafcd22abfa903a82_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0xLTEtMS0xMTY0MzA_acf0b35b-ba8e-4869-aaff-be728167c905"
      unitRef="usd">-65000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9f7c3783e84d45838caeead615497da4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0yLTEtMS0xMTY0MzA_3617861c-4d71-4429-814c-944487a8eb65"
      unitRef="usd">-65000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0xLTEtMS0xMDQzNzI_16eb1aa6-f2b7-49d4-9943-2e1fd6487825"
      unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMy0yLTEtMS0xMDQzNzI_7203f051-8d1a-4bef-a895-1514422eec23"
      unitRef="usd">-25000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0xLTEtMS0xMDQzNzI_a2682e67-38ba-435f-830d-d9ba3c9b3550"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNC0yLTEtMS0xMDQzNzI_553cae15-9bef-44c5-9226-f712d0166335"
      unitRef="usd">-6000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="id53684af0aa84e029bcfa94860cc1cff_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0xLTEtMS0xMDQzNzI_4af66a0d-87e9-4cf2-beb2-f405418fbbb1"
      unitRef="usd">-6000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i50de81fa8c0d443bb9b4d9205818577f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNS0yLTEtMS0xMDQzNzI_90538d30-6bf8-4b86-84f8-96e2c3adcbf7"
      unitRef="usd">-19000000</us-gaap:NetIncomeLoss>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibfc60984e5ff401591292f61763183a1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNy0xLTEtMS0xMDQzNzI_13cccafb-2c7f-4ca9-894e-25e65e8ab63d"
      unitRef="usd">-6000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3f4e1f314d994197aa920eacb9a953ff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfNy0yLTEtMS0xMDQzNzI_fd1fa43c-e1c5-4b7b-9f91-de1be381dab2"
      unitRef="usd">-11000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie4477b37e0684b1584a8e138855d9585_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOC0xLTEtMS0xMDQzNzI_f8af3d43-cb29-4592-8fc7-d251fcfe19fa"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ia6ca2d911f1c41fdbc37513b3ecf53c8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOC0yLTEtMS0xMDQzNzI_3eb72b34-f81f-40dd-96d7-f18f4cf794d7"
      unitRef="usd">-4000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOS0xLTEtMS0xMDQzNzI_d4722c46-2e96-4073-a81c-b4f471769c6a"
      unitRef="usd">5000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfOS0yLTEtMS0xMDQzNzI_ad7c7326-d930-4e26-aa22-78499288cfe6"
      unitRef="usd">7000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTAtMS0xLTEtMTA0Mzcy_8fa3e1ca-918b-4f06-b901-be52d6e7df40"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTAtMi0xLTEtMTA0Mzcy_bc37d424-1844-4b1c-ab97-65ddfcbb865a"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i560628e7092546e9b5c2b8d9bd42876b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTEtMS0xLTEtMTA0Mzcy_7897b5d7-2d20-448d-b527-ec778317e344"
      unitRef="usd">4000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b59d4b932614af2bc84d00b711ac06c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTEtMi0xLTEtMTA0Mzcy_f1ab6267-0fc1-4ffa-bb8b-49c19fe6c54a"
      unitRef="usd">6000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7f7d5ccda5424cd6a7bd67a5706e35ce_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTItMS0xLTEtMTA0Mzcy_8125e22f-3c89-49ed-af8f-da6c23a36583"
      unitRef="usd">-67000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i119bfe21f51144d990801b60bfeb8623_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOjhlMDRiZjgyNzBmODRlYzNhOWUyMjYxZWIwZTFlYWM2L3RhYmxlcmFuZ2U6OGUwNGJmODI3MGY4NGVjM2E5ZTIyNjFlYjBlMWVhYzZfMTItMi0xLTEtMTA0Mzcy_962ae6d3-9323-4819-8028-fe77aedfe025"
      unitRef="usd">-78000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNC0xLTEtMS0xMDQzNzI_b653667d-9b24-416a-a747-27f715fdae96"
      unitRef="usd">-21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i559c50c17138442d8746383974831721_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNC0yLTEtMS0xMDQzNzI_833d9a3a-05c6-46f8-b510-f9abfdc248ad"
      unitRef="usd">-62000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNS0xLTEtMS0xMDQzNzI_fe401265-2572-41af-bd11-1a8be74bb1ad"
      unitRef="usd">-4000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i559c50c17138442d8746383974831721_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNS0yLTEtMS0xMDQzNzI_0f70623f-caa1-4750-8fe5-22752611ddc4"
      unitRef="usd">-12000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i6a106ada68b14157abb19d516da8c3f4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNi0xLTEtMS0xMDQzNzI_0a0e6acc-0f83-4a6e-9dd6-d5119d3abf06"
      unitRef="usd">-17000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i559c50c17138442d8746383974831721_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfNi0yLTEtMS0xMDQzNzI_9da85529-e269-407b-9632-04f669d4bea7"
      unitRef="usd">-50000000</us-gaap:NetIncomeLoss>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i81178378904d4536bccf75c0f969a644_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOC0xLTEtMS0xMDQzNzI_aef061ae-a872-456c-990e-7f86dc61cf93"
      unitRef="usd">5000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i033de94989d94ca29ea116ebb6e361e7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOC0yLTEtMS0xMDQzNzI_56aec4e5-4c3c-43d2-b606-f75afbfc3e81"
      unitRef="usd">23000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4901a3b8cbbd4579a3d8a09a6999f89c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOS0xLTEtMS0xMDQzNzI_c52bfb2c-43c6-47da-b1e8-0fd968a76812"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i57d95941b3e84f7fbc4fd9c0e2f0ecf5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfOS0yLTEtMS0xMDQzNzI_8b141531-6e55-4b46-9f81-e12c1ce96eec"
      unitRef="usd">-4000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTAtMS0xLTEtMTA0Mzcy_9656a2f9-d319-4f00-89d8-8c51b1d13cbe"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTAtMi0xLTEtMTA0Mzcy_bbec37f9-cd65-4b62-8dac-fbc1a8958a96"
      unitRef="usd">-27000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTEtMS0xLTEtMTA0Mzcy_c36a1f24-ea18-4ba0-ab3c-a261ddca5c4a"
      unitRef="usd">-1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTEtMi0xLTEtMTA0Mzcy_5b52058c-bfcc-4693-aa31-1b41d019d8f2"
      unitRef="usd">-6000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="id3efaad41cba41e7af8c20a209d93254_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTItMS0xLTEtMTA0Mzcy_569bb2bf-ace8-48b7-9419-04866f9562a2"
      unitRef="usd">-5000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idfcfc825fda44e6bbeb58986b91ce50f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTItMi0xLTEtMTA0Mzcy_47e91b15-fca4-4396-a1cd-ea1d71471103"
      unitRef="usd">-21000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie18534aa529c45f286ef075afba0cf7b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTMtMS0xLTEtMTA0Mzcy_689f1a72-a150-43d3-84e9-2ed4836ae74c"
      unitRef="usd">-22000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i013b33b74c04418da6c7b638e5d50da1_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM181OC9mcmFnOmYzMmVlNTg0ZDkxNTQ4Y2M5MWE2NmUwYTU3OTZiNTAzL3RhYmxlOmEzODBkN2I2MmE3MTQ3MjJhMjcyZWE2N2M0ZTZiM2ExL3RhYmxlcmFuZ2U6YTM4MGQ3YjYyYTcxNDcyMmEyNzJlYTY3YzRlNmIzYTFfMTMtMi0xLTEtMTA0Mzcy_3320ab40-b748-4290-b0ec-80a4d5b7a288"
      unitRef="usd">-71000000</us-gaap:NetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2OQ_e4f94451-1c67-4509-8657-7e2a56e64df9">REVENUESRevenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contract&#x2019;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, we had $10.9 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 10% of this amount as revenue over the remainder of 2022, 30% in each of 2023 and 2024, 15% in 2025 and 15% thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three and nine months ended September&#160;30, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3 billion and $2.4 billion as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE4NA_4b48d30d-ec79-4a92-a7cd-7e8e20511e7a"&gt;one&lt;/span&gt; to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3MQ_ecb681a4-8097-4734-b0f9-9c8160b702fe"&gt;one&lt;/span&gt; to seven years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the nine months ended September&#160;30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Net Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our acquisition of Hillrom in December 2021, we added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net investment in sales-type leases was $95 million as of September&#160;30, 2022, of which $18 million originated in 2018 and prior, $19 million in 2019, $26&#160;million in 2020, $24 million in 2021, and $8&#160;million in 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="iac7b594f1d824d129657241335c72a8e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfODA1_41e5969b-895a-43f2-b8e5-0ad7b1eb8bc2">P30D</bax:RevenuePerformanceObligationPaymentTerms>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="if0df1ff8a1a54c22872aa4b7544e0a23_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfODA4_3090b234-1de7-4e2b-9d92-45adb81314f4">P90D</bax:RevenuePerformanceObligationPaymentTerms>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjI1NQ_379bcaf2-d789-4c1f-ba2a-e191d22c831e"
      unitRef="usd">10900000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="icbf3c6c583244c2fab2e8204429785e0_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjYzMQ_f4e4e470-81d1-41b1-b6b0-5c188f3aa9a0"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i5e89a0afa4d441e69b487b51d995257f_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjY4Ng_07ed8732-32a1-4cdf-b0a6-14ee8a869fbb"
      unitRef="number">0.30</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="if80d7ff3511a426c8ccbb5d590033061_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjY4Ng_198694e4-8687-4c6a-b8be-cd9e1e308530"
      unitRef="number">0.30</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i70cf6c6b94e648fab5b4e530b9597a22_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjcwNg_3f4593e5-0ddd-4cb1-8bd6-d6037cd97d3f"
      unitRef="number">0.15</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i6114d388ab3d4e49b91f718263e65571_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfMjcxOQ_a10dd354-18b2-4559-af42-05b4f5f820f6"
      unitRef="number">0.15</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:AccountsReceivableNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDYwNA_fa32923f-444e-4e6d-a2aa-aa8f9812eb37"
      unitRef="usd">2300000000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDYxMQ_67762e10-799c-43fb-9074-9da89aa04fd8"
      unitRef="usd">2400000000</us-gaap:AccountsReceivableNet>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i2a2c21ee9026460f83c4f80341476ca8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNDc3OQ_6eafa9d0-ba33-4b65-a80d-5d3c9f5924af">P90D</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i59f2aeeaddd4434b899181df93dd41d4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTE5MA_bbb62c7f-0688-4e03-ab0a-7b3037eed3d4">P5Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="id0750513067f4915aeadf4ccac6ac536_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfNTc3Nw_7041a13d-93e8-4c4f-be5b-4c93c13ed4ea">P7Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk3MA_58f80f0d-61ed-401c-81bd-9f3ce19e215f">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the nine months ended September&#160;30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9a7066ec33c5413cb82aa1ff74f91430_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMS0xLTEtMS0xMDQzNzI_3863bf3c-5356-4af5-a526-5675186d812b"
      unitRef="usd">65000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="if25f331f9c16441697383aa057d1019d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMS0yLTEtMS0xMDQzNzI_7f73fadd-3d75-4798-a6fc-c31808f838eb"
      unitRef="usd">50000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i8c8cc01f04c94d908c036d3fb2209bf1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMi0xLTEtMS0xMDQzNzI_96cb0270-5cc9-47ca-9d3b-f2194d451ddb"
      unitRef="usd">44000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i409ea711e6f845c490f196eb8f645359_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMi0yLTEtMS0xMDQzNzI_c8634e0b-90df-4dc7-8f0e-fd325c52c2fd"
      unitRef="usd">45000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4b3dbd2a395345e89bf32cdbb4960ffd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMy0xLTEtMS0xMDQzNzI_3f30e22f-af0d-45f5-82da-b074e47885e8"
      unitRef="usd">120000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i1d9584798cd648e6b0f68b8de0c67383_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfMy0yLTEtMS0xMDQzNzI_8e01aefd-e594-4a45-a856-5db069e11ba6"
      unitRef="usd">100000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfNC0xLTEtMS0xMDQzNzI_650edcbf-b01f-46b8-98a3-737493c994fa"
      unitRef="usd">229000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmEzNTU2NzgxMTQ3ZTRlMjJhZjllZWJlNWE0NDVlNTg0L3RhYmxlcmFuZ2U6YTM1NTY3ODExNDdlNGUyMmFmOWVlYmU1YTQ0NWU1ODRfNC0yLTEtMS0xMDQzNzI_807fb070-dd6c-47e4-aaac-e72e0e607ef5"
      unitRef="usd">195000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ibae4355d68e2490daec9fa91cb0e265a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMS0xLTEtMS0xMDQzNzI_06d3bb03-d3a3-4b11-9cf3-cf065d0b0219"
      unitRef="usd">106000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i397c997d2efa40a4914ea6ada16e1c97_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMS0yLTEtMS0xMDQzNzI_38765ac0-c362-4315-b73f-6d85772728e3"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ia9100d979f2541629d90815696db7ff7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMi0xLTEtMS0xMDQzNzI_377f906a-19a1-45b2-a61e-9376b626373d"
      unitRef="usd">123000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i3e238159a98e4530b36025474376c7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMi0yLTEtMS0xMDQzNzI_99948ff4-70ef-4c36-932f-ab6e990bd2d5"
      unitRef="usd">111000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMy0xLTEtMS0xMDQzNzI_650edcbf-b01f-46b8-98a3-737493c994fa"
      unitRef="usd">229000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfMy0yLTEtMS0xMDQzNzI_807fb070-dd6c-47e4-aaac-e72e0e607ef5"
      unitRef="usd">195000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="idbc83d9ed3ee4a2ba978e5473f9f7841_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNS0xLTEtMS0xMDQzNzI_52f9e8cd-eb63-4ff1-8964-3006f054d879"
      unitRef="usd">158000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1f24bfa3aee44280868c18852f2add00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNS0yLTEtMS0xMDQzNzI_160e5a6f-8539-443f-93fd-8dfc8fea4ed6"
      unitRef="usd">162000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if4fb2acc48954eb78b81311475eb5154_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNi0xLTEtMS0xMDQzNzI_a0a452ff-797f-4be5-9726-4ff6ecd05b8a"
      unitRef="usd">82000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9fcc59e0f14e4f539af996b7ddacaf81_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNi0yLTEtMS0xMDQzNzI_aa3f624a-13cf-43ad-aa2f-02fd4e3f810c"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNy0xLTEtMS0xMDQzNzI_88af4a7d-6383-429e-a03e-31fe9bbc823e"
      unitRef="usd">240000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmJjNDk3N2NmNzlhYTQ0ODZhOTljNjQyMWM3M2FiNDc1L3RhYmxlcmFuZ2U6YmM0OTc3Y2Y3OWFhNDQ4NmE5OWM2NDIxYzczYWI0NzVfNy0yLTEtMS0xMDQzNzI_6fb90805-2a31-4d0a-8916-2bc5bd0c9e88"
      unitRef="usd">246000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMS0xLTEtMS0xMDQzNzI_0d4a13b5-d144-43a2-a02d-00cde2acfd0d"
      unitRef="usd">246000000</us-gaap:ContractWithCustomerLiability>
    <bax:ContractWithCustomerLiabilityDeferredRevenue
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMi0xLTEtMS0xMDQzNzI_e1a8da8e-c4cb-4cc5-9648-ca2ba8d565ee"
      unitRef="usd">460000000</bax:ContractWithCustomerLiabilityDeferredRevenue>
    <bax:ContractWithCustomerLiabilityTotalRevenueRecognized
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfMy0xLTEtMS0xMDQzNzI_16de8d4c-533f-4b8a-8db9-c039057a5922"
      unitRef="usd">463000000</bax:ContractWithCustomerLiabilityTotalRevenueRecognized>
    <bax:ContractWithCustomerLiabilityCurrencyTranslation
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfNC0xLTEtMS0xMDQzNzI_6a23ee70-8153-40be-ba40-6fe3b2753bd9"
      unitRef="usd">3000000</bax:ContractWithCustomerLiabilityCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjBjZGM5MzgwYWFhZDRkY2M5YmRjYzRjNTNmZGIwYWQwL3RhYmxlcmFuZ2U6MGNkYzkzODBhYWFkNGRjYzliZGNjNGM1M2ZkYjBhZDBfNS0xLTEtMS0xMDQzNzI_d4896523-9129-4fb6-b5bc-75eb20b429b7"
      unitRef="usd">240000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2MQ_dd8de6b4-5ba2-4c27-8a2f-ac06efc454f3">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic00f9b1190024fc69e527ab0f26e42ae_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0xLTEtMS0xMDQzNzI_25015f2a-c034-4f3c-b9d9-57d815acf3cd"
      unitRef="usd">240000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1427edc253df478ab7767e33fbd20045_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0yLTEtMS0xMDQzNzI_d585cc54-1f93-446f-85e0-95e8b1e15853"
      unitRef="usd">702000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id83d13706d9146a79d73c772426d5ff8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy0zLTEtMS0xMDQzNzI_8c3f389d-3ce2-4603-a825-96f946a3c5c9"
      unitRef="usd">942000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f249df241c94811b66eb3658e39ec2d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy00LTEtMS0xMDQzNzI_25d3300b-7b0d-4e00-babf-c16fe7629b8d"
      unitRef="usd">222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if188a3e6d22a4b7db65d00970ac38a45_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy01LTEtMS0xMDQzNzI_7ad023f6-5cc5-46c6-92f1-f1a2a78ab77c"
      unitRef="usd">759000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17d172fc6220427c9f12e31cf1f52b80_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMy02LTEtMS0xMDQzNzI_6763a1aa-aa22-404c-9c46-fe79e1a67f72"
      unitRef="usd">981000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7eefbfc31c346bca35521fabb975893_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0xLTEtMS0xMDQzNzI_2e4d9e55-1216-4b6c-80e7-3899b537ccb8"
      unitRef="usd">475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b0cd3ff62c945c9ad487c37b3fd49a4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0yLTEtMS0xMDQzNzI_dd6d879f-202d-4b6a-94d9-26ba018676b3"
      unitRef="usd">250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82ec5023912a4ca5bfbb4e7fca74a490_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC0zLTEtMS0xMDQzNzI_6eaceca0-5f03-4945-8b9a-6fa1f21a6df8"
      unitRef="usd">725000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie96abd97590140b0860c8ae2063b3fc2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC00LTEtMS0xMDQzNzI_fe3f2d87-fb3a-4d46-abcd-842250ce23d8"
      unitRef="usd">490000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ee44477cbc4457bba565114bc45fa23_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC01LTEtMS0xMDQzNzI_a209523c-1e21-4049-82bd-c9c38ada28cb"
      unitRef="usd">257000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac3907c853c6419a870b4ed9a47ea65c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNC02LTEtMS0xMDQzNzI_f39fbe15-d8ed-46df-8d49-702f1260a28a"
      unitRef="usd">747000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id84f4faab40b4939b60934146442e110_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0xLTEtMS0xMDQzNzI_e4660b40-6ebc-4b90-9211-8fb2604124c4"
      unitRef="usd">173000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36134bef524d47339914de17640d4657_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0yLTEtMS0xMDQzNzI_5d047177-8565-4e42-ada2-a3feb5aba89b"
      unitRef="usd">352000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c190988faf34c569ba539990a780979_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS0zLTEtMS0xMDQzNzI_2ea990c8-2435-4674-afd8-a97d0ff1e6d9"
      unitRef="usd">525000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7778b658da74dfc820fa45dffe480a5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS00LTEtMS0xMDQzNzI_302c38dd-8533-49b7-99cd-06c261c224e0"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a4c4e29d280497495f987d4c7046864_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS01LTEtMS0xMDQzNzI_e4ff5a87-c0c0-476a-8fc1-c56bf371b2b3"
      unitRef="usd">401000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i994b7b3bd9824fcb955199e80b3d015d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNS02LTEtMS0xMDQzNzI_83e56dff-95d6-46d5-8a33-f04a519fe02a"
      unitRef="usd">589000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1684b3656ff54e7b88a81aa5ed514327_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0xLTEtMS0xMDQzNzI_3fc3194b-b4d2-4ff7-9782-09bad81a7d72"
      unitRef="usd">92000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8650d0802a0f4458b2b63e441989ada7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0yLTEtMS0xMDQzNzI_aa5bc89b-be9a-4ecc-a93f-b7f6452328d8"
      unitRef="usd">139000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2aa64b17a72543409df08e6edf8f9be4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi0zLTEtMS0xMDQzNzI_4cdb69ed-ad50-4a29-a5fa-8e0310cc99e5"
      unitRef="usd">231000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d0a55b7d81042cebc2597b4a7828ec0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi00LTEtMS0xMDQzNzI_58918824-a51f-42ba-ae8a-8a8b8cfc641f"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e39a58bafcf47698fa18eba3fd53f41_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi01LTEtMS0xMDQzNzI_fe5c0393-7aa2-4be3-89cc-a5743c4423fe"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf94a6be0e1f4c53a69e7cae23297b88_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNi02LTEtMS0xMDQzNzI_da03da4e-4436-4b14-b25d-9b8885011ebb"
      unitRef="usd">244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3be404ce95e74ed18104ee0224861b9c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0xLTEtMS0xMDQzNzI_42bab010-42b4-4495-8fcf-f2c7da279ea9"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e142953703144db8673afd8a319673d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0yLTEtMS0xMDQzNzI_676712ca-a894-4500-87bb-b137a4458c87"
      unitRef="usd">106000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec3f619d2fc04691841709d7853758c3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy0zLTEtMS0xMDQzNzI_e4d8ed4e-bcc5-4a7f-b04c-efeff9084dd0"
      unitRef="usd">247000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f7b3b26880741cc9326ad463d4a8fb2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy00LTEtMS0xMDQzNzI_bcd3a65a-add3-4fab-8ab3-07526d38a8a3"
      unitRef="usd">135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c9f8959592c42928f31e74aadef1a94_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy01LTEtMS0xMDQzNzI_69052608-9a3a-4d3f-8173-563dd0225e18"
      unitRef="usd">114000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5dd465f33414595a6a158c4dafd368f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfNy02LTEtMS0xMDQzNzI_38d7fde5-b2ae-42dd-8722-0bbe35c9ff28"
      unitRef="usd">249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99b61cb16ec84ff397f4193ae43dab64_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0xLTEtMS0xMDQzNzI_9fd221f8-da62-4173-976f-e3c13cdfc128"
      unitRef="usd">53000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic197cd11b20542f99e6be323e290d337_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0yLTEtMS0xMDQzNzI_9902b4a7-9dbb-493f-acba-d1e68f260351"
      unitRef="usd">105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c4e28760c8541dfbabc414285380144_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC0zLTEtMS0xMDQzNzI_e6b4cb45-6653-42a6-8d73-8b8fb17254fd"
      unitRef="usd">158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib35b235ca2534a9eb3695accabe2e56a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC00LTEtMS0xMDQzNzI_2c38f638-8a7a-4c28-8098-594f0d77a85d"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6bea95b582841779004ba9afa0dcbd3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC01LTEtMS0xMDQzNzI_6715798f-f713-4202-b9f2-7cd16b4d20d4"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50557c7d0a314ffd949e64496b2989ec_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOC02LTEtMS0xMDQzNzI_0b2e676b-da36-43ad-bca1-b61c5d4714ed"
      unitRef="usd">185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87c71d0b092845d79272052bbb18994f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0xLTEtMS0xMDQzNzI_441f4796-54ce-4909-b4c9-f5073251fc18"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic727ea9150bc4dc391144e09e7d7e042_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0yLTEtMS0xMDQzNzI_72847410-8999-4946-991d-834434f1687b"
      unitRef="usd">73000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1e66a2f3c8844b989c39e0f132489b7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS0zLTEtMS0xMDQzNzI_47c1059f-9199-4412-9ed4-d5a283980e62"
      unitRef="usd">172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00ee9e3ed488431ebb9c796f6637ad99_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS00LTEtMS0xMDQzNzI_feabf6c3-84eb-4d5a-abe5-e2c6f54885ff"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c1f1c2c43254a579e54a9790105bb7a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS01LTEtMS0xMDQzNzI_d16d549b-9334-4750-a9e0-a93ba7f3ce4d"
      unitRef="usd">97000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36c1df1cfb0e4a7695077dcdae7a8904_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfOS02LTEtMS0xMDQzNzI_57b04219-81e3-48c4-bb4f-5455625e1ad7"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a234e26b18540b7940a2ea492897975_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMS0xLTEtMTA0Mzcy_7fd545d9-2bb9-40d8-868f-277a0d974807"
      unitRef="usd">301000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23a8ba54205549e490a8217b028c1dd2_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMi0xLTEtMTA0Mzcy_55ccd809-b554-4dbe-9e2a-cf4610e77f13"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78097a5d3545484eb624e2a51be21d04_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtMy0xLTEtMTA0Mzcy_5cbea42b-d034-4e91-97cc-e8a67d0dec65"
      unitRef="usd">380000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i112482d56c394f9c98ec73cd18cf2fef_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNC0xLTEtMTA0Mzcy_2439adfc-43cb-4ee9-aec7-32e380de628e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fc9b003385e4853a584b34e1fa30b4c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNS0xLTEtMTA0Mzcy_aee51662-a03a-4d6a-8aee-942434a1ca1b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48e1509f4a144b719b8606c6c5a8753b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTAtNi0xLTEtMTA0Mzcy_8eb51474-78c6-423b-9589-0af207ba4de9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if689fbf349b341a9ac5411f4ddb65c4e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMS0xLTEtMTA0Mzcy_be57bf37-f012-4a4d-9772-03ca85de7fc9"
      unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad592254e2654405a98370ac967c8207_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMi0xLTEtMTA0Mzcy_760cbab9-57aa-4ba2-a213-9da173047ca4"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb64aca6929b495da3e77fc1aa3d032c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtMy0xLTEtMTA0Mzcy_7e9e62dc-753e-4a1b-aebc-9c8e2084957e"
      unitRef="usd">279000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7295ea739c464a789ba0766d968ab158_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNC0xLTEtMTA0Mzcy_cb7d9824-d66d-49fb-9fea-4235d0a8eb10"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc030e4ae0fb4916827ef25e38848ee5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNS0xLTEtMTA0Mzcy_680f9a91-fff2-4969-aebf-af42b950a7de"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i856404b99b8647e39c3633d9d681e346_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTEtNi0xLTEtMTA0Mzcy_9f9a3e1b-c947-4af1-aea0-0bdcb51198b1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73cf322b7dcd4b9db7fcc6ee06d209ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMS0xLTEtMTA0Mzcy_5370c0b0-e795-4f3d-aa98-222fc8f1fd64"
      unitRef="usd">38000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf0aab70eb4c4d9b9357a0f16a10420e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMi0xLTEtMTA0Mzcy_dddb14bc-3316-44ee-ad85-fe43dea221e2"
      unitRef="usd">38000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16e357fe9d2f4d669a14180154d0f6de_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItMy0xLTEtMTA0Mzcy_efccc9c1-f1f6-4279-8d78-97277888bd85"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7156ab3665b4bd7a5933b82974deaeb_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNC0xLTEtMTA0Mzcy_3022cf31-e715-47a3-bcd9-127dc6d82451"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia78721827a43497b8d32a902112bb683_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNS0xLTEtMTA0Mzcy_feef362a-acc8-4037-b907-f357118c258e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5eea894996f475286c69c6085cb047b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTItNi0xLTEtMTA0Mzcy_7eeca726-a935-4d5c-908a-89c161241271"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if602b15a04ab4cee94de3cc0404d3169_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMS0xLTEtMTA0Mzcy_10452609-654d-4a73-85f2-eb19089ec226"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8ca6e4d1f814edb8b3dceb8cc93f246_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMi0xLTEtMTA0Mzcy_01162595-6c1f-4015-a3a0-a58c4f5cc5dd"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c44836865d447f5a235810c1d8e5421_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtMy0xLTEtMTA0Mzcy_0097e88e-b784-4293-b9ac-fa571546027b"
      unitRef="usd">38000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae27fa4503e943d882c2b6fc4fd1b5e1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNC0xLTEtMTA0Mzcy_82aa87e8-a89b-4d3a-bd31-a5cb731b8283"
      unitRef="usd">18000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iced73c5c9a5c41689687660c8f52e324_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNS0xLTEtMTA0Mzcy_b0501894-9a60-453b-838d-98dfdb70911d"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdfecd8a92a84c1ea9f18f5a8cf72dca_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTMtNi0xLTEtMTA0Mzcy_344d4bac-01e0-4370-bce5-652ef0b1fe37"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36501cc5b8c1437bac9367d0d934737d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMS0xLTEtMTA0Mzcy_a3308d4a-ea2c-4a27-91ea-d0221e54d7fe"
      unitRef="usd">1849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6db8852c6a2a477c9de7a28fc85b2e0e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMi0xLTEtMTA0Mzcy_11d4de79-4f65-4e7c-8956-8a188f9586e2"
      unitRef="usd">1924000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtMy0xLTEtMTA0Mzcy_c8155edb-3634-4500-897f-5e8ddb61fdbd"
      unitRef="usd">3773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i445016d775dd4f209e977cbc25ca6e43_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNC0xLTEtMTA0Mzcy_09359873-80b8-4937-8ca9-9e70aba27784"
      unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9f18b4486f2427c843d513b40f25523_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNS0xLTEtMTA0Mzcy_516bd0bb-ffab-41f1-904c-485a1a92f653"
      unitRef="usd">1907000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjhiNjBlNDI3MWIxMzQ1MzZhOTZhYTYzODU4ZTlmYTVkL3RhYmxlcmFuZ2U6OGI2MGU0MjcxYjEzNDUzNmE5NmFhNjM4NThlOWZhNWRfMTQtNi0xLTEtMTA0Mzcy_ed77b74a-767b-4095-88bd-cb7b2d660db1"
      unitRef="usd">3226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5414e1e552e04f9f8c6d1c6c4b4a4fe6_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0xLTEtMS0xMDQzNzI_6a4dff6a-2119-4994-b4e7-d113480b48da"
      unitRef="usd">690000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8d34e28fa284f1ba780f48fa13f0b66_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0yLTEtMS0xMDQzNzI_042c1345-391a-4009-9d3a-0084628fa7ac"
      unitRef="usd">2077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e6724e55eb34d1790b308a597a419d2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy0zLTEtMS0xMDQzNzI_c20b8213-b0c6-402c-8083-5a258f490b67"
      unitRef="usd">2767000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05ec2539711d4ce5b8b8fed40d4c1deb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy00LTEtMS0xMDQzNzI_ef3331de-03e9-4eaf-b342-9f3d4324961f"
      unitRef="usd">655000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffaa8df2c61540d0bb50ac46d4160159_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy01LTEtMS0xMDQzNzI_cd592302-1db5-4ced-bd81-1a5540f7851d"
      unitRef="usd">2212000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b435d25b05043a6aaa5dba29add366d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMy02LTEtMS0xMDQzNzI_87d3a1f4-1267-4900-a3df-4f9e833fd18b"
      unitRef="usd">2867000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68152a8599574507a548fc0ac92e4967_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0xLTEtMS0xMDQzNzI_798ad5c9-a406-4bcb-b9d8-26f6be78f917"
      unitRef="usd">1406000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id817c0101ced4d6f99e8860b7bbf49e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0yLTEtMS0xMDQzNzI_850064f3-3d00-4c47-94da-df4f7ac4e955"
      unitRef="usd">735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6624a35872d9468488b80d9b5c5a3bbf_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC0zLTEtMS0xMDQzNzI_8ef5ffb0-9742-40e9-b9ee-3e4aaecd9a27"
      unitRef="usd">2141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifacde500ddb74a838f3cc9af62684d7c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC00LTEtMS0xMDQzNzI_c7a4956d-6d3f-4af8-b9c2-9e4affc39681"
      unitRef="usd">1345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0e1514aa7fc443080c274bc42357af8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC01LTEtMS0xMDQzNzI_bf80f62c-ec60-4eb5-95bd-ec85065e7701"
      unitRef="usd">751000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idde5b46f7b324236890c317a7886f38b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNC02LTEtMS0xMDQzNzI_2a739add-2cec-4257-b20a-5d390b7e214c"
      unitRef="usd">2096000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08864ae1bda84a668fd39b3a4061c26c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0xLTEtMS0xMDQzNzI_5474598d-6245-4885-ab44-fadd45b24282"
      unitRef="usd">494000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82c06aa2c44648eaa7913d094f119852_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0yLTEtMS0xMDQzNzI_bdfb48a1-0da8-444e-9ab8-30a0acdb5c7d"
      unitRef="usd">1080000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cda3b1cb17849b68369df08696e2ff8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS0zLTEtMS0xMDQzNzI_be1cd0d6-e87b-4166-b8d1-5aa7717047a2"
      unitRef="usd">1574000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6887a94e2824849a970f1b2b7ac88a8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS00LTEtMS0xMDQzNzI_a73c014b-4e83-44e0-965a-3ba5bc09eaee"
      unitRef="usd">550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2305248e0ec7423c9ec651a058186ca2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS01LTEtMS0xMDQzNzI_1dbf1fb8-bb6e-4acc-9c22-a70f4b643fb5"
      unitRef="usd">1137000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae35539042854319b592f855a1b59d31_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNS02LTEtMS0xMDQzNzI_d820d11f-cbc2-4595-8580-e5449195f019"
      unitRef="usd">1687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i206b2c76cea3434e9b38f340fb7d619a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0xLTEtMS0xMDQzNzI_55ab6457-4803-445f-8b6d-81b4bdd49fa8"
      unitRef="usd">266000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5bd891890ba45da8085b5e18a6d0c2d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0yLTEtMS0xMDQzNzI_aeca8624-b32d-4bbd-b19a-b3addfb073bf"
      unitRef="usd">422000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5b1d5114e8a40e58ad899a25fd25a78_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi0zLTEtMS0xMDQzNzI_2f7c29b2-16b0-4574-87af-2a4937d993e4"
      unitRef="usd">688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48883a929c674841b54b15a5dfa052c9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi00LTEtMS0xMDQzNzI_81198801-e2bd-46bd-8ccb-e51f7cd6f2f9"
      unitRef="usd">255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic709cdea2757418ba8d3eba64ac18cd3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi01LTEtMS0xMDQzNzI_c1fb7738-e5e2-4ac9-80d7-19d55ff49c20"
      unitRef="usd">460000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd006e5337d34042a30f9b2fadf77562_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNi02LTEtMS0xMDQzNzI_ebf83d34-e0c2-40ed-a167-64556de3b97c"
      unitRef="usd">715000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbe1019e59b241e586669181c4ed2172_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0xLTEtMS0xMDQzNzI_824f6069-e58e-40bc-a658-83d1a272c44c"
      unitRef="usd">428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f8f1f99c44f4480975af6d8192015a8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0yLTEtMS0xMDQzNzI_1e50dd59-098b-4d25-ad7e-7938aa3f062e"
      unitRef="usd">310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b82b81097954a6dbe91e74a172c38a0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy0zLTEtMS0xMDQzNzI_e0cbd8a2-0d8d-49bf-b2d8-ec4fee53c22b"
      unitRef="usd">738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i996157eb8f024336abb632e6241bd77b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy00LTEtMS0xMDQzNzI_b34c20d9-f1f1-4e76-a99a-71fead009162"
      unitRef="usd">405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c72c96c8e434f6ca045344246edcf0d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy01LTEtMS0xMDQzNzI_d5a881d8-038f-402c-90e6-67dbd68c449b"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc5d4575471c419c84ba4bf97ce903ce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfNy02LTEtMS0xMDQzNzI_1c9b0f38-abf7-471e-9dbb-2ad30d1633f8"
      unitRef="usd">722000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdae4e4c5a5242a1b88940fdea051045_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0xLTEtMS0xMDQzNzI_00e04b5d-60a4-4b41-928f-124ce3901b56"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia250b656d037452f82c80809f1305d0e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0yLTEtMS0xMDQzNzI_dbfad7d7-bb96-49f3-9121-c73aaf4b371b"
      unitRef="usd">340000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59b4ff6ffd414f62bb45cf05a387070d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC0zLTEtMS0xMDQzNzI_b148f43b-39c6-4c63-97e1-40f9ae2b6f1f"
      unitRef="usd">519000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1240a78f95a245e8a86128ad258992e2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC00LTEtMS0xMDQzNzI_6fb7170d-0330-43f0-b29e-d344e7ed59aa"
      unitRef="usd">211000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc4c7a30b47c41748e6634ad3c972b6a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC01LTEtMS0xMDQzNzI_c497809e-119b-4e15-ad0b-e8a9c4b242ff"
      unitRef="usd">369000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a3ae3d6aa2b4d09a6a8a1fd463caf0c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOC02LTEtMS0xMDQzNzI_0617ad95-0083-4bf0-b5ee-cc8825384917"
      unitRef="usd">580000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bda2e702c6e44df89b96f76ad8d15ab_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0xLTEtMS0xMDQzNzI_218d274a-23c7-4a27-934a-a90800c04099"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id08ebd120d464decaaf14ac1fb137424_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0yLTEtMS0xMDQzNzI_e84d81f9-484a-4be7-958c-4776c90e771e"
      unitRef="usd">265000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e2d778f29a0499e8266532cb33dc627_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS0zLTEtMS0xMDQzNzI_3d2568f3-64a5-4352-b749-61777be7fe7d"
      unitRef="usd">491000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3090e8c3fda94423a0d0912d50961819_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS00LTEtMS0xMDQzNzI_3a9dcad8-6953-4262-9854-7e114683ba28"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8e3034fc19a412ea43aa1cfb0412fc7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS01LTEtMS0xMDQzNzI_b7a59e63-9742-4bda-8757-81f9b209b202"
      unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9dae84b5f6a4563bdf623ffa56038af_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfOS02LTEtMS0xMDQzNzI_df3a70c5-75fe-4fe2-92d9-2cd316005d8d"
      unitRef="usd">524000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6df3f4f4414c4f44918ed058594a3a6d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMS0xLTEtMTA0Mzcy_320decb3-1b02-48b2-83a6-50877ea817d6"
      unitRef="usd">880000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idaddecfa588c45dbbd695699ea74db2e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMi0xLTEtMTA0Mzcy_68bb2de5-b678-42e1-abba-483e302b32d3"
      unitRef="usd">247000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26a0261aa0654089bb88fbb3d2a3a069_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtMy0xLTEtMTA0Mzcy_3ce0db28-cb34-41b2-8bb1-8dcdc06cc1e9"
      unitRef="usd">1127000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b80e53eaaf246c0a006f99d6c332ef9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNC0xLTEtMTA0Mzcy_98ea20d1-5d0c-4299-b002-2429b283a7f3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82485fb2469a47ecbb6c7c2217dbedb5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNS0xLTEtMTA0Mzcy_667f511d-f077-4c12-aec6-4928ee0e5498"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87c244391ad84185a8d527720e081a70_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTAtNi0xLTEtMTA0Mzcy_0e9da41d-0773-4602-9e81-c20fc9e43c3c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i428120bbc00c4484801fe373fa42a492_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMS0xLTEtMTA0Mzcy_a189b3ea-3f34-4644-8d49-9efbf8c6ec09"
      unitRef="usd">618000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e9603e0fe354ab996f5149cb7753360_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMi0xLTEtMTA0Mzcy_ac72e75a-4eb0-42b9-af7a-071e90eaecd8"
      unitRef="usd">237000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2b0d89fe81948dbad94f24b2081b1fd_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtMy0xLTEtMTA0Mzcy_d929f84a-6344-4b98-a607-069e2546ddbd"
      unitRef="usd">855000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddbc08f9e34a4424a04357d4ff58fd2b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNC0xLTEtMTA0Mzcy_2dc3cda3-7c63-4e65-8e2f-6163aa1e66a5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia34ea41012e54e3a8847c03a4116d7c5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNS0xLTEtMTA0Mzcy_c5239733-72e1-448e-b4d2-c81fdef8bfb3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i983f956742e148cd9935461bf9c57d85_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTEtNi0xLTEtMTA0Mzcy_8545d7d0-f853-46fc-9a31-5821ea6f29a7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafa57853da33460a929d418073a4e5ef_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMS0xLTEtMTA0Mzcy_e65c97aa-221d-4227-8f15-f4857b41f40c"
      unitRef="usd">111000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7764dcb4d84344eab48a05c00972e9ca_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMi0xLTEtMTA0Mzcy_856ca449-3761-4fe7-9176-2537c4ad6d23"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79060a21825446f68e990e404b003293_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItMy0xLTEtMTA0Mzcy_672bd16d-a0fa-484f-a300-3c0f0bb81e57"
      unitRef="usd">223000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2e5727a5d734abc8a8eceb71d05ff40_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNC0xLTEtMTA0Mzcy_d7bd95f7-5b9a-4241-80a0-f79706cb2da7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e28f51eca1f4bd9b296c01f4220bd6a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNS0xLTEtMTA0Mzcy_4a134f79-9a31-49f1-8154-317ea8785042"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia374726d39fe4c0c815368587eed129e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTItNi0xLTEtMTA0Mzcy_8594901c-0e84-49c3-9ff5-670e434aef58"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i000aac4b4eb74546bf63b572c100248c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMS0xLTEtMTA0Mzcy_ca184bfa-ca57-41be-ae3b-437ccfb44d5c"
      unitRef="usd">72000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic27396433bf44b738da6b78bd6987adc_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMi0xLTEtMTA0Mzcy_c6bfc022-c87a-4f89-9658-686eddc58ba4"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cd580e555ab485aa20157d901745b91_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtMy0xLTEtMTA0Mzcy_e24da694-7a6d-4751-bc6b-eaa62e654be2"
      unitRef="usd">103000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18ee0893dd9643fdbf0354b01a632557_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNC0xLTEtMTA0Mzcy_57806091-f010-4c45-9f30-91009481d933"
      unitRef="usd">58000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icadc946e2caf484fa6388e999c80bef3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNS0xLTEtMTA0Mzcy_a87f82cc-d6a4-4e0a-a01d-041066fde523"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3361742ed1c42fbbb2de2275dd10be2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTMtNi0xLTEtMTA0Mzcy_a894111a-e49f-4f6a-b35f-dc4f01a5c8c3"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe7dc69941344244b7589680ec54ee1d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMS0xLTEtMTA0Mzcy_97a79fba-cf65-4487-833e-8979a30226d6"
      unitRef="usd">5370000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe952d9c345f44f88320bf99c72fbf4b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMi0xLTEtMTA0Mzcy_8775565c-4480-4b37-9879-d251dc27e899"
      unitRef="usd">5856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtMy0xLTEtMTA0Mzcy_03893772-8d75-431c-b31a-5fbe72069d9a"
      unitRef="usd">11226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice50f6d87c71414ca4f9c37b27e16086_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNC0xLTEtMTA0Mzcy_ec47bd61-d5fe-4e72-998f-1ef60ea395b5"
      unitRef="usd">3697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04c354156cd54db0bdb335313ca518aa_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNS0xLTEtMTA0Mzcy_63f2a3e6-fb60-4417-8e80-76edc6cb6075"
      unitRef="usd">5573000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOjYzNDZhNzY2MGNkZjRlYjc4MWZlMzA4M2RkZWI2OWIzL3RhYmxlcmFuZ2U6NjM0NmE3NjYwY2RmNGViNzgxZmUzMDgzZGRlYjY5YjNfMTQtNi0xLTEtMTA0Mzcy_9333efce-8e1c-4b15-a6da-ce7859af51a3"
      unitRef="usd">9270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2Mw_50981d4d-e5b2-4496-af48-034839d5dca9">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk2Mw_df27d8ca-e235-43af-acdd-bfe9a1ad86d2">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three and nine months ended September&#160;30, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMS0xLTEtMS0xMDQzNzI_8533dfec-e020-400e-a1b9-5a7c3e26ef8a"
      unitRef="usd">3000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMS0yLTEtMS0xMDQzNzI_dd7dd0b6-74da-4140-b429-b09b21ae72d3"
      unitRef="usd">11000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMi0xLTEtMS0xMDQzNzI_cea9b107-807c-4df3-b029-84626054d9dc"
      unitRef="usd">145000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMi0yLTEtMS0xMDQzNzI_53c60cd5-4f76-4e98-a4d2-21abed7fe3d3"
      unitRef="usd">380000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMy0xLTEtMS0xMDQzNzI_44fe5695-5fff-40a1-b9f1-ff5098905373"
      unitRef="usd">9000000</us-gaap:VariableLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfMy0yLTEtMS0xMDQzNzI_4fe0e633-f604-4642-abf7-bf833a160cfb"
      unitRef="usd">41000000</us-gaap:VariableLeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfNC0xLTEtMS0xMDQzNzI_5dd6f741-8af0-4e80-af2c-a9c0578fc370"
      unitRef="usd">157000000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4ZDM2MWM4NmVhNzRjNGQ5MTViYWQzYzc3NWIyZTliL3RhYmxlcmFuZ2U6YThkMzYxYzg2ZWE3NGM0ZDkxNWJhZDNjNzc1YjJlOWJfNC0yLTEtMS0xMDQzNzI_19ec945e-1b70-4710-a1d3-c39610dc30e7"
      unitRef="usd">432000000</us-gaap:LeaseIncome>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMS0xLTEtMS0xMDQzNzI_289e9a11-b5ac-49b5-bd6b-92d7fd62c86f"
      unitRef="usd">3000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMS0yLTEtMS0xMDQzNzI_f96238e3-e41f-4ce0-8d6f-f9e0515fec06"
      unitRef="usd">19000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMi0xLTEtMS0xMDQzNzI_1bf9fd10-950a-44d9-bb68-620122f24f8c"
      unitRef="usd">21000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMi0yLTEtMS0xMDQzNzI_b4ecd74b-0220-4760-9666-5031174bd3a9"
      unitRef="usd">90000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMy0xLTEtMS0xMDQzNzI_a87bd469-ab24-417e-bfdf-274ac20fcdb3"
      unitRef="usd">27000000</us-gaap:VariableLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfMy0yLTEtMS0xMDQzNzI_7263bf0a-0cdf-456c-8e46-eb444b4a6256"
      unitRef="usd">59000000</us-gaap:VariableLeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfNC0xLTEtMS0xMDQzNzI_cb7386aa-9119-420e-83b2-ccb63a192092"
      unitRef="usd">51000000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RhYmxlOmE4N2NjNTAyYzM4YTRhOTU4MjNiMGQ2ZDJmMDA2ZWUzL3RhYmxlcmFuZ2U6YTg3Y2M1MDJjMzhhNGE5NTgyM2IwZDZkMmYwMDZlZTNfNC0yLTEtMS0xMDQzNzI_80fdfd41-4873-4ef0-9d96-f884a1ad6eae"
      unitRef="usd">168000000</us-gaap:LeaseIncome>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTg1NQ_5d83e405-5b05-439e-8295-cd8ce93ee0ca"
      unitRef="usd">95000000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="ia15c872355344ae39ce7dd39d2d327e4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTg3Nw_20bd2d43-6472-4a5d-a72d-cd52e34f6a63"
      unitRef="usd">18000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="if78a45e31e0c4f4d810fb14d428a91ce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkxMA_ec0e0fe8-12d6-4f1e-9bd4-db981173e252"
      unitRef="usd">19000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="ife1a4f269c63413dab2f7eff8c7b4525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkyMg_0630a25e-f294-413c-9a4f-9f168ba596f9"
      unitRef="usd">26000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTkzNA_b75244ea-e685-446d-aba9-b550510a20a4"
      unitRef="usd">24000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182MS9mcmFnOmYyZDNkMGIwMmRjYzQ0N2ZiMmZmMTYxNGEyYjVkNzI5L3RleHRyZWdpb246ZjJkM2QwYjAyZGNjNDQ3ZmIyZmYxNjE0YTJiNWQ3MjlfOTk1MA_c0766c85-2eae-4c16-8b2b-2c5ec742d6d7"
      unitRef="usd">8000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxNg_e0719b4a-cb4e-4a70-b608-66d245913b65">BUSINESS OPTIMIZATION CHARGES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through September&#160;30, 2022, we have incurred cumulative pre-tax costs of $1.4 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $14 million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related to our integration of Hillrom, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For segment reporting purposes, business optimization charges are unallocated expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs to implement business optimization programs for the three and nine months ended September&#160;30, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;amp;A expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our restructuring liabilities as of September&#160;30, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfNjQ2_83c40e17-d4d1-4b1f-9875-cedb96200d96"
      unitRef="usd">1400000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfOTc3_5ef009b2-c53c-44e6-8705-f76cb3ff0820"
      unitRef="usd">14000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bax:BusinessOptimizationChargeTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxMQ_4d7930ee-8f8e-4a44-a699-d7369785e967">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:BusinessOptimizationChargeTableTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi0xLTEtMS0xMDQzNzI_10286021-9a5c-4783-be64-b933dc9f2656"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi0yLTEtMS0xMDQzNzI_cff95e95-3d53-4dcd-bd2c-e5f6e87a5871"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi00LTEtMS0xMDQzNzI_5cd5db9b-4a5f-4377-8c9f-f72175e09e3a"
      unitRef="usd">150000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMi01LTEtMS0xMDQzNzI_370dd891-1fbe-40bd-aae0-0bd11b3e51b8"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy0xLTEtMS0xMDQzNzI_1638836e-6845-4283-a6f1-e80ee193b4dd"
      unitRef="usd">16000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy0yLTEtMS0xMDQzNzI_7b6844e9-0d2e-4b1c-b345-48feb7d8c0d9"
      unitRef="usd">4000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy00LTEtMS0xMDQzNzI_382f9ce3-c5c6-4d72-9ca0-0d4ef63b03bd"
      unitRef="usd">46000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfMy01LTEtMS0xMDQzNzI_e3ea35d4-d53f-4e4f-8e2b-64bf0cad4f33"
      unitRef="usd">14000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringCosts
      contextRef="ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS0xLTEtMS0xMDQzNzI_096170c8-2abc-47f3-9b58-af3599ddcfd9"
      unitRef="usd">73000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ifc06387a4f544444a7bbab606971c606_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS0yLTEtMS0xMDQzNzI_7696429b-bc28-4a07-b0cc-a3739ac30aff"
      unitRef="usd">36000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i918c71be12f94ae78f91f363866ba727_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS00LTEtMS0xMDQzNzI_3a51371f-2af9-4f87-a7ad-88cfe82cbfda"
      unitRef="usd">196000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i7db0c602954d494f9644c4e35d5e7754_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjQzOTcyMTZjZDBjODQ4NTViOTE0OWM5NjU3MWQyYWFiL3RhYmxlcmFuZ2U6NDM5NzIxNmNkMGM4NDg1NWI5MTQ5Yzk2NTcxZDJhYWJfNS01LTEtMS0xMDQzNzI_d18a757b-343b-4c2d-8bcb-a8296a4c51bc"
      unitRef="usd">81000000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxMw_ce05f7ca-44fe-4e85-8008-696edddb20a0">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022 and 2021, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i45a632ba481346bdaf99d141baafe749_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0xLTEtMS0xMDQzNzI_a466f7f0-3725-405e-b4c3-ee9b82b46894"
      unitRef="usd">13000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i17907bd75b564e249364985141865dee_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0yLTEtMS0xMDQzNzI_236b520f-3d14-4da4-8588-6625703b487d"
      unitRef="usd">36000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id66df73b2bcb44c6ab4532b0c9ab728b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi0zLTEtMS0xMDQzNzI_89185888-85e5-4355-9a65-77b70f0e705f"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iea336d5c32bc4861902104cb153044f3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMi00LTEtMS0xMDQzNzI_79199f57-4a19-41cb-8af0-1366991e2459"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i697542fa1b0a4a98875df15a602c28ec_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0xLTEtMS0xMDQzNzI_9fb23a9f-6bbc-48b7-9d4f-ccdfbe3cadf4"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i09cba0015a754f508a844041cd9e4b69_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0yLTEtMS0xMDQzNzI_5d7ab0bd-5043-4eab-a556-3b6f7b0cb8a9"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if55f3be8e44b4bfa864a27180b621ed9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy0zLTEtMS0xMDQzNzI_2c763b8e-cde3-4d09-8850-9d999eb989c7"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2e1f45adb51d457aa5725c517e737b84_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfMy00LTEtMS0xMDQzNzI_5ee1c5c7-afa4-4ae5-9cf1-6d8f1e1539e8"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2588cc62cb4d48b7a46b738e92f4072f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0xLTEtMS0xMDQzNzI_5950e29c-5767-47fa-bbf6-684adcb29398"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99d230df90c142c884206af10ef9f8fc_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0yLTEtMS0xMDQzNzI_41a09ccf-cb4b-4fee-a8d1-e083185ae258"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7199ae522f2f43f4ae0239522889f703_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC0zLTEtMS0xMDQzNzI_d7932ea3-5709-45d9-8b89-3b0b247af112"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2312799038e14136a66c60426b4cb5f9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNC00LTEtMS0xMDQzNzI_a08a2b83-055a-4858-a67c-12a6da3e7629"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibe4632e8764241ee9398872757d10f8e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0xLTEtMS0xMDQzNzI_c683c0c2-cb1f-4ee1-b4dc-f7ba940f4e25"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4990d1e08a374066a38fe1c66495a71f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0yLTEtMS0xMDQzNzI_33be822b-fbb6-439c-87ac-d05a0a094617"
      unitRef="usd">39000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idbfdfaa0e8ef4d4790f5cacb41fbc6d5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS0zLTEtMS0xMDQzNzI_21b66400-6456-4b9f-90bc-0349af1a69bc"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjE1OGFmMjViZGRkNzQ3NTg5YzQ1NTBlOTdlN2I0Yjg3L3RhYmxlcmFuZ2U6MTU4YWYyNWJkZGQ3NDc1ODljNDU1MGU5N2U3YjRiODdfNS00LTEtMS0xMDQzNzI_08375b77-0a8f-40cd-b7b1-214b322925c9"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i87c145ad188b4727a0ff9e2d211c6b95_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi0xLTEtMS0xMDQzNzI_7d22f288-97ac-4ed5-9cc4-eb5a56ae4bba"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i39c83749cf3d4a26b1b79ffab6bc6042_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi0yLTEtMS0xMDQzNzI_b0ad37da-8c4a-47d0-b8de-b1d01a278f22"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i115a2bff9c784ab99914fe29be8d2d98_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMi00LTEtMS0xMDQzNzI_9f0a5e5f-95bf-443f-bbe6-7e8a48a80c0b"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i21e6c07c99ae4e90bc9ff4f65a602520_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy0xLTEtMS0xMDQzNzI_268f5032-2088-4c17-aa3a-6ce1c8bd2d5a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ida458b6715084e3a96aa191749dc91fd_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy0yLTEtMS0xMDQzNzI_c785afa8-947a-40df-a781-2a74e307dd88"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8bdf1fc538624d7d9910380d7d77b626_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfMy00LTEtMS0xMDQzNzI_2622ab86-53bb-4522-b7de-f9b0e4856ea2"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i95260f0037d846208bd14cc3ba8adffb_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC0xLTEtMS0xMDQzNzI_95c95d6e-b153-46ca-b394-17c9008feed8"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icff550217f2b4a8f8d4ae65fe153a1ff_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC0yLTEtMS0xMDQzNzI_5d88cb02-e76f-41b4-81a2-d4240d0c566e"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idbdf433bfc67461d8114a92c13283325_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNC00LTEtMS0xMDQzNzI_8251e380-e7ae-401d-b3b2-a932b5df28d7"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia0679fb1835b4c7795bcea38cf0b9886_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS0xLTEtMS0xMDQzNzI_cdb44ff9-f722-4527-aadd-820b43264aed"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i23e2ab4fa4974f7889612beb65ce8d19_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS0yLTEtMS0xMDQzNzI_f3e1f96d-ea72-4ddf-946a-66beca62c17f"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjY4NGZhN2ZhYzUxZDQ4OTJhMTRmOTA1ZmIxNTliMDRjL3RhYmxlcmFuZ2U6Njg0ZmE3ZmFjNTFkNDg5MmExNGY5MDVmYjE1OWIwNGNfNS00LTEtMS0xMDQzNzI_0ad4123b-68e5-42ab-bcca-65e2d6b27dd5"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i491168a2923441709f7ed1cbfe6c88ad_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0xLTEtMS0xMDQzNzI_30dba572-cc6b-4acc-b316-64a926d6e888"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i59821c1a37b043dd8a8397a39a3d0bd4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0yLTEtMS0xMDQzNzI_2cb7ae1c-53fe-4b72-a7df-9fa342f65e30"
      unitRef="usd">99000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i53f65613766e4c30bdf4b47df7bb28b8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi0zLTEtMS0xMDQzNzI_0e3d7d07-1e06-4e63-af1a-5d9e42ce36ae"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i11a5054d010e43e2bb824d4b0a88a448_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMi00LTEtMS0xMDQzNzI_4f7b6b7a-b53f-403e-811a-41272fa397f5"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id3df95dfd2c54aaea21d90d6cd142885_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0xLTEtMS0xMDQzNzI_2271d00c-c9d8-4fc9-a4e2-b8d4ba47fbc2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id7ff276cb874486b9ea8a16dad3d507f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0yLTEtMS0xMDQzNzI_83ee1d4e-727f-4e9c-b79b-38a6568b97fa"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee715bdb374f4d0fb135cd9a90024cb7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy0zLTEtMS0xMDQzNzI_df58d06b-6ac9-444e-b809-6805414522f0"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i16bdd528aa2f43d699d93d6730eaadc0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfMy00LTEtMS0xMDQzNzI_a59dcf4b-0656-429c-b4f5-c7518415c2d1"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia4eaef49d9cb47cfa238b4be07c3c11e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0xLTEtMS0xMDQzNzI_a1f8c019-c993-481c-aa4e-72954f9d22d2"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6a7daf0d45954200a36a140244cfa8c3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0yLTEtMS0xMDQzNzI_b8b6cc34-c46d-4f60-906c-1cc97dce1ad8"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id0e760ae3df749d7a28496170682fcdb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC0zLTEtMS0xMDQzNzI_89668683-f9e7-4c70-a810-8cb5411d286a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ife9092a352dc419ebd9202ad5227d8e1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNC00LTEtMS0xMDQzNzI_0a1099c9-6cec-4087-9690-d3fe93c8fda1"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaa41f2bd185d4f35992a88175bd33816_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0xLTEtMS0xMDQzNzI_1246fe8d-6f3d-47be-a22b-2b05f1158fc6"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6f72f4b6a78548e09b7e4a30258e2a66_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0yLTEtMS0xMDQzNzI_60d68744-6464-4b67-b723-e096e9c17bb2"
      unitRef="usd">126000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8f4353d73fc0409094a9382a8f5b35ed_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS0zLTEtMS0xMDQzNzI_5233c16e-a258-456e-b506-59bbb4b4d048"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOjYyOTRkMzg5MmFiNTQ4MzY4NTA1NjU5MmVmOWQxNGUzL3RhYmxlcmFuZ2U6NjI5NGQzODkyYWI1NDgzNjg1MDU2NTkyZWY5ZDE0ZTNfNS00LTEtMS0xMDQzNzI_45970d4c-1fc8-4497-aa42-eac109aa5a2f"
      unitRef="usd">150000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i32f7b3dac88f4fdeb34925d2fd733bd2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi0xLTEtMS0xMDQzNzI_17d8df1a-8d79-4832-a203-9b0ba57f7c39"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3f085c0375204e3d928fcb8db88faac6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi0yLTEtMS0xMDQzNzI_fd1073df-2294-4991-b73e-03cd243cea10"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i087c22c00b8342649cb73bf0310b7e9e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMi00LTEtMS0xMDQzNzI_e9e322b7-ea59-4855-bd43-b2eb9f8c3d32"
      unitRef="usd">49000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i89294089c022435cbb391734e7e95a77_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy0xLTEtMS0xMDQzNzI_e985286c-0eee-468f-8597-5ac02ec46763"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i03c1cd55ef43406fb28e3516e8bed426_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy0yLTEtMS0xMDQzNzI_ed1113df-d2be-4315-aeb1-1d256b68d016"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5f66dbec955f46ba8e2a9f09b30f4234_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfMy00LTEtMS0xMDQzNzI_ef629cfa-934e-4f34-a746-de4d8ee2c033"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9dda49a9d7704da6860a7855a38b3484_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC0xLTEtMS0xMDQzNzI_be347cad-3b9f-41aa-9fcf-8b11ba4675e7"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1d3dbfedff62414dbc6b3c751ec05d46_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC0yLTEtMS0xMDQzNzI_20034022-9d3b-452c-8af1-b7fc8664ba88"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4a28025718c7422987d5e9a1bb04a33f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNC00LTEtMS0xMDQzNzI_c97c7d8e-5898-48ef-9162-51875938528b"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie76d49105fd64d3fbed5c1bb08359728_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS0xLTEtMS0xMDQzNzI_485a736e-2c17-42e0-9395-b08194fd4f39"
      unitRef="usd">51000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie0522de9f5b144d58800dd0fd0f71c6a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS0yLTEtMS0xMDQzNzI_19b59635-2f6f-440d-822c-3d5e0019afa9"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmFhZjZhODkzYjM2MzQ2ODNhODM5ZGUxOGNhYWQ5NTdhL3RhYmxlcmFuZ2U6YWFmNmE4OTNiMzYzNDY4M2E4MzlkZTE4Y2FhZDk1N2FfNS00LTEtMS0xMDQzNzI_f44cd1d4-88ce-4d7d-8b50-81301f6978b7"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RleHRyZWdpb246ZGE5NDZkYTU1MzUyNDAxNmEzNjIyZjcwODBlNzU5YjlfMjMxNA_66f9fee6-6b03-41f2-9032-d275c53530d4">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i2166896cc67640a7ae96d097acab1f25_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMS0xLTEtMS0xMDQzNzI_4949f85a-442d-48ed-9d04-a80d49121b1f"
      unitRef="usd">109000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMi0xLTEtMS0xMDQzNzI_b48180c6-2e2f-4bde-a517-84d06f6cbb30"
      unitRef="usd">147000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfMy0xLTEtMS0xMDQzNzI_b158d64c-db18-47af-a794-d72d67a581d8"
      unitRef="usd">108000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNC0xLTEtMS0xMDQzNzI_12fe75d4-812e-4880-afac-8ba6774e456d"
      unitRef="usd">6000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i0575eb665b984a48aff0f0c0bd080f93_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNS0xLTEtMS0xMDQzNzI_51b36bd2-8503-45be-a5e7-55581ddc87bd"
      unitRef="usd">-14000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i950523c03d0e465a8db7b9c48b7e0e3e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM182Ny9mcmFnOmRhOTQ2ZGE1NTM1MjQwMTZhMzYyMmY3MDgwZTc1OWI5L3RhYmxlOmRmYTYyMmMwY2NmZDRjMDk4MTk4YjY0NTcyNGQxMGMyL3RhYmxlcmFuZ2U6ZGZhNjIyYzBjY2ZkNGMwOTgxOThiNjQ1NzI0ZDEwYzJfNi0xLTEtMS0xMDQzNzI_d8b39a32-2e79-4944-abe6-4f24f16226b2"
      unitRef="usd">128000000</us-gaap:RestructuringReserve>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfODQ3_ed177bcd-0400-4cb7-8e13-ee57f9ab60d2">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;U.S. Hillrom Pension Plan Amendment&lt;/span&gt;&lt;/div&gt;In May 2022, we announced that the pay and service amounts used to calculate pension benefits for active non-bargaining participants in our U.S. Hillrom pension plan will freeze as of December 31, 2022. Years of additional service earned and eligible compensation received after December 31, 2022 will not be included in the determination of the benefits payable to those participants. This change resulted in an $11&#160;million decline in the projected benefit obligation (PBO) with an offsetting curtailment gain included within other (income) expense, net on the condensed consolidated statements of income (loss) for the nine months ended September 30, 2022.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfODQ5_cfb5a055-1f6d-4e82-b916-6a512fbb03de">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy0xLTEtMS0xMDQzNzI_0f777b56-4919-48d7-ae09-3000cbe3bd76"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy0yLTEtMS0xMDQzNzI_4d6475c1-60c6-40cb-9e37-bd5c12f66a2e"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy00LTEtMS0xMDQzNzI_909080d4-42eb-4645-b95f-813d350e6d45"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMy01LTEtMS0xMDQzNzI_1c68c110-e85d-40e3-b991-35c95f7b9fff"
      unitRef="usd">66000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC0xLTEtMS0xMDQzNzI_f16e948e-9134-44aa-9d2d-8d08f901421b"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC0yLTEtMS0xMDQzNzI_37b5f16e-32e5-4400-b1ea-7261d14d3b7f"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC00LTEtMS0xMDQzNzI_fe35db7b-8655-4d95-a5b4-693a6e02f98a"
      unitRef="usd">73000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNC01LTEtMS0xMDQzNzI_c4e6fc45-09ca-4f53-9512-f33d9cd43caa"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS0xLTEtMS0xMDQzNzI_a6e5b1ad-8b3a-4833-834c-59de074e6eea"
      unitRef="usd">39000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS0yLTEtMS0xMDQzNzI_3d51bbb7-3ee9-4cf4-9184-8486e71aee75"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS00LTEtMS0xMDQzNzI_357c9bcd-ce19-4fc4-8fb1-3b7211690898"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNS01LTEtMS0xMDQzNzI_b7ad82d4-64a1-434b-87a2-231bb8b37770"
      unitRef="usd">108000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi0xLTEtMS0xMDQzNzI_a42b6451-674c-40e8-8e15-eb7b06aa32e4"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi0yLTEtMS0xMDQzNzI_3d3c68ed-32b7-4269-b5cc-066dc6f2da0b"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi00LTEtMS0xMDQzNzI_7f54ab79-f9a1-4dc4-a097-3a9626dbc987"
      unitRef="usd">-34000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNi01LTEtMS0xMDQzNzI_da345049-430a-4e0d-95c6-17e9a2d763cd"
      unitRef="usd">-69000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i81c946d03b19440fa641ef1a7c5e6f8d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy0xLTEtMS0xMDQzNzI_38f8a3a5-e2f3-4feb-8458-3977f982bf05"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i899baaa09c6e45828cc85bcf22d1a035_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy0yLTEtMS0xMDQzNzI_cc0a4727-9169-44bf-b6ce-021eef0fdede"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4552c3291d6c4c39b77e4a1815741d83_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy00LTEtMS0xMDQzNzI_3515988a-8409-4380-a856-d7d0166058b7"
      unitRef="usd">48000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1591513955fb4023a39b3d2f4993515a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfNy01LTEtMS0xMDQzNzI_b82f2a23-5dd9-4253-9c75-a9cb1ef130a5"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS0xLTEtMS0xMDQzNzI_df7be1d5-979b-4d5b-89d7-9084bbe7fc94"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS0yLTEtMS0xMDQzNzI_a7ebde4d-e6f6-4541-9eda-d00260b0f331"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS00LTEtMS0xMDQzNzI_63fdef21-56cc-43fd-9e4f-8db294fc71a3"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfOS01LTEtMS0xMDQzNzI_b321e46a-2194-497e-b002-06997fa4fa9f"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtMS0xLTEtMTA0Mzcy_e8ceb2bf-629c-4100-ba1c-fa6b66af9260"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtMi0xLTEtMTA0Mzcy_a4307799-fd43-4685-a9a9-4de74df8eb02"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtNC0xLTEtMTA0Mzcy_86a7340d-0206-4ca7-aaf2-03dbce6cf5d4"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTAtNS0xLTEtMTA0Mzcy_9a4e65e5-3756-40ff-bdc1-f6ca16c79b9c"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0ac6354351d445bc997cafdbf252a241_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtMS0xLTEtMTA0Mzcy_3d94f4a0-4fd7-44cd-a227-4264b1a98ef1"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5ca6d1c8838242b4ad314796e16161b3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtMi0xLTEtMTA0Mzcy_97fee40d-79a2-4fc6-853c-d007827a0438"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i229ab9fd268d42b4bad79c1caf5be14e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtNC0xLTEtMTA0Mzcy_8b185d57-e73e-432c-b603-8e41f46809ba"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5074cc5991fa4b5795a5c316889cb0cc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RhYmxlOjJkYzRiMDYyMDU4MzQ0NTM4OTExYzI2ZThhMTdlNmZhL3RhYmxlcmFuZ2U6MmRjNGIwNjIwNTgzNDQ1Mzg5MTFjMjZlOGExN2U2ZmFfMTEtNS0xLTEtMTA0Mzcy_32f39c5e-3c6b-4b1f-9019-e57c1f38f429"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i8ace5ff2293146d4bf055d7cb9bcf636_I20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183MC9mcmFnOjZkZDQ2N2VlM2RiODQ5Yjg5Yjc0OGU3YzM2YTE0ZGVlL3RleHRyZWdpb246NmRkNDY3ZWUzZGI4NDliODliNzQ4ZTdjMzZhMTRkZWVfNjA1_5f6945fa-2554-4fb9-9a16-1a9f31512133"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTIyNA_b7d4c6c9-c169-4ddf-bce9-0f5c57495e8f">INCOME TAXES &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was 1.1% and (0.2)% for the three months ended September 30, 2022 and 2021, respectively, and (1.1)% and 11.8% for the nine months ended September&#160;30, 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to non-deductible goodwill impairments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to a $58&#160;million tax benefit related to a tax-deductible foreign statutory loss on an investment in a foreign subsidiary, as well as a favorable geographic earnings mix and changes related to our ability to realize tax credit carryforwards based on a favorable tax ruling in a foreign jurisdiction.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTg_ddf753e8-6b98-43f6-991a-ce52fb97d505"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNjU_70ca4eb4-3736-422a-8918-c408020cae6c"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTA1_1161ce48-e256-4f7c-8f75-2151f5273452"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMTEy_4527c6df-0ec8-4baf-9df8-f40715bf784b"
      unitRef="number">0.118</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfMjE0_37cb6443-38c0-4130-8464-494d18ae0d5e"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTQ5NzU1ODE2MDc1_689edbee-9f1a-4364-93df-7a8cbdee7c8b"
      unitRef="usd">58000000</bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible>
    <bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183My9mcmFnOmNmMDI0Mzg0NTI5YTQ4MmNhMGEwOTRlYjI5MDgwOTkxL3RleHRyZWdpb246Y2YwMjQzODQ1MjlhNDgyY2EwYTA5NGViMjkwODA5OTFfNTQ5NzU1ODE2MjQ0_4a9e5d65-0fb4-4bae-9646-cd4039e7475a"
      unitRef="usd">58000000</bax:IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfOTUy_71ec7b52-2560-4b69-a266-a98ff1f4ceee">EARNINGS PER SHAREThe numerator for both basic and diluted earnings per share (EPS) is net income (loss) attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted shares are the same for the three and nine months ended September 30, 2022 due to our net losses for those periods. The effect of dilutive securities for the three and nine months ended September 30, 2021 includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted EPS excludes 23 million shares issuable under equity awards for the three and nine months ended September&#160;30, 2022, respectively, and 7 million shares issuable under equity awards for the three and nine months ended September&#160;30, 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS. Refer to Note 7 for additional information regarding items impacting basic and diluted shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfOTUz_b1cc8053-83e0-4b77-aee2-208df0d9eb17">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi0xLTEtMS0xMDQzNzI_7be37722-501e-49d8-ad44-70e6c5a50cd3"
      unitRef="shares">504000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi0yLTEtMS0xMDQzNzI_bee903e0-982f-427d-8ae8-f23461508617"
      unitRef="shares">500000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi00LTEtMS0xMDQzNzI_021d1468-f6ed-4eb7-9b5d-189fc358e227"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMi01LTEtMS0xMDQzNzI_48395e4d-a26e-4801-9189-2c9de1a64048"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy0xLTEtMS0xMDQzNzI_0abee681-86c3-4b1b-9459-e5a7d736607c"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy0yLTEtMS0xMDQzNzI_b876ca17-c792-49c1-8231-689c826fc489"
      unitRef="shares">6000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy00LTEtMS0xMDQzNzI_a60ea63b-21b7-41b9-8ce4-59069b29c955"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfMy01LTEtMS0xMDQzNzI_f97b7201-79b2-4b03-bd55-fca0911771b5"
      unitRef="shares">6000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC0xLTEtMS0xMDQzNzI_9bd3ca87-0830-4db4-9786-90f5d27bb3c3"
      unitRef="shares">504000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC0yLTEtMS0xMDQzNzI_2f69d6c8-4671-4048-91ed-1d25abcc6412"
      unitRef="shares">506000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC00LTEtMS0xMDQzNzI_11e4e4f3-8e88-4d32-a4dc-0769446deac7"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RhYmxlOmNlNzA2YThmNjQ2ZjRkMDliODE0MTdhMjE2NDViMDlmL3RhYmxlcmFuZ2U6Y2U3MDZhOGY2NDZmNGQwOWI4MTQxN2EyMTY0NWIwOWZfNC01LTEtMS0xMDQzNzI_b6cd943c-3170-4aeb-b800-3e92abd336c7"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNjUw_31155439-b4db-4d48-aa6b-045506a16860"
      unitRef="shares">23000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNzIw_9729b0e0-1ec6-4eb0-a353-d68c88f8a074"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183Ni9mcmFnOmRiZWRlY2ZhNDViYjRjOGY5MWFlNDkxNGZhZWUxNDk2L3RleHRyZWdpb246ZGJlZGVjZmE0NWJiNGM4ZjkxYWU0OTE0ZmFlZTE0OTZfNzIw_aadd23ce-6153-4a32-99ac-85f1d11304f7"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNA_e73d6979-b499-406d-a5a2-5d3e87dc7c9d">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cash Flow Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of foreign exchange contracts designated as cash flow hedges were $407 million and $377 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at September&#160;30, 2022 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of September&#160;30, 2022 and December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no outstanding interest rate contracts designated as fair value hedges as of September&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Net Investment Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, we issued &#x20ac;600 million of senior notes due May 2025. In May 2019, we issued &#x20ac;750 million of senior notes due May 2024 and &#x20ac;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of September&#160;30, 2022, we had an accumulated pre-tax unrealized translation gain in AOCI of $265 million related to the Euro-denominated senior notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Dedesignations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no hedge dedesignations in the first nine months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first nine months of 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first nine months of 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total notional amount of undesignated derivative instruments was $548&#160;million as of September&#160;30, 2022 and $851 million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI&lt;br/&gt;into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, $22 million of deferred, net after-tax gains on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of September&#160;30, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2a9b0b9cb7944866bf75d223bb4c8fea_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzU1Ng_9ff0cdd6-3d70-4b13-86d9-0af95870d9b9"
      unitRef="usd">407000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0a10b05f8c504eaea705b787746ae15b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzU2Mw_6215412f-583e-4ca4-8adc-4d6f438cb4e1"
      unitRef="usd">377000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i33b44d74805841d2ac389e7934b1a17f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzcxMg_6986c92d-4443-418a-a1e8-8205bc9dcd67">P12M</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1111c82205474cdda375e71c5738d55b_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzc1OA_7f04c015-401f-459f-be7e-af5a2e827c28"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if77e3cf538fe4a19a12e07001222f635_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfMzc1OA_cc5a787d-c958-4f85-b88b-8462c6cb32b9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i01b9c1c44ba84e60af09ae0057af5a4e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDY1Mg_563ac7e7-f37c-4777-a22c-e1d888b43ddb"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4fd80b73ae2b420ca679db0cac3a60ba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDY1Mg_6b25a2b3-6237-45f0-9388-44d3a2831c2a"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i55e4dbb5ee80417da9485fdfabbcc12b_I20170531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDc4NQ_513c6461-19c0-423a-8a85-7ce418911ad5"
      unitRef="eur">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9812ba731b464628b9581ec75cb13f21_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDgzNQ_b61772c4-1892-4f65-8539-3f0cbf5c7587"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if0c7cce9faa64129b1ddac611011830c_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNDg2NQ_921387be-2e8d-4254-b616-1eeef609037c"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4219ab86c67549bfa1e56276605a8990_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTE5MA_39273513-8a64-45cb-9f8a-ea9f97073301"
      unitRef="usd">265000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTc5Mg_a2ff41c5-eb15-47f5-8b1c-277589ad5d71"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib894e2bbdf8c4de5a0af2174388acc1f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNTc5Mg_ac4b8740-64e7-4f4c-afef-9109e77a7d1e"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <bax:DerivativeFairValueTerminated
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjE4Mg_2fc0994c-c056-47b3-a46d-ae7e0b498444"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeFairValueTerminated
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjE4Mg_bc2d0e5e-7224-4090-8abd-cfe8c54f9816"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjQ3OA_490d19c9-150f-44da-8a2b-41b6371adaab"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNjQ3OA_842eeb01-4b39-4387-be93-7fa685353a89"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic762452cc4494022a233acfc178ebafa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzAwMw_be1845f5-57ec-49aa-8af2-9950c02384b3"
      unitRef="usd">548000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if03565d5005c4f898506b8c013da1feb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzAxOQ_7499cc4a-0dbd-46a0-8c54-75072d933624"
      unitRef="usd">851000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNQ_7dadb8ad-1235-4bab-8d98-c79d66bf7bde">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI&lt;br/&gt;into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ibd4b212abcc54d02b74cb18b61508e58_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy0xLTEtMS0xMDQzNzI_61b09942-0811-43ab-aabb-a10427226e43"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3b0045fb1e0941df98e20a283f36d227_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy0zLTEtMS0xMDQzNzI_b0406203-a9e8-4b79-aa7b-2e3852d99694"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="idec3801c7613438c8124f3cde7757903_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy02LTEtMS0xMDQzNzI_94d59750-7825-4744-a24f-db81b7a9f179"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i524f33dedfef49de9b3bc2b5e9c14c87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfMy04LTEtMS0xMDQzNzI_ae570b65-8ec0-402c-9244-0d2ad0c30d04"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="iaeaa8f4aa8c140688f7b460b580b43ed_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC0xLTEtMS0xMDQzNzI_c00346bb-fd90-4483-9b5b-a1fdb03a232f"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i8cf0aac0647045d5aa67667953993c07_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC0zLTEtMS0xMDQzNzI_c9fcc96c-13d8-48bd-9dbd-941564ae625e"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0d171c4e6be042278f782461c977f45c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC02LTEtMS0xMDQzNzI_150b1733-c6c1-4978-808e-ab748b7fce93"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2542bc7a65744214aae79ec882f3c054_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNC04LTEtMS0xMDQzNzI_d0dbce56-39ae-44f2-83bc-9dea7696e59a"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2c0e3547cbe442938da56027d6f100e8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS0xLTEtMS0xMDQzNzI_9cf3e206-8e0c-451f-9589-095df6672062"
      unitRef="usd">126000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifaa95bf889d043f38f60a617e70b40d3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS0zLTEtMS0xMDQzNzI_da29f570-d775-4b9f-ab31-4092561b650b"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i57bc193f1088457fb04394f5af366882_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS02LTEtMS0xMDQzNzI_96cfaaad-bf3a-474c-965d-d9bce4a93768"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2d4402f6cfbe44c7a47198d315febe1d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNS04LTEtMS0xMDQzNzI_90402676-2ad6-45a1-8f1a-d2758faed049"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi0xLTEtMS0xMDQzNzI_93982453-fa22-4d79-a7ef-579cda6bf207"
      unitRef="usd">152000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi0zLTEtMS0xMDQzNzI_c0885ccf-1633-4097-bf1b-16aa07ff1a5e"
      unitRef="usd">66000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi02LTEtMS0xMDQzNzI_a9cd370d-7f13-4565-b84d-8748bc6e861a"
      unitRef="usd">5000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjcyYjBmZjdmMTk3MTRiYTE4OGY5MmI1MzlkMDRlZGVmL3RhYmxlcmFuZ2U6NzJiMGZmN2YxOTcxNGJhMTg4ZjkyYjUzOWQwNGVkZWZfNi04LTEtMS0xMDQzNzI_ef7cc1c4-2d54-4e34-9773-084390adbf47"
      unitRef="usd">-6000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i6b054901d62649cdb8f927a96ce91ace_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjI0N2ZjNmVjZDFkMTRhOTA5ZjUxOTNjNzk0ZjQ1NTg1L3RhYmxlcmFuZ2U6MjQ3ZmM2ZWNkMWQxNGE5MDlmNTE5M2M3OTRmNDU1ODVfMy0yLTEtMS0xMDQzNzI_0140def1-766b-4800-8615-191bfd6c9faf"
      unitRef="usd">-11000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i0bd9a491ccff4bbda2839a7be1c36b74_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjI0N2ZjNmVjZDFkMTRhOTA5ZjUxOTNjNzk0ZjQ1NTg1L3RhYmxlcmFuZ2U6MjQ3ZmM2ZWNkMWQxNGE5MDlmNTE5M2M3OTRmNDU1ODVfMy00LTEtMS0xMDQzNzI_acd44f9a-9d66-4594-a423-11cc9d5d548d"
      unitRef="usd">-7000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="iaef3027bf73d4dc6910053458adbcef3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy0xLTEtMS0xMDQzNzI_4cda827f-21d7-4d4e-b751-fcb9f7cf87c8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i1d7c0055bf4040c381b494fe4307540c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy0yLTEtMS0xMDQzNzI_5e6fac9c-fc7c-40ad-a23c-78d4d88b815c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic3c83643aa4f4d08a36b0e3403f878e7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy00LTEtMS0xMDQzNzI_53189aee-0dd8-4a34-9b51-a0170033efda"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3597ba90139f4ad88f34ea14d4c322e4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfMy01LTEtMS0xMDQzNzI_c231f289-b36c-4b9b-9255-162865143d7d"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ia23c6ae90b5e43f18f128140d9efd7b9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC0xLTEtMS0xMDQzNzI_8074f4b6-0714-47c6-be34-a306a1438d37"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i20f6cdaf8a75405295f0a68abbdc904e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC0yLTEtMS0xMDQzNzI_8f9e5c5d-32e0-4189-b32a-b40974667e0d"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6b78a3fb7ef44f86a0bd6a81e7c2f5eb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC00LTEtMS0xMDQzNzI_b5570550-d36e-4d68-a03f-d2f4df381c6d"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i02b24494d1e54bcb900d94e60f0b8ac7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNC01LTEtMS0xMDQzNzI_223f35a7-029f-4d7e-8eb7-18f0e6133b41"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4159e70eae1c4a779c9b692aaa4cf78c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS0xLTEtMS0xMDQzNzI_ea2273f3-0a4d-40b0-a7f9-07ddcb2a7312"
      unitRef="usd">311000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5a752302cfc64472917c0dcdd2903e89_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS0yLTEtMS0xMDQzNzI_75d50524-1b8a-43e0-a06c-b62bfadcfdbf"
      unitRef="usd">143000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3e74411bec474aaea6b669ed608cdde3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS00LTEtMS0xMDQzNzI_3a07ba1b-da2d-4a5f-8a37-82e81c12d51f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia96f099a1e7d4398a154facff7209588_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNS01LTEtMS0xMDQzNzI_4fe323c4-0070-4227-b849-84ee3a849fc2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi0xLTEtMS0xMDQzNzI_cfe799d2-c4ec-43d0-896f-fbf5e916d2dc"
      unitRef="usd">353000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi0yLTEtMS0xMDQzNzI_d5a64238-f277-457d-a746-019326a593c5"
      unitRef="usd">150000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi00LTEtMS0xMDQzNzI_9dad71ea-36b6-4b94-9fb3-e09b353a606e"
      unitRef="usd">7000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI4MjAyNTU0NzY3NzRhYzdhMTExODE3NmYxY2QwZDkxL3RhYmxlcmFuZ2U6YjgyMDI1NTQ3Njc3NGFjN2ExMTE4MTc2ZjFjZDBkOTFfNi01LTEtMS0xMDQzNzI_77fe43ea-ddc3-4749-a1cc-cd05363fa756"
      unitRef="usd">-27000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ie089f3302f66450796c1dff4135d452a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI3MjI2YWE1OWVhZTRlZDFhNTJjZDliNzFjZTMxNzdhL3RhYmxlcmFuZ2U6YjcyMjZhYTU5ZWFlNGVkMWE1MmNkOWI3MWNlMzE3N2FfNS0yLTEtMS0xMDQzNzI_dafa3471-ccc0-416c-9c3d-cce4b2945396"
      unitRef="usd">-34000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i1528a977db6d4b2599de78b0fafe3502_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmI3MjI2YWE1OWVhZTRlZDFhNTJjZDliNzFjZTMxNzdhL3RhYmxlcmFuZ2U6YjcyMjZhYTU5ZWFlNGVkMWE1MmNkOWI3MWNlMzE3N2FfNS0zLTEtMS0xMDQzNzI_4e6248e1-8d47-4eb8-82b7-b8d188c19c36"
      unitRef="usd">-26000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfNzU2OA_ab74d345-b14f-4a7f-9b92-7189fdf0e332"
      unitRef="usd">22000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgxMQ_a255cfca-747c-466b-9b36-f5fe4abda382">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of September&#160;30, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1abbbcb680d54d358fcfea6c93ecb0b7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNC0yLTEtMS0xMDQzNzI_05622444-cb5a-4b22-a9f9-69e1e9379b8c"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6de69187ee1449e690027dd9b5781e35_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNC01LTEtMS0xMDQzNzI_b58c2dec-41b3-4917-b15d-aa6008492977"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNi0yLTEtMS0xMDQzNzI_128287e9-6c17-47d8-8155-6bcc515e9d0b"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfNi01LTEtMS0xMDQzNzI_57bdd540-e81e-4aa1-a7e8-306b599e4485"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i468b5d6abb97433c8ced58e53154b575_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOC0yLTEtMS0xMDQzNzI_2a955ca9-d4dd-4a4c-b3d9-5f93e62a0092"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia6cc534a76f6479cb41d07feb73fe749_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOC01LTEtMS0xMDQzNzI_99a06a67-b293-4e8a-b1eb-2c07401eea66"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOS0yLTEtMS0xMDQzNzI_a6037313-1625-437c-84d1-970509e73605"
      unitRef="usd">35000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjBlNzliZDFlMzE5NjQ5ZTU4OWMxMWNlYjA0YjhlMjY2L3RhYmxlcmFuZ2U6MGU3OWJkMWUzMTk2NDllNTg5YzExY2ViMDRiOGUyNjZfOS01LTEtMS0xMDQzNzI_6873fcbf-1a91-4c27-94de-df13067fe3cd"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3173187680714658978b04838fce40b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNC0yLTEtMS0xMDQzNzI_4fb63edc-7a75-4147-b100-4fc1acb06cd1"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1fe54a153e4a40e4a1a669f98ab1f673_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNC01LTEtMS0xMDQzNzI_6fbdcedf-75ad-49ca-b9bc-53979408bca9"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6af24cb81eb1423ab102ead43ce324f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNi0yLTEtMS0xMDQzNzI_33844452-71ce-48a9-8eea-e86d0eda22d9"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6af24cb81eb1423ab102ead43ce324f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfNi01LTEtMS0xMDQzNzI_32e81af5-512a-4f28-90d5-b52287246572"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i32d91b9084444f99a2a267da216d851d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOC0yLTEtMS0xMDQzNzI_be59314a-cc96-4a85-b22a-1d59584f7a21"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i821cd3c29b904c40826ea7cf9fc530c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOC01LTEtMS0xMDQzNzI_87bb6cf7-06e6-40e5-aa13-651ae6781536"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOS0yLTEtMS0xMDQzNzI_2c08a7ce-2f01-4d00-96b7-0698970de7a9"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjFmYjAyZTYyNjZhMDQ4NDY5MGNkMDU1YmNhMTY5NmY3L3RhYmxlcmFuZ2U6MWZiMDJlNjI2NmEwNDg0NjkwY2QwNTViY2ExNjk2ZjdfOS01LTEtMS0xMDQzNzI_16812219-af81-45ee-9e44-279c0dfa7b60"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwMg_4a3eee09-689b-4a75-9058-130d1847bb37">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi0xLTEtMS0xMDQzNzI_a979e4c2-3443-4674-8a07-b26e2359722a"
      unitRef="usd">35000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi0yLTEtMS0xMDQzNzI_afb987b0-0a9c-40d7-92a2-f73c6a0321ff"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi00LTEtMS0xMDQzNzI_1af441a8-fa79-41ea-b09a-26bb40f0e629"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMi01LTEtMS0xMDQzNzI_dbdf1c27-5a83-4e5e-ad80-fb3ca3e65fa4"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy0xLTEtMS0xMDQzNzI_eafc41e5-adae-4c91-8f48-6ef71ccd0657"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy0yLTEtMS0xMDQzNzI_c718934a-0cf3-4319-a21d-58287cfa72df"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy00LTEtMS0xMDQzNzI_970065c9-5a0b-4ff6-b53c-4c3d7970d90b"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfMy01LTEtMS0xMDQzNzI_0b6fe556-7f02-4aec-aed7-1531736cd521"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC0xLTEtMS0xMDQzNzI_c6b2df1e-c59a-4910-98f5-8009e302d782"
      unitRef="usd">28000000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC0yLTEtMS0xMDQzNzI_bbeac79c-2121-44b3-836b-a613fd341d0d"
      unitRef="usd">2000000</us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC00LTEtMS0xMDQzNzI_c9d44093-5590-4f04-a4fc-1dc9af7cf542"
      unitRef="usd">6000000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOmZkYzg3YzkyMzliNDRmZDU5OTJiNWNiZjQyNGQ0Y2Q0L3RhYmxlcmFuZ2U6ZmRjODdjOTIzOWI0NGZkNTk5MmI1Y2JmNDI0ZDRjZDRfNC01LTEtMS0xMDQzNzI_e05b168d-4343-4a68-bccb-c4e7f460cb4e"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RleHRyZWdpb246MjMwMTY0ZDY5NWMyNDRiNTgxNjQ4ZWRiZmExZTVhZTZfODgwNg_83a09c07-b588-4e2e-a4a3-24098b8eb4ce">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="ib6e5214316a649e3860c819c556c69d4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi0xLTEtMS0xMDQzNzI_b2b4fdbc-aff5-4415-a1a9-bbeabc3d733a"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi0yLTEtMS0xMDQzNzI_0037d422-2b6f-4de3-bd2f-c3f44c0b3e64"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ib6e5214316a649e3860c819c556c69d4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi00LTEtMS0xMDQzNzI_5f09f96c-6b48-45a5-986f-714e371407be"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="if960f2ca856c4bb59cf0e20b1ce9e6ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM183OS9mcmFnOjIzMDE2NGQ2OTVjMjQ0YjU4MTY0OGVkYmZhMWU1YWU2L3RhYmxlOjAyYzNiNzA4ODg0NzQ3ZTRhNDY5YmM0MWNjYTJiNTIyL3RhYmxlcmFuZ2U6MDJjM2I3MDg4ODQ3NDdlNGE0NjliYzQxY2NhMmI1MjJfMi01LTEtMS0xMDQzNzI_8581d9b6-81dc-4afe-9e67-5718eee9b138"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMxOA_34deee1e-b2d5-4cf0-831d-529299531f15">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, cash and cash equivalents of $1.6 billion and $3.0 billion, respectively, included money market and other short-term funds of approximately $161 million and $816 million, respectively, which are considered Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#x2019;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2022, $8&#160;million of available-for-sale debt securities that were previously classified as Level 3 converted to marketable equity securities, which are classified as Level 1 in the fair value hierarchy, upon the initial public offering of the investee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Instruments Not Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of September&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $102 million as of September&#160;30, 2022 and $114 million as of December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMA_e60200ce-1a07-4a0b-aa71-6ed1f96ca01e">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0xLTEtMS0xMDQzNzI_360ad04b-2095-413f-ad0a-828bfcdc2eab"
      unitRef="usd">35000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0yLTEtMS0xMDQzNzI_41ab5885-d85f-419c-9f60-a75dbca3ce3b"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy0zLTEtMS0xMDQzNzI_18e7cca7-1147-42be-ba5d-ea5158f54421"
      unitRef="usd">35000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMy00LTEtMS0xMDQzNzI_dcfa6bfd-12fc-4274-a032-26073c35fdf9"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0xLTEtMS0xMDQzNzI_dafffb65-72c0-43cd-b548-b337dd756d12"
      unitRef="usd">44000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0yLTEtMS0xMDQzNzI_4b73b73c-4462-424c-ac0e-f59b5bc87d50"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS0zLTEtMS0xMDQzNzI_6a18ac1f-98c1-40ed-879e-555a3cbebcfb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNS00LTEtMS0xMDQzNzI_4eb1c614-802a-4f1b-ad97-7b6ea274471f"
      unitRef="usd">44000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0xLTEtMS0xMDQzNzI_03a7ca10-d1f0-44f6-b969-a1bbb9a10504"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0yLTEtMS0xMDQzNzI_b6a3f9f6-a41d-40b6-ad09-8a87532a4b7b"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi0zLTEtMS0xMDQzNzI_cd74746b-8208-4a5b-8918-811e245b2003"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNi00LTEtMS0xMDQzNzI_36871a65-112a-4826-9ea7-02c725a76748"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0xLTEtMS0xMDQzNzI_7d205d3a-33c6-4fe4-bda1-07000f2c2101"
      unitRef="usd">104000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0yLTEtMS0xMDQzNzI_a8136d4c-c7d6-4f3a-9426-79de2b9de98f"
      unitRef="usd">25000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy0zLTEtMS0xMDQzNzI_e820bca4-9c5a-4216-8c75-f972855aacad"
      unitRef="usd">35000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfNy00LTEtMS0xMDQzNzI_15663606-f535-4fce-b519-152a6c3f583c"
      unitRef="usd">44000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0xLTEtMS0xMDQzNzI_e202c09d-544c-4a2f-b9d2-773727f93a5a"
      unitRef="usd">9000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0yLTEtMS0xMDQzNzI_a99a4d4a-bead-4a33-aea8-7531e7f0268b"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS0zLTEtMS0xMDQzNzI_949833db-7fca-4a57-ba17-c967bd09c45b"
      unitRef="usd">9000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfOS00LTEtMS0xMDQzNzI_8796b756-4840-46c4-a010-830f0afc64cc"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMS0xLTEtMTA0Mzcy_1dfdfffe-0b18-479b-ab56-ee30a817fb90"
      unitRef="usd">90000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMi0xLTEtMTA0Mzcy_30733f54-3b43-4286-9e13-5afcccade8f8"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtMy0xLTEtMTA0Mzcy_2d806447-cec2-4b77-9704-40940bf9d253"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTEtNC0xLTEtMTA0Mzcy_5cbeb108-863a-4d9e-abc9-ff29d7bcc8ac"
      unitRef="usd">90000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5f5e8ee945c84b1da96f6817955ff214_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMS0xLTEtMTA0Mzcy_0a070fa5-9c42-432f-9c32-6168a89d238a"
      unitRef="usd">99000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia2f6432e8ebe488a9c785fad4fa540c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMi0xLTEtMTA0Mzcy_0dfb1808-1e37-4ea5-bd2d-c73264453efb"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7b104e3d69714250a4d3b01b50f34773_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItMy0xLTEtMTA0Mzcy_ebb9c1e8-3c79-41f4-800a-32792a073c28"
      unitRef="usd">9000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibec49a9c245a406cad720eaf5a91dba8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjQ2ZmFkNDI2Y2MwMTRiMTc5M2YyZTllYjNhZTZlMTRiL3RhYmxlcmFuZ2U6NDZmYWQ0MjZjYzAxNGIxNzkzZjJlOWViM2FlNmUxNGJfMTItNC0xLTEtMTA0Mzcy_7a4d55f1-b8dc-4b89-9e3d-02bf9dd83352"
      unitRef="usd">90000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0xLTEtMS0xMDQzNzI_341efff3-505b-4679-b816-a209cf4e596c"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0yLTEtMS0xMDQzNzI_03004984-60ca-423a-8cbe-4f77138e7ca6"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy0zLTEtMS0xMDQzNzI_75ef0743-cabd-4a81-87a6-a865dff8204c"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMy00LTEtMS0xMDQzNzI_37dce4b1-5f14-4c42-bab1-cc331d654023"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0xLTEtMS0xMDQzNzI_990c3950-4a73-4280-9c25-2b46b887658a"
      unitRef="usd">30000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0yLTEtMS0xMDQzNzI_5ff6f8af-bbd1-4e1f-961c-4b6e8e7272eb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS0zLTEtMS0xMDQzNzI_d53a4c07-3e7d-4e8d-ab34-6912fdb8acc5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNS00LTEtMS0xMDQzNzI_3e8ffb56-c536-4a5f-ba8a-dee72769c14a"
      unitRef="usd">30000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0xLTEtMS0xMDQzNzI_cfdb6027-0082-4acc-8693-0b173a241157"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0yLTEtMS0xMDQzNzI_4dfb186d-3aa6-4ec6-8d2b-7238a0eafea4"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi0zLTEtMS0xMDQzNzI_bcde13e2-4d3e-47b2-8786-6ebb452d2d5d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNi00LTEtMS0xMDQzNzI_6040f90a-54f3-4472-a65f-5da01bc87c92"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0xLTEtMS0xMDQzNzI_5c342883-6601-45ce-9af0-67d213590db1"
      unitRef="usd">48000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0yLTEtMS0xMDQzNzI_9919e451-ae5d-4fe9-a0e9-67de6aa08f7f"
      unitRef="usd">10000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy0zLTEtMS0xMDQzNzI_eb7f2174-341f-4d91-98a0-b7f31eb036a2"
      unitRef="usd">8000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfNy00LTEtMS0xMDQzNzI_88566e8a-eee2-4a90-819b-c2faccef6737"
      unitRef="usd">30000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0xLTEtMS0xMDQzNzI_4a5581b1-e471-402d-b09a-207ad5afb415"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0yLTEtMS0xMDQzNzI_01f61d29-a653-4681-9508-639e63de67fd"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS0zLTEtMS0xMDQzNzI_373e602e-359f-41c7-bc0d-4ccbfeaf6fef"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfOS00LTEtMS0xMDQzNzI_d76022d7-ff33-4b28-a38e-e38f15d8b6b2"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMS0xLTEtMTA0Mzcy_18ff9a8c-2f7c-48b0-95e7-40af6035241a"
      unitRef="usd">143000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMi0xLTEtMTA0Mzcy_55455d63-eaf7-497b-b772-f3c5ee283c3e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtMy0xLTEtMTA0Mzcy_d6c780c8-ae23-4bb6-9790-d32a2d24906d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTEtNC0xLTEtMTA0Mzcy_76a71337-6cb7-4bb4-9d57-e3c049ff7a31"
      unitRef="usd">143000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i655add2ac3494884b74da98ed4989459_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMS0xLTEtMTA0Mzcy_0effa21b-40d7-4671-a7f6-728daee7224c"
      unitRef="usd">148000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1c8eb45afb864f56b69bb3a56a554a9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMi0xLTEtMTA0Mzcy_2b277216-c706-4c46-94dd-1c6be5143b5a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib38d2fefee4f4f3fb7ce25329d990772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItMy0xLTEtMTA0Mzcy_efd43a77-0742-45b8-aa5e-f6d69095c08c"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7c384389756a4c369c17d835b9631cb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjFhOGY3NzdlOTU1NjQwY2I5NjFhOTgyYzFjODU3NGU2L3RhYmxlcmFuZ2U6MWE4Zjc3N2U5NTU2NDBjYjk2MWE5ODJjMWM4NTc0ZTZfMTItNC0xLTEtMTA0Mzcy_1ba7d368-7efc-4007-b637-fa31d0be5810"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i100fa316fc12492f84183e5383c3e332_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMTk0_ede5df97-6235-43b9-b0f4-febfd7018f65"
      unitRef="usd">1600000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b539be2fbed438e9e118c2cdb3604d9_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjAx_bb77843b-7643-489a-be15-9c0be0b8abd8"
      unitRef="usd">3000000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i8db585f6be0041fdbc967569ee16766a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjg1_2a6c8a8a-cfe7-4084-86b6-d432914ee6b0"
      unitRef="usd">161000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ie775ab37506340ba914ddb80c6e46611_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjky_6b89c679-5f64-49f6-b4f6-a12b19b429e7"
      unitRef="usd">816000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMQ_b950f00f-3b2a-4c46-b633-5738e1813021">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1bef60de6abe41cebf0448519a3ac267_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy0xLTEtMS0xMDQzNzI_ac84b08e-10c4-4e84-80dc-94a4faed7c89"
      unitRef="usd">113000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i16e06ddc9fdd4a0295e9c0705d568e98_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy0yLTEtMS0xMDQzNzI_a6dc4685-da75-4f7b-b7be-951a4e5b4bfe"
      unitRef="usd">44000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iefcd1a7cef434b938b81d5633355bbf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMy00LTEtMS0xMDQzNzI_b2288c9a-82b8-4c21-b23f-cc5a6a63f757"
      unitRef="usd">34000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC0xLTEtMS0xMDQzNzI_5123c3ae-78ed-4cc9-9980-8cb28f7257aa"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC0yLTEtMS0xMDQzNzI_58e34ccb-9da3-45cf-8f8f-e9e813575979"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNC00LTEtMS0xMDQzNzI_8424185b-cd59-4575-8166-87f786deae58"
      unitRef="usd">28000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi0xLTEtMS0xMDQzNzI_00686b8b-8b1f-4346-bf7f-3a7374d5bfec"
      unitRef="usd">-6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi0yLTEtMS0xMDQzNzI_76c847c6-5d92-4a95-8bb3-d9d46132683f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfNi00LTEtMS0xMDQzNzI_2641d333-5a15-4efa-a850-dd53270c3507"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ia1f1aefaa0924c3091c1bd073017adde_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS0xLTEtMS0xMDQzNzI_c99c4564-0918-4401-975a-e6da88ed92f1"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS0yLTEtMS0xMDQzNzI_6b2ed3cd-db9f-4516-a94f-7bf22a71bca6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i757405187bb542afbfb19f8e586abf1f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfOS00LTEtMS0xMDQzNzI_b9d79db5-22e1-4e1c-8d5c-b26eb1442e36"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic34110c3d1d548c099e33f7257520862_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtMS0xLTEtMTA0Mzcy_2838a7a5-51e7-492e-a4e8-4cfe06d20f48"
      unitRef="usd">90000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5785042f0a0a48b2a89a8d5e5292f378_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtMi0xLTEtMTA0Mzcy_d6d414e0-9db3-4f68-aebe-c11b457a602e"
      unitRef="usd">44000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6c975de3f94448528111a2732f5ff183_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhhZGYwZjlkMjIyYzRmNjc4YmZkYTJiNTM5NTVkNDM4L3RhYmxlcmFuZ2U6OGFkZjBmOWQyMjJjNGY2NzhiZmRhMmI1Mzk1NWQ0MzhfMTEtNC0xLTEtMTA0Mzcy_58e7b400-c538-4001-831e-def057598f54"
      unitRef="usd">61000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia4b320ae27de4e16915e55e2cea04c39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy0xLTEtMS0xMDQzNzI_18e9c7ca-81de-4e15-a126-23aac1d8476c"
      unitRef="usd">143000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5af787ce477145f395b6c47dad80c78d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy0yLTEtMS0xMDQzNzI_3fbac21d-757f-4495-aa52-c4793282d9b5"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib401981a72924d8cb4fa3b85e149335f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMy00LTEtMS0xMDQzNzI_400526fe-8d72-4ccf-ade2-2c35c6d2830d"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC0xLTEtMS0xMDQzNzI_f51019da-d156-4186-8b33-a7e1260ad5c6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC0yLTEtMS0xMDQzNzI_5bbf1f67-e64c-4cc0-a4a2-2ce48c5db9c0"
      unitRef="usd">21000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNC00LTEtMS0xMDQzNzI_6aaab8bc-39ed-492f-98a9-6934073cfb74"
      unitRef="usd">52000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi0xLTEtMS0xMDQzNzI_0c2abf33-167c-4d52-8ca7-f636e3d6cd3b"
      unitRef="usd">-34000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi0yLTEtMS0xMDQzNzI_22a71d88-87fa-4bc9-beab-15262e9d2097"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNi00LTEtMS0xMDQzNzI_d10f2fec-8274-4c42-9cba-c03e00b376cf"
      unitRef="usd">-6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy0xLTEtMS0xMDQzNzI_2fd98492-6b31-4c63-9097-d70965e3bdeb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy0yLTEtMS0xMDQzNzI_0d44d00b-5725-40fd-9b26-fe75aadbd8d7"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfNy00LTEtMS0xMDQzNzI_1cc4ee67-399e-442b-8e00-835674d95cb3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC0xLTEtMS0xMDQzNzI_a14136de-a9bb-4505-aac8-cbcaedd68131"
      unitRef="usd">19000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC0yLTEtMS0xMDQzNzI_5eda0211-6929-447a-b88c-902c80df7e93"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOC00LTEtMS0xMDQzNzI_5d72a587-8a32-4bbe-b939-1d731b3b61b5"
      unitRef="usd">16000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS0xLTEtMS0xMDQzNzI_4144424f-a7c9-40ca-b7ce-4eef5650ef1c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS0yLTEtMS0xMDQzNzI_6195946f-64d4-4875-92f9-ed0edfde0efa"
      unitRef="usd">-10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfOS00LTEtMS0xMDQzNzI_95ca1fe5-baa5-4bc4-ad8d-1a4641e392a3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation
      contextRef="i36894205b57049ef997539ec21871c49_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtMS0xLTEtMTA0Mzcy_a08169da-3af0-42c5-9656-66bb6cd009ed"
      unitRef="usd">0</bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation>
    <bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtMi0xLTEtMTA0Mzcy_df148535-2127-4c78-93ee-4c233b4ba4a4"
      unitRef="usd">0</bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation>
    <bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation
      contextRef="ia81a6b32733248fc94b18e329ffdee1a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTAtNC0xLTEtMTA0Mzcy_404d4da7-72df-4f01-b106-115a4fd33942"
      unitRef="usd">1000000</bax:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic34110c3d1d548c099e33f7257520862_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtMS0xLTEtMTA0Mzcy_f4377d98-a560-4482-a52f-29519075e76b"
      unitRef="usd">90000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5785042f0a0a48b2a89a8d5e5292f378_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtMi0xLTEtMTA0Mzcy_212a0102-838d-4d72-bc9d-f435518a744c"
      unitRef="usd">44000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6c975de3f94448528111a2732f5ff183_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOmZlMmQwNTEzOTZlNTRhNDViZTBmYWNjNjU4YzQzMmI4L3RhYmxlcmFuZ2U6ZmUyZDA1MTM5NmU1NGE0NWJlMGZhY2M2NThjNDMyYjhfMTEtNC0xLTEtMTA0Mzcy_5d5ea404-56db-4560-a86d-5eb35d40c954"
      unitRef="usd">61000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="if2ff000d306648239fede97f2055f01f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjU5NA_34762a21-67ea-4e16-b687-5553480c6e21"
      unitRef="usd">8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfMjU5NA_ff8d4b04-207e-4dfc-a278-025bb5170026"
      unitRef="usd">8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDMyMg_ca389571-d819-4095-907a-dea0a4fbd72d">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of September&#160;30, 2022 and December&#160;31, 2021.&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy0xLTEtMS0xMDQzNzI_9999009d-f3f9-4ff6-a0c5-249757195f8b"
      unitRef="usd">275000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy0yLTEtMS0xMDQzNzI_c0281551-4b5b-40ac-96be-94593038710f"
      unitRef="usd">301000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy00LTEtMS0xMDQzNzI_ab7f20e9-8e11-4dc0-8413-c353c7816abf"
      unitRef="usd">275000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfMy01LTEtMS0xMDQzNzI_e44ab0a9-fdc6-47fa-8b5a-d6637817f197"
      unitRef="usd">301000000</us-gaap:ShorttermDebtFairValue>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC0xLTEtMS0xMDQzNzI_e2716af6-2f22-4eef-bf2e-33ef375fc028"
      unitRef="usd">4000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC0yLTEtMS0xMDQzNzI_cd60e316-0b7a-4834-a76c-4c6ba73a861b"
      unitRef="usd">210000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC00LTEtMS0xMDQzNzI_aa2bc9e5-7c37-48de-80c5-645a103048cd"
      unitRef="usd">4000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNC01LTEtMS0xMDQzNzI_786a4dc2-6e9e-4ce3-9837-99afb8974934"
      unitRef="usd">212000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i7a8551f83b15496db276708fb0ec4cc2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS0xLTEtMS0xMDQzNzI_e5855417-d3d8-4b68-ace5-8ca58a75ba64"
      unitRef="usd">16153000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="ie5748a1a16bd49a496f9c15a091112fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS0yLTEtMS0xMDQzNzI_61ec7bf2-518a-4cc8-a1a8-8c338f91d2fd"
      unitRef="usd">17149000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i60e9daec1c784937b3bc084af4e7d546_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS00LTEtMS0xMDQzNzI_1f5c2bb9-643f-4891-9359-4a257f59c831"
      unitRef="usd">14402000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i60aa20a1204d41029dcdf01856f5131f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RhYmxlOjhkZTdiOWZmNTA3MjQ3ZTE4YmU1Njc3ZjM2ZjlhMzNkL3RhYmxlcmFuZ2U6OGRlN2I5ZmY1MDcyNDdlMThiZTU2NzdmMzZmOWEzM2RfNS01LTEtMS0xMDQzNzI_08b200ce-eef6-4ee4-a399-090ddf7b3534"
      unitRef="usd">17568000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="i5f7ae0b172974bf08be1404801ce8bf3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDE4NQ_660fb92b-eddd-4b7a-aed0-5bed02fab9e3"
      unitRef="usd">102000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="i672fe12465f04ed1ac1c17454ce41b89_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184Mi9mcmFnOjIyYjQ3MDBlNmM3MzQyYzI4NzA1OWMzZGY4YjJiNmIxL3RleHRyZWdpb246MjJiNDcwMGU2YzczNDJjMjg3MDU5YzNkZjhiMmI2YjFfNDIwMQ_612d3009-363c-4108-bad5-6c84c4e5ae32"
      unitRef="usd">114000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyNw_7513a5a0-208e-4dd2-8888-7ec19b8249c0">SEGMENT INFORMATION&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $3.0&#160;billion and $3.3 billion for the three and nine months ended September&#160;30, 2022, respectively, and primarily related to goodwill and intangible asset impairments are now presented within Corporate as well. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 9 for additional information on Net Sales by product category.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfNjE_471fa98a-60d6-4c58-b4a1-659e2a556301"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8cdf58384f44554b6f0c7ae5b485465_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjE4MQ_471d9fce-e310-4147-ae7c-b21a90dfbffb"
      unitRef="usd">3000000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibd833938b8fd43d887495cb1fa7f7edd_D20220101-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjE4OA_681d94b5-3f47-4dc1-b517-4178f13ba485"
      unitRef="usd">3300000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyOA_8cc5af04-71c9-4eae-abc5-ebf78b2826c0">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy0xLTEtMS0xMDQzNzI_20a12824-a0af-4c0b-a50e-4e158ce441ba"
      unitRef="usd">1703000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4917de1dd954a059d60387d14e89f10_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy0yLTEtMS0xMDQzNzI_4d3acc43-e543-4c04-81f7-0c19376a93f1"
      unitRef="usd">1727000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy00LTEtMS0xMDQzNzI_3a23fff2-980c-4b7b-85e1-bb7505735325"
      unitRef="usd">4975000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMy01LTEtMS0xMDQzNzI_482ae491-70b2-4e1a-a476-c3ebf9bc173d"
      unitRef="usd">4911000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC0xLTEtMS0xMDQzNzI_aef8e04d-3925-4912-aa81-9a857d544582"
      unitRef="usd">692000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC0yLTEtMS0xMDQzNzI_083aecc8-79f7-4778-a6e3-714e60d552a0"
      unitRef="usd">779000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC00LTEtMS0xMDQzNzI_e7b09c4b-5878-49b7-a93d-75d3bbe10b3c"
      unitRef="usd">2129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6123385e384e4137985445ff7eee59cb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNC01LTEtMS0xMDQzNzI_a2ef80e0-089a-4726-ab3c-9eb22f4aa3aa"
      unitRef="usd">2300000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS0xLTEtMS0xMDQzNzI_545173b1-db48-4778-97b8-82a36e1a7469"
      unitRef="usd">643000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS0yLTEtMS0xMDQzNzI_c4cdcbde-93ff-44f6-b59f-8decacc98838"
      unitRef="usd">720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS00LTEtMS0xMDQzNzI_0a5c33e7-da1a-42d0-8b9c-92d042d4a816"
      unitRef="usd">1917000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNS01LTEtMS0xMDQzNzI_c6d74ac8-2d0f-452d-95c1-3f75abedc634"
      unitRef="usd">2059000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i327518eb465544d693c28e6cd73f5736_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi0xLTEtMS0xMDQzNzI_4ce4b5d4-c8e1-451d-a7ce-d5a1ef4c580c"
      unitRef="usd">735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi0yLTEtMS0xMDQzNzI_3125a5bb-1fc1-4535-9caa-780d40641b85"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi00LTEtMS0xMDQzNzI_546d5291-c4f4-4aea-b16c-9fed251f14e4"
      unitRef="usd">2205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNi01LTEtMS0xMDQzNzI_de4c10e7-0fc7-47b2-af5b-8eeec9067877"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy0xLTEtMS0xMDQzNzI_a60b0f81-a41d-48d7-812b-f44ff177c83d"
      unitRef="usd">3773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy0yLTEtMS0xMDQzNzI_90a7fd30-4b24-4f29-ad8e-df4679971d70"
      unitRef="usd">3226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy00LTEtMS0xMDQzNzI_6b0b03e2-24a9-44a6-97cd-50027dae2b56"
      unitRef="usd">11226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfNy01LTEtMS0xMDQzNzI_37e395c3-647c-4b96-92cb-e2d75678e1be"
      unitRef="usd">9270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia83c328bc9764409a34e302e3e2871c6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS0xLTEtMS0xMDQzNzI_d42f7b12-4275-4252-b10e-2849300222fd"
      unitRef="usd">588000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4917de1dd954a059d60387d14e89f10_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS0yLTEtMS0xMDQzNzI_794a0cc0-9e2d-4706-8d9f-a4446760dd50"
      unitRef="usd">676000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d2315d14dc84eda9845c619a7387f2d_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS00LTEtMS0xMDQzNzI_b83d2f8b-8720-4e09-8c4b-d2f67f93bdbc"
      unitRef="usd">1765000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f4414cef47442e9830f1f6ed11a8c8b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfOS01LTEtMS0xMDQzNzI_ee3b5e41-fd19-4f6d-9237-27027b3d4c5e"
      unitRef="usd">1907000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i55cfc45896334fef8f3f6cb429849987_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtMS0xLTEtMTA0Mzcy_15f1abca-79ef-4e15-8d8a-7b8069a3d09a"
      unitRef="usd">145000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iceb69ff7e5c742129f2c2bdeba7ae715_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtMi0xLTEtMTA0Mzcy_330f5519-f58c-4b67-afb8-18b8da208686"
      unitRef="usd">167000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic39092f8ca574e6e8e9fe0eded56a5e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtNC0xLTEtMTA0Mzcy_6abeafab-1d53-4ba4-8be6-aa4837f3f89c"
      unitRef="usd">433000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6123385e384e4137985445ff7eee59cb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTAtNS0xLTEtMTA0Mzcy_6a91c3de-45a7-4ce3-8207-2411a41c57a1"
      unitRef="usd">461000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i285bc940fada445c94c4cb052d1f1311_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtMS0xLTEtMTA0Mzcy_e90f7a45-9743-47cf-8d6b-dc61bcfa16c1"
      unitRef="usd">152000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2a7eac12d15644f1a8f04d295f3f122a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtMi0xLTEtMTA0Mzcy_5a3ad458-72e1-4c39-8a4c-6bb5b02cc3c6"
      unitRef="usd">166000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i45d7370157684cb7bc94d3b49cc2b6ee_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtNC0xLTEtMTA0Mzcy_546aec7d-39a0-4e17-8b3d-f05c9e764890"
      unitRef="usd">459000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifeadb481e2784fdbb563acee93e79f3c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTEtNS0xLTEtMTA0Mzcy_d16492b0-0ac2-49d6-a626-054c0f408177"
      unitRef="usd">456000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i327518eb465544d693c28e6cd73f5736_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItMS0xLTEtMTA0Mzcy_93809774-d590-41fe-8325-e283bc319ad2"
      unitRef="usd">215000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c39fc3b89f348429c6c07f43e2ef89e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItMi0xLTEtMTA0Mzcy_f33c4fb2-0949-445f-a573-26f46fd1be49"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie6363ede217e480081dfdc55b9c6d658_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItNC0xLTEtMTA0Mzcy_3db8ea8e-b48c-4e6c-97d2-d22bbe9b82e2"
      unitRef="usd">564000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib61c22304938414abb9e7daf4730d8aa_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTItNS0xLTEtMTA0Mzcy_a0e0ceab-f076-49c1-ac32-282f1f5aa086"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtMS0xLTEtMTA0Mzcy_bafeb035-381e-4054-ac12-a5ab3c1921a6"
      unitRef="usd">1100000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtMi0xLTEtMTA0Mzcy_e2b2c18b-bbc5-4b28-abaa-8d7ecff8f38b"
      unitRef="usd">1009000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtNC0xLTEtMTA0Mzcy_540b55af-a0dc-4bfc-a892-ed4c5e6807b0"
      unitRef="usd">3221000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjA0YzM4OWQ1OGQ4MzQ2NzA5Nzk0MGRmYTkyMDhkZjZmL3RhYmxlcmFuZ2U6MDRjMzg5ZDU4ZDgzNDY3MDk3OTQwZGZhOTIwOGRmNmZfMTMtNS0xLTEtMTA0Mzcy_9f4953ed-e63e-4806-ac26-b8643bdb4347"
      unitRef="usd">2824000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RleHRyZWdpb246ZTRiZjhmNzZhZTFiNDNlNjllMWExYTg0MmRhOTVlODZfMjcyNQ_f8a5bf39-6667-46cf-8600-820c1a9600c4">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="iacb32846a1f04d539fc16e45c8940b7f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi0xLTEtMS0xMDQzNzI_2c4bd6c7-531e-4682-90aa-57927f9205f2"
      unitRef="usd">1100000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c5ac71196f8479e8d0de4a46dc0fcf1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi0yLTEtMS0xMDQzNzI_6d783f58-35f2-4c47-864e-19b47ed4dbd9"
      unitRef="usd">1009000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i56e1184078a04ff9ad13a1f63ed55b39_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi00LTEtMS0xMDQzNzI_989b2886-9560-432f-a65d-6cfaed0373c9"
      unitRef="usd">3221000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf197800853d45b88e510dc03a56f58a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMi01LTEtMS0xMDQzNzI_ed1a51e2-bd4f-4861-898b-60a13d6dc4fe"
      unitRef="usd">2824000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ca18a38e7b24b8b99d1fe4106969b7b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy0xLTEtMS0xMDQzNzI_32dadca0-c8ec-4e6e-9bad-c011df829de4"
      unitRef="usd">-3899000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if51f0dd41ec94f6b858c4933e0bd444b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy0yLTEtMS0xMDQzNzI_c1fe9af4-8c77-4699-b131-eb0a242563a1"
      unitRef="usd">-496000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i07947bacb9de439897e75f3c619d0f5b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy00LTEtMS0xMDQzNzI_5334d169-c39d-46eb-8a64-70694665b1ea"
      unitRef="usd">-5517000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i44a9d785c00c479d87a0bf2f015e7811_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfMy01LTEtMS0xMDQzNzI_d7e06d72-5a8a-44e5-91a1-30b4bd7dd6c5"
      unitRef="usd">-1497000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC0xLTEtMS0xMDQzNzI_07593cd9-bb5d-43c3-9014-3db7bb6826f0"
      unitRef="usd">-2799000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC0yLTEtMS0xMDQzNzI_d3a9452d-4e97-4d76-89bb-661e1c2ce025"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC00LTEtMS0xMDQzNzI_df2d9042-3d20-4da7-be5d-d369ecc31153"
      unitRef="usd">-2296000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNC01LTEtMS0xMDQzNzI_c0d2f332-8b3e-415f-9ca1-ece768506538"
      unitRef="usd">1327000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS0xLTEtMS0xMDQzNzI_75aba368-f1d0-4226-8cad-42d99f50bb92"
      unitRef="usd">-104000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS0yLTEtMS0xMDQzNzI_4572a194-24f7-4081-b01e-8067d894df9c"
      unitRef="usd">-50000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS00LTEtMS0xMDQzNzI_4630d202-4239-48c1-ad81-6d68100859a6"
      unitRef="usd">-278000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNS01LTEtMS0xMDQzNzI_07fedbea-8460-4613-9ee3-568891f27170"
      unitRef="usd">-118000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi0xLTEtMS0xMDQzNzI_75dc57cf-c235-4f2f-b165-4d1f3a0f1fc2"
      unitRef="usd">-63000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi0yLTEtMS0xMDQzNzI_9c89ef21-f6dd-4b80-97ef-2e1621b94620"
      unitRef="usd">-12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi00LTEtMS0xMDQzNzI_6bd7caf2-34e2-4675-a33c-e8d8f93b569a"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNi01LTEtMS0xMDQzNzI_e9f19069-5b0c-42a3-ac85-fbe23c95ab2b"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id53ca5df30f04301a9054d72614b728c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy0xLTEtMS0xMDQzNzI_f5980f4c-9f35-4ab5-85c7-4a478ed4a541"
      unitRef="usd">-2966000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic9560ea787404b84b9f3c23f59281632_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy0yLTEtMS0xMDQzNzI_d2bd3133-bb33-479b-9bdf-f5a7058cb1e5"
      unitRef="usd">451000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy00LTEtMS0xMDQzNzI_124ab603-cd74-435d-903a-b497a6b331ad"
      unitRef="usd">-2577000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ied65f29b26b246ba97aa9f2d48635b2e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM184NS9mcmFnOmU0YmY4Zjc2YWUxYjQzZTY5ZTFhMWE4NDJkYTk1ZTg2L3RhYmxlOjEyNGY0ZjgwYjE4NTRhOGNhZDA5MzllMWYxNDlhNzYwL3RhYmxlcmFuZ2U6MTI0ZjRmODBiMTg1NGE4Y2FkMDkzOWUxZjE0OWE3NjBfNy01LTEtMS0xMDQzNzI_c543f461-6b02-450d-ad8e-3b1b32c53c0c"
      unitRef="usd">1194000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of September&#160;30, 2022, December&#160;31, 2021, and September&#160;30, 2021 (in millions):<xhtml:table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><xhtml:tr><xhtml:td style="width:1.0%"/><xhtml:td style="width:57.520%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.974%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:14.129%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.977%"/><xhtml:td style="width:0.1%"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2022</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</xhtml:span></xhtml:td></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,601&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,951&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,258&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</xhtml:span></xhtml:td><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,604&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,956&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,261&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMS0xLTEtMTA0Mzcy_c2237cf6-ee11-43d7-b41f-fb57a60da619"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMS0xLTEtMTA0Mzcy_172a13a9-4187-44aa-bfcc-09809e27d5a2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzgtMi0xLTEtMTA0Mzcy_bd6f8db5-a301-4f6a-8e39-9801e37091df"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RhYmxlOjEwNDZkNmViNmE5MDRjOTU5MjNjNTQ5ZTk5ZWQxOThiL3RhYmxlcmFuZ2U6MTA0NmQ2ZWI2YTkwNGM5NTkyM2M1NDllOTllZDE5OGJfMzktMi0xLTEtMTA0Mzcy_0a39e7e7-e6cf-495e-b9f1-296e6093fbca"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmFlZjlmNjY3NzIxMzQzYzQ4MDY3NDQ0NTA2Y2Y1NWMzL3NlYzphZWY5ZjY2NzcyMTM0M2M0ODA2NzQ0NDUwNmNmNTVjM18yOC9mcmFnOmJhZjllZGNiNjAxYTQ1ZDI4M2QzMzFkZDEwYWJkMDhjL3RleHRyZWdpb246YmFmOWVkY2I2MDFhNDVkMjgzZDMzMWRkMTBhYmQwOGNfNDI1_02785f94-15c7-4244-9c5d-88f8e6a43be4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M O1G^G9S#-'Y?ZW/_W/K9\'PV\KQ:W]^C[^F*-I*07^^7PA9J9'_%Y3J@[,
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M!BY,6Z:&UB8 !)DK! @R5?%70.=,.UE,W++X=#RZN-JJ%. *@<SS1A!D<85
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M#RL!_+Y@3.X;:H#J3G+T+U!+ P04    " "$.EM5N_'EVS<#  #*"@  &
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MG,L>'H/,.Z=\HD62M09SH;'1R(8K;#9!&@#N+X30VXEQ4+:O_A]02P,$%
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MM3GQ05-'#T9OK,T&R&7M,R@M@=+F4%H*I650&H?2!(JF2[BQ%P+W5H4+S^^
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MQ:$T@:+I&FK<AM#M-ERV7BZTR_1786 ^LG:*2MP=["T:Z(8&*"WK=#TX-*=
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M>+P9J"Y\*JJJV!Y_7,E\*?=U@/KW^Z*HOKX8*OY3L?]\S''[/U!+ P04
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M5\@ S$31F/]HU\M&$Y2UC1)E/Q@0E+SJ/NF/WA ' V+B&8#[ 7@\(/4,(/T
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M.P)GRRP\L;#88UN\&JK@T%SD/$-U3^MZM87:,HEJT2C)%)>&$T"'1CE-N["
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ME.;KEE&HR+4 W-\(H5Y^Z ?LCU\M_P]02P,$%     @ A#I;53*:;K=^"0
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M=)D.&[5"#PY=4"!@7!Y:Y9SQ.9P)3;89>C3&00$G*,4FOS. !.<A5W@B Z-
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MD2X3%21W38]/(_P%Y+*0@?@*=7.3 WTY#'*6JP:"]4_EV)JYU';+1^-E#D$
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MLKP [Y?&^'K"&S1_$%S\%U!+ P04    " "$.EM5@J+=7+@(  #I%P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6S-6%EOXS@2_BN$)YA- +>MPV=/
M$L YICM 7^ADMQ\6^T!+M,5M25235!S/K]^O*%F1'3LQL/NP@&%;%%E57]W%
M\Y72/TTBA&5/69J;BTYB;?&^WS=1(C)N>JH0.=XLE,ZXQ:->]DVA!8_=H2SM
M!YXWZF=<YIW+<[?V35^>J]*F,A??-#-EEG&]OA*I6EUT_,YFX;M<)I86^I?G
M!5^*>V'_7GS3>.HW5&*9B=Q(E3,M%A>=F?_^:D#[W89_2+$RK?^,D,R5^DD/
M=_%%QR.!1"HB2Q0X?A[%M4A3(@0Q?M4T.PU+.MC^OZ'^I\,.+'-NQ+5*?\C8
M)A>=28?%8L'+U'Y7JX^BQC,D>I%*C?MFJVKO,.RPJ#169?5A2)#)O/KE3[4>
M6@<FWH$#07T@<')7C)R4-]SRRW.M5DS3;E"C/PZJ.PWA9$Y&N;<:;R7.V<L/
M7[_>_+C[](G-OMRPKP\?;[^SNR\/LR\?[JX^W;+9_?WMPWV7?;E]..];L*-#
M_:@F?561#@Z0GK+/*K>)8;=Y+.+M\WV(V<@:;&2]"EXE>"^*'@N]+@N\('B%
M7MA@#QV]\!!VI>*53%/&\YC=Y9;G2SE/!9L9(ZQA-])$J3*E%NR?L[FQ&A[T
MKWUJJ+@,]G.AJ'IO"AZ)BP["Q@C]*#J7O__FC[P_7L$P:# ,7J/^W]GO?T2:
M-8I\2 1;J!21+O,EDX9Q!&ZD\DBFDKLH5 NVW.R>K]F\-.!J##-BB5"W/78J
M<_AYFF*S.6.S3&@9<?C0Y]L9FWV;7;./>*E5QAZ4Y2F[XBG/(\&P!:1O1"2R
MN= L])V7^.R$!=VA/\9OZ$WI*1C@>]0=3T;XG78GX8C-HE^E-++.$I$J<TOB
M\_C?B#^2RK#??YL$?O#'B]]@2)^[K.!2O[[S- #/X5GS>UUJ+?)HS>!7N4DK
M[9P& Y^V3.DKP)<_H".#<'RV@Q2Q8&NH=4 XJ,&88 43C[X]6@N[DXGO((_"
M*?M!YPTI?-EV?HD(7<A<6O$N19*DA28:>!4-R/],-CAQ*B]YFJY97&I2EG66
M+[5-V*^2:PO!<&"5B%P\XC^^2#E8BA(0%@8<6"1U5&;&$BQ:B&%I*T"*6T<O
MXEJOG24RL@G!-F64;"3*^)KERK*Y<$X&-ASR]@@C/2]S^1>D?P;:DAY"Z*5P
MF(A131_^N$HD,0"!0FGG!26T\C?S0A;Q% D10VI2#<BR1YZ68-Z$0MLG9@:%
MPD1:SIUJV1<%F$&7K<":?$]C>>/6\(+&B_VP]F*R48,I9B>CWH3-JR#9BBC:
MAY=>^Z4"0OW2H%TL16D9$Z83OS=M'WG;';K.?BK/Z^*ZDC"\,QQ_#J8>^UKJ
M!E@=X35;&-QN)0N;:"%V]&[>LV\(##IU7Q;TAMVO#?P>_/_4*"[L$[('N^9(
MT03]OM1+^%#*[E5:D@2FQVZ>_=,F4L?/[KEP8>.L4 A-_0V06BV72Z'?4:6/
MVRYCA;$N\HA2HW \"PZ/<>O*B/TPNA2T*T$&JF ?HV!HUTCCB!1:HF.2B#;B
MHWDL6,XS@4U.Y6TWVFL6T1AARSH_MH!7XCN4!U-,7&*+8J?\#+T)Y2^+*(RT
MHARO,AD1[]A1W_(ODD"#+=6$'+H'$Z8IU$7^*&''.J/$;*X5CQ$K$=4BER,$
MY+5K%UV\IDL;3^=G4')<1I!<<)V#M$M1 K6B3E9(1K4U-N!?6"764'[>4B\R
MP :72;"74Z:"*B*!_TZU6:%R>EW B0PK3:5RXE5H!7F(K.8KJ 4X)4\)Q*+.
M[E6FC= [TS$#CP9+I")'&&+W7/U\X7-0%UK,BI%U10]]Q#O+GUY);4[JDZ"5
M)NCPX1AH.1O6.&6$07-T'YN-A@_$YXZNNQ5)[RB2NY&]3<II$=2\(P5\F1-V
M"/;@Z$A$5+J@D1A-7VG<R#&GB:6J>WDU_52#R)+KN';EK9C=9X56TH[?2$25
M]9]K29-L=MS6>07H[13DM\@C2T"7L< 2Q@B<KS(<N:4#354-SXB?A"T(>*9B
MD2+4R77@]P!9P,61[,Z<"9JHR^"<LD@A[RF'V^N?T$2S%<J5P+^ !5SJ+TH"
MH/;@:B%G&2($;7=5/.MZ$3?AW9:2@K@6WF442HD.( R^1"N-].>6#XA<5:@C
M!2%?C%*8&G @ Y+D)[0U*0LWL=4ZF$AT(SI*D%(@<^D*@UACXZ-*'P4S+:64
MN9K35$#-2ZTAB'6H:.?0[IXNNYZI7;T'H@,UOX<IY\U&;[L!OW8CJ" E55G,
M)++ ;$3(54%U0T1)KE*U7+<S?@&ED\XJ'.B9H-^_]K)[>"YGD(ZR:$3MZ7=,
M2J1 9[B:F_/SJNW?4YL^:(5S!Y"[1G@P<'- =SQTC;%/3;+?'8XGU"S[H9L'
M0L_#/("VM 1<LG(E>MV>#WR/FO+N>!"Z#AU/>_K\<(RWKUJ0I/#"L6O9/3>7
M3%\*,^I.@_&>D>8(H&$%=.)1YQ\.!H[VU $.0L\!'4-EAX'Z(S=]=(?#$0'U
M@SU 03'TC@ :C(?5;#*@7S\,7D@S[HZG07L"K_+IEDCBJ1 YXFB%N#OQ1Y.-
MC]8][_/SIJFO:G]674$(NH+8YS5TFK3:I3);"'='E*ZK)N.$K+'%QI].7_#)
MJ5 =RV9/!.Y>/&Q-#H@('E<=U29M[BEV9E.VR(YS3$*NJ6W5GDW#<*!/"&&3
M[(@^@42HNJY]\]E6IW1,AUL-6RZQ4")1[=9VJZ,]T,%V:Y4@ZZ(DRLR1:150
MJJC4U!Y3J'>2.S7.=5OFQDZ>5NVHFQ8C:@-Y[J!3PTM^&;L62J4R=E)@J+5U
MV7#SE"N@IRD"]VS'0<DSCG&A@^W!$;/[_HYAMR$H78/^:C= PIJ7!?VM$JW5
MFJ?HXI]+\7;1KLKPFT#^'RKSOBN[?NOZ%:5RZ2Z9#7, JYO89K6YQYY5U[?/
MVZM+\,_P1HD6-14+'/5ZXV$'DY.[6*X>K"K<9>Y<6=1E]S<1B!I-&_!^H93=
M/!"#YG;_\C]02P,$%     @ A#I;5;(.M @A!@  !A   !D   !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&ULM5=A3QLY$/TK5LI5K02;9)- : $)*+2<KH!(
M>_UPN@_.[B3KZZZ=VEY"_OV]\2:;A!!$J[LO$'L];]Z,WXSMHZFQWUU&Y,5#
MD6MWW,B\G[QK-EV242%=9":D\65D;"$]AG;<=!-+,@U&1=Z,6ZW]9B&5;IP<
MA;E;>W)D2I\K3;=6N+(HI)V=46ZFQXUV8S%QI\:9YXGFR=%$CFE _NODUF+4
MK%%259!VRFAA:73<.&V_.^OR^K#@3T53M_);<"1#8[[SX"H];K28$.64>$:0
M^'=/YY3G# 0:/^:8C=HE&Z[^7J!?AM@1RU Z.C?Y-Y7Z[+C1;XB41K+,_9V9
M?J)Y/#W&2TSNPE\QK=;&!PV1E,Z;8FX,!H72U7_Y,,_#BD&_M<4@GAO$@7?E
M*+#\(+T\.;)F*BRO!AK_"*$&:Y!3FC=EX"V^*MCYD\NKZ]/K\ZOKC^+T[N[T
M^N/%YXOK+X.CI@<VKV@F<YRS"B?>@G,H/AOM,R<N=$KINGT3G&IB\8+86?PL
MX( FD>BT=D7<BN-G\#IUH)V U]F"]X&&7GQ0+LF-*RV)OTZ'SEN(XN^G@JVP
MND]C<:&\<Q.9T'$#E>#(WE/CY/6K]G[K_3-,NS73[G/H/[$EOX(C!FJLU4@E
M4B,?G)13+@SE9^)*8R*A8DB6L][>%5,2RKF24K'3;[6@OSSG4C(CT8KZ^_W?
MA".MC!7:>'(B+;%<LVEG5^RTHZX8+@W:42>.MQIT*X/>NL5AN[?5XB!8Q&L6
M<10?;/?1#Q:]1Q:]SN$VBTX,BX/>6MR=J-W9ZJ*'E.UTUA,URHWT2H^%E9ZV
MYDM(G?Z::5>\00\(3>Z>\MFN\!F)3P"QIJ@6OQ7>B%$)!U),C/5S=%Z7&'37
ME(#/DVCQ:]8R^5$JI_C;+AKP1,Y$0M:CT\-W"NE0JLDY!JM-X 7>>.F(P)/'
M]( 3Q&%@*4<@80&[@3L:&\07L?) Y9]25ZUZJGP6EK#XI$[(+0BO!1;T2=J3
M!:C2@)7P,59<UP''<DL&B;$EPD'B.6733"49&X;90&:D<GILZCRH!IN:S.#B
MO!J@Y"?(-YM*3N4(]8+?])!D4H]IDVC(K,8)%8HI!%/-U]A.%K C6[@YC1 3
M]HRJ+1E04EKL!&Q0KJ$Z#CNH,HGHP!(M-Q)?,N-HR2+P<AN,-\E-X0OI+R8Y
M^9#(BA%A1U+QHY069$*MH!&'K0J;IZSS(I/Y:/$I[ :K1+&2.[U5)9O2BITX
M:M6EYS,D?V]&TH:H!90._<E$Y=R(JF+H/0\Q@MZW(7 R"%,0YX@#9<98F<^0
M'JXHR#H+FQMDI5!/W BGR"92(MRR0];Q8I7=R$8(>9[_JIZP:\HO!>?$V-R3
MU5S$',"66/G3UV@0B125+.U>2MK@K _%8NG>Y/<,, =?LV2G8Y "U=F*SA]O
M.CNX**UY&?(N:X DRB3!?8?M4U3N;-XQ"GA(:)$]1M:X.^:$.'&+$Z%^L.R>
M-)\P4/)D+S535!3NDVF)2BNU5[GXO=2T.-^[D?B&1.;._ _9%"_+)I<&TEBU
MN^!^B#@SW%2_5_TW".F/J[.;NT49A:($Z$T@A58C+N%&)PQ_QR9O!C>7=V]?
MH*%%V>#,>:SY..K6QTU:KK5^5.-Y%<5E%06WAYM?TE+&C03;C4L-#^$;M;8\
M*1=I?;F&GD!\_:K?V>^^CY>'7"0N6&7SWCY:!H';-C+KYG'NAW)&DPJ=2ALQ
M-!9W*GA%*RT]6K5.F4+=+AT]HL.8,O1=7"M]=<-9W"T%$EM?>SKM,-F.0AZ#
MV&VB9(X3;8+/M6,AK>4N6\G2$@Y*4"L=2X.?0N&0!!\KH?RE59V.BBJG=),H
M'Q;0M"P,*D5(KBV)7@L?X#$OYM6PM[-T$,CRXVWX>+HE#4&'F601'JPUW@WX
M5=^AT4B8LOPIW9/S+J#"J0S6H73"O:F%:Q/KB(],',P04+YI%TH:R[N'(I4S
M\*_H;NS/DNVC.]-_P[:%B^1/L.WW*[9/7?Z;*V\S,!N'%Z@#3VQN]4RK9^M'
M[FGUMELNKU[(GZ4%$0<]C&#:B@YZC>J*LQAX,PDOO:'Q>#>&GQD>ZF1Y ;Z/
M# [\^8 =U$__DW\!4$L#!!0    ( (0Z6U52LU5.&@\  ' F   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;*U:76\;MQ+]*X1;% F@R):<M$F;!'!L
MMW':Q$'<CX>+^T#M<B7&JZ5*<J6HO_Z>F2%W5[)LM,5]L:45.9R/,S-G*+W<
M.'\;%L9$]659-^'5T2+&U??'QZ%8F*4.8[<R#3ZIG%_JB+=^?AQ6WNB2-RWK
MX^G)R;?'2VV;H]<O^=E'__JE:V-M&_/1J] NE]IOWYC:;5X=38[R@T]VOHCT
MX/CURY6>FQL3?UM]]'AWW$DI[=(TP;I&>5.].CJ;?/_F*:WG!;];LPF#UXHL
MF3EW2V^NRE=')Z20J4T128+&O[4Y-W5-@J#&GTGF47<D;1R^SM)_9-MARTP'
M<^[J/VP9%Z^.GA^ITE2ZK>,GMWEKDCW/2%[AZL!_U4;6/IL>J:(-T2W39FBP
MM(W\UU^2'P8;GI_<LV&:-DQ9;SF(M;S04;]^Z=U&>5H-:?2"3>7=4,XV%)2;
MZ/&IQ;[X^OSZ_?NK7]]??OCU1IU]N%#GUQ]^O?KPT^6'\ZO+FY?'$4?0PN,B
MB7LCXJ;WB'NAWKLF+H*Z;$I3[NX_AFJ=?M.LWYOI@P)OS&JL3D]&:GHRG3X@
M[[2S]Y3EG=YGKULN;02J8E"Z*=4YU+7-W#2%-4%=V%#4+K3>J/^<S4+T ,U_
M#WE!#GEZ^!!*I._#2A?FU1$R)1B_-D>OO_EJ\NW)#P^8\+0SX>E#TO]YR!X4
M=UC9!\]0?QBEX2+;K%V]-B5>J)5W95M$55L]L[6-VY%:Z0@WCU0!EQM?6%V/
MV.4N+HQ7M9GK&DB.T?B@XD)'R+2!I.*=40WE7(W-K<=#5RF\4+,V0/L0QJ2"
M-X7SI=+]F6JS, T]<"$H&[ 9Q:,T'BI"OYF>U88U(/EZZ=HFJD(W:D:R=' -
M%FR5"=%"+5..U57%2[L/3?<A*:1[H?E K;P&F,3.QN5#-C8NDEG\N2R=&;*]
M$SGBSY'B=MDN\\X[NXK"MTFUWL[&Q5X7Y^]H!B-IR3UVCDC3WH>0)YZE8\X"
M68HDC&8Y@[(Y$]G "U.DIQ-^BK\4I.@B I=EJ(2IP%Z@=RL49"Q*""!!IEE;
M[QK*R@$F-@B<^OIT I_4-5=P+/WZNVE^/\K"4-;K+4-BH=<<(QAH41,'AZ-]
MJ<+XB#9%%K&KTSDEDKX- :MGU*/&&=[D,O8A=.WB/H .)$I<" O-5EP]/*?8
MJ2WTR69ABP7)\$;BEA7DJ)6EI4X%%W2BLHZZIHZ[S<L1F3\6EH(-?P]"QV<V
MJ>&QOW$6TJ>HM5T.<= %O\L'2'9URQM9/QAE&[;+FY7S9(A:&6]=23E9E^)K
MK8*=-[:R$ VT+E%'X)B&]8)$M$8&$#B$UR1;BFZAPT)5\+48R<DOLB4)0!Y0
M-$P*%/07J #4A3$E-.E0;[X0 & &8I04(K.\)625:T.UPU25Z;6BFN!J6[+Q
ME6UT0Y5)K5Q@YV?';@RAP9JU$?4V"5QKC;W4]L%+$-24GSE, 2P*%L'O#*41
M8A/MG"TGC6U#GFTBLJ]M$DI&L*% 2;,DW/C2%G!9Z90KBM9+(=G0 11=/.G-
M^]R6<^EC<"'^(P]M S=T"Z!,K$U:4B4,H'(T'=+(:SN98$+A[2QGPHA.]H:H
M'4C;['/*6T:+#;<DM&HC-4M=4MVB?DG)R$JG[&8H4KW>2_ZY@[$YXVF]-_.V
MUM'Y;59GE(*?9+ /:F0!;<_M!E5&US66VN8S7,H+AUT&)T9ODX"$@#TP+EUC
M(OBH"KH3 %?7+0%M!]Z%7=N:O TGP5Y"C<'?B.R^:R!B :J)-ZT@%X=24TRQ
MI!3\ LP)<H>'#! #J (D#:E!/@\%A.1.V)D8OOGJ^73RW0\("?@G%+EI46)V
MI%"V2C)R2DMU@1QIT*1<3"6#DQ$>3_6$T>1O3<S^AFNDA(G0'(W=*I#%!UT;
M;(!,5G1#S3V#$QF@)2T3@@X6BS%HY+ S[/,.36UTY<@*D4G^IYY/57NEX7#U
MZ..GCX^YRNPVF0*Z-T_:%2P)1 4C3/@"W^'LJH5O40THJK^!QHI/?AO?C(>?
M1QW;*%!?4I6D!RA4>@.34?+)!.?9GH7^2_O2M>AH.F!-(*>SU]!Y@ '-F *2
MMT4MD(MB)Q5V&$+*\S/6&2K;BEN+)@Q2<E?>+5,133B#'I$YEKZ5HD 6#!PP
M5K\N1-FD*SD/F]=@2XF+*3@N0W5A$.S/SG+E(HL#ZJ)L&NA(9X@WN7>LJ<<0
M!F&2)/@2M5O>,YQATIBHA?;DN60$)7SO930*PX6>@CU#R> $VN>>H'"NF3L2
MO!OD[DC.]1 <2CV)XLZX0+URJ T[]2 .20+E6:4+R@5.\7]#AO85$CJ2TX@L
M68*2M411F>&@,1 ?(8)!95@'2XN9"4V^VV5"D^?W,:&SBJ*?V6]R>#"#XP]V
MV=P&_G5OO=M.!=D'4_LG 9[ZI2]5:$UG[1Q#+QPX><&Q9M,;O>PBC9<T6M)4
ML4)'0RI5Z-=PU5;]J+=$J3'3P7NHM3\9Y^=6YR;]_N(7.L&;[]4'G8C61\\M
M;\7'7Z\('D.%4-^Y"R0)7 ,NK+04.L9CO/E _1YENO\ AEXOK),DZ_5$OIBY
M2;/.$BZQJYJ<WK0 &15!+PVI9#FS-M</)VKE$DPLB].\WJ;JG%A<B>A[CA='
M\T[)UBVUFX7V2XKHKK/V=04$:O2X*&ZW5"%)^RZ52,(;_85@QD<[25/6'0YK
MP;YIOMD8S&-HS<"(S"9[IG 7DT*2*01/:[).QKR!@TJI5LC9!V3:9IBX3(K/
M$1\T^+?(%L3K7?8(X$4^"\E*8&["].@#"@VG<H=")JV[A<%5:'?=F-(CE'A6
M"(FT##Q:: 895ET" (VZ1.VSJ&"8<AME"!UCM1YGIUX1GVLR2J^:8IS7"!M%
M! 3V&9D-Q^J&FE#8@VA7G \B]0H5I'$V" )$65M5Y".7(%M2<VA]L= $H  $
MF9#=0,,][$0I+6Y5V?JNNJ-V@!!0HK(_,KT7K3$.XU$;A2[N>,S1/+[0=<6M
M$XS5U)7T'#IWX>J2G4[*%7^VED"1?+:C2@;?CV;F6V)W4R[+DQ<LZ[J(C@-\
M*@_WC,]V=]1_-_XI\&OK:FXG-R81S,G)H]EC7CP]>:0?YT$3G\,QU$/4Y1=X
MD6;&,_'^Y,7I4][PJ064)R>S)\\(R:@.<YU2V9N62<B,TOV6NVD7E4K7(7$0
M&XB-,7\@$/0W7)6V3"N0L:5<;_4TC+(DTKQ?I[[L.C/A":^?$'Z)W>!U$S(1
M9WVBOH5[,[0 #V*S9%(B/R0.GQH00YIPQ.HY)/.\HM?.E@>7$'ND#J4IL^J:
M_A/.K"1$S<S'NQI/D3N#CM--J6-UW:AW*!H<]1?<C$^DXTDZZ-6*J R\^SMJ
MH5;O6^;H']--\U6#=@RAM%R,)R_^XE#3K&YH>6,+NZ(=F".Q[!(I[K8&T?UD
MHO7L>G6S15E9DO9,DCMH=2,C49NQ^M@_E\PXV.&@U;NV,6KZ3*P1^F=Y,L!@
MAH!G LRI!P'#<LT.R7WU:?8'4)U.Q 24AT$ !$ *Z99C3XT=QTZFF>7TCIW#
M;>16BM??E*G0YH"*M1EZB/C<BJ()3\L40II"T:KE O;D@&J<OV#\E&3>Z&*1
M?#GW1@)"8Q8/Q)WW&;Q?3[[M6=3>D,OBC50EIMR5I>\!:$1EC@8 "C@J'@:!
M*S!HO)AM>Z>(9KO^V5N>JD0_KE.\4[PFB4QVUS2#53/,OLM,P:B.8EM/3B>G
MLI-I*Z"2 ))+0)G[)'VWH9X_^9EV=V7QZ:CO?>#98 C:6V[2:QM,TB1B@NM*
MW.6Y7(/UB3J8 %PC4\C?J"U<<>4>*2%IY0TJ;1OJ?!-EZ&JU>9*XY($:$E*=
MX6L(+B=RIU<'NF\KC.7941J%-!0\_K.%M@P);%WE>3A=.SMW&](00[>:X9Z;
MMCL.5'3A1E<]_="5BPJ:*42($7DD.>C6Q+\.N)/+MBG[^Q*F4X.>-WDN TJZ
MR$E9,<10=RQ.DCL,3 7,Q2*[%NXH3;/-71W(3==O4L3V[GWHPA?^"Z$50IX$
M"X6B3)2[&PR5.EVFR 7*ENP=S#."=L*+3NVM-!B$H@R)TG?E1J<:$ V>7T-^
MSNJ:DD>,T#=@GGDEDN(\C\8KMV(\$Y$%H\[WNKAMW 95<IY GZ*7[ESZ",K-
M(94@*PNS8<E1J!Q0_T]$A9@*U*.P\*GO-8A5[E$;QPJV%'#FE:E$,YZC:CO'
M/TCER/7#<DJM0*:8SW"#"7)ODFZ$L(]OHN@2ABZZXV);HX,K]X7N MI!I>B)
M."?=@%^_IQF"$OLMYLF1.O.WE-$\)!"AQ[J_S#Y_SGQ]CWH%%5P[7V"2T$L]
M-SMW<50PT*2E E,,5]0@"'AI<1H1VZ8'A=S52VH,G^?[PG7&%TBH%\F>[GVK
M>UK*X7X23!^W%"%07%_N17S"]454"IE<IF\:.DH&P;NS=)J?^ZG%)YQE;%%S
M6>P?U7\?$BR1&;[?7].W/9N4Y?T=X6CXW4/ZKH#O<!)>..T>0 GLV(' CIGI
MRR_^Y@HE>%C/A]_4:#[RSBT*DXZNK)[D>J:SOP>CT-TL^8-FN[TDZ<"YFQ;;
M?Y 4^^9R'K]K89 P(IHSGWQRRY$,;L.6T\Y6#I5!/<K777N3VS4/%YS,TH7@
MR'Q1DKGV!5V912$*E7IK4&<6#.*W+<V2-\:O(2.H1Q=OW]X\SJV-+"U=T?:#
M@6WD-QWR\PJIAE1TB?58)L!==_B1YXQS00:-+IF.G"%IG_QLB]L92B4;T=*M
M'GF #*0F-Z,QC'Z:01IT$DFW3LJN1>] ?,@)CRZNWSU.E_U\,;FKL-STKDUF
M:]FW_>G<\(?T909*W'"4Q=J.JQ DS4:<F#?S-[B;/%QR)K$I7<FG(M@2I[K'
MJ.MW=[[RW+EGDPK#>UP5Z:*$&F>0X3ANY:Z_0PQ_M;UWJYJFU-V&>"A>G$5=
M;DV?9^[^BVU,5&=+NE/1(>'U$3]]W(T'@QNLE&$9X$!_S7Q =O;(SWTR/\^.
MY<\R0--Q_[<;C-'@CN6@8>OQ?9K_<(_F/]RKM1RP<Z67D7/@7@#^9A^<DKX4
M]9N%7/Q0_D1/3#]?"#Q_<=)!J&OHN\O0W@_]C.1X\"L@&#[GWSH110'^Y0=!
MW=/NYU1G\BNB?KG\%@ND9$X,NC85MIZ,OWMV)-\OY3?1K?@W13,7HUORRP7F
M7.-I 3ZOG(OY#1W0_<CL]?\ 4$L#!!0    ( (0Z6U6+:6<V@@(  ,D%   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;+54WT_;,!#^5T[9Q%ZV)DT+
M%&@CM84)M"&Z%C9-TQ[<^)I$Q'9FNP3^^YV=-A0)JKWLH<V=?=]W=[X?PUKI
M>Y,C6G@4I32C(+>V.@U#D^8HF.FH"B7=K)06S)*JL]!4&AGW(%&&<10=A8(5
M,DB&_FRFDZ%:V[*0.--@UD(P_33!4M6CH!ML#^9%EEMW$";#BF6X0'M7S31I
M8<O""X'2%$J"QM4H&'=/)WUG[PV^%UB;'1E<)DNE[IURQ4=!Y +"$E/K&!A]
M'G"*9>F(*(P_&\Z@=>F N_*6_;//G7)9,H-35?XHN,U'P2  CBNV+NU<U9>X
MR>?0\:6J-/X?ZL:VWPL@71NKQ 9,$8A"-E_VN'F''< @>@,0;P"QC[MQY*,\
M9Y8E0ZUJT,Z:V)S@4_5H"JZ0KB@+J^FV()Q-%K<WTR^7-U_/+^:+@W>#N'M\
M!A??[JYN?PY#2_S.*DPW7).&*WZ#ZP2NE;2Y@0O)D;_$AQ17&UR\#6X2[R5<
M8-6!7O01XBB.]_#UVF1[GJ_W%E_.-'Z:4!$YS-@3]9:%L=9,9NCE7^.EL9H:
MY?=KR3?<_=>YW?"<FHJE. IH.@SJ!PR2@W?=H^AL3^3]-O+^/O879?JPIT#_
MSO*RV#!E)H?SXJ'@*+EI5-ZJ'-.2GHY#A330[A6!]@'8'.FG$8%)#I*\@6@Z
M %T' -7/HE@29EM$J)&P[Z-.?.(Q) V..O_+7??9W2!J_46''5A8E=[#'*NU
M3G/J!YAIE6DFS&NU"G?&2Z#._!(QD*JUM,VDM:?MGAHWX_ELWBRY:Z:S0AHH
M<470J'-\&(!N%D>C6%7Y85TJ2Z/OQ9QV+6IG0/<KI>Q6<0[:[9W\!5!+ P04
M    " "$.EM5$B=\?.P%  #]$   &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6RU6-MNVS@0_96!NR@DP(DMV?(E30(XCKL)T%R0I-V'Q3[0TMC25A)5
MDLYEOWYG2-EU$N?6RT-"2B(/S\R<&9+>O9'JJTX1#=P6>:GW&JDQU4ZKI>,4
M"Z&W984E?9E)50A#CVK>TI5"D=A)1=X*V^U>JQ!9V=C?M>_.U?ZN7)@\*_%<
M@5X4A5!W!YC+F[U&T%B^N,CFJ>$7K?W=2LSQ$LWGZES14VN%DF0%ECJ3)2B<
M[35&P<Y!E\?; 5\RO-%K?6!+IE)^Y8?C9*_19D*88VP805!SC6/,<P8B&M]J
MS,9J29ZXWE^B?[2VDRU3H7$L\[^RQ*1[C4$#$IR)16XNY,T1UO9$C!?+7-O_
M<./&=H8-B!?:R**>3 R*K'2MN*W]L#9AT'YB0EA/""UOMY!E>2B,V-]5\@84
MCR8T[EA3[6PBEY4<E$NCZ&M&\\S^:#S^?/+YT^AJ<@AG5T>3"QB?G9Q?3(XF
MIY?'7R9P?$K/D]V6H;5X1BNN<0\<;O@$[A!.9&E2#9,RP>3^_!9Q7!$-ET0/
MPF<!+[':ADZ["6$[#)_!ZZP,[UB\SA-XDV^+S-S!WZ.I-HJT\<\F&QU$=S,$
MY\N.KD2,>PU*"(WJ&AO[[]\%O?:'9PAV5P2[SZ'_1&1^!2Z,94%&I9Q^UPA9
M&<O"-ODB00TBSR%.13FG?E8"R33^FLH\0:7?OQN$0?\#H'.P286!1$(I#0B5
M:829D@60STLM;&9JDKQ)[V$T090)Q/0MTT:#G$%)]:DFX>52:[])V5$L<L%)
M[="XSWF>_$MI0W6#)GKCJQ&/1&6H/L&<_FD+S1!$W5*IZA+#[Z5)44$E21-H
M,H4, UA4N;Q#A"F6.,L,>&?GDP,?JES4<(^ "2X6.H49%3U(,2$_;<-52L;+
MG%YEY1R,F.;D49K&QFW)V981M\OBR"83E74?B[@V&)<TXTTA<MX!;W0V/O9A
M>F='R9+MH!)N04M2!!0N/9'3$RBY#!93PEQFF#6&.L$V>+1XD>4YA\H'\BB<
MKWF,75%[XHCL9,MLI<U,1KQ'UR++V= M6GQ+"[+X$*<&-,8+Y89<22-R^--Z
MT'/N\^% $&*,(&SP#S&NV06670!_@!<VA^V^S[U.U[5!V./6"C#\8+\T.X.V
M#V<ONFN*Q ]IEXESH74VRV+AI.D- @(-A]#I0 A>/PI]&!5RP>KZ/II<:*7$
M3@=/^-"+(!B"1U.7;/H#."4-OR)R_2CPH3N L,\K]OK=A^[8$"UK:R\:6#^$
MPZ%M76,_=IOMB'!^)I0_$*>VBU,T</&)V!2.4]3QZ^@$W3=$QPLC @HZ$%&W
M,WQ5();NC]I LND'KPV"7:I',>\1W][@Q1#4DAQTG8E1$-22K"7:[ Y(.<SH
MD@J)R_TI'XEL5B9(]2FG4C"E<Q/GJ-Z@Q8<%Q):.!_5"/.\1(]<+:4(IR(6(
MYIE4$2T6P1N+PRM"<%]T5W:EEQ8X?<3BDW1N8$NS@G9=-F-IB394%FVM9DU?
M// <3WEBL^!HLU=0*#)\KCE6O<A?-DZ:GEO%![SEO0*;UHF?4.L=N**:C;,9
MG3%74ENVQXX;5_5ZX@-T*\69'? H#3.R1[-WE<G^6UG!Z]8[#(^L5$;BX8-'
M1LJ,I=TK2=@*D\Q86^J"\%930N@]1=_)>GB/_8.B0%S3Q_6##M%T1"X)S&UJ
MO+W;DQ<3[=%?$-"A0UM0WB@T,3!(YRH#BJ*[-MRCW/(HSU;?[QD30;^N5779
M8(:/++08@;_9RJYEM&:@PWN\.RQWU HI$HGUC\OW/CG>32J_HW R+/.%M%L)
M18KE7.?'A$$YZY-%?2JZGZR_)=&"#8FV8= K<^^A6JO?).K0U=9>^$95=R$(
MGY!U4.]0[0VZ_@$Y>R[)0]KG?H6D.>L\WDE>UG7P9.;6E +_QX0=AD[8P6-A
M;[KLM-:NI 6JN;UX:[*81.QNIZNWJ[O]R%UIOP]W/PR<"#7G..0XHZGM[7[4
M .4NV^[!R,I><*?2T'79=E,4=(_@ ?1])J59/O "JU\\]O\'4$L#!!0    (
M (0Z6U6/>-(ETA(  +0U   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;,5;6Y/;-I;^*Z@>[ZQ=Q:A%ZNY;E=W.5+PU<5SNQ'G8V@>(A"3&%*$!R.[6
M_OK]S@' BT1UV_.R58DLD<#!N9_O .C7]]I\LSNE*O&P+TK[YFI758>7U]<V
MW:F]M"-]4"7>;+39RPH_S?;:'HR2&4_:%]?)>#R_WLN\O'K[FI]]-F]?Z[HJ
M\E)]-L+6^[TTQ_>JT/=OKN*K\.!+OMU5].#Z[>N#W*I;5?UQ^&SPZ[JADN5[
M5=I<E\*HS9NK=_'+]U,:SP.^YNK>=KX+DF2M]3?Z\3%[<S4FAE2ATHHH2/QS
MIVY441 AL/$O3_.J69(F=K\'ZO]@V2'+6EIUHXL_\ZS:O;E:7HE,;61=5%_T
M_2_*RS,C>JDN+'^*>S=VNK@2:6TKO?>3P<$^+]V_\L'KH3-A.;XP(?$3$N;;
M+<1<?I"5?/O:Z'MA:#2HT1<6E6>#N;PDH]Q6!F]SS*O>?OGYZ\^?_OCY]O5U
M!6KT[#KU,]^[F<F%F2OQJRZKG14_EYG*^O.OP47#2A)8>9\\2O!6'49B,HY$
M,DZ21^A-&M$F3&]R231UI\I:B8W1>W$#7@U< .JM=N*&%:N,^.]W:\O/_V=(
M 8[^=)@^A<M+>Y"I>G.%>+#*W*FKMW__6SP?OWJ$^VG#_?0QZH\:YOMF!OES
M*_9*VMJH3$@KJIT2<J_KLA)Z(U*-^,J4D1PC]TJHAP,"1E0:(9<J1(S(2SQ,
M=[+<0I?:".BKM!ME3%YNQ5;KS H\/1A]EV?TB#21I\J.Q#MQ4(831YDJH==%
MOG7K@"5),_:Y9?J2^'#VP<)A 3S.<EOE)1[3.K2,)\[#($@:#"G+C*C2L[K,
M6329IBPEZ/-0OP*Q%;[__6_+)%Z\LFY)Z1+%P= "Q&)1Z%164!M64S+=M>Q<
MD(NX@-KTMLS_UVG;>"/<[U09D0#21LS.9<U8?+.;7&4C<0O92!1=FX9G*W82
M5MDC[>2'XA(A:!]9JS.)_?ZI21%Y0!"[I[5'-!64<T&BVI)3D 1K92N!__,]
M48=8M("MH#19Z!)?D9MIK".+]WV=G[K F5U_PQK;0J]E(0[RB,H!;U)F#T,:
M<'D\Y"E$.X*-ZEZI$JGFI]589/((7?VJ;144?4$W3*6QC9 5N;#.O8.A4(W$
M[SN8#[P6=:;(C@4^/=&UT3+#>%-M=)%KELY:L)B#VYV21;5+:0$$15:3O61J
MM+5N+JD0HR'YEJ2R3M1J9Y02A=K*]"C>RP?(*K9*;XT\[/*T&1P8 L4::B<7
M37=&EQB28?&C=6&#6;FRKV /97)XR,>OPNJB9M%?@<:FYCILCQA *@693'&<
MOX*V#58"B4*4=65RMGN'9E[NH OH#%+@<96G>+A5)59*\?(O)!RY)J_<2>@]
M55@5IL(86@6):TL_H:4]K$1ZIZ=0F83N@[Z<2KPR?LF+@I*^5T'')  >%1P@
M"W(0[U5.8_;02*4YI[%LN=R66 X,5BK=E;K06Y8%F?Z0(UUJ<_1V:_5 $V5V
M1YZ3"?6O.C_P\IPTR=6#)%PU7(#NO>-5.VV5<YGH$2_LY0=1'_ D4P6R-+@Y
M28G('KO\< @"(7]G'%V,@V BY3PZ% "7Y=9(\76Q@?Z8\^Y8D@WC2UV=SY%0
M-9R PGJ8;\2&QJB"?-Z@G%2@SLF&_08& AUI#-48Y[2DLWNX\:[)H'M)H=M-
MKQIB^\@C5:H'N4=N<^I[MR?GDO;<!YI* Q[K#;[4SNB=U1V)BUZ4Y=N\@ADY
ME'19PGW!#8=O$S+^95'(M?;%M=+ :C 1>3"&YL0L$>Y*XM1<%"%MG 5QZU4%
M:KJW2ZI,!?P-!UO;U.0'7L[J375/"]&( @Y:VE,Y1^+/CD(;37M_A3_V3-(R
M267L+/W!$=$I, + ZL2\NI-%[62'.%0!^S5;KXEK;Q%=A(K@<4'68HL6470P
MS9 CN$6HAI%GHTFIF!VP@@Q4IBX64((MNATV1(\?SX=M4!*/PU),264M(??]
M-$PS#7MP?/#X=BFNO?2K@+.7DOH0E$5G&3#+]1RO50E2J>)4:*B;H.@*E8R,
MTETLU>0_%:&$=UQE )^1T=:0(V#HR!'/Q+-X/%J)-?S9V^*\B/>PCE'4SG$I
MOE +C2H:8/2@J+!DIU@# B&=;O,2D9+5IO&#O:9JO*/7J/E')4WD(]W5/Z #
M%*!C\/@LU/G3B/;HJ%W5C_L#>1RS;E$IE#VA0J#.05^:1B&3HWEY^,FYKN)Z
MXJ %F=!2+FY9(\M^*_5]*=AQJ&QR[OGS!#3[:)('./(#8QU($X__P_EWRT('
M'3H'WBFO^8R"8^-M.,%,@N"$A=S#"3L.ODPC$<_X+7[,^"G]ILJKY*;B&I"#
MFPWTA@7_J\Y\-O%A9%UOY&NH!RPD*DEA,H=RB*U2A;=./\_/'.A%T%23)0/0
M8^>\@TW9K_O]1FOMCD,9M>9I'!T[C56Q,J(3X&"+5^DW2TB+TI/ONAS/U)MG
ME'IZ"[?=#CB2IG21ZZI66D@8D.<XW3L6O!I\O>LZ$#H*4U-IA[G+D'PUJ1M)
MQ!C.RA S+SHETS4AUG=3I(.(U:D;])H1+0X?5(\\8Q[6A&Z@:&[L"9_*4KH\
M_)]=S5;RFW+%LZ]7>!EA&<(:Q*L!PDFQ;F RQ$SMBQBAJIH1C:'Z8D(5M/!J
M<A[O]C#5-W!.OE,YZ2J0RS 0+HLDBOG@7D;\"FE#(5HY,80$NZZ/ 8Z$M ;X
M13F1\-L= <@B\J6GL:U1&]K".>\@3NQ[WLU"+<XG?4$@M%T5K%W;FMVU")Y4
M PY<UT*/7&QC/%4SP! %J):Q!W86ON#?ISGL-(Z0#(I\GWO'[\C2PI^<*Q!"
M=,WT'7P0MA/6E$0,J-(B3;N)7,\)2Z<P>EM[@X_7I<<,U='54KC>'=624& [
MU35S (EUQ2T'V0_501%FI@T@2IW90/T):2KN1O>EBM*BVISS@BMW.2& >^G*
M*AD=:BY0\;*,FPSJYZ*3[IB+3W Y,BRP9@.?/+:PO6V&MBMNFB_N,!SHH*&R
M@ZH_*/(85QZA5X[^X8DG\/J)S0,/#>U.UT7&H-JE#L6QU !LY$K7>[5<L-^X
M^AWJ.]GJK,83@O8!WG.@OU 7E"NIS3;9>Y> +/LYXHUQU*;Q+^\>1#QRP*+<
M>BPJ[8Z!K]MV9=^"?IORW)GID4BFAK-D71)AE74>(M4T$<K0RJ_9[ *YYBNT
MIP=M<PQYWLSI9.<7 :5^9P;^1)#Q$K/LHL^2T:0!6<0 'DS;!Q= &H_\ $KN
M:<Q/\4E]IN(MZ^+8W\MYM'$Q+4#N%M<FF!'!NM["QZJ M<EQB<'TF)+67=9I
M=TL*Y'"+3I/"P&^71-ZFM/JP54^-!'7E1;_(]H/$8UE75#J8W)=V]H/3L*>H
M")U/KU'QV(Z5<ZF/AC2^<6X;)8X_1 0%7TT.X?;,5,:%U'?Y#*K/>Z9^*Q[V
MMCSEJ&EE'PN%4Z5QTAY21-OO1&X7A0W%#PE2]^E &*B7%-UWWZ[W2M:9K??\
M*PC<)C6C@FC>1(Z/P=4I7VP0_OJ>4Q-3="<^4)?MY6HOZ$OQ' K9NSA!7/9C
MI!<:-\,AT#C3,S&?X6,V1F_@C>K*[70JIC/QOBZSHK<UXUOXBZ*W925.Q@#Q
MXY8%;Z5G(DE6^(Q7LZ=D9\=&/%E.O)?,[EDZ2UBN7Z =Q!9/?%?N^@']?L8"
M,G\4X#9BQ^,Y/I=3\1N_+W7YT\F8&)U*',>/JNS=CT%J3)HMZ7.>#*S;';E,
MB+>;(45B_>F8/^?# Z %@I^@F"DZZ. :Y#LFOW]#!Q>2@LK%-!N2*I\_-,E<
M9]6!(0S"C-M4;^NI+YV^PGLO/A 1MX-,F,C7\,=WI]'IU9QAGN[<@VR<_^%.
M'<S0^)T##"T*I:-5L?,X;$V[YYZ^3PC]UKT#]XCEO$2#413M$4G8P6^BZZ2)
M=G(?F:6]_ N=3-7DU*<E[!W"=!!+P]/3_'#F;S#[0P57#F#7U81FUU;U'/!I
M<.L))U-/;_14TCA+!<>P*WML-I:_!XR[A0:HA631.(:] !][6T3?90J@IC/.
M/+"DG86UVN9EZ2/!@7T?E9_4?6,X%X*R0!*?CX?Z$RZ]IZ%RR1+/I_/)"W'#
M]DJ/3DKO"<_QHL.=HD34XVLL/K2MT'?H/(Y.VE-SSCRG$T*/W5;Q4OH'B5.D
M.&ZZHPZB1Y.26[G=&K5MR@SAUUNNA1_+L&O-1[[DSQ2E,D55M T:";O?8*=9
MT\E$W726.2RI*#[NFQTD<H\MPE6AZ'SV!RNW]8&RC+AU)RZ1^(>!>.*?I+^;
ML#]]&XY&;L,&^F!@T-Y[(YABMMN6VF7<2WW@^GC*97L2R-N&H]N1.T4N_28M
MX<R7X(*$[%YU& +QW.7VRRP3_-@E)G[7=&QP\<471=]9)W%3I!;C!)^K:<)E
MDSX7,RJ>JV4L?F6XPA;[$*!G(J:+F4@ @1;)3$P!V9/90BRF"_&Y?[HF4)P7
M$S&9)6*&D?%R*:;C6,R6*W&#FL36^-2<YDW%*A'Q9"6222PP-)[-P> 4D-P?
M=Y$%:7U0FL8,#A*L&4_P.Y[B^PJEGLX??P_'@F(N9F!A/..2/E]AW!Q< *7E
MVK':.H-8B-5*+(AC<#%>B=4"*I]?\C&QA&5BL5B)R7(L^.@Z>77V[ZD?0C90
M7D!AF'AITKFC@A\L0_\MYA>G.:P"+)0L_?@8XV$:;WI_? M@$RVGC(VB%6K$
M,S&)%A";?D]B_WR\X.=),G?I]?_#-^<K!E#1>+'@?Q?S!8/O&?^"R/SO$D^'
M?32.IC#? MZ11.POT03X?#&+B>9J/N"KT]44H\:P9QS-%E,QF]&W> (?B^;+
MQ;#/)O.YF$(%<WAL N:H@BSBV9#73F&9"4RSF% <S/ =48.IYUX;DU\A-F<P
M2 *33N"[,_ U[+=DIF1.D0C98G),^#U,>]EUEZ#%L1/%R>('O'<.Z@GTL82@
M/^:^!-)CV"P!8'_2@Q&!$PKP"82&1!1E)SX\BR:+,?^[G%&/$,?LK.2T\]6"
M7\S8J5=1@H%QU[F&;T]0$:[075(;'NXL//_\X47$EP+:1[]\>.$/X<-&P< =
MA]XFW0C...2BPWSD5%Q0PW6-Q3Y^?=$2C=HK$H=Z?\!OF='V'-TN<\>QH;?+
M3+UE!  4FE=LA+"W,(*?GWK^!84 >^4/'GSK,J7K"4='^@ X0]"'6>K=N["Y
M=-TEQ0<YP<F-$]J6=ZL?>4L&L.7D0M=T*,PN<#AT)^3YYT\O3@P1<'E[D6,@
M/"_<J<GY5D9_KP(D3W9LW%X.'X^;9C2HUT:Y>P;^8@F<!( MM[96?+TD'%7(
MC%3',)B//O@ZP_PL,0SS2'@D+VMR&,->#IA=P+Q[WX'YR<]OOGSY_46G^=5F
M*XECEQS:@1N=!G$(M1!8*2V=)[,M^>K;\X\W?[P8(?4,):1S+@-BZF[*W2M_
MGX]O=]'A!@G0OY[C-X+TR5-R'%GFY"W+BTGNHJX&[U*\;/?>VATUK+.O2Q^W
MMD%NVW#VT[FTXP(^7/T!8ZNS['DQW)D@N></71,BK>U4<0COP6]%=P*<>_)9
MGI!TTU>Q<I5K;U&>^9J7(VS] ;1CC1;L7CUR'G&,2%49QP&^W^7NCE8*R%HV
M)VT[I#^VEP4]Z_;YD?0'2L&P%IJP(7_0/3DC#\LC="K;'>T_TSFZY)UHVL5P
M_/ V/+X01R$F6T^7*7Y;;AI&5%]<H3EG99_;5*%K+Q7[HL?RW?9=;] ITD'$
M2/R3E-<TBW\J=UNFXP1P)=HO0>^TIJ,[)*@TZB?&R)TW(6;=@>:.;QOP+BS/
MEQ0F1<%]&;,,/:$!9:7H3N/AC\_"81:WE/(;%+%G'1BW]T,GK;* 'QQJ WTI
MMR6" J ]ZR&I-7N7K00NL32%KK^[>5J6NKQ%O>L6%']_U66G+>SMJM/9G<\)
MC^V8!J;.ZVY$=PHW19UG(5S/;@6.Q(W?T/>^=W[=R;1[J.Z&+3O(3]7QH+I7
MHOJ7*6B6/O"I+$SAAKD&LW?Z&VI1TT1VH\\?EW1VS#9<@>GP%0[9G #[DVU_
M_%\BL@_^>$_3X9ZAXTCM[\ Y/IV!B9.(R!RI5VW/&__LW,@-&PBA<1V\#79F
MDNYQ=VXNWKBU88L(E;]T-[XVGK>3FV'_]CGPO3+J=#O:-=A/D3C?2!H8='OB
M"@W?@)Z,0\5O?2=H!L3H/JA7_!JLV'^]$NA1',H])1S/"-%.)\F_(5;\/6+%
M3XJUNB@6)J\N"H7F8K:Z(-4LYDWV)=^JI2V6O+Q#E/I[D ,QQP>@JUE0P,7C
MSLA=!:0]Y6?H5\)P?U/,'VTD8[SBVD7W "*,7#4CW>L5'J*EZ#U,QO1P>O(P
M=MG[V?+D>3(:^B.-Z\Y?TB#ZMOSW0K0)6Y>5^Z.:YFGS)TGOW%_BM,/=WS/]
M*E$V$?:%VF#J>+287;E;?>%'I0_\=SEK72'4^>M.2:0K&H#W&ZVK\(,6:/Y0
MZ^W_ 5!+ P04    " "$.EM55(?G;MH&  #K$P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6RU6&MOVS@6_2N$IR@Z@,>V;,=)VB1 DG;: -LVB-,I
M,(O]0$O7-K>2J"&I.NZOWW-)2993VVVGLPC@Z,'[.CSW09VMM/EDET1./&1I
M;L\[2^>*Y_V^C9>42=O3!>5X,]<FDPZW9M&WA2&9>*$L[0\'@TD_DRKO7)SY
M9[?FXDR7+E4YW1IARRR39GU%J5Z==Z)._>!.+9:.'_0OS@JYH"FY#\6MP5V_
MT9*HC'*K="X,S<\[E]'SJS&O]PO^4+2RK6O!D<RT_L0W-\EY9\ .44JQ8PT2
M_S[3-:4I*X(;?U4Z.XU)%FQ?U]I_][$CEIFT=*W3CRIQR_/.24<D-)=EZN[T
MZ@U5\1RQOEBGUO^*55@[QN*XM$YGE3 \R%0>_LN'"H>6P,E@C\"P$AAZOX,A
M[^5+Z>3%F=$K87@UM/&%#]5+PSF5\Z9,G<%;!3EW<?5A>O/NU70JWM_>W[R]
M^?/R_N;].W']YO+N]:OI6=_!!"_LQY6ZJZ!NN$?=J7BK<[>TXE6>4+(MWX=K
MC7_#VK^KX4&%4RIZ8C3HBN%@.#R@;]3$._+Z1GOTW9%UIHQ=:52^$#)/Q!VE
MTE$B+ID?RBFRXM^7,ZP"8?ZS"X%@8+S; "?1<UO(F,X[R!)+YC-U+I[^$DT&
M+PZX/V[<'Q_2_N/;]1/JQ VG74RY$VN2QG;%BL12?B918G.-DY\H9)7.K7!:
M +'<<ID0NC0BUM:)&FOR2%.^E'E, A7%2!:3J:#Y7,6*\GC=$_=+X,5/M'%6
MJ#Q.RX3@0GO'W!+R9B%S]<6KZ$*;4YGZ4K_,9%[.9;U\KK4K<.6ZXNZIS(H7
M+S?6K7?*ED61KD6\1 $3.3DN(EU!69'J-6M(E(U5P< E(2880+5"78).5L
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M')N^]NWXL@;Q_YTP.[.]3HIO&=AF_O7[U].-__58$3CY:F_?81HVA!QS4HQ
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MA]];]C<A=HJE8!:OM/Q5<-?,D[,$.%:LE^Z]'G["33RGGJ_4TH9?&*+M=)I
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MX.N\\/MJJ;P%?%BIE![_;$TA6;Y!R:2X6J))9:TJDB!MH(#S1IU *K"2E$7
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M$C!DMX&'.*ZQ-X"V(=PC!=1^/(IE >H)9G6!+4H._ P>T,,YC7^!\91DBKD
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M?1.]W5TCOLRHHBS58?%X6'.(6O,S>OO_1S-,QJ%GX9]U,T">@]'K+#">=$P
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M_DG?88 %Z 4*C%AWL'R*)P$#W+(G(@;B8: OGV"1\(4$_A%4L*F'%-1#,G2
MMJ-6UP;Z2BU<%U]N?4KM:LL>IERI; -5?=J\S)&]9.CJUX:Y+JZF[1WW]LH<
M^(B_#!-VVU+N2K'>*^]]H7:E7+-,@914#XE]0 D VUYK[?\_T6+$:2>B#QZP
M4LZC-%+XR#YP(E.=.%>F_IHD)#BJ>YU2 [*_MF?-T,3@$()QOJ=SP:9@O(C!
MS9NH', WE8^B.711\?5@]W0CNK-FK]/[Q,)Q$L3^'B6XS\;+9.[O8>B[K,4R
M8DFR9-$XC.@:!X'ONA:SF"51@+W+,,%$,%\.U$_B.?O\VU$41E\Q$P6[MT=B
M(GK _N3[Q.)QDL3N'D4+PA)V#\MQE 3L]O6A_<* ^=$1KHMDX8U8S-U]&20>
M?#B;LW"1L%D<L]DB],##>83!!9L!\&R^&$!'X0[F?#%[!;DGQ)LF@A2&< K=
M@V#961+B'HV/HIGKMW8=.D67>*C A%+ROJJ_*QUYTSVM!*@BAG'^#.]AM<M8
MB,OH0,SV^@8Z;=$%"L\JZ/ [_V^,^A_=\K)C\6?P03P^6BX/V<%LN<!U/IZ'
M">[A>+;$W2M\H^B SG*LBL8)[9V',3U')"$<QZ"UZ[?04.^Z!J)?&,S8/&!1
M<@3&';%;#\#+/'RY=!&S,&*XS"%K7^>O0O*)M"\7T(XTFH?^?9XDA]XCRQG^
M[*XI;(K=*%B_=!6 9YD[X5\5!_PH<1]<JJRV;UJER:_^UT[WOCH@4W+W;87:
MN+:V_@/$,#I\OCGS7RUVR_VWGVOT1.B7<!*ML368)/,1T_Y[BG^QJG'?,%;*
M6E6Y1^H=A:8%F%\KV-B]D(+AH];I?P!02P,$%     @ A#I;59G83#:-"0
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MBOX02S_KQ>%6\O]P3=RBYM91L)=IY-@26W#.7;3KO04XR1 7>E4O,4L ,[+
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MRE+3Y(<)=:FHG0'MKY2RVXE+4/6]H_\!4$L#!!0    ( (0Z6U5BCWQ[(@4
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M8*>S4C/#[\H-G2CIO)A2S/*J!\T-':!I<*P,[?]E#-^]&?F>_^&HU?1I(Z?
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M:01@?R.$+FZ,@_(3:_0O4$L#!!0    ( (0Z6U45"I543P,  #0'   9
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MK*&R"K2_E])T$^O@_%#._@502P,$%     @ A#I;56"W18F6 @  RP4  !D
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M-4S7Z^G-+\OKY<W=!GZ":1Q3L^LDA14KSX[)P=D"%:&I/-=3[C<+./MP#A_
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M.J<)=)W<[J4VX,2?/_F1][4I._^)[$VN6G6N6H?8XRG=8C4:4!A^X\F7\*B
MVXZRB:-+K^-N=@-X[Q->^K7/&UWM6E?[H*XG[!VV*',E$]"-RDJ"<&?7EA?N
M*6OR\9J5A;6R\* RK!:&US4E2RG31F'ANTW]Z&(_9PU.810T2XMJ:=%!:3O7
MO$E7].Z8@NA\/V,-3NVPM:?+W>E7]JT84;5D0A,."X1Y9^<8ERK[;SDQ,B]:
MV%P:;(C%<(5/%BCK@.L+*<WKQ';%^A&,_P)02P,$%     @ A#I;5<+$\"?
M @  S08  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULK55=;]HP%/TK
M5E9-K42;#PC0#B)1*"I2H5%IMX=I#R8Q8-6Q4]M NU^_:R=-:9M6D[878COW
M')][[N6FMQ/R7JT)T>@Q8USUG;76^9GKJF1-,JQ.1$XXO%D*F6$-6[ER52X)
M3BTH8V[@>6TWPY0[4<^>Q3+JB8UFE)-8(K7),BR?S@D3N[[C.\\'-W2UUN;
MC7HY7I$YT7=Y+&'G5BPIS0A75' DR;+O#/RS86CB;<!W2G9J;XU,)@LA[LUF
MDO8=SP@BC"3:,&!X;,F0,&:(0,9#R>E45QK@_OJ9?6QSAUP66)&A8#]HJM=]
MI^N@E"SQAND;L;LD93Y68"*8LK]H5\9Z#DHV2HNL!(."C/+BB1]+'_8 ?NL#
M0% "@K\%-$M TR9:*+-IC;#&44^*'9(F&MC,PGICT9 -Y::*<RWA+06<CN9W
M<7QU,;V8W0ZNT'@R&\R&$UA-9N/KF^G@=G(]0\<HEM U4C\U4,PPUPCS%%T\
M;&@.Y=0--(-F.QP1C2E31Q!^-Q^APX,C=( H1U/*&-1+]5P-<LVE;E)*.R^D
M!1])(_D):GH-%'A!4 ,??@X?D03@OH7[K^$NF%0Y%51.!9:O^0'?M5QA3G]C
MTWT--(24!*,I+IH1#(DE46!'<2"6:$PYY@G%#,WAD!BK%/HY6"@MH7=_U?E1
M"&C5"S#_YS.5XX3TG=S<);?$B;Y^\=O>MSIW_A/9*Z^:E5?-S]BCEX;)JX8A
M+PV#-4J$TG46%+QMRVLFT#;R?:_;ZKG;_=SJHCI!MXIZ);I5B6Y]*GJ0))ML
MPZ!6*0P"< 6*9XI9)[-@"O<$'+>#;OA&9EU4&'KU,L-*9O@OWG)2ZVOXSK%6
MY_3TC=[W0:'?>>NJNS=LS*"?8KFB7"%&E@#S3CK (HOA66RTR.W\60@-T\PN
MU_"](=($P/NE$/IY8T9:]06+_@!02P,$%     @ A#I;57\<N_#\ @  O0D
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MP.X6-;RO*/""H,*?T<?-_2HY_V_U\#^O?A*,1IXH#<O7.,.7YL"$13S6*<!
M56UP2M&LIC!GWKW<X0CZCC[4)(@].(,___#;WE]5T?U,LO%GDH6?1':R#\U\
M'YIU[ -]/.K#CR%XB[:8;0!=;?1UH+]#RJ4$>79K4M:V936WQW[@]=S]<;PO
M(L9EQ$W0/L6$94PK1YP(;N6"6[6"Y]FMA-D*<9N$.RZ5 $4$Z!M+H24P6!.%
M=A17'SLI?^O8[59!>QG2+&BO(/$[!>UEC.]7BV_GXML?$A\EPARW1F^5PG9I
MX>+F7D2,RXB;(^]3@74L)_HZN;Y.K;Y1FL/ZWEAC(M >TP007^L;3KSJ"V9)
M <'/A*A?2(*. 5$$*K>X4W*L40A &=$M!*",**9)6(8$U?KO<OUWM?J?(:)8
M2K(F$;:%D]8>)7%"L:F?D!(ZI6DZ8[YOI#@"+!AAF\HPW)7\:Q<SO0PI)L)E
MDK".Y"0.W3P.W=HXV-OE[-G5O9C>9<1-(7?'%9!"CH2UD!-=OO>[OO(N*T-7
MQ%Z<U_K8SHJH,U(SMN/SLUU,Y0J,'Q345F"*:JMHBF>U>U19QB VMJ27*.()
M4VGMD(_FSX:A+98+XP_^_<BO&!^;9X:M9'_3IV^4*18;?;$A"FN]E'?;T?LB
MTK(_[2B^LW7MDBM=)=OF5C^50!B GE]SKMX[9H'\\37X%U!+ P04    " "$
M.EM5D?$O8O8#  #Q#P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6RU
M5VU/XS@0_BNCW.JT*P'I.[#75BH-[%:"4L%R]^%T']QDVEKKV,%V*$CWXV^<
ME-!"B*@N^Z6UG9G',X\]XYG^6NF?9H5HX3$6T@R\E;7)5]\WX0IC9HY4@I*^
M+)2.F:6I7OHFT<BB3"D6?JO1Z/DQX](;]K.UF1[V56H%ESC38-(X9OKI#(5:
M#[RF][QPPY<KZQ;\83]A2[Q%>Y?,-,W\ B7B,4K#E02-BX$W:GX-FIE")O$G
MQ[79&H-S9:[43S>91 .OX2Q"@:%U$(S^'G",0C@DLN-^ ^H5>SK%[?$S^D7F
M/#DS9P;'2OS%([L:>"<>1+A@J; W:OT=-PYU'5ZHA,E^8;V1;7@0IL:J>*-,
M%L1<YO_L<4/$E@+AE"NT-@JMCRJT-PKMUPJ==Q0Z&X5.QDSN2L9#P"P;]K5:
M@W;2A.8&&9F9-KG/I3OW6ZOI*R<].[R]F\TNSZ_.IS]&EW QF8ZFXPF-)M.+
MZYNKT8_)]10.811%W)T2$S"1^5US9_8Y0,NX,%](Y.XV@,^?OL GX!*NN! D
M8/J^)1/=1GZX,><L-Z?UCCEMN%+2K@R<RPBC$OUQM?YIA;Y/U!3\M)[Y.6M5
M MYB<@3MQ@&T&JU6F3W_3SWXN'JSPIMV<=KM#*_]#MY,4\+0]ND 9H))"TQ&
M<'Z?\H0BV<+?ER0.$XNQ^:?LZ'+L3CFV2U!?3<)"''B4@0SJ!_2&O__6[#7^
M*..M3K"@)K =3CL%IYTJ].$-AH(9PQ<\S,-"+2APXU0PE]' :B:-R+\(90Q8
M!<BTY')9&A_Y9KUL,Y>T'X:];M]_V*:NTIY]J:L);(>Z;D%=MYHZEY0/U>(P
M-0C$(3US:DXI16+DT@@^ABLFEPB4<L!=7&)1+D$@Y7D0G,VYX/:IC,3*;?>]
MJ=TW)](]W3V1X*U([T5DAYI>04VODIK*2"USN1)N7Y?K! MJ MNA\;B@\?@7
M)KSC.CFM$RRH"6R'TY."TY/*JSEF";=4"N C%9]4&*2T!85KF&I-<3M/+4AE
MX8F".6&\[ T_J\3?E]<<K%N1,(.3-^'9>2<\3PL.3BLY^(9JJ5FRXB&<,</-
M 8R53A1E*(3O5'[?ITQ;U ;^A8";1!GBZYM6:7( 4R*'UD*J4[A,B;'K/+.]
M4R]5VK$O5W6"!36![?#?;+S4K8U?&-D;\)IHK14MJ MME]BMAJ!9>;5'2XUT
M*Y-4T^M+#VVB>8BE'#;?/HRM5Z7*!V2":GOV]=??ZH5BU,NLIS00JE3:O.PO
M5HN^=91U:Z_6QZZ?S7JL%YB\&;YB>LFEH4)D09"-HV-*/CKO+_.)54G6<<V5
MI?XM&ZXH*:!V O1]H91]GK@-BBY_^!]02P,$%     @ A#I;5<HZN5 M!@
M@C4  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N>&ULM9MK3^,X%(;_BM4=
MK68D((G=&VRI5&HO('$3978^K/9#: W-3BZ=)*4S_WZ=-,1U$HS#GGZ!-LUY
M3_P>USV/$H\V4?P]67*>HI^!'R:GG66:KDXL*YDO>> F1]&*A^*3IR@.W%2\
MC9^M9!5S=Y$'!;Z%;;MO!:X7=L:C_-A=/!Y%Z]3W0GX7HV0=!&[\ZXS[T>:T
MXW1>#]Q[S\LT.V"-1ROWF<]X^G5U%XMW5JFR\ (>)EX4HI@_G78FS@DC_2P@
M/^,OCV^2G=<H&\IC%'W/WEPN3CMV=D7<Y_,TDW#%OQ<^Y;Z?*8GK^%&(=LJ<
M6>#NZU?U/_/!B\$\N@F?1OXW;Y$N3SO##EKP)W?MI_?1YH(7 ^IE>O/(3_*_
M:%.<:W?0?)VD45 $BRL(O'#[W_U9&+$3('2: W 1@*L!W3<"2!% 3#-TBX"N
M:89>$9 /W=J./3>.NJD['L71!L79V4(M>Y&[GT<+O[PPFRBS-!:?>B(N'9_?
MWM)OEU=7:')#T>W#!;M'ES</DYOSR[,KAB:S&7N8': ;]H .T7D4+3:>[Z//
ME*>NYR=?Q,&O,XH^?_J"/B$O1-?B4U'^9&2EXMJR#-:\N(ZS[77@-ZZ#H.LH
M3)<)8N&"+QKBJ3[^6!-O"4]*8_"K,6=8*SCCJR-$[ .$;8P;KF=J'NXT#>?_
M96<?SJZ80<I90G(]\M8L>:W\W_>1^"N^HALW7OS35.:M4+=9*%OV3I*5.^>G
M';&N)3Q^X9WQ[[\Y??N/)H\AQ2BD& ,24ZK1+:O1U:F7U3A C_S9"T,O?!:+
MI>^&<]Y4$:U8VXI BM&M6#\7RW[17L;'0](?62^[3@-E5)SNE4[WM$Y/YC_6
M7N(5/VGS:!VFF=GNXE^Q,HN?R[1QI=-JMC4<4HQNQ7H[AN->Q6Z@?(K=_=+N
MOM'$1EZP<KWX38/[M7ESB ?#RDBF];-L]0S:K]G1H,-T.LHP!^4P!]IA3M=Q
MS,/Y+Y3&;ICX;C:]FH:I56D[CR#%Z*!N7)<,*KX!950L'I86#PV72!XNWED?
MA[7!]/ODN#*9M.G:VF>2D0%E5.P[+NT[UJ][ 8^]N=OXY=-&MIV5D&(44HP!
MB2GV.[;LRFVHAJM0 BH(J!H%56-0:FI-=DC)@6R[]&JMZP*I1@LUM1%PJ@LX
M5$[5;RS]QGMHOO2BK6V'5*.%6N_MEH1!)50]EYSG:,'%N /3R[1V&93S"C6M
MR_O -T?RFZ,'.-,&4"_3VF50=BO4U.:YZU2-W@>].1+?'#V_M6D#G08XPH,*
MC4[U"5N;:)*30>543910YNBIC%VS2:-AVK#6LQ-2C8*J,2@UM0 2%YT!6#,(
MRHR@:A14C4&IJ361?.F8 J99,PC)CU-0->K4<93851J%2JG:+7G4>0=(/]8+
M@K(JJ!HMU+1=RCX8%$L&Q5J>,NX%]3)M7095HX6:SF6HA*K+DBJQGBI->T&]
M3&N707$2UW'R$%=7$*B4JL^2)K&>)MNT@KC.:7A8F3=3?;[6%AJD9% I50LE
M'&(]'$[N)M-&NT!A$%2-@JHQ*#6U )(;<1>J$<2@Z BJ1D'5&)2:6A.)F-@4
M,8T:0;U:Z[J TBANHM%N=0W:!XQB":-8#Z,?:P3UHJU=!T557+\+65OW]\&?
M6/(GUM^O-&X$0>$35(WB^BW+FLO[($HLB1+KB=*X$01%25 UBNLH>9@]OZ3Z
MO ^4Q!(EL1XE6S6"=4C#-JXV@J!<:)*20:54'P:39$CT9'@A[(NCH/'Q+U 8
M!%6CH&H,2DVM@>1&XD#U@@04'4'5**@:@U)3:R(9DY@RIE$OJ%=K71=0'B5U
M'NT/AM4[$U Y5;]WGDI]!T@_U SJ15O;#ON,:OW>9>T)/:B,JND20HG^YJ5I
M-ZB7:6TS*(&2IIN7]2?_H)*J3DNT)'JT-.T(]3*MG09E2E)GRD.G6S-Z'U!)
M)%02L^=.35I"4G\<E R'E?O>4WW"UB::Y&10.;<F6CM[2@(>/^>;>1*4+[+;
MC0/ET7+#T"3?)E,Y?N:<3)V&X]0Y8=OM0%)^NSOIVHW%KV>"?/XD4ME' S$[
MXNV&G^V;-%KE.UH>HS2-@OSEDKL+'F<GB,^?HBA]?9,E*+==C?\#4$L#!!0
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M12]5TB0,I>6IPLAA9@9+Q_W7L6EVAJ/VZW[ D1[I,1YMI$>G[G$XZ)BE1RE
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MA%87I+(W4.]OM$[L!!SVM%*+MENQ':=I%)11MMO1PY6G@7I3TZ<W@VTS<^K
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M S5 >5EM*QN2I45U:,VD9$EQN0>\ 9YW4,^WC,E3(W=0USPG_P%02P,$%
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M]/I(GV9C%V/90(8F)/P#^SP8:K8&?+2%:<B?R6&.BO%T)<\C(<O^@D/1UM"
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MWT0#ZGA :0R*5A\>Z:*(_<%BBX#:)5 :!:4Q*%I]**0%(WM:L*[%EIG;>81
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M*(VA:+KVRNMS]RUM^XX:X+D+W,R!G=6%.GM0&D/1='65L^>:%[CU6 %XA@H
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M7E[S8,[SLH'\?I%EXN%->8#-0]>G_P-02P,$%     @ A#I;59"-@N2Q!0
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M;HO??4L]&==%3;C4L$#JIY9O(5/&&KKLK-8:\T/ C63?2[IA7">=7AC&P?H
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MPTP!Y/L%I6(W4 'RR]_H-U!+ P04    " "$.EM5'A)B)T '  "31P  &0
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M!)CRC8@WQ2-.OL1"Q&'Q<LV]%4_R@.S[^S@6SV_R#G;/X9G]"U!+ P04
M" "$.EM5@P =7>L#  !B$P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6RU6%V3VC84_2L:-]-)9I+U!Q\+6V"&Q6[#PV89G$UGVNF#L"_@1I:H)"#\
M^TJVUXO!ZT"JOH EZYRK>ZYT9=W!GO&O8@T@T;>44#&TUE)N[FQ;1&M(L;AA
M&Z#JS9+Q%$O5Y"M;;#C@. .EQ/8<IVNG.*'6:)#US?AHP+:2)!1F'(EMFF)^
MN ?"]D/+M9X[YLEJ+76'/1IL\ I"D$^;&5<MNV2)DQ2H2!A%')9#:^S>!:ZG
M =F(+PGLQ=$STJXL&/NJ&]-X:#EZ1D @DIH"J[\=3( 0S:3F\4]!:I4V-?#X
M^9G]U\QYY<P""Y@P\GL2R_70ZEDHAB7>$CEG^X]0.-31?!$C(OM%^V*L8Z%H
M*R1+"[":09K0_!]_*X0X BB>>H!7 +Q30/L50*L M"ZUT"X [4LM= I YKJ=
M^YX)YV.)1P/.]HCKT8I-/V3J9VBE5T+U0@DE5V\3A9.C^Z=P^BD(0_0X^SQ]
MF/XQ_CQ]_(0F'\?SWX(0?4!AOH 06Z*QCFDB#RBA: X"^ Z$>B!80HPDTWV2
M;R.YY0E=H2E-9(+U*A#HK0\2)T2\4X1/H8_>OGF'WFB:AX00M5S$P);*%STC
M.RKF?9_/VWMEWBWTP*A<"Q30&.(:O-^,[S?@;:5A*:3W+.2]UT@8PN8&M9SW
MR',\KV8^D\OA;IT[_\UZ\,/6*V*TRE75ROA:K_!5ET*Q6-"?<T8(4OM[CWG\
M5UW,<]9V/:O.F7=B@R,86BHI9IS6Z.>?W*[S2YW@)LE\DV2!(;)*:-IE:-I-
M[*/)&O,5U.ZX'-C-@/J V8TZMP-[=ZSI^9"65QWBGP]Q.TYU3' ^IOMBJ>)6
MIW2KT^A6"#O@F$: ,(W1HUP#1T&Z(>P 4":I"1.RUO-&[FO7G4DRWR198(BL
M$J!N&:#N_Y(2NB9#8Y+,-TD6&"*KA.:V#,UMX]XI@O$>+6"54*KCL\!$;Z:Z
M@#1R71L0DV1^3M8YSCQ._R3S&#)8T;E7ZMS[T=3;"+Q65)-D?N]<U/;)J1 8
M,E@1M5^*VF\4=88/ZMY2G]8;D=>J:I+,[Y^I^L%U>B>R&K)8D=5U7BX&SB59
M >'X;W4->57C9I9K13;*YA=L%9F[)R*;LEA5^>CZY3;GA"WG0*,#DNKK1:C/
M%'4=JI6YD>9JF4VR^05;=36W3W4V9+*JL_>BLW?9&0<T_LX!5S!5OF"]D[TY
M:39WM8(7F Q,F<P5M(]J!BFH<TD7:P2*V);*_*)7]I8%H7%6!CGIOW?O)FY-
MOZ\+2%F-XH4^KSX]J&,PH0(16"I3SLVM6CD\+^CD#<DV6<5BP:1D:?:X!AP#
MUP/4^R5C\KFA#91EM=&_4$L#!!0    ( (0Z6U5TB_5(U00  !0;   9
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M498BP1=7K9%_00-L&N1'?(_XH]S91N94?F39W^;#9'[5\DR/>,QGRB"8_O/
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M*E&LU"T^J&R=KRS]D2F5)?GFBK,Y%^8 _?TBR]3S!Q-@NUYZ^#]02P,$%
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M3[.=TVR_E28M#5$ @BYB(B%0"J,E! NHG9M&\%-;RA!818=.KD/G+#/5,2F
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M@S>$5E6T\)3X^CS=;]0%FD*KGGL4-M!M=%C_Z]6?099_VN__JJX)V9\ NW0
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M9$!%*M"?#SE7GS?IL^?\?PTZ_P-02P,$%     @ A#I;5=5[-\HC!   \Q0
M !D   !X;"]W;W)K<VAE971S+W-H965T-S,N>&ULM5AM;^(X$/XK5FYU:J5M
M\P:4]@")-EEMI?:V*MO>A]-],,D 5AV;M1U8_OW929H"3;/TSOT"=C+/DYEY
MG(G'@S473W(!H-#/C#(Y=!9*+2]<5R8+R+ \Y4M@^LZ,BPPK/15S5RX%X+0
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M1L(<),Q%PCPDC()@!56?[U5]KNVKTY'--AW9J*',$U_X8:A4G@QZUESX4=W
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M*^")2$?2=*%X;*:Z"5<P(YK')8SQ1.@ >#_G7&T6>E#,_S%H_@502P,$%
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M5N-EUZ'+MD-D3X=L=%WD;%VA*%_1E:9]:&X?&-J/^>#T(T1>1^B2&($+NOF
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M)FSCW(C.=_$>C5L5CL/\&S^#3!DZ*3_!RAF[F[!X _LDP;427P"+U_=[Y'*
M?S'F2E[J3I:ZDZ#S=D/G!!:-*!$J4G#;ON3@=8'!OFDX[W_^%=K0*2:=0]#Q
ME^*2[Z/PI.RR=L!67? WX#LWC>@LD5 [,KIYMZ?$3'_5%*#NPPF?-;HVAV'K
M+B(8G^#6:ZWQ&OA>+U<[_P-02P,$%     @ A#I;51?,N&-B P  "!8   T
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M#"P/9'I:K?'=QCMD?Q]@>[JO0["5XIV(K12O-2#VN@$CBNR[C>4!!K8+6.]
M?GL>Z"D[)PA@5S%OV!.,(U&$(="+]AX-0Z0Z(;SM^X,])4$0178$,+N#(, 0
M>!IQ!', 'C D",KOP9WO(Z_^GO+:__V._P)02P,$%     @ A#I;59>*NQS
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M"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>BOJK01Z*^JM!'HKZJT$>NMDLX1
M;T6]E4!O1;V50&]%O95 ;T6]E4!O1;V50&]%O95 ;T.]C4!O0[V-0&]#O8U
M;T.]C4!OFVQV$^AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3
MZ.VHMQ/H[:BW$^CMJ+<3Z.V3CY4$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=
M!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U
M#@*],^J="?3.J'<FT#NCWIE [XQZ9P*],^J="?3.J'<FT#NCWIE [SSY69!
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M19'5HLAJ462U*+):%%GM_Y3UI_?[3XZ?G_7@NO$EG\U_>K[^#5!+ 0(4 Q0
M   ( (0Z6U4'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ A#I;548"]#3N    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ A#I;59E<
MG",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " "$.EM5\4T30VH'   :-   &               @($-
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ A#I;52:6
MQ1^9!@  <!L  !@              ("!K0\  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( (0Z6U7^M%%F^ (  "0(   8
M  " @7P6  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "$
M.EM5/7",_"4&  !6'   &               @(&J&0  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ A#I;5?S7?UKL!   GQ0  !@
M         ("!!2   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( (0Z6U6[\>7;-P,  ,H*   8              " @2<E  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "$.EM5R_\^='\-  "?F
M&               @(&4*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ A#I;55;"FM*&"   BB4  !@              ("!238  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (0Z6U4RFFZW?@D
M ,L6   8              " @04_  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " "$.EM5U:3$OS$+   &'0  &0              @(&Y
M2   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (0Z6U62
M<+E3\P8  "P0   9              " @2%4  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ A#I;58*BW5RX"   Z1<  !D
M     ("!2UL  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (0Z6U6/>-(ETA(  +0U   9              "
M@;^"  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ A#I;
M552'YV[:!@  ZQ,  !D              ("!R)4  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " "$.EM5XJMCOSP#  !5!P  &0
M        @('9G   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( (0Z6U6*/<>4\0,  !D+   9              " @4R@  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ A#I;5?YGO2PA!   #@H
M !D              ("!=*0  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " "$.EM53D*M%R$/   #-   &0              @(',J
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( (0Z6U4)I=/R
M PH  ,<>   9              " @22X  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ A#I;5:M<;L O"   X!(  !D
M ("!7L(  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "$
M.EM5F=A,-HT)  "%%P  &0              @('$R@  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( (0Z6U5D:'RCG00   ,+   9
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M970S,"YX;6Q02P$"% ,4    " "$.EM5J1>W/5\$  !N#0  &0
M    @(&?\@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M (0Z6U45"I543P,  #0'   9              " @37W  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ A#I;56"W18F6 @  RP4  !D
M             ("!N_H  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " "$.EM5P_Z??CH&   8%P  &0              @(&(_0  >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( (0Z6U5HC>8<Q04
M +81   9              " @?D# 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ A#I;5:H"L^0$!   FPD  !D              ("!
M]0D! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "$.EM5
MH%8\&& #   !#   &0              @($P#@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( (0Z6U4!QNND_P(  $0'   9
M      " @<<1 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ A#I;53>7^8KX!   ^QH  !D              ("!_10! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "$.EM5C[VHH,X#  !L$0
M&0              @($L&@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( (0Z6U49#V0X:@,  *T+   9              " @3$> 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ A#I;5>]QEW:^
M @  $ <  !D              ("!TB$! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " "$.EM5PL3P)\ "  #-!@  &0
M@('') $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (0Z
M6U5_'+OP_ (  +T)   9              " @;XG 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ A#I;5<V:1>C9 P  B T  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( (0Z6U5C[WQLCPD  #-M   9
M  " @:)$ 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
MA#I;52H.\:+H P  _Q0  !D              ("!:$X! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " "$.EM5\;#[E' $  "5&   &0
M            @(&'4@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( (0Z6U6+HQ\S) <  &4X   9              " @2Y7 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ A#I;53#.9G!X!@
M&2T  !D              ("!B5X! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " "$.EM5SWW[FW4(  " 70  &0              @($X
M90$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (0Z6U60
MC8+DL04  .4C   9              " @>1M 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ A#I;55N@33"5#0  KY@  !D
M     ("!S',! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (0Z6U6# !U=ZP,  &(3   9              "
M@8*2 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ A#I;
M572+]4C5!   %!L  !D              ("!I)8! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " "$.EM573'\1?4"  "!"@  &0
M        @(&PFP$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( (0Z6U6>GNVDX (  -D)   9              " @=R> 0!X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ A#I;54U4M&&? @  " <
M !D              ("!\Z$! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    " "$.EM5G.9G/=,&   [/0  &0              @(')I $
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( (0Z6U4?9,QF
M^P4  (<I   9              " @=.K 0!X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ A#I;57@OZ=0&!   8A4  !D
M ("!!;(! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " "$
M.EM5%\@M>" #   0"@  &0              @(%"M@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( (0Z6U70W,D^Q0(  'L&   9
M          " @9FY 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#
M%     @ A#I;57PW:_-(!0  =R   !D              ("!E;P! 'AL+W=O
M<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " "$.EM5U7LWRB,$  #S
M%   &0              @($4P@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM
M;%!+ 0(4 Q0    ( (0Z6U4N<I6ZQ 8  *I    9              " @6[&
M 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ A#I;52QM
M.>-* P  ) P  !D              ("!:<T! 'AL+W=O<FMS:&5E=',O<VAE
M970W-2YX;6Q02P$"% ,4    " "$.EM5 *B5I" &  #(+   &0
M    @('JT $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M (0Z6U6F&LS,/ 0  /83   9              " @4'7 0!X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ A#I;55(#*&2_ 0  Y@,  !D
M             ("!M-L! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    " "$.EM5%\RX8V(#   (%@  #0              @ &JW0$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (0Z6U67BKL<P    !,"   +
M      "  3?A 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (0Z6U6>"931X@4
M ,(S   /              "  2#B 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " "$.EM5>@0#75P"   A+@  &@              @ $OZ $ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "$.EM5+B@*V!4"  #\
M+   $P              @ '#Z@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    5@!6 )$7   )[0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>543</ContextCount>
  <ElementCount>344</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>120</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Income (Loss) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Income (Loss) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - FINANCING ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTS</Role>
      <ShortName>FINANCING ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - REVENUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUES</Role>
      <ShortName>REVENUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - BUSINESS OPTIMIZATION CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2147112 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2149113 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2153114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2160115 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2166116 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2329304 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2333305 - Disclosure - REVENUES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESTables</Role>
      <ShortName>REVENUES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/REVENUES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2339306 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2345307 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2350308 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2354309 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2361310 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2367311 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FINANCINGARRANGEMENTS</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - REVENUES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESAdditionalInformationDetails</Role>
      <ShortName>REVENUES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails</Role>
      <ShortName>REVENUES - Contract Assets and Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails</Role>
      <ShortName>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - REVENUES - Lease Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESLeaseRevenueDetails</Role>
      <ShortName>REVENUES - Lease Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2448428 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/INCOMETAXES</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails</Role>
      <ShortName>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2452430 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails</Role>
      <ShortName>EARNINGS PER SHARE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2457433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2458434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2459435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462436 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463437 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2464438 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465439 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468440 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2469441 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bax-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - bax-20220930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - bax-20220930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: bax:RevenueRecognizedContractPeriod, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  bax-20220930.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  bax-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="bax-20220930.htm">bax-20220930.htm</File>
    <File>bax-20220930.xsd</File>
    <File>bax-20220930_cal.xml</File>
    <File>bax-20220930_def.xml</File>
    <File>bax-20220930_lab.xml</File>
    <File>bax-20220930_pre.xml</File>
    <File>bax-20220930ex321.htm</File>
    <File>bax-20220930xex311.htm</File>
    <File>bax-20220930xex312.htm</File>
    <File>bax-20220930xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1351">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bax-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 36,
   "contextCount": 543,
   "dts": {
    "calculationLink": {
     "local": [
      "bax-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bax-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bax-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bax-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 623,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://www.baxter.com/20220930": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 12
   },
   "keyCustom": 32,
   "keyStandard": 312,
   "memberCustom": 51,
   "memberStandard": 67,
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.baxter.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - FINANCING ARRANGEMENTS",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTS",
     "shortName": "FINANCING ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - REVENUES",
     "role": "http://www.baxter.com/role/REVENUES",
     "shortName": "REVENUES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - BUSINESS OPTIMIZATION CHARGES",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES",
     "shortName": "BUSINESS OPTIMIZATION CHARGES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147112 - Disclosure - INCOME TAXES",
     "role": "http://www.baxter.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149113 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160115 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166116 - Disclosure - SEGMENT INFORMATION",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329304 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333305 - Disclosure - REVENUES (Tables)",
     "role": "http://www.baxter.com/role/REVENUESTables",
     "shortName": "REVENUES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339306 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables",
     "shortName": "BUSINESS OPTIMIZATION CHARGES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345307 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350308 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354309 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361310 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2367311 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213",
      "decimals": "-8",
      "lang": "en-US",
      "name": "bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i54ee73c9e21148bfa47a86c4e81ba2ba_D20211213-20211213",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "if52624140cdd4ab390ee1ab86fa1bf13_I20211213",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Income (Loss) (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
     "shortName": "Condensed Consolidated Statements of Income (Loss) (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i773f5845d4754661b8aab38716b10554_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:ProceedsFromDivestitureOfProductRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i773f5845d4754661b8aab38716b10554_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:ProceedsFromDivestitureOfProductRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ida2ec04c98ba4de6aac9364b884a768f_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ida2ec04c98ba4de6aac9364b884a768f_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i4b539be2fbed438e9e118c2cdb3604d9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails",
     "shortName": "FINANCING ARRANGEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i3325a024108447b9bbfde3aa8794fded_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CommercialPaperAverageOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ida2ec04c98ba4de6aac9364b884a768f_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i7f7d5ccda5424cd6a7bd67a5706e35ce_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - REVENUES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
     "shortName": "REVENUES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)",
     "role": "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
     "shortName": "REVENUES - Contract Assets and Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "role": "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
     "shortName": "REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i36501cc5b8c1437bac9367d0d934737d_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - REVENUES - Lease Revenue (Details)",
     "role": "http://www.baxter.com/role/REVENUESLeaseRevenueDetails",
     "shortName": "REVENUES - Lease Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:BusinessOptimizationChargeTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ie81fa3481a8f4f1f8945e6806b257c27_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibe4632e8764241ee9398872757d10f8e_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i2166896cc67640a7ae96d097acab1f25_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i8ace5ff2293146d4bf055d7cb9bcf636_I20220531",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i8ace5ff2293146d4bf055d7cb9bcf636_I20220531",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448428 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.baxter.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails",
     "shortName": "EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452430 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails",
     "shortName": "EARNINGS PER SHARE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibc2452d306d44d6bb37bc0a5227d5cd8_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ic8f53c6faca04460ad2c24de01d0c5f5_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
     "shortName": "Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ic8f53c6faca04460ad2c24de01d0c5f5_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ib6e5214316a649e3860c819c556c69d4_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ib6e5214316a649e3860c819c556c69d4_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i5f5e8ee945c84b1da96f6817955ff214_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462436 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i5f5e8ee945c84b1da96f6817955ff214_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i100fa316fc12492f84183e5383c3e332_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463437 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i850357b8669c4f8ea66da8c85b2d6a98_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ic34110c3d1d548c099e33f7257520862_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464438 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i1bef60de6abe41cebf0448519a3ac267_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i7a8551f83b15496db276708fb0ec4cc2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465439 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i7a8551f83b15496db276708fb0ec4cc2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468440 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails",
     "shortName": "SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "id53ca5df30f04301a9054d72614b728c_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469441 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
     "shortName": "SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "ibd6183fbf2ed4705b046a423d3bb5fff_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i4b539be2fbed438e9e118c2cdb3604d9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - bax-20220930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - bax-20220930.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220930.htm",
      "contextRef": "i4b539be2fbed438e9e118c2cdb3604d9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 120,
   "tag": {
    "bax_A04SeniorNotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero point four percentage senior notes due May two thousand twenty four.",
        "label": "0.4% Senior Notes Due May 2024 [Member]",
        "terseLabel": "0.4% Senior Notes Due May 2024"
       }
      }
     },
     "localname": "A04SeniorNotesDueMay2024Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A0868SeniorNotesDueMay2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.868% Senior Notes Due May 2023",
        "label": "0.868% Senior Notes Due May 2023 [Member]",
        "terseLabel": "0.868% Senior Notes Due May 2023"
       }
      }
     },
     "localname": "A0868SeniorNotesDueMay2023Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A130SeniorNotesDueMay2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Senior Notes Due May 2025",
        "label": "1.30% Senior Notes Due May 2025 [Member]",
        "terseLabel": "1.30% Senior Notes Due May 2025"
       }
      }
     },
     "localname": "A130SeniorNotesDueMay2025Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A1322SeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.322% Senior Notes Due 2024",
        "label": "1.322% Senior Notes Due 2024 [Member]",
        "terseLabel": "1.322% Senior Notes Due 2024"
       }
      }
     },
     "localname": "A1322SeniorNotesDue2024Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A13SeniorNotesDueMay2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point three percentage senior notes due May two thousand twenty nine.",
        "label": "1.3% Senior Notes Due May 2029 [Member]",
        "terseLabel": "1.3% Senior Notes Due May 2029"
       }
      }
     },
     "localname": "A13SeniorNotesDueMay2029Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A1915DebenturesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.915% Debentures Due 2027",
        "label": "1.915% Debentures Due 2027 [Member]",
        "terseLabel": "1.915% Debentures Due 2027"
       }
      }
     },
     "localname": "A1915DebenturesDue2027Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A2272SeniorNotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.272% Senior Notes Due 2028",
        "label": "2.272% Senior Notes Due 2028 [Member]",
        "terseLabel": "2.272% Senior Notes Due 2028"
       }
      }
     },
     "localname": "A2272SeniorNotesDue2028Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A24SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2.4% Senior Notes Due 2022 [Member]",
        "terseLabel": "2.4% Senior Notes Due 2022"
       }
      }
     },
     "localname": "A24SeniorNotesDue2022Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A2539NotesDue2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.539% Senior Notes Due 2032",
        "label": "2.539% Notes Due 2032 [Member]",
        "terseLabel": "2.539% Senior Notes Due 2032"
       }
      }
     },
     "localname": "A2539NotesDue2032Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A3132SeniorNotesDue2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.132% Senior Notes Due 2051",
        "label": "3.132% Senior Notes Due 2051 [Member]",
        "terseLabel": "3.132% Senior Notes Due 2051"
       }
      }
     },
     "localname": "A3132SeniorNotesDue2051Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "label": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "negatedLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses And Other Current Liabilities",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AcquisitionsAndCollaborationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Collaborations [Line Items]",
        "label": "Acquisitions And Collaborations [Line Items]",
        "terseLabel": "Acquisitions And Collaborations [Line Items]"
       }
      }
     },
     "localname": "AcquisitionsAndCollaborationsLineItems",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_AcquisitionsAndCollaborationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Collaborations [Table]",
        "label": "Acquisitions And Collaborations [Table]",
        "terseLabel": "Acquisitions And Collaborations [Table]"
       }
      }
     },
     "localname": "AcquisitionsAndCollaborationsTable",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_AcuteTherapiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acute Therapies.",
        "label": "Acute Therapies [Member]",
        "terseLabel": "Acute Therapies"
       }
      }
     },
     "localname": "AcuteTherapiesMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AdvancedSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced surgery.",
        "label": "Advanced Surgery [Member]",
        "terseLabel": "Advanced Surgery"
       }
      }
     },
     "localname": "AdvancedSurgeryMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AmericasSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas Segment",
        "label": "Americas Segment [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasSegmentMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AsiaPacificSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific Segment",
        "label": "Asia Pacific Segment [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificSegmentMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AssetImpairmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment",
        "label": "Asset Impairment [Member]",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AvailableForSaleDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-For-Sale, Debt Securities",
        "label": "Available-For-Sale, Debt Securities [Member]",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BioPharmaSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioPharma Solutions",
        "label": "BioPharma Solutions [Member]",
        "terseLabel": "BioPharma Solutions"
       }
      }
     },
     "localname": "BioPharmaSolutionsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BundledEquipmentAndConsumableMedicalProductsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bundled Equipment And Consumable Medical Products Contracts",
        "label": "Bundled Equipment And Consumable Medical Products Contracts [Member]",
        "terseLabel": "Bundled equipment and consumable medical products contracts"
       }
      }
     },
     "localname": "BundledEquipmentAndConsumableMedicalProductsContractsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations",
        "label": "Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations",
        "terseLabel": "Enterprise value"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation",
        "negatedTerseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Current Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Current Liabilities",
        "negatedTerseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Short-Term Debt",
        "negatedTerseLabel": "Short-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt and Capital Lease Obligations",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt and Capital Lease Obligations",
        "negatedTerseLabel": "Long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessOptimizationChargeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business optimization charge.",
        "label": "Business Optimization Charge [Table Text Block]",
        "terseLabel": "Summary of Business Optimization Charges"
       }
      }
     },
     "localname": "BusinessOptimizationChargeTableTextBlock",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_BusinessOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Optimization Programs",
        "label": "Business Optimization Programs [Member]",
        "terseLabel": "Business Optimization Programs"
       }
      }
     },
     "localname": "BusinessOptimizationProgramsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_CelerityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celerity",
        "label": "Celerity [Member]",
        "terseLabel": "Celerity"
       }
      }
     },
     "localname": "CelerityMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ClinicalNutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical nutrition.",
        "label": "Clinical Nutrition [Member]",
        "terseLabel": "Clinical Nutrition"
       }
      }
     },
     "localname": "ClinicalNutritionMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_CommonStock100PerValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, $1.00 per Value",
        "label": "Common Stock, $1.00 per Value [Member]",
        "terseLabel": "Common Stock, $1.00 par value"
       }
      }
     },
     "localname": "CommonStock100PerValueMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ConsumableMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumable medical products [Member].",
        "label": "Consumable Medical Products [Member]",
        "terseLabel": "Consumable Medical Products"
       }
      }
     },
     "localname": "ConsumableMedicalProductsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractTerminationAndOtherCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract termination and other costs.",
        "label": "Contract Termination And Other Costs [Member]",
        "terseLabel": "Contract termination and other costs"
       }
      }
     },
     "localname": "ContractTerminationAndOtherCostsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractWithCustomerLiabilityCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Currency Translation",
        "label": "Contract With Customer, Liability, Currency Translation",
        "negatedTerseLabel": "Currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrencyTranslation",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_ContractWithCustomerLiabilityDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Deferred Revenue",
        "label": "Contract With Customer, Liability, Deferred Revenue",
        "terseLabel": "New revenue deferrals"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDeferredRevenue",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_ContractWithCustomerLiabilityTotalRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Liability, Total Revenue Recognized",
        "label": "Contract with Customer, Liability, Total Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized upon satisfaction of performance obligations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTotalRevenueRecognized",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeFairValueTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Fair Value, Terminated",
        "label": "Derivative, Fair Value, Terminated",
        "terseLabel": "Derivative, fair value, terminated"
       }
      }
     },
     "localname": "DerivativeFairValueTerminated",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeNetInvestmentTerminated": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Net Investment Terminated",
        "label": "Derivative, Net Investment Terminated",
        "terseLabel": "Derivative, net investment terminated"
       }
      }
     },
     "localname": "DerivativeNetInvestmentTerminated",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DevelopedTechnologyIncludingPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology including patents.",
        "label": "Developed Technology Including Patents [Member]",
        "terseLabel": "Developed technology, including patents"
       }
      }
     },
     "localname": "DevelopedTechnologyIncludingPatentsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EMEASegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E M E A Segment",
        "label": "E M E A Segment [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEASegmentMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EnviromentalCleanUpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enviromental clean-up.",
        "label": "Enviromental Clean Up [Member]",
        "terseLabel": "Environmental Clean-up"
       }
      }
     },
     "localname": "EnviromentalCleanUpMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value and carrying value by balance sheet grouping.",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingLineItems",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingTable",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosure Line items.",
        "label": "Fair Value Disclosures [Line Items]",
        "terseLabel": "Fair Value Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosuresLineItems",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosures table.",
        "label": "Fair Value Disclosures [Table]",
        "terseLabel": "Fair Value Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueDisclosuresTable",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Currency Translation",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Currency Translation",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCurrencyTranslation",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Translation",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Translation",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslation",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_FloatingRateNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating-rate notes due 2023",
        "label": "Floating-rate notes due 2023 [Member]",
        "terseLabel": "Floating-rate Notes Due 2023"
       }
      }
     },
     "localname": "FloatingRateNotesDue2023Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FloatingRateNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating-rate notes due 2024",
        "label": "Floating-rate notes due 2024 [Member]",
        "terseLabel": "Floating-rate Notes Due 2024"
       }
      }
     },
     "localname": "FloatingRateNotesDue2024Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FrontLineCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Line Care",
        "label": "Front Line Care [Member]",
        "terseLabel": "Front Line Care"
       }
      }
     },
     "localname": "FrontLineCareMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FrontLineCareReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Line Care Reporting Unit",
        "label": "Front Line Care Reporting Unit [Member]",
        "terseLabel": "Front Line Care Reporting Unit"
       }
      }
     },
     "localname": "FrontLineCareReportingUnitMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GainLossOnDispositionOfProductDivestitureArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Product Divestiture Arrangement",
        "label": "Gain (Loss) on Disposition of Product Divestiture Arrangement",
        "negatedTerseLabel": "Loss on product divestiture arrangement"
       }
      }
     },
     "localname": "GainLossOnDispositionOfProductDivestitureArrangement",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_GlobalNotes04Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 0.4% due 2024",
        "label": "Global Notes 0.4% due 2024 [Member]",
        "terseLabel": "0.4% Global Notes due 2024"
       }
      }
     },
     "localname": "GlobalNotes04Due2024Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2025",
        "label": "Global Notes 1.3% due 2025 [Member]",
        "terseLabel": "1.3% Global Notes due 2025"
       }
      }
     },
     "localname": "GlobalNotes13Due2025Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2029",
        "label": "Global Notes 1.3% due 2029 [Member]",
        "terseLabel": "1.3% Global Notes due 2029"
       }
      }
     },
     "localname": "GlobalNotes13Due2029Member",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_HillromMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hillrom Member",
        "label": "Hillrom [Member]",
        "terseLabel": "Hillrom"
       }
      }
     },
     "localname": "HillromMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Reconciliation, Foreign Statutory Loss on Foreign Subsidiary Investment, Tax Deductible",
        "label": "Income Tax Reconciliation, Foreign Statutory Loss on Foreign Subsidiary Investment, Tax Deductible",
        "terseLabel": "Tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignStatutoryLossOnForeignSubsidiaryInvestmentTaxDeductible",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "label": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "negatedTerseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Line Items]",
        "label": "Intangible Asset Excluding Goodwill [Line Items]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillLineItems",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Table]",
        "label": "Intangible Asset Excluding Goodwill [Table]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Table]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillTable",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations, current, fair value disclosure.",
        "label": "Long-Term Debt and Finance Lease Obligations, Current Fair Value Disclosure",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations noncurrent.",
        "label": "Long -Term Debt and Finance Lease Obligations, Noncurrent",
        "terseLabel": "Long-term debt and finance lease obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsNoncurrent",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LossContingencyNumberOfLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Lawsuits",
        "label": "Loss Contingency, Number Of Lawsuits",
        "terseLabel": "Number of lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfLawsuits",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_ManufacturingArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing arrangements.",
        "label": "Manufacturing Arrangements [Member]",
        "terseLabel": "Contract manufacturing services"
       }
      }
     },
     "localname": "ManufacturingArrangementsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_MedicationDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication delivery.",
        "label": "Medication Delivery [Member]",
        "terseLabel": "Medication Delivery"
       }
      }
     },
     "localname": "MedicationDeliveryMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_OriginalWeightedAverageTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original Weighted-Average Term",
        "label": "Original Weighted-Average Term",
        "terseLabel": "Original weighted-average term"
       }
      }
     },
     "localname": "OriginalWeightedAverageTerm",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "totalLabel": "Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "totalLabel": "Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherProductOrServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other product or services.",
        "label": "Other Product Or Services [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductOrServicesMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PatientSupportSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Support Systems",
        "label": "Patient Support Systems [Member]",
        "terseLabel": "Patient Support Systems"
       }
      }
     },
     "localname": "PatientSupportSystemsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PatientSupportSystemsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Support Systems Reporting Unit",
        "label": "Patient Support Systems Reporting Unit [Member]",
        "terseLabel": "Patient Support Systems Reporting Unit"
       }
      }
     },
     "localname": "PatientSupportSystemsReportingUnitMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceuticals.",
        "label": "Pharmaceuticals [Member]",
        "terseLabel": "Pharmaceuticals"
       }
      }
     },
     "localname": "PharmaceuticalsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ProceedsFromDivestitureOfProductRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Divestiture of Product Rights",
        "label": "Proceeds from Divestiture of Product Rights",
        "terseLabel": "Proceeds from divestiture of product rights"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfProductRights",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_RenalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renal.",
        "label": "Renal [Member]",
        "terseLabel": "Renal Care"
       }
      }
     },
     "localname": "RenalMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_RevenueFromContractWithCustomerRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer",
        "label": "Revenue From Contract With Customer [Roll Forward]",
        "terseLabel": "Revenue From Contract With Customer [Roll Forward]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerRollForward",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_RevenuePerformanceObligationPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Payment Terms",
        "label": "Revenue, Performance Obligation, Payment Terms",
        "terseLabel": "Global payment terms"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPaymentTerms",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RevenueRecognizedContractPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognized contract period.",
        "label": "Revenue Recognized Contract Period",
        "terseLabel": "Revenue recognized contract period"
       }
      }
     },
     "localname": "RevenueRecognizedContractPeriod",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and Uncertainties Policy",
        "label": "Risks and Uncertainties Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of derivative positions presented on net basis.",
        "label": "Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]",
        "terseLabel": "Derivative Positions Presented On Net Basis"
       }
      }
     },
     "localname": "ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]",
        "terseLabel": "Other Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_SeniorFiveYearTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Five Year Term Loan",
        "label": "Senior Five Year Term Loan [Member]",
        "terseLabel": "Senior Five Year Term Loan"
       }
      }
     },
     "localname": "SeniorFiveYearTermLoanMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SeniorThreeYearTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Three Year Term Loan",
        "label": "Senior Three Year Term Loan [Member]",
        "terseLabel": "Senior Three Year Term Loan"
       }
      }
     },
     "localname": "SeniorThreeYearTermLoanMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SeveranceAndOtherEmployeeRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance and other employee related costs.",
        "label": "Severance And Other Employee Related Costs [Member]",
        "terseLabel": "Severance and Other Employee Related Costs"
       }
      }
     },
     "localname": "SeveranceAndOtherEmployeeRelatedCostsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SiteContingencyNumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site contingency, number of sites.",
        "label": "Site Contingency Number Of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "SiteContingencyNumberOfSites",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_SoftwareArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software arrangements.",
        "label": "Software Arrangements [Member]",
        "terseLabel": "Software sales"
       }
      }
     },
     "localname": "SoftwareArrangementsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_StockRepurchaseProgramAdditionalAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock repurchase program additional authorized amount.",
        "label": "Stock Repurchase Program, Additional Authorized Amount",
        "terseLabel": "Stock repurchase program, additional authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_SuperfundSitesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Superfund sites.",
        "label": "Superfund Sites [Member]",
        "terseLabel": "Superfund Sites"
       }
      }
     },
     "localname": "SuperfundSitesMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SurgicalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Solutions",
        "label": "Surgical Solutions [Member]",
        "terseLabel": "Surgical Solutions"
       }
      }
     },
     "localname": "SurgicalSolutionsMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SurgicalSolutionsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Solutions Reporting Unit",
        "label": "Surgical Solutions Reporting Unit [Member]",
        "terseLabel": "Surgical Solutions Reporting Unit"
       }
      }
     },
     "localname": "SurgicalSolutionsReportingUnitMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ZosynMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zosyn",
        "label": "Zosyn [Member]",
        "terseLabel": "Zosyn"
       }
      }
     },
     "localname": "ZosynMember",
     "nsuri": "http://www.baxter.com/20220930",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "verboseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "verboseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "verboseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XCHI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYSE CHICAGO, INC. [Member]",
        "terseLabel": "Chicago Stock Exchange"
       }
      }
     },
     "localname": "XCHI",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "New York Stock Exchange"
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r138",
      "r181",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r201",
      "r205",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r138",
      "r181",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r201",
      "r205",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r59",
      "r61",
      "r136",
      "r137",
      "r338",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r337",
      "r369",
      "r490",
      "r495",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r684",
      "r733",
      "r736",
      "r755",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r337",
      "r369",
      "r490",
      "r495",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r684",
      "r733",
      "r736",
      "r755",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r208",
      "r310",
      "r312",
      "r397",
      "r400",
      "r686",
      "r732",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r208",
      "r310",
      "r312",
      "r397",
      "r400",
      "r686",
      "r732",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r279",
      "r308",
      "r310",
      "r312",
      "r313",
      "r337",
      "r369",
      "r434",
      "r490",
      "r495",
      "r499",
      "r500",
      "r501",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r684",
      "r733",
      "r736",
      "r755",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r279",
      "r308",
      "r310",
      "r312",
      "r313",
      "r337",
      "r369",
      "r434",
      "r490",
      "r495",
      "r499",
      "r500",
      "r501",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r684",
      "r733",
      "r736",
      "r755",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r60",
      "r61",
      "r136",
      "r137",
      "r338",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r209",
      "r210",
      "r397",
      "r401",
      "r735",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r397",
      "r401",
      "r735",
      "r743",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r714",
      "r744"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Net trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $120 in 2022 and $122 in 2021"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r280",
      "r282",
      "r283",
      "r285",
      "r306",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Environmental reserves"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r70",
      "r76",
      "r84",
      "r85",
      "r86",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r76",
      "r84",
      "r85",
      "r86",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "verboseLabel": "Pension and OPEB items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r14",
      "r275"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r65",
      "r76",
      "r84",
      "r85",
      "r86",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "CTA"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r76",
      "r84",
      "r85",
      "r86",
      "r87",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "verboseLabel": "Gains (losses) on hedging activities"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r66",
      "r76",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Hedging activities"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r76",
      "r84",
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Available-for-sale Debt securities"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r73",
      "r75",
      "r76",
      "r718",
      "r741",
      "r742"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r84",
      "r85",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r84",
      "r85",
      "r86",
      "r139",
      "r140",
      "r141",
      "r561",
      "r649",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTAL FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r503",
      "r504",
      "r505",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to cash flows from operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r33",
      "r216",
      "r230",
      "r232",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r216",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for accounts receivable, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r261",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r84",
      "r85",
      "r86",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r18",
      "r133",
      "r189",
      "r196",
      "r203",
      "r228",
      "r319",
      "r320",
      "r321",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r554",
      "r562",
      "r619",
      "r650",
      "r652",
      "r693",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r41",
      "r133",
      "r228",
      "r319",
      "r320",
      "r321",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r554",
      "r562",
      "r619",
      "r650",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r602"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Accumulated pre-tax unrealized translation gain in AOCI"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r219",
      "r220",
      "r240",
      "r698"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r573",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r486",
      "r491",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r486",
      "r491",
      "r524",
      "r525",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, equity interest issued or issuable (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Cash consideration transferred (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r537",
      "r538",
      "r540"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total Consideration",
        "totalLabel": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Fair value of equity awards issued to Hillrom equity award holders"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r536",
      "r539",
      "r543"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r531",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS AND OTHER ARRANGEMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Incremental costs of sales"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital expenditures incurred but not yet paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Book values"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r12",
      "r123"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r118",
      "r123",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r118",
      "r623"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Deferred, net after-tax gains on derivative instruments"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r131",
      "r133",
      "r154",
      "r158",
      "r159",
      "r161",
      "r163",
      "r173",
      "r174",
      "r175",
      "r228",
      "r319",
      "r324",
      "r325",
      "r326",
      "r332",
      "r333",
      "r367",
      "r368",
      "r371",
      "r372",
      "r374",
      "r619",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperAverageOutstanding": {
     "auth_ref": [
      "r763",
      "r764"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average amount outstanding of commercial paper.",
        "label": "Commercial Paper, Average Outstanding",
        "terseLabel": "Commercial paper, average outstanding"
       }
      }
     },
     "localname": "CommercialPaperAverageOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r50",
      "r699",
      "r723"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r314",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, end of period (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r80",
      "r82",
      "r83",
      "r94",
      "r705",
      "r728"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to Baxter stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r82",
      "r93",
      "r552",
      "r553",
      "r566",
      "r704",
      "r727"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r82",
      "r92",
      "r551",
      "r566",
      "r703",
      "r726"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r91",
      "r103",
      "r702",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Contract Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r383",
      "r385",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r383",
      "r384",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "verboseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r205",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r99",
      "r686"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "COGS",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r351",
      "r358",
      "r359",
      "r361",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "FINANCING ARRANGEMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r22",
      "r23",
      "r132",
      "r138",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r636",
      "r694",
      "r695",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r334",
      "r362",
      "r363",
      "r634",
      "r636",
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r47",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Senior notes, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48",
      "r132",
      "r138",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r132",
      "r138",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r375",
      "r376",
      "r377",
      "r378",
      "r633",
      "r634",
      "r636",
      "r637",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r411",
      "r450",
      "r474",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net losses and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r411",
      "r449",
      "r473",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r411",
      "r416",
      "r448",
      "r472",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r446",
      "r470",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r412",
      "r453",
      "r477"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedTerseLabel": "Pension curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r414",
      "r447",
      "r471",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r184"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r56",
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.",
        "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "terseLabel": "Derivative asset, fair value, total"
       }
      }
     },
     "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Asset"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r54",
      "r61",
      "r62",
      "r575",
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r55",
      "r57",
      "r63",
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r54",
      "r61",
      "r62",
      "r575",
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r55",
      "r57",
      "r63",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r616"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Derivative, fair value, net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r61",
      "r574",
      "r576",
      "r582",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r597",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r572",
      "r574",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r572",
      "r574",
      "r582",
      "r588",
      "r589",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r581",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain (loss) recognized in income, undesignated derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r55",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of master netting arrangement, of derivative liability, security sold under agreement to repurchase, and security loaned. Includes financial instrument subject to master netting arrangement not elected or qualified to offset. Excludes liability not subject to master netting arrangement or similar agreement.",
        "label": "Derivative Liability, Security Sold under Agreement to Repurchase, and Security Loaned, Subject to Master Netting Arrangement, after Offset",
        "terseLabel": "Derivative liability, fair value, total"
       }
      }
     },
     "localname": "DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivative instruments designated as hedges"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Intangible Asset"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Revenue From Contract With Customer [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r397",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Revenue From Contract With Customer [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Agreed purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is not classified as discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r379",
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r95",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r152",
      "r154",
      "r161",
      "r162",
      "r163",
      "r168",
      "r169",
      "r599",
      "r600",
      "r706",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r95",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r154",
      "r161",
      "r162",
      "r163",
      "r168",
      "r169",
      "r599",
      "r600",
      "r706",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r164",
      "r166",
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r134",
      "r509",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyAxis": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of environmental remediation contingency.",
        "label": "Environmental Remediation Contingency [Axis]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyDomain": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental remediation contingency, for example, but not limited to, asbestos, air emissions and mercury emissions.",
        "label": "Environmental Remediation Contingency [Domain]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteAxis": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Axis]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteDomain": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Domain]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r84",
      "r85",
      "r86",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r172",
      "r229",
      "r374",
      "r379",
      "r503",
      "r504",
      "r505",
      "r513",
      "r514",
      "r598",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631",
      "r649",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r8",
      "r21",
      "r615"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Marketable equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r349",
      "r362",
      "r363",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair values"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r602",
      "r603",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r607",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r602",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Book Values and Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r349",
      "r362",
      "r363",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r480",
      "r603",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r602",
      "r603",
      "r605",
      "r606",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r349",
      "r435",
      "r437",
      "r442",
      "r480",
      "r603",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active markets for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r349",
      "r362",
      "r363",
      "r435",
      "r437",
      "r442",
      "r480",
      "r603",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r349",
      "r362",
      "r363",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r480",
      "r603",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value recognized in AOCI"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "terseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Fair value at end of period",
        "periodStartLabel": "Fair value at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value recognized in AOCI"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value at end of period",
        "terseLabel": "Fair value at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r349",
      "r362",
      "r363",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r480",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r612",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r573",
      "r578",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r231",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r360",
      "r373",
      "r597",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r16",
      "r268"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r262",
      "r265",
      "r268",
      "r271",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r268",
      "r688"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross other intangible assets, finite-lived"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r262",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r268",
      "r687"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Other intangible assets, net, finite-lived"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r620",
      "r622"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "negatedTerseLabel": "Reclassification of cumulative translation loss to earnings"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r122",
      "r620",
      "r622"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange (gains) losses, net"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r61",
      "r435",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Loss on product divestiture arrangement"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicBasisCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Basis, Corporate Headquarters [Member]",
        "terseLabel": "Geographic Basis, Corporate Headquarters"
       }
      }
     },
     "localname": "GeographicBasisCorporateHeadquartersMember",
     "nsuri": "http://fasb.org/us-gaap-sup/2022q3",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r15",
      "r246",
      "r248",
      "r255",
      "r259",
      "r652",
      "r692"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r121",
      "r247",
      "r252",
      "r258",
      "r259"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairments",
        "terseLabel": "Goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r254",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Acquisition accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r98",
      "r133",
      "r189",
      "r195",
      "r199",
      "r202",
      "r205",
      "r228",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r619"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability hedged in fair value hedging relationship.",
        "label": "Hedged Liability, Fair Value Hedge",
        "terseLabel": "Carrying amount of hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r572",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r121",
      "r272"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairments"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r121",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r189",
      "r195",
      "r199",
      "r202",
      "r205",
      "r689",
      "r700",
      "r709",
      "r730"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) before income taxes",
        "totalLabel": "Income (loss) before income taxes",
        "verboseLabel": "Total before tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r277",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r510",
      "r511",
      "r512",
      "r515",
      "r518",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r150",
      "r151",
      "r187",
      "r508",
      "r516",
      "r519",
      "r731"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r116",
      "r224"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "negatedTerseLabel": "Change in fair value of marketable equity securities"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in balance sheet items:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Gains (losses)"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r163",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive securities excluded from the computation of EPS (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r264",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r264",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "terseLabel": "Indefinite-lived intangible assets acquired"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Member]",
        "terseLabel": "In process Research and Development"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r260",
      "r266"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r88",
      "r183",
      "r632",
      "r635",
      "r708"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net of capitalized interest"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r707"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net",
        "negatedTerseLabel": "Interest expense, net",
        "negatedTotalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net [Abstract]",
        "terseLabel": "Interest Income Expense Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r61",
      "r435",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest rate contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r40",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseIncome": {
     "auth_ref": [
      "r647"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.",
        "label": "Lease Income",
        "totalLabel": "Total lease revenue"
       }
      }
     },
     "localname": "LeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r133",
      "r197",
      "r228",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r555",
      "r562",
      "r563",
      "r619",
      "r650",
      "r651"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r133",
      "r228",
      "r619",
      "r652",
      "r697",
      "r721"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r46",
      "r133",
      "r228",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r555",
      "r562",
      "r563",
      "r619",
      "r650",
      "r651",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r602"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r23",
      "r695",
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r50",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserve"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Agreement to settle the case"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Civil settlement amount"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt and finance lease obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-Term Debt, Term",
        "terseLabel": "Weighted-average term"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r48",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum length of time hedge in cash flow hedge"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r133",
      "r228",
      "r319",
      "r324",
      "r325",
      "r326",
      "r332",
      "r333",
      "r619",
      "r696",
      "r720"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Change in noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds, at carrying value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r118",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r90",
      "r122",
      "r133",
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r160",
      "r189",
      "r195",
      "r199",
      "r202",
      "r205",
      "r228",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r600",
      "r619",
      "r701",
      "r724"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Baxter stockholders",
        "verboseLabel": "Total net of tax"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r78",
      "r81",
      "r86",
      "r150",
      "r151",
      "r558",
      "r565"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r379",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Undesignated derivative instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r189",
      "r195",
      "r199",
      "r202",
      "r205"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total segment operating income",
        "totalLabel": "Operating income (loss)",
        "verboseLabel": "Total segment operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r171",
      "r642",
      "r647"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r573",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r73"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Available-for-sale debt securities, net of tax expense of zero for the three months ended September 30, 2022 and 2021, respectively, and $1 and zero for the nine months ended September\u00a030, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Debt securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r76",
      "r84",
      "r85",
      "r87",
      "r624",
      "r626",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r66",
      "r73"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Hedging activities, net of tax expense of $5 and $3 for the three months ended September 30, 2022 and 2021, respectively, and $8 and $8 for the nine months ended September\u00a030, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "terseLabel": "Hedging activities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r73",
      "r77",
      "r580"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments, net of tax expense (benefit) of ($16) and $3 for the three months ended September 30, 2022 and 2021, respectively, and ($25) and $16 for the nine months ended September\u00a030, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r64",
      "r74",
      "r621",
      "r630"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r82",
      "r84",
      "r85",
      "r87",
      "r91",
      "r374",
      "r624",
      "r629",
      "r631",
      "r702",
      "r725"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "netLabel": "Net other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r71",
      "r73"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension and other postretirement benefits, net of tax expense of $5 and $8 for the three months ended September 30, 2022 and 2021, respectively, and $13 and $19 for the nine months ended September\u00a030, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedLabel": "Pension and other postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other amortized intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableFairValue": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.",
        "label": "Other Investment Not Readily Marketable, Fair Value",
        "terseLabel": "Other equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Gains (Losses)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net",
        "negatedTotalLabel": "Other (income) expense, net",
        "verboseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "OPEB"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Baxter stockholders' equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r115",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r105",
      "r541"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration paid to Hillrom shareholders",
        "verboseLabel": "Acquisition price"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired, and investments"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r106",
      "r545",
      "r546",
      "r547"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "terseLabel": "Pension and other postretirement benefit plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r434",
      "r436",
      "r442",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r480",
      "r482",
      "r483",
      "r484",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Net periodic pension and other postretirement costs"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r408",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r485",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Issuances of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r108",
      "r502"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock issued under employee benefit plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r110",
      "r114"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r109",
      "r112",
      "r124"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "terseLabel": "Net increases (decreases) in debt with original maturities of three months or less"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r117",
      "r133",
      "r142",
      "r150",
      "r151",
      "r189",
      "r195",
      "r199",
      "r202",
      "r205",
      "r228",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r328",
      "r330",
      "r332",
      "r333",
      "r551",
      "r557",
      "r559",
      "r565",
      "r566",
      "r600",
      "r619",
      "r709"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r13",
      "r274"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r276",
      "r652",
      "r710",
      "r722"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r96",
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r76",
      "r84",
      "r85",
      "r87",
      "r624",
      "r628",
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r76",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification of cumulative translation loss to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Summary of Reclassification from AOCI to Net Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r195",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r195",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Operating Income to Income Before Income Taxes Reconciliation"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r507",
      "r685",
      "r757"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "R&amp;D"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r12",
      "r128",
      "r691",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash included in prepaid expenses and other current assets"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r289",
      "r292",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "BUSINESS OPTIMIZATION CHARGES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r288",
      "r291",
      "r298",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Cumulative pre-tax costs incurred"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r288",
      "r291",
      "r298",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected additional pre-tax costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r288",
      "r291",
      "r298",
      "r300"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Costs to implement business optimization programs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r121",
      "r286",
      "r295",
      "r298"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r288",
      "r289",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "totalLabel": "Total business optimization charges"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r289",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Reserve, ending balance",
        "periodStartLabel": "Reserve, beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r289",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "negatedTerseLabel": "Reserve adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r289",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r379",
      "r652",
      "r719",
      "r740",
      "r742"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r229",
      "r503",
      "r504",
      "r505",
      "r513",
      "r514",
      "r598",
      "r737",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r180",
      "r181",
      "r194",
      "r200",
      "r201",
      "r208",
      "r209",
      "r212",
      "r396",
      "r397",
      "r686"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Total net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r394",
      "r395",
      "r399",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Transaction price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligations period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Remaining revenue performance obligation, percentage of revenue expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r640",
      "r641"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": {
     "auth_ref": [
      "r643",
      "r648"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable",
        "terseLabel": "Sales-type leases, receivables"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
        "terseLabel": "Sales-type Lease, Lease Income"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r217",
      "r230",
      "r237",
      "r648"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in sales-type lease.",
        "label": "Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss",
        "terseLabel": "Sales-type lease, net of investment in lease"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "auth_ref": [
      "r171",
      "r645"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sales-type lease revenue.",
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Sales-type lease revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r76",
      "r629",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Summary of Changes in AOCI by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r524",
      "r525",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r469",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r574",
      "r582",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Summary of Gains and Losses on Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Classification and Fair Values of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Net Sales from Contracts with Customers by Global Business Unit"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Instruments Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Other (Income) Expense, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r293",
      "r294",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Components of Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r289",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Activity in Reserves Related to Restructuring Initiatives"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r189",
      "r192",
      "r198",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r189",
      "r192",
      "r198",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Information for Our Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r176",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r212",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r291",
      "r300",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r176",
      "r178",
      "r179",
      "r189",
      "r193",
      "r199",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r211",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r382",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r19",
      "r652",
      "r694",
      "r716"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-Term Debt, Fair Value",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r176",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r212",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r278",
      "r291",
      "r300",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r131",
      "r133",
      "r154",
      "r158",
      "r159",
      "r161",
      "r163",
      "r173",
      "r174",
      "r175",
      "r228",
      "r319",
      "r324",
      "r325",
      "r326",
      "r332",
      "r333",
      "r367",
      "r368",
      "r371",
      "r372",
      "r374",
      "r619",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r51",
      "r84",
      "r85",
      "r86",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r172",
      "r229",
      "r374",
      "r379",
      "r503",
      "r504",
      "r505",
      "r513",
      "r514",
      "r598",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631",
      "r649",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r172",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r374",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "negatedLabel": "Stock issued under employee benefit plans and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r379",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock issued under employee benefit plans and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining value available under stock repurchase programs"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r30",
      "r31",
      "r133",
      "r218",
      "r228",
      "r619",
      "r652"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Baxter stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r85",
      "r133",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r228",
      "r229",
      "r379",
      "r503",
      "r504",
      "r505",
      "r513",
      "r514",
      "r549",
      "r550",
      "r564",
      "r598",
      "r619",
      "r624",
      "r625",
      "r631",
      "r649",
      "r738",
      "r739"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, end of period (in usd)",
        "periodStartLabel": "Balance, beginning of period (in usd)",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r360",
      "r373",
      "r597",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Common stock in treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r52",
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r26",
      "r374",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Purchases of treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r374",
      "r379",
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r288",
      "r289",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseIncome": {
     "auth_ref": [
      "r646"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.",
        "label": "Variable Lease, Income",
        "terseLabel": "Variable lease revenue"
       }
      }
     },
     "localname": "VariableLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r153",
      "r163"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r152",
      "r163"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeLossunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13644-110860"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r758": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r759": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r760": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r761": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r762": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r763": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r764": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r765": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r766": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r767": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r768": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r769": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r770": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001628280-22-027149-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-027149-xbrl.zip
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M;QGJ+X[:'0M4WG;3S=[9.[3+/AO?W&O\:D^/=ESX(RZ$=W!!"0(2ECV4BGN
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M_J-;;M]^U[_-+S24V/>:TS!"\[3'Z/L>MMPXE%A /Y0EQ=6>:Q8"S8#F;Y*
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M'1P+']P[/M-3!W?.U7X.K,?6_"?&3I(TD:AD0? E-;,NQIT8>DHQ<_#HL4Z
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M#JL;"YL=2S1LT 'FG*52G@TTZ];<*X0HI#%YA;YK!RG-?(]S*,[\4*K=]]E
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MM'=/NP7G]MG#JZ=\B?;?/\Z)_]:.QWDNH?/N N6/>Z4W+/W% _RKM3=6V'%
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M4PJ^LPB5A!0GXK;_FF7^B^2XG$0;8>$=/5B\T.6K.<H$$E=;[#T'DPFI$C?
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MR[.'KT[M5F8I*!HW"R!LB"-62$VD94K9!"(7:!)VTP\[UKR#-2&S"]DSNYS
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M@,R%A*56/K=I8)7J]O(B"IM=6K_'N05]8?SFU@N=7G?_FB&5CRVGHBEH'"=
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MGM2:Z/$1]&>'KRG4":CQ51J^)ASCY$QDDBCDI8Z(XQ! H5N-I"-..0'V=2"
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M"0U+CI(TN=%T(,CEC'.CP"1U5%G.B]J_=9OI%\H<U<@XK\V&!2&8B1@%%YX
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M&#EK<N1VV&'169$^QZ"4!DS(RA>RX*U28*,(T@?N4^V%+K;9QG> 72WZUM%
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MKL8]0Q^# ,,$ A:@0;#<UU[@SDK$P).KF+MQ8EFK<=8IW*Z]S%G#[6WB=CF
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M7V0SA, EZ! H!ZUT9NJ;J0+MF%97M[)N [@U^;2YWJNB=FG;*B7F./,>7''
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MI:]]Z[)Z6RAL5WW45S7;7(H-&:O>=ES>QECUY:^>O^I?[$__9897E?<+[[W
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MZP?<4C3;L<BS-Q9\F'7ZMAX"CPA>FY"5$-''U #7E,-FVK4;,<U&9.LGLN6
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MDE7<DO[R>1K,7K 4#*#T#E#; $$8 I5,#HX1UZH6ES,W":TUP&U&0+L!;OV
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M9-%H48 3$H$%D;(U.IE<3W@WC=88;5/M>I\[)8W1;IO1EO=-%.:H,1BPR6E
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M2BIPIXOOCVSY^$_+D&Q\U76[WFN&=^.KF_/54JPR>F>C] :4R1$P)0;%US=
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M6P_+'_ZOX](-#R<P,O.M\?KALZ]H R,8#2__RLQ:61\%?#DS'-?J"A.<7\@
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M+DW56/A7ELF=[E!W#\J8,**K*@99=/JZ'*0(C,;6OTM>L#.=Z+UPM@I;<1$
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MRUH8_;"*E:U\^2/6W%Z/M:T:8G6WL99=._"Z\MN^_G>G.UF(#]-U:'3 M73
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M];8!O=JKJ_>^!.CV@[K\ MG(QK2A->K Q>T2"G&>IPA[@P/=+4_3G<^F'_X
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M6__<=G\'O]F39[V-#[XY0;16DB%'' ';/! DE::(>2.#,IP79&X;6POP2F3
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M4K#*F'%?1\N/(PD7CCU=J&?M: "SDL4TPAA'$S,9NN.J.=-\RUD8BT'S=QZ
M?!8;\6&:T;#C8&I3OL16FHY)=-96U_USMMI;]6+O1VQZSF$3>UO?"JIP(7%
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M4C'ON)I+"VBHTU)B,_OZY,:!F8^-,MTG--UA>,'L&^-E?%>O8@-0UP*HG7F
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MP!1+6)BLE+I)1B\IR(.!K_G'<3D\S'[YF-F+R=M_1$7CZG6=ZAAMP53*;&S
M=  :-+:W*+M'WM8U__L@.^7/.N(/T*Q] A>>*-2HB,%*.C@$J#X8@2:+@J'[
M4?WJ]D;VV9_O[!4)3WS0:BPNE9^Y4._L&>*]SOX8MT/H'</0JL.RG]7=8*I^
M;"%6'YPFW>QFMNNX<<+DZFDH\?G&03ZUPNV/J73Z:#DU6Z=L83S6A!'3X93G
MKPQ73'.X\/EA);?![!XO),5764@])@I]@)"3M%IE;&TU.WF1U'3]Q6<\ R3C
MH^4_G@ZX$Y@ND^&##3]=8Z!/U1@AVR7PL1YHG<SU?O8&(U/:$GA<G-5V1(+4
M)>4Z*K@H6!"2"\<+P?.<&*FU8;(@N2%8")Y4,)ZH8$PH(Y<?K(.NM=Z[Z@TL
MQ'::C7((Y'LOO*L?/>75-K;/)9W;WHO6Z2?XW&NQN__Z]%NL56)9D2.:8JJE
M]\@P3Y!EQ%O-"FU3]\;?:-4D!;#=)J*2[&G8E[67R2\2AXF*_+3Q<2.)\.M1
M=$/!QOK439?LCAL0_;-H,T:R'KL)^4[R3NG^"=A@+K[CLU%5R_,0;/8A*'$P
MQT:P9T_Z=<\5&X/\!NF6%\4/1*VJ(6J\I2^3M_3!!8)S;A*2-R;>XU [L"!
M@@%IVB<7)/[B_<84(\V-@;<B'Q[?8?4(Q-02G-@M"Q9Z[%VI1J;R_QW!P\,4
MU"@Y;O@4G_2J(#19MAE30&?M7I56-MWQ9]FII_DZ^$0<)J$0&(0!<^[AG^C=
M\WD1O"'.3CHV%;\P$:)1#[_- M5;>,9_8&Q[W>VRFC@CIS U UU;@T%LBU47
M=6M@ZW>PM4._.>V%8F )6%@ZQ 4A2&+*D62:T1Q+XT*,H[XLU7^*6[^PQ==C
MB[FZG^&DQ9DK85,,? P2-GYX'%NHG;4QB]NR!_]/J<%,6ZC#7K40!.O,B;':
M3DIMK+9]W9UL@I^)<T0(<F>;IL:;WAEI&N-3]$C!)9)0E-'S$+T<T7$"= *>
MM_;F]Z;!@.,<CNQ%[<#_8SWK^M2L+=X.A,3%=UUJT!K/973=9 _^J1T;YSQ5
M4W$&&NA]>K:K&/<KY^#ZC0WQM5>==%=PS,E6V-7 8L]\)K^EEQ&72U?&YF2P
MEN\"W&T 3-5N7%1&9]HO/7^DCK4M$&%\T#L%8>B7<2O8*%PP ?JT9T#J=&>R
M0=?G=/XKW=5.;]17C+LUZ>[I+HH*?,+?X0$&&FGC>IUR[&_S2:3!INF"HH#-
M&_WV_:X?P78K]7I6?1_KB_1+-1S $*+<S'XS>(!5D"#?_I',G,D[M=.MU^E$
MI7&"IG;_]/(;0%.<'X\SMH]=T)PM+4 J('VQ:UL_M@_^;6OCB\U.M:,X]TX:
MXKF31&%"?!!4"$8+S>E82;&)DF*7D>B)'^N=/DE"O-\;G\Q/3'U?O1T ?#2Z
M:+%#ZDMT2('A@GTA"%(F][%2NT92$H.DP58:CP76 !6$SA=SF'13F^3*M4_6
M)T />[4/TQM[/,8-[]MMV(]C&W1\1%N[J%-#8P#A[@3UUQ>ZG&JZ-*M)SGFL
M?W.#&7-R7OH7WJY6G6PCFY$.?49NDD!$NSOJU&&[INF3D<&=0CE,?9[KIZLW
M9ZW[:O<<7+Y&BNA-;2\<W]B_$"\\2GZ%*1ZR550S-7N>-0$.D\7NNY.C^DE7
MU&IR##(\#S'1XP@0/M3=Z&H&WAO/0!:V5IYI-EF[!*:H-EJT6,EW   4#\0'
M2>V/E_SBE"\@+),S'WC9MN&>93A)3S#CA1AZ>]B%F3TXF3O4V,BBQWP0]V"4
MC7C/!B<?'TZ>[I+6P3)P<NJ8J]5FW)=GL2VPW7MVXL)+)/TJ6ZS>EF?P:!*+
M'PR311E/$J.T1:;=29<&6A)&;3!)PVR3\H7-?ZW4S.@B=\XRKJTR*K<%]4H%
M2JDP8N'N.[_?)G%R;TK8Y/Z?J!<NUL+\G"#$NZUXZ'G@/Z7Q_0/#.[<7 9/L
M2S<:Q&;&SV[WP?VWOH5@% >["GFB"8JF/5+8460Q=SA8;1B5*<[F? /=U/[Y
MXL%[$ZKT"R=0+&=\6:Q2''W:?-H'%?*\*"AAG%DN<5YPS@7.;1#"LF\<KSU4
M@-.]TX&Y;K(PC[^R.MF=-QW?FG+#-RD5NCQWF+U=5K;=BV$N*])6'.^^&F-*
MY\WWW<X7^/Q[L?=VE^P>?>A\.6V5N]L[9._SO^VOG=?'K<]? "^VQ$5,^?+Y
M_<G7HYV?K>WO_,OIIY/6VZ]'NW3G>/?HD_CZ^=_.E_TM\O5H"^]NMP.,X>0;
MT[JP.L>H(,(B;IQ"RN4&Y0HKD1-O<Z(O-A77+IY5<T&$EMP&I?)<%PX#'1%&
M&HHO-A7_^.G=NW]>[[Z&"?HG>[/3VFJ]VH'?=EIO]C[L;NWO[+5^W?%[8;#>
M[P=Q?M"$:UEP;RFGGA-,I9*%B)%^0CBMF)Y&G-_9=AS'JIZU.=R*#K7HOG_3
M&[P"!5D.HWMUE5K=/\2>//V6!X4#913%)H:(6R^1 EV'<H-Q09U25KB+>^PR
MP&/W"GAKF],U36;.=F]DAI%J319_U6RVZ8G'C'<WG8NG ZEJU.F,/6F1B@)K
M!6.JFGA3];E'=9-'G<9D7\M[6CNR)R[4].F8M#'E+/6HICPC1=C#K+1UO_(O
M)[_\Y<JJW]8G+\MN>LKTI;_&4SLF)U&97@BP3UJJ?OM,SV[@6M>.<[O&=QZ_
MO9'>NI N4+\GZ(:B]-*W\0:Y]+U?79;@#:9X<UFF\BM=]C=Y>0L[T,]^-)_[
MZ(*DL9JQWF6RE+Q:REV2L%G!2KSPW-'$I7G'C^I)6Q<1Y#</>L5M\  )@5=[
MWA> M6._0367W[HHW_2RW*/?Y(XN7E^XS'T^;$3^9_",Y!D\X_-;QYN6L[CI
M+*Q(PO+?NITHH!YFQ@/-ZD8*"7RQ3ANY;D;^E2?C:>1P7_NI'WFBMM/46\RM
MDD9SYW.MK6(Y-U)R7>0RI$1MBO/?92S,&LX3$VO>O%Z5HXJ;&M'CU.KO_.O^
M ?O2^7*\NWU OAR]9ZVC3[RU[8Z^1J?S=NOHZW:[W/W\GEU,K=[;/VSO;;L2
MC.OCO>U_R]:VI:W] ]RBK?;NY]<PYM;WO<\[/[]NN["[H*&D*+Q6PC!DBMPA
M3@J%C/0$"2^HX38(AED\Z[@LI^S.Y."FN=,- CUW!&*%M(JKPA@FN'=:6A&\
M+0IA:1'=@G6IB :!'@:!3BXB$,:*:ZH\<HH$Q(4LD&%<(N(#-@+G6,:L;$+F
MBP$]001ZAO#SI+"'&\&4\308[SB37GE"I*76&99C[M2D3,WOXC<:[+D+[#F]
MB#V$8:RU9BAP+Q#G.472Q6YLFA6"8.IIK&V]*-)CR=C3 $\#/+>KC^6)YH'F
MRN:,$^:TH:& QY>V,%Q0D8#G%UEJ#?#<)?#@B\"C5 YKQ3"R.?6(YX8B;0J)
M7"@<-P55,IA[,;ONHT#BY,0.'L,O.H=9Y4\^W>+:KP[UX*".0:Q+"J0:6N.&
M&L^BO/9UO%J"62U<8#A@SC#1"HM8-RHG45JEO4*VW84 W4GUC04XVZ#K-="U
MM: /N%1!N$(KA ,M$*<QN(0$C+PS-.>@&Z4&6G=K4K?$0MF-B)56B1Q[7<B"
M8VXD-RHP2UD0BDJ2LSH&GDQ$C#0B=I\B-N>U(3* $ E@+%BDKD %,H0QI*4Q
M!$OJB3>-B*V8B-THPK$1L?L1L3GGA/4TY$41$"9<(RYT@:0K! +JH7$1'!<2
M1\=H(V-W+F/7Z77@72X"5< T8F"LT:K06@7JN,R9,-2/]1CYA1Z[4)BAD;;E
M2]N<1>Y VI3"'A2:IX@'SI%2UB'AC7'<&J^U6%15INFKLE1)^SPHAQ[U0FB:
MJ-RY#7HU7U]:D3U8D 9BK@,Q'^?-4D5!&4A@RA[3',Q2YY .F"(AK-$Y+JPF
M?A%G?I"F)XW$W8%)VDC<G4K<G)6J<V>],P$5#H.5&B10:&H%8J(@G$@O@M&-
MQ*V0Q"W=0FTD[DXE;LYHU<!'!*86^2*6.J94(J4#0V 5%3[/ V6%6=N<+W+6
M2-SC-5<;B;M'B9LS7#GQF&DLD#<QNSN/GEAG,%*6FYPJ#3A:K&VRU9"X)WR<
MFBICV9.Z,E)[W%7AK*/&LSA1?1!S-M8MO6KB_625]L\6Z5SSF0:+KHY%"[()
M< $&DI$^=J0QB#M*D)2*Q?K,5'(IB"6QQNEJ.-$:(5RBA=L(X4,)X7Q O<6:
M,1Z0LP5#G ,%ESSDB#$EL=)24I'?SNAMA' UC=Y&"!]*".?L8!]T()IZ9*D6
MB*L<(T,$1L(0,+04S7TA9JJX-4+XT$*X-#NX$<*'$L)YTQ@':C0K4/"$ !V-
M3%3$FE.2,TH<]2;8M<WYCL&/ZDSWZ7:9GZD[X&/OIEM6'&@:RB]U0E81\*_3
M/P7CH!G)@R64*QHD!P[F!9/,,L_ \ME9Y@%# ^77@?*3><\""3%3QA DC;.(
MTR)'H*I%#,_1D5AY16)X#L7+39AYD/;O#:0UD':C\%ZIN*?&N" M=UYHK ,E
M!6=2:FM)&!<^:"#M02!MSD\CN,9$%,!."P4F8B$-,EIH)#DU7AF6.Y7B>Y><
M ]A 6@-ICP;2&I:VRI VY_62.64VZ(!<+CGBWN6QKI1&A6=%X;T20O&&I360
M]IPAK6%IJPQI<S[$P*0(&@A:022P-!L8DDI1I M*BR+GW-;EJ9X"2TLNR#]3
M1?79#C*S31M^68+_;ILK?+2'WHW:?B_L='_X;NQ*6OO/A\^]G0+^IBQUA14<
MN9 'Q'$P*'9O0I@*0F)/;,+M7#N%^^N8,%FPTE?3AM"/IMI_(384N;R8_2K6
MSQ?+K)__9 JG/X+:]^>KW,>Z]U<LM/T(GFT;2$G]:&3Z:$U];9B8#_HXBTW[
MXI7FXD2;8K;/NICMLAP@4\H$FVUWLM>>B''PZ2=<J8Q-CEM'KT^_;K\_WNV\
M.=P]W:5?]W=$ZW.K ]_#>VELYXV#UOYK&/?.2>OH.]W=;WV'ZYY\^?SZ=/?T
M:WOWZ#OY0K\"UWHO8 QA=T%&)S KZ0H?D-&4( Y;$TEO&<HQH87S.5@(;&TS
M5TOV=ZQF[=H&<)X"X"RK@FT#.$L G/G87J*$YLXB9TVL;(8=TKK($7&6%-HS
MS[59VQ3JUD5A[@MPGFY"T.?>X'MLH]<?]*ROGD?^ST,2FSC?.]UW]6PW0',=
MH%F0R1,D8U@%A:R5H:[O)BV+I2M\4#G+/=%Z;9/A6[L]FS#FE=;>C53=0JKF
MU+?$7@FE8IJNB^I;<P1_$Y0;)L%4$ 4)L6TVOK6]L )QR:NOH=^4W;(Z]"X[
MZ/7<\Z@W]9 *>C+=;^-LKV5UEW:XT<_AR^ZH@UPOM9&/UVEPYCHXLR!:ECE
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M/RH^^XHV\&"CX>5?F4L-O"#PESJ,[[:H$"'GJWG,_CP<G.6$'GAD!EY_1SK
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MQEED>,* @T93(0E6F*\V5KT%P18$OUL0;*/LOP^<FXNRITY)+)E "AN,>!0
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MKU^=O=U^T7GS?NM\KI[VYU<P)WAF^\7[M^^!RK?WW[\%2MU_G:G_U:>WAW\
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MF238HXXAHS%#27D:G<,JIG@56!9P:Q/^*H'+'I)_#TLR3+=;]W:N:Q65-BW
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MZWV8' 2B8456PY9/M?('*":S*,F0V.(DR2PWJ1'5_/V-+A;I0O.4G2CH(D\
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M"R9PIJ-PKBA$C[RB:PE;_V=Z@)YOKPMVW>D)V7D-ZS*D>OJ6&1=?;U?H[&@
M6-V9 "(;'\#9H$7R7DMM2]L5:]\5L/WN#VYS<E9)IF3M<Q03<2Y'PP3D[- 9
M7T+X0B;ERJ4LCB=;BM)"($@378PAZ*0]YTIQ(]I2WLI2"D_+11!GSCA+2VF0
M!1<RB\EGD15WFB;\@FWN#. K$%^=7M6N.P6SZB1*^@&NBVK+8S'1!!J7 4=4
MKP.0;,6#U]ZBO$*X:EOA^[="_$A;01707E6[;$J)M@)QO0NU"8[ARM)^L$D5
MXOKE'*MNY6E)=+?BUUMK(P0DY1P&E6@;^N!%L30'1F6CM6VP7_]:?WK]RQ\H
M:)&5!B9<J 9<[1D6D(P3U(HN)%D5<\5:5_M>[MQP]ZWLK8IJV=C\;4C29HU#
M(J'C7R=I:K+HI5HZV[230:F6G9E%<V8^KN)UE9S':6ISKN)2C5.;?CJ5R?^R
MI+3\=2Z=GYF'YDZY3@/^D_2(3J&_',%PKF%<4&+&.727=6:!O4-Z*CUY/(A[
M-&&Y>HLGU>Y=[3+C7$TBLS$'K,82NNFE!Y_'3TRZJ*^IR6)J0XPC)*6ANV8J
M$TZ',)N&F?7QHM*",8Y/JJ%UFCP^_=)AU[XXGHS'G3F*7G,XNF# G(8U3&;Q
M&74.GDS#_LX\C:G>JU/9NBC&;@RAVIIIHB=[.5<#U18>X-0 ]?]=G-EC_)"G
M9L/+\TK2;[4L5\MO'>MXF.EF3\X&.=?33F;6NVKC/NGLR^-J6!O/S7\3TJ3J
MAIZI6K14'VCD=>\<3]_NF&Z7Z(LD2I],CNEZ&CT^Z3ZJ)8)(0^R4T;EE*9R<
MSHW#<WO.$1Y78U"UIO]9S?FC)S.;V]G:CG,9585NR=N[L+[+\3$T+=,].;.$
M5=_'\:B;W<GYLD_=N;-;G5E%IQ[F^J>I/DG?KV:\/-C/QWN'J=N!%QY\Q?Y>
MU)L7<41*RFBX/YQM_ OO<F[X'7:F-X)HZ.X_M9MV =ISJJG*S7C2!1:>![ ,
M1Z-.23Z,M.CG1L?Y'C\YF!E+CT^G1D3:>G_6&):Y9?&"63%-+</=7'4.H+I^
M=-3EZL$XWJ/]>%!?\0HCUUP6$Q<A?I4IX]S1,.S(86KL&U;[YT><&A7KRE<"
M?#H8/#^+J1R=/EF(NNG,'O.-5Y?W.)\MQ]RT.KD4OG0>;7/F$.N\/E.;:_TJ
M7O!T#%[DNG&FEAF:WHX$5E^YX//X2E32S#0^V3L\&:7.TS%ED-Q!ZLSK090Y
M=8B=CZ+;/E/3T=RTM)=7F)>J"V&&\TO[Z#T=61WR^WFZSH,U!S]-N;&?)VNE
M!:*GSMY>SN X0U-=A"=3V]_!NYG/ B=[G8,DQ[DU;T(;\<R"=N'*F;$PY=6'
MRLE!O7%.%_Y(S'Q&:)T)?O;,LS"\J>=P[EOM8KHF@[^<77/A,/OKW)OQC0=6
MS8*]<K =F._#Z/U\-I9?SX;2E;!N1NYE<7W[Q>['[>=_T+1+7QM+ T!FI!8G
MAA*1(;KBG9 Y*+NQ*9\N]]PXLW'7S76=Q8:@E0]9EI 3*)=]%L)%&5-0AD/R
MW6(+(95HB[V^Q?ZT]<L?QEHCL^#,>E\; )3 /+? :KM(C\BA)%<7>[D:^?EB
M?\GAU6V%%[0<%SX2W4?T;PUSJ"3X)YUM]WT"K>;VBR&Z7W2;C\_=LQ<UG#.)
MBL2HPY-W=,(?SSV]56RHTQ=/8^7RJ>AW'EXX(D%Z,C@YJE+(ET+3),HH1<Z>
M2P.FMA2.4!Q7(,":B.[;0M-^/1OI_,S]=R>$M8BT&5BB>DU@R5C0)\X"*E7K
MUVJ&CB>FDXJ^:"\!RY4Q:4]FYWS=.ZM/^L6#FYAL.+JLIUX6,&=^\*E>=L&?
M/]...]G@Z8+,7"7*>=3$I2"'F4NNV]I7!0;17IQ% IT'672R*TF357 ]J4+"
M-) ]ITX7G84M=7[OY7B+R[%%\U#>V9V?G,7!?$D\6IRT3N]9-1'GL1)/IF%A
M'<RZ/UXBE+K+V? 3VQLFDGJ>_3A[?.<ET.D/ 5Q2M*ESM)X!>LG0QL1L=EER
M+6K=LHW-PX-Y';VO\9/V16+.F%("4!"<]\*)5+RB/X@$M\!/'P_':9(/?C2.
MVGFIMY[_$4(P,MK"N'&.I#>N& :.S ;%E<TYJ00;FZ4&XE3G_V21JZ81@^'D
M((TN!14,#_X\'/U9V>$\$&N&W"Y(D)7QX<'Q/#)L<K+?2?US&CA3DZ=FN/,+
M+X#RN,N//</SA1/U/#IB'G3?66G.QO&5ASX=O#HXX[RS,,C+YS<N$,G%X*=Y
M:&4:ED*#KIQX<1SG)J'S$8V7;2J7N6Y.V5<9LH:5X3J&NJ!#=:;;R^&7KPY6
MOLXT,^A2VLF7LH=_^,P@U_/,H*]F^BQD!H%7X$.R'#6'K!UR(E9GE29IGP1[
MWK_,H!GL0J[%)FKVX253PD44X.2+#%-/_'-^J3B;GO_MU%]]:D1%:F".P3B!
MP!SWEH%5P (OGOGH2&4+ELN2KW/J)VXU"0N*&UO "XTD !2($:/!J)5II_X:
MUV_[XQ^6@T"A$O.J5BPE%9"%K /]Y%44*B?()+5-ZK1>=>Q?YJ+;3<A?E87_
MO.+_^4'ZGYD%\G2GXOL'SLU7),UI1[I\(6G<B)P8<!&9$X&6N:B8A<]2Z++(
M_=$HTE+!$/%S@""<#70)2H]@H@NPF)O?EY.@VM'+(8EZ'SO71L?NQ/+5EO(Y
M3RXY>V;*WK/YGIU]>2Z6='5BNA2$HTE^-O_A[VDX.1KAZ;/A0??P[J*_S]YX
M)LO4 WNA4DPGLDP_/C_+G_+I>3ZK[CA[\NSCI]U'"X5ZII]9_E08N/)C^O3*
MS[YT6Z&>2F-OY[;^FV[[E5J7]UB4TGU;M2U2#?:G!LW)4JVEZ[W05+"]_U<Z
ML\@.%'_2B9N5CA_'N\TMR@,ESEY-K+/XZD.MK7KF,KULK)X;#K^SBMB/65GP
M@18.O(;?S:/EQN2H5-106RLZB2A*L5"\ '5%HD,M%_B-\ER/V@5_KPAW5C1P
M>^=WNN^[3[5@X-N=7T>U:""-=_3VS;]&VV]>TO.FA0A7% T4VSN[ZO6+EY^V
M7Z31]L^_GV[M_W/_]9O_C';W?Q>[._3\-[^+UR]^+5LKVG,K9U1-2&%::<,
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MI60B YN!(6)DV<K,L^$V%TURJ%^7A>D^B6Q%F[:'$3W998TL=4U;62I@12F
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MG@]H,7!C/B)>Q[-*6;OONSS>K*3GUVIR=).X\4=UL#RFXR.%Z%3R.:F< 65
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MDDT%[QM#KJC9#" *6&^8AI@9>.X9Z>2>%<VMDEJ46#W@OC>NN!\==-%*2]J
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MWSN:?+5LR*XM\B(/G&7K-8.B$D/TCDDI2W1%E&2@!JCUQ<WWHZ,."T<,EN<
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MC1;(M1/.1)0MY[9BP)Q*AHL4BBCDHH9@,@.,D?DH)4,B60@&5 FZFD6AEMN
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M<DLXU@8>&B7H[- 9(1TFJ9WW,K=RL1YB;RHE;4JH^CJ)<:4X U4X"])GEA1
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M8CT&41CF@@Q,1IVC!;(@R78=_V[!#W)&8Z;I1DS=*&,NOAACK10*5 3'C04
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MGT[+KMQ!6^9A#$@G0W/+\9BO8-+9\4F?U9*^6'+SM9+LV;.ZX">]98O'E7[
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M@1;G^=F7/S(EZWQC 7T1)-]W95TS[I/!NO9GO?N.1S$77PS%CE(H4$36W%@
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M/7GS=2@MJJYQF*]6;*UB/-VNQN4'7K#ZKUB"1JXU$\4D!ME)%KPPS* 6LH1
MKG3N327CB(SU92'C137'1_EL<$(7/DZT:,)D7CN78.*!=,6/DTK&DPF'=?*&
M6[\__7EP0C'I"I8Q:OE8\F4WPUG$9;_^FA:N3S?[CY<U"VGS8U:IS<_VWCA_
MWN>G<\(^2P]]:Z'IR@[*5.^C?QB3^=84+_YYY];@Z.Y];A;_L+-RG0_P&:<J
MF;\%M0]G.'Z\*>]#F?\\A^%6:>JOQ>B7 ?25A_KE.I!Y#=)M8/4#?L$RKKZ@
MZJ:%K_<U\DK&?X]B[N*M^Y1VW'H3;@G/>.=]N+OMI"WAB>XB=R^B!Y.X"L(#
M\((&1"X";=39%'?5]MW>ND!K@]CO**?+!,SO%(%?KJ&:B^G+]MJWIF$NVR7_
M]G;GP\L1W<O%YL8KV*S7W]Z$K>VG[W<^/)>[VWM[F]OI8'BX.W6(>O/PY?[P
MV?-WPWWZ;_O-!WH6T;5=WOYU?W-_]V#KV=/W0_E*[A[.UK?GQ5H;M&'@16VY
MD2S#S#U3M(QBR"HD:];6Q;U/IMRK.NOCBF],\9"8PON B-Q'DT$[Z6)T.L0B
M91+(E;Y46;"W5EEH3#%'IIA2F(%DP.HHF*E'38#8@?FL+ M5UTP68U#FR=Y=
MGYCB6[RGFXY>8YL'P#:@M8Q*>I%,A*A\L#8#"B>T!9'<W0O'&]O,D6VFQ%T\
M][R>CJV:?(&! <V"UZ6*NR2E>38)]-JZ;GY)8XJYRZ-K+[10M7M) "X5$EFH
M) MXK[30=Q>\:TPQ1Z804R=+HG%1",ZRTXG\DJR(*;Q@2D<B#!L\K<^U=3,O
MY;MY,,6"CI@L 6;/:W8YGY[-S.]\_^,E_2:6!:1&KL:_,<L=F676F;4B3/;@
M,O-"D2,"M:])DHFYQ%WQ7( 4@2*>>;5EGW?$\Z.B[/NG%1K*OAUE4WD%98.N
M2&-*9EV5:SD+(B.STH@D(*E@JSC.O>O[OQ/*[F"VO[B!](,B=0$A>4/JMR-U
M6G U*UV/1C%G-"$U><U0!V#&*S29R^(=KJU;U5.D_J H6T XVU#V[2B;BF<C
M4# 003/R8)!!T8IY+20K2B4?$ZB(A#(]?81Y>2A[N.4*3Z].>(WSV?GX:$!0
MJS7@ ZQM.Y<@S;*$(;B+A,("(MRK&7G93<C64?U=UT2U-SIRJ\$\,\03R(CK
M(+#*J"MB'J<4<PHBTSYE;HF6<B;F4=,Y]P6)M'R;:7_0>/O^L6[#V[SP-AWY
M)BU""):IG#V#6(!YX8 Y<"9;@3E;37A;FBC2=]E,_^$QNX"HMV%V7IB=BH&5
MMM'7H[HQUWHY<M29*T$P%:P4PGCN?-5(G)&N6CIH?U3 +2  ;H";%^"FPN%@
M,3F9@!DB208* G,6)9.*;"<YJM96H8?[B9*VK=U;0.[)X3'=PH?)<?_+8]0'
MQ[3(3[OST2?CT?%X<'JMO'\).LC]SL3-(3K^@L#@-"-=GZVM\@Q'1Z?_VTU6
M(Z2[$-(,02H$&0QHP8REV!AX=E6L0[,<;. &4<D,U0/H47ZN86\>D7+#WJ*Q
M-R-B5M'4]BE*AMJNV7@6=(R,&Y.B*3(AKQ49?=V!:GO%R]PK;OA=-'ZGHF=;
M-&"PGA5?G?E$T3-1LF4*O9$FA>B=75M7?=K;:MB;1P#=L+=H[$T%T@D5: Z>
M8FB.##)/S.MHF+#9HTS6J%@5^.?5@VR9^\HKK0FQMCZ\+E!VI4'V+0?FYR]I
MO0IG4>8H6MUO7E[ ;CLMQ=\O5^(U!<3&Q7?AXAFG[I4K#A5JEF51#$H.S%%4
MRI2WMG@G0^%Z;5W,Z\S*=Y"LOO/1M\9%#YN+OG\E0N.B>7#15$XE1HY@I65>
M&'(.(1063,R,9HD<.5Y23O5<_[R:1RZ"B^;N*]Y5$:"1W8,FNP64<#2RFP?9
MS2C?$-H[A^1N\1H)US9T3AN6;.+"&*Y=L&OK,.=F(LWQ:ES4X^1<XZ)%<-%T
M98N31:)43*=$7"3K08]H-4,?0XWC%4<* MV]-Y(7Q45S4'"=T6ZI[^FZKTFX
MUIX!<Y)M_<K(S$F7M'W#/+_AX1Z)^JK$1Q- >@ N!<=HE 9R'Q* #M%[&[&D
M4*0F>P6BZ90LSY'8FG%N*Q4;LDB:>>L#@Z0#<SY9YKF#$+(MT=>*M!X)(#6F
M>!A,H2.:)*)SRDF0 3 I =:;+ S]+ZBFM;)4IIC*]:+-(65(+)MB&&@0S.>$
M+'$N#0^\*"5ZQQ1-PK6Q3<<V4GH,OB1I7*IL$S!9'P7Y)IKL'^2F%[-4MIE*
MMAI54BY2,&UB9$ _$=M 82X%Z:%$*U"MK=^[6+?Y)8TI;OHEW$*,VGM1$(*V
M7J..2ACG? P\QJ9YLU2FF$Z%*BDR&&12>&#@;6:!7!+&#<6>-(4%?>D74_QX
MY_QFG?(;YS3Z,61>[W+@> 'YDU8F/1<YZ>TG'0UU=+3]A&_2<_V57<Q!AL*,
M].2UB*I'B2+28C+!&"R>(J597'3[X\;M=,)<X;: )$2#V]S@-KH!-P3%K?6>
ME02*@7%U Q0]@Y0MI.)RX')M?;JKS-+AU@[S?3MD%Q#)-\C."[(?I=&O(.L,
M6@4\,2ZY81#1,L1"WKI*(683BTZPMGX?F;AF(>=K(;]_.-S@-C>XW71(/4(V
M.FNF;.W3R$MA(47!BHDH3+0^^+BV/EV?O12XW?/(WN1B-ZLL'M2!OEH4U-5.
M#/XU.HK'A_G..D5S&JL'E;V<UYBL.M7/(?=PZ[/:K2YT#H3_=#H#H9*' L@9
ME&090$P,I>ST3B (]"X7<;^0:.ZD^YV+UQO5-:K['GF?1G4+IKJ;V1]O2\XU
ME+0>9953-<QI%6M!BG72(@?E9A6DK"#5+=@;_L8CBXUI&]-^CW1=8]K%,NUT
MTBX(IY.V+%N5&2@963!<,9=!%#".^X!KZW/0FE\^TS:J:U2WQ%1IH[H%4]U4
M_"R+\E%GIJ()C$+FPCP7GF5MHRC*%9!^;7U:9'#5J*[+M?[7&=(WKE\]S/#\
MD)94I)_3Z._U_Z$_KI[B$,=O1D>3V^&=:_@]$&AO(E!6!+YZ_,?CP7]&!P?C
MX\/![Y>*9A4"@R>'^2C1?Y^JB+K[KD]3<3DZ.N^V%+[X)/*[/<D4E\BK(L3K
M-S:!J.;)4S3JT1I.K$$A*1A(R:/V66OEZZFYP29>#*I[]&CP+@_PZ(@65,QI
M<+:'9_1''IS0Z[7&ZJJZ"@_I'6>G@_/3_Y^]-VUJ(UG:AO^*@GN)F0@7I_9E
MY@XB&(,]S',DQC8>O_#%42L("\21A%E^_9O5+0DA"1 @0((^,0>#EN[JJLHK
ME\J\,G^J78-MX$];MA>'G'"N1(UN+;4[M;R)?\8:[ 'D8()L\QCV%UPT;Z F
MS ]\K'E<:Y]V:M=68W"MHJW9&;Q82YT8+^'VW9S]M1%]/'*Q4V/D73'ZU=IN
MM)WBO;R%\QS8UG#,\!9@7/$8$79L,PN#;Q_EFY33U8'KP3#A(ZD'5YVX?#F$
MXW8/'@[&ZUNG 3X, \\S%")\YZAY/,Q-RR\.)P'F+XM"GJK>0;L;KSW[:FWG
MH-FM^0-[O!]A%-W35J^\,#SV?]^'Z,CZ*%("DY@1+@//5%TB*.^,\TDR^7VK
M,($%(_<^0O/^]*A8X,&KVP[FL'C8E;S$1[8' SCO_79\>H1"NZ@ZSM=?=HW1
MBG]^OMC[%DX<Y;)Q]/E' \:S]^WKY=['+=[8:,'W6TVX']_;"8?URSW0')]_
M['W[)S4.U\EWD:3A(EE$A>"()V>0L40B8DUB1!!*&+N%CQV0H967'.8R2_M@
MJYUTVH=EY[_^_JJUAXM1^^7O/[9_A9W:.\B[IYU2-_9Z6=K\::=GFZV,9[4L
M@5<[.'\XBQ]<NS,\^*G%\RP9\5V19-DN[PR[+>07<\3@N% :>4< NL$_^<*%
MZ)47J/V2$S-_+<0_?_4X/\ 1[-:#;@U@%;[U)9[T^@*&^_([B:VUZ]B;D;;8
M1C8FDZ14"J:0,\\UEHIS+G ^X@>KZ+MB*PNE:&ZKQ:\1@*[_NZ8DKPNV"Q*V
M<'*)QL 5%@YS:3EE@3D' I^F.KG797JK6)4=>[[1['I8FM-.W('K_]%J^Q\O
M+9H7?=&$U^H;6V H[<,UM\3N#MSCJ'%0_[AYMKWSN;5[N"7J&_OP^X_S<=&$
M^Y_5#S]=;F>#[+!UT-C8O]BEFV>[.^NB\?&?9OWPQQG<7VSO9,-LZZ*Q_MVI
MP+WT!OF"7"R$A)R/!N$DO%#<B*A3";"P&V-8SP 7+=<D"(R3LIR#&!LON5 $
MAT!]P !R$?#N!.:]USF%E=UJO-^N;]9VUO^_S2^39E"YLY_/U)EN(-S]3-?G
M /,@")861^*X),E0N  H&!L8E2[*E2RT$S;2-3&>.HZ[K[LHAM8V&"HQI5A:
M-7V\Z]GS6B=;0&=@G=RHM$$] N*-Z>T@F+<B)(83Y@S#$F#!0VXRSYVBVM]Q
M,,K&97US,+:AT'^&@;TO9QQTP?9)+$'H*@,&T3<& N"]?0>15X)%C:0S.A>!
M203.M45@15'0U0J$(E.=KD[JY_\IS,B;G?>IR^R-D#A:I14'2UQS!T: IRP)
M0S61C-YQ*,1N=-^K]9YAO0^_?E?86QX=1TPQB3BE%FE#-/(<:TSAS2C]RAI>
MG7)\_3]#0Z9W #[(799,L3WR(K[+]OQ)N3JMBW</V38/4O[5MIF7K0!F/"&2
M^,@UBC1GN27ED0;D0!1,^"2H8ES0Z3CQ:PD4]UOP&*1(U#C0>C!:9XVRX"_0
MP+5DPM%X1YRO4@</6N?-B^^PC,I+L -Q]* /G$W(A*11XE@1X9("S,[NVNHD
M!^/_S.+HE%[='1BQ6KO=O/!@Y80FO-VII1PDR?=\5D"AL^VOS^#J'/MFJUEL
MK?7>APC^CFU] 5_QM-?N7%S[\!O>>(>;^#M3WDG.&6+:8\0)PTASF:M->2#:
M1AQ$YCF>9H<4 ;-4SFWAB!>36VZ5<%I$G&RMW ;9.4_PQ7:G^Z[O_>?  &Q<
M,&Z/^U\I=E8\]A$^D_<<? X<>UA<^#O'[V!#G\*]<S"K'R'HOP$?+D)<Y7XM
M;M")-K=@!,& W=/_HWE<^VE;?;O?MEKM,YMO5@@#[!4'&Z;7C&78, <A<]#B
MN!C)2;M;A/3*S\9S^%:W>&,89<OEGP?M3B_!=;LY9M'M@7=[/<AGSVPG=%=K
M4P(+SQHCF.Y9?+AF9.3GG!E.WI5AR.'ZP;3TSF(LPZHWPTF^1_[B;?LH>S0G
M'1#_#CQGS?9ZG:8[[0T"FF.[8K_=#D6@M'ET8IN=(BRT^L#)OO%TXSE788;)
M)R\V^?9> >)'>B!7D6)GSZ\B2M>1_D,))T.<SZ46V\-73UVW&9HVPS] 2B_O
MCAR3&FZ?)0DF/[NS^DDT+K^2[8U-6M_PY+O4)@87(S()_%7.0%<8!H:+LMJ[
M$*/R&BP5<1-7]""P/(*>8(,4X?UR4\$;HS(]4!%76[.HNF\7)Q3-X4H61Q97
M'QZN];M\8',6 1/LX)BC.WJ_+"0E\E_D/T%3M$!:B]&59?Q@]'0Z%W#A KQK
MSN80=+NXF?W9[I3"D(7JM)4UVK5A')YVFMW0+!Y_27%H5AVP+##T2 >G@J%%
M@*'#3_@[MR8*6$R$D^/980) DEPB'SAF)BJNA%U0&!J%COW8WN_8DX.F+PZ)
M 4*ZM:/F>2$7"P17TQ,/9CP.D\MS'$;8DY^&;?:7^>_8^7)@%^<HK-$<2/3G
MYMXWD%RZ!Q+Y3W/W\//A]L==4?_VH=78^''>^+@'U_UZ#K_3<8G>^_A7:^_C
M/X=[1YNX\>VO9N-CG>\=_CC?_?85;^>3[?P,\._VSE[:WOEZ\5V1Z)43%%&P
M#D&*I4&62HFLT2F1Q'V,<?P0R"C*N#<IR/QODEI$ D(/X)U33:08/PC;7/_<
MV&I\_%+[>_-S[<N?ZY\W;SH.6RA_;/I)U=T//W9JJ(2BB5"JO82/26LL5C*&
MI#PF@H:5M9VLY?-$6("UPO=U[=Y!1@[8_!F&0K-UFN%GB$\G,3N[L'5KOVS^
M_>776K-;'-1?/WP?5]-_V/.<V5*XQ0?M%DA<D7R2LU>.VT7RRN#NQ8WAPOFZ
MV30H9RD&9'_"(/?C2$BA& 6@\&D/</FX""D$ #'XITA6*+((^W?)#Y$-D-(4
MR5\>_5;IK;=/"B?_7>WSEZ^EJ_]W_J69(3BURKR'8<[-]5$/)BF/^[0[&$$O
M1QY.05F4US^*O0,8T%U'E",;L+\CN( M,PA"_%;H WB6W\^:H7<PH($;^58_
M\PY??<6Z;CL/\,:OC*38Y:!+["R&&9I[EE_30R,_#SJ#P9W KD .YOH'*O*G
M?K.M,WO17?G7=6$&21Z=S_&I*!]X[?]<YU]KT^XZ_03[3OFZ'4^>5M=\\0=@
MPK3B=OK6%Z+U4H8:A0AMIT(#=7>RD+YA/73YW1'O-18,:1:S'E(*V1A!+6$=
M$@XF.J+&]<HSZH*,8*F=(Y8%LI3!SFQ(=JXY'AG52OCL R/@[@"8RE>&9EUY
MC2%>%"FY\ PM>]*-OPU^^3TTNR<M>_%;\[@84_&EW_N;N \R69+&TG$++"G?
MOA*R55P*6I\$H7_G_MNKQ5MC^<7E>X*N4LQO?!NODAO?N^VR!*\RLU"7O?T]
M0?0B#?;.R\J9+GL'+<:=1%%RXJ-3:D]*??:4!1=ZIGJ+G8F0;J%JKIW@S] 6
MYW5-2F,\OG3'G,RX8V8L00)%_)P/^PL8C_W 0W>BJF):(>Q-I1*WD;M,7]EG
M?M)LD+SV!R3S$-97,A=O;+'GT-/MT81-<YN#&<L%_Q@Q+!_#;?RX0M*I]5_/
M/14WGC>4LS/?%-O)&IE;?;GMJZA&L6(+<V+P0+^NK)L\:K0:EW#_G0,8WR>Z
M=_CY1[VH@-G$]9UP4#_<I/E:\-K1>-WD+OW*ZAM[!W /^,S>4>/CI[/M;UN\
MOO/IO$$W8=R[X"-NP6M[:4C$,4+"KEQD2E&*!"81<1,TLH%SI'"47EB!?6 K
M:P)/%D[>DX;] 1@Q8WUD*1^5L,X@K'-+4ZB$]1F$=:*3DXO1X!S",9HFQ*D*
M2-NH4:*,2R*PED1E8<5+)ZSSLBX>0[K\YM#@D>FJ%1H\*QI,=%H"@ Z$2Q!_
M&0/BT2EDG B(:),\$SI26J#!HSNH5*I[ 81U;JD]E; ^@[!.-#OBFAF1FS!:
M*L'.UK!,!@0546]")%:"/::71UB?J='U<TODYO#T?'B@WHW^M%,DSC\H*C!K
M_[@E!*3G<?PWR@.^"51:#X>G95+:]8S"U#P'97@9.^T*LNX#61>3H0%LP=^0
MFB M/<N,2@X9+C*CDE5!,2FQ\BL 3YH2^ON+=FE[@!GQB@7S>9S\602S$L#[
M"."DNZ]5[O:@D%>&(FX\B")E!$EMO*8R>:[--/;&!1"]1W1M?NOB^SQ>>:57
MGTNL)_QVF]%9,H<H 9>=$V>0]I$C8; $_\X ?HM*KRZ>8#Z/!U[IU7D+X(0O
MGHP"#P662<%B@F&+&7)!")2\Q880I8@3"Z17'WD</YVH%,^YP=)SB^[&M<3/
M.9S8SV&:7@O0/=>1_DU05P'</0!NR/D^ G#&!5A!K1#6#",>'$=&:8D,3B)0
MY1SS3W&H/Q^D>:ZC@TK@GSTMH!+X^0C\1*2 )FF"S-1*4A&4SQ*0(>"OD4"%
M==Y+3F@6^$?;-(LG\,]F",TAM:""G&?//:@@9SZ0,Q'%("3RR%/N):,!=P*C
MR/+@$5;2<"Y#M/XIL@\6 7(J@5_8Z$DE\/,2^(FHB9,^&,X\8D2!4V&C0TYC
MC%@TU(+#P60I\),MX)=2X!>QS\KT\MD_)K@,^O6QF<,@U^EW06[&6';O(,"[
MHMOM,QUF9I;,@M JVKOW+U:TVRA8"/ID!_&V_(F'C8 ,NBET 5_B>>SX9K=H
MC'"-T>"TH*B!UX?4!F4M^WX\[K4N:LUN][2L""XG9H1R9K]CC_.OF0IA=3&I
M"S=&R!?B>7\R7CBBLPZS.UCC+\,EWBQ'%SYTVD?OVT<GI[VB<'L[C;/"K!==
M;I:#"^JY*_8;AU_/OC-"A.#,(,># ^L*'#IKI4.8"_#B+)%:XI(_8@QK!Q68
M@ZT^W/H%#5 M_N<TDRN57)WWD\AQ4LQ)^NT7-@BJ/?ET>_)RZ^R[4;!:.&)$
MHI<YWQ@CRP1#06JO==(6*_[BD:=J$SSM)K!@5U'F(Y($EIY;</N,L1YID4@@
MA&&>P I4$[CT4D UT2? 16]/NX5AU.R4QD71"NVL?=H*M0,+-LN!S<W,X+]>
M$TTP*QV/DB&MUF ;PVC!D&BT>[&FRJ9L5RW2FL?E3BJ[H.W#PQ2\=##0;D'C
MZXL.4I-L5&-\)G.@J3-+1%/'GYRF;@.N^M.6U.K=7N>T(%->/PY_QK"?#]OS
M=BF08_&:.FU_&?1;V[JL;X"_]_$3W<[O'7["NX=?>?;CMC_^\V/W:.^@_NTK
M 5&>$/OZ8?TL?VYO8U? ."X:&Y^;C9W]<_ I.4!)$^#@?&_GGX.]S""TL7_6
M6/\>%0O2J&R1&(,XE@%982D2@46M@E?>A'%ZM@38KI6*TKF8>2N-!HN31@:.
M9&#!T''.H8W-SUO_K.]L_;-9VVI\V?G\M;[9V/E26V]LU/[<W/BXU?A86W\/
M;V_M;-W<]>D6.JN[QW-]_%88K4U*X/I2C@G+/9,L)X)$BD-4Y"[ZJ^?S$;Y%
M<(9BP2=;T&'NM]H.X"<#2^D/95\PGI^T^VTE,YAVFMT?92/*@L2VKPG?U;SM
M'M12JWW6YX,OD=@7^.@ ?0,XS=V8W:H"P'*WO OX_*GOE7-=4-$/6#?!82F[
M+^9+-3/; 3AJ!?%MM^S'<%!*7.T$W'=?\-_&HY->0>YT9(\S(1Z,M5N.MG@U
M([/W /:%MFA%@/4K(M#\)(>G8;]@*^WWBK0G)YWV"<QQ+U/6V1!1.Z4A@6^^
M[CN8O)-VIY=ME8N^^]A].+GZDR]U7LPKRN"199V8]6*-BYZ%?2U8\JKZ]OXQ
MW!*V!;CSO8D> >^*"\$^*)QD\)"[I=(N/YCC /WO#7D"KZ@#-T\[[7>U/[+=
M!=OH[QS8>5=[?P"/ 8OX.1[#QUWS7>W_P0U@QKZUC]_5UD\!@BW<_[BVD;FY
M.O %6/HP^L)?%B8X7V(WPC?>PPP?N?S^W[%;W,Y>-HL+?(ZV]:Y6C^=-/WQW
MY[3S(P_FW\V.?5?;.BXN_/GTI&]*?#F+(;_]_SJ@LE=K,+_]C9<WTV!&P9+,
MQ,_]V3XM>!FSH%UKUUB(V[O:V4'3'Y0M&'(CUX+*'^;LZIL%+;3]4<@26!G%
MO1*\>@%:JG>:.:++]I(@(EO'0W.B:"&;39<P5%[E>N3>D<-7FE?ZK-@1IYVB
M^V0GD_V6X:#1L=RX:59K'VVSO^#]H$^_5>5 8$=O5 YW\,'\G?WBVR-?F;:3
M1@8UI-\<@9R?[<P$6; !E[U;BZ8:N37+@#MX&M#TL>4#;,MC#](&J]GYD;=L
M%NO!*HY<^LA>P-X_:O;&Z8<S!J AMS<(6O$8?3@:+N9"@P0X2>W98+^<GBOD
MOR?<3T/V/J(W1[%\^+D"8$>X1#,K=.ZB4J09%X.!<=B\XJALGQ)=KQSU629?
M;S7CSY(D< 3<;?\3O>917*WMC"B09DD[W2PEMES6IF]F)0&?.8Z=0K9.^GW9
M07)!SO-(\WC;UQ^NUCVS)\4SEV*>VSKO9Z^DUQ[NP7=Y*!ENFZD9^VKO)ZS%
MC2SRQ6-?>^JKFPXZ0@\[01<+T(F#:_158AY#0*<G('+'[;[W47YU87=H:!<]
MGS-?;@%^HXA2>'R@K O3X+23=W!W@':QY+?M7&?&G0Z!V:#+?6Y*_G"4-S\:
MA'^O8L2U%#/P+JHTK[=:-SU?EG)X@MQ8H'5Q7;/78K. _KZNA@D=;0,$.S19
M\(!SSZ!A ^0;VA"#*9E["8%7&@?60KZO;\&ERRT.=RL:!*'<J[NX51LDM_AC
M:)L51Q%]RM8 <M?+P9F+@95V]5"%"@XQ]]8KVG+U.Q7UU_QJ'LJ!]/$?#:%]
MU"8I4 /&-DUGY4TQP+MWHW/1[O0)GX>T]P7P+^3>N,V-?I^?[@,\70V\VJ?L
MB3M]T^X_]RUOFXN1%.'%6;P"!+/YD8VZX5G65?^P@JBV4VYSP$#0+84D#3XX
M;(-0J.X.V%Y70E J*5 -0YOE!M\@:ZV!"5 R;V>%W+[5 ;C3?R@D^)HV+2)N
M [KP0HWF2,K8""<&!%=O^V8AR84/<]3^&8?">]WDN#;X'+GSS9/2+<EQQ:(1
M6CZ6!#Q81#$N.])$"_;$5)PO[9IF]PH62VOAJO-,T7ACB&?EI);F1M&2OD#D
M[M @'[U)MUC/3BA=N/7M]UN#MC7'HRL-[PW7)2N')NP-&%BQ+OF2I;!=Y!7H
MF_LYR@F68+%=P5V-1\W3H^X 78=_G]AFJ4V:X'PWAUJL&(_MCFXP>/E*X>0S
MZ4*[Y1YTG0B#[8XTX/D%GN+7&NR6,FS<:J8XT#.E^+R;ZS.^OS[OI5:>)79;
M\>"7//A\P7GP[PP$CG=RE]@P0WRBF'*"O<;!<,N#$-1B3<7B! Y'1"H;1. ;
M%9TG;*MO7@U1MM^3\EV6WG=#$_ J"C624S&B.^#K'8NRC&8#O[SL6-!H+,+2
M'+'KKBY2CN'$7O3C#<>W8_Q8X]>%1/RB,\EU3ZT8_X2>SELKGYI=1__N.-KG
M#DRP(O=I%T:M<=@9[Y3A7$OIDA*!4N8<]QI<HN];LV6#7)VF-/H/M$SGJ,]]
MH%*__$H:^]\!3K /02(6<CZ=(PQI&0S"-AFA%2"&,RMK'$^>I0Z/3K.<W&>]
ML27889&T%YA'&VT^/%-:*2YM),(5ZTT(9:1:[[FN-ZV??9>4"$YH0D*SB+BW
M'&D;/.)!)LZT=SR2E36F;EOO B!NZWJ]$?WH6V3:&7B9JW=DSYM'IT>UTF'/
MEM(PGE4<@H^ARP@* 6:?M*R/-T#^=7>A=^-PF]U;#WD9<YP'Q346FI- K6?:
M1&482(HE:I9#WGKYB/^.Q_N]@^VTTSR*?Q9FV]9QMMBR:US\3:[M6\!S_ULX
M[13)!6]NJ_KS^OYW:;3TA@;$<^ML3K1%ED2-- 6\\";X(-7*&J'C1["#A(S4
M[MRBQHK]UXFENKH'>A'XG]>PU((K#LAIF1)@>WFAF ;+RDW75EN-#S?#UP?;
M[/R3@S[;:033XMW<%_CM;0RRO?Y=)<QSYR<$1G!"7)B$7%01['%A:=14>:IO
M20&;7-.D5&0^"0;F!K?$6$(C5A@32FF23$S72-6:SG%-O1<Y_PX\/C [$$]:
M(*>U0YI+ZJ5WC&8[Y+@]0TK7:#S^^J')S#;L0U7<0N9NWQ:1S-NT5NS3*CR[
MP.'9B2CFM,/ XK#X.->2U&PM)Y+TNY45"00%T%R=818GBC_!9\[I*U>O%TJQ
M>_ULIS2\KIW2CI]^%X'=D:.+TOT=5&V,G]*6H;^A_#EPMP_RZ?CUAUJMS248
M.3*L>T<C!_&XHZ,8<ORW=3$:%R[##_T4B6NY %>WG.RC?6)SJ<]IRW;Z.3_=
MTYRE<>T"UV/*[P8QPY%@WS"[8W"Z/CU\N%I[?]LBE2L[NM;787%\[KKCYVVC
M8QV+S!1M14>2%<9V;!%D'P^LCYVQC>W9A8V?/,"(Q,093SSGSFH>)3C;V-B(
ML5#9AN&Q,B*?SN!H;.P2\"Z$9-:KJ%!B"MQ?E;M14NI1)$&#X<%9".Y>1B1/
M06.GF(W4<8J]E<H$!_]Z9B5VMC(BGWQ-I:/@ 3B&)&4*'(.$D6&Y+IP'9JEF
MQ%/[9$;D%+1\J!6Y@$AWF]T$.[*V=96G4!F2"VI(;AW7ZO8"MAA11:99/K"
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MX AVB40DQI@D-IAE*OV';@E3Y%L5IS8CAE&9IUZ$ ]JNU=SOAP'ZV9#E6?F
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M"C+!M>)\<Y2N<?K,X"RM'X<*C^Z)1U\FHR#&)Q8IEDA'[!$7)"$CM$'8B)#
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M2J"%":.<-9@PD[@%#9X8CY: ,^$9I9'/8,-5T+)@T$(FZ#@H(XEJ@QR3/O,
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MH^#C$XF\PC(3^X.CR$- Q$L7!9BK3MAY'TI5@%<!WM("WKS"9945-U]@&X^
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M/VR;>[5X>,YBI:@''IM[$(4.,8W[8039<RVH0T:IKT-##6="^TEBP]"ES?'
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M5/F]BY6Q!2_C4=,PG+NQ*,6=M-Y%6E>;.]&$)RQ*2<0,(TS$G"1!FA!K?&O
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MGVHK5!INFN1[CL-_-QWV60[O=^,]G=;7FDOT.V#SX0&%8=ZRLW__'45^JI)
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M%;DT'L(Z$"?+D5+P&K@)G;>>E?UQ3TM7 S<W$XUDK=0V$E%J<&W=VW6OR(=
M2P-/76,)253G<@2NU8\  C 8F/Z[__5<95CTJG^$MZ0P9!#'\AIN&%3.AK%?
MP*N%JR-9N (V,(;A9%S4M39G[\R&/1 .(!+,&7X>9QI^O+1#I_RRX2?P<ZOB
MA#T) J;MQ.TBP3WX%5!;E_B?,#UT#F6U**5%6V(\G6A%R8:^S0),JQV:[#(;
MH\L^=";)$+Z(Q@F2:CK+^F*_+U6MMH&W\OX"#4M SK$'IGA#B&.8//BD>-H#
M2#K.75U?1YQ,7@YAO###L=6](8#JI2LIC(Y]!N_/B^MZQ1I"UIQDOJ"19)PO
M.%K@HRDI *ZU/?&\5CK"@/ 33,-I\!/)A]5*T>Z<KDQ5NM357_[L-CM AL$R
ME"#QNJ(]@G0Y71>T+\NJ:F4^O,S=IHPM'""C18D.]+PZ:43GQ'N'C-E\%2M'
M5]:L[6?H0X\K>W9FI<('5[<7;BX /+WX^,HSP)-%=?'8K)+! G5I-L2?J@V&
MG_-BE+M=($>SPFU6-42ML'*Z!$YBKG%K"Y@%-Q9J Q^(T;P$V-/\9P(<#Q1T
ME6<1INLAO/\O.1C]^*;Y&99AD@*H5ZT$OL ;<5UJF8*O 3; )RK-CS(]&F%Y
M[IYTQ'=OJ"79PY%>HG#@30!TS?5R#&:KVS,!SZ)B$?L5_[:S0=G!J)]?6PL2
M.K1I!@  (-&\H!I*=>,E_ ,_@5%<-G)7;<# D(I+&/>+9O-KRE+Y: PL\\U]
M^;B"]*J&MGL:5L%>UJA1?P\79GB9N=TR](Z:*KYR^E#U<S88@=_KV/6':=G>
MNIVCER*<(6O/?Q"XO4$Z^*_&C?-H6'EP\'R13RY[LRN-;^?*$,_51Y_Z=+ Z
MU;#Q)W3I3+/;N:RR9OO9<MRPTCQ"XC/CZU&]W^I>"0"LBTS-RLN.<".QPE/4
M&RC T\+'-S$T8N"JGI^7\P;8D4+33= &+.;7!VV/+W6!=V4!)X?5'75MZ +T
M?LWU=;^+IG;S9%3YL7A?O:_G.F\6.?!:W2AF.M!E703TM%^G>@2Y:S*<268C
M7941A/=/IW#3C"LW?>4E\X91/8:FCOTX'SL]?*?^'4*;E(M0L!0\;LY4E/H:
M?!&NF. LXK=U:! K^T"-7GCGU,)O((*;;?<DS\RT/OWTEIW^&ZUKDZ08#@RI
M3QAE,9$VUD0%5":^ =<'ZQN')S>=XE'-GL\=]_V4$6&8A$*)U+#0"!&SA&L%
MIGZ<QM:8VQJW= O_D(4_?_UW)&#AF>(D3&'-F=&48!<-8(%8I#14DN&V5WBR
MFKKI-6O>&(Z@$&QE$WRGP<_B/O'Q7 2J?UVIR)FM,(<QEWENKN![C1I<U'ES
MRJVV1ZX0_AWNFT:7S)DMH%]LOW^R:MFVQ@8[Q_W-7F;3.0NWL56=-5MX)K=5
M\*<*F"'EKQMZ#"N.QYM!(\Q>T:@)H.*QBZP5J"B0\J!]3%Z_SAE$F[VIZR:R
MN<L2^BWO)G+O[;W:^WOD_6;=LV;2M^?I\L[SNQF3_G1=7WS.>]  ZT)K+E.?
MD9CJA# K+9%*<V)5&@L58.,"?WE/>8?>^R]SN0 S@&F,VNF65.8:/%0[=+-(
MSM[T4>#!2>"S[1?[]T_"I%6O?8(^"H](@\TZ7SRK/@H7SK2;M^B<9EEHV_CL
M&BR<+5NYM]!DNUT7=C_?)VR\L/O)[K[WPI/,L=7M%_9OU?=GF@]LPK"8TKV5
M)@P[;QG^O?R9,UO'<5[>JT'#7<ASKTX$W0<>[P-;*AA8G?L!%X"WD/>/7C7Y
M  ^I*+%Q]=0GF-_F!53736SS-NRM/*\E1:C#0"B=Q!%C?B)#9D,_L*$-1$QU
M=.>.U^_M%SN<V%^*?/!SCH%6[1I>_SPI@0JV>-O$G%Z["+HU%_+K?J37WG-_
MICZ_]=K_Z]LI.__SW_3\5QC3MW_#-U[SLV^?_=-?WP_@_NO3-[W/'S]]'"R?
MWSI]\_[3Z;=+_O'-'^SCF\MO9S"?TS>?P_.+?U]]_/5C[_SBW=4YO.-L\'%M
M PAW&D\$C$A?IH1I7Q')?8OMTKG0EC&JY-$K>AS[#RZZ\*!2,E,YZ?#E@/#%
ML(3&QE)C$LZDSQ,388L!0YD524I]AR^TP1?:X4O;\66E'@0SH=2:A<1R^ ?P
MA1%!TYCXFB9A',DD3*G#ER!N%[YLH[9CAU$'@%&^"4+* 9*,%LP:F0C&=403
M&0-2I<&MJ04=1K4,HU8J480R"(%K Y((7^,I-D4$MY0H%7.?QR$/ W[TBATG
M#V]/T=E ';XLX4N0@I'-M$U9S%A@$Q'Z*4TC:RB50@M5VT"TLX'V!%]6:F0P
M$4@+EBZ)?87EY*DDDL41T:%5::(TC4/C\(4^N-G%%O%E2^U&6[Y]A8=8'E)X
M\WXE>MJ-2)SK5#,NDB@,66I3D89II!4+P/1)$A'O9M>G YV-06==#PL)ZV9]
M9DB8!)P ^@1$2D%)(@7'BFFPOL'1JRC95FVM;;M=SU3VM%51DJ:QY3IF 0V2
M--"!,E;)6-J8\MWLB'2R=Q?96]GT\$4H+9:^C),T)BR.!9&1#4E,F8U\PWD@
M_:-7<;RM"IB[W/*XI8WFLY??,/&3(,6BQ3$LMA4V2:UOC34\DMR&W6[!G@GW
MRFZ!C96?:*8(%R#7+%$QD4EH2,PQ"=E27X7ZZ%5P#-C=4O%^IJ(9T2 ,!<B@
M8);1,$X$6D&H:ZWEB>X<[7T3S15'6P9@]/K6)[Y().C=("(2I)$D5@5!RJ0,
MI431#/T'=Y':HF@^DSR1WU__O/M.D>U&I$!PI1/FI])(@"+X4S.M?!X8FM*0
MTL[1;AOHK.E;P1FG<:@H,8J)RMA/8B6("&0862IC%B7@:+.6Y4\\>]F3L96:
M@JCQB+&42I'ZS 0)3\.4!H'L'.WVR=YJTTBFC5;&DB1,4P++&!'%DY0(6"BI
M=2)$*,#1#IZV:>2CY!8\=_EEW,0A2">/(P%*,T9%"@X82[0.5&1MYVCOF7"O
M.-J^Y#H,;4R,I&#-!\8G0B5@S<-?\%],"AIAZE!"VYHZ]$Q%,[42;2%J@U@P
M+ /)HU""OY3 8B9IJ#M'>\]$<\71UI&)F=2"@"B"W@6'A21<4Q*F,9?*&AVY
M]I/'/G_P'EA;(]IA*[WLNH92%]%>1*0PB#D55K&(<\:P(H4.A(TTF! IC\,=
MG6/H0&=ST,E6'6VLX:ZX840+2P%TJ"$RUI88+JE-L9*KK\'8#Q^<I-=MNV]3
M]J@.DU2'2H#J9X(%B8ZT'Z<LM+A;F]C=Y_BGV5=KR#=;Y)U,WDTF5QSPD 9<
M<J4(337*9,A)HJ4DL? -\R/LN<"/0/Y$0(,?6RJ77;3[_OU;HS *K;$!C2T3
MOB^H28WF'-RTR$1<=$[XG@GXBA/.661XD%"B6<H(DU8212-PPE-K DY3RJRS
M] ._4[NM$DT541T$H<^24##*I%*)C8U,61SZ1DBY>R>\4[OWE<H5_]M8IJEO
M8^*G&A/,5$!DRA41UEJ=^%$LXKB-:O>^H>Y[E<=IB4M^@76,O6%3".2N&Q^;
M3?V@3O=L..4]!VBI51@(%DF*@4>.3A*-+.-:),Q7<=K55M@KE%Y36T%&OO)3
M08EDU!#LBD0$#11)&4M3&L=:X+F?\#B.MY4;L#%./M:)PPZM#A2M LVECBE-
MHE2P.+'"^&"$2/ .--@@*>TJ->P96JULY22^C%,3^H2I #R]-$B(-,(2D[(H
M3I*8FMA'M J":%_0:KLFYEVK.W18>*!8R"-+0=#]6$@?-'DB#0W!BL.=,,Y5
MF'2[7GN&A2N[7I$"RRVT 0F83 AC,B))K WAOA_$1MI <4P]H?L$AAU</5.X
M4BE-8MR<YZ%A7 EA.?7!; LECU(NGF GL(.K!\'5RG9@&-LPX3HD$8NQ@$T"
M<!5H16Q@8A[%PE)ECUXEQT&\K438QT6K+901#N'3)I]@AX>'UA'>7<N>6YIQ
MGR\UJ6P6;7?]-F95C*L>, ^KH_N=-=I2I=[N"]O\PC,YJ-85-#[<8EM;+VB\
MMD]@9\YL;,Z<KSE19UB0QHH&A 4QAW]X0!3U+0D$@_6 90E2<_2*"]&BW.(.
M( X#(+9>D;@#B <#Q,I6=9S TFCMDP0\',)B/R+")"F1C+$HCGQCN'_T"OYJ
M%T!T)84[D'F<DL+W[E;<(=!&"+2R0:Q$:()4*"+BP"?,^@D16!,(?HSB- F5
M4=J5-8^ZDL$=?K2^9'"''X^+'RL[MM:&BEM&26IH0E@:&9($84R"V ]B%1JF
MN75GF_TVG6WN2@(_UVSRK9<$[MRB!]89OWCM ,4!R\5K_Q3F]3?E*95*2Q(G
M-G4MG, O$O"?2OA1(D/C)]C,B75'-5HE7%NO^=L)UQ:$*UL2KA",+,Y!6Z=<
M8) UBHE,E2!4*&%DX(M(8$Y(]&"%W1US;)V ;KNH;R>@#Q?0:='[1D CJ:Q,
MI2+4\! $5#(BE(V(E$R$,1@L(@&?G(4/3K;OM-\VA6OK97D[X=J"<"V;EI%,
MJ Z-)8S+F#!M0R+ WB<!HU0RJGDL*0A7]. .-BTX;;A?[FI76'<'A74[3'DH
MIKQ==5=MXJ>Q9)PD,?8&C346[HP4,3JB2J>21AI[@_('MZAYI##><Q6N;5?.
M[81K"\*U[*YR&4K#N"!Q@-6RP(4A0C)-(J6X\@.M0^W<U0.,D3]W =UZ:=Q.
M0!\NH"ON*F>1M#K&!FT20\@T!G<U-"3UP5ZQ<<1$XH-%W:H*FIUP;;^X;2=<
M6Q"N9=/2T(@E@?*)+W5 6&(B(J,@(CYGVD^9+R@6R&&\3=JO*T_[7+? MEZ>
MML.4AV+*NU5W-0F%G\0Q(X8GH+!I:HD( TYL($*E0YI($QR]"F@776V5<&V]
M_NRMR5)=H;O["]VR&YN&H6:I"HB?,#R)SU,B 1))$*4L2@U5EB5MK'3715[;
M66"VTXP/%](55S8T2E@I+ ''2(,KB_5A8Q,0$P1*V42)P()FY!%KJ8 ^4^':
M>HG83C,^HM MFZ/2M[ZV4I'4CR-P<34E4H<!"420TI1+Z6,^4OLTXP-KP%8O
M6SZS?@ 58DM[.;##L9??4.7ACJ4Y'D2G@SKYL16"[#G4;[W8;'=BY%'Q_G1U
M^T')U"H_Y"04U!+F<T8P"@ON$/:XIDE I6N'1Q_>W'J[B/O(!<LZH.N [A'K
MU'9 ]]A M[SE8P,5:"H444ISK$8KB%12$F%BJU,\>B04 IWO;RLT^L1 MTLK
M^)Y%;#N0[4#V$0O@=B#[R""[)OO$5YS+E$C?X&FF5!,IDH!8=_0X$GZLZFK?
M#\[H;@?(=D#7 =W3E\[M@.ZQ@6XE:I^RA(-B(A;4$V'"C\!M#B*B1,2P3 L+
M68P-[$3PX.A$"X#.;:[^<RSA<Z^:Z9Q-7$7+IF@K_--,82"+RVQ8C<5W9N'"
M$TNR8"(JPE2E >B(V.?*9Y%D06A"I3C,>ZW27RX<#6_463]SI6W/TZDT_%[D
M:39&:<"BTA^JG=#R(O\Y'SH"R;$U%S"2G_JY_KR?DM"W_WI__?%/,U(!BSY>
MO,\^?NH-SKY][,']V=F;L_[9IWX?GOOZU\6E?SIX#YS]O_WS-\#5G_3UV;__
M3H7D*@T3$D513%B$AR4BW\=36)K*!/[4[,BS !<CH/BXF-A=@:JK#'S1LX!C
M_7Y^Y7:N2T]ZQ<)J>WEZXQ:W-\Z;OY0%-+33W^576WIPMS>&]\/KC!V6%CVF
M&5_ _.!_',/@-ZHG3QJA=:(P%=E*]H 2?3DJ[<OFCQ]-5H[Z\OIE-G0S<P_]
M6$M'+<=X^&M)])QH5I=_O,K,N(<*YL2OE$P=X:B_7%\^<9>6@*2ZQH.3P&<W
M7O9/Z(W7OO=:ZI^$2:M>^_UKG(HV#?;6UT8;O?:6F->MV1_1RJUK#$T-(F"+
MQS2PQ&;AK%YAK3> ^WJE9T%DS7^KXI^O/M@1B*D"60[]XQLS0 ^5*&?PRUUH
MLB'';.AO@(;?Y61?9$,/WM4'V"]_V&"I;[2);HG?MF5QT=YY'M.DVQ#<@Z+(
MLUSX+33HN!,A'A73=INE<1LE[K>AM&MB;+Z;=+?YWNKN[GJB78[%SC>+WEZ?
M_?J7__'3Y=5?G^">"W"%?SWK?7SSFI]^0Q?YKZ]G;_J]LV]_7:UL%EV\@^?>
M#\[?_)2=7ES2LU_?LK^"7SZ?OOG\[1R^__'36__\S[?AV:>?TFG8<:XJ9Z"9
M,I&."0\QQ2(2 4E\*0F/DR!.D\#G:;"E%(L[B<7FNT&5>'0@]&Q!J,M_V#,0
M6FEN$)E8A"D7) 2T(4RSF(B(64(3Q6)KF%$FV5+ZPTY :.OVX<8I#'<U.I\!
MT!T4UG5I"'N&=2MM%!*1J$"(B"0\\@D+@Y3(B!L2Z51:XX=QJ),M92'<PP/=
MK<W5H=%^HU&7*[!G:+3:E,%0R:D-B#(L)4Q$E(A$*!+YDH8&+&B6VBVE"NP$
MC;94_[)M^/-S7HRP.Z[UY-!X^;AGB]W7O]SUI%_<J>*!I$*&PL8J8$JH)#$T
MM8SZ41(E*E8;;$25,$?XJX.D74+2]>J.5!@8:;3TB1;6G:RV)%$26-BGU*0B
M2,"Y1P-))*O.X$KD[7&*&-W@[3U+R4LY37UC&+4Z86FD!!>:)6%H?5 IC*D-
M=E_N(GF=<-U%N%9V6C2@8B)31H2.,:4J28BB(256^3)@ 19VPYK6R6J1L*<5
MK5:7QFRS>/IQPF*8KT+8#,'YC&W,TQ!;+QH_Y6J##8-.,3Z)[*[L'/ P9(9&
M"=%A8D!VK2)"1HS$8.2P*.**6GGTBA]SNMJ/I5.,.Y<\QF1B8L$UIJG&B1&Q
M]%4:I#[E-A:4;N <=Y+W))*WXB6;V/J1B0/"I9"$,<M)0B4EH:^8,K$QD>88
MGV!)&R3O^6:JK"19O^B#;-R<CK=!$:2'[5WN'6@9'FK)31KZJ<]"G\K$YPPX
M/Z),Q8'0G1_=2M":GG6< RT_YDFH#1CXBH.Y$.J0)#YE)#0J5BH2093ZN+47
M/\B/WE6,X9G)[%TZM6$@R<I8Q,QG2C"%);F#,.5)(&@4!EUOBMT+XXK?;4*9
M,!Z '-H$_&X31T0D2I$HHI;J0%L_  N"TVTU:MN=/#Y6BL,S$_B[*.E['4OL
ME'0+<&'%IS=I8!*?!:"5 Q]P0<9$65#7)HP2JW5(*0]120</VI'KE/13*VEK
M(IX&B0HB/ NK9!)+F<#:,Q&%7 6VBY2W3%)7]@"T;X(T# /L6&,)HSPEB9:4
M6&WC2' _XJ' /8 PV%8WY"Y2?@^9?(?'AVPY]NS7$1Z</O:&=GSXL?)6N/@-
M[2M(>ELMP)D==]AS%^SYL.K*QUPJ&4:"I-2 E1 $X#UH"<X$& ])RGVE$CRD
MX6^KG$>W^?_T/GDG8X\J8RL>.N-Q(&G"2,!2\-!]08GRJ27"CV(C$F92;*7.
MMU5HMHN.MT!,'\^1[L1T.V*ZXC"S* 1#W ] ]X4)80); !B0U<A$@F(F<H(E
MH8-8M%%.GZ.,;<'S[63L465LQ=7UX]0:9241#(^H1#0DB;4AX9$0"4V#F,8^
MF)NT-3*VI3:2;?-ESS'/VWM1Q;)_>+A'^Z"^/BV&F$<,6N,*G.7#?'&WK<::
M#FCN C1KB@_$W&@>ZY2 ;\0)2X.4*!K!7X:FH?13FFKP:Z-M!<5VO<5]<(+V
M>&YM)VC;%+05YS;1(K%I0$D:&4-@Z7R2Q#8E@:510%7"H@ U>M!&06MU*\D6
M"^LC1HD[8=VBL*ZXN)$RL99I0$)FP<^-8DYD&&IBA1%I$BH>)?+H5:<46R)G
MC^?@=G*V33E;/?N<I#3QHX0 -&K" AD2J04GJ;)!"*:.5 $VW7G:WN9;B-C>
MLSC['F1]OYO/\EY71WM'=>PW2EEI \%VU1%CA2"M _AV),7/DG>P"<#/\-%L
M. &BU=D]^;#\R3%U==\%LO3;K^-" MVSH2RNWXWMH 0-@<,M\G[?Z8AJ5[3+
M!MJ:[EAS2!U<7N&G3!/P@#EA4G$BN([A+Q8+L+<E9Q3S]I)H"R=IMP?@VRWO
MTX'F,P/-ISR5\*A0V:'A7=!P]71#H$Q(PY H!?^P.%$D428E*9>QSX56U/*C
M5XP_<5^UG9Y]V-Y0=]2_LL/CO</C=AP:Z8S8_8#ME8U&&H#A&ODAT29FA(7<
MD,0/)5$LB64$4$ZE02.6QULXUMX9L1UHM@(TG_+43@>5^P&5JZ=_. M3%E$2
M*<P]Y+[!M$-+0D55&&@>:E^[-@G)$[?4W I>/K2EYDZ$V?5@!#G%3HFY=Y:/
MK9>@#'@X>R2\['O9L!(*UXQQZ)W9L?<!Y*#TU+4W*G(ST6-/R[&]S(OK:?_$
M:H(X;5T)J'M^8<KU&!AV2!SEI?O<R\+VX<XO=M88$=%F[JEZ+?W9(U+!RDW&
M-S^RTAEIB;HWLL_CDCVD2\2:^Q='[S!&VC1)HRB. QJR4&,?VI@QD)U(IYSK
M\&\ACIJ'>L6LE=:E):JP\C.1*4SXI>Q?R>ORZ)^+/ <,-[\(R_2KJ/3*=9Q;
M-]2;V;>1'H):^V4<-*H\PT:<XY<$?]DIBR/F>\%)A2*K_Y[*(5 ,&S3]U_\1
M 8U_++TW6:DG98E,C^5B7X,D7)>9:Q7Z"ZB1H88Q>:!\*C%Q][RWY:1?=1.=
MZ:)%PK5-XO-) 5,#Z>S#Z$=Y,48)_P7$W:,^^7\.";"#ZK651=5^T'MCM>L\
M6!$NI,<>:FUWYV"5BF:1BG*.BOCI=$I)O4#)8D;)?$K)$V^E6>PC?W$Z_[%K
M38GW#9?[,7K37HPU17Q'D<#=C:0Y6>6 S20[H4=/QC;Q&K:I1!B,H;PBSTL
M3%O@7<!0;S_\\=O%!^_\%^_\][?O7U^\.S_[T$K6/Q].6=BC8<6]Q]X5=@D>
MC/H6&P,CGTC]GTE6*1CD"=GOP\_C<@RKBKQGX>KX&E1C93<ZOOE7UN^3]_G
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M7D[ZSJ+8%T,B?%:^>-#Y*=L-MCTY/3M??#DBP9]\30Z+GD^SWW3@OOCO52D
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M'7=\!W;"5I:5W/?0/1J40"JKQR5&[<LZ=)#-APY:;V'29Q2<?T&CX,Y5B+I
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MT;[Q2GA"/74;LZS'LLL\-U?P:.U?&;!IA]G8DCZLM'.X%@,\N$N;%97N\I8
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M4G[Z&14753Z)E6_")RQ:0C0-=BKR;0 !D>,#B3A0N)1Y3G6UAZH_;< %QG:
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MP]0EAVST5KEFJ?@\=7FJE 'ET'Z )T_S<RQKLJL"V1VMY:&\Y;J#53IK,P+
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M8 D,*HWC5&37?K\FCI??]-:%V:K K A:K2ZOR@Y68\<SY$Y-=B\D/0JO?)Z
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MQN#N&R4;<7T;ZSIHNVZZ+^S$@'DC:;,[RS/>F,U>NB%X#;4V@;6^8*,B=+L
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MB2D\DM53R.]+.-P"J[0J9D]5+9S.8@OG[2!P9O _XWCB_?S_ 5!+ P04
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MR7_B^#Q)L.DE6:699KEQG0KICEZWX$E$5 (D21YCVR1.U/)/VKK=:E\78%5
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M]O.*7RD.006JH[:5U'A2N%610U*%*H6O6-[,&/&[F.^)TV&#.DM4I;V2S4Z
M_#GJ6.PK.S'Q%L +MY*5I?[)&\=4XX4VI3'VG7EA!)M3N *F/G#,.?A)UC=,
M TULJ#0[,L?4Z\S?&<.C^>D[<KGYR F!,32UJWB_W&8>KZIVRZ@R%*?(-8ZV
MBA7GS<I25\"FP:MW:(QTAX._/;OT#CG>XN#^/*MJ$4^:[<^T\&94U7'H2Y3"
M@^_<?%P1605L(',W]AX;N"M4I<!EFBP<+)S2SR6J0+7N+<).?(TT#Y>/8XNH
M*E"Q?Q!W78#.5I$*J$S]$[HYJ.3B9F[Q"E1EL^4PSO9$4Q=GPB^@JNI /L+@
MCO&QVBI2 7R"57$= U^PH**A.;MP!:IQS"TLAWLI/TF;BF:=[\ WM\@*&Q.L
M+VQBD?DZ3OC"9%_LZ @PJ( I'F?)A5G&CU_IR1=;U95/W??P!#J$MBIQ0">K
M; 5,1FTI6=G2HC6$ JH*5(QW>&?K[$WFT1MZX2HM&5PYL'O89]]#0T>16U4/
M1&U=75QE685<9$M%=!6PIB^@@D.6_)KL%*J VO'(O+EX@W]RB4-0G0-+NS&'
MP,&S<K050&[L@[B9;QMLQU91I;+*5J 2@F?"RUFF$*_*&&VYC1RA:YW1"P_<
M(<)C7%'?/2>_4S";%%%5H%>H+YK)=+@G#GW=*45N3%WA,@>]2]%6H))C,O->
M-0>7SRGS*"I0H<@S&]C0=U;A&=9XDV9BXV9"_]Q.NQ^SJGI^[!X,F$A]1U_
ML .UF#O:<G-?J>I["^+0!$1PF7+^=AQA1A4=NU3I6CJ'O@G/J <5C$&711M7
M>#05Z 'A0N<0? UZ?Q^TXF:"&6KL_6-T(LK/395G\-.7D(-WQ 7=<>",L?-B
MZD5C,Y^F @!FW<<4]K'"X\3%E!6JX#&2G_$]A,&+L>D^A\'LV0U)?TC^M4B%
M_0>_]TR+%5VR5[C]1X#!3]X!% YH].1&UCZ1$;$L\-/ J3'RUV3*<_C9VYU
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M3#"I[B)=GK,&+QD"\RGF)%36S>N5;M,P)+]K %#92D5]'#/72U%GG9-@R!2
MTH19;^M]MQ5<2V*5',5=';ENQ<FEI?-:V2 5B5#7Q*6"X'*T$"53/.8L.6^=
MY[-9><T3'"4_2MO?.#7>1-;MT+M6*> H6ETXCQZRU[F>,U776-'*XHFB99Y%
M,;(U#M:B;$A;8C-LM-=)3Y?K%QQ_O7;79RRJ(FJIOBV,^$4#SNH(1;KB;8K1
M^=8EFM\E:DC!:RN4M-5$V]OV:SQ>HX<7F0(/ J)2Q&/.G#8XE)")2I^LI']Z
MN7*_EYHA1:_-(-%&]K>P\!_/;XOH#?W<L(W$\9*^=O<0LW*5]=Z\G\3W'M-3
M8XE'<=>HP\35<UX3V%97.V>T59SO&43="RRS^7F-P4GX@HO]+\MY(-R/IV'^
M]8 H7CS@L:=<4F!*00Z&=I5(OGLP%)=EATRGS(5QK<^B>V2GF3V\HG'$97%&
M9@W:4"RBG*Z.G$X0G&;%.LO:9Y7?0\:0O.:AX/%!&[JA]EHFMG;<K.@X/WRL
M9]*THVGA*!XPHE:2><O *50@3; H2K2Q^:G#0[0,R=4>*J":Z+&M+T9<SF["
M_)RLD7.F%)T-"/(.R">0$H*("H+&0&X"!:"\].&//4C1D-STH2*LH4Y;%MV4
M\;+;/:7TQ0D9026K:U&: \^\!9&SEU:)(%5KVW?U].UWX7-=GDOS!4Z1/GHD
M2:9,! .%N !5 NG+8P1CC(K)99EZN'J]EY1'&O5^"QTW5/O=/7-[J3<TQ/TM
M>R,L,Q31@4^E>A8EUPM$ S8XERU'FWLH3-F1Y_RT[D!3)#Z]\ML5P,V)EY5P
M1LQK0Q&_!,YL]4"" B>,J%18'4,ILGD2P;7';]_WY#-.S_!"+_.0EG\?+S^^
M/%LL217SR]*C>E%/_^5:+J]0:U:K3;CCHC8JTK5'D0==>/)%%LE8ZY/(#<@<
M4IRV*5[NMD3I5UL-TY(7R\-2Z]6Z!%N<?QXG7!S/)GGD5? R&J0]A$A1BOB/
M2D=@4A07H] :6^>?/DS-(S?;?NU^*Y0T$G[[NXUKIP%6N9P*6C"Z$#6!,W*E
MDP')D*BP5JG4&@7?/<O9T@YPKZVW"$4)5T5K(09E(2'%IU(*%V+K*]T'[<#3
M[G;;ZOM.;?2&4FZ7(H:=S_$S.=#S,*$UM9=/Q]/Q8EG9_'P9([*$1$LTD'W,
MM2K7@[-<@E'H6!))2=WZ3&D]R@:UR[5&1P_*:=A5;H'T,34W_A69[LFLZ]MP
M05)"9= 9#4PP"<HX#K0U>\@BRF!TLDFT]AR_2= CCXE^+)BT4T7S-AH'IY_"
M>%[)Z;A,PGOGB$OM+,7GEIP SX2!$'@.CG8X@:WK2^^GY)%7N3\6'AH(O^UY
M\N&]!X]=_GPHF%).P**G$!==!)^)NLQ\+EK:>L;9QWGR@Q0-J;=":UPTU$4S
M?-"#KW%GF/7DIWOPLG/D+9$0/$+7^B,Z5G1SU_D& 0U/M9/!8%VLIMBY>B>8
MSWM=2]*9S(E+$79TJOVT+O/F&KZG6]0FTNT'JVNE*O,<<Q&2 1K::)4J#ESD
M"#&Z>B*=R?JVMG>/)G)0'G0[L/2KK*?,=WJ@Y6>OR4_??>8.,J$>QW>CM*BU
MFJPF:TV0Q8*,V=7V"/7:B2>007-?"GG:S4?Q/+X-;EO>]SZ'\:0NI]>S^7&8
MX#&FL_FJZT#^[[/%\KR)WTH^T1O!:0%!0LEIMY8"(CFC4$AP3K"@ ^_%RVM
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M@6[G7S='W -&.PEQ Z.=#L!.)[ZDY)Q\/P_-:! SIU%H3H1!RUW*D(G/N'B
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M143O2L3S#839AS :GBW^>#IP!I+@GI,H,TI-H&T1>-G_O37>,"$E%0\LF;T
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M/_1A.$(D,,6?S<\A[20\4@M:_Y&37H1X(ZCBI$?-U,D$+V6VUD$6$H*A&EP
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MZ5CZI?A-X[,_4*#+5!/N4L)-C41;SI$M;GO>64% 1*&=HKC9U6Y^=0O$/AD
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M8DV^O+R]FI]]%YKN98VSX=FBK^LGF,+D*PQDMN@B"T6<*CYS!%3_<HV"DLD
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M>2"@\M0ZLPT3M0NWY[@(Y_DX+0YJUOD=@<; 52+>\4BDU+@_ZY*NFZQ@GM'
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M;T_FY^=^\KW)AY\]2F<Z'!]\.#P*WP^;\R_-&.?X^&20FJ-WSAKI310WTDM
MZ1RR"=1K(\%I&X116J#)RJ6C7 UJ ND<TIV?ST>ED_HBW%,>/X'/97']"D=C
M%!T4>^[RS-$D[CUP1:(T#M5;HQEG<T87SBAGI;7"]Q#:W0IC]PNGX@3\%-[
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M$JD9"B.Z2(R*D>L$,8LV20=;#OOBM:!O4?=@A]Y0V-OXC%6!)\4)5[0T1')
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MQ$BHX9FGS$2$-COB7<]_Z3Q6D5O%>R 6&S6:6C">G<R_?&DFLY/OTW*$=A&
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M[X?K?;9C2*)X%\ 65Q?J:DVJRQ"U=X9S)YAKG5]Y#YSG[ANTTL3N2++<#YN
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M79*9;Z.ZF(JY :YNW:Q78]I71'M[O3U(A2V$ODM2!(Y"5H,/90G5ZHMD\,D
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M(N^B<<9!]B<X  H-:6@P1)6[KE3?!-MK0X/!6AQ2LOX8%>R:)J@CF18*H81
M=JXEE]!Y7W/;B@S9DM.8^G5D?0H-#;JQ8XCD.U<KWRZJQU*\+AJP*#HOA:B^
M3Y9@60B"G!\A3>NFF$^F='V0UC8O71\B\@YAF_N;+&2GN)+9 9+' 2IS 9X)
M [R4[#)ZXW+KA\&GU-UB&TJT$WS7BV-0IG1$DH@K'I+!.EDXDKL:+%';8Q9"
MHHNJ_?SP)U\ \S1,W\;J[Q 069^XO0FPUXJ95IK=N 3B,6K9:<5,%H9+I@44
M7J=:TVE/IS C,] )'0,:X42G'/BG73'3ARY#M-&!)M>#"%?%&YB3CD8$*%+5
MI:8,D6, S#KJ'$@.V+K-RTH@AU0G,TA1]W33?9R4.QC)]Q3O2)FRT2H RYR<
MQ.1X'>I36_GF*,A4BR6T?M-[&L52VY"@D;R[^,XKC;'YJ>>]S4IX!PDK22.9
MZ\$)#@7I&'3!2;Q=^]_ >5X+Y]7$O=?$;:7(#I7?:Z M]]4FX#K9LO<"VX\]
MVTR-F]%C"QWL[C!:@N0^8LR109PWPF.>#F O&.1L@T+K=);MNP_NG" /&+#[
MX<<0T7=\X'WWSU\D)KRPH0+GWA6ZD#$;H(4G F4T>$M':,EHF6S='7TED-T;
M*0V5M>9=]_&2[F"MOIW,SCZ5.B]IM@1DM&!$;Z2+DJY')44UG^D?-F>38M :
M5?/!(;=!/">U;R?A#CM^GOCV<3*>D*%&BZSY1'7M-VDIN#7*B0(FV9KVH2T$
MKPP4%F7@BAE>6I?E;H+K.1&CN1[6/I/NHWSS[8TLS##.EZ.V%H,!9Y.RTOK?
M02WGMM!V5]C95(BWJCR=BRQYE*[XJ%2PCELZE#*QUCNK?-B\RG-;E*W"3[/+
M[WZXFI8CM7%29I RUHBI<> B.:>)SEJ,2B@C^PWX7@&H\_3<H]D,Z\Q-YK-0
M$AP+LDY72#5G3P"&.M).%I6:S_[:!-<^ [+;<F/@A-SA>NA@VSV \<,HQ-'I
MZ.SGB;'.(G.&<!H%*K-0F^=ZNM2*L3R*2$[.;OERB>T%<>9Q^N@QQ.0"W>R:
M+-Z$TS!.^.4;XLHWM^L9#Y<O=]?:6RQ>X5(*D5R< L(Q1N8,^3V>VP2F8%&6
M<R5M\QR1;JO9?:9V:T8>B*8/)2%[72^>J)P)D=.Y77/[;!UU7JP [F)&7Z11
MS3-5#JN[V:'09,/V9P/4M<M.5YO@>M'MSX;H;>/V9X\0^BY)0;"X<;&V_U,<
ME$X1O"^^QBE5$)@=AM;]KYY$^[,>7!@BZRYYDO=4\BV?>Z).BN5 QZ&2J;X&
M(]F S$#(Q>C@3#:\M7VT :P#:H\V2(=W[.^V"NB1/+*B@YNP7JA">\$F'X%^
M92$&JP"S\"$;S0IOG5AVV"WRMN' M@+>4?[T95T)2E]2D ($%DGV$3KP5B?@
MW&1O,9$(7D(9X(%:H,U4UW4NQ:IBA VPO9;]#=;BH,*N1ZA@UV5_3B:O#=V!
MFM=V,)IQB/5=*@>3F).8.;8W1YY2V5\W=@R1?(\GP'L+CG1,B@OA0"1.JS8A
M0?0Q@LX,Z<),2F#K^,)3JO0:I+M!E5Y#!-_!.EUUX<ZW@1:YT,<5Z:U.O5"Y
M)K%D$D"R3A>+'DWK ,(Z+*\62GN5=<A;785KN7TV0=;)-EF/:C^621OM;4")
M+43?X?:Y!Z'T.5I=$)B)ALY6$R!P\M4*5PY-8#Z)UF_QNR;% _;(KCDQ1.(=
MN/#[%/\*H[S,BJK]V!:-V\ZGTSK[M<;9+_+J@O/:N=IC4UL!BED$+^NH<.:B
M0FL]IM9MH39'MWL;I95.)SM12 =SY2BE>?K1[^%GO4<)*?V7Z3GFBTC[Z#(E
M4T53J_,E6>\80!5%2).1D+765L:$&EL_PV^.[ME0IY-"UIXZ^\A[7*:\?<94
ML>3)^&U]<:2=DND7L\GI*->7Q^L"GI<W83Z;7)J0BR:3.\B$; ]V=[F1G05]
M*ULR,LDTRR%9<L$R#T$&5XL(R0X/6>JT>;9D>]P]\R<%^;*%)PM)ECJ.1D4(
M3&A@13$MD(X"U:\_:(?\R;GD+L^;GS<E>N(=%H/"0G0U$B#IU E6TUD7)4>E
M??&LQS"JM8 .+?MM"!M6A67;2+[37,.UX-XN6@8O.@1/,<SP%US\^T0JH5-T
M":R+=;J2\!"$5I =BT5&7^>0[Y(PZZ&^&"HUTM83RZOD=9*]9R!,(=\ORUI
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M4P*HK,EW-<8",LV8#*&8U#R(NQ&R5SNHL?8Z/#^LW =W\5X,^]T [ Z-HK5
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M("$H$1*'L43IXB"@W<#GWZ1WH\_;+';?K6=_)2\@6TDMKR,,L3?;_#J$<JK
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MB ;G+*\Y-%.9SE\DJ+6K3I]W^H%312.W.H)621N[>H*!M3C2><T!GNK,Q^%
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MH6<5 E1^%5J?;)DU97+8IM RO"%E5G[*"%5_63^_5;_4>Y+;@JS*97T9$,J
M1EP22!)E4J#$PS"5*(*>YS&)!/-\9%Q*?'QQYT9%K8A@O9-QP%W.>,-K<?$V
MBT&;[)KN"G1#&K7"H*MQ'>2HW8VZ.NLT1HW6H%+["FP5OP+;C^%VIA_#@&O
M67P4DU\:OO;',>R:<?2Q,KF4'$^(Z:\P1P?TZ(7G^+TZR/I4%[ZJY%W$2$24
MX@B&TA,0Q3K3D[(I8$*Q%T:21#BE%V1ZZG1E1!J39G=J"K55.59T!;<VP=,5
M(.NJ&M65G^ K%/E7 0Z;N%W]G)Y 52([/_6O4O5(Y,<O_^Q?D!VJ.SIF&YJ+
M$'^=+%"UE$TVJ)'2/AU!8HQ43]UN7B^]TQ%E>U,Z'7M^&+7H^Q)=N%/SW=N-
MFDP/HJ@.4CZ+]8)'GJ!I0F#,O0@BC%*U5Y$2HA2EOE#DXE&K,XZ^SF:WOVAD
M'73JV8NJ&2VXPFID:MC"]%V;:JV@5W50EZ)BJ?-@72^7^??*Z4OF!:AKUP&=
M8L<==YC Y8@_>KN:E$-,E-[G$:-W[,]+?EOFE"P_YVM1^N&[C5"HX>:"CP8X
M#GWN081P"%$4^Y#Z*8,$$1QYG,=A;)1-NK^;N?&'_TOX/T M+JCD!7PCM'6!
MS3>F/:">/UUP ]7(]/$"H JR%J4!D5L]<)GOO]W -M&^^31\;C:XY\'HV9CV
MO#S9AO*\ MV-H,'3 Z^4GTBVU-O(#WGQC2P[N4AT^9#=OQ92$BF%%T"?"P*1
M1P6D%'%( X)H$"HJ#:E5!B?#CN?&GENYH;(88*DDKRK[=-(U65Y#FPZ X:WT
M"+".S+1:L$[^)&6AO8!8:^'PJMH2'U<WUZ;=3GN1;0G&P;VV[?O#..I( ;@J
M"=)-D3&QB)DG0B0B&/BZJAC"RHA39 0E0F$0H,@7W*IH96]O<V.CJD*"&NTR
MXTT>]_K628I"[66JO'";DNN:Z/5!DF5ZN'[DS1C)&9XCT]"Q&I-7=8HV4,GJ
MCH2,(''$//U]34HW1FKO<XS92\.(Y6^"W^GZ"*+,[E;5[&G"4G!$XH!X$4Q8
M&#:!I"+B," D$LSC/O:LCI=.=30W.FGD!!U![0CC)*)F7.$"IY%IX@A$(X3[
MG /"$3F<[&927CBG[#XEG'U^&!N\$T7V1-95%6[MLJ-WR5^S\L\ZWL?W8Q03
M 7WJ^Q"QA$.,:0AQ''(D,>>$!3:,T-?9W%AA)RO8"6O'"[W8FG&#*\1&W\T<
M <NYHYT)&(XXHK>K27G"1.E]KC!Z9V"=D8T^?_DBFQ)*J[LFLV&YX BGPB<1
MC$4<0R1E +$^5_8"*5# PB )K<R'DSW-C2EJ076>X[P5%92-K):5,DZ":\86
M3B ;F2IV:&VE;%.*.KQ_.HN$JPH:)_N9MIK&.74/*FN<?6$8/?R6Y_Q[MEQ^
MVF9:0I$7^#(,(*%^"E$<>9!X"$.&TSCT19QZ6-C0PD$/<Z.#5L !::M.HV@V
M_R_"9NRK)2M8K"?\2=4=3?3#]B>=X"?5VY_8IQ\<-J&_K<FZ\L#[(O6QVX=E
M_KV\IF5U9[U(2"P1PP)2+"A$H=H:$#_R(4=^D@2(J*EOM3_HZVQNTWPKJU[*
MJA/)2EQE]#8"6\[Y7J#-IK\K^$9F@@N0LZ8%$T@<,41O5Y.2A8G2^[QA],XP
M"M%4I%JMW(P60OIA(A&"-)$Z3H]R2+ ?02R90%C]*+!5+?-NXW.CB#=Y4>3?
MJ\(G^69=KLE*%Z:UHX47X)G1P%!(1I[VG_+5';P5Q0.H#  ]]RL1W4WV8XH[
MFMPOFIYT,A]3:G_R'GW&/B/M^]4Z6S]?<ZZ&O:P(X4MQ4^1/F1)435S&$C]&
M,(FII]W&0I@F3$(:AYP1GJ(@2<V*7I[KRN:;G:;^92TM:,2] I7 "E;0BFR>
ME;87X_[Y[1*WD>?Z<,"LLM*:H#$H*VUOPY-EI351KYN5UNCY86NXFYB<RK'U
MMKFJ+[]LE+'Q23R)9;A@7HATE#Z4:9A"%" /$A)$T"/4HP$-/$:,@F\GDG=N
MEL961FUHZ*6U$A.$=K;&V(-L9K[,:.A&9LE389;?!X=9-F[^UI^#M:DUT2 Y
MLM[&EG92@W BZ/=MS*FZO7!]JD6HVO0;9W./8D(B%L,XP@@BM<+ E*8$>G$J
MA8@1#9#5EK.GK[FM"__/)E\+#AZUVU 53JEV\_J2]H$4?^HB3SK^)^-J)*O:
M(G5H%?BI9@O?TFVN;P@LF?\R8"=D[5K0JX9?_1&RS!E@XIHDC_3T.@1W6N63
MY-3SRL#S;W8O^&:IMM?_$-G=O9I-UVK/2>Y$>X-6^>655=;M6_%C_49I\N?"
M\U@28)) WXNPKL5'8>JE$41>& F/)HD?A58'XT.DF!L9O5P7M%FBEP16>YN6
M8)V#=[HVK.*K^C>6Y^>#!LKP8'UL^,<^<6_DUYBW&H!&!;"[D&\&HD[]#[0B
MH-+$Y7G\)4BZ.J@?),.T)_B7P'1PM']18P.J+ ?HFUAE>5%%;M5Q6T%;:QDG
M-"$QA:&?*&(,8YU!7 ;0PQZGR%./2N,2@SW]S(WZ@E_0_P"UL$UTX+LZ,#"P
M*#3< VL_C3D$:V2B.HV30]/*$(Z^ZL,];T]7@_B\"B\J$1L\?D$]8EV0H!#W
M8E567H<L?Q ZH\!GH79XM^3'C2BRG*O?Z[09XIVH_[N]WTYUZFZ&*$Q"K"N/
M"JZV:,B#L4\3EI $A=+J^.]RD>;&('697M952>WGM$[@IZ72ZN<J ;A>Q=?D
MQU\'E#J^; #-[*AIAV5DKJI'Y(4VX&,S(I_J$?E<CXC2:A3G!G=PNJR[?)E
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M*M3&2*O$%=C^?L .>\C0F)F.(P,^/ND88-WY]U:EJ\K!2JVB(JL-Q3$SP5X
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MBIF!-PG4([/XE[<?KT %];<.U%OIH<P+J.5_X7%U!8A4GP"XYO^Y*=>:(Z_
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M[>B@!UH<$(YD+&"2>MHO)4(P)0A!@7 8"9)@7Z>%,.=6-\!.P:]'8C>5K,Z
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M'[^^__W]YUOPYOWG]Q\^WH*;KU]^^WK]^S?+Q'U#Q\O,!)EB%$:_.6GE!:W
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M"L9)@HG"1$IE5=+'7?38".[ZN_Z77OG,%H#1>5%N:_5=RG59^?H_7+.KK6?
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M0_%;J3UX5]OQBZ8Z4$]);0O0QM2!&]64?!YZ2NQS(@>:FH%R(_N=(J<L20_
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MWAI<M,D:N+.%A=F'+2UL;NI8#%8N9S^*S,-MM9D[M?NAZ>Z" DD"F2H84%-
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MF9U]J1XGV8X=QS%U/9.J:?(P <U.&L:\JAC-I)S!A^T,ZBOW9OE!S_($;($
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M]&=V!<P#5A?ASK42CMNP?<R_Y0;L&\]JWUNO^Q.Z-=#$3;[J<*E_7?C&M:&
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M5+]7_+U+^/NQ[IVD_;U">U[RW^\P/5L![ 2JN\0=JG-*E84BQN7Y#=%_1)A
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M'^/438=7>3\P^=5V>6Q[<M;;KD!*?Z@51.F_[0*HX_N-\F2>=:-Y#L]?X/&
M10=0]=;@J5/A8K>W$2FD^4V&4#(5ZX!'*LAB$D.9)'$FB8RDVUKN*FNF]G2?
MV;$WB1;-'OW)1(NBQY:4G^F\XE1EB$EZGQ,57_/CYR3%%=<A3U&L;7G_$Q17
MV*Q.3YQOVG-#C7^38C.7C^I^L<[7/_Z>"VU%J2M4=>,LI88^:2#N_](\MJ#S
MNTVQUBO<5?'A1Q.2:5N?Y.I[SF6Q2VNCB4Q)&B*]/I5,!U9<0"P4@4G&&>(A
M2F/LU"MS,$NG1N4F<]F4Q!3 ?/_ 7=-6L^H(O'4*L!^@%H[;BL/^OL@=Q5F&
MFW_+';XIS.K W%\[44UGX\;^1&Y7X^:%T/@"_G@N%YJ#I$(.#KRO3<7![!QW
M^W%HN(\V*@<?L*?X,>>;UTV9!=J57[^MP8UX1C%&%(H,$8BR.(*$)Q)BE>"8
MDS!1TNDUXCC^U%X.+?/KOEL=%72.&LB.,V-'\ /B/3!MMZ&V*$+Z4E77>RUW
M[@F>+RUDQ]''54/N!\V1'G+/VUP;;3<AVRW_YR8O<D/)FG=;?RM?_3.*D,*I
M2B!+N$E98C$D,@UA1%(5"B8D9E8=./H:,#7Z:^PW3]HVZFV[<&.BJ=8_U#&4
MZVFVZSRY!KO^T1_Z/-L[\%=$K&[H>0]$+8=_I_C2#9SS8:/C?7H6Z]#BFSE!
MU_^YUS?^KI>]9N]C?4=7JQ_YXJ7LC#0+:)J)5(8P"77DAV*CMX!"!JF(591&
M@N+,24'1:M2I45]9Y&R6AZ4J@MS9[5BU8X6X'9]YQW'H8_ &PO*'ELDW@*Y!
M8S4HS?98UN."DJ\"'ZLQQRWU<8'AJ.C'Z</]N,C4;R_T5/[X^W+UGP^FY8]>
M]A8SB54FA$HAYYIW$(\4)"I#D$L4&9&7*,Z<%J"GAYD:VQCC3%G.6V6>&\><
M0=*.5*['9V 6V1IX QJ4:B-O0-D*U!]U=&/AB2O.##(J.70[>L@&%Z[NN3%E
M$I>+IL53PI-(2H4AE2B 2(8($L84Y(&&CQ">T8#;"#N=O+O3PSZ"%%,IW-\T
MS@*T--5Q[V@//,N=H;Z0#+WO4]HU1%^K4P[[VJO9N_>X.S&GW#K:9SEY4=\T
MDHZJLD9G6601CS""+(E,USRNG^2(*OV'Q"(C&0ZX<DL6N3CFU%[A'T\6SP*Q
M5\!9ZJ<Y5]1>QM\VN\,KJH/G<'27OGK,,.L!D+=DC,LCCIQR80W!<6*%_4?]
MZQSO241=UH"CE*(XP!Q&4:@C#DX0I#Q,(6.$I8R@.$%.ZPQ_IDV-V-R5([T+
M1 XP_W:,^3ZS.C"QNDO\C:KD-QSV(\@/.QHV&0'B?H"Z2!#W'*%G=Z#CW?3/
MVU181 6E0<0A#E-FFHVE1D4X@7$H,I;A6*E(.'4(ZAAL:F1^ZC#IBISD3ISM
M*-87>@.39G_@W)L'62#BJX%0UU#C-A&R</JHD9#-9_H1R*_Y8KG*US\>%OJI
ME,7ZJU[=+85FLY6DA?PHJ__.&$-(($T@ 644(DF9:1.I_QK&1!(2*Q8Y*=S9
M#3LU4KG[IO]F@D*PT)-M$FB7\[E9K.6U&XXK7DOP[?C%/Z0#,\V7?0P;N\MF
MP-IRT)@.?FJ,]]CBT TM3RQD.>BH?.0&Q"$S.7[:C:.$S&=5ENG3*YW/&Q:<
M96$<,H4%%'&@(&(XA9AE>H6;2(620''+[*4S]Y\:ZU0F@M+&;9*,'=&<0[";
M43S@,C!UN$%B30X7'#_! H7D/[\LO_\/_<F* /0/N^?^W/U&>< O.-,\R9<N
MZQ=6?*+YJCP\_U4__YM5*6WQ:27_N9$+_N/C\E4OBV:!" -"6 8)29&.*02"
MS'1%QEQR&M$DT"L4EYC"8LRI/=K&Y"HOY :TK 9;L]WB"1O4[8()SU@.3 <G
MH0-_5'9Z7+ XH.(I8K 9<=1PP0&"PUC!Y:-7:W1_S+_G0BY$H2.24L_WH]E[
M64DQ,Y+<298%$*- Z.@!<4A9DL(TYI@*O:H165^Q[K.#3HUWRFU/T5@+1&TF
M>*LVP$M%;V-_J>(M=(!.5T7YR_)?^PMZGY\5.UKRC?7 O+0O\;VUN%SA5(K?
MIAU>9?8@>M\70?(O_'U^R/=2 +\(0H<4^.7/7ENQ\46N/\B%5/GZ;EFLBS+[
M>5?MFO&(RUB%1F,PA2A%$:21PE &(6.(QD&4\'Z%&IWC3HVO3!%4M;3,.:C-
M!L;NJMV'V3Y8+_45B\+L5II4W.KLYZN^1+Z^S9<_RMC@OOQ1RNTMONI1'/=L
M;&?.CM &F(^!.:U=L6&FI3T;8Y466V'EO3ZC>]1W*LNP@N)\-8;=QWNN ?-%
MOI:?\^]2'.BXEO+WA%(I<91!%2297OXE"20\S:",HC2+21AC+%Q2(;N'<V*T
MT=I4YCO%85JG!R[D^@:HTA<X-\XX+@&[0;=<_7F#<F RJ@R%I:7@4+ZY\-PE
MP X57PN_[L'&7?-9.7ZTW+/[U!5=ZG*^EF7MQ@PA3I-8ZKB(I:'IETL@$YC#
M3%-,F,0\P,2]_]SV]E.+AG;650E)^<+(8E?]3MY6\HWFHNG$7BE_U!7]5R1B
M'^!M1R/]41R8-EH &LL\-X([\MAGB[?=S<=OWG;DV,FV;,=7]7W$2RF1WZ39
M&-(1OH[_2YD1;>\CF^<O90;-O?Z:F_&>\U=]R:-ZTO]:*,K-[ZH%0SC#<90F
M9N44)DQ %&08DI0B&."4"(52C!/D1@Y^#)L>K=0.F9V>QB.PW+I4[@!IPUV9
MP],TVG+.^),S.%N5+MV W02UO ([MVY XQBH/#-KM+9OS=&Z3\+S"[<WJO1D
MUL@DZQ?,8WKV?/^>Z\+E2N8OBZIHA_]X7M%%4=V_R9;\3=)YV>^1JIAB2DR1
MK,E@Q#B%+(PH##C.A&(R(Z&<+>2+R<5_=C@IM+; B@9(10-'=@Q)"?N)I.9!
MKP5G3)+SVC@TKWYC<M/-YIBD*S/GCG&?PUQ9+BW]0C_2,K,R&C16@Y;9^QGC
MC?$>5YW.@/E:@=H//.YJU!F0HY6I^QW<^VRT]4W*9AYS_9OEJHJD/F]SAWE,
M8DQB!J4,"$1Q*"&E<0ACD26Q"I64U*JUI_V04PL[VU:#6Z.BL6=WS]YFEO!W
MD]8PH Y,5N^*IWV/#O^XCM2JPPN^3AT[W*#J:-QA>:/1^G>X.=9NX^'XR9Z'
MM$8M^5E_5H_P,5_IL/A3OM#1L@ZC/INTUJ+\4\=B,O]>=A2AIB']^L?A&6Z6
MJ9 %6!,[51!%R&2\R1C**%&8DY@&D9/,E!^SIO8:*+V"YKZ@M/^F^D]=L.=X
M1NMGXBR/<$>?CJ%/>'<S83:/*Y_ UJEJ7HIF?G:.W8#&M6&/@;WB[>N4V(]1
MXQXB>P7RZ(S9[]W[,?C7U?)-KM8_3)['6AMB1+[>3(Q@#*L38FE@$FQTW"VE
MV6.0)(.,) 3R* VYDJFK%JK%F%/CWL;DFS(A9ET^]ENS;X Q_'(V;>\)L*-9
MS[ .S*&?EXN7^ECZ>;^GL/^L9 =D/+&=S8BC4ID#!(<\Y?+1ZVJT[Y:O3%-@
MN9&Z6G[/3:X:G;?$\Q\6.J"E\UO.EYO%NE05,6H4<[F6M^(?FV)MS-J*E,WB
M5(D$"0;C+.$0T5A'F$AB&&4LDBP2&(=.B<P#V3DULBN+T\IUXASP,FEMJ4!A
MWE;]2L)]3ZL='4Y@L@:FT&TA>LO%&]!R$K2\O &UGV#G*-AY>@-VOII+:V_]
ME[(/-!V>J^!]6_DN!?0#07VN]GZHX?J*RNY7V#XLZG&+740]HP3C+!$Q5/I%
MH5\020I)G*5F]X'S- AH@E1S>F;WBK 9ML>1V> [S)6-1IEINU9==*0&]H?<
MCKR]P3B6,NU1(;Y)-=O"NC/:IT2M/43>!&LMAAQ9OM8>A&,Q6X?/]MP?_;9<
MK9_EZO7#<K5:_FE.EV>A2H7*(@55&F&(>$(A3:(4LBC%1*91&H5.FD,GQIA:
M0%F:"/5(KT!(YMHH[P2&EON.UR$S]"9B"8HQ#WSL L5]^^^\V[[V\DZ,,.[&
MW'D7CW;9.BYU%]MXDKS<@PLC]IRO]>L,RSA0..0PY7%:]4:FB!+($B5)2@EC
M.+15VCB\^=0>X](HLQ8,HY_8WT!CKKW0QA%ZW<_QM9@,_ "[PN$DLG'.[UX*
M&T<W&TU>XYP;;6V-L]=<6SCZ42J],!%U^599R=AJY%OUCU*!?NLJ(S>/0P01
MT6L!_=A*R&(E%8FC,'7K<.,T^M0>\';E8FT^V"L$W>^/?5V#+YO9L7S/#X7Y
MT!& 5[BOJ!9U@,U[S:C-V.]4.>H R_GZ49>;])3"7KW01?Y?Y1;+W7)1+.>Y
M*/]RNQ!?]1A-PL^CJL\7Z?Q)_TNYP]NR97>J'RF!%.,)##*:0!20!.*849A%
M4DF!*0^YT[:Y;P.G1IL?;I\>GL#C)_#UM_NG^R_/M\\/CU\<Y:Q]SZ$=<[[G
MS Q,KFW7;L"><^7I;=L]0\!;!\'.PQ;_:OH=(E5CJ GPI6_MV[QQ5:X' O=(
MZWJH<?PIR_T]7W_[?;%DA5R5^UH/B[=-N<^ED<SG>=V9W-2_Z@7R!UKD17D6
M7R9^*TVAIC*><L%1S)@.D#,"$55<1\F(04HCK%\262R1TVMA(#NG]G;8V@:6
MF[)1]6?Y7<]:?+UPG8])M7M/3&"J!GY=G-,9_%-["=IN@LI/L.^HJ6NI706E
MKS=5,LL-V/KK6VMAV"D94)W/AY7OKNCG$6H;%4"?P_7M_<76NQX^G[?U#)G*
M1!!E$JH4I1!)_7[ H?YK%@4""QRE 7/JGG-FG*FQNC%SKP/5Y[Z-$\X!:\?,
M'N :F%E[(=6C7U<G#MYZ=)T>9>2^7)VN'O?BZKZ\K_;$VW)E<CA^7^3KV[_R
M8J84#W"" JBOCR!B)((D8@&,4RY"JA +,7$3D3@886H4L#40& O!'\9&QV?_
M&$6[I_XJ; 9^WMU@Z:&G<,9U;\((A_<?6>'@C'O'4@7G+O26@ZN7KV44T2HE
MNV6:2"BW73>XW71"7^)3J97EME&5HK[7^:<Q?X"^/VZX#9<#V37X>Z<V6@!C
MD;%H<Q?W$O<3 YF8_65A2N<?A'X?YRJGC>I;.?9*"FW+9_VO.JY?_]"_T.]M
M\?@F5Z6*:UD3M-,BF44!IR1*%42<(X@2PB!#",%$R9#'A#*4( ?]CU&,MGK.
MQY<,V9H+YF4NW[QV)[?->Q]GQKN9=SH3^)XY\#MW0=O?-GL;,7=#Z%N?0>WT
M#=A]$:H"SIWC4_H>V L)3.K[,)(&P42^%TXJ!J/-4X< PO VC*:=,!J<;=F%
M\0;MF1UE-/L?]!!2?-RL*HFS?"E*Y?ZB_/.#'DZ8SJUR453<DM$L2KB.++!"
M B*211 ;C08A)::2RB0, [<JB1Y6] @:ALZ6,DZ O/0";!9Z#H!LY/-9G<;S
M5J;Q[!1F3;>0LD-(X=@BI,^\669/#3078V51&S-!9?]-U3*DJ/\+2\/!5UKU
M-KA=K4QSRJK"C:JUGHY/RY62^7JS\EB7<06>OI*K>E@P;HI5?XB.$JVNN%5/
MQ83JZU28U"ZV-D,;><BR.< L""))0YY"'BIECL@5I$I$4"',%<ID1'C:0XVQ
M8\B)KJ7*3?^\-K0J(G:41>A V8[7K@5M'/YJK*QR0,U)20/:72=H[AH(E^'P
MI7W0,=*XF@>773[2.K#X2,_ 2[Z8.V^W;4\F7K(4Q6$<PRQ2J6F\ED"<Q F4
M<:)"RM) I$Y'*!9C3NU0Y>G^EU_OOSR#AR^?'G_[M4<FI0W.EH&17_2&#H0J
M:\'N^&7PY$4'@'Q%-A8CCAO)V$-P%+DX?+0OY91]PW_1:Y$5G9L=;O&:+W*S
MJVU$D._K!AB_RE<F5[. QB$2E$-.-0.A5$:0!$9L-9&!(+'^/W%2>7(:?7(T
M],M_IZ]O__/6E7M< +=EH8%@')R/2KMO0&UY=7JV9SMHC =_5.9[Y:8>L'EC
M*9>Q1^:K'K <,U>?FW@6B*X*Q!B/>" B 5&" XA4G$$J%(8!TH%4$F:&T[R(
M0T^R7N^BT*Y+A9XEXI>/G_SB.#!-O0>$GB2@G:&<BORSKT)&-X3ZJCZ/6(+H
MYI"UVK./(L/[8IV_TK5\5-OTY.T/N\BUCFQD0FF* Z1#2=.8-XQ"B*7B$$7Z
M%XF4:1@'+J&DR^!3X^BRL."[L=1Q!\P)<;M8<B@<!^;HQNRR3&];I[%7IN$_
M@.R#E:?XT6GH4</'/J <1H^][N%&6O(O_FWV?[[\Q],L#+(L02&'-%,2(B8S
MHP":0!4)FC!%6<RLFH=L[S@U>ODB_P3_L5S])ZA.(^^UG>:0RXYJ=CAU\T<O
M[P<FA2_W?P?_\?C;_P)/SX]W_PO<_Y^[?[_]\LO]#7CX<O>S1SXX\KU#@<5<
M6S_@^J?=@[V[QRA/ZY')S2-X_(LK*TRK9K6M[(7<+/M*6A:/NX(D?<&7Y6*U
M5Y_T7 LPAAFF*(,9BE*( JXC!93HF"'E2*-'E&1.D8(WRZ;VG)]^[Q7MND.S
MP=)VII] B[^YM8M)WF7&!N:F=C'I%?/3OR;4%Y:^JT"OMNM]ZCY]P7FVTM/;
M /WX_+,>L,HN>Y+K];RDEMM7(X5Y^R?5]Q'/RT>3OO25KM8_9DIDDLL 0XP5
MAB@C(21QFD)&8I*DB@2"QRZ<[33ZU'CY]F4EJR7(>@F*TGZ@C35MQQU;\KA-
M@AVY#@;MP 2ZLQOL#+\!E>F@MMT@7EH/2O/]T6@OU#Q1I=O8H])A+U@.*:_?
M3?K1VM]E_O)M+<7M=[FB+_++QBP)'E65&_:X61=K_4HVM-H4M:6AC!,9(HC3
M4,>@G.F?XHC ,*,4ASR(XR!S8397 Z9&;HW]D%8.@$7I0=D.HLJ[7.Z<<&,[
MY[FQ([PA$1^8\QK306T[^+(%NTYR;=E_ S[F\XVY>HCRP[XH>N) Y^%'I<&^
MX!PR8>_[].V'4/=5,*H_,J,!YZG4ZVQ"(6(\@D1A"6F$99($)(@P=R&Z]LVG
M1F*-;=9E?*<12Q52& 4P#G3DBQC58"F5PH2G48+2#--8([9<T_G B&V'F#IB
M=H3=%X>!R7AKEF?5IE/N>FO.T+KUR$T8CITZ;K9PXII^3-9T:?A*?YBU;]6D
M?#W#,6>)Y E4 NO@+3)="K.8PY3%B4)"AJ%TVDH\/<S4V&W;8N2M,M/M@3T#
MI=VC>SU  S_$6VQJ"V] ;:._Y[D; T]/]IE!1GW&NQT]?-HO7-U7<LB(&/%U
M6>9SI\.D%UG,,LY#%H@ !HSK]S(6%-*0"!C%2F8HB6.>9#,=8;&EO>[0\3 N
M7^KV8,-]M_>L!+PRTU5\Z 2>B1 4,R1@2)+(Z.$GICL-@E+_6Z "))B^@Y.*
MTW5HCL&A=][0LR/.:S$9F#;WOUJ7P.DAX'3>>V\:3B>&&%G&Z;R3QTI.'=?V
M#I%6&SK_M%S=+[[GJ^6BZN;Y>6D*T\O6>W+!=7@_"PAF09*9%8W)CR RA92R
M$*8Z9@IBGF4D<%H(V@X\-0K8LQ88S>;5=U=&L ;=.KSR#N7P 9<Q&:CE"NPC
M:JP&>V9[C<&<@/(7E=D-.W:<Y@3&B<C-[?/]".K?I7C1]_I-SJL4U6_Y6]WK
M/,U4QE"HPXZ,,HC"+( 8Z9](D(0$(Y32Q"ICZ^)(4Z.@VE#0MM2-@,Z#:L<X
M7J :F&).H31 Q_B+4'@BD?/CC,H:%]T]I(G+'[B*%S[*(G^IA?F,*BHU:SF5
M!#HN,0HT,M!\$"<$QGJ%%P8)3U#H5!A]>IBI,D++S%Z$<(BF$QM<@=%(5-"R
MT+O:;#<(?DG@<)#W8( SCIYY_,]=[=Y7\UZ'%NL?G_*Y7-W1M7Q9KG[,N(@E
MPV$*18BP>>@E)(R'4*6""!ZD@8RM"I+/W']J3WME(BAM!(V1]KTU3R'8_:![
MP&7@)]P-$J?^FAV.]VJQ>>I^HW79['"FW6BSZ[)A,VQ,IB*?15S)4*$0,AZ8
M%.\D@SB0%#(<I"%6)$U9-$1Z33GZU![WTJC^>G!NR-,T$XIG>CW%(@)1C(VV
M0Q;"#/%()!&*99JX[9(/AOTXV^>CHF\7;PV&Z, D[9BW5)H_?JK2'FHCYRE5
M8T\R26D/EKX92OLWN4*7]-MRKC]1W/]SH]]3#PL^WYC;?S7Z.#K"7*]7.=NL
MS8'B\_*+QF&Y6&M,]$U?'A::LF6QWF8+<A03AM(,ACS6K*=H!'%(]$\9C@,J
M18254XZZ7_.F]BZJ//I_>BB2^ILQ.Y)\OWD8F$7;COW?H'+M!FR= [5WH.V>
M28#?=Q T'@Z2%CH,^#Y%3_T9-[X>JG=@3TJE^A_%C>_+O!"]-/W]:18G1#%%
M*!0TEA!%40")H@K&4@113+GF;ZOU_>Z64^/5WW]^^MF.5%NP=!-A/V<')J_?
MOSP\WW\$3\^WS_=/U_/-L8\=2_+ZXHHBZK_LV*%UJU&>Z&/3FZ?PQ&_<%;%^
MF2\9G7]9KF41QA\W4ON9U H@*%19HI?1,)1(+_%8G$":X@PR%.NU-4LS9;=%
MWCW,U)ZP\.?XWT!E+BCM!6(C@;'77K&I ]3N9]$?5 ,_GWL E9 U*%T62G"!
MRU[8R@]L(PE:G8?/CX;593 ZM*LZ/CR:9M5E!]I:5197]RUCWA9/GU"4V:XT
M,&-I%"<1Y$10B*@,(9$JABP@24)5EM',J6.MW;!38\Z6U:YURE8HVZWG_&,W
M,)6V#+YIBU&UQ98'6'JYX>2M%MEJT)&+D%V .*X^=OIT']6INW]_F(DH$AFA
M##+%S$%'*B!.16J.+W& PB#.:&BO.J7O.#7RN/N6<_JRO$)TRL#431&]G!_X
MZ?_R'T_W0)MT=_O+XT!*4RV'>RM-F7N,J#35,GE?::K]"_?%SI-<Y,O5I_R[
M_ ])5\]R]?IY21=-J)G$2,0D@ 114^V5QOHECB@,L> TP(H&L=59XJ6!IO;D
M5;8"8RPPU@)C+C#VVD?PG<!>7O+X@FOH'=6S2/58]'1_%ZV7/;Z@&VGAT^/+
MYK3PL8&C8^G3^?'1%C\V3K27/U;7]UL W2U?7_-U*0Q7B@"WBPXDQQ&6.(6A
M*?) RL0D/!.0\)#A1 5!(H3+JJ=CK*EQ9LO44H2-6]4A."-LM^+QA-O Y'D(
MV4"E&Q9@>%K+=(TTZ@+&PN7#58O-1]Q3+I^,C%R^_M%$[U_TUV%&,AQGB"-(
M= P%$=>Q%46"PCB)J*)8Q)19G9N?&V!JU-#8N%W# &.E?=;E21"[B< '-(.'
M3DZH."5>=KG>*_/RY U'2[WL<J>=>]EY79_6*%6!_6^2R_Q[V4]X/E_^:9K5
M?5JN[E92Y.NR9JNLO.<_GE=T452U&K?B'YNB8I,9RX)0("(@#XA^W-,X@\P4
M5^!,<9JB@/!(VG7V]6>4U7,P:J/?QEZPWAD,Z,YBE^8@7J;M\AIMQ*D86<MC
MY]$-V/I45IQ67I6EIHW2AYZSEF?@]AWGS*7IR]AS-UICF)'FT+&#C$^X.[O,
M>!EHQ$XT/H'9[U;C]<[NK\]_S^=S[6N]?Y/R0"98![THH00B$J00,Y[!F(0$
M15@9.3S;O<2].T\MVJV-L^>^?9PNOW9Z>S_PVZ.VJ\?&WSX"]B3>&XF1N+A!
MI#+0#Y.>]+F#$/>O'XW73IK9IJ?3%_158OGG)M>$]BE?Y&OY.?\NQ8.>W,5+
M;EBOE'T_2+/_O9!J,_^<*SE+D41Q*B1,LM!DL6>&F!B'(99A)G$8$N4DQG2-
M,5/CLB-MXDUI*IAK6UUU6ZZ8(KM-O[& 'SP(K]P E1^P= 3L/ &5*S?@J":H
M<@=\[IJ<'L(OUZ/J30SF"E-&%HBY'K1CT1@/][Q.#'072AKM69I1)5F2PH#'
M 40A91!'J8)1@K#@$F<\E'VT0/=&F1HC:I/,#H60@#8+K=76WGZZH/NHVG+=
ME5B]QTX"57J&SJ]%_0N&GD3'LU[H_ACO(A=ZTLUS:J&G+^['"Q_E2M_*M*/^
MLC21-)U7729FB B,B,P@#TP1NA$,93A3D"#)XPBEG!*G'@_G!IH:.^SLO &+
MVE) 2U/=N.$LLG;TX .O@1FB#55C9-U[QA\17,+!$Q><'694.KCD["$C7+R^
MQXE)',91E7M1IIZ7B>=)6"_L.0H3%,8,4AP0<^X90Q(&$<P$40I11<+8*F"X
M.-+4:"'^61O[;Z#.]*E*'#Z6U0U)Z+!'W@FNQ7&%+\@&9H8NM'IL+G7#YG!B
MX N^D3:?>GWIW#;U;1#IVJOO_/QX6_ V;NSMK%M]H%](]76U?).K]8^O>B[7
MMPMA:HC?S+?E<[Z0#VOY6LQ8S (EH@1F2L80"9)!(IB".&-Q* 12F7"2$[X\
MY-3XM+'X!I0VE\E36ZO!'\9N4!KNV);5 GR[^,LOI /SK0<TG0,S>X \A6@6
M XX:K-D#<!BV.7RR'P5]V!3Z3D:*^)7EE?"@7C0N7Q;Y?TGQ(/1(N<KI=M.I
MV9?:;ZRJ?Z=?<J:3*J_Z4K1^5_8>G&6$D-BL#'F($XB2)( T"U.8!1PIR5$J
MTJA)BWFV9[-QK.^1/_,\ C%6G3H7RP6L[0;SOA6((WT+[/AT0I,Z#B<W#H.6
MQV6;Z]IGT':Z/A$ VY,#P^ MYT#M^0W8^0[V:BQ+]_VQ^[C3Y>D-,9+1H[YE
MQIV(PS?5R*/W;7CT72XV\I/&SB1]F]+4O^?K;W>;8KU\E:O[OVKU'F.C_K]X
MU@N .&!1A!(&E4Q"B+(H@RPR\CJIR#*$ Z6P4W%[#QNF%I*;<Y&"SMT;_+BC
M'V8J(J9Q$N4QAPB)$-(XPY!A3G0$H9(0A:[=J ;%?QRUS6?3M!(LQIL'NU?W
MP-@._!ZNK0>&6D%C/_A3.P :#V[ U@?0. &T%SZ;.?6&T%NO)W<+1FX%U1NB
MXTY1_6_5[Q6T54GX55(CD6 6<V;(WQ=+9GHDF5?DP^)M4Q[>:3STVZ]YF>I7
M8JT-6I0OT5]HOC!GJ97HG,D0*-^1^@W\MI+?Y*+(O^M;<>V(N6K&!<.24@%3
M) 1$)(L@I@1#19!(*,TP2YS:>;Z;)U-['=Y5%3WY B@C7_*]E"]9[<)W_8O;
MQ[L'-Y)^O^^)'=7_2\S^P"^,G5K-#6C!4+TRVD" "@FP#T6YQJO *$6<]=JL
MQ.,&&$3 3\;;OX$&%?,UJI;\>\" "IGZ:G_OH7>?7T]OL_?S8]1WXKM/U^&;
M]?T-<C_1_JHMT&8^;=[>EJOUTX_";+#^)LU?M$&_+_)U?9 8,R12J1CDM)3
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M?\@MUI^[4D&Y$4WF!$4(<RC25*]3HRR$.(D)S#)!1,0RPI'5L<^9^T]M+_5
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M[%AYC*7=<O ZA 9^LEO&W=0]U#UV?#KONJ\FE<<#C-NB\JR#1PTJSU_95U_
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M/"[*OB!E@#'+4)HP@K%F M.N(Q;Z?9]PO782" 4LCLT.MYL6D,OP5H_!J-I
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MDQ0EZSQDTMN6Q*J/K8]51595$#*<XB2$<4PXQ &5,$_B%,91AE&,8XX3JQ#
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M>=],R ,!RP?Z70IS1<'LR2G.Z GDSD'DED,6"D-!5QWE)N"HJPTJ#;VG[C8
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MG0-E/0!O^ZIF[![PK:@=_HR!@D*!0M2U"64&)[P549$QS:W;P#Q$2[^-AKH
M3A.I#\/<5//Y=C:=;;2@HVRX\EQEX,4R4%XGV@VU0Y<G\7'!K7*M':#'*>JY
MDU!G)U@;%0P"4C?&]"J#.IY>$%N7UG8V7?R"93:_?+?R(?R)BU=_DAA)>>-I
MF'];35Y^H#)6AV %SQE82+7CG*UVVB!H'3"EA)R)ULW4.F2GY^Y%W5C&82A_
M$$?S)8N7._D7G&+-YP5AT466049GR26U"0)+'*1-GJ541#'=7&K=(Z7G3DC=
MX>\PH0\@KERG?E<.*0L!:YLF<($1ZJ-T$"Q1KG0P03A1%&M]!-^LWG.;HRX0
MLJ=H!V!0R,&\,:];/23AEI =-(?,Z\PF)3R$:"S(G)4QQ+!*K8. G8GLN1U1
M%Q#K5E$#,$_?,3C*.J/7OK[68YZ(#P%<#H*"'G)4G2W6I]9E>]\1T/-;GLX1
MM). !V"GKEHJ7)4\7TM$"(^*&0^"UV1<[3[CE4 P.5O#T&IG6K=B?XB6[3#S
MK#+J3<0^ .-REX]?PF*<1E)'KBS/H!-%P,H+#;4T$4J=#\<<E]ZVKC7?2$B_
MY4YM=/P$<'87^ !1\W(\N5AB'FD*#).FD]5ZX>K)*B$ZE2%E56S10@G;^G!Z
M@)1^:YF.@IQ]A#X [/P-ZT1*S"=?<1X^XMN+SQ'G9V5=QGQVL5PLPW15\'?]
M1CQH48)UM!D<\8>,^..E *>MDJ-UC#<?"[$KC=O9J6=UU=>IFIX1#-?VV0JM
MBN0"DHL65+VC"DXET"X%8W3M3M7Z@>E.!/9[4':+E3V!N;OBAHO*2U-_C\<1
M3XQ[;RWY#5[1#J^5T(Y'L-9)5Z*M8S6.@\N'2.SW(!X",ILH[YD^V7F@=UJG
M[W>>7/,8CWEV8[Q]PXCUDJMN\O<(N08[CQZ#+!)\]+8V7A3@"EH@NRC06Z,+
M;UX6O!N)#5/[W*ZF$!<P*HO:=J ^NUM=2FCM"W/%VM8/?'9-[7=E!;O$Q2,9
M_UTD/H"S=YMFCQ1[C6>9OE_?8>)+7/_[9D:;0A%C3& D]ZL.4A T"4!8J4+0
M07/7^L;\<*H'TR:B<VP>6<,#Q_3KV9P<ENFZ+4OZ]F$>I@MBL>I]FE=_FJQ1
MD/_K8K&:3G+=\E1ITH$3!IQ(FI3 /#@C5\U<9$*M>#:MQ\-TPTF_=OG8>-QA
M.QP)' /?(N?U&RN65[]U/B.IXW(\7QFLRVJ'\PD)8X,8;"+W7@<%/'!=1X99
MB-%RH".1ZR*R"ZGUHYB.6.GW@!CP)CD6/ 91:?B8(%Z$Q:?7D]D??\7\$7\-
MX^GJ+K[0)GV':1(6BW$9IW!E/8A[;:R-3-+9'5(&%;6J]QW$O<Q">Z5S:MZD
MLB7]_;Z!'?".Z!0( S\L3KZ&\:06GM#9^3Y,\#VFB_FZ*>C][6]L\MXH 3[7
MH[$>DK[F)7THPB*RR-PQ3X==:._WS>Z P=\9  8._&N>1"Q"9HD0%8]TII4Z
M?;YHB)*)P(FM4DP/X6^_SX$'#-B]%#> FJ<-[%RQLE<+\&*=\BE[8$4I4)PV
MI(_6T2&4A/?*.HD=M%9LR<)@VC%VGL/I4_?#AOY6[#**SC4W$I!V-B@A.026
M$\CLM:?=7^N-C@?U9M ^1G?(/J'=7+<#<"D>87=$'E#A10?RB;@ 54IMPV-)
MJHC6Z\!ETJTO:QXA9S!-)?N$X$XZ>49##)ZXM>UVK,%^B_=T@=W/Z(.M,!]-
M2MPD#Q@YF3YO./FND8-(N22=.8K4?IK/46^R=TW6WTW/KV).5-%JS.#UJNVP
MKY9!,7!!IZQ$S%X=,S[;DNSG=7>^"Q(/O9 Y5,<#< *:I-=7MTY992UJ/36O
MQ52.60B%:= B.9*'EBQWTCRA >W/ZP*^*X!WINT?Z/:DIHI62ATI+YSEM,V=
M0B0!< :ACG$6-C)$3G[_4?/'>[#PO%(67:&^:]T/W,0_G#)?I269YMIF SEK
M#G2N&?"&.=!).8$Q".>/64[U*+'/*TW1%9S;Z?.Y%CQ_"M./N!A/UY/_NBUT
M?FBMH\2'6S':/AR\/UWQ!M0ZHJC-X(4U#I3@'B+Y V"$-($9$;EN/\9Z"\(.
MGWA[N<B'NK-&20D=)$.0TM/>U25 0)WK="M/N]DX5EHW*/R>@L$$9(VP<'^P
M[-[R'L!Q>TW]6B+54,^F=<^>_#E>C#(Y",[*"#8Q8L80']$K#XHCDTY9:7UG
MXR(W$300+.VAZ8= <[#8!X"A.SR\G'TFSW2$Y%CJ3/&6D?4Y*=:^*2):.L.U
MB[XDE;%U^F@C(0/!S.&*OOO ^V"I#P ZZQCE-ZQOWT99*,8%5Q"S-F2%:WV+
MSP*(<$S26,YTZ]O&V^OWW#[B<'7>?5NSKVP'@(L7-U/P+AD01F@*"'(=MDU'
MM.<)'"-^BB<;;%/DF;6.[NX1T2]"]M?GPR,&]Q#N -"Q8:[=)2,N)9$#G<E:
M" O*91(+XPXL$F,FLFAC:Y0\2$R_B=IF:&DC[ &@YB3GU6C%,#D/XWPZ?1&^
MC)=A<LD,UR)%XQ2$K"-M 300K$Q@<BH\%9:3;NVN/$I0OPG/9NAI)_0!(.@=
M+NE0QGS56^>2BX"UUL$[\"43%XD+""Z8VK!'"\=CEJ%UB+V9DGZSBLTPTT#,
M P#+24H7GR\F-1/V4 [TDC'OBK'UY3.J5$ Q0_Y=I'@@<JV4(;9<;-U[;VOB
M^BUF:F>&.E'& %"VN;CODA?- UE7S<&PJ$EB65/TD"S]T2<>N57(6I]IC]'3
M<Y>UY@%6,]D/ $?7>8HW9'E7G=Y'7D53@A 4!4B*#*3@$(4M$(H(TIK:CKGU
MI?%]*@92[= PX[>?@ < D;L/3DZG]S/J[V@OO)[-_PCS/)+):J9* :=I5RE&
M;IX7V4/63B%Y>=+(UF[1CB0.)#6X)R+NM]?O3#T#0-^MI,7]WEA!<>[)5 .=
MW.0:,&TAU.&&Q401<DS1R=8/A!^CI_>YV]T!X>%4TF%:V1MA7U:/X6@OS9>-
M#L*[LMKKH1!SN=33 G1-BRA9:DVE1#".V^)3SJRT;Y;5@O+>QWH?#;L]:'HP
M*-^0U%OOWY%FN?#,.& T"E3)Y LGVK2!1<\Q4G3D6I=%/$A,[\/#CX;%-OH8
MP#%]JZ&;+=D8GQD9?2/(6T8%3I8,C'%$7TJ)O/4KBQU;Z'4YN>1HT-E3X@/
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M\X*^.5XN1IXGBYH\HR0PU7[.!KPF]RCI:.H@'I2IM6_]%$W]VM !PK*A"@<
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MVJ*O:*.^VL=Z//9I#6S(UL0VLB3U5<MX/1&D7F"N2OH^(CG/N/&\$D@^N37
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M?*HCW[_B>F;=V]GR=D8W1YX1$[C*EXJ($$3PD*42M .R2;9Y5>X3-/5KI Y
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MXCQ\Q+<7GR/.S\IJM7OO&W4N-A#;G)DZYCXD<+5+(=<F:HJ07!;-QVKO0^A
MF_OO@I^'C5%7"ANF:=JZ7_[>-FO7%8XY!*!#*W=(VW6)*2:!&:)BB8 <Z52-
MM2R&I625=#':UK.X>QP%<+/U-A+Q:QA/:[W;Z?3Z,<^M!SYD!%9WF--T:ULF
M[P/3Z,"9.AV(4RSOG(YD%P1WFLR$8MVE81HQ\7R'!NR"WH?-<!]8&%1R9Z,
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MXJHY_24C5F464LG D+Q0E5VATX*<4JY%XEYY+4+KV0 /$M/O:7M,>+711X_
M6LR7HQ>UE@SG)-WEMRJ7E;WWW#C#E(3L+(+"@!!,8:"S52Z[Q*W?JDTU+7 +
M2_2G&QP]M':_,W^/XJPU$7O/L'F'7ZYFRUZ!_RY+5SLL9@J09 !F+4G(24W"
M*0BEN) T?:7O/@O:"TM;$]3/\==&Y[.N%=!S9N$%3G ^7GZ[-*,Q1E;0"3 R
M%5"!B Y,*/!!)FM9L3)L4VOV_:?VI_^.5#9K(K\!^#>/#A!&A3Z1285,&X..
M5#JC8S8)%+=<.IUYNEN]VT6+T6MZ^AT<?M2<0C.U# !B3PYUDED5%;(&H[.L
M[30I)*AYOZ@=PR"M-_'_'U.VVFM_U_E:NZAB;VA]Q7F<M;I(N2SI>"0&^1O6
M^!/S":T;/N+O"RP7DS?C4L>1R)PBQ:(\4:"@ JN,V@(R"A>L]$XT'_1\"+W]
M1GF=@?)H*NS9T3J?SQ)B7KRNLQR(R\5RO+R8TWE"/\@7:;E.DXRTUU:KF,DE
M-10B8Z(3HS@/Z QZITB<=R??;G3 MENMW\BO.:0Z$G//P/F5W-,W9)W/IB_'
MBR^SM:"N^;G%X\E\3MMFY>2.F!&!97)BC9-DR66L+SZC ^22J9@D\9>V@-$^
M:_?KIW4"JLY5T+JFMFDQX?O?S\_?K,KE3MZ\/GU[\O;%Z<F;T[>OS][]=E(+
MZTXFD]D?89JPS.8O9Q=Q2=;YZL7D_F6$+59M4$#8G/E&I8-G\X]A.O[O%3]U
MDM]L,LY7Y5WGMW@]*W2P$GWC,'E/WUGG3*_KO7),'FLK>YXC!2DR.0C.!]"8
M72 <&NM;NT!-"#_8;[S2VNO[6KOIL_MN-IF06O\(\SQ*P=0>U &$*&4]9]W;
MFA_@-C'#8O"F>6W.KD3V&[8<'Y'W7,E.M3J 6'H[!D?>9\Y1>M!%(BAF,WB?
M%!AKC&/.T ];C[S<CK*>"XVZA<=>8-Q)5WLC\ O.Q[-,NVV^;)/3F<^^DG,U
MFV[@;21B=C%D"^1*$T<I1MK!]$<N6*G"=$JV?CWS&#W]ALW'Q5PSO3P;6_>W
M^7A)P5TA]DKT-:\*Z%&01Q\RQ* T..^\-=((V;YX=C<2^XVVAVC]]M->_P\0
MU^_;[G)SF^<71--X66/&=2N,]&TU87NR5G?^KXO%<N7WC KS,6BI0$M<]:_/
MX&0RP!S33#*D_ZHG(J5VU/0;NA\'H3WI[E#0'M-_M,XDB]*"Y8$V8_01'$,)
M3-J8H\HI;5<_T(__V/RI]Y MZ$ZZ.M!_?#7-?:68KB9_'/0P=8]%CI! >HJU
M0>6+A!;D)CH# D4"E64!+^O-ME(>53$Z-'>R!I$ONIX\\R[\\1M]^)Q668R"
M4H7E5,"AJI6,R"&8R,'EXE-D0K'F-]<;"?D1\CZ[(.NNJ3Q<.P.(=ZZ9^-ML
M_O?3Z>H>:[$8L:1*2$: %5@[V:H$3DMB17!OI=?2-:\SWDQ)OW'T@$"VOWZ&
MA+)ZW;[XM&Z&07N%/%GD-@*O;RI521JB2Q%R+$5:7ER.K>> ;*:DWQAY0"C;
M7S]#0EGMIJ*8,Y8Y"X65""I$"R[E -YC"LP:@[KU$_G;Z_<;TPX(4;OJ8IB=
M;9YRI[^;T11NS6@B]KL+';99]0BQQ,[,#RJX,,AL=I:B6&%J*,OKBV]-(7/P
MJ0A6+..M79U!!!</CA5;%V4FU,$5[2%Z;LCV"TL221:$#T[G'&)RK:<D/4[1
MCQ!N[(*U#;<LK?0U@+/Z)*6+SQ>3FF-\B40$"6S5A0')*EZU"_H\FR\O1?[P
M##R9C"4GV &R^F(Y^02^H )&1PMB2#JZYEG#1K3_"+'-(8CN!0.#R(@_R$KU
MEH) %G@L4%2H;_"E <>1O"4TGMC1TJ36@X4>H^='B(TZL;N[ZNIY>K:G]=D:
M+I:7O?8[]6<?7NLH&?&M&!V4[ZID8CPE@G21 12C -TKZ4%)$Z+7(4O?>A;]
M('S7*UV=3DF]>*.Q:\%05%EWI(&DI2/!5+](YPBHD&>CM$+96C!/T?0C^*^[
MX.U^1J"AS@;@P=ZQ%Z/@I ]9%9*(CJ \_2-Z1 B1*/?>,ZY;M\:Z0T*_"&NK
MWP? LX^P!X25M6RN1PF,DDZ.VSJ3AGL&2F<'42H$-#9;)Y5UJG60_0 I_<8B
M1\'.(<+OO_CK*5&-LE=>.,LA95] 853@76)@)4N6*143;_UN_B%:^@T9C@BF
M/<5_,)KZ# A6O<N/$0T\L- 10H%M6!Q4'(",*U\AQY,E1,<DR:BI!-*RPC4B
MO]><]<>( Z[&\,ZNC/IWV_):/$Z3<QJ%!4:;G7S7J"$6E\AOB"+1#QW*UOW:
MMZ/L1X@)=L'>76O:@?X&X.V]GLUQ_''Z71DOL4&2O'K1^_MTCF%2YX6,L$BI
M2_:0&)(G2_XKA-JF3H:@9;+*9-OZ^FD7^GI&: ?XN-NUM"ME#2/17/L6KC;T
M2I3G,Y(8+L?SU1[^!:=8QM<Q%;<FNH@!DJ_,98?@DQ5@M2J"\4+>3>L&ICN0
MU_-E2?= [$I5 S"(+XGV*>9+)FHB_69@$OE75QOMY05^F-%&K-[6^JE#[9<A
M,V.0ZXFB$D5G7CGZHV,V%A,,5ZUS*OO2VO,U2??X/(H2AQ1GIWF=]/@2U_\^
MG=:+G^6W]Y@NYJL13:^_OAV/8DX)2U%0<JV1<BC );$2JXC"(&>N?=9O&\IZ
M+D#[_]A[T_:VCB1=\!?%W-R7C[1$N_2,3&E$NGMZOO#))5)"-P6H 5!E]:^_
MD2!(2B1(8LF#DZP[U=4N2;9Y8GDS,B(REN'Q.(""^D'?RU[)IUN?A)G$#9(G
MPFV]"Y1GX$16(#W6852%.]U\_/W6U(W;.M6%^[B7HOI!XB,95KX6E3%<7'*3
M<BG<@DTVD.2, 9(DA^3J9*-BT<36^>OGZ-D*;<W73AX1;<V4T45P\KS +G4P
MFNF@@>LZ+(VI H[%NBS6N.@D9P+ET.#ZA:*MX&7_E>"UOT)>=8K[).?5K+5P
M]6Y:9O.OZ[*TP6:*/?>Y8PP3VYK=KI+>/!?%9<F J!$4UP%BM!I8L8+)J&)N
MW@?91=+[?B;TDZ5I-[.@N7!1*Y((&BU!117 29D@,K0.4PJ\^8O@MK3]*R2^
M=\'?TUM+&^JP@TS/D]S\]N."?L1J$4(4C'-N,K#D#2B;/03O-"1I6&*9!;I/
MCE7?>D]6+[M,6^)AVTK6/973,]XJ0^L="[D6=-2=&YP73B++\F86570^HTHJ
M<3; 9+"7R!H7;\VAL"W4]M1+SU!;[^#(SGGDF,";6@!2K 3/R?&FV,L75I^'
M1.M&E!=(ZA1B^T)@6XCMH8_QX06+ZV\42:S:6?[ V>=Y^/9EDGX+B\GBS6S^
M;4;Q&/X#0_[OZS"O'[U=_"(PLKHOO0A'UT%1$5RL^\=RYLD4BM/\SK;MO^7_
M^HDHN/FC7W"W/8'COMH-#,$CZ&Q\8%[>S!X/5W_,9]??5EOU)F62;G18KXF@
MA6+"1_#.1KHF$CDCY R#247)A+SDU#K__ ))O:P!'M"5:ZF4OC&V/J;<.T\'
M-8#/A8%BQ9"PZB)')02RDET(1T19#RY<4PAL#Z\]]-$;P,YF2_I]FDV7D^DU
MYG5%^&QZ:Z YQ>Y>"P=*2U$3I^1#D&$&)EF.JK"D;6M/;A?ZNH7=/M!X#G@M
M]=0!!I^\#M[?;0IA4F87"X(Q-:4DD@"GN !M=3&H,7'5>H3ZRU3ULJAUC,S(
M?JKI &R_'*1WTW1UG2?3SQN/4\V 3O+Z-Y><T6GBGDZO%1I4</4<ZT*Q4U V
MZN*$;UU*OB^MG<:W>V+F.4LXE ([ .HG3+]<(G6#ULDL36XJ*I8?5S-@SW#Y
MH5R$OT^6R_DD7B_K@;^8?5SIZ=)JS9U/'%Q2=-^DHB$*H^B^X2QE89-WK9\Y
M#B:ZT[BX#72/J](>,%RWNWTH?RUN-@=^B,M02R7?34__3E_J9J[?9_.[OL/W
MM5CM_23$R=5D^>-22<TYCPC,U.67IGARTXT$S%J[9*+FH74!X0'DCNL+#(W;
M(ZFQ \2^"=\FRW"UJNS(JQUR"[ICZOG,OUTOR?'^#UQ^#)-\F4U G9DC-XK5
M/G\F*9XLKA:M689>:\36@Q2VI6W<"M>!L3B(@IH!KVDUSA\?/KS]]W?OWY^<
MO?UP\8_33^_.+D[._GCWV_O3D_/STXOSL].+.H[TGY.KJ_UK</;X2(/*FT-9
M:U1O<_L-@NG#);?5H;R:+>H2R;LA'\8C^CI#R[-ZY68%/J(#'H0*V@NMF@\E
MV(G =O4SMY^]"2!]K$LZ6:UG<^1T>"<@*,W *$Y>",N1-Q^F\P0IXP8VPZ'E
MZ2J8_34QXF6ZF"\O[^J"[A^ PM4J_RJT(4.<#7FN=45&LAE"W7ZEF#%26Q:9
MWBHLH:_\!"7ZW3V,GB6@EX*6 U0[:RWGL<&"GQ^RL,Z9,N1%,J6@L$RW>)0,
M@L[D.9!00K99Y[15UN4EL#Q%P#A@::C866LICPR5DZ\4):=PF^I.=&Y,%!'0
MDFU5F04(62;R)UF4=8P)2UM%B2_@X]>OC@B*-BJ<-9%G!^':Z9^G)VO*A8K%
M2^^ **3[-E!0X8EJ*%(ZG9(T,K3.S]Y_?9RT57M$'"C7L6W#8A(^AE3S:VOB
MT19CT61P.9 ,K$@W3VXN9)12*H%JJQ?+E\S#PP^/DPX:R$(<)-41(5%7"_Z#
M'"R2SYIP;Y5#'BUX4U2M3/?@$J/K4QBCE%6&/YPILG&[XR\_=)QL2WM5'R:M
M#NZ"6W_Z/L^$3$;)C0>LS"L>Z#(+5H()(7H;B \E&E\)CXCHI>;J\&BCC9P[
M LJGV=75[^O5D,Y8.A.806AD-5IG=:./@TS'Q40E-3.M>RHWD-%'?F-/Q3X!
MDWVEW!%0+@W&S*W,(&6J>WJ4AA C!QV0D2$4UOK6+ZFWW^X#$GLK\0E0["31
M _>D4B ]7S;%P\?K>?H2%KC>_SJ9?OYY#7'BN:"DR]);'T#)5%^\0@&M#3+M
MJ[_<>JC>5H2->Q,-A:1VNNC(X+S[^BU,YJM'L[K"QA.M7)= @M$&E%/5$<L)
M$E/.HA!6;9<QW0-1OU(R[BOW4! Z0-K]C".Y96;3W)6;5>FW<U?H4#CT/&4@
MCZ]V=K  GCE>QQ5X(4K4(;;>H[(]=>,^7@\%L<9:Z<A472:=3<D8P,10NW:D
MA&@5!8VI2&-=[?D>*L@:=XC28+[1+A+M=X?\%D_\C<>)'/K%X]0U''VHR&[/
MUIF\(A^X(N,CZ/8C/QWHMQ8L2PRM9<+EH2Z'48L<LK4F(%($XF0]=%@+Y$4
M+(+"%&^4Y*T3 /\"10Z[H&7;(H==--'!1?C;]6(RQ<7B)/WW]60QN6\S<R4[
M7SQ9<?J+PCH%A?YMR,7Z@E%GWWS(S!.D]%GPL).:9^UEWBETZB_G>-N$K;B+
M,CD$47A]CJV5DI@2!(M.)XO6I-96Z46BQH53$]5O :?]]=#5BU>407JN-3 7
M:@;7DEA4ID.7$Q:=I#=RF!>OHP+@ &4]^?JUB^0ZL"6?\%O="#O]_-=TLKPI
M$Q(^9S*DD)QQ=< OKV-J)*!,TGC-R,"V+E=]1$2?KU^'7#V'R;DWH*Q/3,E1
M6YXD6&OKCB8MP3%GH,2 7)J"MK2>&+B!C''MRH&*?0XF>TAYY$OD(XF=9'9^
M_:VR<?YC49\#?^%I;26U%\;4IAXE5A6(D8Z2(,8PU($M@DGZSQ;WR[;?ZP@B
M^RAU-K"$1T;-[_/939O/&Q+G)EY"+MEB)">-8:9P,=4)"-[1Q2I2"CJ:(L,6
M:'GI.^/>.BU1TE2B(Z/C_'K^N=8HG<^NKE?3*C;Q0\Z:*2I:**$N)&>>?#<I
M"C#Z6>@3(=Z*+1"RS;?&?<QJB9+FDNW 37DWS76ORF2)[R??\5$NZK<??X;_
MG,U7<U96E[55CG-N!>14EZEHZ<E,2@,B,&Z3\B;EUJ_N.Y+8R[B0=K[PD#KJ
M'X+WS)V%K[>QI^#*<NLBG5FK:_V\AU!RHD,72A E&6Y;I\_W('/LA=@#PF8W
MB!ZLPPY@>C$/&2OY=ST<UB9&MP<(+AE=(U*!TS:2T!@%+LF&TGQ8TD,:N@;8
MX4J?-=1 !PAZ7/CIBT3R*C5H5M?(6SIWT:D(!BU3V6CCMVNK&KQR>K!*D"'N
MR\/DW!%0+F.)*-!0V('!4=C!,\12DR0*>=)".B=:-UOU51"[IPJ?*OG819X=
MX. V!_]F]C5.IBOAW^\\?)=)CI,R"7<&=YV?SR?3?#L89H(+^GO77Q];Y]6N
MG8LO87HO'*]+4HJ!I_B'K*E@$&4T=;V$HB-7''^8-6CV"'84!OLHS&V#Z'Z1
MT<&QN?=+KC;Y);?"N#0ZYE(';A<I+?DB*"&:Z, [IHP*20:6!@LBGB6MCP+@
M-E =0AL=@.R)JF9NG+'12K"Z#@U@Q(ISP8+42617T)OF^U@/J"$?O,"W[?U]
M@*P[0,S)UYHL_)_U9J>'Y^"2VXR1@B,H6 N32RIUD!8#I&A<NYPCUZU]O><I
MZJ/LMPV"&LJ^ R3=GX/'O#PPMZ=_KR>WWEWF4AJ&IDZTK&73*F8-WO  /+,<
MA G:ZN:ILP/H'7>G:N.K\%AZ>[6#]E:^YT/1G.%RT&KUESYZG(+UG5@?9S!?
MP<)9LA!MJ.DV+^A7!D%[&[DQ1FC3>@?&46K6Z]O>@Y_^Z/C=9*70I%"8-N"Q
MUF%GY2#J&$ KQDN2+K%87L#CUA_K(P'3'AD_OZBVEWH'M_/ON[RYB)RL$W7J
M#\4[JHY0=5D(X#;9NHU)9MWZ#6$'\L:!X$# F!U'2WT#<..;C,=$)S1D*+XN
M3,GT*V]$A,B*DPXUN;^M*UAW)'%<6S@85+:'Y,%ZZP"6;ZX7R]E7G'_"FY;<
MQ9?)M[M5.G24I?2IMF$J4(9.LN>*0K%@M5/9EFA:!R7/D-,MW Z'P<,QWXUT
M,G+-VUO\CE>S;[71/WV9SJYFGW_<K2SY&)9U1L5MF6<J(3JI 7F],H*LD7Y6
MH.M+,@]2*K--H\;6'QSWT>$84!I._AW8K(U!V9H5HY5-)"-(%@.=CZCJJXB&
MPKD1/#K,I?7SP3/DC/MD<$R;U4HG'<!KUQ*M:$HN]*_4X14"%!=(<18SD- $
M(U7TSK4.%X:HOFQN[XX3,@RIK?[!N/D<9^:#%QJT*,2BC;7X"BT8[:76$K.S
MK7?;_\O78>X$FP9UF+OHL .8/JH"]#*+P)V')'2]2WR!@+P ,R)KP8,MS=.2
MK[\.<R>EOU2'N8L&.D#0"Q4)MP.YR2GQ,@D0INZ ,\%!, E!!ALU%J&38,>M
M#NDAHC@VUMKK:N10]24WY?ZEL?A SC!+8)VKG?%&TZD*#)(KKFBB2[&7'K]V
M^N X$<2PKMMP$N_ CCT3=/TQKP4RH:!W+!5(P=>5Q"50E"4-9"T]X\IY]G .
M^Y")W15-_3XI[ F#[7.XN^ND XR]8.\?ERGXH"TR=&"%T^3"<@_1, 8Q65F"
ME";EUM[8KC3V&Z.VP>"@.NL"DQL.UF.N>'9&TU$#YX@7Q6P %^ID8N\L9I$*
M#^W+>[>AK-^+MA7^FNMG?]3-EN%JZ-OV)*7KK]=7==+PSX6&E[;.6)<H(-@Z
M?3U6#H4I(*(06>2L5?-TW>Y4CE,HW,6-W$)O_8RF?H;1,UQ>:BY<J.(SB@(E
MI:,!5[@!6XHP.JMZ&H\'1J)HG/KB+H"WJSXZ,'\;6'ALTFTQ=7I[ >X4.1)1
M>?#"TZ^D"-)FDT7[VN(MZ!JGAGB\"_=@W33#6]/ZX=_?G9V<O7EW]L?)IT\G
M9W^<_GEZ=G&^?V7PLS^N0<WO]N0VJN9]BW&YH3BS>!42Q@+!U>H-+NI<AVC!
M4!RJE>#2IM;E79LI.=0$U9_Z;DH_Z[J6T-\DA0QZ;F1PH"TG)Y(K!=$9"]I(
MXM8E[G+K%,<&,L;-_S?0^T.+<JBH.X@2?V5A];*F6)&*>0[!U%FCI4XL=3J
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M4?(ZNIEG<)D[X"'$6+C+XF$!P>:M(L]^9;NT%GLUX&@HTS[1<>LZY\"YBRE
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M=XT$WP.$)LO)YY4J/I%6YM_Q4A6G3)$:O*Y]= E=G9&K0:MLD3.=C&K_T/^
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MVZ68WM]50MHL0D"A(2EB4FE3TTRE4"!CM:^<RC! V\1.-([K?Q\M:3>HZCJ
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M@O[-];%FMABI$D)$3D)RJ"%FH<!Q+X(Q"GTQ@^'M,3TC3V-MIO4GX72@"CJ
MT]J"G_Z=5L.=;AE:VV*%6EAA';"0-*B4 W@I)&A/+HHV,I<<&N/I68)Z =2A
M>I\-I80.$'5[G7\*RX><Z,@\#Q1M256+LIV/$$704#+7Z+/*V/PZ?)J:D6?S
M#H6E1N+O $@/_85[[W);S^']76L-=S'6S0&09#7WC'OPD7Q,(;0ILN@D7.N+
ML2'YXQ9J]O-D?2P$= #^%4,4)\V^8=V04*.DRL_MIA.E*"0R)$NG+4G5^PQ>
M2P-!$9-),HNB]5JCYRGJZ['N:$#95&?<1FM=I'IN#_+?:P[6N=1+CN0QZY(
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M(:,@X\=\D=FQK<+XEQ3_\T?'L?G-%+^W_#KP9-^$;Y-EN*J[*&\]__KJL#*
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M'XM:5G17H8]84R*@A6'DSA@%+OD(AEN7$\4[J+:)")[YQ#CCX09R"1M)<F1
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M0R7; 2A>;'A*SCD6C 819!V67I_I62:DUT8H[SV/23=&RBMNAM['!QE$%1U
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MW;2P$X&=G(P-$;+-X=A$73UA\</X^]5\MI 87QWX3/K"?/0@3(Z@3%%U6D@
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M)=I%&=W!Z:9[32=KI>2@H[:@L-;O<<D@:HE6JI#-=KTPKZ66:">=;E-+M(N
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M"E66!'LBW1 =M 6DWD":MT#3M$ WQSA,L&2Z'(97#;?.UL,-6"9S3"AA8Y'
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MQ1">(,>4;G7()[Z$JG[#=UG^"['3/P%02P,$%     @ A#I;589_ <[X!P
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M+[M.\O?NQ.(XU%?L0V2X#LD5$1&HOB"!V,@[EZ9QS#V=-G:IV?X'G#++I',
MGZ#ZD<:L@-J%1/O\)(<(7&162\R-?RD#7IPV^+V4:+X_666>^)+_]?_+H6_#
MI><*<RK,\?R3$;2$"M=$ N*@TMME63(#?DL"&G(L+Z$^._1W%!?W8KX(754%
M$8K]+83%!0ZTL.2K1Y%8Y90X!.&$J5\]J+A%";=EAF# 7?+.5#JQ]:[5_X!"
M[TV]<HY"G!HDA#K&&#R'(4K\W=X*3O6@8S*?:C4%$K.<CZN;UJ:B/<@*I>>
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M'[Q84^CP9M$@W$.=PL:K-JL3Y=FVO1K"1WBL2K<YY#-OYU2?X5TA_];2V7\
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M,#(R,#DS,"YX<V102P$"% ,4    " "$.EM5XI)<-&(G  !-B0$ %
M        @ %3)0, 8F%X+3(P,C(P.3,P7V-A;"YX;6Q02P$"% ,4    " "$
M.EM50J%A-C1Y  !D404 %               @ 'G3 , 8F%X+3(P,C(P.3,P
M7V1E9BYX;6Q02P$"% ,4    " "$.EM5G4/KC+0J 0!/(@P %
M    @ %-Q@, 8F%X+3(P,C(P.3,P7VQA8BYX;6Q02P$"% ,4    " "$.EM5
M]LJY?RVS  ">\@< %               @ $S\00 8F%X+3(P,C(P.3,P7W!R
M92YX;6Q02P$"% ,4    " "$.EM5 H"U@'\$   0$0  %0
M@ &2I 4 8F%X+3(P,C(P.3,P97@S,C$N:'1M4$L! A0#%     @ A#I;54^W
M4W,&"   ?"8  !8              ( !1*D% &)A>"TR,#(R,#DS,'AE>#,Q
M,2YH=&U02P$"% ,4    " "$.EM5AG\!SO@'   0)0  %@
M@ %^L04 8F%X+3(P,C(P.3,P>&5X,S$R+FAT;5!+ 0(4 Q0    ( (0Z6U4E
MYZRD= 0  !,0   6              "  :JY!0!B87@M,C R,C Y,S!X97@S
<,C(N:'1M4$L%!@     *  H DP(  %*^!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
